Citrus Sinensis ID: 022575
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | 2.2.26 [Sep-21-2011] | |||||||
| P46573 | 412 | Protein kinase APK1B, chl | yes | no | 0.867 | 0.621 | 0.715 | 1e-105 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.925 | 0.665 | 0.676 | 1e-105 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.918 | 0.696 | 0.660 | 1e-103 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.922 | 0.688 | 0.658 | 1e-100 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.786 | 0.544 | 0.670 | 4e-92 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.786 | 0.596 | 0.682 | 9e-91 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.779 | 0.539 | 0.659 | 1e-89 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.827 | 0.494 | 0.629 | 7e-89 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.830 | 0.5 | 0.636 | 2e-87 | |
| P27450 | 419 | Probable serine/threonine | no | no | 0.833 | 0.587 | 0.58 | 4e-81 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 380 bits (976), Expect = e-105, Method: Compositional matrix adjust.
Identities = 184/257 (71%), Positives = 209/257 (81%), Gaps = 1/257 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MG C SA+ + P GA+ K + N + GS S S+ PRTEGEIL N+KSF+F
Sbjct: 1 MGICLSAQIKAVSP-GASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTF 59
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
LK ATRNFRPDSVLGEGGFG VFKGWIDE T ++PGTG+VIAVK+LNQ+ QGH E
Sbjct: 60 AELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQE 119
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WL E+ +LGQ HPNLVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR SY QPLSWT+R
Sbjct: 120 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLR 179
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+KVALGAAKGLA+LH+ + VIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHVST
Sbjct: 180 LKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 239
Query: 241 RVMGTYGYAAPEYMATG 257
R+MGTYGYAAPEY+ATG
Sbjct: 240 RIMGTYGYAAPEYLATG 256
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (975), Expect = e-105, Method: Compositional matrix adjust.
Identities = 186/275 (67%), Positives = 216/275 (78%), Gaps = 2/275 (0%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MG C SA+ + +GA++K KD G+ GS + SV PRTEGEIL N+KSFSF
Sbjct: 1 MGICLSAQVKAE-SSGASTKYDAKD-IGSLGSKASSVSVRPSPRTEGEILQSPNLKSFSF 58
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
LK+ATRNFRPDSVLGEGGFGCVFKGWIDE + +RPGTG+VIAVK+LNQ+ QGH E
Sbjct: 59 AELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQE 118
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WL E+ +LGQ H +LVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR Y QPLSW +R
Sbjct: 119 WLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLR 178
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+KVALGAAKGLA+LHS + +VIYRDFKTSNILLD YNAKLSDFGLAKDGP G +SHVST
Sbjct: 179 LKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVST 238
Query: 241 RVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
RVMGT+GYAAPEY+ATG +++F LL
Sbjct: 239 RVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLEL 273
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 183/277 (66%), Positives = 220/277 (79%), Gaps = 6/277 (2%)
Query: 1 MGSCFS--AETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG CFS +TD +SK +DG + GSS+ +S S +PRTEGEIL +N+K+F
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDG--SKGSST--ASFSYMPRTEGEILQNANLKNF 56
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
S + LK+ATRNFRPDSV+GEGGFGCVFKGWIDE + AP++PGTG+VIAVKRLNQE QGH
Sbjct: 57 SLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGH 116
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL EI +LGQL HPNLVKLIGYCLE++HRLLVYEFM +GSLENHLFRR ++ QPLSW
Sbjct: 117 REWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWN 176
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
R+++ALGAA+GLA+LH+ + +VIYRDFK SNILLD NYNAKLSDFGLA+DGP G SHV
Sbjct: 177 TRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHV 236
Query: 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
STRVMGT GYAAPEY+ATG + +++F LL
Sbjct: 237 STRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLEL 273
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = e-100, Method: Compositional matrix adjust.
Identities = 181/275 (65%), Positives = 211/275 (76%), Gaps = 3/275 (1%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSF 60
MGSCFS+ + + + N K S G S S S+V+ +TEGEIL + +KSF+F
Sbjct: 1 MGSCFSSRVKADIFH--NGKSSDLYGLSLS-SRKSSSTVAAAQKTEGEILSSTPVKSFTF 57
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N LK ATRNFRPDSV+GEGGFGCVFKGW+DE T P +PGTG+VIAVK+LNQE QGH E
Sbjct: 58 NELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHRE 117
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WLTEI +LGQL HPNLVKLIGYCLED+HRLLVYEFM KGSLENHLFRR +Y +PL W +R
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLR 177
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ VAL AAKGLA+LHSD KVIYRD K SNILLD +YNAKLSDFGLA+DGP G S+VST
Sbjct: 178 VNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVST 237
Query: 241 RVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
RVMGTYGYAAPEYM++G +++F LL
Sbjct: 238 RVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEI 272
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 157/234 (67%), Positives = 190/234 (81%), Gaps = 2/234 (0%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
PRTEGEIL N+K+F+FN LK ATRNFRPDS+LGEGGFG VFKGWID T ++PG+
Sbjct: 55 TPRTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGS 114
Query: 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 161
G+V+AVK+L E QGH EWLTE+ +LGQL HPNLVKL+GYC+E ++RLLVYEFMPKGSL
Sbjct: 115 GIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSL 174
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
ENHLFRR + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD +N+KL
Sbjct: 175 ENHLFRRGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKL 232
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
SDFGLAK GPTG ++HVST+VMGT+GYAAPEY+ATG +++F LL
Sbjct: 233 SDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEL 286
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 9e-91, Method: Compositional matrix adjust.
Identities = 159/233 (68%), Positives = 186/233 (79%), Gaps = 1/233 (0%)
Query: 44 RTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM 103
+TEGEIL + +KSFSFN LK ATRNFR DSV+GEGGFGCVF+GW+DE T P + +G+
Sbjct: 35 KTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGL 94
Query: 104 VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN 163
VIAVKRLN + QGH EWLTEI +LGQL HPNLVKLIGYCLED+ RLLVYEFM KGSLEN
Sbjct: 95 VIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLEN 154
Query: 164 HLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222
HLF + +PLSW +R+KVAL AAKGLA+LHSD KVIYRD K SNILLD ++NAKLS
Sbjct: 155 HLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLS 214
Query: 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
DFGLA+DGP G QS+VSTRVMGT+GYAAPEY++TG +++F LL
Sbjct: 215 DFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLEL 267
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 153/232 (65%), Positives = 188/232 (81%), Gaps = 2/232 (0%)
Query: 44 RTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM 103
RTEGEIL N+K+F+FN LK AT+NFR D++LGEGGFGCVFKGWID+ + +RPG+G+
Sbjct: 60 RTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGI 119
Query: 104 VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN 163
V+AVK+L E QGH EWLTE+ +LGQL HPNLV L+GYC E ++RLLVYEFMPKGSLEN
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 164 HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223
HLFRR + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD ++NAKLSD
Sbjct: 180 HLFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSD 237
Query: 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
FGLAK GPTG +HVST+V+GT+GYAAPEY+ATG +++F LL
Sbjct: 238 FGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEL 289
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 156/248 (62%), Positives = 191/248 (77%), Gaps = 4/248 (1%)
Query: 29 TSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGW 88
++ ++S S S P E+ + S+++ F+FN LK +TRNFRP+S+LGEGGFGCVFKGW
Sbjct: 101 STTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGW 160
Query: 89 IDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148
I+E+ AP +PGTG+ +AVK LN + LQGH EWL EI LG L HPNLVKL+GYC+EDD
Sbjct: 161 IEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQ 220
Query: 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFK 207
RLLVYEFMP+GSLENHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRDFK
Sbjct: 221 RLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFK 277
Query: 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFT 267
TSNILLD +YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TG +++
Sbjct: 278 TSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 337
Query: 268 FECSLLHF 275
F LL
Sbjct: 338 FGVVLLEM 345
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 159/250 (63%), Positives = 193/250 (77%), Gaps = 5/250 (2%)
Query: 27 NGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFK 86
+ T+ +S+ SS+S P E+ + S++K FSF LK ATRNFRP+S+LGEGGFGCVFK
Sbjct: 94 SSTTTTSNAESSLST-PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFK 152
Query: 87 GWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146
GW++E+ AP +PGTG+ +AVK LN + LQGH EWL EI +LG L HPNLVKL+GYC+ED
Sbjct: 153 GWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIED 212
Query: 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRD 205
D RLLVYEFMP+GSLENHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRD
Sbjct: 213 DQRLLVYEFMPRGSLENHLFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRD 269
Query: 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLL 265
FKTSNILLD YNAKLSDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TG +
Sbjct: 270 FKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV 329
Query: 266 FTFECSLLHF 275
++F LL
Sbjct: 330 YSFGVVLLEM 339
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P27450|CX32_ARATH Probable serine/threonine-protein kinase Cx32, chloroplastic OS=Arabidopsis thaliana GN=At4g35600 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 301 bits (771), Expect = 4e-81, Method: Compositional matrix adjust.
Identities = 145/250 (58%), Positives = 185/250 (74%), Gaps = 4/250 (1%)
Query: 27 NGTSGSSSRVSSVSV-VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVF 85
N + G S+ S +S + G++L N+K ++F LKTAT+NF+PDS+LG+GGFG V+
Sbjct: 42 NSSVGQQSQFSDISTGIISDSGKLLESPNLKVYNFLDLKTATKNFKPDSMLGQGGFGKVY 101
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145
+GW+D T AP+R G+GM++A+KRLN ES+QG EW +E+ LG L H NLVKL+GYC E
Sbjct: 102 RGWVDATTLAPSRVGSGMIVAIKRLNSESVQGFAEWRSEVNFLGMLSHRNLVKLLGYCRE 161
Query: 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205
D LLVYEFMPKGSLE+HLFRR P W +R+K+ +GAA+GLA+LHS + +VIYRD
Sbjct: 162 DKELLLVYEFMPKGSLESHLFRRN---DPFPWDLRIKIVIGAARGLAFLHSLQREVIYRD 218
Query: 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLL 265
FK SNILLD NY+AKLSDFGLAK GP +SHV+TR+MGTYGYAAPEYMATG + +
Sbjct: 219 FKASNILLDSNYDAKLSDFGLAKLGPADEKSHVTTRIMGTYGYAAPEYMATGHLYVKSDV 278
Query: 266 FTFECSLLHF 275
F F LL
Sbjct: 279 FAFGVVLLEI 288
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | ||||||
| 255584865 | 410 | Protein kinase APK1B, chloroplast precur | 0.922 | 0.663 | 0.750 | 1e-116 | |
| 356501055 | 392 | PREDICTED: protein kinase APK1A, chlorop | 0.928 | 0.698 | 0.750 | 1e-115 | |
| 255637885 | 392 | unknown [Glycine max] | 0.928 | 0.698 | 0.750 | 1e-115 | |
| 224112765 | 415 | predicted protein [Populus trichocarpa] | 0.932 | 0.662 | 0.770 | 1e-115 | |
| 356501057 | 390 | PREDICTED: protein kinase APK1A, chlorop | 0.922 | 0.697 | 0.743 | 1e-114 | |
| 356551743 | 399 | PREDICTED: protein kinase APK1A, chlorop | 0.922 | 0.681 | 0.741 | 1e-113 | |
| 357492229 | 418 | Serine/threonine protein kinase [Medicag | 0.932 | 0.657 | 0.721 | 1e-112 | |
| 449450018 | 401 | PREDICTED: protein kinase APK1A, chlorop | 0.928 | 0.683 | 0.708 | 1e-111 | |
| 224098423 | 368 | predicted protein [Populus trichocarpa] | 0.793 | 0.635 | 0.811 | 1e-110 | |
| 359478936 | 442 | PREDICTED: protein kinase APK1A, chlorop | 0.932 | 0.622 | 0.702 | 1e-110 |
| >gi|255584865|ref|XP_002533148.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223527043|gb|EEF29229.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-116, Method: Compositional matrix adjust.
Identities = 208/277 (75%), Positives = 229/277 (82%), Gaps = 5/277 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MGSCFS + +SPL +GA+ + K G+ SGSSS V S PRTEGEIL SN+KSF
Sbjct: 1 MGSCFSVRIKAESPLHHGADPRNRSKGGHDVSGSSSAVPST---PRTEGEILQSSNLKSF 57
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
SFN LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGTG+VIAVKRLNQE QGH
Sbjct: 58 SFNELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGTGIVIAVKRLNQEGFQGH 117
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL EI +LGQL HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY+QPLSW
Sbjct: 118 QEWLAEINYLGQLDHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYVQPLSWN 177
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+R+++AL AAKGLA+LHSDKAKVIYRDFK SNILLD NY AKLSDFGLAKDGPTGS+SHV
Sbjct: 178 LRIQIALDAAKGLAFLHSDKAKVIYRDFKASNILLDSNYRAKLSDFGLAKDGPTGSKSHV 237
Query: 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
STRVMGTYGYAAPEYMATG +++F LL
Sbjct: 238 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEM 274
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501055|ref|XP_003519344.1| PREDICTED: protein kinase APK1A, chloroplastic-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1081), Expect = e-115, Method: Compositional matrix adjust.
Identities = 208/277 (75%), Positives = 226/277 (81%), Gaps = 3/277 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG +SK K+ +G S +S SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLSSKAS-TPSVPPTPRTEGEILKSSNMKSF 59
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 60 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 119
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFRRASY QPLSW
Sbjct: 120 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRRASYFQPLSWN 179
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SHV
Sbjct: 180 IRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSHV 239
Query: 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
STRVMGTYGYAAPEYMATG +++F LL
Sbjct: 240 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEI 276
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255637885|gb|ACU19261.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-115, Method: Compositional matrix adjust.
Identities = 208/277 (75%), Positives = 226/277 (81%), Gaps = 3/277 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG +SK K+ +G S +S SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLSSKAS-TPSVPPTPRTEGEILKSSNMKSF 59
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 60 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 119
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFRRASY QPLSW
Sbjct: 120 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRRASYFQPLSWN 179
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SHV
Sbjct: 180 IRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSHV 239
Query: 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
STRVMGTYGYAAPEYMATG +++F LL
Sbjct: 240 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEI 276
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112765|ref|XP_002316286.1| predicted protein [Populus trichocarpa] gi|222865326|gb|EEF02457.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1077), Expect = e-115, Method: Compositional matrix adjust.
Identities = 215/279 (77%), Positives = 233/279 (83%), Gaps = 4/279 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIK 56
MGSCFSA + +SP NG N+K + K GN SGSSS+VSS +V PRT+GEIL SN+K
Sbjct: 1 MGSCFSARIKAESPSRNGGNTKYAGKGGNDKSGSSSKVSSSTVPSTPRTQGEILQSSNLK 60
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
SFSF+ LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGTG VIAVKRLNQES Q
Sbjct: 61 SFSFSELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGTGTVIAVKRLNQESSQ 120
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
GH EWL EI +LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY QPLS
Sbjct: 121 GHQEWLAEINYLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYFQPLS 180
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W +RMKVAL AAKGL YLHSDKAKVIYRDFK SNILLD NY AKLSDFGLAKDGPTGS+S
Sbjct: 181 WNLRMKVALDAAKGLEYLHSDKAKVIYRDFKASNILLDSNYRAKLSDFGLAKDGPTGSKS 240
Query: 237 HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
HVSTR+MGTYGYAAPEYMATG +++F LL
Sbjct: 241 HVSTRIMGTYGYAAPEYMATGHLTARSDVYSFGVVLLEM 279
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501057|ref|XP_003519345.1| PREDICTED: protein kinase APK1A, chloroplastic-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1073), Expect = e-114, Method: Compositional matrix adjust.
Identities = 206/277 (74%), Positives = 223/277 (80%), Gaps = 5/277 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSF 58
MG C SA + +SP NG C +DG + S+ SV PRTEGEIL SN+KSF
Sbjct: 1 MGCCLSARIKAESPPRNGNYHSCKEEDGLSSKASTP---SVPPTPRTEGEILKSSNMKSF 57
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQGH
Sbjct: 58 NFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQGH 117
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWLTEI +LGQL HPNLVKLIGYCLEDDHRLLVYEF+ KGSL+NHLFRRASY QPLSW
Sbjct: 118 SEWLTEINYLGQLRHPNLVKLIGYCLEDDHRLLVYEFLTKGSLDNHLFRRASYFQPLSWN 177
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
IRMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +SHV
Sbjct: 178 IRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKSHV 237
Query: 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
STRVMGTYGYAAPEYMATG +++F LL
Sbjct: 238 STRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEI 274
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551743|ref|XP_003544233.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 412 bits (1060), Expect = e-113, Method: Compositional matrix adjust.
Identities = 207/279 (74%), Positives = 226/279 (81%), Gaps = 7/279 (2%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVS--VVPRTEGEILLGSNIK 56
MG C SA + +SP NG +SK K+ +G S S+VS+ S PRTEGEIL SN+K
Sbjct: 1 MGCCLSARIKAESPPRNGLSSKDGNKEEDGLS---SKVSTPSDPPTPRTEGEILKSSNMK 57
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
SF+F+ LKTATRNFRPDSV+GEGGFGCVFKGWIDE T AP RPGTGMVIAVKRLNQE LQ
Sbjct: 58 SFNFSELKTATRNFRPDSVVGEGGFGCVFKGWIDEQTLAPVRPGTGMVIAVKRLNQEGLQ 117
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
GH EWLTEI +LGQL HPNLVKLIGYCLEDD RLLVYEF+ KGSL+NHLFRRASY QPLS
Sbjct: 118 GHSEWLTEINYLGQLRHPNLVKLIGYCLEDDQRLLVYEFLTKGSLDNHLFRRASYFQPLS 177
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W RMKVAL AAKGLAYLHSD+AKVIYRDFK SNILLD NYNAKLSDFGLAKDGP G +S
Sbjct: 178 WNFRMKVALDAAKGLAYLHSDEAKVIYRDFKASNILLDSNYNAKLSDFGLAKDGPAGDKS 237
Query: 237 HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
HVSTRVMGTYGYAAPEYMATG +++F LL
Sbjct: 238 HVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEI 276
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492229|ref|XP_003616403.1| Serine/threonine protein kinase [Medicago truncatula] gi|355517738|gb|AES99361.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 411 bits (1056), Expect = e-112, Method: Compositional matrix adjust.
Identities = 202/280 (72%), Positives = 227/280 (81%), Gaps = 5/280 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVP---RTEGEILLGSNI 55
MG C SA + +SP NG++SK ++ + SS +VS+ P RTEGEIL SN+
Sbjct: 1 MGCCLSARIKAESPPRNGSSSKDRSRETGLSGRSSGKVSTAPTAPPTPRTEGEILKSSNM 60
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
KSF+F+ LKTATRNFRPDSV+GEGGFG VFKGWIDE+T P RPGTG+VIAVKRLNQE L
Sbjct: 61 KSFTFSELKTATRNFRPDSVVGEGGFGAVFKGWIDENTLVPVRPGTGVVIAVKRLNQEGL 120
Query: 116 QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPL 175
QGH EWLTEI +LGQL+HPNLVKLIGYC ED+HRLLVYEF+ KGSL+NHLFRRASY QPL
Sbjct: 121 QGHSEWLTEINYLGQLHHPNLVKLIGYCFEDEHRLLVYEFLTKGSLDNHLFRRASYFQPL 180
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
SW+IRMKVAL AAKGLAYLHSD+AKVIYRDFKTSNILLD NYNAKLSDFGLAKDGP G
Sbjct: 181 SWSIRMKVALDAAKGLAYLHSDEAKVIYRDFKTSNILLDTNYNAKLSDFGLAKDGPAGDN 240
Query: 236 SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
SHVSTRVMGTYGYAAPEYMATG +++F LL
Sbjct: 241 SHVSTRVMGTYGYAAPEYMATGHLTKKSDVYSFGVVLLEI 280
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450018|ref|XP_004142761.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] gi|449527906|ref|XP_004170949.1| PREDICTED: protein kinase APK1A, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1047), Expect = e-111, Method: Compositional matrix adjust.
Identities = 197/278 (70%), Positives = 232/278 (83%), Gaps = 4/278 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVS-SVSVVPRTEGEILLGSNIKS 57
MGSC SA + +SPL NG +S+ +R DGN S+S+ S S PRTEGEIL SN+K+
Sbjct: 1 MGSCLSARIKAESPLHNGLSSRYAR-DGNDKGNSTSKSSVSTPRTPRTEGEILQSSNLKN 59
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
FS+N LK ATRNFRPDSVLGEGGFG VFKGWIDE ++A +PGTG+VIAVKRLNQE QG
Sbjct: 60 FSYNELKAATRNFRPDSVLGEGGFGSVFKGWIDEQSFAVTKPGTGLVIAVKRLNQEGFQG 119
Query: 118 HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
H EWLTEI +LGQL+HPNLV+LIG+CLED+HRLLVYEFMP+GSLENHLFRR+S+ QPLSW
Sbjct: 120 HREWLTEIDYLGQLHHPNLVRLIGFCLEDEHRLLVYEFMPRGSLENHLFRRSSHFQPLSW 179
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
++R+KVALGAAKGLA+LHSD+AKVIYRDFK+SNILLD +YNAKLSDFGLAKDGPTG +S+
Sbjct: 180 SLRLKVALGAAKGLAFLHSDEAKVIYRDFKSSNILLDSDYNAKLSDFGLAKDGPTGDRSY 239
Query: 238 VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
VSTRVMGT+GYAAPEYM TG +++F LL
Sbjct: 240 VSTRVMGTFGYAAPEYMITGHLTAKSDVYSFGVVLLEI 277
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098423|ref|XP_002311169.1| predicted protein [Populus trichocarpa] gi|222850989|gb|EEE88536.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1036), Expect = e-110, Method: Compositional matrix adjust.
Identities = 190/234 (81%), Positives = 205/234 (87%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
PRT+GEIL SN+KSFSFN LK ATRNFRPDSVLGEGGFGCVFKGWIDEH+ A+PGT
Sbjct: 29 TPRTQGEILQSSNLKSFSFNELKAATRNFRPDSVLGEGGFGCVFKGWIDEHSLTAAKPGT 88
Query: 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 161
G+VIAVKRL+QES QGH EWL EI +LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL
Sbjct: 89 GIVIAVKRLSQESFQGHQEWLAEINYLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL 148
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
ENHLFRRASY QPLSW +RMKVALGAA+GLAYLHSDKAKVIYRDFK SNILLD +Y AKL
Sbjct: 149 ENHLFRRASYFQPLSWNLRMKVALGAAEGLAYLHSDKAKVIYRDFKASNILLDSSYGAKL 208
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
SDFGLAKDGPTGS+SHVSTRVMGT+GYAAPEYMATG +++F LL
Sbjct: 209 SDFGLAKDGPTGSKSHVSTRVMGTHGYAAPEYMATGHLTAKSDVYSFGVVLLEM 262
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478936|ref|XP_002283646.2| PREDICTED: protein kinase APK1A, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1034), Expect = e-110, Method: Compositional matrix adjust.
Identities = 196/279 (70%), Positives = 225/279 (80%), Gaps = 4/279 (1%)
Query: 1 MGSCFSA--ETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSV--VPRTEGEILLGSNIK 56
MG C SA + +SP G +SK DGN + +SS+VS SV PR+EG+IL N+K
Sbjct: 1 MGVCLSARIKAESPCHTGGSSKYVSTDGNEQNSTSSKVSVASVPPTPRSEGDILQSPNLK 60
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ 116
+F+F+ LK ATRNFRPDSVLGEGGFG VFKGWIDE ++A ARPGTGMVIAVKRLN ES Q
Sbjct: 61 NFTFSELKMATRNFRPDSVLGEGGFGSVFKGWIDEQSFAAARPGTGMVIAVKRLNLESFQ 120
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
GH EWL E+ +LGQLYHP+LVKLIG+C ED+HRLLVYEFMP+GSLENHLFRR SY QPLS
Sbjct: 121 GHKEWLAEVNYLGQLYHPHLVKLIGFCSEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 180
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W +R+KVALGAAKGLA+LHS + KVIYRDFKTSNILLD NYNAKLSDFGLAKDGPTG +S
Sbjct: 181 WNLRLKVALGAAKGLAFLHSAETKVIYRDFKTSNILLDSNYNAKLSDFGLAKDGPTGDKS 240
Query: 237 HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
HVSTRVMGTYGYAAPEY+ATG +++F LL
Sbjct: 241 HVSTRVMGTYGYAAPEYLATGHLTARSDVYSFGVVLLEM 279
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | ||||||
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.820 | 0.572 | 0.719 | 4.8e-94 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.911 | 0.691 | 0.647 | 1.9e-92 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.915 | 0.683 | 0.648 | 2.1e-91 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.918 | 0.636 | 0.597 | 8e-85 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.918 | 0.636 | 0.584 | 1.9e-83 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.718 | 0.430 | 0.694 | 1.4e-80 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.772 | 0.503 | 0.663 | 2.9e-80 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.718 | 0.432 | 0.699 | 4.7e-80 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.769 | 0.550 | 0.655 | 7.6e-80 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.715 | 0.545 | 0.674 | 1.2e-79 |
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
Identities = 174/242 (71%), Positives = 196/242 (80%)
Query: 16 GANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
GA+ K + N + PRTEGEIL N+KSF+F LK ATRNFRPDSV
Sbjct: 26 GASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSV 85
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEGGFG VFKGWIDE T ++PGTG+VIAVK+LNQ+ QGH EWL E+ +LGQ HPN
Sbjct: 86 LGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPN 145
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LVKLIGYCLED+HRLLVYEFMP+GSLENHLFRR SY QPLSWT+R+KVALGAAKGLA+LH
Sbjct: 146 LVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLH 205
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
+ + VIYRDFKTSNILLD YNAKLSDFGLAKDGPTG +SHVSTR+MGTYGYAAPEY+A
Sbjct: 206 NAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLA 265
Query: 256 TG 257
TG
Sbjct: 266 TG 267
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 1.9e-92, P = 1.9e-92
Identities = 178/275 (64%), Positives = 212/275 (77%)
Query: 1 MGSCFS--AETDSPLPNGANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSF 58
MG CFS +TD +SK +DG+ PRTEGEIL +N+K+F
Sbjct: 1 MGGCFSNRIKTDIASSTWLSSKFLSRDGS----KGSSTASFSYMPRTEGEILQNANLKNF 56
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
S + LK+ATRNFRPDSV+GEGGFGCVFKGWIDE + AP++PGTG+VIAVKRLNQE QGH
Sbjct: 57 SLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGH 116
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
EWL EI +LGQL HPNLVKLIGYCLE++HRLLVYEFM +GSLENHLFRR ++ QPLSW
Sbjct: 117 REWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWN 176
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
R+++ALGAA+GLA+LH+ + +VIYRDFK SNILLD NYNAKLSDFGLA+DGP G SHV
Sbjct: 177 TRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHV 236
Query: 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLL 273
STRVMGT GYAAPEY+ATG + +++F LL
Sbjct: 237 STRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLL 271
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 177/273 (64%), Positives = 206/273 (75%)
Query: 1 MGSCFSAETDSPLPNGANSKCSRKDGNGTXXXXXXXXXXXXXPRTEGEILLGSNIKSFSF 60
MGSCFS+ + + + N K S G + +TEGEIL + +KSF+F
Sbjct: 1 MGSCFSSRVKADIFH--NGKSSDLYGL-SLSSRKSSSTVAAAQKTEGEILSSTPVKSFTF 57
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N LK ATRNFRPDSV+GEGGFGCVFKGW+DE T P +PGTG+VIAVK+LNQE QGH E
Sbjct: 58 NELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHRE 117
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
WLTEI +LGQL HPNLVKLIGYCLED+HRLLVYEFM KGSLENHLFRR +Y +PL W +R
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLR 177
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ VAL AAKGLA+LHSD KVIYRD K SNILLD +YNAKLSDFGLA+DGP G S+VST
Sbjct: 178 VNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVST 237
Query: 241 RVMGTYGYAAPEYMATGIFQLVLLLFTFECSLL 273
RVMGTYGYAAPEYM++G +++F LL
Sbjct: 238 RVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLL 270
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 8.0e-85, P = 8.0e-85
Identities = 171/286 (59%), Positives = 208/286 (72%)
Query: 1 MGSCF--SAETDS----PLPNGAN--SKCSRKDGNGTXXXXXXXXXXXX-----XPRTEG 47
MG+C SA+ DS P N A+ S+ S K T PRTEG
Sbjct: 1 MGNCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEG 60
Query: 48 EILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV 107
EIL N+K+F+FN LK ATRNFRPDS+LGEGGFG VFKGWID T ++PG+G+V+AV
Sbjct: 61 EILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAV 120
Query: 108 KRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR 167
K+L E QGH EWLTE+ +LGQL HPNLVKL+GYC+E ++RLLVYEFMPKGSLENHLFR
Sbjct: 121 KKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFR 180
Query: 168 RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
R + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD +N+KLSDFGLA
Sbjct: 181 RGA--QPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLA 238
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLL 273
K GPTG ++HVST+VMGT+GYAAPEY+ATG +++F LL
Sbjct: 239 KAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLL 284
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 169/289 (58%), Positives = 207/289 (71%)
Query: 1 MGSCF--SAETD----SPLPNGANS------KCSRKDGNGTXXXXXXXXXXXXXP----R 44
MG+C SA+ D SP N A+S K SR G P R
Sbjct: 1 MGNCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLR 60
Query: 45 TEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV 104
TEGEIL N+K+F+FN LK AT+NFR D++LGEGGFGCVFKGWID+ + +RPG+G+V
Sbjct: 61 TEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIV 120
Query: 105 IAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH 164
+AVK+L E QGH EWLTE+ +LGQL HPNLV L+GYC E ++RLLVYEFMPKGSLENH
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 165 LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224
LFRR + QPL+W IRMKVA+GAAKGL +LH K++VIYRDFK +NILLD ++NAKLSDF
Sbjct: 181 LFRRGA--QPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDF 238
Query: 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLL 273
GLAK GPTG +HVST+V+GT+GYAAPEY+ATG +++F LL
Sbjct: 239 GLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLL 287
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 1.4e-80, P = 1.4e-80
Identities = 150/216 (69%), Positives = 178/216 (82%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P E+ + S+++ F+FN LK +TRNFRP+S+LGEGGFGCVFKGWI+E+ AP +PGTG
Sbjct: 115 PVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 174
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI LG L HPNLVKL+GYC+EDD RLLVYEFMP+GSLE
Sbjct: 175 LTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 234
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAKL 221
NHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRDFKTSNILLD +YNAKL
Sbjct: 235 NHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKL 291
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG 257
SDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TG
Sbjct: 292 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 327
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
Identities = 154/232 (66%), Positives = 180/232 (77%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P GE+ S ++ F FN LK ATRNFRP+S+LGEGGFGCVFKGWI+E+ AP +PGTG
Sbjct: 76 PLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 135
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI LG L HP+LVKL+GYC+E+D RLLVYEFMP+GSLE
Sbjct: 136 LTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLE 195
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAKL 221
NHLFRR PL W++RMK+ALGAAKGLA+LH + K VIYRDFKTSNILLD YNAKL
Sbjct: 196 NHLFRRTL---PLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 252
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLL 273
SDFGLAKD P +SHVSTRVMGTYGYAAPEY+ TG +++F LL
Sbjct: 253 SDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLL 304
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 4.7e-80, P = 4.7e-80
Identities = 151/216 (69%), Positives = 177/216 (81%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
P E+ + S++K FSF LK ATRNFRP+S+LGEGGFGCVFKGW++E+ AP +PGTG
Sbjct: 109 PIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 168
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
+ +AVK LN + LQGH EWL EI +LG L HPNLVKL+GYC+EDD RLLVYEFMP+GSLE
Sbjct: 169 LTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 228
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK-VIYRDFKTSNILLDLNYNAKL 221
NHLFRR+ PL W+IRMK+ALGAAKGL++LH + K VIYRDFKTSNILLD YNAKL
Sbjct: 229 NHLFRRSL---PLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKL 285
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG 257
SDFGLAKD P ++HVSTRVMGTYGYAAPEY+ TG
Sbjct: 286 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 321
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 802 (287.4 bits), Expect = 7.6e-80, P = 7.6e-80
Identities = 152/232 (65%), Positives = 189/232 (81%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
PR+EGE+L +K+F+FN LKTATRNFRPDSV+GEGGFG V+KGWIDE T +P++PG+G
Sbjct: 56 PRSEGELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSG 115
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH-RLLVYEFMPKGSL 161
MV+AVK+L +E QGH +WL E+ LG+L+H NLVKLIGYC + DH RLLVYE+MPKGSL
Sbjct: 116 MVVAVKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSL 175
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
ENHLFRR + +P+ W R+KVA+GAA+GLA+LH +A+VIYRDFK SNILLD +NAKL
Sbjct: 176 ENHLFRRGA--EPIPWRTRIKVAIGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAKL 231
Query: 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLL 273
SDFGLAK GPTG ++HVST+VMGT GYAAPEY+ATG +++F LL
Sbjct: 232 SDFGLAKVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLL 283
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 145/215 (67%), Positives = 184/215 (85%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTG 102
PR+EGE+L +K+F+FN LKTATRNF+P+S++GEGGFGCV+KGWI E + +P++PG+G
Sbjct: 57 PRSEGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSG 116
Query: 103 MVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
MV+AVK+L E QGH EWLTE+ +LG+L+H NLVKLIGYCLE + RLLVYE+MPKGSLE
Sbjct: 117 MVVAVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLE 176
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222
NHLFRR + +P+ W RMKVA AA+GL++LH +AKVIYRDFK SNILLD+++NAKLS
Sbjct: 177 NHLFRRGA--EPIPWKTRMKVAFSAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKLS 232
Query: 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG 257
DFGLAK GPTG ++HV+T+V+GT GYAAPEY+ATG
Sbjct: 233 DFGLAKAGPTGDRTHVTTQVIGTQGYAAPEYIATG 267
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P46573 | APK1B_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7159 | 0.8677 | 0.6213 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_X000819 | hypothetical protein (415 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 295 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-44
Identities = 68/181 (37%), Positives = 95/181 (52%), Gaps = 18/181 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQLYHP 134
LGEGGFG V+ + TG +A+K + +E LE L EI+ L +L HP
Sbjct: 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+VKL G +++H LV E+ GSL++ L LS +++ L +GL YL
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYL 108
Query: 195 HSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
HS +I+RD K NILLD N KL+DFGL+K S + ++GT Y APE
Sbjct: 109 HS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEV 164
Query: 254 M 254
+
Sbjct: 165 L 165
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-42
Identities = 73/185 (39%), Positives = 95/185 (51%), Gaps = 19/185 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKH 127
+ LG G FG V+K GTG ++AVK L + S + EI+
Sbjct: 1 YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L +L HPN+V+LI + DH LV E+ G L ++L R PLS K+AL
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQI 107
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
+GL YLHS +I+RD K NILLD N K++DFGLAK S S ++T V GT
Sbjct: 108 LRGLEYLHS--NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPW 163
Query: 248 YAAPE 252
Y APE
Sbjct: 164 YMAPE 168
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 4e-40
Identities = 62/191 (32%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LGEG FG V+KG + +AVK L ++ S Q E+L E + + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----KLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+VKL+G C E++ +V E+M G L ++L + + S + + AL A+G+
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL---SLSDLLSFALQIARGM 115
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT---YGY 248
YL S I+RD N L+ N K+SDFGL++D R G +
Sbjct: 116 EYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRW 169
Query: 249 AAPEYMATGIF 259
APE + G F
Sbjct: 170 MAPESLKEGKF 180
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-40
Identities = 65/188 (34%), Positives = 97/188 (51%), Gaps = 11/188 (5%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LGEG FG V+KG T G + +AVK L ++ S Q E+L E + + +L
Sbjct: 4 GKKLGEGAFGEVYKG-----TLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+VKL+G C E++ ++V E+MP G L ++L R + + LS + + AL A+G+
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGM 116
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YL S I+RD N L+ N K+SDFGL++D + + AP
Sbjct: 117 EYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDL-YDDDYYKVKGGKLPIRWMAP 173
Query: 252 EYMATGIF 259
E + G F
Sbjct: 174 ESLKEGKF 181
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 23/192 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGEG FG V+KG T GT +AVK L + S + E+L E + +L H
Sbjct: 6 KLGEGAFGEVYKG-----TLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+V+L+G C + + +V E+MP G L + L + + L+ +++AL AKG+ Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEY 117
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST------RVMGTYG 247
L S ++RD N L+ N K+SDFGL++D + M
Sbjct: 118 LES--KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM---- 171
Query: 248 YAAPEYMATGIF 259
APE + G F
Sbjct: 172 --APESLKDGKF 181
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-37
Identities = 60/188 (31%), Positives = 88/188 (46%), Gaps = 27/188 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ LGEG FG V+ TG ++A+K + ++ ++ E L EIK L
Sbjct: 1 YEILEKLGEGSFGKVYLAR---------DKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY----IQPLSWTIRMKVA 184
+L HPN+V+L ++D LV E+ G L + L +R + I
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI----- 106
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L YLHS +++RD K NILLD + + KL+DFGLA+ ++T V G
Sbjct: 107 ---LSALEYLHS--KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-G 158
Query: 245 TYGYAAPE 252
T Y APE
Sbjct: 159 TPEYMAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIKHLGQLY 132
LGEG FG V+KG + G +AVK L S + ++L E + + +L
Sbjct: 2 KLGEGAFGEVYKGKLKGK-------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG 54
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----FRRASYIQPLSWTIRMKVALGA 187
HPN+V+L+G C E++ LV E+M G L ++L + LS + A+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP------TGSQSHVSTR 241
AKG+ YL S K ++RD N L+ + K+SDFGL++D + + R
Sbjct: 115 AKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 242 VMGTYGYAAPEYMATGIF 259
M APE + GIF
Sbjct: 173 WM------APESLKDGIF 184
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 61/183 (33%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
F +G+GGFG V+K TG +A+K + ES + + + EI+ L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
+ HPN+VK G L+ D +V EF GSL++ L S Q L+ + V K
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLK 109
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
GL YLH +I+RD K +NILL + KL DFGL+ + ++GT +
Sbjct: 110 GLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWM 164
Query: 250 APE 252
APE
Sbjct: 165 APE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 57/166 (34%), Positives = 81/166 (48%), Gaps = 21/166 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYHP 134
LGEG FG V Y P TG +AVK LN + H ++ EI+ L L H
Sbjct: 12 LGEGHFGKVELC-----RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 135 NLVKLIGYCLEDDHR---LLVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAA 188
N+VK G C E L+ E++P GSL ++L R + + + L ++ ++
Sbjct: 67 NIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI------C 119
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
KG+ YL S + I+RD NIL++ K+SDFGLAK P
Sbjct: 120 KGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 23/184 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWL-TEIKHLGQLY 132
+LG G FG V+ +D+ T G ++AVK + + LE L EI+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 133 HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVALGAA 188
HPN+V+ G E + + E++ GSL + L F + +T ++
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI------L 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GLAYLHS +++RD K +NIL+D + KL+DFG AK + V GT +
Sbjct: 112 EGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 249 AAPE 252
APE
Sbjct: 170 MAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 65/169 (38%), Positives = 86/169 (50%), Gaps = 15/169 (8%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIK 126
R + VLGEG FG V + Y PA GTG ++AVK L +E Q + W EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL-----YCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58
Query: 127 HLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L LYH N+VK G C E L+ E++P GSL ++L + L+ + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFA 113
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+G+AYLHS I+RD N+LLD + K+ DFGLAK P G
Sbjct: 114 QQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-24
Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 19/180 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
++G G FG V+KG ++ T G +A+K+++ E + + + EI L L
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN+VK IG D ++ E+ GSL + + + + L + + L +GLA
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QGLA 113
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLH + VI+RD K +NIL + KL+DFG+A S V+GT + APE
Sbjct: 114 YLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPE 169
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 6e-24
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 25/188 (13%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQL 131
+ +G+G FG V G Y G +AVK L + + Q +L E + L
Sbjct: 12 ATIGKGEFGDVMLG-----DYR------GQKVAVKCLKDDSTAAQ---AFLAEASVMTTL 57
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPNLV+L+G L+ + +V E+M KGSL ++L R ++ ++ AL +G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGM 115
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YL ++RD N+L+ + AK+SDFGLAK+ SQ S ++ + AP
Sbjct: 116 EYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSGKL--PVKWTAP 168
Query: 252 EYMATGIF 259
E + F
Sbjct: 169 EALREKKF 176
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 95.6 bits (236), Expect = 2e-22
Identities = 67/192 (34%), Positives = 92/192 (47%), Gaps = 18/192 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++R LGEG FG V+ D A V+A K ++ L EI+ L
Sbjct: 1 SYRILRKLGEGSFGEVYLA-RDRKLVA------LKVLAKKLESKSKEVERF--LREIQIL 51
Query: 129 GQLYHP-NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L HP N+VKL + ++ LV E++ GSLE L ++ PLS + + +
Sbjct: 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQI 110
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFGLAK----DGPTGSQSHVSTRV 242
L YLHS +I+RD K NILLD + KL DFGLAK G T S + +
Sbjct: 111 LSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 243 MGTYGYAAPEYM 254
+GT GY APE +
Sbjct: 169 VGTPGYMAPEVL 180
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-22
Identities = 60/189 (31%), Positives = 90/189 (47%), Gaps = 37/189 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR----LNQESLQGHLEWLT-EIKHLGQ 130
LG G FG V++G + G AVK + ++ Q ++ L EI L +
Sbjct: 8 LGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSK 58
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM--KVALGAA 188
L HPN+V+ +G E+D+ + E +P GSL L + S+ +P+ IR+ + L
Sbjct: 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQIL--- 112
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM----- 243
GL YLH ++RD K +NIL+D N KL+DFG+AK V
Sbjct: 113 LGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFK 162
Query: 244 GTYGYAAPE 252
G+ + APE
Sbjct: 163 GSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-21
Identities = 55/173 (31%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
+G+G FG VF+ P P T ++AVK L +E S ++ E + + HP
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ------------------PLS 176
N+VKL+G C L++E+M G L L R+ Q PLS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
T ++ +A A G+AYL S++ K ++RD T N L+ N K++DFGL+++
Sbjct: 129 CTEQLCIAKQVAAGMAYL-SER-KFVHRDLATRNCLVGENMVVKIADFGLSRN 179
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-20
Identities = 63/186 (33%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 76 LGEGGFGCVF----KGWIDEHTYAPARPGTGM-VIAVKRLNQESLQGHLEWLTEIKHLGQ 130
LG+G FG V K YA M V+ K++ + H LTE L +
Sbjct: 1 LGKGSFGKVLLVRKKD--TGKLYA-------MKVLKKKKIIKRKEVEHT--LTERNILSR 49
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGA 187
+ HP +VKL Y + + +L LV E+ P G L +HL + + + + + + +AL
Sbjct: 50 INHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE- 107
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
YLHS +IYRD K NILLD + + KL+DFGLAK+ + +T GT
Sbjct: 108 -----YLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC-GTPE 158
Query: 248 YAAPEY 253
Y APE
Sbjct: 159 YLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-20
Identities = 57/189 (30%), Positives = 83/189 (43%), Gaps = 37/189 (19%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQL 131
+GEG G V+K TG +A+K RL +++ + + EI +
Sbjct: 25 EKIGEGASGEVYKA---------TDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDC 72
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSL----ENHLFR----RASYIQPLSWTIRMKV 183
HPN+V L D +V E+M GSL + R + +Y+ +
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV--------CRE 124
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L +GL YLHS VI+RD K+ NILL + + KL+DFG A S V+
Sbjct: 125 VL---QGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VV 177
Query: 244 GTYGYAAPE 252
GT + APE
Sbjct: 178 GTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLEWLT--EIKHLGQ 130
V+GEG +G V K R TG ++A+K+ + ++ E+K L Q
Sbjct: 7 GVVGEGAYGVVLK----------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ 56
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-----ASYIQPLSWTIRMKVAL 185
L H N+V L LV+E++ + LE L ++ W +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQL------ 109
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ +AY HS +I+RD K NIL+ + KL DFG A+ S ++ V T
Sbjct: 110 --LQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 246 YGYAAPE 252
Y APE
Sbjct: 165 RWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-20
Identities = 58/183 (31%), Positives = 83/183 (45%), Gaps = 26/183 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYH 133
+GEG G VFK E TG +A+K++ L+G + L EIK L H
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P +VKL+ +LV E+MP L L +PL KG+AY
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAY 114
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ-SH-VSTRVMGTYGYA 249
+H +++RD K +N+L+ + K++DFGLA+ SH V+TR Y
Sbjct: 115 MH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYR 167
Query: 250 APE 252
APE
Sbjct: 168 APE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-20
Identities = 63/191 (32%), Positives = 95/191 (49%), Gaps = 23/191 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE----SLQGHLEWL-T 123
N+R +LG+G FG V Y TG +AVK++ + + + L
Sbjct: 3 NWRRGKLLGQGAFGRV---------YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIRMK 182
EI+ L L H +V+ G CL DD L ++ E+MP GS+++ L +Y L+ T+ K
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAY-GALTETVTRK 108
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR- 241
+G+ YLHS+ +++RD K +NIL D N KL DFG +K T S +
Sbjct: 109 YTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 242 VMGTYGYAAPE 252
V GT + +PE
Sbjct: 167 VTGTPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 9e-20
Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 27/192 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWLTEIK 126
+ +G+G FG V+ G + +K L+ S + + L E+K
Sbjct: 1 KYEIIKQIGKGSFGKVYLV---RRKS------DGKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS------WTIR 180
L +L HPN++K E +V E+ G L + ++ +P W ++
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ L YLHS K +++RD K NI L N KL DFG++K + + T
Sbjct: 112 L------CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKT 162
Query: 241 RVMGTYGYAAPE 252
V GT Y +PE
Sbjct: 163 VV-GTPYYLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN---QESLQGHLEWLTEIKHLGQ 130
VLG+G G V+K + P TG + A+K+++ E + L L E+K L
Sbjct: 7 KVLGQGSSGVVYKV-----RHKP----TGKIYALKKIHVDGDEEFRKQL--LRELKTLRS 55
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
P +VK G ++ +V E+M GSL + L + + + +A KG
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKG 111
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLH+ + +I+RD K SN+L++ K++DFG++K +T V GT Y +
Sbjct: 112 LDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMS 168
Query: 251 PE------Y-MATGIFQLVLLLFTFECSLLHFSLQLP 280
PE Y A I+ L L L EC+L F P
Sbjct: 169 PERIQGESYSYAADIWSLGLTL--LECALGKFPFLPP 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 20/190 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLY 132
VLG G FG V+KG WI P + +A+K L +E+ + + E L E + +
Sbjct: 14 VLGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAK 189
HP++V+L+G CL L+ + MP G L +++ I L+W +++ AK
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G++YL ++ ++++RD N+L+ + K++DFGLAK + + + +
Sbjct: 121 GMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 250 APEYMATGIF 259
A E + I+
Sbjct: 179 ALESILHRIY 188
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 31/187 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LTEIKHLGQ 130
+GEG +G V+K TG ++A+K++ L+ E L EIK L +
Sbjct: 7 IGEGTYGVVYKARDKL---------TGEIVAIKKI---KLRFESEGIPKTALREIKLLKE 54
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L HPN++KL+ LV+EFM L L + L ++ +G
Sbjct: 55 LNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQR--GLPESLIKSYLYQLLQG 110
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSH-VSTRVMGTYG 247
LA+ HS +++RD K N+L++ KL+DFGLA+ P +H V TR
Sbjct: 111 LAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----W 163
Query: 248 YAAPEYM 254
Y APE +
Sbjct: 164 YRAPELL 170
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 2e-18
Identities = 62/194 (31%), Positives = 94/194 (48%), Gaps = 37/194 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLE 120
+ LGEG +G V+K D+ T G ++A+K RL+ E +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDNEEEGIPSTALR---- 47
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
EI L +L HPN+VKL+ + LV+E+ L+ +L +R + P I+
Sbjct: 48 ---EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN--LIK 101
Query: 181 --MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
M L +GLAY HS ++++RD K NIL++ + KL+DFGLA+ G
Sbjct: 102 SIMYQLL---RGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLAR--AFGIPLRT 154
Query: 239 STRVMGTYGYAAPE 252
T + T Y APE
Sbjct: 155 YTHEVVTLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 26/188 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWL-TEIKHL 128
VLG+G +G V+ G + G +IAVK++ N + + E L E+ L
Sbjct: 7 VLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L H N+V+ +G CL+D+ + EF+P GS+ + L R +P + K
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP----VFCKYTKQIL 112
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRVMG 244
G+AYLH++ V++RD K +N++L N KL DFG A+ G G+ S++ + G
Sbjct: 113 DGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 245 TYGYAAPE 252
T + APE
Sbjct: 171 TPYWMAPE 178
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHP 134
+G+G FG V+KG + +AVK ++L E + L Q HP
Sbjct: 3 IGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+VKLIG C++ +V E +P GSL L ++ + L+ ++++L AA G+ YL
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYL 109
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
S I+RD N L+ N K+SDFG++++ G + + APE +
Sbjct: 110 ESKNC--IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 255 ATG 257
G
Sbjct: 168 NYG 170
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
F + LG G FG V++G W + + +A+K L + L ++ E++ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQAL 56
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+L H +L+ L C + ++ E M KGSL L + P++ I M A A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM--ACQVA 114
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+G+AYL I+RD NIL+ + K++DFGLA+
Sbjct: 115 EGMAYLEEQ--NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-18
Identities = 59/156 (37%), Positives = 82/156 (52%), Gaps = 13/156 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYHP 134
LGEG FG V + Y P TG +AVK L ES H+ L EI+ L LYH
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 135 NLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
N+VK G C ED L+ EF+P GSL+ +L R + I + ++K A+ KG+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI---NLKQQLKYAVQICKGMD 123
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
YL S + ++RD N+L++ + K+ DFGL K
Sbjct: 124 YLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-18
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 25/183 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+G+G FG VFK R V A+K+++ + E + E + L +L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS----WTIRMKVALGAAK 189
+++ L+ +V E+ G L H + +PL W +++ LG
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLG--- 113
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
LA+LHS K +++RD K+ N+ LD N K+ D G+AK ++ + ++GT Y
Sbjct: 114 -LAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYL 168
Query: 250 APE 252
+PE
Sbjct: 169 SPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-18
Identities = 59/168 (35%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG G FG V KG Y + G + +AVK L QE G E+L E + QL HP
Sbjct: 3 LGHGNFGSVVKGV-----YLM-KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV-ALGAAKGLAY 193
+V+LIG C + +LV E P G L +L +R +K A A G+AY
Sbjct: 57 CIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L S ++RD N+LL + AK+SDFG+++ GS + +T
Sbjct: 111 LES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-18
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LGEG FG V+KG P + +A+K L + + E+ E + + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMK 182
N+V L+G C ++ +++E++ G L L R + + L + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A+ A G+ YL S ++RD N L+ K+SDFGL++D + V ++
Sbjct: 129 IAIQIAAGMEYLSSH--HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 243 MGTYGYAAPEYMATGIF 259
+ + PE + G F
Sbjct: 187 LLPVRWMPPEAILYGKF 203
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-18
Identities = 59/186 (31%), Positives = 80/186 (43%), Gaps = 28/186 (15%)
Query: 76 LGEGGFGCVFKGW-IDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+G G FG V+ +D TG ++AVK R+ + E E+K L L
Sbjct: 8 IGGGTFGKVYTAVNLD----------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPNLVK G + + + E+ G+LE L I + L +GLA
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQL--LEGLA 113
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY---A 249
YLHS +++RD K +NI LD N KL DFG A + +T MG
Sbjct: 114 YLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAG 165
Query: 250 APEYMA 255
P YMA
Sbjct: 166 TPAYMA 171
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 36/189 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHLG 129
+GEG +G V+K TG ++A+K++ E + + + EIK L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRME----NEKEGFPITAIREIKLLQ 53
Query: 130 QLYHPNLVKLIGYCLEDDHR--LLVYEFMP---KGSLENHLFR-RASYIQPLSWTIRMKV 183
+L HPN+V+L +V+E+M G L++ + S I+ MK
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCY-----MKQ 108
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L +GL YLHS +++RD K SNIL++ + KL+DFGLA+ T S T +
Sbjct: 109 LL---EGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRV 162
Query: 244 GTYGYAAPE 252
T Y PE
Sbjct: 163 ITLWYRPPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
LG+G FG V +G W G + +AVK L + L + ++L E + L H
Sbjct: 3 LGDGSFGVVRRGEWS-----TSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH 55
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGL 191
NL++L G L ++V E P GSL + L + A +S +++A G+
Sbjct: 56 ENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGM 110
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST---RVMGTYGY 248
YL S + I+RD NILL + K+ DFGL + P +V +V + +
Sbjct: 111 RYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAW 166
Query: 249 AAPEYMATGIF 259
APE + T F
Sbjct: 167 CAPESLRTRTF 177
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-17
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 30/197 (15%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQL 131
+ V+G G FG V +G + P + + +A+K L S + L++LTE +GQ
Sbjct: 9 EKVIGGGEFGEVCRGRLKL----PGKKE--IDVAIKTLKAGSSDKQRLDFLTEASIMGQF 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+++L G + +++ E+M GSL+ L + + + G A G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGM 119
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG---- 247
YL S+ V +RD NIL++ N K+SDFGL S TY
Sbjct: 120 KYL-SEMNYV-HRDLAARNILVNSNLVCKVSDFGL---------SRRLEDSEATYTTKGG 168
Query: 248 -----YAAPEYMATGIF 259
+ APE +A F
Sbjct: 169 KIPIRWTAPEAIAYRKF 185
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 48/166 (28%), Positives = 76/166 (45%), Gaps = 17/166 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYH 133
LGEG FG VF G Y ++AVK L + + ++ E + L H
Sbjct: 12 ELGEGAFGKVFLG----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRRA----SYIQPLSWTIRMKV 183
N+VK G C E D ++V+E+M G L L S + L+ + +++
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A+ A G+ YL S ++RD T N L+ + K+ DFG+++D
Sbjct: 128 AVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 76 LGEGGFG----CVFKGWID-EHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLG 129
LGEG FG C +G + AP G +++AVK L + + ++L EIK +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--------FRRASYIQPLSWTIRM 181
+L +PN+++L+G C+ DD ++ E+M G L L F A+ I +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+A+ A G+ YL S ++RD T N L+ +Y K++DFG++++ +G + R
Sbjct: 133 YMAVQIASGMKYLAS--LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 242 VMGTYGYAAPEYMATGIF 259
+ + A E + G F
Sbjct: 191 AVLPIRWMAWESILLGKF 208
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 59/192 (30%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG G FG V++G + + +AVK L + S Q ++L E + + H
Sbjct: 13 ALGHGAFGEVYEG---LYRGRDGDA-VELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-RASYIQPLSWTIR--MKVALGAAKG 190
N+V+LIG E R ++ E M G L++ L R +P S T++ + A AKG
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
YL I+RD N LL AK++DFG+A+D S R M
Sbjct: 129 CKYLEE--NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 248 YAAPEYMATGIF 259
+ PE GIF
Sbjct: 187 WMPPEAFLDGIF 198
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 55/182 (30%), Positives = 84/182 (46%), Gaps = 27/182 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
N LGEG FG V K R G V AVK L + + L + L+E
Sbjct: 1 NLVLGKTLGEGEFGKVVKATA---FRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNL 56
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL---------------FRRASYI 172
L Q+ HP+++KL G C +D LL+ E+ GSL + L R +SY+
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 173 -----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+ L+ + A ++G+ YL + K+++RD N+L+ K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 228 KD 229
+D
Sbjct: 175 RD 176
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 41/192 (21%)
Query: 74 SVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQ 130
LG+G FG V+ + TG ++A+K++ + S + + L E+K L +
Sbjct: 5 KQLGDGTFGSVYLARNKE----------TGELVAIKKMKKKFYSWEECMN-LREVKSLRK 53
Query: 131 L-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF-----RRASYIQPLSWTIRMKVA 184
L HPN+VKL E+D V+E+M E +L+ R+ IR +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSES--VIR-SII 105
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ----SHVST 240
+GLA++H K +RD K N+L+ K++DFGLA++ S+ +VST
Sbjct: 106 YQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLARE--IRSRPPYTDYVST 161
Query: 241 RVMGTYGYAAPE 252
R Y APE
Sbjct: 162 R-----WYRAPE 168
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG 159
+A+KR++ E Q ++ L E++ + Q HPN+VK + D LV ++ G
Sbjct: 25 NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGG 84
Query: 160 SLEN---HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216
SL + + R + + T+ +K L KGL YLHS+ I+RD K NILL +
Sbjct: 85 SLLDIMKSSYPRGGLDEAIIATV-LKEVL---KGLEYLHSNGQ--IHRDIKAGNILLGED 138
Query: 217 YNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
+ K++DFG LA G V +GT + APE M
Sbjct: 139 GSVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPEVM 178
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 60/187 (32%), Positives = 96/187 (51%), Gaps = 25/187 (13%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
++GEG FG V +G E+T G +AVK + + + Q LE E + +L+
Sbjct: 12 EIIGEGEFGAVLQG---EYT--------GQKVAVKNIKCDVTAQAFLE---ETAVMTKLH 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
H NLV+L+G L + +V E M KG+L N L R + + ++ +L A+G+
Sbjct: 58 HKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQF--SLDVAEGME 114
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YL S K +++RD NIL+ + AK+SDFGLA+ G G ++++ + APE
Sbjct: 115 YLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPE 167
Query: 253 YMATGIF 259
+ F
Sbjct: 168 ALKHKKF 174
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLT 123
+F+ ++GEG F V E T A+K +L +E ++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYV--KI 50
Query: 124 EIKHLGQL-YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E + L +L HP ++KL Y +D+ L V E+ P G L ++ + S + R
Sbjct: 51 EKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRF 106
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP---------- 231
A L YLHS +I+RD K NILLD + + K++DFG AK
Sbjct: 107 YAAE-ILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 232 ----TGSQSHVSTR----VMGTYGYAAPE 252
SQ + R +GT Y +PE
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPE 192
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-17
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+L+++ L +G L E K L ++
Sbjct: 1 LGKGGFGEV---------CACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 133 HPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+V L Y E D LV M G L+ H++ P + I + GL
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI--ICGL 108
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
+LH + +++YRD K N+LLD + N ++SD GLA + G + GT GY AP
Sbjct: 109 EHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAP 163
Query: 252 EYMATGIFQLVLLLFTFECSL 272
E + ++ + F C+L
Sbjct: 164 EVLQGEVYDFSVDWFALGCTL 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-17
Identities = 60/184 (32%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYH 133
+LG+G FG VFKG + + T +AVK ++ Q +++L+E + L Q H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+VKLIG C + +V E +P G + L ++ L +K AL AA G+AY
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAY 108
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S I+RD N L+ N K+SDFG+++ G S + + + APE
Sbjct: 109 LESKNC--IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEA 165
Query: 254 MATG 257
+ G
Sbjct: 166 LNYG 169
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 56/160 (35%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLY 132
V+G+G FGCV+ G ID G + AVK LN+ L+ ++L E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 133 HPNLVKLIGYCLEDDHR-LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG--AAK 189
HPN++ L+G CL + L+V +M G L N F R+ P T++ + G AK
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNP---TVKDLIGFGLQVAK 109
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
G+ YL S K ++RD N +LD ++ K++DFGLA+D
Sbjct: 110 GMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARD 147
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 59/194 (30%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIK 126
LG G G V K RP TG ++AVK + E +Q + L E+
Sbjct: 3 LEYLGELGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQI--LRELD 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L + P +V G + + E+M GSL+ L + I K+A+
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVA 108
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM--- 243
KGL YLH K K+I+RD K SNIL++ KL DFG VS +++
Sbjct: 109 VLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSL 155
Query: 244 -----GTYGYAAPE 252
GT Y APE
Sbjct: 156 AKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 32/194 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLT 123
+ LGEG + V+K D+ T G ++A+K++ + + L
Sbjct: 1 RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE-----NHLFRRASYIQPLSWT 178
EIK L +L HPN++ L+ + LV+EFM LE + + I+ S+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK--SYM 108
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ +GL YLHS+ +++RD K +N+L+ + KL+DFGLA+ GS +
Sbjct: 109 LMT------LRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRK 158
Query: 239 STRVMGTYGYAAPE 252
T + T Y APE
Sbjct: 159 MTHQVVTRWYRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 27/181 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-----EWLTEIKHLG 129
+LGEG FG V +G + G+ + +AVK + L H E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLS------QDDGSQLKVAVKTMK---LDIHTYSEIEEFLSEAACMK 56
Query: 130 QLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIRM-- 181
HPN++KLIG C E +++ FM G L + L P ++
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS---QSHV 238
K + A G+ YL + I+RD N +L + ++DFGL+K +G Q +
Sbjct: 117 KFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 239 S 239
+
Sbjct: 175 A 175
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 29/195 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------L 122
+F V+G+G FG V I + T + A+K +N+ Q +E L
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQKRD------TKKMFAMKYMNK---QKCVEKGSVRNVL 48
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E + L +L HP LV L Y +D+ + LV + + G L HL ++ + + ++
Sbjct: 49 NERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKF 104
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+ L YLHS +I+RD K NILLD + ++DF +A + +T
Sbjct: 105 WIC-EIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTS 158
Query: 242 VMGTYGYAAPEYMAT 256
GT GY APE +
Sbjct: 159 TSGTPGYMAPEVLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 51/153 (33%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G + T +AVK L ++ +L E + + +L H
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L C E++ +V E+M KGSL + L L + M A A+G+AYL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM--AAQIAEGMAYLE 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
S I+RD NIL+ N K++DFGLA+
Sbjct: 121 S--RNYIHRDLAARNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 61/190 (32%), Positives = 85/190 (44%), Gaps = 34/190 (17%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQ 130
S LGEG G V K + TGM+ A+K + + LQ + L E++
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQI--LRELEINKS 55
Query: 131 LYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRASYIQPLSWTIRM------K 182
P +VK G L++ + E+ GSL+ + Y + R+ K
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD------SIYKKVKKRGGRIGEKVLGK 109
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A KGL+YLHS K+I+RD K SNILL KL DFG++ G + S T
Sbjct: 110 IAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVN-SLAGTFT 164
Query: 243 MGTYGYAAPE 252
GT Y APE
Sbjct: 165 -GTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-16
Identities = 44/153 (28%), Positives = 83/153 (54%), Gaps = 14/153 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G +G V++G ++ + +AVK L +++++ E+L E + ++ HPN
Sbjct: 14 LGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L+G C + ++ EFM G+L ++L R Q ++ + + +A + + YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL- 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+K I+RD N L+ N+ K++DFGL++
Sbjct: 121 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-16
Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMV-IAVKRLNQESL-QGHLEWLTEIKHLGQLY 132
LG G FG V++G D PG+G + +AVK L + + Q E+L E +
Sbjct: 3 LGSGAFGEVYEGTATDI-----LGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQP-LSWTIRMKVALGAAK 189
HPN+VKL+G CL ++ + ++ E M G L ++L R + P L+ + + L AK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 190 GLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
G YL ++ I+RD N L+ D + K+ DFGLA+D +
Sbjct: 118 GCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 245 TYGYAAPEYMATGIF 259
+ APE + G F
Sbjct: 176 PVRWMAPESLLDGKF 190
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-16
Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+L+++ L+ G L E + L ++
Sbjct: 1 LGKGGFGEVC---------AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 133 HPNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
P +V L Y E H LV M G L+ H++ + I + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI--TCGI 108
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
+LHS ++YRD K N+LLD N +LSD GLA + G T+ GT GY AP
Sbjct: 109 LHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAP 163
Query: 252 EYMATGIFQLVLLLFTFECSL 272
E + + + F CS+
Sbjct: 164 EILKEEPYSYPVDWFAMGCSI 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-16
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKH 127
F LGEG +G V+K + TG V+A+K + +E LQ E + EI
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKE----------TGQVVAIKVVPVEEDLQ---EIIKEISI 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L Q P +VK G ++ +V E+ GS+ + + + + + L+ +
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITN--KTLTEEEIAAILYQT 108
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
KGL YLHS+ K I+RD K NILL+ AKL+DFG++ T + + +T V+GT
Sbjct: 109 LKGLEYLHSN--KKIHRDIKAGNILLNEEGQAKLADFGVSGQ-LTDTMAKRNT-VIGTPF 164
Query: 248 YAAPE 252
+ APE
Sbjct: 165 WMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 61/180 (33%), Positives = 87/180 (48%), Gaps = 24/180 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+AVK+++ Q + +W + E+K L QL
Sbjct: 29 IGHGSFGAV---------YFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN ++ G L++ LV E+ GS + L + +PL + GA +GLA
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLA 135
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLHS +I+RD K NILL KL+DFG A S+S + +GT + APE
Sbjct: 136 YLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-16
Identities = 59/169 (34%), Positives = 84/169 (49%), Gaps = 24/169 (14%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIK 126
R+ + LG+G FG V + Y P + TG V+AVK+L Q S HL + EI+
Sbjct: 4 RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKL-QHSTAEHLRDFEREIE 57
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFR---RASYIQPL--SWTI 179
L L H N+VK G C R LV E++P GSL ++L + R + + L + I
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
KG+ YL S + ++RD T NIL++ K+ DFGL K
Sbjct: 118 --------CKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-16
Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 76 LGEGGFG----CVFKG---WIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKH 127
LGEG FG C +G ++D+ +++AVK L +++ + ++L EIK
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-------LSWTIR 180
+ +L PN+++L+ C+ D ++ E+M G L L R +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ +A A G+ YL S ++RD T N L+ NY K++DFG++++
Sbjct: 133 IFMATQIASGMKYLSS--LNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-16
Identities = 49/159 (30%), Positives = 88/159 (55%), Gaps = 20/159 (12%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLY 132
VLG G FG V+KG W+ P + +A+K LN+ + + ++E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAK 189
HP+LV+L+G CL +L V + MP G L +++ I L+W +++ AK
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
G+ YL ++ ++++RD N+L+ + K++DFGLA+
Sbjct: 121 GMMYL--EERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 8e-16
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 36/200 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F LG G FG V + H G+G A+K L++ + +E L E
Sbjct: 1 DDFEFIKTLGTGSFGRVM---LVRHK------GSGKYYALKILSKAKIVKLKQVEHVLNE 51
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L + HP LV L G +DD L LV E++P G L +HL + + +P++ +V
Sbjct: 52 KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L L YLHS ++YRD K N+LLD + K++DFG AK V R
Sbjct: 111 VLA----LEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTY 156
Query: 244 ---GTYGYAAPEYMATGIFQ 260
GT PEY+A I
Sbjct: 157 TLCGT-----PEYLAPEIIL 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 40/210 (19%)
Query: 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWL 122
+ R++ LGEG FG V+K + TG V+A+K++ + + + L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITAL 55
Query: 123 TEIKHLGQLYHPNLVKLIGYCLE--DDH---RLLVYEFMP------KGSLENHLFRRASY 171
EIK L +L HPN+V LI +E D R VY P G LEN +
Sbjct: 56 REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---- 111
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--- 228
+ M L +G+ YLH + +++RD K +NIL+D K++DFGLA+
Sbjct: 112 LTESQIKCYMLQLL---EGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 229 ------DGPTGSQSHVSTRVMGTYGYAAPE 252
G G + T ++ T Y PE
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 27/199 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G +A+K +N+ S++ +E+L E + +
Sbjct: 14 LGQGSFGMVYEGLA--KGVVK--GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------ASYIQPLSWTIRMKVALGAA 188
++V+L+G L+V E M KG L+++L R + P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-------GPTGSQSHVSTR 241
G+AYL + K ++RD N ++ + K+ DFG+ +D G + + R
Sbjct: 130 DGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLPVR 186
Query: 242 VMGTYGYAAPEYMATGIFQ 260
M APE + G+F
Sbjct: 187 WM------APESLKDGVFT 199
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 24/170 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEI---KHLGQL 131
LGEG FG V K E T +AVK L ++ + L + ++E+ K +G+
Sbjct: 20 LGEGAFGQVVKA---EAVGLDNPNET-STVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 74
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------ASYI------QPLSWTI 179
H N++ L+G C ++ +V E+ G+L + L R AS + L+
Sbjct: 75 -HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A A+G+ +L S K I+RD N+L+ ++ K++DFGLA+D
Sbjct: 134 LVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARD 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 26/190 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG+G FG V+K E TG+ A K + ES + +++ EI L + HPN
Sbjct: 13 LGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-----RASYIQPLSWTIRMKVALGAAKG 190
+V L ++ ++ EF G+L++ + I+ + + +
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQM--------LEA 115
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L +LHS K VI+RD K NILL L+ + KL+DFG++ + Q + +GT + A
Sbjct: 116 LNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 251 PEYMATGIFQ 260
PE +A F+
Sbjct: 172 PEVVACETFK 181
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-15
Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 19/170 (11%)
Query: 94 YAPARPGTGMVIAVKRL----NQESLQGHL--EWLTEIKHLGQLYHPNLVKLIGYCLEDD 147
Y TG ++AVK++ N S Q + EI+ + +L HP++++++G ED
Sbjct: 17 YQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76
Query: 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207
H L E+M GS+ + L S + + +GL+YLH + ++I+RD K
Sbjct: 77 HFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN--QIIHRDVK 130
Query: 208 TSNILLD-LNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+N+L+D +++DFG LA G TG+ +++GT + APE
Sbjct: 131 GANLLIDSTGQRLRIADFGAAARLAAKG-TGA-GEFQGQLLGTIAFMAPE 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 49/164 (29%), Positives = 86/164 (52%), Gaps = 20/164 (12%)
Query: 70 FRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
F+ VLG G FG V+KG WI P + +A+K L + S + + E L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVA 184
+ + +P++ +L+G CL +L + + MP G L +++ I L+W +++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
AKG+ YL ++ ++++RD N+L+ + K++DFGLAK
Sbjct: 119 ---AKGMNYL--EERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 58/191 (30%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 68 RNFRPDSV------LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
R+ P+ V LG+G FG V+K E TG + A K + +S + ++
Sbjct: 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDY 56
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ EI+ L HP +VKL+G D ++ EF P G+++ + + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+ L A L YLHS K+I+RD K N+LL L+ + KL+DFG++ Q S
Sbjct: 117 RQMLEA---LQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-- 169
Query: 242 VMGTYGYAAPE 252
+GT + APE
Sbjct: 170 FIGTPYWMAPE 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 25/187 (13%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHL 128
F +G+G FG V+K ID+ T V+A+K ++ E + +E + EI+ L
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
Q P + K G L+ ++ E+ GS L + L T +
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKP----GKLDETYIAFILREVL 108
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR---VMGT 245
GL YLH + I+RD K +NILL + KL+DFG++ G + ++ +GT
Sbjct: 109 LGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 246 YGYAAPE 252
+ APE
Sbjct: 162 PFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 76 LGEGGFGCV-------FKGWIDEHTYAPARPGTGMVIAVKRL----NQESLQGHLEWLTE 124
LGEG FG V + + ++ +++AVK L + + + ++L E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLKE 69
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSW 177
+K L +L PN+ +L+G C D ++ E+M G L L + A + LS+
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ + +A A G+ YL S ++RD T N L+ NY K++DFG++++ +
Sbjct: 130 STLLYMATQIASGMRYLES--LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 238 VSTRVM 243
V R
Sbjct: 188 VQGRAP 193
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 40/197 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIK 126
NF+ +GEG +G V+K TG V+A+K RL+ E+ + EI
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREIS 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFM-----------PKGSLENHLFRRASYIQPL 175
L +L HPN+VKL+ ++ LV+EF+ P + L + SY+ L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQL 109
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
+GLA+ HS + V++RD K N+L++ KL+DFGLA+ G
Sbjct: 110 ------------LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVP 153
Query: 236 SHVSTRVMGTYGYAAPE 252
T + T Y APE
Sbjct: 154 VRTYTHEVVTLWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPA-------RPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
LGEG FG V + P R G +++AVK L + + ++L E+K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR---------------ASYI 172
L +L PN+++L+G C+++D ++ E+M G L L A +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232
+S++ + VAL A G+ YL S ++RD T N L+ N K++DFG++++
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 233 GSQSHVSTRVMGTYGYAAPEYMATGIF 259
G + R + + A E + G F
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKF 217
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 54/208 (25%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
+ +G G +G V +D+ T G +A+K+++ + L L EIK
Sbjct: 2 YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNVFDDLIDAKRILREIKL 52
Query: 128 LGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
L L H N++ L+ + + +V E M E L + I+
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHK----------VIKSP 97
Query: 183 VALGAA----------KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---- 228
L +GL YLHS A VI+RD K SNIL++ N + K+ DFGLA+
Sbjct: 98 QPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155
Query: 229 DGPTGSQ--SHVSTRVMGTYGYAAPEYM 254
D +V TR Y APE +
Sbjct: 156 DEDEKGFLTEYVVTRW-----YRAPELL 178
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 23/189 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+F+ LG+G +G V+K R A+K ++ S+ + + + EI+
Sbjct: 1 DFKVLKKLGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR 51
Query: 127 HLGQLYHPNLVKLIGY--CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
L + HPN+ I Y D ++L +V E+ P G L + +R + + ++
Sbjct: 52 ILASVNHPNI---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
+ +GL LH K +++RD K++NILL N K+ D G++K + +++ +
Sbjct: 109 FIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQI 162
Query: 244 GTYGYAAPE 252
GT Y APE
Sbjct: 163 GTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 62/188 (32%), Positives = 85/188 (45%), Gaps = 33/188 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH------- 127
V+G+G FG V G AVK L ++++ E KH
Sbjct: 2 VIGKGSFGKVLLA---------KHKADGKFYAVKVLQKKAILKK----KEQKHIMAERNV 48
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV-A 184
L + HP LV L Y + +L V +++ G L HL R S+ +P R + A
Sbjct: 49 LLKNVKHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYA 102
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
A L YLHS +IYRD K NILLD + L+DFGL K+G S++ ++ G
Sbjct: 103 AEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCG 158
Query: 245 TYGYAAPE 252
T Y APE
Sbjct: 159 TPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 49/188 (26%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWL--------TE 124
++G+G +G V+ TG ++AVK+ L H +E
Sbjct: 8 LIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
I+ L L H N+V+ +G+ +++ + E++P GS+ + L + + L +V
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
+GLAYLHS +++RD K N+L+D + K+SDFG++K + + + G
Sbjct: 119 ----EGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 245 TYGYAAPE 252
+ + APE
Sbjct: 173 SVFWMAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 20/155 (12%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G FG V+ G W+++ +A+K + +E +++ E + + +L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L G C E LV+EFM G L ++L +R S + + L +G+AY
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAY 115
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
L S + VI+RD N L+ N K+SDFG+ +
Sbjct: 116 LES--SNVIHRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 58/198 (29%), Positives = 84/198 (42%), Gaps = 58/198 (29%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH-------L 128
+G+GG+G VF A + TG ++A+KR+ + L L E++H L
Sbjct: 9 VGQGGYGQVF--------LAKKK-DTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMP----------KGSLENHLFRRASYIQPLSW 177
LVKL+ Y +DD L L E++P G L R Y+
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR--FYM----- 107
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
M A+ A L Y+H RD K N L+D + + KL+DFGL+K T + S
Sbjct: 108 -AEMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158
Query: 238 VSTRVMGTYGYAAPEYMA 255
V +P+YMA
Sbjct: 159 V----------GSPDYMA 166
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 57/183 (31%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
VLG+G FG V GT + AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVL---------LAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 133 --HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L +L D V E++ G L H+ R + +P + ++ LG
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG---- 108
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGYA 249
L +LH +IYRD K N+LLD + K++DFG+ K+G G V+T GT Y
Sbjct: 109 LQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYI 163
Query: 250 APE 252
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG+G FG V+K E TG++ A K ++ +S + +++ EI L HPN
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+VKL+ +++ ++ EF G+++ + +PL+ V + L YLH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+K +I+RD K NIL L+ + KL+DFG++ Q S +GT + APE
Sbjct: 121 ENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 25/169 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + + + H ++ E++ L +L +
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-------------LSWTI 179
HPN++ L+G C + L E+ P G+L + L R++ ++ LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ A A+G+ YL + + I+RD NIL+ NY AK++DFGL++
Sbjct: 126 LLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-14
Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 24/164 (14%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--------NQESLQGHLEWLT-E 124
+++G G FG V+ G +G ++AVK++ +++ + L+ L E
Sbjct: 6 ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
I L +L H N+V+ +G L+ DH + E++P GS+ L ++ + L +R V
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVR 113
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
KGL YLH+ +I+RD K +NIL+D K+SDFG++K
Sbjct: 114 -QILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 76 LGEGGFGCV----FKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL 131
LG G FG V ++G ID +A+K + + ++ +++ E K + +L
Sbjct: 12 LGSGQFGVVHLGKWRGKID--------------VAIKMIREGAMSED-DFIEEAKVMMKL 56
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPNLV+L G C + +V E+M G L N+L R W + M + +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDM--CSDVCEAM 113
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
YL S I+RD N L+ + K+SDFGLA+
Sbjct: 114 EYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 58/197 (29%), Positives = 86/197 (43%), Gaps = 43/197 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR--LNQESLQGHLEWLTEIKHLGQLYH 133
+G+G FG VFK H T ++A+K+ + E + L EIK L L H
Sbjct: 20 IGQGTFGEVFKA---RHKK------TKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 134 PNLVKLIGYC-----LEDDHR---LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
N+V LI C + ++ LV+EF E+ L S +K L
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNKN-------VKFTL 118
Query: 186 GAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ 235
K GL Y+H +K +++RD K +NIL+ + KL+DFGLA+ S+
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 236 SHVSTRVMGTYGYAAPE 252
+ T + T Y PE
Sbjct: 177 PNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 35/194 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------------QESLQGHLEWL 122
LG G FGCV+K + ++A+K +N +S+ + +
Sbjct: 8 LGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF----RRASYIQPLSWT 178
T IK QL HPN+V+ LE+D +V + + L H ++ + + W
Sbjct: 60 TIIKE--QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
I +++ L L YLH +K ++++RD +NI+L + ++DFGLAK +S +
Sbjct: 118 IFVQMVLA----LRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL 170
Query: 239 STRVMGTYGYAAPE 252
T V+GT Y+ PE
Sbjct: 171 -TSVVGTILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-14
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIA---VKRLNQES-LQGHLEWLTEIKHLGQL 131
+G G FG V G GM A VK L + L +L E++ +L
Sbjct: 3 IGNGWFGKVLLGEAH----------RGMSKARVVVKELRASATPDEQLLFLQEVQPYREL 52
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT-IRMKVALGAAKG 190
HPN+++ +G C+E LLV EF P G L+N+L + ++ + ++A A G
Sbjct: 53 NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
L +LH +A I+ D N L + + K+ D+GLA
Sbjct: 113 LLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-14
Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 27/184 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+GEG +G V+KG TG ++A+K++ ES + + + EI L +L H
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPL---SWTIRMKVALGAA 188
PN+V L +++ L++EF+ L+ +L + Y+ S+ ++
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------L 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+ + HS +V++RD K N+L+D KL+DFGLA+ G V T + T Y
Sbjct: 112 QGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWY 167
Query: 249 AAPE 252
APE
Sbjct: 168 RAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 61/196 (31%), Positives = 86/196 (43%), Gaps = 53/196 (27%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQLYH 133
+GEG +G VFK E TG ++A+K+ +++ L EI+ L QL H
Sbjct: 9 IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 134 PNLVKLI-------------GYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTI 179
PNLV LI YC DH +L E P+G + HL ++ + Q L
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRG-VPEHLIKKIIW-QTL---- 110
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQS- 236
+ + + H K I+RD K NIL+ KL DFG A+ GP +
Sbjct: 111 ---------QAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159
Query: 237 HVSTRVMGTYGYAAPE 252
+V+TR Y APE
Sbjct: 160 YVATR-----WYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ESLQGHLEWLTEI 125
N + + LG G FG VF G ++ VK L + E+LQ E+ E+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKG----IEEEGGETLVLVKALQKTKDENLQ--SEFRREL 59
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-----QPLSWTIR 180
+L H N+V+L+G C E + ++ E+ G L+ L S PLS +
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + A G+ +L A+ ++RD N L+ K+S L+KD
Sbjct: 120 VALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 57/191 (29%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y + M++AVK L +L ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA----SYI----QP------LSWTIRM 181
+VK G C + D ++V+E+M G L F RA + I QP L + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+A A G+ YL S ++RD T N L+ N K+ DFG+++D + V
Sbjct: 127 HIASQIASGMVYLASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 242 VMGTYGYAAPE 252
M + PE
Sbjct: 185 TMLPIRWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 13/158 (8%)
Query: 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQ 130
+GEG FG V++G Y + + +AVK + E +L E + Q
Sbjct: 10 LGRCIGEGQFGDVYQG-----VYM-SPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP++VKLIG ++ +V E P G L ++L + S + +
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI---LYSYQLSTA 119
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
LAYL S + ++RD N+L+ KL DFGL++
Sbjct: 120 LAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 20/166 (12%)
Query: 67 TRNFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE- 124
R +LG G FG V KG WI P + +A+K + S + + +T+
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRM 181
+ +G L H +V+L+G C +L V + P GSL +H+ + + P L+W +++
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
AKG+ YL ++ ++++R+ NILL + +++DFG+A
Sbjct: 119 ------AKGMYYL--EEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIK 126
+ + +G+G FG V G ++ G +AVK + N + Q +L E
Sbjct: 6 KELKLLQTIGKGEFGDVMLG---DYR--------GNKVAVKCIKNDATAQA---FLAEAS 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ QL H NLV+L+G +E+ L +V E+M KGSL ++L R + L +K +L
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSL 109
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + YL ++ ++RD N+L+ + AK+SDFGL K+
Sbjct: 110 DVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ V+G G FG V + R ++ +K++ E + L E +
Sbjct: 1 KYEKIRVVGRGAFGIV---------HLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQ 51
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP----LSWTIRMK 182
L L HPN+++ LED ++V E+ P G+L ++ +R + + L + +++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFGLAKDGPTGSQSHVSTR 241
+AL H +++RD KT NILLD + K+ DFG++K S+S T
Sbjct: 112 LALH--------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT- 160
Query: 242 VMGTYGYAAPE 252
V+GT Y +PE
Sbjct: 161 VVGTPCYISPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 19/189 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF + H P + M++AVK L + S ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR------------RASYIQPLSWTIRMKV 183
+V+ G C E L+V+E+M G L N R L+ + +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A A G+ YL S ++RD T N L+ K+ DFG+++D + V R M
Sbjct: 128 ASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 244 GTYGYAAPE 252
+ PE
Sbjct: 186 LPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 15/153 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V++G + T +AVK L ++ ++L E + + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
L++L C ++ +V E M GSL +L A L I M A A G+AYL
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYLE 120
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ I+RD N+L+ N K++DFGLA+
Sbjct: 121 AQ--NYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + S + + E L E + +
Sbjct: 14 VLGSGAFGTVYKG-----IWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P + +L+G CL +L V + MP G L +++ I L+W +++ AKG
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
++YL ++ ++++RD N+L+ + K++DFGLA+
Sbjct: 122 MSYL--EEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 15/186 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y +++AVK L S ++ E + L L H +
Sbjct: 13 LGEGAFGKVFLA----ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENH---------LFRRASYIQPLSWTIRMKVALG 186
+VK G C+E D ++V+E+M G L L + L+ + + +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
A G+ YL S ++RD T N L+ N K+ DFG+++D + V M
Sbjct: 129 IAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 247 GYAAPE 252
+ PE
Sbjct: 187 RWMPPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 62/178 (34%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG VFKG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+ K G L+ ++ E++ GS + L RA +K L KGL YL
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL---KGLDYL 117
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
HS+K I+RD K +N+LL + KL+DFG+A T +Q +T V GT + APE
Sbjct: 118 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQ-LTDTQIKRNTFV-GTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 17/162 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV-KRLNQESLQGHLEWLTEIKHLGQLYHP 134
LGEG FG V +G +++ M IA+ R E ++L+E + + HP
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME------DFLSEAVCMKEFDHP 60
Query: 135 NLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA- 187
N+++LIG CL+ +++ FM G L + L P +M V
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 188 -AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
A G+ YL S I+RD N +L+ N N ++DFGL+K
Sbjct: 121 IASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 60/184 (32%), Positives = 84/184 (45%), Gaps = 32/184 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+A+K+++ Q + +W + E++ L QL
Sbjct: 23 IGHGSFGAV---------YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGS----LENHLFRRASYIQPLSWTIRMKVALGAA 188
HPN ++ G L + LV E+ GS LE H +PL + GA
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHK-------KPLQEVEIAAICHGAL 125
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GLAYLHS + I+RD K NILL KL+DFG A S + +GT +
Sbjct: 126 QGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYW 177
Query: 249 AAPE 252
APE
Sbjct: 178 MAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 65/189 (34%), Positives = 86/189 (45%), Gaps = 31/189 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH------- 127
V+G+G FG V R G AVK L ++ + E KH
Sbjct: 2 VIGKGSFGKVL---------LAKRKLDGKCYAVKVLQKKIVLNR----KEQKHIMAERNV 48
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L + HP LV L Y + +L V +F+ G L HL R S+ +P + R A
Sbjct: 49 LLKNVKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA---RFYAA- 103
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
A L YLHS ++YRD K NILLD + L+DFGL K+G +QS +T GT
Sbjct: 104 EIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCGT 159
Query: 246 YGYAAPEYM 254
Y APE +
Sbjct: 160 PEYLAPEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 49/171 (28%), Positives = 87/171 (50%), Gaps = 25/171 (14%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL 131
+ V+GEG FG V + I + G M A+K L + S H ++ E++ L +L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 132 -YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-------------LSW 177
+HPN++ L+G C + + E+ P G+L + L R++ ++ L+
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTS 118
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
++ A A G+ YL S+K + I+RD N+L+ N +K++DFGL++
Sbjct: 119 QQLLQFASDVATGMQYL-SEK-QFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 8e-13
Identities = 53/180 (29%), Positives = 80/180 (44%), Gaps = 19/180 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLY 132
++GEG +G V K E TG ++A+K+ + ++ + EI+ L QL
Sbjct: 8 LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
H NLV LI LV+EF+ L++ Y L + K +G+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD----LEKYPNGLDESRVRKYLFQILRGIE 114
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+ HS +I+RD K NIL+ + KL DFG A+ + V T + T Y APE
Sbjct: 115 FCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 51/157 (32%), Positives = 82/157 (52%), Gaps = 20/157 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+GEG +G V+K AR TG ++A+K RL E + EI L +L
Sbjct: 7 IGEGTYGVVYK----------ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN 56
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+V+L+ + +++L LV+EF+ L+ + +S + L + +G+
Sbjct: 57 HPNIVRLLD-VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
AY HS + V++RD K N+L+D KL+DFGLA+
Sbjct: 113 AYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 62/192 (32%), Positives = 86/192 (44%), Gaps = 29/192 (15%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKH 127
FR +VLG G FG V + E+ TG + A+K L + + +E L K
Sbjct: 1 FRCLAVLGRGHFGKVL---LAEYK------KTGELYAIKALKKGDIIARDEVESLMCEKR 51
Query: 128 L----GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ HP LV L +DH V E+ G L H+ + +P + V
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACV 110
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
LG L YLH +K ++YRD K N+LLD K++DFGL K+G G ST
Sbjct: 111 VLG----LQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FC 162
Query: 244 GTYGYAAPEYMA 255
GT PE++A
Sbjct: 163 GT-----PEFLA 169
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-12
Identities = 59/178 (33%), Positives = 85/178 (47%), Gaps = 19/178 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG VFKG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+ K G L+D ++ E++ GS + L PL T + KGL YL
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYL 117
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
HS+K I+RD K +N+LL + KL+DFG+A G +GT + APE
Sbjct: 118 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 68/201 (33%), Positives = 94/201 (46%), Gaps = 57/201 (28%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLT--EIKHL 128
LG+G +G V+K ID T V+A+K++ N Q T EI L
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKIFDAFRNATDAQ-----RTFREIMFL 60
Query: 129 GQLY-HPNLVKLIG-YCLEDDHRL-LVYEFMP--------KGSLEN-HLFRRASYI--QP 174
+L HPN+VKL+ E+D + LV+E+M LE+ H +R YI Q
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH--KR--YIMYQL 116
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGP 231
L K L Y+HS VI+RD K SNILL+ + KL+DFGLA+ +
Sbjct: 117 L-------------KALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 232 TGSQSHVSTRVMGTYGYAAPE 252
++ V T + T Y APE
Sbjct: 162 ENPENPVLTDYVATRWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-12
Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 24/180 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y T V+A+K+++ Q + +W + E+K L ++
Sbjct: 33 IGHGSFGAV---------YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN ++ G L + LV E+ GS + L + +PL + GA +GLA
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLA 139
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLHS +I+RD K NILL KL+DFG A S + + +GT + APE
Sbjct: 140 YLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 29/165 (17%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
TG +AVK+++ Q E+ + HPN+V++ L D +V EF+ G+
Sbjct: 43 TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 161 LENHLFRRASYIQPLSWTIRMK------VALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214
L + + RM V L K L++LH+ VI+RD K+ +ILL
Sbjct: 103 LTD-----------IVTHTRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT 149
Query: 215 LNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
+ KLSDFG ++K+ P ++GT + APE ++
Sbjct: 150 SDGRVKLSDFGFCAQVSKEVPR------RKSLVGTPYWMAPEVIS 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 62/195 (31%), Positives = 89/195 (45%), Gaps = 36/195 (18%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQL 131
+GEG +G V+K D+ T G ++A+K RL+ E + + EIK L QL
Sbjct: 13 GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 132 YHPNLVKLIGYCLEDDHRL----------LVYEFMPK---GSLENHLFR-RASYIQPLSW 177
H N+V L + L LV+E+M G LE+ L +I+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-- 121
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
MK L +GL Y H K ++RD K SNILL+ KL+DFGLA+ +
Sbjct: 122 ---MKQLL---EGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 238 VSTRVMGTYGYAAPE 252
+ +V+ T Y PE
Sbjct: 174 YTNKVI-TLWYRPPE 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 30/196 (15%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-------LQGHLEWL 122
++ ++G G +G V++G TG V+A+K +N ++ +Q + L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALL 53
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
++++ Q PN+ K G RL ++ E+ GS+ + +A I ++ +
Sbjct: 54 SQLRQ-SQP--PNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVII 107
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+ L A L Y+H K VI+RD K +NIL+ N KL DFG+A S S ST
Sbjct: 108 REVLVA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTF 161
Query: 242 VMGTYGYAAPEYMATG 257
V GT + APE + G
Sbjct: 162 V-GTPYWMAPEVITEG 176
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 32/190 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY 132
LG+GGFG V A TG + A K+LN++ L +G+ + E + L ++
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF----RRASYIQPLSWTIRMKVALGA 187
H + + Y + L LV M G L H++ + +P + ++ G
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG- 109
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQSHVSTRVMG 244
L +LH + ++IYRD K N+LLD + N ++SD GLA KDG + ++ + G
Sbjct: 110 ---LEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----G 159
Query: 245 TYGYAAPEYM 254
T G+ APE +
Sbjct: 160 TPGFMAPELL 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
LG G FG V ++ Y ++ M +AVK L +E+L L+ ++ H
Sbjct: 42 TLGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS---H 94
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
LG H N+V L+G C L++ E+ G L N L R+ L+ + +
Sbjct: 95 LGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQV 150
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
AKG+A+L S I+RD N+LL K+ DFGLA+D
Sbjct: 151 AKGMAFLASKNC--IHRDLAARNVLLTHGKIVKICDFGLARD 190
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 42/172 (24%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLT--EIKHLGQLYHPNLVKL----------IGYCLE--- 145
TG +A+K++ + L T E+K L L H N++ L I + E
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG 93
Query: 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204
D HRLL LE +IQ + I +GL Y+HS A V++R
Sbjct: 94 TDLHRLL-----TSRPLEKQ------FIQYFLYQI--------LRGLKYVHS--AGVVHR 132
Query: 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT 256
D K SNIL++ N + K+ DFGLA+ +VSTR Y APE M T
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLT 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 42/199 (21%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLY 132
S +GEG +G V + T G+ +A+K+++ Q L EIK L +
Sbjct: 11 SYIGEGAYGMVCSA-THKPT--------GVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 133 HPNLVK----LIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS---------WT 178
H N++ + E + + +V E M E L++ Q LS
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYK-LIKTQHLSNDHIQYFLYQI 115
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK-DGPTGSQSH 237
+R GL Y+HS A V++RD K SN+LL+ N + K+ DFGLA+ P +
Sbjct: 116 LR---------GLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 238 VSTRVMGTYGYAAPEYMAT 256
T + T Y APE M
Sbjct: 165 FLTEYVATRWYRAPEIMLN 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 49/195 (25%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPG-TGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLY 132
+GEG +G V++ AR +G ++A+K R++ E + L EI L L
Sbjct: 15 IGEGTYGIVYR----------ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR 64
Query: 133 HPNLVKL---------------IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
HPN+V+L + YC +D LL + MP P S
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP---------------TPFSE 107
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ + L +GL YLH + +I+RD K SN+LL K++DFGLA+ G +
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAK 163
Query: 238 VSTRVMGTYGYAAPE 252
T + T Y APE
Sbjct: 164 PMTPKVVTLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLT 123
N+R +LG G FG V Y TG +AVK++ +QE+ +
Sbjct: 3 NWRLGKLLGRGAFGEV---------YLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIR 180
EI+ L L H +V+ G CL D + +L ++ E+MP GS+++ L + L+ +
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVT 108
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+ +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 109 RRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 241 R-VMGTYGYAAPE 252
+ V GT + +PE
Sbjct: 167 KSVTGTPYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 15/184 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
V+G G FG VF+G + P R + I + Q ++L+E +GQ H
Sbjct: 12 VIGAGEFGEVFRGILK----MPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHH 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+++L G + +++ E+M G+L+ +L ++ G A G+ YL
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL 123
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAAP 251
SD V +RD NIL++ N K+SDFGL++ D P G+ + ++ + AP
Sbjct: 124 -SDMNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAP 179
Query: 252 EYMA 255
E +A
Sbjct: 180 EAIA 183
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 101 TGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYE 154
TG + A+K + + + + LTE L Q P +VKL Y + L LV E
Sbjct: 17 TGDIYAIKVIKKADMIRKNQVDQV--LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVME 73
Query: 155 FMPKGSLENHLFRRASYIQPL-SWTIRMKVALGA--AKGLAYLHSDKAKVIYRDFKTSNI 211
++P G L AS ++ + S + A L YLHS+ +I+RD K NI
Sbjct: 74 YLPGGDL-------ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNI 124
Query: 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVS------TRVMGTYGYAAPE 252
L+D N + KL+DFGL+K G Q +++ R++GT Y APE
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 62/192 (32%), Positives = 89/192 (46%), Gaps = 31/192 (16%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E K
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGESMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFR--RASYIQPLSWTIRMKV 183
+ + + V + Y E D LV M G L+ H++ A + + +
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-------RA 104
Query: 184 ALGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
AA+ GL LH ++ ++YRD K NILLD + + ++SD GLA P G +
Sbjct: 105 VFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKG 160
Query: 241 RVMGTYGYAAPE 252
RV GT GY APE
Sbjct: 161 RV-GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 28/173 (16%)
Query: 76 LGEGGFGCVFKG---WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHL 128
LGEG FG V ID+ +P + +AVK L ++ + L L +K +
Sbjct: 23 LGEGCFGQVVMAEALGIDKD-----KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA------SYI------QPLS 176
G+ H N++ L+G C +D ++ E+ KG+L +L R SY + ++
Sbjct: 78 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + A+G+ YL S K I+RD N+L+ N K++DFGLA+D
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKC--IHRDLAARNVLVTENNVMKIADFGLARD 186
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 16/153 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G+ + HT +A+K L Q S+ +L E + QL HP
Sbjct: 14 LGAGQFGEVWMGYYNGHTK----------VAIKSLKQGSMSPE-AFLAEANLMKQLQHPR 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L ++ ++ E+M GSL + L ++ I M A A+G+A++
Sbjct: 63 LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDM--AAQIAEGMAFI- 118
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
++ I+RD + +NIL+ K++DFGLA+
Sbjct: 119 -ERKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--H 133
LGEG FG V + + + +RP + +AVK L + L L L +L H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWTIRM 181
N++ L+G C ++ ++ E+ KG+L L R + LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A A+G+ YL S + I+RD N+L+ + K++DFGLA+
Sbjct: 138 SCAYQVARGMEYLESRRC--IHRDLAARNVLVTEDNVMKIADFGLARG 183
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 63/221 (28%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQG 117
L T F V+GEG +G V+K + T G ++A+K ++ +E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIEDEEEEIKE 51
Query: 118 HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL------LVYEFMPKGSL---------- 161
L + HPN+ G ++ + LV E GS+
Sbjct: 52 EYNIL---RKYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106
Query: 162 -----ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216
E + +YI +R +GLAYLH +K VI+RD K NILL N
Sbjct: 107 GKRLKEEWI----AYI------LR-----ETLRGLAYLHENK--VIHRDIKGQNILLTKN 149
Query: 217 YNAKLSDFGLAKDGPTGSQSHVSTR--VMGTYGYAAPEYMA 255
KL DFG++ S + R +GT + APE +A
Sbjct: 150 AEVKLVDFGVSAQ----LDSTLGRRNTFIGTPYWMAPEVIA 186
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 60/219 (27%), Positives = 82/219 (37%), Gaps = 55/219 (25%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGH-LEWLTEI 125
+F V+G G FG V+ TG V A+K L + + + E
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT----IR 180
L P +VKL Y +D+ L LV E+MP G L N L R+ + P
Sbjct: 53 DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAE 109
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS---- 236
+ +AL + L ++H RD K NIL+D + + KL+DFGL K
Sbjct: 110 LVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161
Query: 237 ------------------HVSTRVM-----GTYGYAAPE 252
H RV GT Y APE
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 58/178 (32%), Positives = 88/178 (49%), Gaps = 19/178 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
+G+G FG V+KG ID T V+A+K ++ E + +E + EI L Q P
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+ + G L+ ++ E++ GS + L PL T + KGL YL
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYL 117
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
HS++ I+RD K +N+LL + KL+DFG+A T +Q +T V GT + APE
Sbjct: 118 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQ-LTDTQIKRNTFV-GTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 58/182 (31%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI--LVREKA-------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA---- 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS V+YRD K N++LD + + K++DFGL K+G + + GT Y A
Sbjct: 108 LGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 163
Query: 251 PE 252
PE
Sbjct: 164 PE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 26/187 (13%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKH 127
VLG+GG+G VF+ TG + A+K L + ++ H + E
Sbjct: 2 KVLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L + HP +V LI Y + +L L+ E++ G L HL R +++ + +++L
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG-PTGSQSHVSTRVMGT 245
L +LH + +IYRD K NILLD + KL+DFGL K+ G+ +H GT
Sbjct: 113 ----LEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGT 163
Query: 246 YGYAAPE 252
Y APE
Sbjct: 164 IEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-12
Identities = 51/156 (32%), Positives = 72/156 (46%), Gaps = 18/156 (11%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G G +G V+K D T G ++A+K + E EI L + H
Sbjct: 9 QRIGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRH 59
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLEN--HLFRRASYIQPLSWTIRMKVALGAAKGL 191
PN+V G L D +V E+ GSL++ + R PLS V KGL
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGL 114
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
AYLH I+RD K +NILL + + KL+DFG++
Sbjct: 115 AYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQLYHP 134
LGE FG ++KG H Y P +V A+K L + Q E+ E + +L+HP
Sbjct: 13 LGECAFGKIYKG----HLYLPGMDHAQLV-AIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-------------QPLSWTIRM 181
N+V L+G ++ +++E++ +G L L R+ + L +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
+A+ A G+ YL S +++D NIL+ + K+SD GL+++ + V +
Sbjct: 128 HIAIQIAAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 242 VMGTYGYAAPEYMATGIF 259
+ + PE + G F
Sbjct: 186 SLLPIRWMPPEAIMYGKF 203
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 62/196 (31%), Positives = 93/196 (47%), Gaps = 45/196 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLN-QESLQG-HLEWLTEI---KHLG 129
+GEG +G V+K AR TG +A+K++ S +G L L EI K L
Sbjct: 7 IGEGAYGTVYK----------ARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE 56
Query: 130 QLYHPNLVKLIGYCL--EDDHRL---LVYEFMPKGSLENHLFRRASYIQPL------SWT 178
HPN+V+L+ C D L LV+E + + L A+Y+ T
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-----DQDL---ATYLSKCPKPGLPPET 108
Query: 179 IR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
I+ M+ L +G+ +LHS ++++RD K NIL+ + K++DFGLA+ S
Sbjct: 109 IKDLMRQLL---RGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFE 160
Query: 237 HVSTRVMGTYGYAAPE 252
T V+ T Y APE
Sbjct: 161 MALTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 62/190 (32%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E +
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L ++ +V L Y E D LV M G L+ H++ + +
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD-----EERAVF 106
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL LH ++ ++YRD K NILLD + ++SD GLA + P G + RV
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV 162
Query: 243 MGTYGYAAPE 252
GT GY APE
Sbjct: 163 -GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V G W ++ +A+K + + S+ E++ E K + +L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMKLSHE 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
LV+L G C + +V E+M G L N+L QP +++ +G+AYL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYL 116
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
S + I+RD N L+D K+SDFGL++
Sbjct: 117 ESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 57/186 (30%), Positives = 85/186 (45%), Gaps = 31/186 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEWLTEIKHLGQLYH 133
+GEG +G V+K D T IA+K RL QE + EI L ++ H
Sbjct: 10 IGEGTYGVVYKAR-DRVT--------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRRASYIQPLSWTIRMKVALGA 187
N+V+L + LV+E++ L+ H+ + I+ + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI-------- 111
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+G+AY HS + V++RD K N+L+D NA KL+DFGLA+ G T + T
Sbjct: 112 LRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTL 167
Query: 247 GYAAPE 252
Y APE
Sbjct: 168 WYRAPE 173
|
Length = 294 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-11
Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 23/168 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + S H ++ E++ L +L +
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------------FRRASYIQPLSWTIR 180
HPN++ L+G C + L E+ P G+L + L S LS
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ A A+G+ YL + + I+RD NIL+ NY AK++DFGL++
Sbjct: 115 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 27/222 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGW-IDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLT-- 123
N+R +LG+G FG V+ + +D TG +A K++ + ES + E
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAAKQVQFDPESPETSKEVSALE 52
Query: 124 -EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTI 179
EI+ L L H +V+ G CL D + L ++ E+MP GS+++ L + L+ ++
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESV 107
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
K +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 108 TRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 240 TR-VMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLP 280
R V GT + +PE ++ + +++ C+++ + P
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 51/187 (27%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIKHLGQL 131
+ V+G G FG V +G P + +A+K L + + ++L+E +GQ
Sbjct: 9 EEVIGAGEFGEVCRG----RLKLPGKREI--FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN++ L G + +++ EFM G+L++ L + + ++ G A G+
Sbjct: 63 DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGM 119
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG---TYGY 248
YL S+ V +RD NIL++ N K+SDFGL++ + T +G +
Sbjct: 120 KYL-SEMNYV-HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 249 AAPEYMA 255
APE +A
Sbjct: 178 TAPEAIA 184
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 57/180 (31%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLY 132
+G G FG V Y V+A+K+++ Q + +W + E++ L +L
Sbjct: 23 IGHGSFGAV---------YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HPN ++ G L + LV E+ GS + L + +PL V GA +GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLHS +I+RD K NILL KL DFG A S + +GT + APE
Sbjct: 130 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 47/193 (24%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G P T +A+K +N+ S++ +E+L E + +
Sbjct: 14 LGQGSFGMVYEGI--AKGVVKDEPETR--VAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ--------PLSWTIRMKVALG 186
++V+L+G + L++ E M +G L+++L ++ L I+M A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM--AGE 127
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
A G+AYL+++ K ++RD N ++ ++ K+ DFG+ +D + +
Sbjct: 128 IADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 247 GYAAPEYMATGIF 259
+ +PE + G+F
Sbjct: 186 RWMSPESLKDGVF 198
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 55/159 (34%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 101 TGMVIAVKRL----NQESLQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLEDDHRLLVYE 154
TG V+AVK++ N+E + L L + H P +VK GY + D + E
Sbjct: 39 TGHVMAVKQMRRTGNKEENKRILMDLDVV----LKSHDCPYIVKCYGYFITDSDVFICME 94
Query: 155 FMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214
M + + L +R P+ I K+ + K L YL +K VI+RD K SNILLD
Sbjct: 95 LM--STCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYL-KEKHGVIHRDVKPSNILLD 149
Query: 215 LNYNAKLSDFGLAKDGP-TGSQSHVSTRVMGTYGYAAPE 252
+ N KL DFG++ G S++ TR G Y APE
Sbjct: 150 ASGNVKLCDFGIS--GRLVDSKAK--TRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 32/213 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLGQ 130
LG GGFG V A+K + + Q H+ +E + L +
Sbjct: 1 LGVGGFGRVELV-----KVKS----KNRTFALKCVKKRHIVETGQQEHI--FSEKEILEE 49
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP +VKL + + ++ E+ G L L R + +T R +A
Sbjct: 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD---EYTARFYIA-CVVLA 105
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
YLH+ +IYRD K N+LLD N KL DFG AK +G ++ GT Y A
Sbjct: 106 FEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVA 160
Query: 251 PEYM-------ATGIFQLVLLLFTFECSLLHFS 276
PE + + + L +LL+ F
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 60/183 (32%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLG-Q 130
VLG+G FG V GT V A+K L ++ + + +TE + L
Sbjct: 2 VLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 131 LYHPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HP L L C + RL V E++ G L + R + +P S +V L
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--- 108
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
L +LH + VIYRD K NILLD + KL+DFG+ K+G +T GT Y
Sbjct: 109 -LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYI 163
Query: 250 APE 252
APE
Sbjct: 164 APE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 25/221 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLE---WLT 123
N+R +LG+G FG V Y TG +AVK++ + ES + E
Sbjct: 3 NWRLGKLLGQGAFGRV---------YLCYDADTGRELAVKQVQFDPESPETSKEVNALEC 53
Query: 124 EIKHLGQLYHPNLVKLIGYCLED--DHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIR 180
EI+ L L H +V+ G CL D + L ++ E MP GS+++ L SY L+ +
Sbjct: 54 EIQLLKNLLHERIVQYYG-CLRDPMERTLSIFMEHMPGGSIKDQL---KSY-GALTENVT 108
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
K +G++YLHS+ +++RD K +NIL D N KL DFG +K T S
Sbjct: 109 RKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 241 R-VMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLP 280
+ V GT + +PE ++ + +++ C+++ + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 61/188 (32%), Positives = 86/188 (45%), Gaps = 29/188 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLG 129
V+G+G FG V R G AVK L ++++ Q H+ + L
Sbjct: 2 VIGKGSFGKVL---------LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-LK 51
Query: 130 QLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L HP LV L Y + +L V +++ G L HL R +++P + +VA
Sbjct: 52 NLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA---- 106
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGTY 246
+ YLHS +IYRD K NILLD + L+DFGL K+G P + S GT
Sbjct: 107 SAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS----TFCGTP 160
Query: 247 GYAAPEYM 254
Y APE +
Sbjct: 161 EYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G +G V YA T + IA+K + + + EI L H
Sbjct: 15 VLGKGTYGIV---------YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM--KVALGAAKGLA 192
N+V+ +G E+ + E +P GSL L + ++ TI K L +GL
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---EGLK 122
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
YLH + ++++RD K N+L++ Y+ K+SDFG +K + + GT Y A
Sbjct: 123 YLHDN--QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKR--LAGINPCTETFTGTLQYMA 177
Query: 251 PEYMATG 257
PE + G
Sbjct: 178 PEVIDKG 184
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-11
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 16/153 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V G + +A+K +N+ ++ +++ E K + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQ----------IKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPK 60
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L G C + +V EFM G L N+L +R + + + + +G+ YL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYL- 116
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
++ I+RD N L+ K+SDFG+ +
Sbjct: 117 -ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL---NQESLQGHLEWLTEIKHLGQLY 132
LG G G V K +H P TG V+A K + + S++ + L E++ + +
Sbjct: 13 LGAGNGGSVSKV---KH-----IP-TGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECR 61
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
P +V G L +++ + EFM GSL+ ++++ P+ I K+A+ +GL
Sbjct: 62 SPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG---PIPVEILGKIAVAVVEGLT 117
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YL+ + ++++RD K SNIL++ KL DFG++ + + ++ +GT Y +PE
Sbjct: 118 YLY-NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGE----LINSIADTFVGTSTYMSPE 172
Query: 253 YMATGIFQLVLLLFTFECSLLHFSLQ 278
+ G + + +++ S++ +L
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 31/195 (15%)
Query: 69 NFRPDSVLGEGGFG--CVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ +G G FG + + I EH YA VI RL QE H+ E +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI---RLKQEQ---HVH--NEKR 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L ++ HP +++L + E D R L + E++P G L ++L + S + + A
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRF----SNSTGLFYA 107
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR--- 241
L YLHS +++YRD K NILLD + KL+DFG AK + R
Sbjct: 108 SEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--------LRDRTWT 157
Query: 242 VMGTYGYAAPEYMAT 256
+ GT Y APE + +
Sbjct: 158 LCGTPEYLAPEVIQS 172
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 23/192 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
+F VLG+G FG V R GT + A+K L ++ + +E + E
Sbjct: 1 DFNFLMVLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ L P + + C + RL V E++ G L H+ + + +P + +++
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM- 243
+G L +LH + +IYRD K N++LD + K++DFG+ K+ V+TR
Sbjct: 112 VG----LFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFC 162
Query: 244 GTYGYAAPEYMA 255
GT Y APE +A
Sbjct: 163 GTPDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 27/160 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
+GEG +G VFK E T ++A+KR+ + + L EI L +L H
Sbjct: 8 IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA----LGAA 188
N+V+L L D +L LV+E+ + L + Y + I ++
Sbjct: 59 KNIVRLYD-VLHSDKKLTLVFEY-----CDQDLKK---YFDSCNGDIDPEIVKSFMFQLL 109
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
KGLA+ HS V++RD K N+L++ N KL+DFGLA+
Sbjct: 110 KGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 56/193 (29%), Positives = 84/193 (43%), Gaps = 28/193 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLT-EIKHLGQLY 132
+G+G FG V K R G ++ K ++ ++ + L E+ L +L
Sbjct: 7 TIGKGSFGTVRK---------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 133 HPNLVKLIGYCLEDDHRLL--VYEFMPKGSLENHLFRRA----SYI-QPLSWTIRMKVAL 185
HPN+V+ ++ ++ L V E+ G L L ++ YI + W I ++ L
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 186 GAAKGLAYLH---SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
L H V++RD K +NI LD N N KL DFGLAK S T V
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYV 171
Query: 243 MGTYGYAAPEYMA 255
GT Y +PE +
Sbjct: 172 -GTPYYMSPEQLN 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-11
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 26/168 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV-IAVKRLNQESLQGHLE-----WL 122
+ + V+G G FG V G + PG + +A+K L G+ E +L
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLK-------LPGKREIPVAIKTLKA----GYTEKQRRDFL 53
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+E +GQ HPN++ L G + ++V E+M GSL+ L + +T+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-----QFTVIQL 108
Query: 183 VAL--GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
V + G A G+ YL SD V +RD NIL++ N K+SDFGL++
Sbjct: 109 VGMLRGIASGMKYL-SDMGYV-HRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLY 132
VLG+G FG VF P G + A+K L + +L+ + E L ++
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA-AKG 190
HP +VKL Y + + +L L+ +F+ G L L + + + +K L A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAELALA 110
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L +LHS +IYRD K NILLD + KL+DFGL+K+ + S GT Y A
Sbjct: 111 LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 166
Query: 251 PE 252
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 18/177 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A+K++N + + EI + + HPN
Sbjct: 27 IGQGASGTV---------YTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + + V + L +LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLH 132
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
S++ VI+RD K+ NILL ++ + KL+DFG T QS ST V GT + APE
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 61/190 (32%), Positives = 85/190 (44%), Gaps = 27/190 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A K+L ++ ++ G L E K
Sbjct: 2 FRHYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ + + V + Y E D LV M G L+ H++ + +
Sbjct: 52 RILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-----PGFDEQRAIF 106
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL L + +++YRD K NILLD + ++SD GLA P G V RV
Sbjct: 107 YAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV 162
Query: 243 MGTYGYAAPE 252
GT GY APE
Sbjct: 163 -GTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 48/196 (24%), Positives = 90/196 (45%), Gaps = 30/196 (15%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR------LNQESLQGHLE 120
NF+ + +G+G F V+K G V+A+K+ ++ ++ Q +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQ---D 48
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE---NHLFRRASYI-QPLS 176
L EI L QL HPN++K + +E++ +V E G L H ++ I +
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
W +++ L ++HS ++++RD K +N+ + KL D GL + S++
Sbjct: 109 WKYFVQL----CSALEHMHSK--RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKT 160
Query: 237 HVSTRVMGTYGYAAPE 252
+ ++GT Y +PE
Sbjct: 161 TAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQLYHP 134
+G G FG V G ++ Y PA+ + VK L S+Q +++L E + L H
Sbjct: 3 IGNGWFGKVILGEVNS-GYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVALGAAKGLA 192
NL++ +G C E LLV EF P G L+ +L R+A + P T++ ++A A GL
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLL 114
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+LH K I+ D N LL + K+ D+GL+
Sbjct: 115 HLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 22/170 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHLGQL 131
LGEG FG V + +P +AVK L ++ + L L +K +G+
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK- 82
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA------SY------IQPLSWTI 179
H N++ L+G C +D ++ E+ KG+L +L R Y + LS+
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 142 LVSCAYQVARGMEYLASKKC--IHRDLAARNVLVTEDNVMKIADFGLARD 189
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 7e-11
Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 33/185 (17%)
Query: 78 EGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQES-LQGH-LEWLTEIKHLGQLYHP 134
EG +G V++ AR TG ++A+K+L E +G + L EI L +L HP
Sbjct: 15 EGTYGVVYR----------ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 135 NLVKL----IGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLSWTIRMKVALGA 187
N+V + +G L D +V E++ K +E + ++Q + M L
Sbjct: 65 NIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCL-MLQLL-- 116
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+A+LH + +++RD KTSN+LL+ K+ DFGLA+ GS T+++ T
Sbjct: 117 -SGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 248 YAAPE 252
Y APE
Sbjct: 172 YRAPE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-11
Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 24/139 (17%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
EI+ L + HPN+VK + ++ EFM GSLE ++ ++ I
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI---- 177
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------DGPTGSQSH 237
G+AYLH + +++RD K SN+L++ N K++DFG+++ D P S
Sbjct: 178 ----LSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS-- 228
Query: 238 VSTRVMGTYGYAAPEYMAT 256
+GT Y +PE + T
Sbjct: 229 -----VGTIAYMSPERINT 242
|
Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V +G A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI---------LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E++ G L HL R + + + ++
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIV----SA 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS K++YRD K N++LD + + K++DFGL K+G T + + + GT Y A
Sbjct: 108 LDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLA 163
Query: 251 PEYM-------ATGIFQLVLLLFTFECSLLHFSLQ 278
PE + A + L ++++ C L F Q
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGH-LEWLTEI 125
+ + + +GEG +G VFK A G +A+KR+ Q +G L + E+
Sbjct: 1 QQYECVAEIGEGAYGKVFK--------ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 52
Query: 126 ---KHLGQLYHPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
+HL HPN+V+L C + LV+E + + L +L + P
Sbjct: 53 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 111
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
M L +GL +LHS + V++RD K NIL+ + KL+DFGLA+ S
Sbjct: 112 IKDMMFQL--LRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQM 164
Query: 238 VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFEC 270
T V+ T Y APE + + + L++ C
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHT-YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
++ P VLG+G FG E T Y + +V L + S + + L EI
Sbjct: 1 HYIPIRVLGKGAFG--------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVI 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L L HPN++ + ++D+ L+ E+ G+L + + R+ + + + +
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
A ++Y+H KA +++RD KT NI L KL DFG++K GS+ ++ V+GT
Sbjct: 113 A--VSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPY 166
Query: 248 YAAPE 252
Y +PE
Sbjct: 167 YMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-10
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG+G F ++KG + PG + + +K L + L + + QL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+LVKL G C+ D++ ++V E++ G L+ L R L W ++ VA A L YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 195 HSDKAKVIYRDFKTSNILL---DLNYN----AKLSDFGLA 227
K+++ + NIL+ LN KLSD G+
Sbjct: 118 EDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E +TE + L
Sbjct: 2 LLGKGTFGKVI--LVREK-------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SA 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS V+YRD K N++LD + + K++DFGL K+G + + + GT Y A
Sbjct: 108 LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 163
Query: 251 PEYM-------ATGIFQLVLLLFTFECSLLHFSLQ 278
PE + A + L ++++ C L F Q
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 23/185 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLY 132
VLG+G FG V + E +G + AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 133 --HPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HP L +L C + RL V EF+ G L H+ + + + + ++
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----S 107
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
L +LH +IYRD K N+LLD + KL+DFG+ K+G ++ ++ GT Y
Sbjct: 108 ALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYI 163
Query: 250 APEYM 254
APE +
Sbjct: 164 APEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 62/192 (32%), Positives = 85/192 (44%), Gaps = 27/192 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK 126
FR VLG+GGFG V A TG + A KRL ++ ++ G L E K
Sbjct: 2 FRQYRVLGKGGFGEVC---------ACQVRATGKMYACKRLEKKRIKKRKGESMALNE-K 51
Query: 127 HLGQLYHPNLVKLIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ + + V + Y E D LV M G L+ H++ + +
Sbjct: 52 QILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-----PGFEEERALF 106
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL LH + +YRD K NILLD + ++SD GLA P G + RV
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV 162
Query: 243 MGTYGYAAPEYM 254
GT GY APE +
Sbjct: 163 -GTVGYMAPEVL 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 23/187 (12%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQ 130
VLG+G FG V R GT + A+K L ++ + +E + E + L
Sbjct: 6 MVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
P + + C + RL V E++ G L H+ + + +P + ++A+G
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG--- 113
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGY 248
L +LHS +IYRD K N++LD + K++DFG+ K+ G +TR GT Y
Sbjct: 114 -LFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG---KTTRTFCGTPDY 167
Query: 249 AAPEYMA 255
APE +A
Sbjct: 168 IAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 48/166 (28%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY 132
+LG+G FG V + + G+ +AVK L + E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 133 HPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYI--QP--LSWTIRMK 182
HPN++KLIG L + +++ FM G L H F S I +P L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVR 117
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ A G+ YL S I+RD N +L+ N ++DFGL+K
Sbjct: 118 FMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 17/163 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQL 131
+L EG FG +F G IDE +PG + VK + + +Q L L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGL 65
Query: 132 YHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVALGA- 187
H N++ ++ C+ED + ++Y +M G+L+ L R P + + + V +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 188 -AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A G++YLH K VI++D N ++D K++D L++D
Sbjct: 126 IACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRD 166
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 48/155 (30%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FGCV KG Y + + I V + E E + E + + QL +P
Sbjct: 3 LGSGNFGCVKKG-----VYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPY 56
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM--KVALGAAKGLAY 193
+V++IG C E + +LV E G L L + I +S + + +V++G + Y
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI-TVSNVVELMHQVSMG----MKY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
L + ++RD N+LL + AK+SDFGL+K
Sbjct: 111 L--EGKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 58/196 (29%), Positives = 89/196 (45%), Gaps = 34/196 (17%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
++ V+G+G +G V ID HT G +A+K++N E + L EIK
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHR-----LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
L L HP++V++ L R +V+E M S + + + + P +
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGS--QS 236
L + L Y+H+ A V +RD K NIL + + K+ DFGLA+ D PT
Sbjct: 111 QLL---RALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 237 HVSTRVMGTYGYAAPE 252
+V+TR Y APE
Sbjct: 166 YVATR-----WYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 57/190 (30%), Positives = 83/190 (43%), Gaps = 32/190 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL----QGHLEWLTEIKHLGQ 130
LG G FG V I +H GTG A+K L +E L H+ E L +
Sbjct: 26 LGTGSFGRV---RIAKHK------GTGEYYAIKCLKKREILKMKQVQHV--AQEKSILME 74
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L HP +V ++ +++ + EF+ G L HL + + ++ ++ L
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA---- 130
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
YLHS +IYRD K N+LLD + K++DFG AK V R G
Sbjct: 131 FEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCG--T 178
Query: 251 PEYMATGIFQ 260
PEY+A + Q
Sbjct: 179 PEYLAPEVIQ 188
|
Length = 329 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 17/184 (9%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLYH 133
+G G FG VF G + +AVK +E+L L+ +L E + L Q H
Sbjct: 3 IGRGNFGEVFSGRLR---------ADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSH 52
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+V+LIG C + +V E + G L L +++ AA G+ Y
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEY 109
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 110 LESKHC--IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA 167
Query: 254 MATG 257
+ G
Sbjct: 168 LNYG 171
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 55/189 (29%), Positives = 81/189 (42%), Gaps = 27/189 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL----NQESLQGHLEWLTEIKHLGQL 131
+G G FG V K +G ++AVKR+ +++ + L L +
Sbjct: 12 IGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP--LSWTIRMKVALGAAK 189
P +VK G + + E M SL+ ++ + + I K+A+ K
Sbjct: 63 --PYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVSTRVMGTYG 247
L YL + K+I+RD K SNILLD N N KL DFG++ G S TR G
Sbjct: 119 ALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRP 172
Query: 248 YAAPEYMAT 256
Y APE +
Sbjct: 173 YMAPERIDP 181
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 33/198 (16%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRL----NQESLQ-GHLEWLT 123
+ P + +G G +G V+K AR P +G +A+K + N++ L + +
Sbjct: 2 YEPVAEIGVGAYGTVYK----------ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVA 51
Query: 124 EIKHLGQLYHPNLVKLIGYC--LEDDHRL---LVYEFMPKGSLENHLFRRASYIQPLSWT 178
+K L HPN+V+L+ C D LV+E + + L +L + P T
Sbjct: 52 LLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE-T 109
Query: 179 IR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
I+ M+ L +GL +LH++ +++RD K NIL+ KL+DFGLA+ S
Sbjct: 110 IKDLMRQFL---RGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQ 161
Query: 237 HVSTRVMGTYGYAAPEYM 254
T V+ T Y APE +
Sbjct: 162 MALTPVVVTLWYRAPEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE----IKHLGQL 131
LGEG FG V + +P + +AVK L ++ L L +K +G+
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK- 76
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYI-----------QPLSWTI 179
H N++ L+G C +D ++ E+ KG+L +L RR + + L++
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 136 LVSCAYQVARGMEYLASQKC--IHRDLAARNVLVTEDNVMKIADFGLARD 183
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 5e-10
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 18/177 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G VF TG +A+K++N + + EI + +L +PN
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + ++ R + L +LH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRE-----CLQALEFLH 132
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+++ VI+RD K+ N+LL ++ + KL+DFG T QS ST V GT + APE
Sbjct: 133 ANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 33/197 (16%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ P +G G +G V E T +A+K++ ++ L E
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLRE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWT 178
IK L L H N++ + + HR +VYE M + H R+S Q LS
Sbjct: 55 IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSS--QTLSDD 108
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ--- 235
+GL Y+HS A V++RD K SN+LL+ N + K+ DFGLA+
Sbjct: 109 HCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT 166
Query: 236 SHVSTRVMGTYGYAAPE 252
+V TR Y APE
Sbjct: 167 EYVVTR-----WYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 46/167 (27%), Positives = 86/167 (51%), Gaps = 26/167 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIKH 127
NF+ LGEG + V+KG TG ++A+K ++ ++ +G + EI
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRA---SYIQPLSWTIRM 181
+ +L H N+V+L ++ +LV+E+M K ++ H R A + ++ ++ +
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL-- 109
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
KG+A+ H ++ V++RD K N+L++ KL+DFGLA+
Sbjct: 110 ------LKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 47/182 (25%), Positives = 91/182 (50%), Gaps = 24/182 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+LG G G V+K + T ++AVK + + +++ + ++E++ L +
Sbjct: 8 ILGHGNGGTVYKAY---------HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS 58
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P ++ G ++ + EFM GSL+ ++R+ + + ++A+ KGL Y
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK------IPEHVLGRIAVAVVKGLTY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S K+++RD K SN+L++ KL DFG++ T + ++ +GT Y APE
Sbjct: 111 LWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPER 164
Query: 254 MA 255
++
Sbjct: 165 IS 166
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 24/197 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWL 122
NF VLG G +G VF G + A+K L + ++ H
Sbjct: 1 NFELLRVLGTGAYGKVFL------VRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT--R 52
Query: 123 TEIKHLGQLYH-PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
TE + L + P LV L Y + D +L L+ +++ G L HL++R + +
Sbjct: 53 TERQVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-----E 106
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
++V + LA H + +IYRD K NILLD + L+DFGL+K+ + +
Sbjct: 107 VRVYIAEIV-LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS 165
Query: 241 RVMGTYGYAAPEYMATG 257
GT Y APE + G
Sbjct: 166 -FCGTIEYMAPEVIRGG 181
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 48/202 (23%), Positives = 81/202 (40%), Gaps = 40/202 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIK 126
++P +G G +G V +G +A+K++ + L E+K
Sbjct: 6 RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSL-----------ENHLFRRASYIQPL 175
L H N++ + D P G+ E+ L QPL
Sbjct: 57 ILRHFKHDNII-----AIRD-------ILRPPGADFKDVYVVMDLMESDLHHIIHSDQPL 104
Query: 176 SWTIRMKVALGAA-KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
+ ++ L +GL Y+HS A VI+RD K SN+L++ + ++ DFG+A+ +
Sbjct: 105 T-EEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 235 QSH--VSTRVMGTYGYAAPEYM 254
H T + T Y APE +
Sbjct: 162 TEHKYFMTEYVATRWYRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-10
Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL 131
++G GGFG V Y + TG + A+K L+++ + QG L E L +
Sbjct: 1 IIGRGGFGEV---------YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 132 YHPN--LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ + + Y +L + + M G L HL + + + ++ LG
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG-- 109
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L ++H+ V+YRD K +NILLD + + ++SD GLA D + + H S +GT+GY
Sbjct: 110 --LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 249 AAPEYMATGI 258
APE + G+
Sbjct: 162 MAPEVLQKGV 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 65/215 (30%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQL 131
+LG+G FG V + E TG A+K L +E + E LTE + L
Sbjct: 2 LLGKGTFGKVI--LVKEK-------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HP L L Y + RL V E+ G L HL R + + + ++
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SA 107
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L YLHS+K V+YRD K N++LD + + K++DFGL K+G + + GT Y A
Sbjct: 108 LDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 164
Query: 251 PEYM-------ATGIFQLVLLLFTFECSLLHFSLQ 278
PE + A + L ++++ C L F Q
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 38/197 (19%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKH 127
++ S +G G +G V A TG +A+K+L++ +S E++
Sbjct: 17 YQNLSPVGSGAYGQVCS--------AFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67
Query: 128 LGQLYHPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRA----SYIQPLSW 177
L + H N++ L+ LV M G+ N++ + +IQ L +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVY 125
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
I +GL Y+HS A +I+RD K SNI ++ + K+ DFGLA+ +
Sbjct: 126 QI--------LRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175
Query: 238 VSTRVMGTYGYAAPEYM 254
V+TR Y APE M
Sbjct: 176 VATR-----WYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 37/197 (18%)
Query: 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYH 133
G G +G V+K G A+K+ + Q EI L +L H
Sbjct: 9 GRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 134 PNLVKLIGYCLEDDHRL--LVYEFMPKGSLE---NHLFRRASYIQP-----LSWTIRMKV 183
N+V L+ LE + L++++ + H + I P L W I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI---- 117
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA----KLSDFGLAK--DGPTGSQSH 237
G+ YLHS+ V++RD K +NIL+ K+ D GLA+ + P +
Sbjct: 118 ----LNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 238 VSTRVMGTYGYAAPEYM 254
+ V+ T Y APE +
Sbjct: 172 LD-PVVVTIWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 52/177 (29%), Positives = 83/177 (46%), Gaps = 18/177 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A+K++N + + EI + + +PN
Sbjct: 27 IGQGASGTV---------YTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + ++ R + L +LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALDFLH 132
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
S++ VI+RD K+ NILL ++ + KL+DFG T QS ST V GT + APE
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 101 TGMVIAVKRLNQESLQGHLE---WLTEIKHLGQLYHPNLVKLI--GYCLEDDHRLLVYEF 155
TG +A+K L ++ + + + E +LYHPN+V L+ G V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60
Query: 156 MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-- 213
+P +L L A P T R+ L LA H +++RD K NI++
Sbjct: 61 VPGRTLREVL--AADGALPAGETGRL--MLQVLDALACAH--NQGIVHRDLKPQNIMVSQ 114
Query: 214 -DLNYNAKLSDFGLAKDGP-----TGSQSHVSTRVMGTYGYAAPE 252
+ +AK+ DFG+ P + +T V+GT Y APE
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 101 TGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLL-VYEF 155
T + A+K + +E + ++W+ KH+ + HP LV L C + + RL V E+
Sbjct: 19 TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS-CFQTESRLFFVIEY 77
Query: 156 MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
+ G L H+ R+ + + +++L L YLH + +IYRD K N+LLD
Sbjct: 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH--ERGIIYRDLKLDNVLLDS 131
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
+ KL+D+G+ K+G + ++ GT Y APE +
Sbjct: 132 EGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE 124
NFR + +G G F V++ + + +A+K++ L + + + E
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGV----------PVALKKVQIFDLMDAKARADCIKE 52
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMK 182
I L QL HPN++K +ED+ +V E G L + F++ + P +
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
V L +A L ++HS +V++RD K +N+ + KL D GL + S++ + +
Sbjct: 113 VQLCSA--LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSL 166
Query: 243 MGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF-SLQLP 280
+GT Y +PE + + +++ C L +LQ P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 16/155 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
LG G FG V KG + +AVK L ++ L E L E + QL +
Sbjct: 3 LGSGNFGTVKKGMYKMKK-------SEKTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P +V++IG C E + +LV E G L L + + + +V++G + Y
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKY 110
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
L ++ ++RD N+LL + AK+SDFGL+K
Sbjct: 111 L--EETNFVHRDLAARNVLLVTQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 25/186 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY 132
+LG+G FG VF + GT A+K L ++ + +E K + L
Sbjct: 2 MLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 133 --HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HP L L YC ++ V E++ G L H+ + P + ++ G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L +LHS ++YRD K NILLD + + K++DFG+ K+ G + GT Y
Sbjct: 109 --LQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 249 AAPEYM 254
APE +
Sbjct: 163 IAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 35/123 (28%), Positives = 56/123 (45%), Gaps = 12/123 (9%)
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
Q P + KL D+ LV E++ G + L + + P W +
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGL-PEDWA--KQYIAEVVL 108
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ LH +I+RD K N+L+D + KL+DFGL+++G + + +GT Y
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYL 160
Query: 250 APE 252
APE
Sbjct: 161 APE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 23/185 (12%)
Query: 75 VLGEGGFGCVF--KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY 132
V+G+G FG V + +E YA V+ K + ++ + H+ + L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK------VLQKKAILKKKEEKHIMSERNVL-LKNVK 54
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HP LV L + + +L V +++ G L HL R +++P + ++A L
Sbjct: 55 HPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SAL 109
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG--PTGSQSHVSTRVMGTYGYA 249
YLHS ++YRD K NILLD + L+DFGL K+ G+ S GT Y
Sbjct: 110 GYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS----TFCGTPEYL 163
Query: 250 APEYM 254
APE +
Sbjct: 164 APEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 23/189 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI 125
+F S LG G G VFK +P +G+++A K ++ E +++ + + E+
Sbjct: 6 DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQI--IREL 54
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L + P +V G D + E M GSL+ + ++A I I KV++
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPE---QILGKVSI 110
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
KGL YL +K K+++RD K SNIL++ KL DFG++ ++ +GT
Sbjct: 111 AVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGT 165
Query: 246 YGYAAPEYM 254
Y +PE +
Sbjct: 166 RSYMSPERL 174
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 25/189 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL 131
++G GGFG V Y + TG + A+K L+++ + QG L E L +
Sbjct: 1 IIGRGGFGEV---------YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 132 YH---PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
P +V + D + + M G L HL + + + ++ LG
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG-- 109
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L ++H+ V+YRD K +NILLD + + ++SD GLA D + + H S +GT+GY
Sbjct: 110 --LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGY 161
Query: 249 AAPEYMATG 257
APE + G
Sbjct: 162 MAPEVLQKG 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 13/191 (6%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V++G + T +AVK +N+ SL+ +E+L E +
Sbjct: 14 LGQGSFGMVYEGNARD--IIKGEAETR--VAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQP--LSWTIRMKVALGA--A 188
++V+L+G + L+V E M G L+++L R + P T++ + + A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
G+AYL++ K ++RD N ++ ++ K+ DFG+ +D + + +
Sbjct: 130 DGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 249 AAPEYMATGIF 259
APE + G+F
Sbjct: 188 MAPESLKDGVF 198
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 22/159 (13%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPAR---PGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG G FG V+ ++HT + PG+ V A +L E +
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--------------FLAEANVMK 56
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
L H LVKL + + ++ EFM KGSL + L QPL I + A+
Sbjct: 57 TLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AE 113
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
G+A++ ++ I+RD + +NIL+ + K++DFGLA+
Sbjct: 114 GMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 69 NFRPDSVLGEGGFGCVF-KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL----T 123
NF VLG G +G VF + H +G + A+K L + ++ + T
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD-------SGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 124 E---IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTI 179
E ++H+ Q P LV L Y + D +L L+ +++ G L HL +R + +
Sbjct: 54 ERQVLEHIRQ--SPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ----- 105
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+++ G LA H K +IYRD K NILLD N + L+DFGL+K+ + +
Sbjct: 106 EVQIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERA 163
Query: 240 TRVMGTYGYAAPEYMATG 257
GT Y AP+ + G
Sbjct: 164 YSFCGTIEYMAPDIVRGG 181
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 46/214 (21%)
Query: 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH 118
L+ +F V+G G FG V + H + V A+K L++ +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHK------SSKQVYAMKLLSKFEMIKR 84
Query: 119 LE----WLTEIKHLGQLYHPN---LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRAS 170
+ W E + + + H N +V+L Y +DD L +V E+MP G L N + ++
Sbjct: 85 SDSAFFW--EERDI--MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM---SN 136
Query: 171 YIQPLSW----TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG- 225
Y P W T + +AL A + ++H RD K N+LLD + + KL+DFG
Sbjct: 137 YDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGT 188
Query: 226 ---LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT 256
+ +G T V GT Y +PE + +
Sbjct: 189 CMKMDANG----MVRCDTAV-GTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 27/171 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYH 133
LGE FG V+KG H + A +A+K L ++ +G L E+ E +L H
Sbjct: 13 LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRA---------------SYIQPLSWT 178
PN+V L+G ++ +++ + L L R+ S ++P +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + A G+ +L S V+++D T N+L+ N K+SD GL ++
Sbjct: 127 --VHIVTQIAAGMEFLSSH--HVVHKDLATRNVLVFDKLNVKISDLGLFRE 173
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 69 NFRPDSVLGEGGFGCVF--KGWID-EHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
+ +GEG FG ++ K D EH T M + K +++ E+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----------EV 50
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI----QPLSWTIRM 181
L ++ HPN+V E+ +V E+ G L + R+ + Q LSW +++
Sbjct: 51 ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVST 240
+ GL ++H K+++RD K+ NI L N AKL DFG+A+ ++
Sbjct: 111 SL------GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 241 RVMGTYGYAAPEYM-------ATGIFQLVLLLFTFECSLLH 274
+GT Y +PE T I+ L +L+ C+L H
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL-CTLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 56/194 (28%), Positives = 84/194 (43%), Gaps = 37/194 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-------- 120
+F LG G G V K H +G+++A K + HLE
Sbjct: 2 DFEKLGELGAGNGGVVTKV---LHRP------SGLIMARKLI-------HLEIKPAIRNQ 45
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
+ E+K L + P +V G D + E M GSL+ L ++A I I
Sbjct: 46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPE---NIL 101
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS- 239
K+++ +GL YL +K K+++RD K SNIL++ KL DFG++ Q S
Sbjct: 102 GKISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSM 154
Query: 240 -TRVMGTYGYAAPE 252
+GT Y +PE
Sbjct: 155 ANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-09
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 20/178 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G+G G V Y TG +A++++N + + EI + + +PN
Sbjct: 28 IGQGASGTV---------YTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
+V + L D +V E++ GSL + + ++ R + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE-----CLQALEFLH 133
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGL-AKDGPTGSQSHVSTRVMGTYGYAAPE 252
S++ VI+RD K+ NILL ++ + KL+DFG A+ P S+ + ++GT + APE
Sbjct: 134 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 48/161 (29%), Positives = 82/161 (50%), Gaps = 18/161 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ R + LG+G FG V+ G W GT V A+K L ++ +L E +
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW----------NGTTRV-AIKTLKPGTMSPE-AFLQEAQV 54
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ +L H LV+L + ++ +V E+M KGSL + F + + L + +A
Sbjct: 55 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQI 111
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
A G+AY+ ++ ++RD + +NIL+ N K++DFGLA+
Sbjct: 112 ASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 101 TGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRL-LVYEF 155
T + A+K + +E + ++W+ KH+ + HP LV L C + + RL V EF
Sbjct: 19 TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEF 77
Query: 156 MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
+ G L H+ R+ + + +++L L +LH +IYRD K N+LLD
Sbjct: 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHE--RGIIYRDLKLDNVLLDA 131
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+ KL+D+G+ K+G ST GT Y APE
Sbjct: 132 EGHIKLTDYGMCKEG-IRPGDTTST-FCGTPNYIAPE 166
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ G+ + T +AVK L S+Q LE E + L H
Sbjct: 14 LGAGQFGEVWMGYYNNSTK----------VAVKTLKPGTMSVQAFLE---EANLMKTLQH 60
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L +++ ++ E+M KGSL + L L I + A+G+AY
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAY 118
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ ++ I+RD + +N+L+ + K++DFGLA+
Sbjct: 119 I--ERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 22/194 (11%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW 121
K +F LG G FG V + P +A+KR + + Q ++
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPP--------VAIKRFEKSKIIKQKQVDH 77
Query: 122 L-TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
+ +E K L + HP V L G ++ + LV EF+ G L R + +
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
++ L YL S ++YRD K N+LLD + K++DFG AK T + +
Sbjct: 138 AQIVLI----FEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT---- 187
Query: 241 RVMGTYGYAAPEYM 254
+ GT Y APE +
Sbjct: 188 -LCGTPEYIAPEIL 200
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 31/190 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQL 131
VLG+G FG V R GT + A+K L ++ + +E + E + L
Sbjct: 7 VLGKGSFGKVM---------LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
P + + C + RL V E++ G L + + + +P + ++A+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK----DGPTGSQSHVSTRVM-GT 245
L +LHS +IYRD K N++LD + K++DFG+ K DG V+T+ GT
Sbjct: 114 LFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-------VTTKTFCGT 164
Query: 246 YGYAAPEYMA 255
Y APE +A
Sbjct: 165 PDYIAPEIIA 174
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 52/189 (27%), Positives = 90/189 (47%), Gaps = 23/189 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI 125
+F S LG G G V K +P +G+++A K ++ E +++ + + E+
Sbjct: 6 DFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQI--IREL 54
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L + P +V G D + E M GSL+ + + A I I KV++
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPE---EILGKVSI 110
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+GLAYL +K ++++RD K SNIL++ KL DFG++ ++ +GT
Sbjct: 111 AVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGT 165
Query: 246 YGYAAPEYM 254
Y +PE +
Sbjct: 166 RSYMSPERL 174
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 56/182 (30%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K TG + A+K + E + EI + H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLEN--HLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
+V G L D + EF GSL++ H+ PLS + V+ +GL Y
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV------TGPLSESQIAYVSRETLQGLYY 121
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
LHS K K ++RD K +NILL N + KL+DFG++ S +GT + APE
Sbjct: 122 LHS-KGK-MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEV 177
Query: 254 MA 255
A
Sbjct: 178 AA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 31/73 (42%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS--QSHVS 239
K+A+ K L YLHS K VI+RD K SN+L++ N KL DFG+ +G S
Sbjct: 107 KIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAK 160
Query: 240 TRVMGTYGYAAPE 252
T G Y APE
Sbjct: 161 TIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 55/187 (29%), Positives = 80/187 (42%), Gaps = 27/187 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY 132
VLG+G FG V + G G AVK L ++ + +E K + L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 133 --HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK- 189
+P L L +H V EF+ G L H IQ + AA+
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFH-------IQDKGRFDLYRATFYAAEI 105
Query: 190 --GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
GL +LHS +IYRD K N++LD + + K++DFG+ K+ G ++ GT
Sbjct: 106 VCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPD 161
Query: 248 YAAPEYM 254
Y APE +
Sbjct: 162 YIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 26/168 (15%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ES 114
KS + N + ++ + ++V+ G G +KG GM VK +N S
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKG---------KSIKNGMQFVVKEINDVNS 728
Query: 115 LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP 174
+ +EI +G+L HPN+VKLIG C + L++E++ +L L +
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RN 776
Query: 175 LSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKL 221
LSW R K+A+G AK L +LH V+ + I++D L
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 28/194 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWL 122
NF VLG G +G VF TG + A+K L + +L H
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 123 TE---IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
TE ++H+ Q P LV L Y + + +L L+ +++ G + HL++R ++ +
Sbjct: 53 TERNVLEHVRQ--SPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---E 106
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+R LA H K ++YRD K NILLD + L+DFGL+K+ + +
Sbjct: 107 VRF---YSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 239 STRVMGTYGYAAPE 252
+ GT Y APE
Sbjct: 164 YS-FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 51/161 (31%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ R D LG+G FG V+ G W GT V A+K L ++ +L E +
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTW----------NGTTKV-AIKTLKPGTMMPE-AFLQEAQI 54
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ +L H LV L + ++ +V EFM KGSL + L L + M +
Sbjct: 55 MKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI-- 111
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
A G+AY+ ++ I+RD + +NIL+ N K++DFGLA+
Sbjct: 112 ADGMAYI--ERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + VFKG T ++A+K + E +G + E+ L L H
Sbjct: 14 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L D LV+E++ K L+ ++ + + + I + L +GLAY
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYC 120
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL--AKDGPTGSQSH 237
H + KV++RD K N+L++ KL+DFGL AK PT + S+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 35/194 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLG 129
V+G G +G V+KG H TG + A+K ++ +E ++ + L + H
Sbjct: 23 VVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH-- 71
Query: 130 QLYHPNLVKLIGYCLE------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
H N+ G ++ DD LV EF GS+ + + W +
Sbjct: 72 ---HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYI 126
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVSTR 241
+GLA+LH+ K VI+RD K N+LL N KL DFG++ D G ++
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----T 180
Query: 242 VMGTYGYAAPEYMA 255
+GT + APE +A
Sbjct: 181 FIGTPYWMAPEVIA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 52/217 (23%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKG--WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
NF+ + +G G F V++ +D A + V+ + + + EI
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--------VQIFEMMDAKARQDCVKEID 54
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIRMKVA 184
L QL HPN++K + +ED+ +V E G L + F++ + P + V
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L +A + ++HS +V++RD K +N+ + KL D GL + S++ + ++G
Sbjct: 115 LCSA--VEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVG 168
Query: 245 TYGYAAPEYMATGIFQLVLLLFTFECSLLHFS-LQLP 280
T Y +PE + + +++ C L + LQ P
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 44/139 (31%), Positives = 71/139 (51%), Gaps = 12/139 (8%)
Query: 119 LEWLTEIKHLGQL--YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPL 175
++W+ KH+ + +P LV L C + RL LV E++ G L H+ R+ +
Sbjct: 39 IDWVQTEKHVFEQASSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH 97
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
+ ++ + L +LH + +IYRD K N+LLD + + KL+D+G+ K+G G
Sbjct: 98 ARFYAAEICIA----LNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG-LGPG 150
Query: 236 SHVSTRVMGTYGYAAPEYM 254
ST GT Y APE +
Sbjct: 151 DTTST-FCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
TG +AVK+++ Q E+ + +H N+V + L D +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L + + + ++ V L + L+YLH+ VI+RD K+ +ILL + K
Sbjct: 106 LTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIK 158
Query: 221 LSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
LSDFG ++K+ P ++GT + APE ++
Sbjct: 159 LSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVIS 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGH-LEWLTEIKHLGQL 131
LGEG + V+KG + T G ++A+K RL E +G + E L L
Sbjct: 12 KLGEGSYATVYKG-RSKLT--------GQLVALKEIRLEHE--EGAPFTAIREASLLKDL 60
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
H N+V L LV+E++ L+ ++ + + + + L +GL
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGL 116
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL--AKDGPTGSQSH 237
AY H + +V++RD K N+L+ KL+DFGL AK P+ + S+
Sbjct: 117 AYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 57/190 (30%), Positives = 83/190 (43%), Gaps = 37/190 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------WLTEIKHL 128
VLG+G FG V A + GT A+K L ++ + LE + E + L
Sbjct: 2 VLGKGSFGKVM--------LAELK-GTNEFFAIKALKKDVV---LEDDDVECTMVERRVL 49
Query: 129 GQLY-HPNLVKLIGYCL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ HP L L +C +H V E++ G L H IQ +
Sbjct: 50 ALAWEHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFH-------IQSSGRFDEARARF 100
Query: 186 GAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
AA+ GL +LH +IYRD K N+LLD + + K++DFG+ K+ G ++
Sbjct: 101 YAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTF 156
Query: 243 MGTYGYAAPE 252
GT Y APE
Sbjct: 157 CGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-08
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 35/194 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-----QESLQGHLEWLTEIKHLG 129
++G G +G V+KG H TG + A+K ++ +E ++ + L + H
Sbjct: 13 LVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-- 61
Query: 130 QLYHPNLVKLIGYCLE------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
H N+ G ++ DD LV EF GS+ + + W +
Sbjct: 62 ---HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYI 116
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSHVSTR 241
+GL++LH + KVI+RD K N+LL N KL DFG++ D G ++
Sbjct: 117 CREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----T 170
Query: 242 VMGTYGYAAPEYMA 255
+GT + APE +A
Sbjct: 171 FIGTPYWMAPEVIA 184
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + VFKG T ++A+K + E +G + E+ L L H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + LV+E++ L+ +L + + + I M L +GL+Y
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYC 119
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL--AKDGPTGSQSH 237
H K K+++RD K N+L++ KL+DFGL AK PT + S+
Sbjct: 120 H--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
+G ++AVK+++ Q E+ + H N+V++ L D +V EF+ G+
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L + + + ++ V L K L+ LH+ VI+RD K+ +ILL + K
Sbjct: 104 LTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVK 156
Query: 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
LSDFG S ++GT + APE ++
Sbjct: 157 LSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELIS 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LG G FG V+ G + +T +AVK L ++ +L E + + +L H
Sbjct: 14 LGNGQFGEVWMGTWNGNTK----------VAVKTLKPGTMSPE-SFLEEAQIMKKLRHDK 62
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195
LV+L + ++ +V E+M KGSL + L L + M A A G+AY+
Sbjct: 63 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYI- 118
Query: 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
++ I+RD +++NIL+ K++DFGLA+
Sbjct: 119 -ERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 43/198 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-----NQESLQGHLEWLTEIKHLGQ 130
LG+G +G V A +A+K++ + + L L ++H
Sbjct: 8 LGQGAYGIVCSA-----RNAETSEEET--VAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ-PLSWTIRMKVALGAAK 189
H N+ CL D + F N L+ ++ L IR L A
Sbjct: 61 --HKNIT-----CLYDMDIVFPGNF-------NELYLYEELMEADLHQIIRSGQPLTDAH 106
Query: 190 ----------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQS 236
GL Y+HS A V++RD K N+L++ + K+ DFGLA+ + P +
Sbjct: 107 FQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 237 HVSTRVMGTYGYAAPEYM 254
+ T + T Y APE M
Sbjct: 165 FM-TEYVATRWYRAPEIM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 16/127 (12%)
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW----TIRMKVALGAAK 189
P +V+L +D + +V E+MP G L N + ++Y P W T + +AL A
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
+ +H RD K N+LLD + + KL+DFG T V GT Y
Sbjct: 160 SMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYI 210
Query: 250 APEYMAT 256
+PE + +
Sbjct: 211 SPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 58/253 (22%), Positives = 109/253 (43%), Gaps = 43/253 (16%)
Query: 14 PNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPD 73
G + K D S ++ + E ++ ++I ++ ++++
Sbjct: 21 NKGGSGKFEMNDKKLDEEERSHNNNAG--EDEDEEKMIDNDIN-------RSPNKSYKLG 71
Query: 74 SVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY 132
+++G G FG V++ ID T +A+K++ Q+ + E L + L
Sbjct: 72 NIIGNGSFGVVYEAICID----------TSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 133 HPNLVKLIGY----CLEDDHRLL----VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
H N++ L Y C + + + + V EF+P+ ++ ++ A L + +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKD--GPTGSQSHVSTR 241
+ LAY+HS + +RD K N+L+D N + KL DFG AK+ S S++ +R
Sbjct: 177 YQLCRALAYIHSK--FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 242 VMGTYGYAAPEYM 254
Y APE M
Sbjct: 235 F-----YRAPELM 242
|
Length = 440 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 57/182 (31%), Positives = 80/182 (43%), Gaps = 21/182 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K TG + AVK + E EI + + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLEN--HLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
+V G L + + E+ GSL++ H+ PLS V +GLAY
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHV------TGPLSELQIAYVCRETLQGLAY 121
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
LHS K K ++RD K +NILL N + KL+DFG+A S +GT + APE
Sbjct: 122 LHS-KGK-MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEV 177
Query: 254 MA 255
A
Sbjct: 178 AA 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 101 TGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
+G +AVK ++ Q E+ + H N+V++ L + ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L + + S + I V + L YLHS VI+RD K+ +ILL L+ K
Sbjct: 105 LTDIV----SQTRLNEEQI-ATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVK 157
Query: 221 LSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
LSDFG ++KD P ++GT + APE ++
Sbjct: 158 LSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVIS 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 44/131 (33%), Positives = 63/131 (48%), Gaps = 15/131 (11%)
Query: 133 HPNLVKLIGYCLEDDHRL-----LVYEFMPKGS---LENHLFRRASYIQPLSWTIRMKVA 184
HPN+VK G + D + LV E GS L L Q L + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG---QRLDEAMISYIL 134
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
GA GL +LH+++ +I+RD K +NILL KL DFG++ T ++ +T V G
Sbjct: 135 YGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQ-LTSTRLRRNTSV-G 190
Query: 245 TYGYAAPEYMA 255
T + APE +A
Sbjct: 191 TPFWMAPEVIA 201
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHP 134
LGEG + V+KG G ++A+K ++ ++ +G + E L L H
Sbjct: 13 LGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + V+E+M L ++ + + P + + M L +GLAY+
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLL---RGLAYI 119
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
H +++RD K N+L+ KL+DFGLA+ SQ++ S V T Y P+ +
Sbjct: 120 H--GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 49/222 (22%)
Query: 61 NGLKTATRNFRP-DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-- 117
N + + + + LGEG +G V K D T G ++A+K++ +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDV 51
Query: 118 ------------HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLE 162
H L E+K + ++ H N++ L+ +E D LV + M K ++
Sbjct: 52 TKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD 111
Query: 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222
+ S ++ + I GL LH K ++RD +NI ++ K++
Sbjct: 112 RKIRLTESQVKCILLQI--------LNGLNVLH--KWYFMHRDLSPANIFINSKGICKIA 161
Query: 223 DFGLAK-------DGPTGSQSHVSTRVMGTYG-----YAAPE 252
DFGLA+ + R T Y APE
Sbjct: 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPE 203
|
Length = 335 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 26/132 (19%)
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSW----TIRMKVALGAA 188
P +V+L Y +DD L +V E+MP G L N + ++Y P W T + +AL A
Sbjct: 103 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAI 158
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMG 244
+ ++H RD K N+LLD + + KL+DFG + K+G + V G
Sbjct: 159 HSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----G 205
Query: 245 TYGYAAPEYMAT 256
T Y +PE + +
Sbjct: 206 TPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 2/64 (3%)
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
LA H K ++YRD K NILLD + L DFGL+K + + + GT Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164
Query: 251 PEYM 254
PE +
Sbjct: 165 PEVL 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + V+KG T ++A+K + E +G + E+ L L H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + LV+E++ K L+ +L + I + + + L +GL Y
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYC 120
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL--AKDGPTGSQSH 237
H + KV++RD K N+L++ KL+DFGL AK PT + S+
Sbjct: 121 H--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 52/228 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----HLEWLTEIKHLGQL 131
+G+GG G V+ Y P +A+K++ +E L +L E K L
Sbjct: 10 IGKGGMGEVYLA------YDPV---CSRRVALKKI-REDLSENPLLKKRFLREAKIAADL 59
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMP--KGSLENHLFRRASYIQPLSWTIRMKVALGA-- 187
HP +V + C + D VY MP +G L + + LS + K ++GA
Sbjct: 60 IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 188 ------AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD------------ 229
+ Y+HS V++RD K NILL L + D+G A
Sbjct: 117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 230 -GPTGSQSHVST---RVMGTYGYAAPEYM-------ATGIFQLVLLLF 266
T +++GT Y APE + +T I+ L ++L+
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILY 222
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 23/184 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEIKHLGQLYHP 134
LG+G FG V+ D+ A R I V LN E++Q + E + L +L HP
Sbjct: 8 LGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHP 62
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHL--FRRASYI----QPLSWTIRMKVALGAA 188
+VK LE D ++ E+ L+ L + Q W I++ +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
G+ Y+H + ++++RD K NI L N K+ DFG+++ GS ++T GT Y
Sbjct: 118 -GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGS-CDLATTFTGTPYY 171
Query: 249 AAPE 252
+PE
Sbjct: 172 MSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 26/64 (40%), Positives = 38/64 (59%), Gaps = 3/64 (4%)
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+GL YLHS A +++RD K N+L++ N K+ DFGLA+ H++ V+ Y Y
Sbjct: 114 RGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170
Query: 249 AAPE 252
APE
Sbjct: 171 RAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 56/183 (30%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTE 124
++F+ +LG+G G VF + GTG + A+K L+++ + + LTE
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ L L HP L L + + LV ++ P G L L +R QP + +VA
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR----QPGK-CLSEEVA 105
Query: 185 -LGAAK---GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
AA+ L YLH ++YRD K NILL + + LSDF L+K QS V
Sbjct: 106 RFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSK------QSDVEP 157
Query: 241 RVM 243
+
Sbjct: 158 PPV 160
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 39/129 (30%), Positives = 57/129 (44%), Gaps = 14/129 (10%)
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP----LSWTIRMKV 183
L ++ HPN+V D H +V E+ G L + + + P L W ++M
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM-- 109
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
L H + +V++RD K+ NI L N KL DFG A+ T ++ T V
Sbjct: 110 ------CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV- 161
Query: 244 GTYGYAAPE 252
GT Y PE
Sbjct: 162 GTPYYVPPE 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+GEG FG K + + G VI +++ S + E E+ L + HPN
Sbjct: 8 IGEGSFG---KAILVKSK----EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI----QPLSWTIRMKVALGAAKGL 191
+V+ E+ + +V ++ G L + + + Q L W +++ +AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
H K+++RD K+ NI L + KL DFG+A+ S ++ +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSP 170
Query: 252 E 252
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL--NQESLQGHLEWLTEIKHLGQLY 132
V+GEG +G V K E T ++A+K+ ++E+ + L E+K L L
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 133 HPNLVKLIGYCLEDDHRLLVYEF-----------MPKGSLENHLFRRASYIQPLSWTIRM 181
N+V+L LV+E+ MP G + SYI L
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV---RSYIYQL------ 109
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
K + + H K +++RD K N+L+ N KL DFG A++ GS ++ T
Sbjct: 110 ------IKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TE 160
Query: 242 VMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPM 281
+ T Y +PE + + + +++ C L S P+
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 46/183 (25%), Positives = 87/183 (47%), Gaps = 16/183 (8%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYHP 134
LG+G +G V+K RP TG+ +A+K + E + + + E+ L + P
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+V G + + E+M GSL+ L+ + + + ++ KGL +L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
++ +I+RD K +N+L++ N KL DFG++ + + ++ +G Y APE +
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERI 173
Query: 255 ATG 257
+G
Sbjct: 174 KSG 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 15/107 (14%)
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-----FRRASYIQPLSWTIRMKVAL 185
L HPN+++ +G C+E LLV+E+ G L+++L RR S + L ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMAC 106
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232
A G+ ++H K ++ D N L + K+ D+G+ GP+
Sbjct: 107 EIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPS 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 29/166 (17%)
Query: 101 TGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYHPNLVKLI-----GYCLED-DHRLLV 152
TG+ +AVK+L++ +S+ E++ L + H N++ L+ LE+ + LV
Sbjct: 41 TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 153 YEFMPKGSLENHLFR----RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKT 208
M G+ N++ + ++Q L + I +GL Y+HS A +I+RD K
Sbjct: 101 THLM--GADLNNIVKCQKLTDDHVQFLIYQI--------LRGLKYIHS--ADIIHRDLKP 148
Query: 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
SN+ ++ + K+ DFGLA+ +V+TR Y APE M
Sbjct: 149 SNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 189
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 40/174 (22%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ----ESLQ-GHLEWLT 123
+F V+G G FG V + + TG + A+K+L + E Q H+
Sbjct: 2 DFESIKVIGRGAFGEV--RLVQKKD-------TGHIYAMKKLRKSEMLEKEQVAHVR--A 50
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRAS--------YIQP 174
E L + +P +VKL Y +D++ L L+ E++P G + L ++ + YI
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYI-- 107
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ TI +A+ + L Y+H RD K N+LLD + KLSDFGL
Sbjct: 108 -AETI---LAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 45/136 (33%), Positives = 59/136 (43%), Gaps = 14/136 (10%)
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WT 178
L E L Q+ P +V L + + +L LV F+ G L +HL R + + +T
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ AL LH K VIYRD K NILLD + L DFGL K
Sbjct: 100 AELLCAL------ENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDK 149
Query: 239 STRVMGTYGYAAPEYM 254
+ GT Y APE +
Sbjct: 150 TNTFCGTPEYLAPELL 165
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 47/175 (26%), Positives = 74/175 (42%), Gaps = 44/175 (25%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+F V+G+G FG V + TG + A+K L + +E+
Sbjct: 2 DFHTVKVIGKGAFGEV---------RLVQKKDTGKIYAMKTLLK----------SEMFKK 42
Query: 129 GQLYH-------------PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP 174
QL H P +V L Y +D L L+ EF+P G L L + ++ +
Sbjct: 43 DQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED 101
Query: 175 LS--WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
++ + +A+ A L ++H RD K NIL+D + KLSDFGL+
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-06
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 7/130 (5%)
Query: 124 EIKHLGQLYHPNLVKLI-GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
E + L QL HPN+V + ED +V F G L + L + + P + +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
V + A L YLH + +++RD KT N+ L K+ D G+A+ +Q +++ +
Sbjct: 109 VQIAMA--LQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTL 162
Query: 243 MGTYGYAAPE 252
+GT Y +PE
Sbjct: 163 IGTPYYMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 7e-06
Identities = 43/131 (32%), Positives = 58/131 (44%), Gaps = 15/131 (11%)
Query: 133 HPNLVKLIG-YCLED----DHRLLVYEFMPKGS---LENHLFRRASYIQPLSWTIRMKVA 184
HPN+VK G Y +D D LV E GS L +R ++ + A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L GL +LH +K I+RD K +NILL KL DFG++ S +G
Sbjct: 134 L---MGLQHLHVNKT--IHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVG 186
Query: 245 TYGYAAPEYMA 255
T + APE +A
Sbjct: 187 TPFWMAPEVIA 197
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 27/163 (16%)
Query: 101 TGMVIAVKRLNQESLQGHL---EWLTEIKHLGQLYHPNLVKLIGY-----CLEDDHRL-L 151
TG +A+K+L + Q L E++ L + H N++ L+ L+ H L
Sbjct: 39 TGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97
Query: 152 VYEFMPK--GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209
V FM G L H IQ L + + KGL Y+H+ A +I+RD K
Sbjct: 98 VMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--------LKGLKYIHA--AGIIHRDLKPG 147
Query: 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
N+ ++ + K+ DFGLA+ + +V TR Y APE
Sbjct: 148 NLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 37/197 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEI 125
+N P +G G +G V + D +AVK+L++ +SL E+
Sbjct: 18 QNLTP---VGSGAYGSVCSAY-DTRLRQK--------VAVKKLSRPFQSLIHARRTYREL 65
Query: 126 KHLGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHL-FRRAS--YIQPLSW 177
+ L + H N++ L+ +E+ + + + + L N + ++ S ++Q L +
Sbjct: 66 RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIY 125
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ +GL Y+HS A +I+RD K SN+ ++ + ++ DFGLA+ +
Sbjct: 126 QL--------LRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY 175
Query: 238 VSTRVMGTYGYAAPEYM 254
V+TR Y APE M
Sbjct: 176 VATR-----WYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
+ +LG G FG + +G + P++ + +A+ L S + +L E LGQ
Sbjct: 10 ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQF 63
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
H N+V+L G + ++V E+M G+L++ L + L M + G A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGM 120
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225
YL + +++ +L++ + K+S F
Sbjct: 121 KYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 101 TGMVIAVKRLNQESL--QGHLEWLTEIKH-LGQLYHPNLVKLIGYCLEDDHRL-LVYEFM 156
TG + A+K + + L Q + + E + L P + +L Y +D L LV E+
Sbjct: 25 TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ-YAFQDKDNLYLVMEYQ 83
Query: 157 PKGSLENHLFRRASYIQPLS------WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210
P G L + L R Y + + +A+ + + Y+H RD K N
Sbjct: 84 PGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMGYVH--------RDIKPEN 132
Query: 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMAT 256
+L+D + KL+DFG A + V S +GT Y APE + T
Sbjct: 133 VLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYIAPEVLTT 177
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 38/202 (18%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ RP LG G G VF +D +AVK++ Q L EIK
Sbjct: 8 MDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHALREIKI 55
Query: 128 LGQLYHPNLVKLI------GYCLEDDHRLL--------VYEFMPKGSLENHLFRRASYIQ 173
+ +L H N+VK+ G L +D L V E+M E L
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDL-ANVLEQG 109
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAK--DG 230
PLS +GL Y+HS A V++RD K +N+ ++ + K+ DFGLA+ D
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
Query: 231 PTGSQSHVSTRVMGTYGYAAPE 252
+ ++S ++ + Y +P
Sbjct: 168 HYSHKGYLSEGLVTKW-YRSPR 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 53/186 (28%), Positives = 81/186 (43%), Gaps = 25/186 (13%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQL-Y 132
+GEG F V K + TG A+K + + +SL+ L EI+ L +L
Sbjct: 7 IGEGTFSEVLKA---QSRK------TGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSP 56
Query: 133 HPNLVKLIGYCLEDDH-RL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
HPN+++LI + RL LV+E M +L + R + M L K
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLL---KS 112
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
L ++H + + +RD K NIL+ + KL+DFG + T + T Y A
Sbjct: 113 LDHMHRNG--IFHRDIKPENILIK-DDILKLADFGSCR---GIYSKPPYTEYISTRWYRA 166
Query: 251 PEYMAT 256
PE + T
Sbjct: 167 PECLLT 172
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 11/107 (10%)
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL--LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
EI L + H ++ LI +R V MPK + LF PL
Sbjct: 135 REIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQA 187
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+ + + LAYLH +I+RD KT NI LD NA L DFG A
Sbjct: 188 ITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 26/63 (41%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 130 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 250 APE 252
APE
Sbjct: 185 APE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LGEG + V+KG G ++A+K + + +G + E L L H
Sbjct: 13 LGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L + LV+E++ L ++ + + P + + + L +GL+Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYI 119
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
H + +++RD K N+L+ KL+DFGLA+ SH + + T Y P+ +
Sbjct: 120 H--QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 37/133 (27%), Positives = 54/133 (40%), Gaps = 20/133 (15%)
Query: 101 TGMVIAVKRLNQES--------LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-L 151
T ++AVK++N +S LQ EI QL HPN++ D L +
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQ------EIITSRQLQHPNILP-YVTSFIVDSELYV 76
Query: 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211
V M GS E+ L + + + L + L Y+HS I+R K S+I
Sbjct: 77 VSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHI 132
Query: 212 LLDLNYNAKLSDF 224
LL + LS
Sbjct: 133 LLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 25/62 (40%), Positives = 30/62 (48%)
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
LA H +I+RD K++NILL N KL DFG +K V GT Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 251 PE 252
PE
Sbjct: 214 PE 215
|
Length = 496 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 37/126 (29%), Positives = 60/126 (47%), Gaps = 21/126 (16%)
Query: 137 VKLIGYCLEDDHRL-LVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLA 192
+ + Y +D++ L LV ++ G L L + R + M +A+ + L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGY 248
Y+H RD K NIL+D+N + +L+DFG L +DG QS V+ +GT Y
Sbjct: 123 YVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSVA---VGTPDY 169
Query: 249 AAPEYM 254
+PE +
Sbjct: 170 ISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 25/63 (39%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T + + T + T Y
Sbjct: 135 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 250 APE 252
APE
Sbjct: 190 APE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 30/82 (36%), Positives = 38/82 (46%), Gaps = 9/82 (10%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
AKG+++L S I+RD NILL K+ DFGLA+D S V
Sbjct: 224 AKGMSFLASKNC--IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 248 YAAPEYMATGIFQLVLLLFTFE 269
+ APE IF V +TFE
Sbjct: 282 WMAPE----SIFNCV---YTFE 296
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 26/63 (41%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 131 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 250 APE 252
APE
Sbjct: 186 APE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 57/242 (23%), Positives = 86/242 (35%), Gaps = 40/242 (16%)
Query: 8 ETDSPLPNGANSKCSRKDGNGTSGS-SSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTA 66
E P N + +G S +S + P G + L L
Sbjct: 91 ELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLA-- 148
Query: 67 TRNFRPDSVLGEGGFG----CVFKGWIDE-------HTYAPARPGTGMVIAVKRLNQESL 115
+FR L G FG C + +E ++ +P +IA +
Sbjct: 149 --HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 116 QGHLEWLTEIKHLGQLYHPNLVKL--------IGYCLEDDHRLLVYEFMPKGSLENHLFR 167
LE EI LG+L H N++K+ Y + + +Y FM + +
Sbjct: 207 AIQLE--NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK--- 261
Query: 168 RASYIQPLSWTIR--MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225
+PL R MK L A + Y+H K +I+RD K NI L+ + L DFG
Sbjct: 262 ----DRPLLKQTRAIMKQLLCA---VEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 226 LA 227
A
Sbjct: 313 TA 314
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 12/104 (11%)
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
Q+ H ++V L G C+ D ++V EF+ G L+ + R++ L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLAS 116
Query: 190 GLAYLHSDKAKVIYRDFKTSNILL-----DLNYNA--KLSDFGL 226
L+YL DK +++ + T NILL D KLSD G+
Sbjct: 117 ALSYLE-DK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 24/64 (37%), Positives = 34/64 (53%), Gaps = 7/64 (10%)
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
GL Y+HS A +I+RD K N+ ++ + K+ DFGLA+ +V TR Y
Sbjct: 128 CGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180
Query: 249 AAPE 252
APE
Sbjct: 181 RAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 28/166 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLT 123
+F V+G G FG V + TG V A+K L + + GH+
Sbjct: 2 DFESLKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAER 52
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WTIR 180
+I L + +VK+ Y +D L L+ EF+P G + L ++ + + + +
Sbjct: 53 DI--LVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAE 109
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226
+A+ + L ++H RD K N+LLD + KLSDFGL
Sbjct: 110 TVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 28/109 (25%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRRASYIQPLSWTI 179
EIK+L ++ N++K+ G+ ++ L L+ E+ +G L L + LS+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL----DKEKDLSFKT 123
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
++ +A+ KGL L+ Y++ + + L+ NY K+ GL K
Sbjct: 124 KLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171
|
Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 23/59 (38%), Positives = 33/59 (55%), Gaps = 2/59 (3%)
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
Y +PL+ + + A+G+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARD 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 26/63 (41%), Positives = 37/63 (58%), Gaps = 5/63 (7%)
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+ +LHS A +I+RD K SNI++ + K+ DFGLA+ T S + T + T Y
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 250 APE 252
APE
Sbjct: 193 APE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 136 LVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGLA 192
+VKL Y +D D+ V +++P G + + L R + + L+ + + +A+ + +
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226
++H RD K NIL+DL+ + KL+DFGL
Sbjct: 122 FIH--------RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 16/105 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
LG G FG V ++ + + + +AVK L +E+L L+ L+ H
Sbjct: 45 TLGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS---H 97
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI 172
LGQ H N+V L+G C L++ E+ G L N L ++A
Sbjct: 98 LGQ--HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 136 LVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGLA 192
+VK+ Y +D L L+ EF+P G + L ++ + + + + +A+ A L
Sbjct: 63 VVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226
++H RD K N+LLD + KLSDFGL
Sbjct: 122 FIH--------RDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 38/139 (27%), Positives = 65/139 (46%), Gaps = 9/139 (6%)
Query: 76 LGEGGFGCVFKGWIDE-HTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG+G F +FKG E Y + +K L++ + + QL H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHK---TEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+LV G C+ D ++V E++ GSL+ +L + + I +SW +++VA A L +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLI-NISW--KLEVAKQLAWALHFL 116
Query: 195 HSDKAKVIYRDFKTSNILL 213
DK + + + N+LL
Sbjct: 117 E-DK-GLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 17/133 (12%)
Query: 101 TGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYE 154
T + A+K L + + H++ +I L + + +VKL Y +D L V +
Sbjct: 25 TNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKLY-YSFQDKDNLYFVMD 81
Query: 155 FMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAAKGLAYLHSDKAKVIYRDFKTSNILL 213
++P G + + L R + + L+ R +A L A + +H K I+RD K NIL+
Sbjct: 82 YIPGGDMMSLLIRLGIFEEDLA---RFYIAELTCA--IESVH--KMGFIHRDIKPDNILI 134
Query: 214 DLNYNAKLSDFGL 226
D + + KL+DFGL
Sbjct: 135 DRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 7e-04
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 30/190 (15%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+GEG +G V+K AR TG ++A+K+ E + + L EI L L
Sbjct: 9 IGEGTYGKVYK----------ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS 58
Query: 133 H-PNLVKLIG--YCLEDDHRL---LVYEFMPKGSLENHLFR-RASYIQPLSWTIRMKVAL 185
+V+L+ + E + + LV+E++ L+ + +PL
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDG--PTGSQSHVSTRV 242
KG+A+ H K V++RD K N+L+D K++D GL + P S +H
Sbjct: 118 QLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----E 171
Query: 243 MGTYGYAAPE 252
+ T Y APE
Sbjct: 172 IVTLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 50/218 (22%), Positives = 80/218 (36%), Gaps = 71/218 (32%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEIK---HLGQ 130
VLG G FG V ++ + + + +AVK L + + H ++E+K H+G
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 131 LYHPNLVKLIGYCLEDDHRLL-VYEF---------------------------------- 155
H N+V L+G C + + L+ + EF
Sbjct: 70 --HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAM 127
Query: 156 --------MPKGSLENHLFRRAS----------------YIQPLSWTIRMKVALGAAKGL 191
+ + LF R + PL+ + + A+G+
Sbjct: 128 VEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGM 187
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+L S K I+RD NILL N K+ DFGLA+D
Sbjct: 188 EFLASRKC--IHRDLAARNILLSENNVVKICDFGLARD 223
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 21/121 (17%)
Query: 142 YCLEDDHRL-LVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLAYLHSD 197
Y +D++ L LV ++ G L L + R + M +A+ + L Y+H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 198 KAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
RD K N+LLD+N + +L+DFG + +DG QS V+ +GT Y +PE
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSVA---VGTPDYISPEI 174
Query: 254 M 254
+
Sbjct: 175 L 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 7/103 (6%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQL-Y 132
LG G FG V ++ Y + M +AVK L + E L +E+K L L
Sbjct: 42 TLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-RASYIQP 174
H N+V L+G C L++ E+ G L N L R R S+I P
Sbjct: 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICP 140
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 21/42 (50%), Positives = 26/42 (61%), Gaps = 2/42 (4%)
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
AKG+ +L S K I+RD NILL N K+ DFGLA+D
Sbjct: 189 AKGMEFLASRKC--IHRDLAARNILLSENNVVKICDFGLARD 228
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 37/129 (28%), Positives = 55/129 (42%), Gaps = 15/129 (11%)
Query: 99 PGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158
T +K L + S E LT I H PN+V L Y + +D LV +
Sbjct: 15 TRTQQTFILKGLRKSSEYSR-ERLTIIPHC----VPNMVCLHKYIVSEDSVFLVLQHAEG 69
Query: 159 GSLENHLFRRASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216
G L +H+ + + + W M VAL A LH + ++ RD +NILLD
Sbjct: 70 GKLWSHISKFLNIPEECVKRWAAEMVVALDA------LH--REGIVCRDLNPNNILLDDR 121
Query: 217 YNAKLSDFG 225
+ +L+ F
Sbjct: 122 GHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 28/76 (36%), Positives = 40/76 (52%), Gaps = 17/76 (22%)
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQS 236
M +A+ + L Y+H RD K N+LLD N + +L+DFG L DG QS
Sbjct: 111 MVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QS 160
Query: 237 HVSTRVMGTYGYAAPE 252
+V+ +GT Y +PE
Sbjct: 161 NVA---VGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 15/40 (37%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+GL YLH+ ++I+RD KT NI ++ + D G A+
Sbjct: 168 EGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 17/108 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-------QESLQGHLEWLTEIKH 127
+LG G FG V +G Y +R M +AVK L +++L L+ +T H
Sbjct: 44 ILGSGAFGKVVEG----TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMT---H 96
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFR-RASYIQP 174
LG H N+V L+G C + ++ E+ G L N+L + R +++
Sbjct: 97 LGP--HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSR 142
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 20/57 (35%), Positives = 30/57 (52%), Gaps = 2/57 (3%)
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
PL ++ + A+G+ +L S I+RD N+LL AK+ DFGLA+D
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNC--IHRDVAARNVLLTDGRVAKICDFGLARD 261
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 38/134 (28%), Positives = 54/134 (40%), Gaps = 8/134 (5%)
Query: 119 LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
L L H G + H + K DD LL+ E+ G L + +R P
Sbjct: 116 LHCLAACDHFGIVKHFDDFK------SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY 169
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ L +HS K+++RD K++NI L KL DFG +K V
Sbjct: 170 EVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 239 STRVMGTYGYAAPE 252
++ GT Y APE
Sbjct: 228 ASSFCGTPYYLAPE 241
|
Length = 478 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 24/88 (27%), Positives = 45/88 (51%), Gaps = 11/88 (12%)
Query: 142 YCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLS--WTIRMKVALGAAKGLAYLHSDK 198
Y +D D+ V +++P G + + L R + + L+ + + A+ + + ++H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--- 124
Query: 199 AKVIYRDFKTSNILLDLNYNAKLSDFGL 226
RD K NIL+D + + KL+DFGL
Sbjct: 125 -----RDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 25/78 (32%), Positives = 43/78 (55%), Gaps = 6/78 (7%)
Query: 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210
LV E++ G +++ L + + ++ +VAL L YLH + +I+RD K N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA----LDYLH--RHGIIHRDLKPDN 134
Query: 211 ILLDLNYNAKLSDFGLAK 228
+L+ + KL+DFGL+K
Sbjct: 135 MLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 24/75 (32%), Positives = 37/75 (49%), Gaps = 15/75 (20%)
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG-------------PTGSQSH 237
L YLH+ +++RD K N+L+ + KL+DFGL+K G ++
Sbjct: 114 LEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 238 VSTRVMGTYGYAAPE 252
+ +V GT Y APE
Sbjct: 172 LDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.62 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.82 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.42 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.95 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.76 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.73 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.7 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.43 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.1 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.94 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.63 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.61 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.49 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.19 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.03 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.52 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.39 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 95.08 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.05 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 94.61 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.47 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.45 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-55 Score=366.79 Aligned_cols=200 Identities=29% Similarity=0.419 Sum_probs=180.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.+|.+.+.||.|+||+||+|+.+ .++..||||.+.+..+ +..+-+..|+.+|+.++|||||+++++..+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~---------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHK---------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred ccceehhhccCcceEEEEEeEec---------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence 58999999999999999999655 4579999999988743 344557899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC------CcE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------YNA 219 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------~~~ 219 (295)
++.+|||||||.||+|.++|++++ .+++..+..++.||+.||++||+++ ||||||||+||||+.. -.+
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceE
Confidence 999999999999999999999885 4899999999999999999999988 9999999999999764 468
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+|+....+. ...+.||+|.|||||++....|+.|+|+||+|+++|+|++|++||...
T Consensus 155 KIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred EecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999876433 455689999999999999999999999999999999999999999843
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=354.09 Aligned_cols=203 Identities=29% Similarity=0.374 Sum_probs=182.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.++||+|+||+||.++. ..+++.+|+|++++...-. .....+|..+|..++||+|++++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk---------~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRK---------KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEE---------cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 35899999999999999999954 3579999999998876533 34567899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
++.+.+|||+||+.||.|..+|++.+ .+++..+..++.+|+.||.|||++| ||||||||+|||||.+|+++|+|
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEec
Confidence 99999999999999999999999875 4889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
||+|+....... ...++|||+.|||||++....|+..+|+||||+++|||++|.|||....
T Consensus 169 FgL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 169 FGLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 999996433322 3445899999999999999999999999999999999999999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=344.41 Aligned_cols=206 Identities=27% Similarity=0.370 Sum_probs=178.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-------HHHHHHHHHHHcccCCCCccc
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYHPNLVK 138 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~h~ni~~ 138 (295)
..+.|.+.+.||+|+||.|-+| .++.+|+.||||++.+..... .....+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla---------~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLA---------YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEE---------EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 3467889999999999999999 455689999999998765432 123468999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC--
Q 022575 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-- 216 (295)
Q Consensus 139 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-- 216 (295)
++++|+..++.||||||++||+|.+.+-.++. +.+.....++.|++.|+.|||++| |+||||||+|||++.+
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAE 314 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCc
Confidence 99999999999999999999999999988753 667777899999999999999988 9999999999999765
Q ss_pred -CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCccc---ccceeeehhHHHHHHhccCChhheeeeee
Q 022575 217 -YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ---LVLLLFTFECSLLHFSLQLPMCVLYLTYA 289 (295)
Q Consensus 217 -~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Di~slG~~l~el~~g~~pf~~~~~~~ 289 (295)
..+||+|||+|+.... .....++||||.|.|||++.+..++ .++|+||+||+||-+++|.|||....+.+
T Consensus 315 ~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 7799999999997643 2356678999999999999866433 57899999999999999999999876544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=356.36 Aligned_cols=201 Identities=29% Similarity=0.452 Sum_probs=182.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+|...+.||+|+|+.+|++ ++..+|+.||+|++.+... ..+++..+|+++.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~---------~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEA---------RDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEE---------EEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 47999999999999999999 4445799999999987543 34567889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+.+|||+|+|..++|..+++++ .++.+..+..++.||+.||.|||+++ |+|||||..|++|+++.+|||+||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEeccc
Confidence 999999999999999999999865 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|........ ...+.||||.|+|||++.....+..+||||+||+||-|+.|+|||..-
T Consensus 163 GLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 163 GLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred ceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 99997654322 234689999999999999989999999999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-53 Score=336.94 Aligned_cols=207 Identities=24% Similarity=0.326 Sum_probs=183.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceee-EEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG-YCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~-~~~ 144 (295)
.+|++.++||+|+||.||++ ....++..+|.|.+.-... +.++....|+.+|++|+||||+++++ .+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 47999999999999999999 4556799999999985543 34566889999999999999999998 555
Q ss_pred eCCe-eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eEeecCCCCCeEEcCCCcEEE
Q 022575 145 EDDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK--VIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 145 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl 221 (295)
++.. ++||||||.+|+|.++|+..+.....+++..+++++.|++.||..||+.-++ |+||||||.||+|+.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 8999999999999999998777778899999999999999999999994333 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++.+... .....+++|||.||+||.+....|++++||||+||++|||+.-.+||.+-
T Consensus 170 GDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 170 GDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred ccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 999999986543 33456789999999999999999999999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=349.57 Aligned_cols=210 Identities=28% Similarity=0.372 Sum_probs=184.9
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH---HHHHHHHHHHccc-CCCCccce
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQL-YHPNLVKL 139 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l-~h~ni~~l 139 (295)
+....+|.+.+.||+|+|++|++| ++..+++++|||++.++..... .....|-.+|.+| .||.|++|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 455679999999999999999999 5556899999999987754332 2355788888888 89999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
+..|++...+|+|+||+++|+|.++|.+.+ .+++..+..++.||+.||+|||++| ||||||||+|||||.|+++
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhi 213 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHI 213 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcE
Confidence 999999999999999999999999999885 4889999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCc---------ce--eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeeee
Q 022575 220 KLSDFGLAKDGPTGSQS---------HV--STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLTY 288 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 288 (295)
||+|||.|+.+...... .. ..+++||..|.+||+|..+..+.++|||+|||+||.|+.|+|||....+|
T Consensus 214 kITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 214 KITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred EEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 99999999976543221 11 14589999999999999999999999999999999999999999987665
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=325.37 Aligned_cols=200 Identities=28% Similarity=0.353 Sum_probs=181.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|+..+.||.|+||.|.+++ .+.++..+|+|++++...- +.+...+|..+|+.+.||+++++++.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr---------~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVR---------EKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEEE---------EccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 589999999999999999994 4456899999999887543 3445678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+.+||||||++||.|..++++.+ ++++..+..++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+||
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999998875 4888999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
|+|+..... .-+.||||.|+|||++....|..++|.|||||++|||+.|.|||.....
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 999976432 3457999999999999999999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=324.84 Aligned_cols=199 Identities=26% Similarity=0.356 Sum_probs=177.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+.+..+.||+|..|+||+++ ++.+++.+|+|.+.... .....++.+|+++++..+||+||.+|+.|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~---------Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVR---------HKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEE---------EcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 466778899999999999995 44579999999995443 23456788999999999999999999999999
Q ss_pred C-eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 D-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+ .+.|+||||.+|+|++++...+ .+++.....++.++++||.|||. ++ ||||||||+|||++..|.||||||
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccc
Confidence 9 5999999999999999998764 48899999999999999999995 55 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|.++.+... ...++.||..|||||-+.+..|+.++||||||++++|+++|+.||...
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 999876543 456789999999999999999999999999999999999999998764
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=338.95 Aligned_cols=209 Identities=23% Similarity=0.300 Sum_probs=182.3
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH---HHHHHHHHHHcccCCCCccceee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
...++|++.++||+|+||.||+| +.+.+|..+|+|++++...... ...+.|-.+|...+.|+||+|+-
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred CCcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 44578999999999999999999 5556899999999998866433 34678999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
.|++.+++||||||++||++..+|.+.+ .+++..+..++.+++.|++-||+.| +|||||||+|+|||..|++||
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEee
Confidence 9999999999999999999999998874 5899999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCC----------------------CCc-------c----------------eeeccccccCccCceeecc
Q 022575 222 SDFGLAKDGPTG----------------------SQS-------H----------------VSTRVMGTYGYAAPEYMAT 256 (295)
Q Consensus 222 ~DFG~a~~~~~~----------------------~~~-------~----------------~~~~~~gt~~y~aPE~~~~ 256 (295)
+|||+|...... ... . .....+|||.|||||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 999999632110 000 0 0123579999999999999
Q ss_pred CcccccceeeehhHHHHHHhccCChhheeeee
Q 022575 257 GIFQLVLLLFTFECSLLHFSLQLPMCVLYLTY 288 (295)
Q Consensus 257 ~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 288 (295)
..|+..+|+|||||++|||+.|-|||.....+
T Consensus 363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~ 394 (550)
T KOG0605|consen 363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ 394 (550)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999999999887543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=344.95 Aligned_cols=205 Identities=26% Similarity=0.372 Sum_probs=177.9
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHccc-CCCCccce
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKL 139 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l-~h~ni~~l 139 (295)
....++|++.++||+|+||+|+++.++ .+++.+|||.+++...- +.+....|-+++... +||.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k---------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELK---------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEc---------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 344579999999999999999999554 46889999999987643 334456777777766 59999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
+.+|++.+++|+||||+.||++..+++. ..+++..+..|+..|+.||+|||++| ||+||||.+|||||.+|++
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~ 507 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHV 507 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcE
Confidence 9999999999999999999995544432 35899999999999999999999998 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
||+|||+|+....... ...++||||.|||||++.+..|+..+|.|||||+||||+.|.+||.+..
T Consensus 508 kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 508 KIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred EecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999997543222 4567999999999999999999999999999999999999999999654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=318.35 Aligned_cols=201 Identities=26% Similarity=0.346 Sum_probs=175.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.|+...++|+|+||+||+| +++.+|+.||||++...... -.+-.++|++.|++++|+|+|.++++|...
T Consensus 3 kYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK 73 (396)
T ss_pred HHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence 5777889999999999999 66678999999998655432 223467999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..++||+|||+. ++.+-|.+.. ..++...+..++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchh
Confidence 999999999955 6666666654 56889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhheee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|+.+.... ...+.++.|.+|+|||.+.+ -.|...+||||+||++.||++|.|.|.+..
T Consensus 148 AR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 148 ARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred hHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 99876422 23456788999999999997 589999999999999999999999998754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=330.43 Aligned_cols=219 Identities=53% Similarity=0.897 Sum_probs=190.3
Q ss_pred CcceeehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC
Q 022575 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133 (295)
Q Consensus 54 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h 133 (295)
....|++.++..++++|.-...||+|+||.||+|.+.+ +..||||++.........+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 56789999999999999999999999999999998774 57899998876654314459999999999999
Q ss_pred CCccceeeEEEeCC-eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeEeecCCCCCe
Q 022575 134 PNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK-AKVIYRDFKTSNI 211 (295)
Q Consensus 134 ~ni~~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrDlkp~Ni 211 (295)
||+++|+|||.+.+ ..+||+||+++|+|.++|...... +++|..+++|+.+++.||+|||... ++||||||||.||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999999999988 599999999999999999876532 7899999999999999999999853 3799999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||++.++||+|||+|+..... .........||.+|+|||++..+..+.++||||||++|+||++|+++....
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred eECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999999999999999765431 111111117999999999999999999999999999999999999876643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=338.61 Aligned_cols=200 Identities=30% Similarity=0.417 Sum_probs=182.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|.+.+.||+|+||.||+| +++.+.+.||+|.+.+... ++...+.+|+++++.++||||+.++++|++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 47889999999999999999 6777899999999987643 334567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
..++|+|.|||.| +|..+|...+ .++++.+..++.+++.||.|||+.+ |+|||+||+|||++..+.+|+||||
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg 145 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFG 145 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhh
Confidence 9999999999965 9999998875 4899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+.... .....+...|||.|||||++.++.|+..+|+||+||++|||+.|+|||+..
T Consensus 146 ~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 146 LARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred hhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 9997654 334556778999999999999999999999999999999999999999865
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=331.93 Aligned_cols=203 Identities=32% Similarity=0.520 Sum_probs=175.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcE-EEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV-IAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~-vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..+.+.+.||+|+||+||+|.++ |.. ||+|.+....... ..+|.+|+.+|.+++||||++++|++.
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 34555677999999999999887 444 9999998765433 458999999999999999999999999
Q ss_pred eCC-eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEEc
Q 022575 145 EDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLS 222 (295)
Q Consensus 145 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~ 222 (295)
... ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++++ ||||||||+|||++.++ ++||+
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~--~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKR--KRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEEC
Confidence 887 7999999999999999998741 2568999999999999999999999765 99999999999999997 99999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeec--cCcccccceeeehhHHHHHHhccCChhheee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--TGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|||+++...... ...+...||+.|||||++. ...|+.++||||||+++|||++|+.||....
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~ 250 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA 250 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence 999998654321 1223367999999999999 5699999999999999999999999998764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=326.50 Aligned_cols=205 Identities=28% Similarity=0.365 Sum_probs=177.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+.|+.+++||+|.||.||+| ++..+|+.||+|++.....+ ...-..+||.+|++|+||||++|.+...
T Consensus 116 ~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred hHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 356888899999999999999 56668999999999876533 2344578999999999999999999988
Q ss_pred eC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 145 ED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 145 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+. ..+|||+|||+ -+|.-++...+ ..|++.++..++.|++.||+|||++| |+|||||..|||||.+|.+||+
T Consensus 187 ~~~~~siYlVFeYMd-hDL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMD-HDLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred ecCCceEEEEEeccc-chhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEec
Confidence 76 68999999995 58988887654 46899999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheeee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
|||+|+.+...... ..+..+-|.+|.|||++++. .|+.++|+||.||+|.||+.|+|.|.+..+
T Consensus 261 DFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 261 DFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred cccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 99999976544322 24456779999999999975 799999999999999999999999987643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=326.87 Aligned_cols=202 Identities=26% Similarity=0.318 Sum_probs=176.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----hhHHHHHHHHHHHcccC-CCCcccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLY-HPNLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~-h~ni~~l~ 140 (295)
..+|.+.+.||+|+||+|++|+ +..++..||+|++.+... .....+.+|+.+++.++ ||||++++
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~---------~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ 86 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAK---------HRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLL 86 (370)
T ss_pred cCceeeeeeecCCCCeeEEEee---------eccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEE
Confidence 4689999999999999999994 444689999998776521 12234557999999998 99999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNA 219 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~ 219 (295)
+++.....+|+||||+.||+|.+++.+.+ ++.+..+..++.|++.|++|||++| |+||||||+|||++.+ +++
T Consensus 87 ev~~t~~~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 87 EVFATPTKIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred EEEecCCeEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCE
Confidence 99999999999999999999999999853 4788999999999999999999988 9999999999999999 999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCc-cc-ccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-FQ-LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+|++||-|++|..||...
T Consensus 161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 999999998763 1122345679999999999999877 86 8999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=297.56 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=177.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.+|...+.||+|.||.||+|+ +..+|+.||||+++..+..+ ....++|++.|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~---------d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKAR---------DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEE---------ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 468888999999999999994 55589999999998776543 2346899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+.+-||+||+ ..+|+..|+... ..++...+..++.+++.||+|||++. |+||||||.|+|++.+|.+||+|||
T Consensus 73 ~~~l~lVfEfm-~tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFG 146 (318)
T KOG0659|consen 73 KSNLSLVFEFM-PTDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFG 146 (318)
T ss_pred CCceEEEEEec-cccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeeccc
Confidence 99999999999 569999998765 56888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+|+.+......... .+-|.+|.|||.+.+. .|+..+|+||.||++.||+.|.|.|.+..
T Consensus 147 LAr~f~~p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 147 LARFFGSPNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred chhccCCCCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 99987655433222 2579999999998864 89999999999999999999999998763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=325.63 Aligned_cols=201 Identities=27% Similarity=0.401 Sum_probs=178.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHH--HHHHHHHHcccC-CCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE--WLTEIKHLGQLY-HPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~E~~~l~~l~-h~ni~~l~~~~ 143 (295)
-++|.+.+.||.|.||.||+| +...++..||||.++++-.. +++ -++|+..|++|+ ||||+++++++
T Consensus 9 m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi 78 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVI 78 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence 368999999999999999999 45557899999999876432 333 368999999998 99999999999
Q ss_pred EeCC-eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 144 LEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 144 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
.+.+ .+|+||||| ..+|+++++.+. ..+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+
T Consensus 79 ~d~~~~L~fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 79 RDNDRILYFVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred hccCceEeeeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEec
Confidence 9988 999999999 679999998874 67999999999999999999999998 9999999999999988899999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeec-cCcccccceeeehhHHHHHHhccCChhheee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|||+|+...... ..+.++.|.+|+|||++. .+.|+.+.|+||+||+++|+++=+|+|.+-.
T Consensus 153 DFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 153 DFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 999999865433 345678999999999987 5689999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=326.79 Aligned_cols=199 Identities=24% Similarity=0.364 Sum_probs=181.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
..|.....||+|+-|.||.| ....+++.||||.+.......++-+++|+.+|+..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 46777889999999999999 455578899999998887666667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
.+|+||||++||+|.+.+.... +++.++..++.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|
T Consensus 344 eLWVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred eeEEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeee
Confidence 9999999999999999997643 899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
..+..... ...+.+|||+|||||++....|.++.||||||++++||+-|.|||.-
T Consensus 417 aqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 417 AQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred eccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 98755443 34567899999999999999999999999999999999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=313.92 Aligned_cols=207 Identities=23% Similarity=0.307 Sum_probs=181.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH-HHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.++||.|.-++||+|+... +++.||||++..++.... ..+.+|+..+..++||||++++..|..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 3689999999999999999996543 579999999988776544 678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..+|+||.||.+|++.++++..-. ..+++..+..++.+++.||.|||++| .||||||+.||||+.+|.|||+|||
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCce
Confidence 9999999999999999999987643 56899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCC-ccee-eccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhheee
Q 022575 226 LAKDGPTGSQ-SHVS-TRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 226 ~a~~~~~~~~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
.+..+..... .... ..+.||++|||||++.. ..|+.|+||||||++..||.+|..||..|.
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 9875433321 1112 55789999999999653 479999999999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=313.22 Aligned_cols=204 Identities=31% Similarity=0.478 Sum_probs=173.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.++...+.||+|+||.||++... .+|...|||.+...+......+.+|+.+|.+++|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~---------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK---------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEec---------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 46788899999999999999544 348899999987764333556789999999999999999999755444
Q ss_pred --eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CCcEEEccc
Q 022575 148 --HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDF 224 (295)
Q Consensus 148 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DF 224 (295)
.++++|||+++|+|.+++.+.+. .+++..+..+..||+.||+|||++| ||||||||+|||++. ++.+||+||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDF 162 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADF 162 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccC
Confidence 68999999999999999998763 4899999999999999999999988 999999999999999 799999999
Q ss_pred cCCCCCCC-CCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPT-GSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++.... .........+.||+.|||||++..+ ...+++|||||||++.||+||++||..+
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 99987653 1111223346899999999999964 3346999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=323.09 Aligned_cols=206 Identities=30% Similarity=0.373 Sum_probs=176.5
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
...+.+++.+.||+|.||.||+|+++. ...||+|.++..... ...|.+|+.+|++|+|+|||++++++.
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~----------~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNG----------STKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcC----------CCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 334567778999999999999999985 346899999876433 456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.++.+||||||++.|+|.++|+.... ..+...+.+.++.|||.||+||.+++ +|||||.++||||+++..+||+||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEccc
Confidence 98999999999999999999997433 45778889999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
|+|+....+. ........-...|.|||.+..+.|+.+||||||||+|+||+| |+.|+..+.
T Consensus 348 GLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms 409 (468)
T KOG0197|consen 348 GLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS 409 (468)
T ss_pred ccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence 9999543332 222222334678999999999999999999999999999999 888987763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=306.94 Aligned_cols=211 Identities=28% Similarity=0.291 Sum_probs=181.6
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH---HHHHHHHHHHcccCCCCccce
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~h~ni~~l 139 (295)
.....++|++.+.||.|.-|+||+|..+. ++..+|+|++.+.....+ .+...|-+||..++||.++.|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTL 142 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTL 142 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchh
Confidence 33445688999999999999999996553 568999999998766543 356679999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
|..|+.++..|++||||+||+|..+++++.. ..+++..+..++.+++.||+|||..| ||+|||||+||||.++|++
T Consensus 143 Ya~fet~~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 143 YASFETDKYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHI 218 (459)
T ss_pred hheeeccceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcE
Confidence 9999999999999999999999999988765 66899999999999999999999977 9999999999999999999
Q ss_pred EEccccCCCCCCC---------------------------------CCC---------------------cceeeccccc
Q 022575 220 KLSDFGLAKDGPT---------------------------------GSQ---------------------SHVSTRVMGT 245 (295)
Q Consensus 220 kl~DFG~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt 245 (295)
.|+||.++..... ... ......++||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 9999998743210 000 0012347899
Q ss_pred cCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 246 YGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 246 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
-+|+|||++.+..-+.++|+|+|||++|||+.|..||.+..
T Consensus 299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999999999999999999998764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=304.68 Aligned_cols=203 Identities=26% Similarity=0.373 Sum_probs=177.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+.|+....|++|+||.||+| +++.+++.||+|+++.+.... ....++|+.+|.+++||||+.+-++..
T Consensus 75 v~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred HHHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 357888999999999999999 677789999999998765322 234579999999999999999999876
Q ss_pred eC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 145 ED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 145 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
.. +.+|||||||++ +|..++...+ +++...++..++.|++.|++|||.+. |+||||||+|+|++..|.+||+
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEec
Confidence 54 679999999954 9999998766 67899999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|||+|+.+..... ..+..+-|.+|.|||++.+. .|+.+.|+||+||++.||++++|.|.+-.
T Consensus 220 DFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 220 DFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred ccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 9999998765432 34456779999999999865 79999999999999999999999998753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=313.09 Aligned_cols=215 Identities=27% Similarity=0.349 Sum_probs=174.9
Q ss_pred ehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--------------HHHHHHH
Q 022575 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--------------HLEWLTE 124 (295)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E 124 (295)
...+.....+.|++.+.||+|.||+|-+|+ +..+++.||||++.+..... .++..+|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar---------~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~E 158 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLAR---------DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRRE 158 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEe---------ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHH
Confidence 333445566899999999999999999994 44569999999997654321 2357899
Q ss_pred HHHHcccCCCCccceeeEEEeC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 022575 125 IKHLGQLYHPNLVKLIGYCLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (295)
Q Consensus 125 ~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 202 (295)
+.+|+++.|||||+|+++..+. +.+|||+|||..|.+...-... ..+.+.++..++.+++.||+|||.+| ||
T Consensus 159 IailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH~Qg--ii 232 (576)
T KOG0585|consen 159 IAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLHYQG--II 232 (576)
T ss_pred HHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHHhcC--ee
Confidence 9999999999999999998765 6789999999988875432211 22889999999999999999999988 99
Q ss_pred eecCCCCCeEEcCCCcEEEccccCCCCCCCCCCc---ceeeccccccCccCceeeccC---cc-cccceeeehhHHHHHH
Q 022575 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS---HVSTRVMGTYGYAAPEYMATG---IF-QLVLLLFTFECSLLHF 275 (295)
Q Consensus 203 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~-~~~~Di~slG~~l~el 275 (295)
||||||.|+||+.+|++||+|||.+.....+... .......|||.|+|||...++ .+ +.+.||||+||+||.|
T Consensus 233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl 312 (576)
T KOG0585|consen 233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL 312 (576)
T ss_pred ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence 9999999999999999999999999865333211 112235899999999998863 33 4789999999999999
Q ss_pred hccCChhheeeee
Q 022575 276 SLQLPMCVLYLTY 288 (295)
Q Consensus 276 ~~g~~pf~~~~~~ 288 (295)
+.|+.||.....+
T Consensus 313 lfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 313 LFGQLPFFDDFEL 325 (576)
T ss_pred hhccCCcccchHH
Confidence 9999999887554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=309.88 Aligned_cols=201 Identities=22% Similarity=0.322 Sum_probs=182.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH---HHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+|++.+.||+|.||+|-+| .....|+.||||.+++...++. ..+.+|+++|..|+||||+.+|++|+
T Consensus 53 HRyE~~etLGkGTYGKVk~A---------~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLA---------YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hHHHHHHHhcCCcccceeeh---------hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 58999999999999999998 4455799999999988766543 45679999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+.+.|||||..+|.|++++.+++ .+++..+..++.||..|+.|||.++ +||||||.+|||+|.++++||+||
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeecc
Confidence 9999999999999999999998875 5899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCccc-ccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ-LVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|++..+... ....++||+|-|.+||++.+..|. +.+|-||||++||-|+.|..||.+..
T Consensus 198 GLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 198 GLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred chhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 999865443 245678999999999999998885 89999999999999999999998864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.41 Aligned_cols=203 Identities=23% Similarity=0.278 Sum_probs=173.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|.. ..+++.||+|++.+... .....+.+|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQK---------KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4789999999999999999953 34688999999976432 22345678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DF 145 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDF 145 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeec
Confidence 9999999999999999999997653 4788999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCc---------------------------------ceeeccccccCccCceeeccCcccccceeeehhHH
Q 022575 225 GLAKDGPTGSQS---------------------------------HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECS 271 (295)
Q Consensus 225 G~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 271 (295)
|+++........ ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi 225 (363)
T cd05628 146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (363)
T ss_pred cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence 998754221100 00123579999999999998899999999999999
Q ss_pred HHHHhccCChhhee
Q 022575 272 LLHFSLQLPMCVLY 285 (295)
Q Consensus 272 l~el~~g~~pf~~~ 285 (295)
+|||++|.+||...
T Consensus 226 l~ell~G~~Pf~~~ 239 (363)
T cd05628 226 MYEMLIGYPPFCSE 239 (363)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=300.89 Aligned_cols=206 Identities=26% Similarity=0.346 Sum_probs=175.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCC-ccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPN-LVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-i~~l~~~~~ 144 (295)
..|...+.||+|+||+||+|+ ...+|+.||+|++...... ......+|+.+|+.++|+| |+.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar---------~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKAR---------SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEE---------EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 356667789999999999994 4457899999999766442 2234578999999999999 999999998
Q ss_pred eCC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
+.+ .+++|+||+ ..+|..++.........++...+..++.||+.||+|||+++ |+||||||+||||+++|.
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCc
Confidence 877 789999999 67999999886533235677889999999999999999998 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheeee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
+||+|||+|+....... ..+...+|.+|.|||++.+. .|+...||||+||+++||++++|.|.+..+
T Consensus 159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 99999999996553332 23445789999999999976 799999999999999999999999988754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=301.03 Aligned_cols=203 Identities=27% Similarity=0.364 Sum_probs=175.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcC--ccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
...|...+.||+|+||.|+.| .+..+|+.||||++. .......++..+|+++|+.++|+||+.+++.+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA---------~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSA---------KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred cceecccccccCcceeeEEEE---------EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 357777899999999999999 455578999999997 334445667889999999999999999999987
Q ss_pred e-----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 145 E-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 145 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. -..+|+|+|+| +.+|.+.++.. +.++...+..++.|++.||+|+|+.+ ++||||||.|+|++.+..+
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCE
Confidence 6 25689999999 77999999875 34889999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeec-cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+|+...........+..+-|.+|.|||++. ...|+.+.||||+||++.||++|+|.|.+-
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 999999999765432233345678899999999986 458999999999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=318.46 Aligned_cols=200 Identities=27% Similarity=0.368 Sum_probs=178.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hh--hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.-|++.+.||.|+-|.|-+| ++..||+.+|||++.+.. .. ....+.+|+-+|+-+.|||++++|++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 46889999999999999998 666799999999998762 21 2334668999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
++.++|+|+||+++|.|++++.+++ ++++..+.+++.||+.|+.|||..+ |+||||||+|+|||.++++||+||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeecc
Confidence 9999999999999999999999886 4888999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCccc-ccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ-LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|.....+. ...+.||+|.|.|||++.+..|. .++||||+||+||.|++|+.||.+.
T Consensus 157 GMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 157 GMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred ceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 9998643322 34456999999999999999986 8999999999999999999999864
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=316.00 Aligned_cols=203 Identities=24% Similarity=0.281 Sum_probs=171.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+.+... .....+.+|++++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK---------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 37889999999999999999543 4688999999865432 22345678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~Df 145 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDF 145 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeec
Confidence 999999999999999999999765 34788889999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCc---------------------------------------------ceeeccccccCccCceeeccCcc
Q 022575 225 GLAKDGPTGSQS---------------------------------------------HVSTRVMGTYGYAAPEYMATGIF 259 (295)
Q Consensus 225 G~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 259 (295)
|+++........ ......+||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (377)
T cd05629 146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence 998632110000 00012469999999999998899
Q ss_pred cccceeeehhHHHHHHhccCChhhee
Q 022575 260 QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 260 ~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.++|||||||++|||++|.+||...
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 226 GQECDWWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred CCceeeEecchhhhhhhcCCCCCCCC
Confidence 99999999999999999999999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=315.72 Aligned_cols=202 Identities=23% Similarity=0.273 Sum_probs=172.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|++.+.||+|+||+||+|... .++..||+|++..... .....+.+|+.++..++||||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV---------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 6888999999999999999543 4688999999976532 223457789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCc
Confidence 999999999999999999997653 4788888999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCc---------------------------------------------ceeeccccccCccCceeeccCccc
Q 022575 226 LAKDGPTGSQS---------------------------------------------HVSTRVMGTYGYAAPEYMATGIFQ 260 (295)
Q Consensus 226 ~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 260 (295)
+++........ ......+||+.|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 98643110000 001235799999999999988899
Q ss_pred ccceeeehhHHHHHHhccCChhhee
Q 022575 261 LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 261 ~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.++|||||||++|||++|.+||...
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCC
Confidence 9999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=315.57 Aligned_cols=202 Identities=22% Similarity=0.255 Sum_probs=171.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|++.+.||+|+||.||+|.. ..+++.||+|.+..... .....+.+|+.++++++||||+++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~---------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARK---------VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEE---------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 688899999999999999954 34688999999876532 223457789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFG 146 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFG 146 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECC
Confidence 999999999999999999997653 4788889999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCC---------------------------------------------cceeeccccccCccCceeeccCccc
Q 022575 226 LAKDGPTGSQ---------------------------------------------SHVSTRVMGTYGYAAPEYMATGIFQ 260 (295)
Q Consensus 226 ~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 260 (295)
++........ .......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 9753211000 0001234799999999999988999
Q ss_pred ccceeeehhHHHHHHhccCChhhee
Q 022575 261 LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 261 ~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.++|||||||++|||++|.+||...
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=285.01 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=179.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|.||.||+|+.+ .++..||+|++.+..... ..++.+|+++-..|+||||+++|++|.
T Consensus 22 ~dfeigr~LgkgkFG~vYlarek---------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREK---------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred hhccccccccCCccccEeEeeec---------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 58999999999999999999655 468899999998776432 346789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+....||++||..+|+|...|+.... ..+++.....++.|++.||.|+|.++ ++||||||+|+|++.++.+||+||
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999999985433 45788889999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|.+.....+ ...+.|||..|.+||...+...+..+|+|++|++.||++.|.|||+...
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 999764322 2445799999999999999999999999999999999999999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=314.19 Aligned_cols=203 Identities=23% Similarity=0.302 Sum_probs=173.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK---------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 47899999999999999999543 4588999999976432 22345678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeec
Confidence 9999999999999999999997653 4888999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcc------------------------------------eeeccccccCccCceeeccCcccccceeeeh
Q 022575 225 GLAKDGPTGSQSH------------------------------------VSTRVMGTYGYAAPEYMATGIFQLVLLLFTF 268 (295)
Q Consensus 225 G~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 268 (295)
|++.......... .....+||+.|+|||++....++.++|||||
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 9987542211000 0112469999999999998899999999999
Q ss_pred hHHHHHHhccCChhhee
Q 022575 269 ECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 269 G~~l~el~~g~~pf~~~ 285 (295)
||++|||++|.+||...
T Consensus 226 G~il~el~~G~~Pf~~~ 242 (364)
T cd05599 226 GVIMYEMLVGYPPFCSD 242 (364)
T ss_pred hhHHHHhhcCCCCCCCC
Confidence 99999999999999754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=299.54 Aligned_cols=198 Identities=25% Similarity=0.359 Sum_probs=167.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD- 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~- 147 (295)
.|.-.+++|+|+||.||+|.... +++.||||++..+... -.+|+++|+.++||||+++.-+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 56778999999999999997664 4789999998765431 136999999999999999998886542
Q ss_pred ----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcEEEc
Q 022575 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLS 222 (295)
Q Consensus 148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~ 222 (295)
...+||||++ .+|.+.++........++...+.-+..||.+||.|||+.| |+||||||+|+|+|.+ |.+|||
T Consensus 92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEec
Confidence 3458999995 5999999865333466888888999999999999999987 9999999999999987 889999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||.|+....+.. ..+...|..|+|||.+.+. .|+.+.||||.||++.||+-|+|.|.+-
T Consensus 169 DFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 169 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred cCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 9999998765543 2446789999999999875 7999999999999999999999999875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.35 Aligned_cols=203 Identities=22% Similarity=0.248 Sum_probs=172.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|.. ..+++.||+|.+..... .....+.+|++++..++||||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRK---------VDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEE---------CCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 3789999999999999999954 34688999999875432 12345678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DF 145 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDF 145 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999997653 4788888999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCC-----------------------------------------cceeeccccccCccCceeeccCcccccc
Q 022575 225 GLAKDGPTGSQ-----------------------------------------SHVSTRVMGTYGYAAPEYMATGIFQLVL 263 (295)
Q Consensus 225 G~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 263 (295)
|+|..+..... .......+||+.|+|||++.+..++.++
T Consensus 146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 225 (376)
T cd05598 146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225 (376)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence 99853210000 0001135799999999999988999999
Q ss_pred eeeehhHHHHHHhccCChhhee
Q 022575 264 LLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 264 Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||||||++|||++|.+||...
T Consensus 226 DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 226 DWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=308.22 Aligned_cols=198 Identities=28% Similarity=0.382 Sum_probs=174.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++..++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHK---------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 58999999999999999999554 3588999999875432 23345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+.+++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997653 4788888999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 163 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 163 GFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred cCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 9998653221 2357999999999999888999999999999999999999999654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=312.21 Aligned_cols=206 Identities=24% Similarity=0.349 Sum_probs=182.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|...+++|+|+||.++++ +++..+..+++|.+...... .+....+|+.++++++||||+.+.+.|..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 57899999999999999988 44456779999999766543 33457899999999999999999999999
Q ss_pred CCe-eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 DDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
++. ++|||+||+||+|.+.|.+.++ .-++++.+..++.|++.|+.|||+++ |+|||||+.||+++.++.|||.||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecch
Confidence 988 9999999999999999988763 56899999999999999999999877 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeeee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLTY 288 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 288 (295)
|+|+...... ....+..|||.||+||++.+..|..++|||||||++|||++-+++|......
T Consensus 151 GlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~ 212 (426)
T KOG0589|consen 151 GLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS 212 (426)
T ss_pred hhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH
Confidence 9999865543 2345678999999999999999999999999999999999999999877543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=310.97 Aligned_cols=209 Identities=23% Similarity=0.367 Sum_probs=180.3
Q ss_pred eehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCC
Q 022575 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPN 135 (295)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~n 135 (295)
.+..++.+..+...+...||+|.||+||+|+|.. .||||++..... ...+.|.+|+..+++-+|.|
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3446666777788899999999999999998874 499999987654 34567999999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 136 i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
|+-+.|++..+.. .||+.+|+|.+|+.+|.... ..|.....+.|+.||++||.|||.++ |||||||..||++.+
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHE 523 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEcc
Confidence 9999999988776 89999999999999998765 55777888999999999999999988 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhe
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++.|||+|||++................|...|||||++. ...|++.+|||||||++|||++|..||..
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 9999999999997544433333334456889999999987 34899999999999999999999999983
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=307.00 Aligned_cols=198 Identities=28% Similarity=0.368 Sum_probs=174.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK---------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 36899999999999999999544 3578999999976532 23345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999997653 4788899999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++..... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 99986433 123457999999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=304.80 Aligned_cols=195 Identities=28% Similarity=0.330 Sum_probs=168.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
++||+|+||.||+|... .+++.||+|.++.... .....+.+|+.++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREK---------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 46999999999999543 4688999999876432 22345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 72 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 72 FVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999999999999987653 4788899999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 231 PTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 146 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 22211 123457999999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=311.30 Aligned_cols=204 Identities=22% Similarity=0.230 Sum_probs=172.8
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
...++|++.+.||+|+||.||++... .+++.+|+|.+.+... .....+.+|+.++..++||||+++++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHK---------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34468999999999999999999544 4688999999865322 22334678999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
++.+.+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL 183 (370)
T cd05621 111 AFQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKL 183 (370)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEE
Confidence 999999999999999999999998653 3788889999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccC----cccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++........ .......||+.|+|||++... .++.++|+|||||++|+|++|.+||...
T Consensus 184 ~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 184 ADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred EecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 99999986532221 112345799999999998753 3789999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=306.83 Aligned_cols=199 Identities=26% Similarity=0.304 Sum_probs=173.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|..... .+..||+|.+..... .....+.+|+.++..++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 5899999999999999999965431 246899999865432 22345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecC
Confidence 9999999999999999999997653 4788899999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++..... .....||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 999864321 12357999999999999888999999999999999999999999764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=303.40 Aligned_cols=198 Identities=24% Similarity=0.299 Sum_probs=173.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR---------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 37889999999999999999543 4588999999865432 23345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..++||||+++++|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Df 145 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDF 145 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEec
Confidence 9999999999999999999997653 4788888999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999865332 12346899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=299.21 Aligned_cols=201 Identities=28% Similarity=0.393 Sum_probs=172.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|+..+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe---------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 3677899999999999999544 35889999998755432 23356789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg 147 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLG 147 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 35788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...
T Consensus 148 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 148 LAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred CcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 997643322 122357899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=307.33 Aligned_cols=214 Identities=26% Similarity=0.346 Sum_probs=173.2
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+.++..+ +||||+++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 346899999999999999999975321 1233567899999875432 2345678999999999 899999999988
Q ss_pred EeC-CeeEEEEeccCCCCHHHHHhhccCC---------------------------------------------------
Q 022575 144 LED-DHRLLVYEFMPKGSLENHLFRRASY--------------------------------------------------- 171 (295)
Q Consensus 144 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------- 171 (295)
... +..+++|||+++|+|.+++......
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4579999999999999999753211
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeecccc
Q 022575 172 -------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244 (295)
Q Consensus 172 -------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g 244 (295)
..++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 134677888899999999999999987 99999999999999999999999999986533222212223346
Q ss_pred ccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 245 TYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 245 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 788999999998899999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=306.93 Aligned_cols=203 Identities=26% Similarity=0.326 Sum_probs=179.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-HHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
..|+..+.||+|+||.||+| .+..+++.||||++..+.... ...+.+|+.+|.+++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~---------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKA---------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeee---------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 36777799999999999999 455689999999998876554 34577899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..+|++||||.||++.+.++... .+.+..+..++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecce
Confidence 99999999999999999997653 2467777888999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
+......... ..+++|||.|||||++....|+.++||||||++.+||++|.||+...-.
T Consensus 158 a~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 158 AGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred eeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 9876544332 3568999999999999988999999999999999999999999987643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=325.10 Aligned_cols=214 Identities=28% Similarity=0.384 Sum_probs=186.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
..+.++.+.||+|+||+||+|..... ........||||.++..... .+.+|.+|++++..++|||||+|+|+|..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 35667789999999999999976542 22345788999999887665 67889999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASY----------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
++.+++|+|||..|||.++|..+... ..+++..+.+.|+.||+.||+||-++. +|||||..+|+||.+
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGE 638 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceecc
Confidence 99999999999999999999865321 234788899999999999999999987 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
+..|||+|||+++.....+.........-..+||+||.|..++|+.+||||||||+|||+++ |+.||++..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 99999999999998776665554433445789999999999999999999999999999999 999998874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=310.63 Aligned_cols=191 Identities=29% Similarity=0.433 Sum_probs=171.4
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
.+-||+|+-|.||+|+++ ++.||||+++.-+ ..+|+.|++|+||||+.+.|+|.....+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 467999999999999887 6789999875332 2588999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
||||..|.|...|+.. ..+.......+..+|+.||.|||.++ |||||||.-||||..+..|||+|||.++....
T Consensus 191 MEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 9999999999999876 45778888999999999999999998 99999999999999999999999999987544
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeeeeeE
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLTYAL 290 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~ 290 (295)
. .....++||..|||||+|.....+.|+|||||||+||||+||..||.....-|+
T Consensus 265 ~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI 319 (904)
T KOG4721|consen 265 K---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI 319 (904)
T ss_pred h---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence 3 234468999999999999999999999999999999999999999998877766
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=309.72 Aligned_cols=203 Identities=23% Similarity=0.298 Sum_probs=173.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK---------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 36888999999999999999544 4688999999875432 22345678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~Df 145 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDF 145 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997653 4788899999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCc---------------------------------ceeeccccccCccCceeeccCcccccceeeehhHH
Q 022575 225 GLAKDGPTGSQS---------------------------------HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECS 271 (295)
Q Consensus 225 G~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 271 (295)
|++......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 225 (360)
T cd05627 146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225 (360)
T ss_pred cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence 998754221100 00123479999999999999999999999999999
Q ss_pred HHHHhccCChhhee
Q 022575 272 LLHFSLQLPMCVLY 285 (295)
Q Consensus 272 l~el~~g~~pf~~~ 285 (295)
+|||++|.+||...
T Consensus 226 lyel~tG~~Pf~~~ 239 (360)
T cd05627 226 MYEMLIGYPPFCSE 239 (360)
T ss_pred eeecccCCCCCCCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.12 Aligned_cols=199 Identities=25% Similarity=0.313 Sum_probs=173.1
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-C-----CCccceeeE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H-----PNLVKLIGY 142 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~ni~~l~~~ 142 (295)
+|.+.++||+|+||.|.+|+ +..+++.||||+++.... ...+...|+.+|..|+ | -|+|+++++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~---------d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAY---------DHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEEEEEEecccccceeEEEE---------ecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 67888999999999999995 445799999999986643 3345578999999987 4 489999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC--CcEE
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN--YNAK 220 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~k 220 (295)
|...+++|||+|.+ ..+|+++|+.+.- ..++...+..++.||+.||.+||+.+ |||+|||||||||..- ..+|
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCcee
Confidence 99999999999999 6799999988754 66899999999999999999999987 9999999999999543 3799
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
|+|||.|....... ...+.+..|+|||++.+..|+.+.|||||||+++||++|.|+|.+..+
T Consensus 332 VIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 332 VIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred EEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 99999998643322 246788999999999999999999999999999999999999988754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=307.97 Aligned_cols=206 Identities=22% Similarity=0.230 Sum_probs=173.9
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccce
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
.....++|++.+.||+|+||.||+|... .+++.+|+|.+.+... .....+.+|+.++..++||||+++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEEC---------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3445579999999999999999999544 4688999999865332 223346789999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
++.+...+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCE
Confidence 99999999999999999999999998653 3778888999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccC----cccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++........ .......||+.|+|||++... .++.++|||||||++|||++|.+||...
T Consensus 182 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 182 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred EEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 9999999986533221 112345799999999998753 3789999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=292.64 Aligned_cols=202 Identities=28% Similarity=0.322 Sum_probs=180.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHH---HHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL---EWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
-++|...++||+|.||+|.++ +.+.+++.+|+|++++.-.-... .-+.|-++|...+||.+..+.-.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred cchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 468899999999999999999 56678999999999887554433 346799999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
++.+.+|+||||..||.|.-+|.+.. .+++.....+..+|+.||.|||+++ ||.||||.+|+|+|.+|++||+|
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeee
Confidence 99999999999999999999998763 5888899999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|+..... .....++||||.|+|||++....|..++|.|.+|+++|||++|+.||+--
T Consensus 312 FGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 312 FGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 9999964332 22456789999999999999999999999999999999999999999743
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.83 Aligned_cols=195 Identities=27% Similarity=0.325 Sum_probs=167.5
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
+.||+|+||.||++... .++..||+|.+..... .....+.+|++++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 46999999999999543 4688999999876432 22345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
+||||+++++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 72 FVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9999999999998887653 4788999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 231 PTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 146 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 22211 123357999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=308.68 Aligned_cols=203 Identities=22% Similarity=0.218 Sum_probs=171.8
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
..++|++.+.||+|+||.||+|... .++..||+|.+.+... .....+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHK---------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3468999999999999999999543 4688999999865432 223346789999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+.+.+..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~ 184 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLA 184 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEE
Confidence 99999999999999999999998653 3678888899999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccC----cccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||++........ .......||+.|+|||++... .++.++|||||||++|||++|.+||...
T Consensus 185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 9999976433221 112345799999999998643 4789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=300.48 Aligned_cols=194 Identities=28% Similarity=0.351 Sum_probs=167.5
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
++||+|+||.||++.. ..++..||+|.+.+... .....+.+|++++..++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVRE---------KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 4699999999999954 34688999999975432 23345778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
+||||+++++|.+.+... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 72 lv~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 999999999999888765 34788999999999999999999988 999999999999999999999999998753
Q ss_pred CCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 231 PTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 146 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 146 ITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred CCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 22211 12335799999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.16 Aligned_cols=207 Identities=20% Similarity=0.170 Sum_probs=176.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.|.+.+.||+|+||.||+|.... ..+..||+|.+..........+.+|+.++..++||||+++++++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~--------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGS--------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcC--------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 58899999999999999995332 1267889998766554555567789999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.|+||||+++|+|.+++.+......++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999999988754333346888899999999999999999987 9999999999999999999999999998
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..............+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 654432222234467999999999999889999999999999999999999998643
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=298.67 Aligned_cols=193 Identities=27% Similarity=0.317 Sum_probs=166.8
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||+|+||.||+|+.. .+++.||+|.+..... .....+.+|+.++.+++||||+++++++...+..|+|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKR---------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 699999999999544 3588999999875432 2334567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 72 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 72 LAFINGGELFHHLQREG----RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred EcCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99999999999997653 4788899999999999999999988 99999999999999999999999999975322
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 146 DDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred CCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 211 223457999999999999989999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.97 Aligned_cols=200 Identities=28% Similarity=0.341 Sum_probs=179.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHcccC-CCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~-h~ni~~l~~~~ 143 (295)
..|++.+.||+|.||.||+| ..+.+|+.+|+|.+.+..... ...+.+|+.+|+++. ||||+.++++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 57999999999999999999 455679999999998876643 346789999999998 99999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC----CCcE
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----NYNA 219 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~ 219 (295)
++.+..++|||+|.||.|.+.|... .+++..+..++.|++.+++|||+.| |+||||||+|+|+.. ++.+
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcE
Confidence 9999999999999999999999876 2889999999999999999999988 999999999999943 3579
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|++|||++..... .......+||+.|+|||++....|+..+|+||+|+++|.|++|.+||....
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9999999997655 223455799999999999999999999999999999999999999998765
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=300.58 Aligned_cols=202 Identities=20% Similarity=0.210 Sum_probs=171.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+++.. .+++.||+|.+.+... .....+.+|..++..++|+||+++++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK---------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47899999999999999999544 3578899999875322 12334678899999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~Df 146 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADF 146 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEec
Confidence 9999999999999999999997643 35788889999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++......... ......||+.|+|||++.+ +.++.++|+|||||++|+|++|++||..
T Consensus 147 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 147 GSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred cceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 999765332211 1223579999999999875 5678999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=299.99 Aligned_cols=202 Identities=21% Similarity=0.216 Sum_probs=171.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+++.. .+++.||+|.+.+... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK---------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 47899999999999999999544 3578999999875322 22344678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++++|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Df 146 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADF 146 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999999997643 35788899999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++......... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||..
T Consensus 147 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 147 GSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 998764332211 1222468999999999873 4578899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.33 Aligned_cols=203 Identities=28% Similarity=0.337 Sum_probs=175.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK---------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 37899999999999999999543 3688999999976532 23345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++++|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecC
Confidence 999999999999999999999775 34788999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCC---------------------------CcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc
Q 022575 225 GLAKDGPTGS---------------------------QSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 225 G~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 277 (295)
|++....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9998654322 0011223569999999999999999999999999999999999
Q ss_pred cCChhhee
Q 022575 278 QLPMCVLY 285 (295)
Q Consensus 278 g~~pf~~~ 285 (295)
|.+||...
T Consensus 226 g~~Pf~~~ 233 (350)
T cd05573 226 GFPPFYSD 233 (350)
T ss_pred CCCCCCCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=297.04 Aligned_cols=198 Identities=28% Similarity=0.367 Sum_probs=168.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHcccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+++.. ....+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..
T Consensus 2 ~~lg~G~~g~V~~~~~~------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKV------TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEc------ccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 67999999999999653 2234688999999875432 2233467899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.+.+ .+.+..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999999997653 4677888889999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 150 SIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred cccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 322221 123357999999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=299.62 Aligned_cols=195 Identities=28% Similarity=0.328 Sum_probs=166.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
+.||+|+||.||++.. ..++..||+|.+..... .....+.+|++++..++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~V~~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKE---------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEE---------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 4699999999999954 34688999999976432 22345678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+ ++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 lv~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 72 FVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 999999999999988765 347889999999999999999997 56 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 146 GIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred cCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 322211 123357999999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=297.92 Aligned_cols=200 Identities=28% Similarity=0.351 Sum_probs=169.9
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCC-CccceeeEEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHP-NLVKLIGYCL 144 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~-ni~~l~~~~~ 144 (295)
+|++.+.||+|+||.||+|... .+++.||+|.+.+... .....+..|.+++..++|+ +|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 5788999999999999999544 3578999999876432 2334567889999988764 5888999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Df 145 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADF 145 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeec
Confidence 9999999999999999999987653 4788899999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|++||...
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 146 GMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 99875322211 223457999999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=299.93 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=180.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH--HHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.-|.+.+.||+|-|++|-+| ++..+|+.||||++.+..+... ..+.+|++-|+-++|||||+||++..+
T Consensus 18 GLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred eeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 46888999999999999888 6667899999999998876543 357899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~DF 224 (295)
...+|||+|+-.+|+|+++|-++. ..+.+..+.+++.||+.|+.|||+.. +|||||||+||.+. .-|-|||+||
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeec
Confidence 999999999999999999999887 56899999999999999999999966 99999999999884 5688999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCccc-ccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ-LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++..+..+.. ..+.||+..|.|||++.+..|+ +++||||||++||.|++|++||..-
T Consensus 164 GFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 164 GFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred cccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 99988766543 4567999999999999999998 7899999999999999999999865
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=299.10 Aligned_cols=206 Identities=29% Similarity=0.409 Sum_probs=183.9
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHcccCCCCccceee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
...+.|+..++||+|+||.||-+.. ..+|+.+|+|.+.++..+. ....++|-.+|.+++.+.||.+--
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqv---------raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY 252 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQV---------RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY 252 (591)
T ss_pred ccccceeeeEEEecccccceeEEEE---------ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence 3446789999999999999998844 4579999999998776543 334689999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
.|++.+.+++||..|+||+|.-+|.+.++ ..+++..+..++.+|+.||++||..+ ||.|||||+|||+|+.|+++|
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEe
Confidence 99999999999999999999999998875 56899999999999999999999987 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+|+|+|..+..+.. ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||..+-
T Consensus 329 SDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred eccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 99999998765442 233489999999999999999999999999999999999999998663
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=298.01 Aligned_cols=203 Identities=26% Similarity=0.296 Sum_probs=171.1
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
+|++.+.||+|+||.||+++.. ....++..||+|++.+... .....+..|+.++..+ +||||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKV------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEc------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 4788899999999999998643 2334688999999865432 2233567899999999 599999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEee
Confidence 99999999999999999999997653 4788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|.+||..
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 9999864332221 12245799999999998765 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=300.52 Aligned_cols=203 Identities=23% Similarity=0.240 Sum_probs=173.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|.+.+.||+|+||.||+|... .+++.||+|.++.... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK---------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 37889999999999999999543 4688999999976533 23345678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Df 146 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADF 146 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccC
Confidence 9999999999999999999998753 35888999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec------cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++......... ......||+.|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 147 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 147 GSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 999865432221 222346899999999987 456789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=297.42 Aligned_cols=200 Identities=26% Similarity=0.307 Sum_probs=169.8
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
+|++.+.||+|+||.||+|... .++..||+|.+.+.... .......|..++..+ .|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 5788899999999999999543 35789999998764321 223456677777776 5899999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++|+|.+.+.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Df 145 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccC
Confidence 9999999999999999999987653 4788899999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 146 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 146 GMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 9997532211 1223457999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=297.91 Aligned_cols=203 Identities=20% Similarity=0.212 Sum_probs=171.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||++... .+++.+|+|.+.+... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 37889999999999999999654 3578899999865322 12234678899999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~Df 146 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADF 146 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999997643 35788889999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ .......||+.|+|||++. .+.++.++|||||||++|||++|.+||...
T Consensus 147 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 147 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred chheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 99875432221 1222357999999999986 346889999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=297.28 Aligned_cols=198 Identities=28% Similarity=0.378 Sum_probs=166.6
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHH---HcccCCCCccceeeEE
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKH---LGQLYHPNLVKLIGYC 143 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~---l~~l~h~ni~~l~~~~ 143 (295)
|++.+.||+|+||.||+|... .+++.||||.+++... .....+..|+++ +..++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK---------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 677899999999999999544 3588999999975432 122345556554 4567899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..|+||||+++++|...+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~D 144 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIAD 144 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCc
Confidence 999999999999999999988754 34889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++....... ......|++.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 145 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 145 FGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred ccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 999875322211 223467999999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=295.48 Aligned_cols=195 Identities=27% Similarity=0.383 Sum_probs=164.5
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcc-cCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|... .+++.||+|.++.... ........|..++.. .+||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELK---------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999999654 3578899999876432 223344566666664 4899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence 99999999999999987653 4788899999999999999999987 99999999999999999999999999975
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 43222 1233457999999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=294.56 Aligned_cols=201 Identities=22% Similarity=0.319 Sum_probs=169.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSK---------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEEC---------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence 68999999999999999999543 35889999998754322 233567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+ .++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 76 ETLTLVFEYV-HTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred CeEEEEEECC-CcCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCc
Confidence 9999999999 568888886653 34788889999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 150 ARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred ceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 875432211 1223468999999999865 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.11 Aligned_cols=194 Identities=24% Similarity=0.340 Sum_probs=166.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|... .++..||+|.+++... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELK---------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 47999999999999544 3588999999976432 2234467899999888 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 9999999999999988765 34889999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
...... .....+||+.|+|||++.+..++.++|+|||||++|+|++|.+||..
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 146 GIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 322111 22345799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=274.72 Aligned_cols=212 Identities=25% Similarity=0.302 Sum_probs=182.5
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
+..++|++.+.||+|||+.||++ ....++..+|+|++.....++.+..++|++..++++|||+++++++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EcCceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 44579999999999999999998 566789999999998877777778899999999999999999988764
Q ss_pred eC-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 145 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.+ ...|++++|...|+|.+.+.........+++.+++.|+.+|+.||++||+..+++.||||||.|||+.+++.+
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 33 4589999999999999999987766678999999999999999999999988889999999999999999999
Q ss_pred EEccccCCCCCCCCCCc-------ceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQS-------HVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|.|||.+......... ........|..|.|||.+. +...+.++|||||||+||.|+.|..||...
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 99999999864332111 1122345799999999987 446779999999999999999999999754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.45 Aligned_cols=193 Identities=25% Similarity=0.339 Sum_probs=165.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|... .+++.||+|.+++... .....+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK---------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 47999999999999544 3588999999976432 2234466788888776 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
++||||+++++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 99999999999998887653 4788999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
...... ......||+.|+|||++.+..++.++|+|||||++|+|++|.+||.
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 146 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 322111 1234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=292.66 Aligned_cols=200 Identities=25% Similarity=0.357 Sum_probs=169.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .++..||+|.++..... ....+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 57999999999999999999543 35889999998754322 234567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 76 RCLTLVFEYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred CeEEEEEeCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999999996 59999887654 34678889999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 150 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred eeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 975432221 1223468999999999875 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=294.76 Aligned_cols=195 Identities=30% Similarity=0.397 Sum_probs=164.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHH-HHcccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|... .+++.||+|.+...... ...++..|.. +++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK---------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 46999999999999543 45889999998754322 2233445544 55778999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|..++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred EEEEcCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 99999999999999987653 4788889999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 146 GIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred cccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 322221 223457999999999999989999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.06 Aligned_cols=195 Identities=29% Similarity=0.367 Sum_probs=165.9
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|... .+++.||+|.+..... .....+..|.+++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELK---------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 46999999999999543 4588999999876432 2233466788888765 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+.+.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeeccccee
Confidence 99999999999999987653 4788889999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 146 GILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 322221 123457999999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=293.98 Aligned_cols=195 Identities=29% Similarity=0.388 Sum_probs=163.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHH-HHcccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|+.. .+++.||+|.+.+.... ....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK---------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 46999999999999543 35889999998754322 2233445554 57888999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|...+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 9999999999999888754 34778888999999999999999987 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 146 GVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred CCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 322211 223457999999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=290.59 Aligned_cols=216 Identities=26% Similarity=0.410 Sum_probs=174.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCc-------CCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccce
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTY-------APARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-------~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
++|++.+.||+|+||.||+|.++...- ......++..||+|.+..... .....+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 589999999999999999997654210 001233566899999876532 334568899999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRAS---------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 204 (295)
++++.+.+..+++|||+++++|.+++..... ....+++..+..++.||+.||.|||+++ |+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~ 162 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHR 162 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence 9999999999999999999999999865321 1124677888999999999999999988 9999
Q ss_pred cCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc--cCChh
Q 022575 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL--QLPMC 282 (295)
Q Consensus 205 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~pf 282 (295)
||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986543322222223456789999999998899999999999999999986 55677
Q ss_pred hee
Q 022575 283 VLY 285 (295)
Q Consensus 283 ~~~ 285 (295)
...
T Consensus 243 ~~~ 245 (304)
T cd05096 243 GEL 245 (304)
T ss_pred CcC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=305.21 Aligned_cols=196 Identities=29% Similarity=0.409 Sum_probs=174.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|.-.+.||.|+||.||-| .+..+.+.||||.+.-... ..+..+++|++.|.+++|||++.+.++|..
T Consensus 27 lf~dLrEIGHGSFGAVYfA---------rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHHhcCCccceeEEe---------eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 4666788999999999999 4555789999999976543 346678899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
....||||||| -|+-.|++.-++ .++.+..+..|..+.+.||.|||+++ .||||||+.|||+++.|.|||+|||
T Consensus 98 e~TaWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 98 EHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred cchHHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeecccc
Confidence 99999999999 678889888776 57888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.|..... ..+++|||+|||||+|. .|.|+-++||||||++-.||.-++||.+-.
T Consensus 172 SAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 172 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred chhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 9876433 34579999999999987 679999999999999999999999998754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.38 Aligned_cols=195 Identities=27% Similarity=0.381 Sum_probs=166.2
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|+.. .+++.||+|.+.+... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLK---------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 46999999999999544 3588999999875432 2234566788888776 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999999999999887653 4788899999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 146 GIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred cCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 322211 223457999999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.51 Aligned_cols=195 Identities=30% Similarity=0.392 Sum_probs=164.2
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHH-HHcccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK-HLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|... .+++.+|+|++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK---------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 46999999999999543 4588999999875432 22234455554 46778999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|..++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred EEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 9999999999999888764 34788999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 146 GIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred CCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 322211 223457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.51 Aligned_cols=206 Identities=27% Similarity=0.417 Sum_probs=181.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..+...+.+.||+|.||.|.+|.... +..||+|.++..... .+.+|.+|+++|.+|+||||++++++|.
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 34567888999999999999997663 688999999877544 3578999999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.++.+++++||+++|+|.+++..+.... ........++.||+.||+||.+.+ +|||||.++|+|++.++++||+||
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCc
Confidence 9999999999999999999999875321 344556779999999999999977 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc--cCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL--QLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~pf~~~ 285 (295)
|+++.+..+.........+-..+|||||.+..++|+.++|+|+||+++||+++ ...||...
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 99998877777766666777899999999999999999999999999999876 67788754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=296.26 Aligned_cols=195 Identities=27% Similarity=0.327 Sum_probs=163.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|+..+.||+|+||.||+|... .+++.||||.+..... .....+.+|+++++.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHR---------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEEC---------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 46788899999999999999544 3578999999865432 2345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+.. ...+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 145 ~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred CeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccccc
Confidence 9999999999999986432 2456777889999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhh
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
++....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||.
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 986533221 1233578999999998753 234568999999999999999999996
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.51 Aligned_cols=200 Identities=26% Similarity=0.324 Sum_probs=169.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccC-CCCccceeeEEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~ 144 (295)
+|++.+.||+|+||.||+|... .+++.||+|.+.+... .....+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK---------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 4677899999999999999543 4688999999875432 22334667888888875 577888999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Df 145 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADF 145 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEecc
Confidence 9999999999999999999987653 4888999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|.+||...
T Consensus 146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 146 GMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred ccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 99875322211 123456999999999999889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=302.30 Aligned_cols=211 Identities=28% Similarity=0.391 Sum_probs=176.6
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc---chhhHHHHHHHHHHHcccCCCCccce
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
+....++-.+.++||+|+||.||+|.+.... ......||+|..+.. ......++.+|++++++++||||+++
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~-----~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKN-----GFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecC-----CceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3344456667799999999999999887421 111223999998852 24556789999999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
||+......+++|||+|.||+|.++|++.+ ..++..+...++.+++.||+|||+++ ++||||.++|+|++.++.+
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeE
Confidence 999999999999999999999999999876 35888999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceee-ccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 220 KLSDFGLAKDGPTGSQSHVST-RVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
||+|||+++.... ..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+..
T Consensus 302 KISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 302 KISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred EeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 9999999886431 11111 1124678999999999999999999999999999999 788988764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=280.80 Aligned_cols=199 Identities=26% Similarity=0.369 Sum_probs=176.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+.|++.++||+|.|+.|+++ .+..+|+.+|+|++....+. ..+++.+|+++...|+||||+++++.+..
T Consensus 11 d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE 81 (355)
T ss_pred hhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence 58899999999999999998 56678999999998766543 45677899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc---CCCcEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~ 222 (295)
.+..|||+|++.|++|..-|-++ ..+++..+-.++.||+.+|.|+|.++ |||||+||+|+|+. ...-+||+
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred cceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeec
Confidence 99999999999999998777655 34678888899999999999999988 99999999999994 34568999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+|..... ......+.|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+
T Consensus 156 ~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 156 DFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred ccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 9999998762 3355668999999999999999999999999999999999999999987
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=292.66 Aligned_cols=195 Identities=27% Similarity=0.393 Sum_probs=165.4
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|... .++..||+|.++.... ........|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 47999999999999544 4688999999976432 2233456777777654 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+.+++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999999999999987653 4788889999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 146 NVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred cccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 322211 233467999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=293.56 Aligned_cols=195 Identities=28% Similarity=0.355 Sum_probs=163.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHH-HHHcccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEI-KHLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~-~~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|+.. .+++.||+|.+...... ....+..|. .+++.++||||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHK---------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 46999999999999544 35788999998754321 222334444 356778999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.... .+.+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~ 145 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKE 145 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence 99999999999999997653 4677888889999999999999988 99999999999999999999999999975
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 146 NIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred cccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 322211 223457999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=293.58 Aligned_cols=200 Identities=26% Similarity=0.336 Sum_probs=173.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||++... .++..+|+|.+..... .....+.+|++++.+++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 368999999999999999999543 4688999999876532 234568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCCCcEEEccCc
Confidence 999999999999999999997653 4788899999999999999999852 39999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 150 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 150 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 987653321 2235689999999999988999999999999999999999999953
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=310.97 Aligned_cols=209 Identities=23% Similarity=0.203 Sum_probs=176.2
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|+.. .+++.||||.+..... .....+.+|+..+..++|+||++++..+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~ 100 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV---------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF 100 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc---------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence 3469999999999999999999543 3588999999876532 3345677899999999999999998877
Q ss_pred EeCC--------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 144 LEDD--------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 144 ~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
...+ ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCS 178 (496)
T ss_pred ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeC
Confidence 5432 368999999999999999765544456889999999999999999999987 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999998654332222233467999999999999999999999999999999999999999643
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.07 Aligned_cols=202 Identities=25% Similarity=0.320 Sum_probs=170.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++..++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK---------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 37899999999999999999544 3588999999875432 223456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..|+||||++++.+..+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg 145 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFG 145 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeecc
Confidence 99999999999887666544322 35788899999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++......... ......||+.|+|||++.+..++.++|+|||||++|||++|++||...
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 146 FARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred Ccccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 99865432211 122356899999999999888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=292.94 Aligned_cols=194 Identities=24% Similarity=0.331 Sum_probs=166.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
++||+|+||.||+|... .+++.||+|.+.+.... ....+.+|+.++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK---------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 47999999999999654 35789999999765332 234567899888888 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEecccccee
Confidence 99999999999999887653 4889999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 146 GLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 322111 22346799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=300.60 Aligned_cols=195 Identities=19% Similarity=0.200 Sum_probs=167.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
..+|++.+.||+|+||.||+|.. ..+++.||+|.... ..+.+|+++++.++||||+++++++...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d---------~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~ 155 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACID---------NKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN 155 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEE---------CCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence 36799999999999999999944 44688999997542 2356899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
...++++|++ +++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 156 ~~~~lv~e~~-~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~ 228 (391)
T PHA03212 156 KFTCLILPRY-KTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGA 228 (391)
T ss_pred CeeEEEEecC-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCc
Confidence 9999999999 578988886653 4788899999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 229 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 229 ACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 97532211 1122345799999999999988999999999999999999999987654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=290.87 Aligned_cols=204 Identities=27% Similarity=0.348 Sum_probs=176.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHccc-CCCCccceeeE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
..+|.+..+||+|+||+|.+| .++.+.+.+|||++++.-..+ .+--..|-++|... +-|.+++++.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence 358899999999999999998 677789999999998764322 22234566777665 57899999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
|++-+.+|+||||+.||+|...|++.+. +.+..+..++.+|+.||-|||++| |+.||||.+|||++.+|++||+
T Consensus 419 FQTmDRLyFVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 419 FQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred hhhhhheeeEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEee
Confidence 9999999999999999999999999876 445567888999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
|||+++....... ...+++|||.|+|||+++..+|+..+|.||+|++||||+.|+|||.+..+
T Consensus 493 DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 493 DFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999996443332 34568999999999999999999999999999999999999999987643
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=293.20 Aligned_cols=198 Identities=28% Similarity=0.317 Sum_probs=170.0
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 151 (295)
+.||+|+||.||+++.. ....++..+|+|++...... ....+.+|++++.+++||||+++++++...+..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 67999999999998643 23346899999999765432 33456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence 99999999999998664 34789999999999999999999988 9999999999999999999999999988643
Q ss_pred CCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 232 TGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 150 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 3211 223457999999999999888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=287.41 Aligned_cols=197 Identities=27% Similarity=0.358 Sum_probs=167.9
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||+|+||+||++.. ..+++.+|+|.+...... ....+..|++++..++|+||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQM---------RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEE---------ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 68999999999954 346889999998765432 224567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.........+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999999888654333356889999999999999999999988 99999999999999999999999999976533
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||...
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 221 123357899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.76 Aligned_cols=200 Identities=25% Similarity=0.380 Sum_probs=166.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||+|.. ..++..||+|.+.... .....++.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAID---------THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEE---------CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 578889999999999999954 3468899999986432 22344678999999999999999999988643
Q ss_pred C-----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 147 D-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 147 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
+ ..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEE
Confidence 2 479999999 579999887653 4788999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCC-cceeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhhe
Q 022575 222 SDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999985432211 111234579999999999865 6788999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.77 Aligned_cols=215 Identities=25% Similarity=0.319 Sum_probs=174.9
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+++++.+ +|+||++++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 3345899999999999999999965321 1223466899999976533 2344578899999999 89999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccC----------------------------------------------------
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRAS---------------------------------------------------- 170 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------- 170 (295)
+...+..++||||+.+|+|.+++.....
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 9999999999999999999999865321
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCc
Q 022575 171 --------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236 (295)
Q Consensus 171 --------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 236 (295)
...++++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 0124677888999999999999999988 999999999999999999999999999865433222
Q ss_pred ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 237 HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 237 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.......++..|+|||++....++.++|||||||++|||++ |++||...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 22222345678999999998899999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=287.31 Aligned_cols=199 Identities=29% Similarity=0.364 Sum_probs=178.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
-|.+...||+|+||.||+| .++.+|..+|||.+.... +.+++.+|+.++.+.+.|+++++|+.+.....
T Consensus 34 VFDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 4667789999999999999 555679999999987664 56688899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
+|+|||||..|++.+.++.+. .++.+..+..++...+.||+|||..+ -+|||||+.|||++.+|..||+|||.|.
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999999998766 57999999999999999999999866 8999999999999999999999999998
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+.+... ...++.|||.|||||++..-.|+.++||||||++..||..|+|||...
T Consensus 178 QLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 178 QLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred hhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 6544332 234578999999999999999999999999999999999999999865
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=290.67 Aligned_cols=195 Identities=27% Similarity=0.389 Sum_probs=164.7
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcc-cCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|... .+++.||+|.++.... ........|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELK---------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 46999999999999544 3578999999876532 223345667777775 4899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 9999999999999999764 34788888999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 146 NMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred CCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 322211 123457999999999999889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=276.33 Aligned_cols=201 Identities=28% Similarity=0.371 Sum_probs=174.8
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--------hhHHHHHHHHHHHccc-CCCCc
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQL-YHPNL 136 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~ni 136 (295)
.-..|...+.||.|..++|.++ ..+.++..+|+|++..... .-.++-.+|+.+|+++ .||+|
T Consensus 15 fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I 85 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI 85 (411)
T ss_pred HHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence 3467888899999999999887 5556788999998854321 1133457899999998 59999
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
+++.++++.+..+++|+|.|+.|.|.++|... ..+++.....|+.|+..|++|||.++ ||||||||+|||++++
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN 159 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc
Confidence 99999999999999999999999999999876 45899999999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeec------cCcccccceeeehhHHHHHHhccCChhhe
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.++||+|||++..+..+.. ....||||+|+|||.+. ...|+...|+|++|++||-|+.|.|||.-
T Consensus 160 ~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred cceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 9999999999998766543 44579999999999986 33688999999999999999999999963
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=307.85 Aligned_cols=212 Identities=25% Similarity=0.264 Sum_probs=177.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeE-EEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGY-CLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~-~~~ 145 (295)
.++++.++|.+|||+.||+|.... .+..||+|++-..+........+|+++|++|+ |+|||.+++. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 477888999999999999996554 34889999998777777788899999999996 9999999993 221
Q ss_pred C------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 D------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. -.++|+||||.||.|-+++..+.. ..|.+.++++|+.|+++|+.+||...++|||||||.|||||+.++..
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 1 246899999999999999987654 45999999999999999999999999999999999999999999999
Q ss_pred EEccccCCCCCCCCCCcce-------eeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhheeeeee
Q 022575 220 KLSDFGLAKDGPTGSQSHV-------STRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLYLTYA 289 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 289 (295)
||||||.|........... .-....|+.|+|||++. +...+.|+|||+|||+||-|+....||+..-..+
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 9999999975433321110 01124699999999986 5578899999999999999999999999875555
Q ss_pred E
Q 022575 290 L 290 (295)
Q Consensus 290 ~ 290 (295)
+
T Consensus 266 I 266 (738)
T KOG1989|consen 266 I 266 (738)
T ss_pred E
Confidence 4
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=297.94 Aligned_cols=213 Identities=26% Similarity=0.326 Sum_probs=174.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|..... ....++..||+|.++... ......+.+|++++..+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 45899999999999999999965321 233457789999987543 23345678899999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCC-----------------------------------------------------
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASY----------------------------------------------------- 171 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 171 (295)
..+..++||||+++|+|.+++......
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999999999753210
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCC
Q 022575 172 ------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (295)
Q Consensus 172 ------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 233 (295)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 124677888999999999999999987 999999999999999999999999999865433
Q ss_pred CCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 234 SQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
..........++..|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 22212222345678999999999999999999999999999997 88898653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=285.77 Aligned_cols=201 Identities=28% Similarity=0.394 Sum_probs=172.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|++.++||+|+||.||++... .++..||+|.+...... ....+.+|+.+++.++||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc---------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 4778899999999999999543 35789999998754332 22346789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLG 147 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999999988865432 45889999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ .....|++.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 148 LAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred CceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 9876433221 12346899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.24 Aligned_cols=204 Identities=29% Similarity=0.412 Sum_probs=174.0
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeCC-
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD- 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~- 147 (295)
+...+.||+|+||.||++ +++.+|+.||||.++... ....+.+.+|+++|++++|+|||++++.-++..
T Consensus 15 W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred eeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 445578999999999999 566689999999997643 334566789999999999999999998765443
Q ss_pred -----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE--cCCCc--
Q 022575 148 -----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYN-- 218 (295)
Q Consensus 148 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~-- 218 (295)
...++||||.+|+|...+.+..+- ..+++...+.++.+++.||.|||++| |+||||||.||++ ..+|+
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceE
Confidence 458999999999999999875432 45899999999999999999999988 9999999999999 33343
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeec-cCcccccceeeehhHHHHHHhccCChhheeeee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGIFQLVLLLFTFECSLLHFSLQLPMCVLYLTY 288 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 288 (295)
-||+|||.|+....+. ...++.||+.|.+||+.. .+.|+..+|+|||||++|+.+||..||..+-+-
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 5999999999876554 456789999999999999 489999999999999999999999999877543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=294.02 Aligned_cols=200 Identities=24% Similarity=0.197 Sum_probs=171.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
..+|++.+.||+|+||.||+|.... ...+..||+|.+.... ...+|++++++++||||+++++++...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 4579999999999999999986432 2347789999886543 235799999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++||++ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999 57898888543 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+................||+.|+|||++....++.++|||||||++|||++|.+||...
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 97654433322233467999999999999889999999999999999999999998654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.49 Aligned_cols=206 Identities=20% Similarity=0.303 Sum_probs=172.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|++.. ....+..||+|.++.... .....+.+|+..+.+++||||+++++++...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKL------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEec------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 578999999999999999997652 223578899999876533 2344678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCcc
Confidence 99999999999999999997653 35788999999999999999999987 99999999999999999999999998
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+......... ......++..|+|||.+.+..++.++|||||||++||+++ |.+||...
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 7653222111 1112235678999999999999999999999999999775 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.83 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=164.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHccc---CCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~l~~~ 142 (295)
++|++.+.||+|+||.||+|.... ..+..||+|.+...... ....+.+|+.++..+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC--------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 378999999999999999996432 23678999988654321 223345566665554 79999999998
Q ss_pred EEe-----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 143 CLE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 143 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
+.. ....++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~ 147 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSG 147 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCC
Confidence 853 356899999995 699999876432 34788999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 148 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 148 QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred CEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 99999999997643321 223456899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=318.80 Aligned_cols=211 Identities=23% Similarity=0.210 Sum_probs=183.2
Q ss_pred ehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCC
Q 022575 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPN 135 (295)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~n 135 (295)
...+.....++|.+.++||+|+||.|.+++ .+.+++.||+|++.+... ....-|+.|-.+|..-+.+-
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr---------~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~W 136 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVR---------HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEW 136 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEE---------eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHH
Confidence 344556667899999999999999999984 555799999999987433 23345778889999989999
Q ss_pred ccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 136 i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
|+.++-.|+++.++|+||||++||+|..++.+.. .+++..+..|+.+|+.||.-||+.| +|||||||+|||||.
T Consensus 137 iv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 137 IVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDK 210 (1317)
T ss_pred HHHHHHHhcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecc
Confidence 9999999999999999999999999999998764 5899999999999999999999977 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeec----c-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA----T-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.|++||+|||.|-.+.... .......+|||.|++||++. + +.|+...|+||+||++|||+.|..||+..
T Consensus 211 ~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred cCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 9999999999998765433 22344568999999999987 3 68999999999999999999999999754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.76 Aligned_cols=199 Identities=21% Similarity=0.314 Sum_probs=160.6
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC------CCCcc
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY------HPNLV 137 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------h~ni~ 137 (295)
....++|++.+.||+|+||.||+|+.. .+++.||||+++.... .......|+.++..++ |.+++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~---------~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDR---------KRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEc---------CCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCccee
Confidence 344578999999999999999999543 3578999999864321 1223344555555554 55688
Q ss_pred ceeeEEEeC-CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcC
Q 022575 138 KLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 138 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~ 215 (295)
++++++... +..|+|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||++ + ||||||||+|||++.
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~ 267 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMET 267 (467)
T ss_pred eeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEec
Confidence 999888764 5789999998 789999887653 488899999999999999999974 6 999999999999987
Q ss_pred CC----------------cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccC
Q 022575 216 NY----------------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQL 279 (295)
Q Consensus 216 ~~----------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 279 (295)
++ .+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 65 499999998864221 123467999999999999999999999999999999999999
Q ss_pred Chhhe
Q 022575 280 PMCVL 284 (295)
Q Consensus 280 ~pf~~ 284 (295)
+||..
T Consensus 343 ~pf~~ 347 (467)
T PTZ00284 343 LLYDT 347 (467)
T ss_pred CCCCC
Confidence 99964
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.42 Aligned_cols=194 Identities=28% Similarity=0.390 Sum_probs=165.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|... .++..||+|.+.+... .....+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELK---------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEEC---------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 46999999999999544 3578899999976532 2234456788888877 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99999999999999887653 4889999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
...... .....+||+.|+|||++.+..++.++|+|||||++|+|++|.+||..
T Consensus 146 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 146 GILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred cCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 322211 12335789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.40 Aligned_cols=195 Identities=28% Similarity=0.417 Sum_probs=173.1
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEe
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYE 154 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 154 (295)
+||+|.||+||-| ++..+...+|||.+..+.....+-+..|+.+.+.|+|.|||+++|.+..++.+-|.||
T Consensus 582 VLGKGTYG~VYA~---------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAA---------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEee---------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 6999999999999 5666788999999988877777778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEEEccccCCCCCC
Q 022575 155 FMPKGSLENHLFRRASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 155 ~~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~ 231 (295)
-++||+|.++++...+ ++ .+..+-.+..||+.||+|||++. |||||||-+||||+ -.|.+||+|||.++.+.
T Consensus 653 qVPGGSLSsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred cCCCCcHHHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhc
Confidence 9999999999987663 44 67788899999999999999988 99999999999995 57899999999999764
Q ss_pred CCCCcceeeccccccCccCceeeccC--cccccceeeehhHHHHHHhccCChhhee
Q 022575 232 TGSQSHVSTRVMGTYGYAAPEYMATG--IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.-. ....++.||..|||||++..+ .|..++|||||||++.||.||+|||...
T Consensus 728 gin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 728 GIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred cCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 322 234567899999999999876 6789999999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.89 Aligned_cols=200 Identities=26% Similarity=0.388 Sum_probs=163.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... .+++.||||.+..... ...+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICI---------DTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEEC---------CCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 468999999999999999999543 3588999998854321 234699999999999999999887532
Q ss_pred --------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-
Q 022575 147 --------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY- 217 (295)
Q Consensus 147 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~- 217 (295)
..+++||||++ ++|.+++.........+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCC
Confidence 24679999995 5888877654333356889999999999999999999988 99999999999998665
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus 209 ~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 699999999986543221 2235789999999998754 6899999999999999999999999753
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=289.19 Aligned_cols=200 Identities=27% Similarity=0.360 Sum_probs=172.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||++... .++..+|+|.+..... .....+.+|++++..++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK---------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 368999999999999999999543 4578899998876432 234567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 999999999999999999997653 478888899999999999999974 139999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++...... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 98754322 12234689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=293.21 Aligned_cols=214 Identities=23% Similarity=0.301 Sum_probs=174.9
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccC-CCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|..... .+...+..||+|.+..... .....+.+|+.++.++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 356899999999999999999975421 2233466899999975433 23456889999999996 99999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccC-----------------------------------------------------
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRAS----------------------------------------------------- 170 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 170 (295)
...+..|+|||||++|+|.+++.+...
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999999865321
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 171 ---------------------------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 171 ---------------------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
....+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhE
Confidence 0123677788899999999999999987 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999999986533222212223456788999999998899999999999999999997 88888654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=284.93 Aligned_cols=207 Identities=22% Similarity=0.339 Sum_probs=171.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|.+... .......||+|.++.... ....++.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 5799999999999999999976431 112245699999875432 3445678899999999999999999998764
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..++++||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccc
Confidence 5789999999999999998654 35788888999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............++..|+|||.+....++.++|||||||++|||++ |.+||...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 986544332222222334678999999999999999999999999999987 99998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=280.30 Aligned_cols=194 Identities=30% Similarity=0.431 Sum_probs=165.7
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||+|+||.||++... .+++.+|+|.+...... .......|++++.+++||||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVK---------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEc---------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 699999999999543 36889999998754332 223445799999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred EecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 999999999988865442 45788888999999999999999988 99999999999999999999999999876543
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.. ......|++.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 148 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 148 GK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred Cc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 22 122346899999999999888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=280.70 Aligned_cols=213 Identities=25% Similarity=0.355 Sum_probs=177.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
..+|.+.+.||+|+||.||++..... ....++..+|+|.+..........+.+|+.++.+++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35899999999999999999965321 12335677999998766555556788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRAS---------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
+..+++|||+++++|.+++...+. ....+++..++.++.|++.||+|||+++ ++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 999999999999999999975431 2234889999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.+||+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |.+||...
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999986533222111222345778999999998899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.93 Aligned_cols=202 Identities=24% Similarity=0.285 Sum_probs=180.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
...|.+.+.||+|.|++|.+|+ +..++..||||.+++.... .+..+.+|+++|..|+||||++++.+.+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~---------~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLAR---------HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred ccceeeeeeeccceeEEEEeeE---------ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 3589999999999999999994 4557999999999887553 3455789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
....+|+||||+.+|.+++++.+++. +.+..+..++.|++.|++|||+++ |||||||++||||+.+..+||+||
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeecc
Confidence 99999999999999999999998864 555788899999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCccc-ccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ-LVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|++..+..+. ...+++|++.|.|||++.+..|. +++|+||+|+++|-|+.|..||.+-.
T Consensus 200 gfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 200 GFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 9998765433 34568999999999999988775 89999999999999999999998654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.10 Aligned_cols=207 Identities=20% Similarity=0.262 Sum_probs=172.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+|++.++||+|+||.||+|.. ..+++.||+|.+..... ....++.+|++++..++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d---------~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYD---------PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEE---------CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 4799999999999999999954 34688999999875422 23456889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRAS-------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
+.+..+++|||++|++|.+++..... ....++...++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCC
Confidence 99999999999999999999875311 1123456677889999999999999987 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCC----------------cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCCh
Q 022575 218 NAKLSDFGLAKDGPTGSQ----------------SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPM 281 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 281 (295)
.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999986521110 0011235699999999999999999999999999999999999999
Q ss_pred hhee
Q 022575 282 CVLY 285 (295)
Q Consensus 282 f~~~ 285 (295)
|...
T Consensus 231 F~~~ 234 (932)
T PRK13184 231 YRRK 234 (932)
T ss_pred CCCc
Confidence 9653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=294.58 Aligned_cols=196 Identities=22% Similarity=0.259 Sum_probs=166.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
...|.+.+.||+|+||.||+|... .+++.||||..... .+.+|++++++++|+||+++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~---------~~~~~vavK~~~~~------~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP---------DYPQRVVVKAGWYA------SSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC---------CCCCEEEEeccccc------CHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 457999999999999999999543 35788999964322 345899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++||++ .++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCC
Confidence 9999999999 578988886543 35889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
++...............||+.|+|||++.+..++.++|||||||++|||++|..|++
T Consensus 307 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 986533222222234579999999999999999999999999999999999876543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=287.10 Aligned_cols=206 Identities=22% Similarity=0.226 Sum_probs=173.6
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc--chhhHHHHHHHHHHHcccC-CCCcccee
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY-HPNLVKLI 140 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-h~ni~~l~ 140 (295)
...++.|++.+.||+||.+.||++...+ ...+|+|++... +.+...-+.+|+..|.+|+ |.+|++|+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 4455789999999999999999985432 456787776543 2234556899999999995 99999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+|-..++.+||||||= ..+|..+|++... ..+...++.+..|++.++.++|++| |||.||||.|+|+- .|.+|
T Consensus 427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LK 499 (677)
T KOG0596|consen 427 DYEVTDGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLK 499 (677)
T ss_pred eeeccCceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEE
Confidence 9999999999999987 7799999988763 2343478899999999999999998 99999999999995 67999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccC-----------cccccceeeehhHHHHHHhccCChhheee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----------IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|+|||+|..+............+||+.||+||.+... +.++++|||||||+||+|+.|++||..+.
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 9999999987766655555667999999999998632 35689999999999999999999999875
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=290.60 Aligned_cols=197 Identities=23% Similarity=0.269 Sum_probs=165.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||++.. ..++..||+|.+.... .....++.+|+.++..++||||+++++++.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFD---------TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT 90 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEE---------cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 46899999999999999999953 3468899999986542 233456778999999999999999999986
Q ss_pred eCC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
..+ ..|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~ 161 (359)
T cd07876 91 PQKSLEEFQDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 161 (359)
T ss_pred cCCCccccceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCC
Confidence 543 4799999995 567766632 3677888899999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 162 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 162 LKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred EEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999997543221 12234689999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=279.60 Aligned_cols=214 Identities=21% Similarity=0.374 Sum_probs=174.6
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..++|++.+.||+|+||.||+|..... ....++..||+|.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456899999999999999999976531 122356789999986543 234456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
.....++||||+++++|.+++.+.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 989999999999999999999764321 123567788899999999999999987 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++|+|||+++...............+++.|+|||++.++.++.++|+|||||++|||++ |.+||...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999876543322211222345788999999998899999999999999999998 78888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=279.19 Aligned_cols=212 Identities=25% Similarity=0.376 Sum_probs=176.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|.+.+.||+|+||.||+|..... ....++..||+|.++..... ....+.+|++++..++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 5788999999999999999965431 12245688999998765443 345788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRAS----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
+..+++|||+++++|.+++...+. ....+++..+..++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence 999999999999999999976532 1234678889999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999875433221111223346788999999999999999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=280.14 Aligned_cols=200 Identities=29% Similarity=0.409 Sum_probs=171.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|+..+.||+|+||.||++... .+++.+|+|.+...... ....+.+|+.++.+++|+||+.+++.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc---------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 3677789999999999999544 46889999998654322 22346789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg 147 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLG 147 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999865432 45888999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++........ .....|+..|+|||++.+..++.++|+|||||++|+|++|.+||..
T Consensus 148 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 148 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred ceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 9875433221 1234689999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=291.65 Aligned_cols=200 Identities=25% Similarity=0.346 Sum_probs=167.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||++.. ..+++.||+|.+.... .....++.+|++++..++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTD---------PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEE---------CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 478899999999999999953 3468899999986532 23345678999999999999999999999877
Q ss_pred C-----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 147 D-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 147 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
+ ..|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL 144 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKI 144 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEe
Confidence 6 7899999995 6888887654 35888999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++........ ......+++.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 145 ~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 145 CDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred ccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 999999864332211 12234678999999998764 5789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.52 Aligned_cols=212 Identities=30% Similarity=0.401 Sum_probs=178.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+-.+.+.||+|.||.||.|.+.... .......||+|.+++.. .+...+|++|..+|++++||||++++|++.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 45667789999999999999877532 11114569999997764 34566899999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRAS---YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+|++|||++|+|..+|++.+. ....+.....+.++.||++|++||++++ +|||||.++|+||+....+||+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999987621 1255778889999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+|+.+.............-...|||||.+..+.|+.++|||||||++||+++ |.+||..-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~ 908 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR 908 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence 999996555443333322234578999999999999999999999999999999 88998765
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=288.64 Aligned_cols=193 Identities=25% Similarity=0.298 Sum_probs=160.6
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHccc---CCCCccceeeEEEeCCee
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l---~h~ni~~l~~~~~~~~~~ 149 (295)
||+|+||.||+|+. ..++..||+|++....... ......|..++..+ +||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRK---------KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEE---------CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 69999999999954 3468899999987543322 22344566666554 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+||||+++++|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999999999999987653 4788999999999999999999988 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 146 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 146 NLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred CCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 332221 12345799999999998754 4789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=300.03 Aligned_cols=202 Identities=24% Similarity=0.379 Sum_probs=178.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.+.++..||.|+||+||+| .++.++...|.|++..........++-|+++|..++||+|++|++.|...+.
T Consensus 33 ~WeIiGELGDGAFGKVyKA---------~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKA---------VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHhhhcCccchhhhhh---------hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 4667788999999999999 4555678888999988877778889999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
+||+.|||.||.++.++..-+ ..+.+.++..+++|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+.
T Consensus 104 LwiliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccc
Confidence 999999999999998887766 67899999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhheee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
..... .....++.|||+|||||+.. ..+|+.++||||||++|.||..+.||.....
T Consensus 179 Kn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 179 KNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred cchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 53322 22345689999999999986 4589999999999999999999999987643
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.33 Aligned_cols=212 Identities=26% Similarity=0.375 Sum_probs=178.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|.+.+.||+|+||.||+|..... ....++..+++|.+..........+.+|+.++..++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 5788899999999999999965431 123456779999998776666667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
..++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence 99999999999999999976431 1134788899999999999999999988 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999976543322222223456888999999998899999999999999999998 99998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=278.44 Aligned_cols=211 Identities=24% Similarity=0.367 Sum_probs=174.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|.... .....+..+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 478889999999999999997532 2334578899999975433 2335678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRAS-------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
+..|++|||+.+++|.+++..... ....+++..+..++.|++.||+|||+++ ++||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEE
Confidence 999999999999999999864321 1134678888999999999999999987 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+.++.+||+|||+++...............++..|+|||++.++.++.++|+|||||++|||++ |.+||...
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999986543322222233456778999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=286.05 Aligned_cols=213 Identities=24% Similarity=0.321 Sum_probs=172.7
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|..... ....+++.||+|.+..... .....+.+|+.++.++ +|+||+++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 346899999999999999999964321 2334678999999875432 2334567899999999 899999999987
Q ss_pred EeC-CeeEEEEeccCCCCHHHHHhhccCC---------------------------------------------------
Q 022575 144 LED-DHRLLVYEFMPKGSLENHLFRRASY--------------------------------------------------- 171 (295)
Q Consensus 144 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------- 171 (295)
... ...+++|||+++++|.+++......
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 5678999999999999998653210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccc
Q 022575 172 ------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245 (295)
Q Consensus 172 ------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 245 (295)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++................++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 125788899999999999999999987 999999999999999999999999999865433222222234567
Q ss_pred cCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 246 YGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 246 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
..|+|||++.+..++.++|||||||++|||++ |.+||..
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 78999999999999999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=277.77 Aligned_cols=190 Identities=17% Similarity=0.239 Sum_probs=163.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHcccCCCCccceeeEEEe----C
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNLVKLIGYCLE----D 146 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~ 146 (295)
..||+|++|.||+|.++ ++.||+|.+....... ...+.+|+.+|.+++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 67999999999999764 6789999997654322 3456799999999999999999999877 3
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
...++||||+++|+|.+++.... .+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg 168 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHG 168 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccc
Confidence 46899999999999999997653 477888899999999999999974 5 8899999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 169 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 169 LEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred hHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 988643321 12468899999999876 68899999999999999999999999764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=282.78 Aligned_cols=200 Identities=25% Similarity=0.356 Sum_probs=168.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|.+.+.||+|+||.||+|... .++..||+|.++..... ....+.+|+.+++.++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK---------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec---------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 57999999999999999999543 45788999998754322 233567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~ 150 (309)
T cd07872 77 KSLTLVFEYLD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGL 150 (309)
T ss_pred CeEEEEEeCCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcccc
Confidence 99999999996 58888886654 34788888999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+........ ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 151 ARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred ceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 875433221 1223467899999998865 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.75 Aligned_cols=200 Identities=30% Similarity=0.387 Sum_probs=171.5
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
|+..+.||+|+||.||+|... .+++.+|+|.+...... ....+.+|++++..++|+||+.+++.+...
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 667788999999999999554 35889999998765432 223467899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+.+++|.+++...+. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCc
Confidence 999999999999999988865432 35899999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... ......|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 149 ~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 149 AVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred ceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 87543222 122346899999999999889999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.66 Aligned_cols=212 Identities=25% Similarity=0.420 Sum_probs=175.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|..... ........||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGP----NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecC----CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4789999999999999999976532 1123457899999875543 2345678999999999999999999999998
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
+..+++|||+++++|.+++...... ...+++..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc
Confidence 9999999999999999999764221 134778888999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.++.+||+|||+++...............+++.|+|||.+.++.++.++|+|||||++|||++ |.+||...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999976533322222233456889999999988899999999999999999998 99998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.32 Aligned_cols=194 Identities=21% Similarity=0.260 Sum_probs=164.6
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
...+|++.+.||+|+||.||+|... .++..||+|...... ...|+.++.+++||||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP---------GQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC---------CCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEe
Confidence 3457999999999999999999544 357889999764432 2468999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++|||++ .++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCc
Confidence 99999999999 568988886644 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccC-Chhh
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQL-PMCV 283 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~pf~ 283 (295)
+++...... ......||+.|+|||++.+..++.++|||||||++|||+++. ++|.
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 203 AAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred cccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 997532221 122356899999999999999999999999999999999854 4443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.77 Aligned_cols=212 Identities=26% Similarity=0.347 Sum_probs=176.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.++||+|+||.||++..... ....++..+|+|.+..........+.+|++++..++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35788899999999999999964321 23345778999998876655566788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASY-----------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
+..+++|||+.+++|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 9999999999999999999765321 124788889999999999999999987 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999875433221111222345788999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=267.37 Aligned_cols=204 Identities=24% Similarity=0.246 Sum_probs=172.1
Q ss_pred hcCCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
.+++|++. ++||-|-.|+|..| .++.+++.+|+|++... .+.++|+++.-.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 34677765 68999999999988 55568999999988543 2445788766555 599999999998
Q ss_pred Ee----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc---CC
Q 022575 144 LE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LN 216 (295)
Q Consensus 144 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~ 216 (295)
+. ...+.+|||.++||.|.+.|+.++. ..+.+..+..|+.||+.|+.|||+.+ |.||||||+|+|.. .|
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCC
Confidence 64 3467899999999999999998876 67999999999999999999999987 99999999999995 45
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeeeeeE
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLTYAL 290 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~ 290 (295)
..+||+|||+|+...... ...+.+-||+|.|||++-..+|+...|+||+|+++|-|++|.|||+..-++++
T Consensus 201 a~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai 271 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_pred cceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC
Confidence 678999999999754322 23345789999999999999999999999999999999999999998877664
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=309.00 Aligned_cols=208 Identities=22% Similarity=0.314 Sum_probs=170.9
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
....+|++.+.||+|+||.||+|+.. .++..+|+|.+..... .....+..|+.++..|+||||++++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk---------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHK---------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC---------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 33468999999999999999999543 4588999999875432 234567899999999999999999998
Q ss_pred EEeC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCeEeecCCCCCeEEcC
Q 022575 143 CLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK-----AKVIYRDFKTSNILLDL 215 (295)
Q Consensus 143 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~ivHrDlkp~Nill~~ 215 (295)
|... ..+||||||+++++|.++|.........+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8653 5689999999999999999764333346899999999999999999999843 34999999999999954
Q ss_pred -----------------CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc--CcccccceeeehhHHHHHHh
Q 022575 216 -----------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFS 276 (295)
Q Consensus 216 -----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~ 276 (295)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 2348999999998653322 1234579999999999864 45889999999999999999
Q ss_pred ccCChhhe
Q 022575 277 LQLPMCVL 284 (295)
Q Consensus 277 ~g~~pf~~ 284 (295)
+|.+||..
T Consensus 238 TGk~PF~~ 245 (1021)
T PTZ00266 238 SGKTPFHK 245 (1021)
T ss_pred HCCCCCCc
Confidence 99999964
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=287.67 Aligned_cols=198 Identities=21% Similarity=0.254 Sum_probs=166.3
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|. +..+++.||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEE---------ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 34689999999999999999994 33468889999987543 22344677899999999999999999988
Q ss_pred EeC------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 144 LED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 144 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~ 156 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 156 (355)
T ss_pred eccccccccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCC
Confidence 654 34699999995 577776643 3678888999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|++||..
T Consensus 157 ~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 157 TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998643321 12335789999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.66 Aligned_cols=198 Identities=21% Similarity=0.230 Sum_probs=166.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|.. ..+++.||||.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEE---------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 36899999999999999999953 3457889999987542 223456778999999999999999999875
Q ss_pred eC------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
.. ...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~ 164 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 164 (364)
T ss_pred ccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCc
Confidence 43 35799999995 578777743 3677888999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 165 ~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 165 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred EEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999998643321 122356899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=270.83 Aligned_cols=207 Identities=25% Similarity=0.356 Sum_probs=174.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|.+.. .......||+|.+...... ....+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKL------PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEcc------CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 578999999999999999997653 1223568999998765432 345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccch
Confidence 99999999999999999997654 35788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 987642222111122345678999999998899999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=276.53 Aligned_cols=199 Identities=26% Similarity=0.409 Sum_probs=162.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcc---cCCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQ---LYHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~---l~h~ni~~l~~~~ 143 (295)
+|++.+.||+|+||.||+|.. ..+++.||+|.++..... ......+|+.+++. ++||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARD---------PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEE---------CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 478889999999999999954 346889999998754322 12234456666655 4799999999988
Q ss_pred EeC-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 144 LED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 144 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
... ...+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCC
Confidence 642 45799999996 589888876432 34789999999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 147 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~ 209 (288)
T cd07863 147 VKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 209 (288)
T ss_pred EEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCC
Confidence 99999999986533221 2234689999999999988999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=271.21 Aligned_cols=210 Identities=22% Similarity=0.297 Sum_probs=172.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
..|+....||+|.||.||+|.-.+ .+......+|||.++..... -.....+|+.+++.++|||++.+..++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~-----~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKN-----TNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeecc-----CCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 479999999999999999994332 12222457999999766332 12356799999999999999999999887
Q ss_pred -CCeeEEEEeccCCCCHHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC----CcE
Q 022575 146 -DDHRLLVYEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----YNA 219 (295)
Q Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~ 219 (295)
+..+|+++||.+. +|.+.|+.+.. ....++...+..|+.||+.|+.|||++. |+||||||.|||+..+ |.|
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCee
Confidence 7789999999965 99999975432 2356888999999999999999999988 9999999999999877 999
Q ss_pred EEccccCCCCCCCCCCcc-eeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+++.+...-... ....++-|.+|.|||.+.+. .|+.+.|+|++||++.||++-.|.|..-
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999999765543221 12335679999999999865 7999999999999999999999999764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.24 Aligned_cols=197 Identities=23% Similarity=0.321 Sum_probs=166.7
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYD---------TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEE---------CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 447899999999999999999953 34688999999875432 2334567899999999999999999987
Q ss_pred EeC------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 144 LED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 144 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
... ...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~ 155 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDC 155 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCC
Confidence 643 3468999998 8899888754 34889999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus 156 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 156 ELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999864332 223468999999999876 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.67 Aligned_cols=203 Identities=23% Similarity=0.353 Sum_probs=173.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.+..+...+||+|+|-+||+|.. ..+|..||--.++.... ...+++..|+.+|+.|+||||+++|.+
T Consensus 39 gRy~k~~evLGrGafKtVYka~D---------e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~S 109 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFD---------EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDS 109 (632)
T ss_pred Cceeehhhhcccccceeeeeccc---------cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeh
Confidence 34556778999999999999954 34688888655543322 335678899999999999999999999
Q ss_pred EEeCCe--eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CCcE
Q 022575 143 CLEDDH--RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNA 219 (295)
Q Consensus 143 ~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~ 219 (295)
|.+... +-+|+|++..|+|..|+++++. +....+..|+.||+.||.|||++.++|+|||||.+||+|+. -|.|
T Consensus 110 W~d~~n~~in~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~V 185 (632)
T KOG0584|consen 110 WVDTDNKTINFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEV 185 (632)
T ss_pred eecCCCceeeeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCce
Confidence 988765 7789999999999999998864 77788999999999999999999999999999999999965 5899
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
||+|+|+|+..... ......|||.|||||+.. ..|+..+||||||++++||+|+..||.....
T Consensus 186 KIGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 186 KIGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred eecchhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 99999999875433 234478999999999987 7899999999999999999999999987643
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=274.21 Aligned_cols=202 Identities=27% Similarity=0.392 Sum_probs=173.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+.|++.+.||+|+||.||+|... .++..+++|.+..........+.+|+.+++.++||||+++++.+..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEEC---------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 57999999999999999999544 357899999998776666667888999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|..++.+.. ..+++..+..++.|++.+|.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccc
Confidence 9999999999999988876543 35788999999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......+++.|+|||++. ...++.++|+|||||++|+|++|.+||...
T Consensus 158 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 158 AKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred eecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 75322211 122346889999999985 345678999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=271.83 Aligned_cols=201 Identities=27% Similarity=0.320 Sum_probs=171.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .++..||+|.+..........+.+|+.++.+++||||+++++++...+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNL---------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhcchhheeecCCCeEEEEEEEC---------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 58999999999999999999543 357899999987654444456678999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999999998654 34788899999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......|++.|+|||.+. ...++.++|+|||||++|||++|.+||...
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 154 AKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred eeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 86532211 112346889999999885 345788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=273.26 Aligned_cols=207 Identities=22% Similarity=0.306 Sum_probs=168.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|.+... .......+++|.+...... ...++..|+..+..++||||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 4788899999999999999976431 1112335888887644322 2345677888999999999999999875 4
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
...++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcc
Confidence 56789999999999999997654 35788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............++..|+|||.+.++.++.++|||||||++|||++ |.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 986543322222233456788999999998899999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=273.09 Aligned_cols=194 Identities=24% Similarity=0.365 Sum_probs=167.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.++||+|+||.||+|.. ..++..||+|.+.... .....++.+|+.++.+++||||+++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEE---------cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 3688889999999999999953 3468899999986542 23345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~ 141 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGV 141 (279)
T ss_pred CEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 9999999999999986542 3577888899999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+....... .....||..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 142 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 142 STQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 97643321 2235789999999999988999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=276.74 Aligned_cols=198 Identities=25% Similarity=0.343 Sum_probs=171.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||++... .++..+|+|.+..... ....++.+|++++.+++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR---------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc---------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 36889999999999999999543 4578899998875432 2344678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg 145 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 145 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCC
Confidence 9999999999999999999765 347888899999999999999997 45 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++....... .....|++.|+|||.+.+..++.++|+|||||++|+|++|.+||..
T Consensus 146 ~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 146 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred Ccccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 987543221 2335789999999999888899999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=276.53 Aligned_cols=212 Identities=25% Similarity=0.326 Sum_probs=175.8
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|.+.+.||+|+||.||++..... ....++..+|+|.++.... .....+.+|+.+++++ +||||+++++++
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345899999999999999999965321 2334577899999876532 2345678899999999 799999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+++ |+|+||||+|||++.++.++|+|
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECC
Confidence 999999999999999999999976432 33788999999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |.+||...
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 999986543322112222346788999999998899999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.90 Aligned_cols=212 Identities=23% Similarity=0.367 Sum_probs=175.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 5889999999999999999976532 1134568899999875532 3345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEE
Confidence 9999999999999999999764321 123678889999999999999999987 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+|||+++...............++..|+|||.+..+.++.++|||||||++|||++ |.+||...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 999999986543322222233456789999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=269.75 Aligned_cols=202 Identities=29% Similarity=0.402 Sum_probs=171.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
++|.+.+.||+|++|.||+|.. ..++..+|+|.+..... .....+.+|++++.+++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYD---------VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEE---------cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 4789999999999999999953 34588999998865432 123457789999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+...+..++++||+++++|.+.+.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~ 146 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLG 146 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEe
Confidence 999999999999999999999987653 4788888999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+++.......... .....|+..|+|||++.+..++.++||||||+++|+|++|++||..
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 9999875432211111 1234678899999999988899999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=273.75 Aligned_cols=200 Identities=28% Similarity=0.345 Sum_probs=172.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .++..||+|.++.........+.+|+.++..++||||+++++.+...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNV---------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEc---------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 47888999999999999999543 458899999987665444456778999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|++|||+++++|.+++...+ .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999999987653 4788999999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
........ ......|++.|+|||++. .+.++.++|+|||||++|+|++|.+||..
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 154 AQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred eEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 75432211 122346899999999875 45688999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.24 Aligned_cols=207 Identities=24% Similarity=0.405 Sum_probs=169.1
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
|++.+.||+|+||.||+|.... +..++..||+|.+..... .....+.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 5678999999999999997653 223467899999875432 23456789999999999999999999886655
Q ss_pred e------eEEEEeccCCCCHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 148 H------RLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 148 ~------~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. .+++|||+++++|..++.... .....+++..+..++.|++.||.|||+++ ++||||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeE
Confidence 4 799999999999999986532 12245788899999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |.+||..
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9999999986543322211222335678999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=277.86 Aligned_cols=200 Identities=22% Similarity=0.324 Sum_probs=160.8
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe--CCeeE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--DDHRL 150 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~ 150 (295)
.+.||+|+||.||+|.... ..++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. ....|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 3689999999999996432 23567899999875532 2345689999999999999999998864 45689
Q ss_pred EEEeccCCCCHHHHHhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE----cCCCcEEE
Q 022575 151 LVYEFMPKGSLENHLFRRAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKL 221 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl 221 (295)
++|||+ +++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEE
Confidence 999999 5689888764321 1235788999999999999999999988 9999999999999 45678999
Q ss_pred ccccCCCCCCCCCCc-ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 222 SDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+|||+++........ .......||+.|+|||++.+. .++.++||||+||++|+|++|.+||..
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 999999865432211 112345789999999998764 588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=273.94 Aligned_cols=213 Identities=22% Similarity=0.355 Sum_probs=172.6
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..++|++.+.||+|+||.||+|..... .....+..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 346899999999999999999965431 1122356899998875532 23446778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASY------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
..+..++||||+.+|+|.+++...... ........+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 999999999999999999999764321 123456778899999999999999987 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
++|+|||+++...............++..|+|||.+.++.++.++|+|||||++|||++ |.+||..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999986433222211222345778999999998899999999999999999998 7888854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=268.43 Aligned_cols=198 Identities=25% Similarity=0.363 Sum_probs=164.4
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEe---------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 46899999999999543 3578899998765432 3345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 72 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 146 (252)
T cd05084 72 MELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEED 146 (252)
T ss_pred EeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccc
Confidence 99999999999997643 35788899999999999999999988 99999999999999999999999999875432
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
...........++..|+|||.+.++.++.++|+|||||++|||++ |.+||...
T Consensus 147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 211111111123457999999998899999999999999999997 88888643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.83 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=172.0
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.|++.+.||+|+||.||+|... .++..+++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNK---------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEEC---------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 4678899999999999999544 3578899999977665556678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++|+||+++++|..++.+.. .++++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~ 151 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSA 151 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccc
Confidence 999999999999998876533 45889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
....... ......+++.|+|||++. ...++.++|+|||||++|+|++|.+||...
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 152 KNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred ccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 6432211 122346899999999984 346778999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=270.75 Aligned_cols=203 Identities=23% Similarity=0.349 Sum_probs=171.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ....+.+|+.+++.++|+||+++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3689999999999999999996542 56799998875443 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999999999976432 34778888999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+......... ......++..|+|||.+....++.++|+|||||++|+|++ |.+||...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 9865432211 1122345678999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=268.90 Aligned_cols=201 Identities=24% Similarity=0.341 Sum_probs=169.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468888999999999999996543 45799998865432 3456788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~ 147 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMT 147 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCc
Confidence 9999999999999999987543 34788899999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |++||...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 148 RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred cccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 864332211 1112235668999999988889999999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=274.67 Aligned_cols=212 Identities=23% Similarity=0.317 Sum_probs=173.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|..... .....+..||+|.+...... ....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 3678889999999999999976431 12234678999999755432 234577899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
+..++++||+.+++|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 99999999999999999985321 11134778888999999999999999987 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.++.+||+|||+++...............+++.|+|||.+..+.++.++|||||||++|||++ |.+||...
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999886543332222233456789999999988889999999999999999998 88888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=271.14 Aligned_cols=204 Identities=21% Similarity=0.302 Sum_probs=173.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|+.. .++..||+|.+.... ......+.+|+++++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL---------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe---------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 47999999999999999999644 357899999876432 233446788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++++||+++++|.+++.........+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988754333345788899999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 99886533221 11234688999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=267.71 Aligned_cols=198 Identities=24% Similarity=0.321 Sum_probs=170.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv 152 (295)
++||+|+|+.|-.| ....++..+|||++.+..-..+.+..+|++++.+. .|+||++|+++|+++..+|||
T Consensus 84 e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 68999999999888 56668999999999988666777889999999888 599999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---cEEEccccCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLAKD 229 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~~ 229 (295)
||-+.||.|...|+++. .+++..+..+..+|+.||.|||.+| |.||||||+|||-..-. -+|||||.+...
T Consensus 155 fEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccc
Confidence 99999999999999874 4889999999999999999999988 99999999999986544 379999988764
Q ss_pred CCCCCC-----cceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhheee
Q 022575 230 GPTGSQ-----SHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 230 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
...... .....+.+|+..|||||+.. ...|+.+.|+||||++||-|+.|-|||.+.-
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 322211 11223458999999999875 3378999999999999999999999998763
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=275.60 Aligned_cols=200 Identities=23% Similarity=0.338 Sum_probs=174.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||+|+||.||+|.. ..++..+++|.+..........+.+|+.+++.++|+||+++++.+....
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMD---------VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEE---------CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 5899999999999999999953 3357899999998766555667789999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999999998643 3678889999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred hhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 76433221 122346889999999999888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=284.63 Aligned_cols=213 Identities=23% Similarity=0.317 Sum_probs=173.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccC-CCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~-h~ni~~l~~~~ 143 (295)
..++|.+.+.||+|+||.||+|++... .....+..||+|.++..... ....+.+|+.++..+. ||||+++++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 345788999999999999999976531 12335678999999765332 2346789999999997 99999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccC-----------------------------------------------------
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRAS----------------------------------------------------- 170 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 170 (295)
...+..++||||+.+|+|.+++.+...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975421
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 022575 171 -----------------------------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (295)
Q Consensus 171 -----------------------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 209 (295)
....+++..+..++.|++.||+|||+.+ ++||||||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~ 268 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAAR 268 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcc
Confidence 0123566778889999999999999977 999999999
Q ss_pred CeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 210 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
|||++.++.+||+|||+++...............+++.|+|||.+....++.++|+|||||++|||++ |.+||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999986433221111223457889999999998889999999999999999998 8888854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=271.88 Aligned_cols=205 Identities=34% Similarity=0.496 Sum_probs=169.5
Q ss_pred CCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
+.+.||.|.||.||+|.+.. .....+..|+||.++.... .....+.+|++.+.+++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999998873 2344578899999965433 34677899999999999999999999999888899
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
+|+||+++|+|.++|..... ..+++..+..++.||+.||.|||+++ ++|+||+++||+++.++.+||+|||++...
T Consensus 78 lv~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccc--cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence 99999999999999988722 45889999999999999999999987 999999999999999999999999999865
Q ss_pred CCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 231 PTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.............+...|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 32222222233456788999999999999999999999999999999 77888654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=268.13 Aligned_cols=202 Identities=24% Similarity=0.314 Sum_probs=174.0
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|.+.+.||+|++|.||+|... .++..|++|.+.... ......+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK---------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc---------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 4778899999999999999554 357889999986543 23455678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~ 147 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGV 147 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEccccc
Confidence 999999999999999999976532 45788899999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++....... ......|++.|+|||++.+..++.++|+|||||++++|++|.+||...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 148 AKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred ceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 886543322 123346889999999999888999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=270.80 Aligned_cols=204 Identities=34% Similarity=0.456 Sum_probs=169.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
.|++.+.||+|+||+||++.++. ....++..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 45889999999999999886542 3344678899999876533 2345678899999999999999999987653
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
...+++|||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecc
Confidence 4679999999999999999653 3889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+++......... ......++..|+|||.+....++.++||||||+++|+|++|..||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 998654322211 11123456779999999888899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=292.77 Aligned_cols=212 Identities=20% Similarity=0.242 Sum_probs=159.8
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCC------CCCCCcE----EEEEEcCccchhhHHHHHHHHHHHcccCCC
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPA------RPGTGMV----IAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~------~~~~~~~----vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ 134 (295)
....+|++.+.||+|+||.||+|..+....... ....+.. ++.|.+... ......+.+|+.+|..++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999986543210000 0000111 111222111 12234577899999999999
Q ss_pred CccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 135 ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
||+++++++...+..|++++++ +++|.+++..... .........+..++.||+.||+|||+++ ||||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 9999999999999999999999 5678777754321 1122345667789999999999999988 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCCh
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPM 281 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 281 (295)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999865432221 22335799999999999999999999999999999999998753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=282.22 Aligned_cols=196 Identities=25% Similarity=0.313 Sum_probs=170.6
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
.++||+|.||+||-| .++.+|+.||||++.+.++. ....+++|+.+|.++.||.|+.+...|++.+.++
T Consensus 569 devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 478999999999999 45568999999999877653 3456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC---CcEEEccccCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNAKLSDFGLA 227 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~DFG~a 227 (295)
+|||-+ +|+..++|..... ..+++.....++.||+.||.|||.++ |||+||||+|||+... -.+||||||+|
T Consensus 640 VVMEKl-~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhh-cchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccce
Confidence 999999 5677666655433 56889999999999999999999988 9999999999999543 47999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+... ....+.+|||.|+|||++....|...-|+||.|+++|--+.|..||-..
T Consensus 715 RiIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 715 RIIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred eecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 986543 2456689999999999999999999999999999999999999999654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.62 Aligned_cols=215 Identities=23% Similarity=0.317 Sum_probs=174.9
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||++..... ........+|+|.+..... .....+.+|+.++.++ +|+||++++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3446899999999999999999976531 1123457899999875432 3344578899999999 79999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCC
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 210 (295)
+...+..+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 999999999999999999999997532 12245788899999999999999999987 9999999999
Q ss_pred eEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 211 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999999999986543322111222235678999999988899999999999999999997 88887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.86 Aligned_cols=199 Identities=32% Similarity=0.440 Sum_probs=172.1
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHH--HHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
|++.+.||+|+||.||++.. ..+++.+|+|.+......... ...+|+.++..++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~---------~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKN---------KKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEE---------TTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEE---------CCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 67789999999999999954 446889999999877654332 2356999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+.+++|.+++... ..+++..+..++.|++.||++||+++ ++|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~ 145 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSS 145 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence 999999999988999999844 35789999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeec-cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..... .........++..|+|||++. +..++.++|+||||+++++|++|..||...
T Consensus 146 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 146 VKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp EESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 75311 112233457899999999998 788999999999999999999999998865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=287.00 Aligned_cols=207 Identities=22% Similarity=0.262 Sum_probs=176.2
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH---HHHHHHHHHHcccCCCCcccee
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH---LEWLTEIKHLGQLYHPNLVKLI 140 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~h~ni~~l~ 140 (295)
+....-|..++.||-|+||.|.++ ....+...+|.|.+.+.+.-.+ .....|.+||..-+.+-||+||
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv---------~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLV---------RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hccccceEEEeeecccccceeEEE---------eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 344456777889999999999998 3444688999999987654332 2356799999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
-.|++++.+|+||||++||++..+|.+.+ -|++..+..++.++.+|+++.|..| +|||||||+|||||.+|++|
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCcee
Confidence 99999999999999999999999998875 4788999999999999999999877 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcc----------------------------------------eeeccccccCccCceeeccCccc
Q 022575 221 LSDFGLAKDGPTGSQSH----------------------------------------VSTRVMGTYGYAAPEYMATGIFQ 260 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~ 260 (295)
|+|||+|+-+....+.. .....+||+.|+|||+++...|+
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 99999997532110000 01235799999999999999999
Q ss_pred ccceeeehhHHHHHHhccCChhhee
Q 022575 261 LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 261 ~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.-.|+||.|++||||+.|.+||-..
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCC
Confidence 9999999999999999999999765
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.96 Aligned_cols=207 Identities=21% Similarity=0.306 Sum_probs=169.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.+... .......||+|.+..... .....+.+|+.++..+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 35889999999999999999976532 111234689999875433 234567889999999999999999998875
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCC
Confidence 45789999999999999997643 35788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
+++...............+++.|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9986543222111112234678999999998899999999999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=273.12 Aligned_cols=198 Identities=28% Similarity=0.380 Sum_probs=173.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||++.... +++.+|+|.+..... .....+.+|++++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 378899999999999999996543 578999999865432 23445778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~df 145 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDF 145 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeC
Confidence 999999999999999999999775 34788899999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|.+||...
T Consensus 146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999865432 22346899999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=267.81 Aligned_cols=202 Identities=28% Similarity=0.338 Sum_probs=175.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .++..+++|.+..........+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDI---------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEec---------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 57899999999999999999543 357789999998765555667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccc
Confidence 9999999999999999987653 35788999999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccC---cccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG---IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......++..|+|||.+... .++.++|+|||||++|+|++|.+||...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~ 207 (262)
T cd06613 149 AQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207 (262)
T ss_pred hhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 76433211 12235688899999998876 8889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.07 Aligned_cols=210 Identities=23% Similarity=0.363 Sum_probs=180.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.+...+.++||.|.||.|++|+++. .......||||.++.... +++.+|+.|+.||.+++||||++|.|+...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~------pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKL------PGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhheEEEEEEecccccceecccccC------CCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 3456788999999999999998873 334567899999988754 456679999999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
....+||.|||++|+|+.+|+++.+ ++...+...++++|+.||+||-+.+ +|||||.++|||++.+..+|++|||
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecccc
Confidence 9999999999999999999998873 4778888899999999999999977 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeecccc--ccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheeeee
Q 022575 226 LAKDGPTGSQSHVSTRVMG--TYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYLTY 288 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~ 288 (295)
+++.+.+.... ..++..| ..+|.|||.|+..+|+.++|+||+|++|||.++ |..||..+..|
T Consensus 777 LSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 777 LSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred ceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 99976554321 1222222 578999999999999999999999999999887 99999887543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=274.97 Aligned_cols=200 Identities=24% Similarity=0.350 Sum_probs=168.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc---------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 57999999999999999999543 35789999998754322 234567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999999995 69998887654 35788899999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+........ ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||..
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 975432221 11223578999999988654 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=260.24 Aligned_cols=202 Identities=27% Similarity=0.353 Sum_probs=166.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
++.+....||.|+.|.|++++++ .+|...|||.+.+.. .++..+++..++++.+- +.|.||+.+|+|..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~r---------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFR---------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEc---------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 45566678999999999999655 468999999997654 33445667777766655 48999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+...++.||.| ..-++.++++-. .++++..+-++...++.||.||..+ .+|+|||+||+|||+|+.|++||||||
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeeccc
Confidence 99999999998 545666665544 5688888889999999999999876 459999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhheee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
++..+.... ..+...|.+.|||||-+. ...|+.++||||||++++||.||..||....
T Consensus 238 IsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 238 ISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred ccceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 998765433 233457999999999986 3478999999999999999999999998853
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=269.84 Aligned_cols=202 Identities=24% Similarity=0.372 Sum_probs=171.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|.+.+.||+|+||.||+|.... ++..||+|.+.... ....++.+|++++..++||||+++++++...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 468888999999999999996543 47889999987543 33456789999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999976432 45788889999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 865432211 1112234668999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=267.72 Aligned_cols=207 Identities=23% Similarity=0.345 Sum_probs=170.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|..... ...+..||+|.+.... .....++..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLP------GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecC------CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 4688899999999999999976531 2234579999987653 33455788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCcc
Confidence 99999999999999999997654 35788899999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceee-ccc--cccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVST-RVM--GTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+............. ... .+..|+|||.+....++.++|+|||||++|||++ |.+||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 87543322111111 111 2457999999998899999999999999999886 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=271.53 Aligned_cols=216 Identities=28% Similarity=0.431 Sum_probs=172.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCc-----CCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTY-----APARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
++|++.+.||+|+||.||+|+...... ..........||+|.+..... .....+.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999986543110 001122345689999876532 23456889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRAS--------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence 99999999999999999999999965321 1123678888999999999999999988 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc--cCChhhee
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL--QLPMCVLY 285 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~pf~~~ 285 (295)
+.++.+||+|||++................++..|+|||++..+.++.++|+|||||++|+|++ |.+||...
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999976533322111222345778999999998899999999999999999988 66787653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=267.68 Aligned_cols=203 Identities=26% Similarity=0.339 Sum_probs=171.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|++|.||+|.... +..||+|.++.... ....+.+|+.++.+++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 3579999999999999999996432 46799999876543 345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcce
Confidence 999999999999999999976532 45788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++........ .......+..|+|||.+.+..++.++|+||||+++|||++ |++||...
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9865422111 1111223457999999998899999999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=270.99 Aligned_cols=211 Identities=25% Similarity=0.298 Sum_probs=171.8
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.++..++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 478889999999999999975421 1122346789998875543 23456789999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRAS--------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 207 (295)
..++++||+.+++|.+++..... ....+++..+..++.|++.||+|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 99999999999999999865321 1134778889999999999999999987 9999999
Q ss_pred CCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 208 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999986433222111222345778999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.55 Aligned_cols=201 Identities=24% Similarity=0.319 Sum_probs=170.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.++.+++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 478889999999999999996542 34599999875543 3456789999999999999999999999889
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccc
Confidence 9999999999999999997643 35788999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........ ......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred eecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 765332211 1112235678999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=272.41 Aligned_cols=202 Identities=28% Similarity=0.395 Sum_probs=174.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||++... .++..+|+|.+..........+.+|+.++++++||||+++++.+...+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK---------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc---------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 57999999999999999999654 257889999997766555667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccc
Confidence 9999999999999999987654 35888999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......+++.|+|||.+. ...++.++|+|||||++|+|++|.+||...
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 151 AKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred hhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 75432221 122346899999999975 345678999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=268.94 Aligned_cols=206 Identities=31% Similarity=0.423 Sum_probs=171.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+.|++.+.||+|+||.||+|.++. ....++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 467899999999999999997653 334568899999987553 23345678999999999999999999998775
Q ss_pred --CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
...++||||+++++|.+++.+.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCC
Confidence 56899999999999999997643 35788999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 225 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 225 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
|+++........ .......++..|+|||.+.+..++.++|||||||++|+|+++..|+.
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 999865433221 11123456778999999988889999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.92 Aligned_cols=214 Identities=25% Similarity=0.318 Sum_probs=172.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
++|.+.+.||+|+||.||++...... .........+|+|.+.... .....++..|+.++..+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLD--KEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccC--CcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 57999999999999999999754311 0112245679999997643 23345677899999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
.+..|+||||+.+++|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLV 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEE
Confidence 99999999999999999999765321 134788899999999999999999987 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|+|||||++|||++ |.+||...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999999999999876532221111111234578999999998889999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=268.06 Aligned_cols=207 Identities=23% Similarity=0.350 Sum_probs=172.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|..... .......+|+|.+..... ....++.+|+.++..++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 5789999999999999999976531 122245799998876643 234567889999999999999999999887
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
...+++|||+++++|.+++.+.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcc
Confidence 78899999999999999997654 34789999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............++..|+|||.+....++.++|+|||||++||+++ |.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 986543332211112234578999999988899999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=267.41 Aligned_cols=203 Identities=28% Similarity=0.388 Sum_probs=169.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-----hhhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-----LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.+|++.+.||+|+||.||++... .++..||+|.+.... ......+.+|+.++..++||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~---------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA---------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc---------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 47899999999999999999543 468899999875322 1223467789999999999999999998
Q ss_pred EEeC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 143 CLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 143 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+.+. ...+++|||+++++|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEE
Confidence 8764 46789999999999999987653 3678888999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++......... .......|+..|+|||++.+..++.++|+|||||++|+|++|.+||...
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 9999998754321111 1122346889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=273.72 Aligned_cols=200 Identities=23% Similarity=0.335 Sum_probs=174.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||+|+||.||++... .++..||+|.+..........+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC---------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 68999999999999999999533 358899999997665555566788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred EEEEeecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999999998653 3788889999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred eEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 76433221 122346889999999999888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=269.41 Aligned_cols=203 Identities=27% Similarity=0.378 Sum_probs=175.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
..+|++.+.||+|+||.||+|.... +..+++|.+..........+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 3579999999999999999996542 678999999877665566788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999999976433 45788899999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+......... .....++..|+|||.+....++.++|+||||+++|+|++ |.+||...
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 151 ARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred hhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 9765332211 112345778999999988899999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=266.33 Aligned_cols=202 Identities=21% Similarity=0.263 Sum_probs=172.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+|++.+.||+|+||.||++.. ..++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQH---------VNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEE---------cCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 578889999999999999943 3468889999886433 234456778999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcc
Confidence 99999999999999998875432 45788889999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......|++.|+|||++.+..++.++|+||||+++|+|++|.+||...
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 203 (255)
T cd08219 148 RLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203 (255)
T ss_pred eeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC
Confidence 76533221 123356899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=270.69 Aligned_cols=216 Identities=24% Similarity=0.380 Sum_probs=172.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCc-------CCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccce
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTY-------APARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-------~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
++|++.+.||+|+||.||++....... ......+...+|+|.+..... .....+.+|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999985432100 001223456799999875532 334567899999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-------QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
++++...+..+++|||+.+++|.+++....... ..+++..+..++.|++.||+|||+++ ++||||||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence 999999999999999999999999997643211 23667789999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc--cCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL--QLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~pf~~~ 285 (295)
++.++.++|+|||+++...............+++.|+|||....+.++.++|+|||||++|||++ |..||...
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999986533322111222345678999999888899999999999999999998 77888643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.74 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=174.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||.|++|.||+|. +..+++.|++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAI---------DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEE---------EcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 479999999999999999994 33468899999987665555567789999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++|+||+.+++|..++... .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999999988643 3788999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred hhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76433221 122346889999999999888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=266.72 Aligned_cols=203 Identities=24% Similarity=0.288 Sum_probs=163.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|.... ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 368999999999996542 22466799998876542 2334678899999999999999999999998999999
Q ss_pred EeccCCCCHHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
|||+++++|.+++...... ....++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999999764321 123566777889999999999999987 9999999999999999999999999997543
Q ss_pred CCCCcceeeccccccCccCceeeccC-------cccccceeeehhHHHHHHhc-cCChhhee
Q 022575 232 TGSQSHVSTRVMGTYGYAAPEYMATG-------IFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
............++..|+|||++... .++.++|+||||+++|||++ |.+||...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 32211112234578889999998632 35789999999999999996 99998643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=268.83 Aligned_cols=204 Identities=23% Similarity=0.338 Sum_probs=173.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .++..+|+|.+..... ....++.+|+.+++.++||||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec---------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 47889999999999999999543 3578999998765332 23456788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999998754333356788999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|.+||..
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99876533221 12234688999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=270.05 Aligned_cols=215 Identities=26% Similarity=0.360 Sum_probs=176.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcC-------CCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccce
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYA-------PARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
.+|++.+.||+|+||.||+|........ ..+...+..||+|.+..... .....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 5899999999999999999976532100 12333567899999876543 334567889999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASY-------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
++++..++..+++|||+.+++|.+++...... ...+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nil 162 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhcee
Confidence 99999999999999999999999999765411 125789999999999999999999987 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc--cCChhhe
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL--QLPMCVL 284 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~pf~~ 284 (295)
++.++.++|+|||+++...............+++.|+|||.+....++.++|||||||++|||++ |.+||..
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999986543322222233456788999999988889999999999999999998 6677754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=271.42 Aligned_cols=215 Identities=23% Similarity=0.324 Sum_probs=173.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
..+|.+.+.||+|+||.||+|...... ......+..||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccC--CCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 458899999999999999999753210 0122345689999987543 23345678999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
..+..+++|||+.+++|.+++.+.... ...+++..++.++.||+.||.|||+++ ++||||||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEE
Confidence 999999999999999999999764321 134677888999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999986543222212222345678999999988889999999999999999998 78887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=268.47 Aligned_cols=206 Identities=29% Similarity=0.396 Sum_probs=170.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
.+|++.+.||+|+||.||+|.+.. .+..++..||+|.+..........+.+|++++..++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 478999999999999999997542 24456889999998876655566788999999999999999999987543
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCc
Confidence 46799999999999999997643 34788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 226 LAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 226 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
++........... .....++..|+|||++.+..++.++|+|||||++|||++|..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9986543322111 111223456999999988889999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=267.58 Aligned_cols=203 Identities=24% Similarity=0.307 Sum_probs=161.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|..... .....+++|.+..... .....+.+|+..++.++||||+++++.+...+..++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3589999999999964321 2356789998765432 2334578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
|||+++|+|.+++...... ....++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccc
Confidence 9999999999999775432 123456778899999999999999987 9999999999999999999999999987543
Q ss_pred CCCCcceeeccccccCccCceeecc-------CcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 232 TGSQSHVSTRVMGTYGYAAPEYMAT-------GIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
............+++.|+|||++.. ..++.++|||||||++|||++ |.+||...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 2221111122345778999998752 356789999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=266.39 Aligned_cols=204 Identities=23% Similarity=0.338 Sum_probs=174.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.++... ......+.+|++++++++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL---------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc---------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 57999999999999999999544 358899999886432 223456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..+++|||+++++|.+++.........+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999998764433356788999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||..
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 99875433221 12234688999999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=266.06 Aligned_cols=207 Identities=23% Similarity=0.340 Sum_probs=171.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|.... ....+..+|+|.++.... .....+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKL------PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEec------CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 578899999999999999996542 112345799999875432 2345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999999999999997654 35788889999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 986543221111 111223568999999998899999999999999999886 99998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=277.07 Aligned_cols=212 Identities=25% Similarity=0.321 Sum_probs=170.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|..... ....+++.||||.++..... ....+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 35899999999999999999974421 23346789999999764322 344577899999999 6899999999876
Q ss_pred eC-CeeEEEEeccCCCCHHHHHhhccCC----------------------------------------------------
Q 022575 145 ED-DHRLLVYEFMPKGSLENHLFRRASY---------------------------------------------------- 171 (295)
Q Consensus 145 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 171 (295)
.. ...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4678999999999999998753210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceee
Q 022575 172 -----------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240 (295)
Q Consensus 172 -----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 240 (295)
...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 123577788899999999999999988 9999999999999999999999999998643322211122
Q ss_pred ccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 241 RVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 241 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
...++..|+|||.+.+..++.++||||||+++|+|++ |.+||..
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 2345678999999988899999999999999999996 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=271.70 Aligned_cols=205 Identities=27% Similarity=0.404 Sum_probs=167.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|..... .....+++|.++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccC-------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 5889999999999999999965431 1223568887764322 2344677899999999 89999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
.+..|++|||+++++|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEe
Confidence 99999999999999999999764321 124788899999999999999999987 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
+.++.+||+|||++....... ......++..|+|||++....++.++|||||||++|||++ |.+||..
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 999999999999986422111 1111234667999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=267.84 Aligned_cols=213 Identities=22% Similarity=0.285 Sum_probs=174.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..++|++.+.||+|+||.||+|.... .....+..|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~-----~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILID-----EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEec-----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34689999999999999999997653 122346889999887543 233456788999999999999999999876
Q ss_pred e-CCeeEEEEeccCCCCHHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 145 E-DDHRLLVYEFMPKGSLENHLFRRASY----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 145 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. ....++++||+.+++|.+++...... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcE
Confidence 6 46789999999999999999765321 145889999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |.+||...
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9999999986543322211222346778999999988889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=269.69 Aligned_cols=206 Identities=24% Similarity=0.370 Sum_probs=167.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
++|++.++||+|+||.||+|..... .....+++|.++... ......+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 5789999999999999999966432 122347888877432 23345678899999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
.+..+++|||+++++|.+++..... ....+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEE
Confidence 9999999999999999999975431 1134788899999999999999999987 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+.++.+||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |.+||...
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~ 222 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM 222 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999986432111 1111123557999999988889999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=264.04 Aligned_cols=203 Identities=23% Similarity=0.311 Sum_probs=177.2
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHccc-CCCCcccee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQL-YHPNLVKLI 140 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l-~h~ni~~l~ 140 (295)
....+|.+.++||+|+|++|.++ ....+.+.+|+|+++++-.. +......|-.+..+- +||.++-++
T Consensus 247 l~l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence 33468999999999999999988 44557899999999876432 333455677677665 799999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
.+|++...+++|.||++||+|.-.+++.+ .++++.+..+..+|+.||.|||++| |+.||||.+|+|+|..|++|
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghik 391 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIK 391 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCcee
Confidence 99999999999999999999998888764 4899999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|+|+|+++...... ....++||||.|.|||++.+..|...+|.|+||++++||+.|+.||.-
T Consensus 392 ltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 99999999643332 235678999999999999999999999999999999999999999964
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=272.97 Aligned_cols=199 Identities=22% Similarity=0.323 Sum_probs=159.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe--CCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE--DDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~l 151 (295)
..||+|+||.||+|.... ..++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~-------~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKD-------GKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEecC-------CCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 579999999999996532 23567899999875532 2346789999999999999999998854 457899
Q ss_pred EEeccCCCCHHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE----cCCCcEEEc
Q 022575 152 VYEFMPKGSLENHLFRRA-----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLS 222 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl~ 222 (295)
+|||+. ++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999995 58888875321 11235788889999999999999999988 9999999999999 566789999
Q ss_pred cccCCCCCCCCCCc-ceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99999865433211 11223568999999999876 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=265.43 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=168.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||+|+||.||++... .+..+|+|.+..... ....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 46889999999999999999653 245799999865432 3346778999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccc
Confidence 9999999999999999997654 35788999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 148 RYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred eeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 764322111 1111123457999999998899999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=269.16 Aligned_cols=212 Identities=26% Similarity=0.350 Sum_probs=171.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|.+.+.||+|+||.||+|..... ....++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 35789999999999999999976531 11125778999988754332 34467889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---cE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASY---IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NA 219 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 219 (295)
.+..+++|||+++++|.+++...... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 99999999999999999999765421 135788999999999999999999988 99999999999998654 59
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999986532221111112234568999999998899999999999999999997 9999865
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=265.32 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=170.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---------hHHHHHHHHHHHcccCCCCccce
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------GHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
+|.+.+.||+|++|.||+|... .++..+|+|.+...... ....+.+|+.++.+++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA---------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEec---------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 4778899999999999999543 35788999988654321 12356789999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~ 145 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGI 145 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCE
Confidence 999999999999999999999999997653 4778888999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCc----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQS----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+|||+++........ .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 99999999865422111 0112346889999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=274.15 Aligned_cols=200 Identities=19% Similarity=0.182 Sum_probs=164.2
Q ss_pred CCCeeecc--CCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 72 PDSVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 72 ~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+.++||+| +|++||++. +..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLAR---------YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEe---------ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 45789999 678999984 445689999999976532 22335667999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++..+.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++++||+.+
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~ 148 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN 148 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchh
Confidence 99999999999999999976432 34788999999999999999999988 999999999999999999999999875
Q ss_pred CCCCCCCCc-----ceeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQS-----HVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
......... .......++..|+|||++.+ ..++.++|||||||++|||++|.+||..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 433211110 01112356788999999876 3588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=271.33 Aligned_cols=215 Identities=22% Similarity=0.329 Sum_probs=172.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
..+|.+.+.||+|+||.||+|...... .........+|+|.+..... .....+.+|+.++..+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGID--KSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccC--CccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 358899999999999999999643210 01223467799999875432 3345678899999999 6999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
..+..+++|||+.+++|.+++..... ....+++..+..++.|++.||.|||+++ ++||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEE
Confidence 99999999999999999999976431 1134788889999999999999999987 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++ |..||...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999986543221111111234567999999998899999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=272.81 Aligned_cols=205 Identities=29% Similarity=0.342 Sum_probs=173.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.+|+|.+...... ....+..|++++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK---------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc---------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 37888999999999999999543 35889999999765433 3445788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~df 147 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDF 147 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeec
Confidence 99999999999999999999875432 45888999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCc---------------------------ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc
Q 022575 225 GLAKDGPTGSQS---------------------------HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 225 G~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 277 (295)
|++......... .......||..|+|||++.+..++.++||||||+++|+|++
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~ 227 (316)
T cd05574 148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY 227 (316)
T ss_pred chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence 998754221110 01123468899999999998889999999999999999999
Q ss_pred cCChhhee
Q 022575 278 QLPMCVLY 285 (295)
Q Consensus 278 g~~pf~~~ 285 (295)
|..||...
T Consensus 228 g~~pf~~~ 235 (316)
T cd05574 228 GTTPFKGS 235 (316)
T ss_pred CCCCCCCC
Confidence 99998644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=265.48 Aligned_cols=207 Identities=23% Similarity=0.344 Sum_probs=171.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|+..+.||+|+||.||+|.... .......+|+|.+.... ......+.+|++++.+++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKM------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 478888999999999999997542 12234579999987653 23345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcc
Confidence 99999999999999999997643 35788899999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCccee-eccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVS-TRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+............ .....+..|+|||++....++.++|+|||||++|||++ |..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 9765432221111 11123457999999988889999999999999999997 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=270.45 Aligned_cols=202 Identities=22% Similarity=0.286 Sum_probs=170.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||++.. ..+++.|++|.+..... .....+.+|+.++..++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRH---------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEE---------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 3788899999999999999954 34588999999876542 22345778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~df 145 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDF 145 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeC
Confidence 9999999999999999999997653 4788889999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCc-------------ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQS-------------HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|+++........ .......++..|+|||.+....++.++|+|||||++|||++|..||..
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 998742111000 011124578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=263.72 Aligned_cols=201 Identities=19% Similarity=0.255 Sum_probs=160.6
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEE
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 153 (295)
.||+|+||.||++..... .....+++|.+..... .....+.+|+.++..++||||+++++.+......++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 589999999999964321 1245577887765432 34557889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCC
Q 022575 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (295)
Q Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 233 (295)
||+++++|.+++.+........+...+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcc
Confidence 999999999999875433345667778899999999999999987 999999999999999999999999998643222
Q ss_pred CCcceeeccccccCccCceeecc-------CcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 234 SQSHVSTRVMGTYGYAAPEYMAT-------GIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
..........++..|+|||++.. ..++.++|||||||++|||++ |.+||..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 11112233567899999998753 245789999999999999996 5778754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=263.64 Aligned_cols=203 Identities=27% Similarity=0.400 Sum_probs=169.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.+|+..+.||+|+||.||+|. +..++..|++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCY---------DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEE---------EcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 378999999999999999994 334688999998864321 223457789999999999999999998
Q ss_pred EEeC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 143 CLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 143 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+... +..++++||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEE
Confidence 8753 57889999999999999997653 3778888999999999999999987 99999999999999999999
Q ss_pred EccccCCCCCCCCCC-cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++........ ........++..|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 999999875432111 11112345889999999999888999999999999999999999999644
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=265.34 Aligned_cols=206 Identities=25% Similarity=0.385 Sum_probs=164.8
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
|.+.+.||+|+||.||+|.+... .....+|+|.++... ......+.+|+.++..++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 35678999999999999976532 112468999887542 23345678899999999999999999977432
Q ss_pred -----CeeEEEEeccCCCCHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 147 -----DHRLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 147 -----~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
...+++|||+.+++|.+++.... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCE
Confidence 24689999999999999885322 12245788999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
||+|||+++...............+++.|+|||.+....++.++|||||||++|||++ |.+||..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999986543322111122346778999999998899999999999999999999 8899865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=267.57 Aligned_cols=203 Identities=26% Similarity=0.351 Sum_probs=169.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
...|++.+.||+|+||.||+|... .+++.+|+|.+.... .....+.+|+.++.++ +|+||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 74 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEc---------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence 357888999999999999999544 357899999986543 3344677899999988 69999999999875
Q ss_pred C------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 D------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. ...|++|||+.+++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred cCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCE
Confidence 3 467999999999999999976432 45788999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+|||++........ ......|++.|+|||++. ...++.++|+|||||++|||++|.+||...
T Consensus 151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999875432211 123357899999999986 346788999999999999999999998643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=264.10 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=170.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
..++|++.++||+|+||.||+|... .+..||+|.+..... ....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT- 71 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence 3468999999999999999999643 267899999876543 3456788999999999999999999864
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 72 QEPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred cCCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCc
Confidence 5678999999999999999876443 45788899999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++......... ......++..|+|||++....++.++||||||+++|||++ |.+||...
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 148 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred ceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99765422211 1122345778999999998889999999999999999998 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=267.87 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=167.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|++|.||+|... .++..||+|.+...... ....+.+|+.++..++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK---------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEEC---------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 5788899999999999999544 35789999998654322 234567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..|+||||++ ++|.+++..... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccc
Confidence 99999999996 689888865432 245788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+........ ......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 148 ARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred eeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 875433221 12223578999999988654 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=262.42 Aligned_cols=199 Identities=28% Similarity=0.407 Sum_probs=168.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
++||+|++|.||+|.+.. .......||+|.+..... .....+.+|+.++++++||||+++++.+.. ...+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST------SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEec------CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 468999999999997653 122345799999988766 455678899999999999999999999988 889999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+.+.+... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999999999987542 45788999999999999999999987 99999999999999999999999999986544
Q ss_pred CCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhh
Q 022575 233 GSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCV 283 (295)
Q Consensus 233 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~ 283 (295)
.... .......++..|+|||.+....++.++|||||||++|+|++ |.+||.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2211 11122456788999999988899999999999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=262.35 Aligned_cols=202 Identities=23% Similarity=0.324 Sum_probs=173.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.++||+|+||.||.++.. .++..+++|.+.... .....++.+|++++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT---------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEc---------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 5888999999999999998543 357889999886543 23345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++.+... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcc
Confidence 999999999999999999976532 45788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......|++.|+|||.+.+..++.++|+||||+++++|++|.+||...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 148 SKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred eEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 876533221 223356899999999998888899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=266.37 Aligned_cols=200 Identities=25% Similarity=0.308 Sum_probs=173.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||.|++|.||+|... .++..+|+|.+.... ......+.+|+++++.++|+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK---------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC---------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 36888999999999999999544 358899999987654 23345677899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
...++|+||+++++|.+++... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~ 144 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGV 144 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999998754 4788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++....... ......+++.|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 145 SGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred ceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 986543321 123346889999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.27 Aligned_cols=198 Identities=24% Similarity=0.335 Sum_probs=162.2
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEE
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 153 (295)
.||+|+||.||+|.+... ..+..||+|.+...... ....+.+|+.++++++||||+++++++. .+..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 389999999999976421 23567999998765432 3456789999999999999999999875 45789999
Q ss_pred eccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCC
Q 022575 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (295)
Q Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 233 (295)
||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 74 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 74 EMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999999999987543 45889999999999999999999988 999999999999999999999999999754332
Q ss_pred CCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 234 SQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 234 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
..... .....++..|+|||.+....++.++|||||||++|+|++ |.+||...
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 22111 111123578999999988889999999999999999996 99998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=263.90 Aligned_cols=201 Identities=25% Similarity=0.343 Sum_probs=167.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||+|+||.||+|.... ...||+|.+..... ....+.+|+.++..++||||+++++.+. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CC
Confidence 579999999999999999996542 34599999976443 3346788999999999999999999874 45
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++.+... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCce
Confidence 68999999999999999976432 34688889999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
......... ......++..|+|||++....++.++|+|||||++|+|++ |.+||...
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 765332211 1122346778999999988889999999999999999999 88888653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=264.91 Aligned_cols=200 Identities=20% Similarity=0.261 Sum_probs=161.6
Q ss_pred eeeccCCcEEEEEEecCCC---------------cCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccce
Q 022575 75 VLGEGGFGCVFKGWIDEHT---------------YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~---------------~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
.||+|+||.||+|.+.... ....+......|++|.+.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999754211 0111233456789999876654445567889999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC--
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-- 217 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-- 217 (295)
++++...+..++||||+++++|..++.+.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999987543 35788889999999999999999987 99999999999997543
Q ss_pred -----cEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHh-ccCChhhee
Q 022575 218 -----NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFS-LQLPMCVLY 285 (295)
Q Consensus 218 -----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~-~g~~pf~~~ 285 (295)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|+|||||++|||+ +|.+||...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 4899999988643221 11357888999998875 56889999999999999984 699998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=272.50 Aligned_cols=215 Identities=24% Similarity=0.329 Sum_probs=172.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
..+|++.+.||+|+||.||+|...... .........||+|.+..... .....+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~--~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGID--KDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccC--CccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 357999999999999999999654211 01122345799998875432 2345678999999999 7999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
..+..+++|||+++++|.+++.+... ....+++..++.++.|++.||.|||+++ ++||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nil 166 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVL 166 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEE
Confidence 99999999999999999999976431 1134778888999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999986533221111122234567999999998899999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.98 Aligned_cols=200 Identities=22% Similarity=0.282 Sum_probs=162.7
Q ss_pred CeeeccCCcEEEEEEecCCCcCCC---CCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPA---RPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~ 150 (295)
+.||+|+||.||+|.+..+..... .......|++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997653321110 11234568999887665555556788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc-------EEEcc
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-------AKLSD 223 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-------~kl~D 223 (295)
++|||+++++|..++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999999887543 35788899999999999999999987 999999999999987664 89999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeec-cCcccccceeeehhHHHHHHh-ccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-TGIFQLVLLLFTFECSLLHFS-LQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~-~g~~pf~~ 284 (295)
||++...... ....++..|+|||.+. ...++.++|||||||++|||+ .|.+||..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998754321 1245788999999887 467889999999999999997 58888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=266.08 Aligned_cols=202 Identities=25% Similarity=0.297 Sum_probs=166.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHH-HcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKH-LGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~-l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||++.. ..+++.||+|.++.... ....++..|+.. ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRH---------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEE---------cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 4788999999999999999954 34689999999876532 223345566665 556689999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
++..|++|||++ ++|.+++.........+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeec
Confidence 999999999995 789888876443335689999999999999999999986 6 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc----CcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 9988643221 1122468899999998864 4568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=267.19 Aligned_cols=211 Identities=26% Similarity=0.279 Sum_probs=171.3
Q ss_pred hhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccce
Q 022575 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKL 139 (295)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l 139 (295)
..+....++|++.+.||+|+||.||+|... .++..+|+|.+..... ....+.+|+.++..+ +||||+++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~ 80 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNK---------KNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKF 80 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEEC---------CCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeee
Confidence 344455679999999999999999999543 3578899998765332 234567899999998 69999999
Q ss_pred eeEEE-----eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 140 IGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 140 ~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
++++. ..+..+++|||+++++|.+++.........+++..+..++.|++.||.|||+++ ++||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~ 158 (286)
T cd06638 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT 158 (286)
T ss_pred eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC
Confidence 99874 345689999999999999988653322345788889999999999999999987 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhee
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.++.+||+|||++........ ......|++.|+|||++.. ..++.++|+|||||++|+|++|.+||...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999999999876533211 1223468999999998753 45788999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=267.45 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=166.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-HHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|... .++..||+|.+....... ...+.+|+.++..++|+||+++++++...
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISR---------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEc---------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 58999999999999999999543 357889999986553322 23567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..|+||||+. ++|.+.+.... ..+.+..+..++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 76 ETLTFVFEYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred CeEEEEEeccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccc
Confidence 99999999994 78877775443 34677888899999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++....... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 150 ARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred ccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 875433221 12234578999999998754 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.86 Aligned_cols=204 Identities=30% Similarity=0.441 Sum_probs=172.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-HHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|..... ...+..+++|.+....... ...+.+|++.+..++|+||+++++++......+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4689999999999976531 1347889999998765443 56778999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 153 YEFMPKGSLENHLFRRASY-----IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
|||+++++|.+++...... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999875211 256899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
................+++.|+|||.+....++.++|+|||||++|+|++ |.+||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 87654332222333467889999999988889999999999999999999 69998754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.32 Aligned_cols=200 Identities=29% Similarity=0.453 Sum_probs=169.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch------hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
+|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4788899999999999999542 377899998864421 122457789999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+.+.+..++++||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~ 144 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLI 144 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEec
Confidence 999999999999999999999997653 4788888999999999999999987 9999999999999999999999
Q ss_pred cccCCCCCCCCC----CcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGS----QSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||++....... .........|+..|+|||++.+..++.++|+|||||++|+|++|.+||..
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 145 DFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 999987542211 11112235689999999999988899999999999999999999999965
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=263.27 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=168.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++++++|+|++++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 3579999999999999999996542 55699999876543 3456789999999999999999999875 4
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~ 148 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGL 148 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCcee
Confidence 568999999999999999976432 34788899999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+......... ......++..|+|||.+....++.++|+||||+++|+|++ |.+||...
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 149 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred eeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9765332211 1112235678999999988889999999999999999999 89998653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=266.30 Aligned_cols=201 Identities=26% Similarity=0.334 Sum_probs=169.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR---------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC---------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 37889999999999999999544 3588999998865432 223456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
....++||||++++.|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccc
Confidence 99999999999988887776543 34789999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 146 FARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred cceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9986543321 1123457889999999875 46789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=262.22 Aligned_cols=201 Identities=22% Similarity=0.297 Sum_probs=169.9
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
+|++.+.||+|++|.||++... .+++.+|+|.+..... .....+.+|+.++++++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR---------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc---------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 4888999999999999999543 3578899999865432 233457789999999999999999988764
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
....+++|||+++++|.+++..... ..+++..+..++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEeccc
Confidence 4467999999999999999976432 45789999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++........ ......+++.|+|||++.+..++.++|+|||||++++|++|.+||..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 148 IARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred ceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 9876533221 22345689999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=267.48 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=168.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|++|.||+|... .+++.||+|.+...... ....+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK---------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc---------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 58999999999999999999543 35788999998654322 223456899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 76 KTLTLVFEYLD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred CeEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECcccc
Confidence 99999999996 59999887654 35788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 150 ARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8754322111 122346889999999875 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=260.55 Aligned_cols=197 Identities=26% Similarity=0.303 Sum_probs=163.0
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
.||+|+||.||+|.+.. ..++..+|+|+++.... ....++.+|+.++..++||||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 58999999999996542 23578899999875432 23456789999999999999999999875 4567899
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||.||+++.++.+||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 74 MELAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 99999999999997643 4788899999999999999999987 99999999999999999999999999986543
Q ss_pred CCCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 233 GSQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
...... .....++..|+|||.+....++.++|+|||||++|||++ |.+||...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 322111 111234678999999988889999999999999999997 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=244.61 Aligned_cols=206 Identities=22% Similarity=0.288 Sum_probs=169.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
.++......||+|++|.|=+- ++..+|...|+|.+...- .+...+.++|+.+..+. .+|.++++||.+.
T Consensus 45 ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred hhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 356666788999999998665 455679999999997653 23445677888776554 7999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.....|+.||.| ..+|..+-.+--.....+++..+-+++..+..||.|||++ ..++|||+||.||||+.+|++|+|||
T Consensus 116 regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 116 REGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred ccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEccc
Confidence 999999999999 6788877765444446788898999999999999999997 67999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc----CcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----GIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|++..+.+.... +-..|...|||||.+.. ..|+.++||||||+++.||.++..||..+.
T Consensus 194 GIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 194 GISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999876443322 22358889999999863 378999999999999999999999987653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=240.99 Aligned_cols=201 Identities=26% Similarity=0.356 Sum_probs=171.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|.-.+.||+|.||+||+| ++..+++.||+|.+......+ ....++|+.+|+.++|.||++++++...+
T Consensus 3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 4555678999999999999 555689999999987654322 33568999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..+-+|+||| ..+|..+..... ..+..+.+..++.|++.||.|+|+++ +.||||||+|+||+.+|++||+|||+
T Consensus 74 kkltlvfe~c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccch
Confidence 9999999999 668988887655 45778889999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhc-cCChhheee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
++.+..... -....+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |.|.|.+..
T Consensus 148 arafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred hhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 997655432 22334679999999999875 57899999999999999998 889888763
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=266.71 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=168.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.++.+++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR---------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc---------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 36889999999999999999554 357899999886542 23345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999999999887532 11358899999999999999999996 36 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccC------cccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG------IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++....... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||..
T Consensus 149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 987643221 1223578899999998644 357899999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=261.57 Aligned_cols=200 Identities=29% Similarity=0.363 Sum_probs=174.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|.... ++..+++|.+..... ...+.+|+++++.++||||+++++.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 589999999999999999996543 478899999876543 557889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+++||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999999999999997644 45789999999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......++..|+|||++.+..++.++||||||+++|+|++|++||...
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 147 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred hhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 86543321 122345789999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=270.35 Aligned_cols=198 Identities=24% Similarity=0.314 Sum_probs=169.8
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.|.....||+|+||.||++... .++..||||.+..........+.+|+..+..++|+||+++++.+...+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK---------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC---------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 4444577999999999999543 3578999999876655556668899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++||||+++++|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 99999999999999988542 3788889999999999999999987 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
....... ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 167 QVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred hcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5432221 12234689999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=282.43 Aligned_cols=201 Identities=23% Similarity=0.249 Sum_probs=176.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+++.+..||-|+||.|=++..+.. ...+|+|++++...- +.+....|-.+|...+.|.|+++|..|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 4667778899999999988866531 235899988876542 3344678999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
++.++|++||-|-||.|+..++.++. +.......++..++.|++|||+++ ||+|||||+|+|++.+|.+||.||
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeeh
Confidence 99999999999999999999988764 777888899999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|+|+.+..+.. .-++||||.|.|||++.+...+.++|+||||+++|||++|.|||....
T Consensus 565 GFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 565 GFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred hhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 99998766543 345899999999999999999999999999999999999999998764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=263.42 Aligned_cols=206 Identities=25% Similarity=0.326 Sum_probs=167.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
.+.+-...||.|+||+|++- .++.+|+..|||++..... ....+++.|.+...+- +.|||+++||....
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred chHHHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 34555678999999999987 5556799999999987655 4556788888765554 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRR-ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
++..|+.||+| ..+|..+-..- ......+++..+-.|....+.||.||-.. ..|||||+||+|||++..|.+|||||
T Consensus 135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecc
Confidence 99999999999 67777655431 11124578888888888889999999865 56999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhheeee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
|++..+.... ..+.-.|...|||||-+.. ..|+.++|+||||++|||+.||..|+..+..
T Consensus 213 GIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 213 GICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred cchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 9997654332 2223468899999999873 3599999999999999999999999988754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.92 Aligned_cols=207 Identities=23% Similarity=0.359 Sum_probs=168.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|+..+.||+|+||.||+|..... .......+|+|.+...... ...++.+|+.++..++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 5788899999999999999965431 1112346899988755432 234678899999999999999999988654
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccc
Confidence 4678999999999999987654 35788889999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 986543322111222345778999999998899999999999999999997 88888653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=270.51 Aligned_cols=198 Identities=24% Similarity=0.311 Sum_probs=169.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.|.....||+|+||.||+|... .++..||+|.+..........+.+|+.++..++||||+++++++...+.
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEc---------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 3444567999999999999543 3578999999876554455567899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++++||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~ 165 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCA 165 (297)
T ss_pred EEEEEecCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHh
Confidence 99999999999999987542 3788899999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
....... ......|+..|+|||++.+..++.++|+|||||++|||++|.+||..
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 166 QISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred hcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5433221 12335689999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=261.06 Aligned_cols=203 Identities=27% Similarity=0.391 Sum_probs=169.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc-----chhhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-----SLQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.+|++.+.||+|+||.||+|.. ..++..+|+|.+... .......+.+|+.++++++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYD---------ADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEE---------cCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 4789999999999999999943 346889999987432 12233467789999999999999999999
Q ss_pred EEeC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 143 CLED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 143 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+.+. +..++++||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEE
Confidence 8764 46789999999999999987653 3778888999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCC-cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... ........++..|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 999999986432111 11112346899999999998888999999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=262.24 Aligned_cols=203 Identities=28% Similarity=0.371 Sum_probs=171.9
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
..++|++.+.||+|+||.||+|..+. +..+|+|.+..... ...++.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 34689999999999999999996542 46799999876543 34567899999999999999999999998
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
....+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g 148 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFG 148 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccc
Confidence 8999999999999999999976542 35788999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |++||..
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 149 LARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred cceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 98765432111 1112234678999999998889999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.73 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=170.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR---------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC---------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 5788899999999999999543 3588999999876542 2245678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++|+||+ +++|.+++.... ..+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~ 145 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGL 145 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeee
Confidence 9999999999 999999987654 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+........ .......|+..|+|||.+.+. .++.++||||+||++++|++|.+||..
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 146 ARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred cccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 986544321 112234689999999998654 468999999999999999999888854
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.25 Aligned_cols=210 Identities=22% Similarity=0.286 Sum_probs=174.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|+.... ........+++|.+...... ....+.+|++++++++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 5789999999999999999976542 12345678999988765443 345688999999999999999999999988
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYI-----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
+..++||||+++++|.+++....... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEE
Confidence 99999999999999999997654211 25889999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||..
T Consensus 159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999875432211 11223356788999999988888999999999999999998 7888854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.32 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=169.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+++.....||+|+||.||+|... .++..|++|.+..........+.+|+.+++.++|+||+++++++...+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDL---------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEec---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 34455578999999999999543 357889999988776666667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CCcEEEccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPL--SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDF 224 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DF 224 (295)
..++++||+++++|.+++.... ..+ ++..+..++.|++.||.|||+++ |+||||||+||+++. ++.++|+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecc
Confidence 9999999999999999997643 223 67788889999999999999987 999999999999976 678999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCc--ccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI--FQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ ......|++.|+|||++.... ++.++|+||||+++|+|++|.+||...
T Consensus 154 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 154 GTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred hhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 99875432211 122345889999999987543 788999999999999999999998754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=260.13 Aligned_cols=195 Identities=27% Similarity=0.386 Sum_probs=165.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE-eC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-ED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~ 146 (295)
++|++.+.||+|+||.||++... +..+|+|.++... ....+.+|+.+++.++|+|++++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 58899999999999999998543 6679999986543 2346788999999999999999999764 45
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++.+... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCcc
Confidence 678999999999999999976543 34788899999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
+....... ....++..|+|||++....++.++|||||||++|+|++ |.+||..
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 87543322 12245678999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.23 Aligned_cols=212 Identities=25% Similarity=0.352 Sum_probs=172.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|..... ....++..+|+|.+..... .....+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 35899999999999999999975421 1233578899999876543 234567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRAS------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 207 (295)
.+..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eeccccc
Confidence 9999999999999999999975321 1124678888999999999999999987 9999999
Q ss_pred CCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 208 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|||++ |..||..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999875433221111122235677999999988899999999999999999997 8888754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.60 Aligned_cols=202 Identities=23% Similarity=0.404 Sum_probs=170.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch------hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
+|+..+.||+|++|.||++.. ..++..+|+|.+..... .....+.+|+..++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~---------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARD---------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEE---------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 477889999999999999943 34688999999865431 123567889999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEE
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKL 221 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl 221 (295)
+.+.+..++|+||+++++|.+++.+.. ++++..+..++.|++.||.|||+++ ++|+||||+||+++.++ .+||
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l 145 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRI 145 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999999999997653 5788899999999999999999988 99999999999998776 5999
Q ss_pred ccccCCCCCCCCCCc--ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||.+......... .......|+..|+|||.+.+..++.++|+||+||++++|++|.+||...
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999998765432111 1122346889999999998888899999999999999999999998643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=259.94 Aligned_cols=200 Identities=30% Similarity=0.448 Sum_probs=160.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEE-eCCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-EDDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~l 151 (295)
+.||+|+||.||+|.... .......+|+|.+.... ......+.+|+.+++.++||||+++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999997542 22345789999986432 334556788999999999999999999765 4556799
Q ss_pred EEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
+|||+.+++|.+++.+.. ....+..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 75 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 999999999999997643 23566777889999999999999987 9999999999999999999999999997543
Q ss_pred CCCCc--ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 232 TGSQS--HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 232 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
..... .......++..|+|||.+....++.++|||||||++|||++ |.+||..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 22111 01112346778999999988889999999999999999999 5677754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.31 Aligned_cols=200 Identities=24% Similarity=0.345 Sum_probs=173.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|.+.+.||+|+||.||++... .++..||+|.+..........+.+|+.+++.++||||+++++.+...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDV---------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEc---------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 58999999999999999999533 357789999987655555567789999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999999998653 3678888999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......|++.|+|||.+....++.++|+|||||++|++++|.+||...
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 75433222 122346889999999998888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=260.15 Aligned_cols=198 Identities=29% Similarity=0.439 Sum_probs=171.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ...++.+|+.++..++|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 458999999999999999999543 67899999976654 456788999999999999999999999988
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccc
Confidence 999999999999999999976542 35789999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++....... ...++..|+|||.+..+.++.++|+||||+++++|++ |.+||...
T Consensus 149 ~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 149 AKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 986532211 2234667999999988889999999999999999997 99988654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=268.10 Aligned_cols=198 Identities=25% Similarity=0.338 Sum_probs=165.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~---------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC---------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 4788899999999999999543 45889999998654322 223567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++++||+. ++|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~ 145 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGL 145 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccch
Confidence 99999999995 68888876543 35889999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhh
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 146 ARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred hhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 9865332211 2234578999999998764 47899999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.91 Aligned_cols=208 Identities=22% Similarity=0.275 Sum_probs=169.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+|++.+.||+|+||.||+|..... .++..||+|.+.... ......+.+|+.++..++||||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 477889999999999999965421 258899999998743 2223456789999999999999999999998
Q ss_pred C--CeeEEEEeccCCCCHHHHHhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC----CCc
Q 022575 146 D--DHRLLVYEFMPKGSLENHLFRRASYI-QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----NYN 218 (295)
Q Consensus 146 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~ 218 (295)
. +..++||||++ ++|.+.+....... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccce
Confidence 8 88999999995 57877776443222 36788999999999999999999988 999999999999999 999
Q ss_pred EEEccccCCCCCCCCCCc-ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheee
Q 022575 219 AKLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+||+|||++......... .......+++.|+|||++.+. .++.++|+|||||++++|++|.+||....
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 999999999865433221 112234678999999988754 57899999999999999999999997553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=257.59 Aligned_cols=196 Identities=31% Similarity=0.432 Sum_probs=164.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
++||+|+||.||+|... .+..+|+|.+...... ....+.+|++++..++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 46899999999999643 2678999998765432 234678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.... ..+.+..++.++.|++.+|.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 71 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 145 (250)
T cd05085 71 MELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDD 145 (250)
T ss_pred EECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccc
Confidence 99999999999987543 34788899999999999999999988 99999999999999999999999999875432
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.... ......++..|+|||++..+.++.++|+||||+++|++++ |.+||...
T Consensus 146 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 146 GIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred cccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2211 1111234677999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=265.42 Aligned_cols=210 Identities=27% Similarity=0.299 Sum_probs=171.0
Q ss_pred hHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCcccee
Q 022575 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLI 140 (295)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~ 140 (295)
++....++|.+.+.||+|+||.||++... .+++.+|+|.+..... ....+.+|+.++.++ +|||+++++
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~---------~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~ 85 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNK---------KDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFY 85 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEEC---------CCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 33444678999999999999999999543 3588999999865432 233556788899888 799999999
Q ss_pred eEEEeC-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 141 GYCLED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 141 ~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
+++... +..++||||+++++|.+++.........+++..++.++.|++.||+|||+++ ++||||||+||+++.
T Consensus 86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~ 163 (291)
T cd06639 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTT 163 (291)
T ss_pred EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcC
Confidence 998754 3589999999999999988753322345788999999999999999999987 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-----cccccceeeehhHHHHHHhccCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.+||+|||++......... .....|+..|+|||.+... .++.++|+|||||++|+|++|.+||...
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred CCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 999999999998864332211 1234688999999998643 3678999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.35 Aligned_cols=206 Identities=24% Similarity=0.309 Sum_probs=169.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|.+.+.||+|+||.||+|..... ......|++|...... ......+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 35788999999999999999976431 1234568999887654 3445578899999999999999999998865
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCc
Confidence 56789999999999999997643 35788999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++........ ......++..|+|||.+....++.++|+||||+++|||++ |.+||...
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 98764332211 1122234568999999988889999999999999999886 99998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.78 Aligned_cols=201 Identities=23% Similarity=0.361 Sum_probs=168.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh----------hHHHHHHHHHHHcccCCCCccc
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------GHLEWLTEIKHLGQLYHPNLVK 138 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~E~~~l~~l~h~ni~~ 138 (295)
+|.+.+.||+|+||.||+|.. ..+++.+|+|.+...... ....+.+|+.++..++||||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~---------~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALN---------VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEee---------cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 577889999999999999943 345889999987542111 1234678999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 139 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
+++++...+..++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~ 146 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGI 146 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCe
Confidence 9999999999999999999999999997653 4788888999999999999999987 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCc--ccccceeeehhHHHHHHhccCChhhe
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI--FQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++|+|||++................|+..|+|||.+.... ++.++|+||||+++++|++|.+||..
T Consensus 147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 9999999997643322222223346889999999987654 78999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.93 Aligned_cols=209 Identities=30% Similarity=0.360 Sum_probs=175.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
++|++.+.||+|+||.||+|.+.. ....++..+|+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 578888999999999999997653 22346889999999766543 45578899999999999999999999877
Q ss_pred -CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
....+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccc
Confidence 557899999999999999997654 35888999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|++.......... ......++..|+|||.+....++.++|+||||++++||++|..||....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 9998764322211 1112234567999999988899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=263.35 Aligned_cols=200 Identities=27% Similarity=0.346 Sum_probs=171.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
..|+..+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++..++||||+++++.+...
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN---------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc---------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 36788899999999999999543 3578999999875532 3345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~ 147 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGV 147 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEccccc
Confidence 9999999999999999988642 4778888999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......++..|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 148 AGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred ceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 976533221 122346788999999998888999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=259.50 Aligned_cols=203 Identities=24% Similarity=0.335 Sum_probs=169.6
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
...+|++.+.||+|+||.||++.... +..+|+|.+..... ....+.+|+.+++.++|+||+++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK 72 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence 34689999999999999999996442 45699998875432 34567889999999999999999999877
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~ 147 (260)
T cd05073 73 -EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFG 147 (260)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCc
Confidence 778999999999999999976432 34677888999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.+......... ......++..|+|||++..+.++.++|+|||||++|++++ |.+||...
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 148 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred ceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 98765332211 1112345677999999998889999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=259.16 Aligned_cols=199 Identities=30% Similarity=0.438 Sum_probs=170.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
+|+..+.||+|+||.||+|... .++..|++|.+..... +....+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL---------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEc---------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 4777899999999999999544 3478899998865431 2345678899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++++||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999999999997653 4778888999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCc-ccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-FQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|.+||...
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 99987643322 123356899999999987766 899999999999999999999999664
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=274.47 Aligned_cols=205 Identities=25% Similarity=0.372 Sum_probs=176.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc-chhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
...+.+.||.|.||.||+|.+... .++..-.||||..+.+ .....+.|++|.-+|++++||||++++|++.+ .
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 445567899999999999988752 2445667999998874 44567789999999999999999999999975 5
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|||||+++.|.|..+|+.++ ..++......++.||+.||.|||+.+ +|||||..+|||+.....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchh
Confidence 6899999999999999999876 56888888999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........... ...-...|||||.+....|+.++|||-||+++||++. |..||.+-
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 987665544332 2334678999999999999999999999999999987 88888754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.37 Aligned_cols=206 Identities=26% Similarity=0.369 Sum_probs=167.2
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|...... .....+..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 36899999999999765321 1123456899998865432 3345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-----cEEEccc
Q 022575 153 YEFMPKGSLENHLFRRASY---IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-----NAKLSDF 224 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~DF 224 (295)
|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999999754321 134678889999999999999999987 99999999999999877 8999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
|++................++..|+|||.+.++.++.++|||||||++|+|++ |.+||..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 99976533322222223345788999999999999999999999999999998 9999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=259.40 Aligned_cols=206 Identities=27% Similarity=0.357 Sum_probs=174.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||.|+||.||+|... .++..+++|.+...... ....+.+|+..++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL---------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc---------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 47899999999999999999543 24788999998755432 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++||++++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccch
Confidence 999999999999999999976431 134788899999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcc--eeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.......... ......|+..|+|||++... .++.++|+|||||++++|++|++||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 87654433221 22334689999999998877 7889999999999999999999998654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=257.85 Aligned_cols=197 Identities=28% Similarity=0.406 Sum_probs=165.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
++||+|+||.||++... . ++.||+|.+...... ....+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~---------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK---------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEe---------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 46899999999999543 2 778999998765443 455788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+.+++|.+++.... ..+++..+..++.+++.||.|||+++ ++||||||+||+++.++.+||+|||++.....
T Consensus 71 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 145 (251)
T cd05041 71 MELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEG 145 (251)
T ss_pred EEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccC
Confidence 99999999999997643 35788888999999999999999987 99999999999999999999999999986432
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
...........++..|+|||.+.++.++.++|+||||+++|+|++ |.+||...
T Consensus 146 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 146 GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred CcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 221111111234567999999988899999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=259.64 Aligned_cols=208 Identities=24% Similarity=0.350 Sum_probs=167.9
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
|++.++||+|+||.||+|.+.. ...++..||+|.+.... .....++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 5678899999999999997652 33468899999987543 233456788999999999999999999886542
Q ss_pred ------eeEEEEeccCCCCHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 148 ------HRLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 148 ------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
..++++||+.+++|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCE
Confidence 2478899999999998875422 11234788889999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+|||+++...............+++.|++||.+....++.++|||||||++|+|++ |.+||...
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 9999999986543322211222345678999999998889999999999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=265.51 Aligned_cols=199 Identities=27% Similarity=0.364 Sum_probs=170.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.|+..+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN---------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc---------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 5667788999999999999543 3578899999875432 23446788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccc
Confidence 99999999999999998854 34788899999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......|+..|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred ccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 76543221 122346889999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=262.01 Aligned_cols=200 Identities=26% Similarity=0.310 Sum_probs=173.8
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+|++.+.||.|+||.||+|... .++..+|+|.+..... .....+.+|++++++++||||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR---------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc---------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 4788899999999999999543 3588899999976532 234567889999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++|+||+.+++|.+++... .++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~ 145 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFN 145 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecc
Confidence 99999999999999999999765 35788999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
.+....... ......|+..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 146 IATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred cccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 988654332 1223468899999999988889999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.67 Aligned_cols=201 Identities=27% Similarity=0.336 Sum_probs=167.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|++|.||+|.... +..+|+|.+..... ....+.+|+++++.++|+|++++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 578899999999999999996542 34589998865442 3456778999999999999999998875 45
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccc
Confidence 68999999999999999976432 34788889999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred eEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764332211 1122345678999999988899999999999999999999 89998654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=265.00 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=171.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||++... .++..+|+|.+..... .....+.+|++++..++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI---------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc---------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 57899999999999999999544 3578899998765432 3345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++++|.+++...+ .+++..+..++.+++.||.|||+ ++ ++||||||+||+++.++.++|+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCC
Confidence 99999999999999999887643 47889999999999999999997 45 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++....... .....|+..|+|||++.+..++.++|+|||||++|+|++|.+||...
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 987542211 12346899999999998889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.18 Aligned_cols=199 Identities=28% Similarity=0.415 Sum_probs=167.9
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-----hHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
+|++.+.||+|+||.||+|... .++..||+|.+...... ....+..|+.++..++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK---------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC---------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 4778899999999999999543 35789999999765433 223456899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~d 145 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLAD 145 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEcc
Confidence 9999999999999 899999997653 35889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++........ ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||..
T Consensus 146 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 146 FGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred ceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 999986543221 1122356788999998864 4678999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.71 Aligned_cols=205 Identities=27% Similarity=0.334 Sum_probs=171.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|++|.||+|... .+++.+++|.+..... ....+.+|+.++.++ +|+||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHK---------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEEC---------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 468999999999999999999543 3578899999876543 335678899999998 79999999999976
Q ss_pred CC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 DD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.. ..++||||+++++|.+++.........+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeE
Confidence 54 489999999999999998764422356889999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|.+||...
T Consensus 153 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 153 KLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred EECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9999999875433221 1223468999999998753 35678999999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=256.95 Aligned_cols=199 Identities=32% Similarity=0.431 Sum_probs=164.4
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|.+.. ...++..+|+|.+...... ...++.+|+.+++.++||||+++++++. .+..+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 469999999999997653 2224578999999866543 3456789999999999999999999876 4568999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 74 MELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 99999999999997653 4788999999999999999999987 99999999999999999999999999986533
Q ss_pred CCCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 233 GSQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
...... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~ 202 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence 322111 111123567999999998899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=263.14 Aligned_cols=204 Identities=27% Similarity=0.354 Sum_probs=169.0
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
....|++.+.||+|+||.||+|... .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEc---------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4468999999999999999999654 357899999986543 2334567889988888 6999999999985
Q ss_pred e------CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 E------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
. .+..|++|||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCC
Confidence 3 4578999999999999999976543 34778888999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++|+|||++........ ......|++.|+|||.+. ...++.++|+|||||++|+|++|.+||...
T Consensus 160 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999875432211 122356899999999986 346788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=258.35 Aligned_cols=201 Identities=26% Similarity=0.376 Sum_probs=175.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|++|.||+|... .+++.|++|.+..... .....+.+|+..+..++|+||+++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK---------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc---------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 36888999999999999999544 3688999999877654 3345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~ 145 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFG 145 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999999765 357889999999999999999999 88 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+......... .....++..|+|||.+....++.++|+||||+++|+|++|.+||...
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 146 ISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred cceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99865433221 12346789999999999889999999999999999999999998665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=261.19 Aligned_cols=198 Identities=21% Similarity=0.254 Sum_probs=162.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~ 153 (295)
+.||+|+||.||+|...... .........+++|.+..........+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~--~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVG--DYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccc--cccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 46899999999999654311 0001235568899887655445567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--------EEEcccc
Q 022575 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--------AKLSDFG 225 (295)
Q Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~kl~DFG 225 (295)
||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++. ++++|||
T Consensus 79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999997654 35788889999999999999999987 999999999999987765 6999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccC-Chhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQL-PMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~-~pf~~ 284 (295)
++...... ....+++.|+|||++.+ ..++.++|+|||||++|+|++|. +||..
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 98754321 22467889999999986 45789999999999999999984 66654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.64 Aligned_cols=205 Identities=30% Similarity=0.418 Sum_probs=172.0
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
+++.+.||.|+||.||++..... ....+..||+|.+...... ....+.+|++.+..++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 45678999999999999976541 1134588999999766543 45578899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCce
Confidence 9999999999999999976542 12789999999999999999999987 9999999999999999999999999998
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
........... ...+++.|+|||.+....++.++|+||||+++++|++ |.+||..
T Consensus 152 ~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 152 DLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 65443221111 1236789999999988889999999999999999998 8888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=258.44 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=161.4
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHccc-CCCCccceeeEEEeCCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~l 151 (295)
++||+|+||.||+|..... .....+++|.++... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 3689999999999965431 112357888887533 23345678899999999 79999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 152 VYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
+|||+++++|.+++..... ....+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeE
Confidence 9999999999999976431 1134788899999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
||+|||++....... .......+..|+|||++....++.++|+|||||++|||++ |.+||..
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999986422111 1111234567999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=264.09 Aligned_cols=206 Identities=17% Similarity=0.183 Sum_probs=156.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH-----------HHHHHHHHHHcccCCCC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-----------LEWLTEIKHLGQLYHPN 135 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~n 135 (295)
.++|++.++||+|+||.||+|..... ...+..+|+|.......... .....+...+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~------~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASD------HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCC------cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 46899999999999999999975531 11245567776433221110 11223445566778999
Q ss_pred ccceeeEEEeCC----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 136 LVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 136 i~~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
|+++++++.... ..++++|++ ..++.+.+... ...++..+..++.|++.||+|||+++ |+||||||+||
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Ni 157 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENI 157 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence 999998766543 347888887 45777766543 23567788899999999999999987 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++.++.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999865322111 1112346999999999999999999999999999999999999999765
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.25 Aligned_cols=200 Identities=28% Similarity=0.335 Sum_probs=173.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|++|.||++... .+++.+|+|.+..... ....++.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR---------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc---------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 36788899999999999999554 3578899999876543 3345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g 146 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG 146 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997653 457888999999999999999999 77 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+........ ....++..|+|||.+.+..++.++|+||||+++|+|++|.+||...
T Consensus 147 ~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 147 VSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9875432211 1156889999999999889999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=257.63 Aligned_cols=201 Identities=20% Similarity=0.280 Sum_probs=171.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||++... .+++.||+|.+.... .....++.+|+.++++++||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK---------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc---------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 5788899999999999999543 357889999986542 23344678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++|+||+.+++|.+++..... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~ 147 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGI 147 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999999999999999876432 34788889999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+........ ......|++.|+|||++.+..++.++|+|||||++++|++|..||..
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 148 ARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred eeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 976433221 12234588899999999888899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=262.82 Aligned_cols=200 Identities=27% Similarity=0.327 Sum_probs=169.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||+|... .+++.||+|.++.... .....+.+|+++++.++|+||+++++++...
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK---------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK 72 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC---------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence 6889999999999999999544 3578999998875432 2345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||++++.+..++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeec
Confidence 9999999999876666555433 34788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+......... ......++..|+|||++... .++.++|+||||+++|+|++|.+||..
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 147 ARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 8865443321 22335678999999999888 888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=256.27 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=171.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK---------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEc---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 5788899999999999999543 3588999999876532 2345678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFG 225 (295)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .+||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~ 147 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFG 147 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCC
Confidence 999999999999999999976532 45788899999999999999999987 99999999999998654 57999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ .....|+..|+|||.+....++.++|+||||+++|+|++|..||...
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 148 ISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred CceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 9986543321 12346889999999999888899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=265.04 Aligned_cols=200 Identities=27% Similarity=0.364 Sum_probs=168.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|++++..++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK---------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC---------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 36888999999999999999654 35788999988654322 23456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++|+||+++++|..+.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg 145 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 145 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeee
Confidence 99999999999998888776543 24788999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++........ ......++..|+|||++.+ ..++.++||||||+++|||++|.+||..
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 146 FARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred eeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 9876433221 1223467899999999875 3577899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=260.02 Aligned_cols=192 Identities=28% Similarity=0.371 Sum_probs=158.4
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHH---HHHcccCCCCccceeeEEEeCCe
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEI---KHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~---~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
+||+|+||.||+|... .+++.||+|.+.+.... ....+..|. ..+....||||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEe---------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999543 35889999998764322 111223333 34455679999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 99999999999999988654 35889999999999999999999987 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... .....|+..|+|||.+..+ .++.++||||+||++|+|++|.+||...
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 146 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 543221 1234689999999998755 6889999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=257.66 Aligned_cols=204 Identities=23% Similarity=0.351 Sum_probs=172.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
+|++.+.||.|+||.||++.. ..++..+|+|.+..... ....++.+|+.+++.++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~---------~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRR---------KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeee---------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 478889999999999999943 34578899999865432 334567889999999999999999998764
Q ss_pred -CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH-----SDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-----~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
....+++|||+++++|.+++.........+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNV 149 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCE
Confidence 35679999999999999999875443456889999999999999999999 766 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++........ ......+++.|+|||.+....++.++|+||||+++++|++|.+||...
T Consensus 150 kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 150 KLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred EEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 9999999987543321 122346899999999999888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=256.42 Aligned_cols=199 Identities=25% Similarity=0.380 Sum_probs=162.1
Q ss_pred CeeeccCCcEEEEEEecCCC-cCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHT-YAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~-~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
+.||+|+||.||+|...... +..........+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999776421 00001223356888887655433 5677889999999999999999999888 778999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-------cEEEcccc
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-------NAKLSDFG 225 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-------~~kl~DFG 225 (295)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999998754 25788889999999999999999987 99999999999999887 79999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccC--cccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--IFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...... ....++..|+|||++... .++.++|+|||||++|+|++ |.+||...
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 99864331 123467789999998876 78899999999999999999 57777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=300.81 Aligned_cols=204 Identities=27% Similarity=0.350 Sum_probs=170.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+++-...||.|.||.||.| .+..+|+..|+|.++..... ....+.+|+.+|..++|||+++++|+-.+.
T Consensus 1236 rWqrg~~Ig~G~fG~VYta---------vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTA---------VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred eeccccccCCcceeeeEEe---------ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence 4556678999999999999 66678999999988654332 223456899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+|.||||++|+|.+.+...+ -.++.....+..|++.|+.|||++| ||||||||+||+++.+|-+|++|||.
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccc
Confidence 99999999999999999997653 2455566678899999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCCcc--eeeccccccCccCceeeccC---cccccceeeehhHHHHHHhccCChhheeee
Q 022575 227 AKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG---IFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 227 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
|..+....... ......||+.|||||++.+. .-..++||||+||++.||+||+.||..+..
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 98765543111 12246899999999999854 344789999999999999999999987743
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.35 Aligned_cols=202 Identities=29% Similarity=0.387 Sum_probs=172.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||+|... .++..|++|.+...... ....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL---------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC---------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5788899999999999999543 34788999998766543 456788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~ 145 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGC 145 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999999997642 3678888999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcce--eeccccccCccCceeeccCc---ccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHV--STRVMGTYGYAAPEYMATGI---FQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........... .....+++.|+|||++.... ++.++|+||||+++++|++|.+||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 986543322111 11246789999999998766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=269.13 Aligned_cols=197 Identities=22% Similarity=0.268 Sum_probs=166.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|.. ..++..||+|.+.... .....++.+|+.+++.++||||+++++++.
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYD---------TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT 85 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEE---------CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeec
Confidence 46899999999999999999943 3468899999986532 233445678999999999999999999886
Q ss_pred eC------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
.. ...|+||||+ .++|.+.+... ++...+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~ 156 (353)
T cd07850 86 PQKSLEEFQDVYLVMELM-DANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 156 (353)
T ss_pred cCCCccccCcEEEEEecc-CCCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCC
Confidence 44 3569999999 46888877532 678888999999999999999987 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+||+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999986533221 2234678999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.37 Aligned_cols=204 Identities=23% Similarity=0.263 Sum_probs=171.9
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC--C----Cc
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH--P----NL 136 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~----ni 136 (295)
......+|.+...+|+|.||.|..++.+. ++..||+|+++.-. .-++..+-|+++|.++.+ | -+
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 34446899999999999999999997553 47899999997554 234455679999999842 2 37
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL- 215 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~- 215 (295)
+.+.++|...++.|+|+|.+ |.++.+++..+.. .+++...+..++.|++.+++|||+.+ ++|-||||+|||+..
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSS 228 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEecc
Confidence 78888899999999999999 8899999987654 67899999999999999999999988 999999999999832
Q ss_pred -------------------CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHh
Q 022575 216 -------------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFS 276 (295)
Q Consensus 216 -------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 276 (295)
+..+||+|||.|+...... ...+.|..|.|||++.+-.|+.++||||+||+|+|++
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3458999999998643322 3467899999999999999999999999999999999
Q ss_pred ccCChhheee
Q 022575 277 LQLPMCVLYL 286 (295)
Q Consensus 277 ~g~~pf~~~~ 286 (295)
+|..+|....
T Consensus 304 tG~~LFqtHe 313 (415)
T KOG0671|consen 304 TGETLFQTHE 313 (415)
T ss_pred ccceecccCC
Confidence 9999997653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.13 Aligned_cols=198 Identities=25% Similarity=0.330 Sum_probs=170.1
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.|...+.||+|++|.||++... .++..+++|.+..........+.+|+.++..++||||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK---------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC---------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 4555679999999999999543 3578899998875554455567899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++++||+.+++|.+++... .+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~ 163 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCA 163 (285)
T ss_pred EEEEEeccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccch
Confidence 99999999999999998762 3788889999999999999999988 9999999999999999999999999887
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
....... ......|++.|+|||.+.+..++.++|+||||+++|+|++|.+||..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 164 QVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred hhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 5433221 12234689999999999888899999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=261.02 Aligned_cols=202 Identities=28% Similarity=0.323 Sum_probs=171.1
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
+|+..+.||.|++|.||+|... .+++.+|+|.+..... ....++.+|+++++.++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLK---------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred ceEEEEEeccCCceEEEEEEEC---------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 6778899999999999999654 3578999999875433 3345678999999999999999999988653
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecc
Confidence 4689999999999999988654333356788899999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 151 ~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 151 VSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9875432221 2345788999999999889999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=268.65 Aligned_cols=201 Identities=27% Similarity=0.357 Sum_probs=165.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.++..++||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATH---------KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEE---------cCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 36899999999999999999954 34688999999864322 233456789999999999999999988765
Q ss_pred C-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
. ...++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~k 146 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLK 146 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEE
Confidence 4 35799999995 588887754 34888999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcc-eeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 221 LSDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|+|||++.......... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999987643322111 1123468999999998754 4688999999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=260.29 Aligned_cols=194 Identities=29% Similarity=0.417 Sum_probs=165.5
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||+|+||.||+|... .+++.+|+|.+...... ....+.+|+.++..++||||+++++.+...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVK---------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEc---------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 689999999999543 35889999998654322 233457899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.+... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.....
T Consensus 72 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred EecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 999999999999976543 35888999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.. ......++..|+|||.+.++.++.++|+|||||++|+|++|.+||...
T Consensus 148 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 148 GK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 21 122345788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=256.21 Aligned_cols=195 Identities=30% Similarity=0.435 Sum_probs=165.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||+|+||.||++.. ++..+|+|.+.... ....+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence 4789999999999999998843 36679999986543 234677899999999999999999998654
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccc
Confidence 57999999999999999976542 35788889999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
....... .....+..|+|||.+.++.++.++|+|||||++|+|++ |.+||...
T Consensus 148 ~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 148 RVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred eeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 7543221 11234577999999988899999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.45 Aligned_cols=202 Identities=26% Similarity=0.302 Sum_probs=168.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
+|++.+.||+|+||.||+|.... ...++..||+|.+..... .....+.+|++++.++ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 47888999999999999996431 223588999999875432 2234567899999999 599999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEee
Confidence 9999999999999999999999765 34778888999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccC--cccccceeeehhHHHHHHhccCChhh
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--IFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
||++......... ......|+..|+|||.+... .++.++|+||||+++|+|++|.+||.
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 9999764332211 12235689999999998753 46789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=259.69 Aligned_cols=192 Identities=28% Similarity=0.359 Sum_probs=157.2
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHH---HHcccCCCCccceeeEEEeCCe
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIK---HLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~---~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.||+|+||.||++... .++..+|+|.+...... ....+.+|.. ++...+||||+.+++++...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKA---------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEEC---------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 4899999999999543 35889999988654321 1122334433 3344579999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++||||+++++|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 999999999999999987653 4889999999999999999999988 9999999999999999999999999987
Q ss_pred CCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... .....|++.|+|||.+.. ..++.++|+|||||++|+|++|..||...
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 543221 122468999999999864 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=260.93 Aligned_cols=196 Identities=29% Similarity=0.410 Sum_probs=166.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..|++.+.||+|+||.||+|... .+++.||+|.+..... ....++.+|+.++..++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEc---------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 46899999999999999999543 3578999998864322 23346788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++|+||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeec
Confidence 9999999999995 68877776543 35788999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++...... ....+++.|+|||++. .+.++.++||||||+++|||++|.+||..
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 160 GSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred CcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 998754322 2346788999999984 45688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.86 Aligned_cols=196 Identities=28% Similarity=0.444 Sum_probs=163.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcc--cCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~~~~ 145 (295)
...++.++||+|.||.||+|.++ ++.||||++... ..+.|.+|-++... ++|+||+++++.-..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 45667789999999999999876 578999999754 34566677766654 589999999988765
Q ss_pred CC----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCeEeecCCCCCeEEc
Q 022575 146 DD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-------KAKVIYRDFKTSNILLD 214 (295)
Q Consensus 146 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------~~~ivHrDlkp~Nill~ 214 (295)
.. ..|||++|.+.|+|.++|..+- .+|....+++..+++||+|||+. +++|+|||||.+||||.
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK 350 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK 350 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence 55 7899999999999999998864 89999999999999999999963 46799999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCc-c-----cccceeeehhHHHHHHhccCChh
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-F-----QLVLLLFTFECSLLHFSLQLPMC 282 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~Di~slG~~l~el~~g~~pf 282 (295)
+|+++.|+|||+|..+..+.........+||.+|||||++.+.. + -.+.||||+|.+||||+++-.-+
T Consensus 351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99999999999998776554433344468999999999998542 1 15799999999999999965544
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.85 Aligned_cols=199 Identities=29% Similarity=0.368 Sum_probs=170.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
-|++.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.++..++||||+++++++...+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC---------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 5778899999999999999543 3478999998865443 23346778999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+.+++|.+++... .+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccc
Confidence 999999999999999988642 4788999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 149 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred eecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 75433211 122346888999999998888899999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=262.26 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=168.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .++..+|+|.++...... ...+.+|+.++.+++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK---------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC---------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 47899999999999999999544 357889999987554322 2345689999999999999999999887
Q ss_pred C--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 146 D--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 146 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
. +..|+||||+. ++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEee
Confidence 7 88999999996 59999887654 35889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||..
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 150 FGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred cCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999986544321 12234578899999988754 468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=263.99 Aligned_cols=201 Identities=28% Similarity=0.406 Sum_probs=166.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+....... .....+|+.++.+++|+||+++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDT---------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 358999999999999999999543 468899999986543221 234568999999999999999999987
Q ss_pred eC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 145 ED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 145 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
.. +..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~ 150 (309)
T cd07845 77 GKHLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIA 150 (309)
T ss_pred cCCCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEC
Confidence 65 56899999995 58988887643 45888999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||++......... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||..
T Consensus 151 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 151 DFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred ccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999865432211 122345788999999875 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=260.71 Aligned_cols=200 Identities=27% Similarity=0.407 Sum_probs=167.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|+..+.||+|++|.||+|... .++..||||.+...... ....+.+|++++++++||||+++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK---------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC---------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 4788899999999999999543 35789999988754322 234677899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999995 689888865432 45788999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCc-ccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-FQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+........ ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 147 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred hhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 875433221 112235688999999887644 58899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=255.21 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=169.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|++++.+++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 478888999999999999996542 56799998875433 2346788999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~ 147 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMT 147 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcce
Confidence 9999999999999999987644 34788889999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
......... ......++..|+|||.+.++.++.++|+||||+++|||++ |.+||...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 148 RFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred eecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 754322111 1112235678999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.49 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=169.0
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccC---CCCccceeeEEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY---HPNLVKLIGYCL 144 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~ 144 (295)
.|++.+.||+|+||.||+|... .++..+|+|.+..... ....++.+|+.+++.++ |||++++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV---------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc---------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 5778899999999999999543 3578999999875432 23445778988888886 999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.....+++|||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccC
Confidence 999999999999999999988653 4788999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ ......|+..|+|||.+..+ .++.++|+|||||++|+|++|.+||...
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 146 GVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred CceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99986544321 12234689999999988754 5689999999999999999999999654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=255.89 Aligned_cols=193 Identities=26% Similarity=0.305 Sum_probs=167.2
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||.|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++.+.+.+..+++
T Consensus 1 lg~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVK---------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 689999999999644 3578999999875432 2335678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
+||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 72 MEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred EecCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 99999999999997653 3788889999999999999999987 99999999999999999999999999986543
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
.. ......+++.|++||.+....++.++|+||||+++|+|++|.+||....
T Consensus 146 ~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 146 GQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 32 1223468899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=256.82 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=169.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc----------hhhHHHHHHHHHHHcc-cCCCCcc
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----------LQGHLEWLTEIKHLGQ-LYHPNLV 137 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~ni~ 137 (295)
+|++.+.||+|+||.||+|.... ..+..+|+|.+.... .....++.+|+.++.+ ++||||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 47888999999999999996543 146789999875332 1223456778887765 7999999
Q ss_pred ceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCC
Q 022575 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 138 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~ 216 (295)
++++++...+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~ 150 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED 150 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC
Confidence 99999999999999999999999999986533333568889999999999999999996 45 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+||+|||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|.+||...
T Consensus 151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 999999999998644332 223356899999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=260.10 Aligned_cols=204 Identities=24% Similarity=0.302 Sum_probs=166.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccC-CCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~-h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..+. ||||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~---------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK---------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC---------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 36889999999999999999544 35889999987654322 2345678999999995 699999999988
Q ss_pred eCCe-----eEEEEeccCCCCHHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CC
Q 022575 145 EDDH-----RLLVYEFMPKGSLENHLFRRASY-IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NY 217 (295)
Q Consensus 145 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~ 217 (295)
..+. .|++|||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCC
Confidence 7665 8999999975 898888754322 245789999999999999999999987 999999999999998 88
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++......... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 149 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 149 LLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred eEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999998764332211 112356889999998865 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=258.01 Aligned_cols=202 Identities=26% Similarity=0.341 Sum_probs=175.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+.|++.+.||+|++|.||++... .++..+++|.+..... ....+.+|++.+..++|+||+++++.+...
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDR---------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEc---------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 457888899999999999999654 2478899999876543 455678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..|+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccch
Confidence 99999999999999999998764 35888999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|.+||...
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~ 219 (286)
T cd06614 163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219 (286)
T ss_pred hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 875433221 122345788999999998888999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.08 Aligned_cols=210 Identities=23% Similarity=0.354 Sum_probs=180.5
Q ss_pred hhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCcccee
Q 022575 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLI 140 (295)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~ 140 (295)
+++.....+....++||-|.||.||.|.|+. ....||||.++.+.. ...+|++|..+|+.++|||+++|+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk---------yslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeec---------cceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHh
Confidence 4455555677788899999999999998775 356799999987664 366899999999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
++|.....+|||.|||..|+|.++|++... ..++....+.++.||..||+||..++ +|||||.++|+|+.++..||
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEE
Confidence 999999999999999999999999998764 45677777899999999999999877 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+|||+++.+.... ........-...|.|||.++.+.|+.++|||+||++|||+.| |..||.+.
T Consensus 406 vADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred eeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 99999999764432 222222234678999999999999999999999999999998 88898764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=255.31 Aligned_cols=194 Identities=21% Similarity=0.178 Sum_probs=161.7
Q ss_pred hcCCCCCCCee--eccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 66 ATRNFRPDSVL--GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 66 ~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
..++|.+.+.+ |+|+||.||++.. ..++..+|+|.+........ |+.....+ +||||+++++.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~---------~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKH---------KPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEE---------cCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEE
Confidence 34577777776 9999999999943 34588899999876533221 22222212 69999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEE
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKL 221 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl 221 (295)
+...+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999999999997653 5889999999999999999999988 99999999999999998 9999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++...... ....++..|+|||++.+..++.++|+||||+++|+|++|.+||...
T Consensus 152 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 152 CDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999998764322 1235889999999999888999999999999999999999999744
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.66 Aligned_cols=203 Identities=28% Similarity=0.368 Sum_probs=165.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHK---------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEEC---------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 57999999999999999999543 46889999988644322 22345689999999999999999998876
Q ss_pred CC--------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 146 DD--------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 146 ~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
.+ ..++||||+. ++|.+.+.... ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDG 156 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCC
Confidence 54 4599999995 58888886543 35789999999999999999999987 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCc--ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999865432211 111234578899999988654 4688999999999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.53 Aligned_cols=201 Identities=24% Similarity=0.386 Sum_probs=168.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+|++.+.||+|++|.||+|... .++..||+|.+...... ....+.+|+.++++++|+||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR---------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC---------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 5788899999999999999543 45889999998765432 2345678999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||++ ++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999996 589888876442 235789999999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
........ ......++..|++||.+.+. .++.++|+|||||++|+|++|.+||..
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 75433221 11223578899999988654 568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=263.42 Aligned_cols=215 Identities=24% Similarity=0.284 Sum_probs=177.6
Q ss_pred hhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-h------HHHHHHHHHHHcccC
Q 022575 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-G------HLEWLTEIKHLGQLY 132 (295)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~------~~~~~~E~~~l~~l~ 132 (295)
|++.....++|-+.++||+|+|+.||+|. +....+.||+|+-...... + .....+|.++.+.|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAF---------Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD 525 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAF---------DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD 525 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhc---------ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC
Confidence 33444555678888999999999999994 4445788999987543221 1 223568999999999
Q ss_pred CCCccceeeEEE-eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 133 HPNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 133 h~ni~~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
||.||++|++|. +.+.+|-|+|||+|.+|+-+|++++ .+++..+..|+.||+.||.||....++|||-||||.||
T Consensus 526 HpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNI 601 (775)
T KOG1151|consen 526 HPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNI 601 (775)
T ss_pred cceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccE
Confidence 999999999986 4567899999999999999999885 48899999999999999999999999999999999999
Q ss_pred EE---cCCCcEEEccccCCCCCCCCCCcc-----eeeccccccCccCceeeccC----cccccceeeehhHHHHHHhccC
Q 022575 212 LL---DLNYNAKLSDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMATG----IFQLVLLLFTFECSLLHFSLQL 279 (295)
Q Consensus 212 ll---~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~ 279 (295)
|+ +..|.+||+|||+++.+....... ......||.+|++||.+--+ ..+.++||||+||++|..+.|+
T Consensus 602 LLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGr 681 (775)
T KOG1151|consen 602 LLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGR 681 (775)
T ss_pred EEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccC
Confidence 99 456889999999999876544332 23446899999999998744 5778999999999999999999
Q ss_pred Chhheeee
Q 022575 280 PMCVLYLT 287 (295)
Q Consensus 280 ~pf~~~~~ 287 (295)
-||.-..+
T Consensus 682 KPFGhnqs 689 (775)
T KOG1151|consen 682 KPFGHNQS 689 (775)
T ss_pred CCCCCchh
Confidence 99986543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=251.13 Aligned_cols=200 Identities=31% Similarity=0.422 Sum_probs=175.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
+|.+.+.||+|++|.||++... .++..+++|.+..........+.+|+..+..++|+|++++++.+...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK---------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC---------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 4778899999999999999654 3578899999987665455678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++++||+.+++|.+++.... ..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeeccccc
Confidence 999999999999999987753 45788999999999999999999977 9999999999999999999999999998
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
....... .....++..|+|||.+....++.++|+||||+++|+|++|.+||...
T Consensus 147 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 147 QLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 6544321 23356889999999998888899999999999999999999998654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.16 Aligned_cols=194 Identities=24% Similarity=0.326 Sum_probs=167.5
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
...||+|+||.||++... .++..||+|.+..........+.+|+.+++.++|+||+++++.+...+..+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK---------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHHcCCCCCeEEEEEEEc---------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 367999999999999544 35889999998765545556688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 96 MEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999999987542 3788889999999999999999987 99999999999999999999999999875433
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
... ......|++.|+|||.+....++.++|+||||+++|+|++|.+||..
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 221 12335688999999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=259.04 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=165.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|++|.||+|... .+++.||+|.+...... ....+.+|+++++.++||||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR---------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec---------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 47889999999999999999543 35889999998654322 23456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DF 224 (295)
.+..|+||||++ ++|.+.+..... ..+++..+..++.||+.||+|||+++ ++||||+|+||+++. ++.+||+||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEccc
Confidence 999999999995 688888765432 23577888899999999999999987 999999999999985 567999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++........ ......+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||..
T Consensus 148 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 148 GLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred ccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99975433211 11223578899999988654 578999999999999999999999963
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=253.42 Aligned_cols=191 Identities=24% Similarity=0.303 Sum_probs=160.1
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHH-cccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHL-GQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l-~~l~h~ni~~l~~~~~~~~~~ 149 (295)
+.||+|+||.||+|.. ..+++.||+|.+....... ...+..|..++ ...+|+|++++++++...+..
T Consensus 2 ~~l~~g~~~~v~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKK---------RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEe---------cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 5689999999999954 3357899999987654321 22334454443 455899999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|+++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeeccccee
Confidence 99999999999999997653 4788899999999999999999987 99999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
... .....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||...
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 432 12346889999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=265.55 Aligned_cols=202 Identities=22% Similarity=0.338 Sum_probs=167.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~---------~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 75 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAID---------TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP 75 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEE---------cCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence 6899999999999999999943 34688999999875432 234456789999999999999999998763
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
....++||||+ +++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 76 ~~~~~~~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 76 PGADFKDVYVVMDLM-ESDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred cCCCCceEEEEEehh-hhhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEe
Confidence 34689999999 46899888654 34889999999999999999999987 999999999999999999999
Q ss_pred ccccCCCCCCCCCCc--ceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++......... .......|+..|+|||.+.. ..++.++|+|||||++|+|++|.+||...
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 999999754332211 11123468999999998765 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=259.33 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=166.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|...+.||+|+||.||++... .++..+|+|.+..... .....+.+|+++++.++|||++++++++..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDV---------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEc---------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4778899999999999999543 3578999999864422 233467789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||
T Consensus 97 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg 170 (317)
T cd06635 97 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 170 (317)
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCC
Confidence 999999999995 58888776544 45788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++...... ....|++.|+|||.+. .+.++.++|+|||||++|+|++|.+||...
T Consensus 171 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 171 SASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred CccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 98754321 2246889999999974 457889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.11 Aligned_cols=203 Identities=27% Similarity=0.353 Sum_probs=173.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
...|++.++||.|.+|.||++ +...+++..|+|++...... .++...|.++|+.. .|||++.+++++..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 357889999999999999999 44556888899988766432 33445678888877 69999999999864
Q ss_pred -----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 146 -----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
++.+|||||||.+|+.-|+++... ...+.|..+..|+.+++.||.+||.+. ++|||||-.|||++.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEE
Confidence 478999999999999999998766 367899999999999999999999987 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||.+........ ...++.|||.|||||+++. ..|+.++|+||||++..||..|.||+...
T Consensus 164 LvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred Eeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 999999986544332 2345789999999999983 36789999999999999999999999765
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=251.15 Aligned_cols=204 Identities=24% Similarity=0.349 Sum_probs=175.9
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||++... .++..+++|.+..... .....+.+|+++++.++|||++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK---------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc---------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 5788899999999999999654 3578899999876543 3455678899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++++||+++++|.+++.+.......+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999999875422356889999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .......|++.|+|||.+....++.++|+||+|+++++|++|.+||...
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 97653332 1223356899999999998888999999999999999999999998553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=263.61 Aligned_cols=202 Identities=23% Similarity=0.332 Sum_probs=167.7
Q ss_pred hhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccc
Q 022575 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVK 138 (295)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~ 138 (295)
.++....++|.+.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++.+++||||++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~ 80 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDT---------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEc---------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccc
Confidence 345556789999999999999999999543 3588999999875432 22345678999999999999999
Q ss_pred eeeEEEeC------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 139 LIGYCLED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 139 l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
+++++... ...+++++++ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl 152 (345)
T cd07877 81 LLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLA 152 (345)
T ss_pred eeeeeeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEE
Confidence 99988643 3468888887 88998887643 3788899999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||..
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred EcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998764321 123467899999998865 4678899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=255.34 Aligned_cols=196 Identities=27% Similarity=0.364 Sum_probs=162.1
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccC-CCCccceeeEEEeC-
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLED- 146 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~- 146 (295)
|++.+.||+|+||.||+|... .++..+|+|.+..... .......+|+..+.++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~---------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR---------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEc---------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 667889999999999999543 3578899999875422 12233457888888885 99999999999987
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||++ ++|.+.+.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecc
Confidence 88999999996 58888886543 35789999999999999999999987 999999999999999 999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++........ .....++..|+|||.+.. +.++.++|+|||||++|||++|.+||..
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 9986533221 122457899999997654 5678899999999999999999999964
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.08 Aligned_cols=207 Identities=27% Similarity=0.393 Sum_probs=177.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
..++.++||+|.||+|++|.|.. ..++...||||.+...... ....|++|+.+|.+|+|+|+++|||+..+ .
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~------psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQ------PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccC------CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 45667899999999999998874 2345567999999877665 56689999999999999999999999887 6
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
...||||+++.|+|.+.|.+.. ...+.......++.||+.||.||.+++ +|||||..+|+|+.....|||+|||+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccce
Confidence 7889999999999999998732 256778888999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCccee-eccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 228 KDGPTGSQSHVS-TRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 228 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
+.+..+.+.... ....-...|.|||.+....|+.++|+|+|||+||||++ |..||.+..
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 987665543322 22234678999999999999999999999999999999 788988764
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=254.28 Aligned_cols=195 Identities=30% Similarity=0.405 Sum_probs=166.6
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||+|+||.||++... .+++.+++|.+..... .....+.+|++++.+++||||+++++.+...+..|++
T Consensus 1 lg~g~~~~vy~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKK---------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEEC---------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999999544 3588999999876544 3345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
+||+.+++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 72 MEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred EecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99999999999997653 4788999999999999999999987 99999999999999999999999999875433
Q ss_pred CCC------cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 233 GSQ------SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 233 ~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
... ........++..|+|||.+....++.++|+||||+++|+|++|.+||...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 211 01123346788999999998888899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=263.46 Aligned_cols=201 Identities=30% Similarity=0.401 Sum_probs=165.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc--chhhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
.++|++.+.||+|+||.||+|... .++..+|+|.+... .......+.+|+.++.++ +||||+++++++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~ 76 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR---------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVI 76 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc---------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeee
Confidence 468999999999999999999543 35788999988543 223334567899999999 999999999988
Q ss_pred EeC--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 144 LED--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 144 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
... ...|+||||+. ++|.+++... .+.+.....++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl 148 (337)
T cd07852 77 KAENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKL 148 (337)
T ss_pred ccCCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEE
Confidence 654 36799999995 6999888653 4678888899999999999999987 999999999999999999999
Q ss_pred ccccCCCCCCCCCCc---ceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 222 SDFGLAKDGPTGSQS---HVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+|||++......... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||..
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999865433221 12233568999999998765 4678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=258.95 Aligned_cols=203 Identities=26% Similarity=0.337 Sum_probs=164.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccC-CCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~ 145 (295)
++|...+.||+|+||.||++... .++..+|+|.+..... .....+.+|+.++.++. |+||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK---------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC---------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 35667789999999999999543 4588999999875433 23446788999999996 9999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRR-ASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
++..+++|||+. ++|.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|
T Consensus 75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEee
Confidence 999999999984 5666554321 11114588899999999999999999974 6 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccC---cccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++........ .....|++.|+|||++... .++.++|||||||++|+|++|++||...
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 999875433221 1223588999999998866 6889999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=263.88 Aligned_cols=200 Identities=26% Similarity=0.367 Sum_probs=166.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|.+.+.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.++..++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKN---------SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEe---------cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 35799999999999999999943 3468999999987532 223345678999999999999999999876
Q ss_pred eC-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 145 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.. ...|+++||+ +++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~ 147 (337)
T cd07858 75 PPHREAFNDVYIVYELM-DTDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDL 147 (337)
T ss_pred cccccccCcEEEEEeCC-CCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCE
Confidence 54 3479999999 57898888754 34888999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||+|||++....... .......++..|+|||.+.. ..++.++|+|||||++|+|++|.+||..
T Consensus 148 kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 148 KICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred EECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 999999998654322 11233467899999998865 4688999999999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=255.64 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=166.7
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
|++.+.||.|++|.||+|... .++..||+|.+...... ....+.+|+..++.++|||++++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK---------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEc---------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 677889999999999999543 35889999998755322 2345678999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+++|||+ +++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++
T Consensus 72 ~~~iv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~ 146 (283)
T cd07835 72 KLYLVFEFL-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLA 146 (283)
T ss_pred eEEEEEecc-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccc
Confidence 999999999 5699999876542 35789999999999999999999987 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
......... .....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||..
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 147 RAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred cccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 754332211 1223568899999988764 578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=252.67 Aligned_cols=201 Identities=22% Similarity=0.325 Sum_probs=170.6
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|.+.+.||+|+||.||++... .++..+|+|.+..... .....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK---------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc---------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 4778899999999999999554 3578899999866432 2344567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc-EEEcccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-AKLSDFG 225 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-~kl~DFG 225 (295)
+..++++||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~ 147 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFG 147 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccc
Confidence 999999999999999999976543 35788999999999999999999987 999999999999988864 6999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.+........ ......|++.|+|||++....++.++|+||||+++++|++|.+||..
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 148 IARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred cchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9976543221 12234689999999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.53 Aligned_cols=200 Identities=30% Similarity=0.449 Sum_probs=173.8
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|++|.||++... ..++.+++|.+..... .....+.+|++++.+++|+|++++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL---------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc---------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 4788899999999999999543 3578899999977654 3455688999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEecccc
Confidence 9999999999999999999765 35789999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+......... .....++..|+|||.+....++.++|+|+||+++++|++|.+||...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 146 ATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred ceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 9865443221 22346889999999988777889999999999999999999998643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=252.36 Aligned_cols=202 Identities=24% Similarity=0.368 Sum_probs=173.8
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|+||.||++... .+++.+++|.+..... ....++.+|+++++.++|+||+++++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL---------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC---------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 4788899999999999999543 3578899999875432 2344667899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
...++|+||+++++|.+++.+.......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999999774433356888999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .....+++.|++||.+.+..++.++|+||||+++++|++|++||...
T Consensus 150 ~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 150 SKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred hhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98654431 12245789999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.13 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=174.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|+..+.||+|++|.||+|... .++..|++|.+..... .....+.+|+..+++++||||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 4777899999999999999544 3588999999876653 3455678999999999999999999999988
Q ss_pred --CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+..++++||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccc
Confidence 88999999999999999997653 5888999999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|.+................++..|+|||.+....++.++|+||||+++++|++|..||....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99886544332111233568899999999988889999999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=256.72 Aligned_cols=194 Identities=29% Similarity=0.429 Sum_probs=159.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcc--cCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~ 142 (295)
...+...+.+.||+|.||.||+|.|+ |+.||||++...+.. .+.+|.++... |+|+||+.+++.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhc
Confidence 44567888999999999999999988 788999999765533 45566666654 699999999987
Q ss_pred EEeCC----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeEeecCCCCCeE
Q 022575 143 CLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNIL 212 (295)
Q Consensus 143 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nil 212 (295)
-..+. ++|||.+|.+.|+|+|+|.+. .++....+.++..++.||++||.. ++.|.|||||..|||
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 65543 679999999999999999874 488899999999999999999942 467999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCc--ceeeccccccCccCceeeccC----ccc--ccceeeehhHHHHHHhc
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG----IFQ--LVLLLFTFECSLLHFSL 277 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~~--~~~Di~slG~~l~el~~ 277 (295)
+..++.+.|+|+|+|.......+. ......+||.+|||||++... .|. ..+||||||.++||++.
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999999999999999865443211 123346899999999998632 343 57999999999999987
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=254.17 Aligned_cols=200 Identities=28% Similarity=0.368 Sum_probs=167.4
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
|++.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK---------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 567789999999999999544 357899999997663 22334577899999999999999999999988
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++|+||++ ++|.+++.+.. ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 72 KGSIYMVFEYMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred CCcEEEEecccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEcccc
Confidence 88999999996 58988887653 35888999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 146 LARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred ceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99865443211 1122356888999998764 45789999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=255.06 Aligned_cols=203 Identities=27% Similarity=0.339 Sum_probs=173.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccC-CCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLY-HPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-h~ni~~l~~~~ 143 (295)
++|.+.+.||+|+||.||+|... .++..||+|.+..... .....+..|..++.+++ ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK---------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc---------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 37889999999999999999544 3588999999876432 22345678999999998 99999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..+++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~d 145 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITD 145 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecC
Confidence 99999999999999999999997753 5889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCc------------------ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQS------------------HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++......... .......++..|+|||.+....++.++|+||||++++++++|.+||...
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9998764332210 1122346789999999998888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=256.70 Aligned_cols=203 Identities=27% Similarity=0.336 Sum_probs=166.5
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK---------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC---------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 4468999999999999999999654 3578899999865432 2234566899999999999999999988
Q ss_pred EeCC----------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 144 LEDD----------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 144 ~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
.+.. ..++++||+++ +|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili 149 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILL 149 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 7654 78999999965 7777776542 45889999999999999999999987 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
++++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++++|++|++||..
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999865433211 1122346788999998864 3578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=259.60 Aligned_cols=204 Identities=28% Similarity=0.378 Sum_probs=164.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .++..+|+|.+....... ...+.+|+++++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI---------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 368999999999999999999543 357889999886543222 234568999999999999999999875
Q ss_pred eCC--------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 145 EDD--------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 145 ~~~--------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
... ..+++|||+. ++|...+.... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.+
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~ 151 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ 151 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 433 4699999995 57777776533 35889999999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCc---------ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQS---------HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.++|+|||++......... .......+++.|+|||.+.+. .++.++|||||||++|+|++|++||...
T Consensus 152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999754322211 011234578899999988654 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=261.02 Aligned_cols=198 Identities=24% Similarity=0.317 Sum_probs=166.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALD---------RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEE---------CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 457899999999999999999953 34588999999865322 2234577899999999999999999998
Q ss_pred EeCC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 144 LEDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 144 ~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
.... ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~ 155 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDC 155 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 7654 358999999 7899888864 34788999999999999999999987 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.++|+|||++....... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...
T Consensus 156 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 156 ELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred CEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999998643221 22457899999999875 35789999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=254.03 Aligned_cols=196 Identities=30% Similarity=0.428 Sum_probs=165.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|...+.||+|+||.||+|.. ..++..|++|.+..... .....+.+|+.++..++|||++++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~---------~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATN---------SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEE---------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 366678899999999999954 34588999999865432 223457789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..|+||||+. ++|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecC
Confidence 999999999995 68888876544 45788999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++..... .....|+..|+|||++. .+.++.++|+|||||++|+|++|.+||...
T Consensus 167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 167 SASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred CCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9864321 12346889999999984 456889999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.08 Aligned_cols=198 Identities=23% Similarity=0.281 Sum_probs=170.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HH------HHHHHHHHHcccC---CCC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HL------EWLTEIKHLGQLY---HPN 135 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~------~~~~E~~~l~~l~---h~n 135 (295)
..+|...+.+|+|+||.|++|.++. ....|+||.+.+++.-. +. ..-.|+++|..++ |+|
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N 630 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN 630 (772)
T ss_pred cccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence 3578999999999999999996554 47889999998775421 11 1236999999997 999
Q ss_pred ccceeeEEEeCCeeEEEEecc-CCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 136 LVKLIGYCLEDDHRLLVYEFM-PKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 136 i~~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
|++++++|++++..||+||-. ++.+|.++|..+. .+.+..+..|+.|++.|+++||++| |||||||-+|++++
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd 704 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD 704 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEe
Confidence 999999999999999999975 5679999998764 5888999999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCccc-ccceeeehhHHHHHHhccCChhh
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ-LVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~pf~ 283 (295)
.+|-+||+|||.+.....+. ...+.||..|.|||++.+..|- ...|||++|++||-++...-||+
T Consensus 705 ~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999998654443 3347899999999999988875 78999999999999999988875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=259.87 Aligned_cols=202 Identities=24% Similarity=0.357 Sum_probs=164.8
Q ss_pred CCCC-CCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--------------HHHHHHHHHHHcccC
Q 022575 68 RNFR-PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--------------HLEWLTEIKHLGQLY 132 (295)
Q Consensus 68 ~~y~-~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~ 132 (295)
++|. +.+.||+|+||.||+|... .+++.||+|.+....... ...+.+|++++..++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT---------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC---------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 3554 5678999999999999533 358899999886543221 124678999999999
Q ss_pred CCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 133 h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
|+||+++++++...+..+++|||+. ++|.+++... ..+++.....++.|++.||+|||+.+ ++|+||||+||+
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nil 151 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIF 151 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeE
Confidence 9999999999999999999999995 6999988654 34788999999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCC------------CcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccC
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGS------------QSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQL 279 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~ 279 (295)
++.++.++|+|||++....... .........+++.|+|||.+.+. .++.++|+|||||++|+|++|.
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999987543110 00011123468899999998754 4689999999999999999999
Q ss_pred Chhhee
Q 022575 280 PMCVLY 285 (295)
Q Consensus 280 ~pf~~~ 285 (295)
+||...
T Consensus 232 ~p~~~~ 237 (335)
T PTZ00024 232 PLFPGE 237 (335)
T ss_pred CCCCCC
Confidence 999643
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.52 Aligned_cols=198 Identities=27% Similarity=0.351 Sum_probs=165.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|. +..++..||+|.+.+... .....+.+|+.++..++||||++++++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSAR---------DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEE---------ECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 345789999999999999999994 334688999998764322 233456789999999999999999999
Q ss_pred EEe-CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 143 CLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 143 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
+.. ....++++||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEe
Confidence 876 45789999999 67898887642 3677888889999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+|||.+...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||..
T Consensus 150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999998754221 122457889999999876 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.41 Aligned_cols=203 Identities=26% Similarity=0.313 Sum_probs=168.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
+|++.+.||+|++|.||++.... ...++..||+|.+..... .....+.+|+.++.++ +||||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 47788999999999999986432 233578899999875432 1234567899999999 599999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEE
Confidence 9999999999999999999998754 34788888999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCc--ccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI--FQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++......... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|.+||..
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 9998765433211 122346899999999987654 77899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=260.36 Aligned_cols=201 Identities=27% Similarity=0.372 Sum_probs=169.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+|++.+.||+|++|.||+|... .++..||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~---------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK---------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC---------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 5888999999999999999543 358899999987643 23345678899999999999999999998877
Q ss_pred C-----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 147 D-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 147 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
+ ..|++|||+. ++|.+++.+.. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L 144 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKI 144 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEE
Confidence 5 7899999996 58988886542 5889999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCc-ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++......... .......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||...
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 999999865443210 112234678999999999887 7899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.53 Aligned_cols=199 Identities=18% Similarity=0.200 Sum_probs=160.7
Q ss_pred Ceeecc--CCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeCCee
Q 022575 74 SVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 74 ~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
..||+| +||+||++.. ..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARH---------TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEE---------cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 456666 8999999954 34689999999875432 2335677899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
++|+||+.+++|.+++.+... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++||+.+..
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~ 150 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYS 150 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence 999999999999999887543 35788899999999999999999987 99999999999999999999999986543
Q ss_pred CCCCCCcc-----eeeccccccCccCceeeccC--cccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSH-----VSTRVMGTYGYAAPEYMATG--IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ ......++..|+|||++.++ .++.++|||||||++|+|++|.+||...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 21111000 00112346679999998764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=261.20 Aligned_cols=200 Identities=25% Similarity=0.310 Sum_probs=163.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
.+|.+.+.||.|+||.||+|.. ..++..||+|.+..........+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~---------~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVD---------SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEE---------CCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 6899999999999999999954 346889999998776655556678899999999999999999876543
Q ss_pred -------------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 147 -------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 147 -------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
...|++|||+. ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili 147 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFI 147 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE
Confidence 35789999995 6898887542 4788999999999999999999988 9999999999999
Q ss_pred cC-CCcEEEccccCCCCCCCCCCcc-eeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 214 DL-NYNAKLSDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 214 ~~-~~~~kl~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+. ++.+||+|||++.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|.+||..
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 74 5578999999987543221111 1122357889999998754 4678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=250.35 Aligned_cols=199 Identities=27% Similarity=0.385 Sum_probs=164.1
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHccc---CCCCccceeeEEE
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIGYCL 144 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~l~~~~~ 144 (295)
|++.+.||+|+||.||+|.... ++..+|+|.+...... ....+.+|+.++.++ +||||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 5677899999999999996542 5789999999754322 123445677666554 6999999999998
Q ss_pred eCCe-----eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 145 EDDH-----RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 145 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
..+. .+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCE
Confidence 8776 899999995 589998876442 35889999999999999999999987 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||...
T Consensus 147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 147 KIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred EEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 9999999976533221 12235788999999999888999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=257.68 Aligned_cols=202 Identities=24% Similarity=0.312 Sum_probs=162.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
+|++.+.||+|+||.||++..... ..+..||+|.+..... .....+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 477889999999999999965421 1277899999864321 2234567899999999 59999999987543
Q ss_pred C----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 146 D----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 146 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
. ...++++||+ +++|.+.+... ..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||
T Consensus 74 ~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 74 FPGNFNELYLYEELM-EADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred ccccCCcEEEEEecc-cCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEe
Confidence 2 4578999998 47899988654 35788999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCc--ceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 222 SDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+|||+++........ .......||+.|+|||.+.+ ..++.++|+|||||++|+|++|.+||..
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 999999864332211 11123568999999998765 4688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=252.14 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=168.1
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
|++.+.||+|++|.||+|.. ..+++.+++|.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~---------~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARD---------KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEc---------CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 56778999999999999954 345889999998765433 3446778999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++++||++ ++|.+++.... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~ 145 (283)
T cd05118 72 DLYLVFEFMD-TDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLA 145 (283)
T ss_pred CEEEEEeccC-CCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeee
Confidence 9999999996 58888887643 45888999999999999999999988 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|++||..
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 146 RSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred EecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 76544321 12224578899999998876 788999999999999999999999854
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=252.39 Aligned_cols=200 Identities=28% Similarity=0.377 Sum_probs=164.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+...... ...++..|+.++.+. .||||+++++++.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFK---------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEEC---------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 368899999999999999999654 35788999998754322 334456677766666 4999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
+....|++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|
T Consensus 85 ~~~~~~~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 85 TDSDVFICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred cCCeEEEEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECc
Confidence 999999999998 557888776543 368889999999999999999997 46 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCc----ccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI----FQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++........ .....++..|+|||.+.... ++.++|+||||+++|+|++|++||..
T Consensus 159 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 159 FGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 999876433221 12235788999999987543 78899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=254.90 Aligned_cols=180 Identities=20% Similarity=0.196 Sum_probs=151.3
Q ss_pred CCcEEEEEEcCcc--chhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHH
Q 022575 101 TGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178 (295)
Q Consensus 101 ~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 178 (295)
+++.||+|.+... .......+.+|+.+++.++|+||+++++++...+..+++|||+++++|.+++..... ..+++.
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~ 101 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPEL 101 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc--cCCCHH
Confidence 5889999998765 233445688999999999999999999999999999999999999999999986532 357888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCc-----ceeeccccccCccCcee
Q 022575 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEY 253 (295)
Q Consensus 179 ~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 253 (295)
.+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+......... .......++..|+|||+
T Consensus 102 ~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 179 (314)
T cd08216 102 AIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179 (314)
T ss_pred HHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHH
Confidence 89999999999999999988 999999999999999999999999988754322110 01122357788999999
Q ss_pred eccC--cccccceeeehhHHHHHHhccCChhhe
Q 022575 254 MATG--IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 254 ~~~~--~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+... .++.++|+|||||+++||++|.+||..
T Consensus 180 ~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred hcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 8753 578999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=258.41 Aligned_cols=196 Identities=22% Similarity=0.305 Sum_probs=162.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|.+.+.||+|+||.||+|.. ..++..||+|.+...... ....+.+|+.++..++||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAID---------KRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEe---------CCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 46899999999999999999954 345889999998754221 2345678999999999999999999987
Q ss_pred eCC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
... ..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~ 155 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCE 155 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCC
Confidence 543 4589999995 57766542 24788889999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++..... .....+++.|+|||.+.+ ..++.++|+|||||++|||++|++||...
T Consensus 156 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 156 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred EEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998764322 123467889999999876 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=253.39 Aligned_cols=197 Identities=28% Similarity=0.399 Sum_probs=165.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
+.|...+.||+|+||.||+|... .++..+|+|.+.... .....++.+|+++++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEc---------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 35777889999999999999543 357889999886432 123346778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+. ++|.+.+.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999995 68888776543 45788899999999999999999987 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++...... ....+++.|+|||.+. .+.++.++|||||||++|+|++|.+||...
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 160 GSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred ccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 998754321 2346889999999974 356788999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=276.88 Aligned_cols=146 Identities=26% Similarity=0.343 Sum_probs=129.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|.+.+.||+|+||.||+|+.. .+++.||||++..... .....+..|+.++..++||||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK---------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC---------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 58999999999999999999654 3588999999875432 22346778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+.+++|.+++...+ .+.+..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeC
Confidence 9999999999999999999997653 4778889999999999999999987 999999999999999999999999
Q ss_pred cCCC
Q 022575 225 GLAK 228 (295)
Q Consensus 225 G~a~ 228 (295)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=249.57 Aligned_cols=199 Identities=28% Similarity=0.431 Sum_probs=166.5
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccC-CCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~ 147 (295)
|++.+.||+|++|.||+|.... +++.|+||.+..... .......+|+..+.+++ |+||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6678899999999999996543 478899999865432 12223457899999998 999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+ +++|.+++..... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccc
Confidence 999999999 8899998876542 35789999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
........ .....++..|+|||++.. ..++.++|+||||+++++|++|.+||...
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 147 REIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred eeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 76533221 123467889999998854 45789999999999999999999999543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=278.56 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=160.4
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
+-..+|+..++||+||||.||++ +++-+|..+|||+|..... ....+..+|+..|.+|+|||||+++..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 34468888999999999999999 4555799999999976642 2234577899999999999999998765
Q ss_pred EeC-----------------------------------------------------------------------------
Q 022575 144 LED----------------------------------------------------------------------------- 146 (295)
Q Consensus 144 ~~~----------------------------------------------------------------------------- 146 (295)
.+.
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 410
Q ss_pred ------------------------------------------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHH
Q 022575 147 ------------------------------------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184 (295)
Q Consensus 147 ------------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 184 (295)
..+||.||||+..+|.+++.++... -.....+.++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLF 703 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLF 703 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHH
Confidence 1247899999988888888765421 1356788999
Q ss_pred HHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC------C----------CCCcceeeccccccCc
Q 022575 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP------T----------GSQSHVSTRVMGTYGY 248 (295)
Q Consensus 185 ~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~------~----------~~~~~~~~~~~gt~~y 248 (295)
.+|+.||.|+|+.| ||||||||.||++++++.|||+|||+|+... . +......+..+||.-|
T Consensus 704 reIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 704 REILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 99999999999988 9999999999999999999999999998621 0 0111123456899999
Q ss_pred cCceeeccC---cccccceeeehhHHHHHHhc
Q 022575 249 AAPEYMATG---IFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 249 ~aPE~~~~~---~~~~~~Di~slG~~l~el~~ 277 (295)
+|||++.+. .|+.|+|+||||++++||+.
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence 999998754 59999999999999999996
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=248.29 Aligned_cols=198 Identities=29% Similarity=0.423 Sum_probs=167.8
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
|++.+.||+|++|.||+|.. ..+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~---------~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARD---------KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeee---------cCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 56678899999999999954 3458899999987653 222345678999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++|+||++ ++|.+++.+.. ..+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~ 145 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLA 145 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcc
Confidence 9999999996 69999998753 35889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
........ ......++..|+|||.+... .++.++|+|||||+++||++|.+||..
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 146 RAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred cccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 86543221 11223467889999998766 788999999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=242.01 Aligned_cols=182 Identities=20% Similarity=0.167 Sum_probs=154.0
Q ss_pred cCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEeccCC
Q 022575 79 GGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158 (295)
Q Consensus 79 G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 158 (295)
|.+|.||+++ +..+++.+|+|.+..... ..+|...+....||||+++++++...+..+++|||+++
T Consensus 4 g~~~~v~~~~---------~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVM---------DTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEE---------EccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999994 445688999999976532 22444555556799999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcce
Q 022575 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (295)
Q Consensus 159 g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 238 (295)
++|.+++.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.++++|||.+.......
T Consensus 70 ~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---- 139 (237)
T cd05576 70 GKLWSHISKFL----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---- 139 (237)
T ss_pred CCHHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc----
Confidence 99999987653 4788999999999999999999987 9999999999999999999999999886543321
Q ss_pred eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
....++..|+|||.+....++.++|+||+|+++|||++|.+||...
T Consensus 140 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 140 -DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred -ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 1234677899999998888899999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=257.53 Aligned_cols=197 Identities=25% Similarity=0.329 Sum_probs=166.3
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|++|.||+|... .++..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDT---------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEEC---------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 3468999999999999999999554 357889999986532 22334567899999999999999999988
Q ss_pred EeCCe------eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 144 LEDDH------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 144 ~~~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~ 155 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDC 155 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCC
Confidence 76654 89999999 7799998865 34888999999999999999999987 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.++|+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||..
T Consensus 156 ~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 156 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred CEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999865332 223467889999999865 3678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=245.72 Aligned_cols=202 Identities=22% Similarity=0.274 Sum_probs=164.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCc---cch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~---~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
+|.+.+.||+|+||.||++.... .+..+++|.++. ... ....++..|+.++..++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 58888999999999999996542 233344444432 221 2233556789999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+....++++||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecc
Confidence 9999999999999999999998764333356889999999999999999999987 999999999999975 5799999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999876533221 12234688999999998888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=244.40 Aligned_cols=199 Identities=24% Similarity=0.390 Sum_probs=166.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc--chhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+.+..+.||-|+||+||.+ .++.+|+.||+|++..- +.....++.+|++.|..++|.|++..++..+..
T Consensus 54 Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp 124 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA 124 (449)
T ss_pred cCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence 4456689999999999987 77778999999988643 234456788999999999999999999887654
Q ss_pred C-----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 147 D-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 147 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
. .+|++.|++ ..+|..+|-.. +.++.+.+..++.||+.||+|||+.+ |+||||||.|+|++.+..+||
T Consensus 125 h~dfFqEiYV~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKI 197 (449)
T KOG0664|consen 125 NPSFFQELYVLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKI 197 (449)
T ss_pred CchHHHHHHHHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEe
Confidence 3 457888988 56888877554 56888999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||||+++.-....... .+..+-|.+|.|||++.+. .|+.+.||||.||++.||+.++.+|..
T Consensus 198 CDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 198 CDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred cccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 9999999654433332 3334568999999999864 799999999999999999998888854
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=244.89 Aligned_cols=205 Identities=29% Similarity=0.389 Sum_probs=168.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+.|.-...||+|.||.||+| +.+.+++.||+|++-.++. .--...++|+++|..|+|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 35666678999999999999 4555788899987654322 223456799999999999999999887753
Q ss_pred C--------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 146 D--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 146 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
. ..+|+|+++|+. +|.-++.... ..++...+..++.+++.||.|+|... |+|||+||+|+||+.++
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dg 161 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDG 161 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCc
Confidence 2 358999999954 8988886654 56889999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCc--ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheeee
Q 022575 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
.+||+|||+++.+...... ...+..+-|.+|.+||.+.+. .|+++.|||..||++.||.+|.|.|.+..+
T Consensus 162 ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 162 ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 9999999999866543322 122334569999999999865 789999999999999999999999987654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=240.79 Aligned_cols=193 Identities=32% Similarity=0.386 Sum_probs=165.9
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
||+|+||.||++... .+++.+|+|.+...... ....+..|+.++++++||||+++++.+...+..+++
T Consensus 1 lg~G~~~~v~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKK---------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEEC---------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 689999999999544 35789999998765432 334677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 72 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 72 LEYAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99999999999997653 4788999999999999999999977 99999999999999999999999999876533
Q ss_pred CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
... ......++..|+|||.+.+...+.++|+||||+++|+|++|..||...
T Consensus 146 ~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 146 EGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 211 123346788999999998888899999999999999999999998543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=266.07 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=174.7
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
.+..++||+|+||+||+|.|-. .....+.+||||++..... +..++++.|+-+|.+++|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 4456889999999999998765 3334577899999866543 34568899999999999999999999998766
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
+.||++|+++|+|.++++.++ ..+-.+..+.|..||++||.|||.++ +|||||-++|||+..-..+||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 889999999999999999877 56778889999999999999999877 9999999999999999999999999999
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
...............-.+.|||-|.+....|+.++|||||||++||++| |..|+...
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi 904 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI 904 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence 7655443322222334678999999999999999999999999999999 88887765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=280.66 Aligned_cols=190 Identities=28% Similarity=0.415 Sum_probs=159.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
..|...++||+|+||.||+|... .++..||+|.+....... ..|++.+++++||||+++++++.+.+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSI---------KNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEEC---------CCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 46777889999999999999653 347889999986543221 25688899999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..|+||||+++|+|.+++.. +++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||.
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 99999999999999999942 67888999999999999999943 2349999999999999999888876 665
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
....... ....||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 829 ~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 829 PGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 5432111 123678999999999999999999999999999999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.20 Aligned_cols=195 Identities=23% Similarity=0.231 Sum_probs=163.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
...|.+...+|.|+|+.|-.+ .+..+++..++|++.+.... ..+|+.++... +||||+++++.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeee---------eccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecC
Confidence 457888888999999999888 55567888999999876322 23566555554 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE-cCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~DF 224 (295)
..+.|+|||++.|+-|.+.+.... .....+..|+.+|+.++.|||++| +|||||||+|||+ +..++++|+||
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEe
Confidence 999999999999998888886653 223667789999999999999988 9999999999999 68999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|.++..... ....+-|..|.|||++....|+.++||||||++||+|++|..||..-.
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 999875443 112355889999999999999999999999999999999999997643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=264.97 Aligned_cols=215 Identities=26% Similarity=0.364 Sum_probs=175.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
...++..+.+.||+|.||.|++|........ .......||||.++.... .+...+..|+.+|..+ +|+||+.++++
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~--~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKA--LLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccc--cccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3345567778999999999999987642210 012367899999976543 3456788999999998 69999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhcc---CC-------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCC
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRA---SY-------I--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 210 (295)
+...+..++|+||++.|+|.++++..+ .. . ..+.....+.++.||+.||+||++.. +|||||.++|
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRN 448 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARN 448 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhh
Confidence 999999999999999999999998876 11 1 13788899999999999999999977 9999999999
Q ss_pred eEEcCCCcEEEccccCCCCCCCCCCcceeecccc--ccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG--TYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 211 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
||+..+..+||+|||+|+............ -.| ...|||||.+....|+.++||||||++|||+++ |.+||..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999654443332111 112 445999999999999999999999999999999 8899886
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=249.43 Aligned_cols=215 Identities=20% Similarity=0.258 Sum_probs=154.6
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCc-------CCCCCCCCcEEEEEEcCccchhhHHH--------------HHHH
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTY-------APARPGTGMVIAVKRLNQESLQGHLE--------------WLTE 124 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-------~~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~~E 124 (295)
..++|++.++||+|+||.||+|....... .......++.||||.+.........+ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 45789999999999999999996532110 01122346789999987543322222 2346
Q ss_pred HHHHcccCCCCc-----cceeeEEEe--------CCeeEEEEeccCCCCHHHHHhhccCC--------------------
Q 022575 125 IKHLGQLYHPNL-----VKLIGYCLE--------DDHRLLVYEFMPKGSLENHLFRRASY-------------------- 171 (295)
Q Consensus 125 ~~~l~~l~h~ni-----~~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------- 171 (295)
+..+.+++|.++ +++++++.. .+..|+||||+++++|.+++......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766544 667777653 35689999999999999998753210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCc
Q 022575 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251 (295)
Q Consensus 172 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP 251 (295)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++.......... .....+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence 012456778889999999999999987 9999999999999999999999999997543322111 1112358999999
Q ss_pred eeeccCc--------------------cc--ccceeeehhHHHHHHhccCC-hhh
Q 022575 252 EYMATGI--------------------FQ--LVLLLFTFECSLLHFSLQLP-MCV 283 (295)
Q Consensus 252 E~~~~~~--------------------~~--~~~Di~slG~~l~el~~g~~-pf~ 283 (295)
|.+.... +. .+.|+||+||++|+|++|.. ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9876322 11 24699999999999999874 664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=246.35 Aligned_cols=210 Identities=20% Similarity=0.207 Sum_probs=175.1
Q ss_pred eehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-----
Q 022575 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY----- 132 (295)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~----- 132 (295)
+...-......+|.+....|+|-|+.|.+|. +...+..||||+|.....- ...-+.|+++|++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~---------D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~E 491 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRAR---------DQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPE 491 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeecc---------ccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCch
Confidence 3444445667889999999999999999994 4445779999999766432 334468999999996
Q ss_pred -CCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 133 -HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 133 -h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
--|+++|+..|...+++|||+|-+ ..+|.++|++.+.. ..+....+..++.|+..||..|-..| |+|.||||+||
T Consensus 492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNi 567 (752)
T KOG0670|consen 492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNI 567 (752)
T ss_pred hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccce
Confidence 358999999999999999999998 78999999887643 45778889999999999999999877 99999999999
Q ss_pred EEcCCC-cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 212 LLDLNY-NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 212 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++.. .+||||||.|.....+. -+.+.-+..|.|||++.+-.|+...|+||+||+||||+||+.+|.+-
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred EeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 998754 57999999998654433 12244577899999999999999999999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=254.53 Aligned_cols=206 Identities=18% Similarity=0.217 Sum_probs=142.5
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeE---
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGY--- 142 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~--- 142 (295)
..++|++.+.||+|+||.||+|..... ....+..||+|.+...... .....| .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~-----~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNK-----QSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCC-----ccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 457899999999999999999976542 1123788999987643321 111111 1122222233222221
Q ss_pred ---EEeCCeeEEEEeccCCCCHHHHHhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 022575 143 ---CLEDDHRLLVYEFMPKGSLENHLFRRASY----------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (295)
Q Consensus 143 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 203 (295)
....+..++|+||+.+++|.+++...... ........+..++.|++.||+|||+++ |+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 23456789999999999999998754210 001123345678999999999999987 999
Q ss_pred ecCCCCCeEEcC-CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC----------------------ccc
Q 022575 204 RDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG----------------------IFQ 260 (295)
Q Consensus 204 rDlkp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 260 (295)
|||||+|||++. ++.+||+|||+|+........ ......+++.|+|||.+... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 578999999999865433222 23346789999999975422 234
Q ss_pred ccceeeehhHHHHHHhccCChhh
Q 022575 261 LVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 261 ~~~Di~slG~~l~el~~g~~pf~ 283 (295)
.++|||||||++|||+++..++.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCc
Confidence 56799999999999998765543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=222.44 Aligned_cols=194 Identities=21% Similarity=0.315 Sum_probs=162.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~ 145 (295)
.++|++.+.+|+|.++.||.| .+..+++.++||++++... ..+.+|+.+|..|+ ||||+++++...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 468999999999999999999 4445688999999986543 35678999999997 9999999999876
Q ss_pred CC--eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcEEEc
Q 022575 146 DD--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLS 222 (295)
Q Consensus 146 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~ 222 (295)
+. ..-|++||+++.+...+. ..++...+..++.+++.||.|||+.| |+|||+||.|++||.. ..++|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlI 175 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLI 175 (338)
T ss_pred ccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeee
Confidence 64 457999999888877665 34677888999999999999999988 9999999999999754 569999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|+|+|.....+... .-.+.+..|..||.+-. ..|+..-|+|||||++..|+..+.||+-
T Consensus 176 DWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 176 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred ecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 99999876554433 22456888999999874 5788999999999999999999988763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=223.06 Aligned_cols=200 Identities=31% Similarity=0.379 Sum_probs=170.6
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
|.+.+.||+|++|.||++.... ++..+++|.+...... ....+.+|++.+..++|+|++++++++...+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5667899999999999996543 4788999999876554 55677889999999999999999999999899
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
.++++|++.+++|.+++..... .+++.....++.+++.++.+||+++ ++|+||+|.||+++.++.++|+|||.+.
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred eEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 9999999999999999976542 1678889999999999999999987 9999999999999999999999999988
Q ss_pred CCCCCCCcceeeccccccCccCceee-ccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYM-ATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
........ ......++..|++||.+ ....++.++|+|+||+++++|++|++||..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 65433200 12234678899999998 666778899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=253.55 Aligned_cols=203 Identities=30% Similarity=0.360 Sum_probs=163.5
Q ss_pred CCCCCCeeeccCCcE-EEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGC-VFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~-V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 146 (295)
-|.-.+++|.|+.|+ ||+|.++ ++.||||++-..... -..+|+..|+.- +||||+++|+.-.+.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~~---~A~rEi~lL~eSD~H~NviRyyc~E~d~ 575 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFFD---FAQREIQLLQESDEHPNVIRYYCSEQDR 575 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhHH---HHHHHHHHHHhccCCCceEEEEeeccCC
Confidence 355567899999875 7999887 678999998654432 345899988877 699999999998889
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---C--CcEEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---N--YNAKL 221 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~--~~~kl 221 (295)
...||..|.| ..+|.+++.................++.|++.||++||+.+ ||||||||+||||+. + .+++|
T Consensus 576 qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 576 QFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred ceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEe
Confidence 9999999999 67999999875211111122445778899999999999977 999999999999965 3 57899
Q ss_pred ccccCCCCCCCCCCcce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhcc-CChhheeeee
Q 022575 222 SDFGLAKDGPTGSQSHV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQ-LPMCVLYLTY 288 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~pf~~~~~~ 288 (295)
+|||+|+....+..... .....||-+|+|||++....-+.++|||||||++|+.++| +.||......
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 99999998766554322 3456899999999999988888899999999999999995 8999987544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=226.24 Aligned_cols=134 Identities=24% Similarity=0.347 Sum_probs=112.9
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-----C---CCcc
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----H---PNLV 137 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~ni~ 137 (295)
...+|.+.++||=|-|++||+|+... ..+.||+|+.+-.. .-.+..+.||++|++++ | ..||
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred cCceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 34789999999999999999997553 47889999987543 22345678999999884 2 4699
Q ss_pred ceeeEEEeC----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 138 KLIGYCLED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 138 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
+|++.|... .++|||+|++ |.+|..+|..... +.++...+.+|+.||+.||.|||.. ++|||-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence 999999764 4789999999 8899999987654 5688899999999999999999986 779999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-33 Score=246.11 Aligned_cols=199 Identities=28% Similarity=0.361 Sum_probs=174.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|.+...+|+|.||.||++ ++..+++..|+|.++...-.+..-..+|+-+++..+||||+.+++.+...+
T Consensus 15 ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred cchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 58999999999999999999 666789999999998776555556678999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+.||||.+|+|.+.-+-. .++++.++....++.+.||+|||+.| -+|||||-.|||+++.|.+|++|||.+
T Consensus 86 klwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred CcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCch
Confidence 999999999999999876554 46888999999999999999999987 999999999999999999999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhh
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
..+..... ....+.||++|||||+-. .+.|...+|||++|++..|+.--+||-+
T Consensus 160 aqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 160 AQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred hhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 76544332 234578999999999875 5688999999999999999998877654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=222.39 Aligned_cols=195 Identities=23% Similarity=0.282 Sum_probs=162.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.+|.-.+.+|.|.- .|..| .+.-.++.||+|.+.... .....+..+|...+..++|+||++++.+|.-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a---------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAA---------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeecccCCCCc-eEEec---------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 46777788888886 56555 444568899999876542 2234466789999999999999999999875
Q ss_pred CC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 DD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.. ..|+|||++ ..+|.+.+... +.-..+..++.|+++|++|||+.| |+||||||+||++..+..+
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~l 157 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTL 157 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhhe
Confidence 43 469999999 77999988732 556778899999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||.|||+|+..... ...+..+.|..|.|||++.+-.|...+||||+||++.||++|...|.+
T Consensus 158 Ki~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 158 KILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred eeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 99999999864332 234556789999999999988899999999999999999999988864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=218.91 Aligned_cols=187 Identities=32% Similarity=0.426 Sum_probs=162.9
Q ss_pred CCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-HHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEeccCC
Q 022575 80 GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK 158 (295)
Q Consensus 80 ~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~ 158 (295)
+||.||+|.... +++.+|+|.+....... ...+.+|++.+++++|+||+++++.+......++++||+.+
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999996543 57899999998765544 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcce
Q 022575 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (295)
Q Consensus 159 g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 238 (295)
++|.+++.... .++...+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 72 ~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~ 142 (244)
T smart00220 72 GDLFDLLKKRG----RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---L 142 (244)
T ss_pred CCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---c
Confidence 99999987653 2788899999999999999999987 9999999999999999999999999998654432 1
Q ss_pred eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.....++..|++||.+....++.++|+|+||+++++|++|.+||..
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2234688899999999888889999999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=218.19 Aligned_cols=196 Identities=21% Similarity=0.280 Sum_probs=159.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceee-EEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIG-YCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~-~~~~ 145 (295)
+.|.+.+.||+|.||.+.+| .++.+...+++|.+.+.. ....+|.+|...--.| .|.||+.-|+ .|++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 57999999999999999999 555678999999997664 3355778887655555 4899998876 5778
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc--CCCcEEEcc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSD 223 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~D 223 (295)
.+...+++||++.|+|.+-+...+ +-+.....++.|++.|+.|||+++ +||||||.+||||- +..++||||
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeee
Confidence 888899999999999998886643 677888999999999999999988 99999999999993 345899999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeecc---C--cccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---G--IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||..+....... ..--+..|.+||.... + ...+.+|+|.||++++..++|.+||..-
T Consensus 167 FG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 167 FGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred cccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 999987543321 1234667999998652 2 4458899999999999999999999743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=218.79 Aligned_cols=222 Identities=22% Similarity=0.245 Sum_probs=178.3
Q ss_pred ehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCcc
Q 022575 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLV 137 (295)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~ 137 (295)
...++.....++++..++.+|.||.||+|.|++. +.....+.|-+|.++....+ +...++.|.-.+..+.|||+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 4455566667889999999999999999988753 23334566777777654332 345678899999999999999
Q ss_pred ceeeEEEeC-CeeEEEEeccCCCCHHHHHhhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 138 KLIGYCLED-DHRLLVYEFMPKGSLENHLFRRA----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 138 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
.+.++..++ +..++++.+..-|+|..++...+ +..+.+...+...++.|++.||+|||.++ +||.||.++|++
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCv 428 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCV 428 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcce
Confidence 999988654 56788899999999999998432 22355677788889999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
|++..++||+|=.+++..-...........-....||+||.+....|+.++|+||||++||||++ |+.|+....
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 99999999999999987544433222223345778999999999999999999999999999999 888887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=207.74 Aligned_cols=201 Identities=20% Similarity=0.207 Sum_probs=172.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 146 (295)
-.|++.+.||+|+||+++.| .+.-+++.||||.-...... -++..|.+..+.| ..++|..+|-+..+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecc---------cccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 38999999999999999999 56667999999987655422 2445677777777 479999999888888
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-----CCcEEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAKL 221 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl 221 (295)
.+..||+|++ |.+|+|++.-++ ..|+...++.++.|++.-++|+|++. +|.|||||+|+||.. ...+.|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEE
Confidence 8999999999 999999998877 56899999999999999999999988 999999999999953 345899
Q ss_pred ccccCCCCCCCCCCcc-----eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+|+...+..... ...+..||.+||+-....+..-+.+.|+-|||.+++.++-|..||.+.
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 9999999766544322 234578999999999999999999999999999999999999999764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=215.61 Aligned_cols=165 Identities=21% Similarity=0.162 Sum_probs=126.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc-----chhhHHHHHHHHHHHcccCCCCccc-e
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-----SLQGHLEWLTEIKHLGQLYHPNLVK-L 139 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~h~ni~~-l 139 (295)
...+|.+.+.||+|+||+||+|.... .++..+|||.+... .......+.+|+++|.+++|+|++. +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~--------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAG--------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcC--------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 34689999999999999999996542 13677899986533 1123445789999999999999985 4
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecC-CCCCeEEcCCCc
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF-KTSNILLDLNYN 218 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~ 218 (295)
++ .+..|+||||++|++|.. +.. .. ...++.+++.+|.|||++| |+|||| ||+|||++.++.
T Consensus 88 ~~----~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 88 LA----TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred EE----cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCC
Confidence 43 245799999999999963 211 11 1456789999999999988 999999 999999999999
Q ss_pred EEEccccCCCCCCCCCCcce------eeccccccCccCceeec
Q 022575 219 AKLSDFGLAKDGPTGSQSHV------STRVMGTYGYAAPEYMA 255 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~ 255 (295)
+||+|||+|+.......... -....+++.|+|||.+.
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99999999986543321111 13457889999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=197.22 Aligned_cols=184 Identities=36% Similarity=0.525 Sum_probs=157.1
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEe
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYE 154 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e 154 (295)
||+|++|.||++... .+++.+++|.+...... ....+.+|++.+..++|++|+++++++......++++|
T Consensus 1 l~~g~~~~v~~~~~~---------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDK---------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEec---------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 689999999999554 25788999999876543 24567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CCcEEEccccCCCCCCCC
Q 022575 155 FMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTG 233 (295)
Q Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~~~~ 233 (295)
++.+++|.+++.... ..++...+..++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+......
T Consensus 72 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 72 YCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred cCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 999899999997653 34788899999999999999999987 999999999999999 899999999999865433
Q ss_pred CCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHH
Q 022575 234 SQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHF 275 (295)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el 275 (295)
.. ......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 147 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 147 KS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 21 12224578889999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=211.48 Aligned_cols=206 Identities=23% Similarity=0.278 Sum_probs=167.8
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceee
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~ 141 (295)
+....+.|.++++||+|.|++||++.... .....+.||+|.+....... +..+|++.|..+ -+.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~ts~p~--ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRTSSPS--RILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeecccccCch--HHHHHHHHHHHhccchhhhcchh
Confidence 44556789999999999999999996553 12357889999997765443 567899999988 5999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAK 220 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 220 (295)
++..+++..+||||+++....++... ++...+..++..++.||+++|.+| ||||||||.|+|.+.. +.-.
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCce
Confidence 99999999999999999999888743 567888999999999999999988 9999999999999754 5678
Q ss_pred EccccCCCCCC-----------------C--C-----------------------CCcceeeccccccCccCceeeccC-
Q 022575 221 LSDFGLAKDGP-----------------T--G-----------------------SQSHVSTRVMGTYGYAAPEYMATG- 257 (295)
Q Consensus 221 l~DFG~a~~~~-----------------~--~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~- 257 (295)
|+|||+|.... . + ..........||++|.|||++...
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999986110 0 0 000011235799999999998854
Q ss_pred cccccceeeehhHHHHHHhccCChhhee
Q 022575 258 IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 258 ~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..+.++||||.|++++.++++..||+..
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred CcCCccceeeccceeehhhccccccccC
Confidence 5578999999999999999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=196.45 Aligned_cols=203 Identities=22% Similarity=0.212 Sum_probs=169.0
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCL 144 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~ 144 (295)
...+|++++.||+|+||.+|+| .....|+.||||.-..... .-.+..|.++...|+ -..|..+..+..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeee---------eeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3468999999999999999999 4455799999998765432 224567888888886 467888888888
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCcEEE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKL 221 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl 221 (295)
+.++..+|||++ |.+|.+++.-.. ..++-..++.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~L 155 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYL 155 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEE
Confidence 999999999999 999999987654 45788899999999999999999988 999999999999853 456899
Q ss_pred ccccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+|+...+.... .......||..|.+-....+..-+.+.|+-|+|.+|..+-.|..||.+.
T Consensus 156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 999999976543321 2234568999999988888888899999999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=208.20 Aligned_cols=204 Identities=23% Similarity=0.189 Sum_probs=164.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC----CCccceeeEE-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH----PNLVKLIGYC- 143 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----~ni~~l~~~~- 143 (295)
+|++.+.||+|+||.||.+..... ....+|+|............+..|..++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~--------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE--------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC--------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999964421 146789998766533322245678888877762 6899999988
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-----Cc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-----YN 218 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-----~~ 218 (295)
......|+||+.+ |.+|.++..... ...++...+..++.|++.+|++||+.| ++||||||+|+++... ..
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~ 165 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRT 165 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccce
Confidence 4778899999999 999999886655 366899999999999999999999988 9999999999999754 46
Q ss_pred EEEccccCCC--CCCCCCCc-----ce-eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAK--DGPTGSQS-----HV-STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~--~~~~~~~~-----~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.|.|||+++ ........ .. ...+.||..|+++++..+...+++.|+||++.++.||+.|..||...
T Consensus 166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 9999999998 32222111 01 12356999999999999999999999999999999999999888543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=233.33 Aligned_cols=145 Identities=14% Similarity=0.094 Sum_probs=111.6
Q ss_pred CCccceeeEE-------EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecC
Q 022575 134 PNLVKLIGYC-------LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (295)
Q Consensus 134 ~ni~~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 206 (295)
.||.++++++ ...+.+++++|++ +++|.++|.... ..+++..++.++.||+.||.|||++| |+||||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDl 106 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNV 106 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCC--eeeccC
Confidence 5777777776 2334567888988 779999997543 45889999999999999999999988 999999
Q ss_pred CCCCeEEcCCC-------------------cEEEccccCCCCCCCCCC--------------cceeeccccccCccCcee
Q 022575 207 KTSNILLDLNY-------------------NAKLSDFGLAKDGPTGSQ--------------SHVSTRVMGTYGYAAPEY 253 (295)
Q Consensus 207 kp~Nill~~~~-------------------~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~ 253 (295)
||+||||+..+ .+||+|||+++....... ........||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996544 455666666553211000 000112468999999999
Q ss_pred eccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 254 MATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 254 ~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+.+..++.++|||||||+||||++|.+|+..
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 9999999999999999999999999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=185.04 Aligned_cols=173 Identities=12% Similarity=0.045 Sum_probs=132.5
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHH---H------HHHHHHHHcccCCC
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL---E------WLTEIKHLGQLYHP 134 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---~------~~~E~~~l~~l~h~ 134 (295)
.....+|++.++||.|+||.||++.. ++..+|+|.+......... . +.+|++.+.++.|+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~ 95 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE 95 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence 45678999999999999999998632 1456999999755432222 1 56899999999999
Q ss_pred CccceeeEEEeC--------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecC
Q 022575 135 NLVKLIGYCLED--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (295)
Q Consensus 135 ni~~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 206 (295)
+|..+.+++... +..+++|||++|.+|.++.. ++. ....+++.+|..+|+.| ++|||+
T Consensus 96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g--i~H~Di 161 (232)
T PRK10359 96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG--MVSGDP 161 (232)
T ss_pred CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC--CccCCC
Confidence 999999887644 35789999999999987631 222 24568899999999988 999999
Q ss_pred CCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHh
Q 022575 207 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFS 276 (295)
Q Consensus 207 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 276 (295)
||.||+++.++ ++|+|||........... ..++....|..++|+|+||+++..+.
T Consensus 162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999999888 999999988754221100 01334456778999999999987654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=191.40 Aligned_cols=202 Identities=33% Similarity=0.425 Sum_probs=167.7
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCC-CccceeeEEEe
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHP-NLVKLIGYCLE 145 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~-ni~~l~~~~~~ 145 (295)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 667789999999999999543 56899988766543 255678999999999988 79999999988
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DF 224 (295)
....+++++++.++++.+++...... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++..+ .++++||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEecc
Confidence 78889999999999999777654311 25788889999999999999999988 99999999999999988 7999999
Q ss_pred cCCCCCCCCCCcc----eeeccccccCccCceeecc---CcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSH----VSTRVMGTYGYAAPEYMAT---GIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|.+.......... ......||..|+|||.+.+ ..+....|+|++|+++++++.|..||....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998544332211 2345689999999999987 578899999999999999999999966543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=176.97 Aligned_cols=139 Identities=17% Similarity=0.182 Sum_probs=106.1
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--h------------------------HHHHHHHHH
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--G------------------------HLEWLTEIK 126 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~E~~ 126 (295)
...||+|+||.||+|.. . +|+.||+|+++..... . .....+|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~---------~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATT---------A-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEEC---------C-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 46899999999999943 2 5899999998654211 0 012235999
Q ss_pred HHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeEeec
Q 022575 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVIYRD 205 (295)
Q Consensus 127 ~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ivHrD 205 (295)
.+.++.++++........ ...+|||||++++++....... ..++...+..++.|++.+|.++ |+.| |+|||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrD 143 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDCR--LVHAD 143 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCC
Confidence 999998877754433322 2248999999887776543332 3478888999999999999999 6877 99999
Q ss_pred CCCCCeEEcCCCcEEEccccCCCCC
Q 022575 206 FKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 206 lkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
|||+|||++ ++.++|+|||+|...
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCHHHEEEE-CCcEEEEEccccccC
Confidence 999999998 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=169.86 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=108.1
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---------------------h-----HHHHHHHHH
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------------------G-----HLEWLTEIK 126 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~E~~ 126 (295)
.+.||+|+||.||+|... +|+.||||++...... . ......|.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05145 2 NGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR 71 (190)
T ss_pred CceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH
Confidence 478999999999999532 5899999998754210 0 112357889
Q ss_pred HHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeec
Q 022575 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRD 205 (295)
Q Consensus 127 ~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrD 205 (295)
.+.++.|+++.....+.... .+|||||++++++....... ..++......++.|++.+|.++|+ +| |+|||
T Consensus 72 ~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrD 143 (190)
T cd05145 72 NLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGD 143 (190)
T ss_pred HHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCC
Confidence 99999999886554443332 48999999887554432222 236677889999999999999999 88 99999
Q ss_pred CCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 206 FKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 206 lkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
|||+|||++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999998 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=166.43 Aligned_cols=136 Identities=18% Similarity=0.165 Sum_probs=104.5
Q ss_pred CCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-----CCCCccceeeEEEeC
Q 022575 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-----YHPNLVKLIGYCLED 146 (295)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~l~~~~~~~ 146 (295)
-.+.||+|+||.||. .. .++.. +||++..........+.+|+.++..+ +||||++++++++++
T Consensus 6 ~~~~LG~G~~~~Vy~---hp--------~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 6 EQSPLGTGRHRKCYA---HP--------EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CcceecCCCceEEEE---CC--------CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 357899999999995 11 12444 68988765444556788999999999 579999999999987
Q ss_pred C---eeE-EEEec--cCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCeEeecCCCCCeEEcC----
Q 022575 147 D---HRL-LVYEF--MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL-AYLHSDKAKVIYRDFKTSNILLDL---- 215 (295)
Q Consensus 147 ~---~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l-~~lH~~~~~ivHrDlkp~Nill~~---- 215 (295)
. ..+ +|+|| +.+++|.+++.+.. +++. ..++.+++.++ +|||+++ |+||||||+|||++.
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISES 144 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCC
Confidence 3 434 78999 55799999996532 4444 35577888777 8999988 999999999999964
Q ss_pred CCcEEEccccCCC
Q 022575 216 NYNAKLSDFGLAK 228 (295)
Q Consensus 216 ~~~~kl~DFG~a~ 228 (295)
+..++|+||+.+.
T Consensus 145 ~~~~~LiDg~G~~ 157 (210)
T PRK10345 145 EVIPVVCDNIGES 157 (210)
T ss_pred CCcEEEEECCCCc
Confidence 3479999954444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=165.71 Aligned_cols=187 Identities=18% Similarity=0.090 Sum_probs=137.0
Q ss_pred CCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh----HHHHHHHHHHHcccC-CCCccceeeEEEe
Q 022575 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----HLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (295)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~-h~ni~~l~~~~~~ 145 (295)
-+...|++|+||+|+.+.- .+..++.+.+....... ...+.+|+++|.+|. |+++++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3457899999999997632 36778877776554311 224678999999995 5889999886
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecC-CCCCeEEcCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF-KTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~kl~DF 224 (295)
+..+++|||+.|.+|.+.+.. ....++.|++.+|+++|++| |+|||| ||+|||++.++.++|+||
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEEC
Confidence 446999999999998654321 11346788999999999988 999999 799999999999999999
Q ss_pred cCCCCCCCCCCc----ce-------eeccccccCccCceeecc-Cccc-ccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQS----HV-------STRVMGTYGYAAPEYMAT-GIFQ-LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~-~~~~-~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|......... .. ......++.|++|+.-.. ...+ .+.+.++.|+-+|.++||..|+...
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999854332210 00 001135777888865332 1334 6789999999999999998877653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-24 Score=169.26 Aligned_cols=107 Identities=21% Similarity=0.102 Sum_probs=93.9
Q ss_pred CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcce
Q 022575 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (295)
Q Consensus 159 g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 238 (295)
|+|.+++..++ ..+++..+..++.|++.||.|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997654 45899999999999999999999864 999999999999999 99987643221
Q ss_pred eeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..||+.|||||++.+..++.++|||||||++|||++|.+||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25899999999999999999999999999999999999998654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=201.38 Aligned_cols=199 Identities=18% Similarity=0.192 Sum_probs=158.7
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC---CCCccceee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIG 141 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~ 141 (295)
.....|.+.+.||+|+||+||+|... . ++.||+|+-+.......- -=.+++.+|+ -+.|..+..
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~---------~-~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHS---------N-GKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecC---------C-CcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHH
Confidence 44567888899999999999999433 2 899999998776543210 0111222222 345667777
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-------
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD------- 214 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~------- 214 (295)
.+...+..+||+||.+.|+|.+++... ..+++..++.+..|++.-++.||..+ |||+||||+|+||.
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCC
Confidence 777788889999999999999999844 45889999999999999999999988 99999999999993
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChh
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMC 282 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf 282 (295)
....++|+|||.+..+..-.........++|-.+-++|+..+..|+..+|.|.|+.+++-|+.|+..-
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 24568999999998655444444556678899999999999999999999999999999999988543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-25 Score=201.25 Aligned_cols=203 Identities=23% Similarity=0.231 Sum_probs=153.7
Q ss_pred CCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEc-CccchhhHH-HHHHHHHHHcccCCCCccceeeEEEeCCe
Q 022575 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHL-EWLTEIKHLGQLYHPNLVKLIGYCLEDDH 148 (295)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~-~~~~~~~~~-~~~~E~~~l~~l~h~ni~~l~~~~~~~~~ 148 (295)
....++|.|++|.|+.+..... ......+.+++| . ......... .+..|+.+-..+.|||++..+..+.+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~----~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD----LKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred CccceeeecccCceEEEEecCC----Cccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4668899999997776643221 111112222322 1 111111111 25567777888999999888777666665
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
..-.||||++ +|..++.... .+....+..++.|++.|++|||+.| |.||||||+|+++..++.+||+|||.+.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred chhhhhcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcce
Confidence 5556999998 9999997752 3667788899999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCCc--ceeeccccccCccCceeeccCcccc-cceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQS--HVSTRVMGTYGYAAPEYMATGIFQL-VLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+...... .....++|+..|+|||++....|.+ ..||||.|++++.|.+|+.||..-
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 65444333 4556688999999999999999984 689999999999999999888654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-25 Score=197.05 Aligned_cols=190 Identities=27% Similarity=0.288 Sum_probs=158.4
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHH--HHHHHHHHHcccC-CCCccceeeEEEeCCeeEE
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~l 151 (295)
++|+|+||.|++++- ......+..+|+|.+++....... ....|..++..++ ||.+++++-.++.+...++
T Consensus 1 vlg~g~~gkvfLvrk------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 479999999998732 133446788899988776543221 3456788888886 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
++++..+|.|...+.+.. .+.+.....+...++.+++++|+.+ |+|||+|++||+++.+|++++.|||+++...
T Consensus 75 ~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhH
Confidence 999999999998887653 3666777788888999999999987 9999999999999999999999999998754
Q ss_pred CCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 232 TGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.... .|||..|||||++. ....++|.||||++++||++|..||..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 3321 28999999999988 456789999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-21 Score=157.38 Aligned_cols=148 Identities=18% Similarity=0.172 Sum_probs=110.2
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------------------------hHHH
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------------------------GHLE 120 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~ 120 (295)
.....|.+.+.||+|+||.||+|.. +..+|+.||+|.+...... ....
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLW 96 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHH
Confidence 3345689999999999999999951 2235889999998654210 0123
Q ss_pred HHHHHHHHcccCCC--CccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022575 121 WLTEIKHLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK 198 (295)
Q Consensus 121 ~~~E~~~l~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 198 (295)
+..|+..+.++.+. .++++++. ...++||||+.+.+|....... .......+..++.|++.+|++||++|
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 45799999999753 34444432 2358999999888887654332 22445566789999999999999853
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
+++||||||+||+++ ++.++|+|||.+...
T Consensus 169 -~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 -ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 399999999999999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=154.19 Aligned_cols=134 Identities=18% Similarity=0.248 Sum_probs=111.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--------hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+.||+|++|.||+|... +..+++|........ ...++.+|++++..+.|+++.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 57999999999999653 567889976543211 12346789999999999998887777777
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..+++|||++|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECC
Confidence 788899999999999999886432 1 66788999999999999988 99999999999999 7899999999
Q ss_pred CCCC
Q 022575 226 LAKD 229 (295)
Q Consensus 226 ~a~~ 229 (295)
.+..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 9875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-22 Score=161.82 Aligned_cols=200 Identities=20% Similarity=0.269 Sum_probs=154.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH--HHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+..+..+|.+...|..|+|++.. ..+++|++.......+ ..|..|.-.|+.+.||||+.+++.+..+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred hhhhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 44555678888999999999884 3467787765544332 3577888899999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..+.++..|++.|+|+..+....+ ..+...++.+++.+++.|++|||+..+-|.---|....++||++.+.+|.- +-
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad 336 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-AD 336 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-cc
Confidence 999999999999999999987644 235667889999999999999999754344446889999999998887751 11
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCccc---ccceeeehhHHHHHHhccCChhheeeee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ---LVLLLFTFECSLLHFSLQLPMCVLYLTY 288 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Di~slG~~l~el~~g~~pf~~~~~~ 288 (295)
++. +.......-.|.||+||.+....-+ .++|+|||++++|||.|+..||......
T Consensus 337 ~kf------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm 395 (448)
T KOG0195|consen 337 TKF------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM 395 (448)
T ss_pred cee------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence 111 0011112347889999999865433 6899999999999999999999876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-22 Score=185.93 Aligned_cols=166 Identities=24% Similarity=0.313 Sum_probs=124.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|..++.|..|+||.||.+ +++.+.+.+|+ .+.+.++-.+ + ++.....|.++
T Consensus 83 ~df~~IklisngAygavylv---------rh~~trqrfa~-kiNkq~lilR----n---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLV---------RHKETRQRFAM-KINKQNLILR----N---ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeee---------eccccccchhh-cccccchhhh----c---cccccCCccee----------
Confidence 58889999999999999998 45556788898 4444332211 1 22333333333
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
|+-...++..+. ++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||++
T Consensus 136 -----------gDc~tllk~~g~----lPvd--------mvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGP----LPVD--------MVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred -----------chhhhhcccCCC----Ccch--------hhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhh
Confidence 555555654432 3222 256899999987 999999999999999999999999998
Q ss_pred CCCCCCCC-------------cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQ-------------SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .......+|||.|+|||++....|...+|+|++|+++||++.|..||++.
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 75321110 11234569999999999999999999999999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=151.25 Aligned_cols=131 Identities=19% Similarity=0.274 Sum_probs=105.1
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--------hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.||+|+||.||+|.+. +..+++|....... ....++.+|++++..+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 4799999999999643 56789998543321 1124567899999999988766655566667
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..+++|||++|++|.+.+.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCC
Confidence 77899999999999998875431 067889999999999988 99999999999999 88999999999
Q ss_pred CCCC
Q 022575 227 AKDG 230 (295)
Q Consensus 227 a~~~ 230 (295)
+...
T Consensus 136 a~~~ 139 (199)
T TIGR03724 136 GKYS 139 (199)
T ss_pred CcCC
Confidence 8763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=173.01 Aligned_cols=137 Identities=21% Similarity=0.241 Sum_probs=109.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEc-Ccc-c---h---hhHHHHHHHHHHHcccCCCCccce
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQE-S---L---QGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~-~~~-~---~---~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
..|...+.||+|+||.||++.+.. ..+++|.. .+. . . ....++.+|++++..++|++++..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 456778999999999999986653 22333322 111 1 1 112457789999999999999988
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
..++...+..++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.+
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcE
Confidence 877777778899999999999998874 23567899999999999988 9999999999999 67899
Q ss_pred EEccccCCCCC
Q 022575 220 KLSDFGLAKDG 230 (295)
Q Consensus 220 kl~DFG~a~~~ 230 (295)
+|+|||+++..
T Consensus 467 ~liDFGla~~~ 477 (535)
T PRK09605 467 YLIDFGLGKYS 477 (535)
T ss_pred EEEeCcccccC
Confidence 99999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=149.46 Aligned_cols=143 Identities=17% Similarity=0.090 Sum_probs=108.1
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh----------------------hHHH
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------------------GHLE 120 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~ 120 (295)
+......|.+.+.||+|+||.||++... +++.||||++...... ....
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLA 79 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHH
Confidence 3344445888999999999999999532 4889999986543200 0112
Q ss_pred HHHHHHHHcccCCCC--ccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 022575 121 WLTEIKHLGQLYHPN--LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK 198 (295)
Q Consensus 121 ~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 198 (295)
...|..++..+.|++ ++..++ ....+++|||+++++|...... .....++.+++.++.++|+.+
T Consensus 80 ~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g 145 (198)
T cd05144 80 AQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG 145 (198)
T ss_pred HHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC
Confidence 457888888887774 444443 2456899999999998765421 234567889999999999987
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
|+||||||+||++++++.++|+|||.+....
T Consensus 146 --i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 146 --IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred --CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=156.60 Aligned_cols=201 Identities=19% Similarity=0.205 Sum_probs=126.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCC----------CC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYH----------PN 135 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~n 135 (295)
.+...+.||.|+++.||.+ .+..+++.+|+|....... ...+++.+|......+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v---------~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEV---------TDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEE---------EEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 4455688999999999999 4556899999998754332 223344445433333221 12
Q ss_pred ccceeeEEE---------eC---C-----eeEEEEeccCCCCHHHHHhh---ccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 022575 136 LVKLIGYCL---------ED---D-----HRLLVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLAYLH 195 (295)
Q Consensus 136 i~~l~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lH 195 (295)
++--++... .. . ..+++|+-+ .++|.+++.. .......+.....+.+..|++..+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 222222221 11 1 236778877 6788888653 2211111223334566789999999999
Q ss_pred cCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc--------Ccccccceeee
Q 022575 196 SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--------GIFQLVLLLFT 267 (295)
Q Consensus 196 ~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~s 267 (295)
..| +||+||||+|++++.+|.++|+||+........ ......+..|.+||.... -.++.+.|.|+
T Consensus 163 ~~G--lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 SYG--LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp HTT--EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred hcc--eEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 988 999999999999999999999999887653221 111234677999997643 25789999999
Q ss_pred hhHHHHHHhccCChhheee
Q 022575 268 FECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 268 lG~~l~el~~g~~pf~~~~ 286 (295)
||+++|.|.++..||....
T Consensus 236 LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp HHHHHHHHHHSS-STCCCG
T ss_pred HHHHHHHHHHccCCCCCCC
Confidence 9999999999999998653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-21 Score=182.63 Aligned_cols=198 Identities=23% Similarity=0.232 Sum_probs=151.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
+|...+.||++.|=+|.+|+.++ |. |+||++-+... ....+.+.|++ ...++|||++.+..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57778899999999999996653 44 89998865542 22333345555 55668999999988877
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.+...|||-+|. ..+|+|.|..+. -+...+.+-|+.|++.||.-+|..| |+|+|||.+||||+..+-+.|+||
T Consensus 92 t~kAAylvRqyv-khnLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 92 TDKAAYLVRQYV-KHNLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred hhHHHHHHHHHH-hhhhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcc
Confidence 778889999999 569999987652 2455566778899999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcce-----eeccccccCccCceeeccC----------c-ccccceeeehhHHHHHHhc-cCChhhee
Q 022575 225 GLAKDGPTGSQSHV-----STRVMGTYGYAAPEYMATG----------I-FQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~----------~-~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
..-+......+... ..+...-.+|+|||-+-.. . .+++-||||+||++.||++ |.|||...
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 88775433322211 1112234569999986531 2 5688999999999999999 79999754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-18 Score=140.84 Aligned_cols=135 Identities=23% Similarity=0.230 Sum_probs=102.1
Q ss_pred Ceee-ccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-------------hhHHHHHHHHHHHcccCCCCc--c
Q 022575 74 SVLG-EGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYHPNL--V 137 (295)
Q Consensus 74 ~~lg-~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni--~ 137 (295)
..|| .|+.|+||.+... +..+++|....... ....++.+|++++..|.|++| +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 5677 7888889887543 56788887754221 122356789999999998775 6
Q ss_pred ceeeEEEeCC----eeEEEEeccCC-CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 138 KLIGYCLEDD----HRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 138 ~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
+.+++..... ..++|||+++| .+|.+++... .++.. .+.+++.+|.+||++| |+||||||+|||
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NIL 174 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNIL 174 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEE
Confidence 7776644332 23599999987 6999887542 24433 3567899999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCC
Q 022575 213 LDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~ 230 (295)
++.++.++|+|||.+...
T Consensus 175 v~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 175 LDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EcCCCCEEEEECCCcccC
Confidence 999899999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=137.03 Aligned_cols=135 Identities=20% Similarity=0.184 Sum_probs=94.3
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHH----------------------HHHHHHHH
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLE----------------------WLTEIKHL 128 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~E~~~l 128 (295)
.+.||+|+||.||+|... +++.||||++...... .... ...|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence 468999999999999532 4788999987653211 1111 12455555
Q ss_pred cccCCC--CccceeeEEEeCCeeEEEEeccCCCCHHHH-HhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEee
Q 022575 129 GQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENH-LFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYR 204 (295)
Q Consensus 129 ~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHr 204 (295)
..+.+. .+.+.++. ...+++|||++++++... +.... . ......++.+++.++.++|. .+ |+|+
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~ 139 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAG--LVHG 139 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccC--cCcC
Confidence 555433 24444443 246899999988543221 11111 0 14567889999999999999 77 9999
Q ss_pred cCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 205 DFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 205 Dlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
||||+||+++ ++.++|+|||.+...
T Consensus 140 Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 140 DLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCChhhEEEE-CCcEEEEECcccccc
Confidence 9999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.7e-20 Score=159.52 Aligned_cols=124 Identities=23% Similarity=0.331 Sum_probs=105.4
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
++|+.|++|...+|.++|.++.. ....++...+.++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999975542 2445778889999999999999 66 999999999999999999999999998
Q ss_pred CCCCCCCC----cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc
Q 022575 228 KDGPTGSQ----SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 228 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 277 (295)
........ ....+...||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 76544331 111234579999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=127.65 Aligned_cols=134 Identities=19% Similarity=0.095 Sum_probs=109.0
Q ss_pred CCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC--CCccceeeEEEeCCee
Q 022575 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLEDDHR 149 (295)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~ 149 (295)
+.+.||+|.++.||++... +..+++|....... ...+.+|+..+..+.| .++++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 3567999999999999643 35689999866543 4456789999999976 5899999988888889
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeEeecCCCCCeEEcCCCcEEEccccCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK-AKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
+++|||++++.+..+ +......++.+++.+|+++|... .+++|+|++|+||+++..+.++++|||.+.
T Consensus 69 ~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 69 YLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred EEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 999999988777543 33455677889999999999742 249999999999999998999999999987
Q ss_pred C
Q 022575 229 D 229 (295)
Q Consensus 229 ~ 229 (295)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 5
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-18 Score=145.06 Aligned_cols=145 Identities=19% Similarity=0.201 Sum_probs=111.4
Q ss_pred CCCCccceeeEEEeC---------------------------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHH
Q 022575 132 YHPNLVKLIGYCLED---------------------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184 (295)
Q Consensus 132 ~h~ni~~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 184 (295)
+||||++++++|.+. ..+|+||.-+ ..+|..++..+. .+......++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence 599999999988642 3568999988 569999997653 4566677889
Q ss_pred HHHHHHHHHhhcCCCCeEeecCCCCCeEE--cCC--CcEEEccccCCCCCCCCCC----cceeeccccccCccCceeecc
Q 022575 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLN--YNAKLSDFGLAKDGPTGSQ----SHVSTRVMGTYGYAAPEYMAT 256 (295)
Q Consensus 185 ~~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~--~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~ 256 (295)
.|++.|+.|||.+| |.|||+|.+|||+ ++| -.+.|+|||+|-......- ....-...|...-||||+...
T Consensus 348 aQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999998 9999999999999 333 3478999999854222100 011122467888999999763
Q ss_pred C-----ccc-ccceeeehhHHHHHHhccCChhhe
Q 022575 257 G-----IFQ-LVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 257 ~-----~~~-~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
. ..+ .++|.|+.|.+.||++...-||+.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 2 222 589999999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-19 Score=165.16 Aligned_cols=208 Identities=21% Similarity=0.184 Sum_probs=162.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccC-CCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~ 145 (295)
.|.+.+.||+|+|+.|-.+... ......+|.|.+.... .........|..+-..+. |.|++++++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~--------~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNS--------RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhc--------CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 6777788999999998766322 2235567777765543 111222335666666676 9999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHh-hccCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCeEeecCCCCCeEEcCCC-cEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLF-RRASYIQPLSWTIRMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNY-NAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~ivHrDlkp~Nill~~~~-~~kl~ 222 (295)
.+..+++++|..++++.+.+. ... ...+......++.|+..++.|+| ..+ +.|||+||+|.+++..+ .++++
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred CcccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCC
Confidence 999999999999999999883 332 23555667788999999999999 766 99999999999999999 99999
Q ss_pred cccCCCCCCC-CCCcceeecccc-ccCccCceeeccC-cccccceeeehhHHHHHHhccCChhheeeeee
Q 022575 223 DFGLAKDGPT-GSQSHVSTRVMG-TYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLYLTYA 289 (295)
Q Consensus 223 DFG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 289 (295)
|||+|..... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.......
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 9999987655 333333445678 9999999999874 55688999999999999999999987765443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.7e-18 Score=149.33 Aligned_cols=154 Identities=25% Similarity=0.339 Sum_probs=126.4
Q ss_pred HcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC
Q 022575 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK 207 (295)
Q Consensus 128 l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 207 (295)
|+.+.|.|+.++++.+.+....++|.+||..|+|.+.+.... ..+++.....++.+|+.||.|||..- -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeec
Confidence 457889999999999999999999999999999999998744 56888889999999999999999864 23999999
Q ss_pred CCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC---c----ccccceeeehhHHHHHHhccCC
Q 022575 208 TSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG---I----FQLVLLLFTFECSLLHFSLQLP 280 (295)
Q Consensus 208 p~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~Di~slG~~l~el~~g~~ 280 (295)
..|++++....+||+|||+.................-..-|.|||.+... . .+.+.|+||||++++|+++++-
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321111111111234569999998753 1 4678999999999999999999
Q ss_pred hhhee
Q 022575 281 MCVLY 285 (295)
Q Consensus 281 pf~~~ 285 (295)
||...
T Consensus 157 ~~~~~ 161 (484)
T KOG1023|consen 157 PFDLR 161 (484)
T ss_pred ccccc
Confidence 99764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=135.96 Aligned_cols=202 Identities=24% Similarity=0.238 Sum_probs=156.9
Q ss_pred CCCCCCCeeec--cCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCc--cchhhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 68 RNFRPDSVLGE--GGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~--G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
..|.+.+.+|. |.+|.||.+... ....+..+|+|.-+. .......+-.+|+...+++ .|+|.++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~-------~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCT-------NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhcccccccccCCCCCceeecccCC-------cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 46777889999 999999998542 144678889887332 2222333335677777777 49999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCeEeecCCCCCeEEcCC-C
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----GLAYLHSDKAKVIYRDFKTSNILLDLN-Y 217 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~----~l~~lH~~~~~ivHrDlkp~Nill~~~-~ 217 (295)
++..+..++-+|+| +.+|..+..... ..++...++..+.+... ||.++|+.+ ++|-|+||+||++..+ .
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccc
Confidence 99999999999999 678888776554 33666777888888888 999999987 9999999999999998 8
Q ss_pred cEEEccccCCCCCCCCCCcc---eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 218 NAKLSDFGLAKDGPTGSQSH---VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
.++++|||+...+....... ......|...|++||.+. +.++..+|++++|.++.+..++.-++.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 89999999998765544221 112235778899999765 678899999999999999999875443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=135.01 Aligned_cols=141 Identities=19% Similarity=0.161 Sum_probs=94.9
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-----------------------------------
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG----------------------------------- 117 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------- 117 (295)
.+.||+|++|.||+|.+. +|+.||||+..+.-...
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 368999999999999765 37899999986542110
Q ss_pred -----HHHHHHHHHHHcccC----CCCccceeeEE-EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 022575 118 -----HLEWLTEIKHLGQLY----HPNLVKLIGYC-LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187 (295)
Q Consensus 118 -----~~~~~~E~~~l~~l~----h~ni~~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i 187 (295)
...+.+|.+.+.++. |.+-+.+-.++ ......+|||||++|++|.+....... ... ...++..+
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~ 265 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENL 265 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHH
Confidence 012344555555442 22222222222 223457899999999999887653221 122 23344444
Q ss_pred HH-HHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 188 AK-GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 188 ~~-~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
+. .+..+|..| ++|+|+||.||+++.++.++|+|||++....
T Consensus 266 ~~~~l~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 266 ARSFLNQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 44 467888877 9999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-15 Score=136.39 Aligned_cols=146 Identities=16% Similarity=0.134 Sum_probs=93.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh------------------------------
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------------------------------ 117 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------ 117 (295)
.+|.. +.||+|++|.||+|++.+ +|+.||||++.+.-...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45665 789999999999997653 48899999997542100
Q ss_pred ----------HHHHHHHHHHHcccC----CCCccceeeEEE-eCCeeEEEEeccCCCCHHHHH--hhccCCCCCCCHHHH
Q 022575 118 ----------HLEWLTEIKHLGQLY----HPNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHL--FRRASYIQPLSWTIR 180 (295)
Q Consensus 118 ----------~~~~~~E~~~l~~l~----h~ni~~l~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~ 180 (295)
...+.+|+..+.+++ +.+.+.+-.++. .....+|||||+.|+.+.++- ...+.....+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 012334444444442 333333322222 234567999999999998743 222211112333333
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC----cEEEccccCCCCCCC
Q 022575 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY----NAKLSDFGLAKDGPT 232 (295)
Q Consensus 181 ~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~kl~DFG~a~~~~~ 232 (295)
..++.|+. ..| ++|+|+||.||+++.++ .++++|||++.....
T Consensus 270 ~~~~~Qif-------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF-------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH-------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 44444443 456 99999999999999888 999999999986543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.6e-14 Score=110.04 Aligned_cols=129 Identities=19% Similarity=0.105 Sum_probs=92.9
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCc-cceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv 152 (295)
+.|+.|.++.||++... +..+++|....... ....+.+|+..+..+.+.++ .+++.+. ....++|
T Consensus 4 ~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv 69 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI 69 (170)
T ss_pred eecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence 56788999999998543 66799998765432 12234578888888765443 4555543 3345899
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC---CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA---KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
|||++|.++.+. . . ....++.+++.+|..||+.+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 70 ~e~i~G~~l~~~---~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 70 TEFIEGSELLTE---D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEecCCCccccc---c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999999887542 0 0 112346788899999998751 259999999999999 67899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.4e-13 Score=124.02 Aligned_cols=168 Identities=15% Similarity=0.141 Sum_probs=124.6
Q ss_pred CCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCC
Q 022575 97 ARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176 (295)
Q Consensus 97 ~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 176 (295)
..+.++.+|.|...+...........+-+..|+.++||||+++++.++.++..|||+|-+. .|..++.+.+
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------- 102 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------- 102 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------
Confidence 3444677888888776654223345577889999999999999999999999999999883 7777776543
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc
Q 022575 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT 256 (295)
Q Consensus 177 ~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 256 (295)
...+.--+.||+.||.|||+. .+++|++|.-..|+++..|..||++|-++........ ......--..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 455566688999999999865 4599999999999999999999999988765322211 0111111223556654432
Q ss_pred CcccccceeeehhHHHHHHhcc
Q 022575 257 GIFQLVLLLFTFECSLLHFSLQ 278 (295)
Q Consensus 257 ~~~~~~~Di~slG~~l~el~~g 278 (295)
.. ...|.|.|||+++|++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.1e-13 Score=106.76 Aligned_cols=143 Identities=11% Similarity=0.081 Sum_probs=97.3
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---------------h------h-H----HHHHHHHH
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---------------Q------G-H----LEWLTEIK 126 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------------~------~-~----~~~~~E~~ 126 (295)
...||.|.-+.||.|.-.... .....+..+|||+.+.... . . . ....+|.+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 357899999999999533110 0011357899997642110 0 0 1 12347999
Q ss_pred HHcccC--CCCccceeeEEEeCCeeEEEEeccCCCCHHH-HHhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeE
Q 022575 127 HLGQLY--HPNLVKLIGYCLEDDHRLLVYEFMPKGSLEN-HLFRRASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVI 202 (295)
Q Consensus 127 ~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~iv 202 (295)
.|.++. .-++++++++ ...+|||||+.+..+.. .+.. ..++......+..+++.+|..| |..| +|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lV 147 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN--LV 147 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 998885 3567777764 45689999996643322 2221 1234455667788999999988 8877 99
Q ss_pred eecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 203 YRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 203 HrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
|+||++.|||++ ++.+.|+|||.+...
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999999997 568999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.6e-14 Score=118.54 Aligned_cols=155 Identities=23% Similarity=0.284 Sum_probs=119.3
Q ss_pred HHHHcccCCCCccceeeEEEeCC-----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022575 125 IKHLGQLYHPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA 199 (295)
Q Consensus 125 ~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 199 (295)
...|.++.|.||++++.+|.+.. ...++.||++.|+|.++|++.+.....+......+|+.||+.||.|||+..+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34556677999999999997654 4688999999999999999876655667788889999999999999999999
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCCCCC--CCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT--GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 277 (295)
+|+|+++..+.|++..++-+|+.--........ ...........+-++|.|||.-.....+.++|||+||...+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999998888752111100000 000000111245788999998776677789999999999999987
Q ss_pred cC
Q 022575 278 QL 279 (295)
Q Consensus 278 g~ 279 (295)
+.
T Consensus 278 lE 279 (458)
T KOG1266|consen 278 LE 279 (458)
T ss_pred he
Confidence 65
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.9e-12 Score=98.85 Aligned_cols=132 Identities=20% Similarity=0.251 Sum_probs=96.7
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----h---hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----Q---GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
..+++|+-+.++.+.+. +..+++|.-.++.. . ...+..+|++++.+++--.|..-.=+..+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 45788999999988543 44567775433221 1 12345789999998875555555555566
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+...|+|||++|..|.+.+... ...++..+-.-+.-||..| |||+||.+.||++..+ .+.++|||
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~-~i~~IDfG 136 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG-RIYFIDFG 136 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC-cEEEEECC
Confidence 77788999999998888888654 1345556666688899988 9999999999999766 49999999
Q ss_pred CCCCC
Q 022575 226 LAKDG 230 (295)
Q Consensus 226 ~a~~~ 230 (295)
++...
T Consensus 137 Lg~~s 141 (204)
T COG3642 137 LGEFS 141 (204)
T ss_pred ccccc
Confidence 99753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-14 Score=130.75 Aligned_cols=205 Identities=19% Similarity=0.142 Sum_probs=145.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
+.+.+.+-+-+|+++.++.+ ....++...++|.......- +......+-.++....+|.++...-.+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 35666777888999998876 34445555555554333211 1112223333333344566666655555
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.....+|+++|+.+++|...++..+ ..+..-...+...+.+++++||+.. ++|||++|.|+|+..++..++.||
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~ 948 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDF 948 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcc
Confidence 6677899999999999999987764 2344445556677888999999876 899999999999999999999999
Q ss_pred cCCCCCCCC--------CC---------------------cceeeccccccCccCceeeccCcccccceeeehhHHHHHH
Q 022575 225 GLAKDGPTG--------SQ---------------------SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275 (295)
Q Consensus 225 G~a~~~~~~--------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 275 (295)
|........ .. ........||+.|.+||.+.+..-...+|+|++|++++|.
T Consensus 949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen 949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence 844321110 00 0012235789999999999999889999999999999999
Q ss_pred hccCChhheeee
Q 022575 276 SLQLPMCVLYLT 287 (295)
Q Consensus 276 ~~g~~pf~~~~~ 287 (295)
++|.|||-....
T Consensus 1029 l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1029 LTGIPPFNAETP 1040 (1205)
T ss_pred hcCCCCCCCcch
Confidence 999999976543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.3e-12 Score=96.30 Aligned_cols=144 Identities=17% Similarity=0.171 Sum_probs=105.1
Q ss_pred CCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----h---hHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----Q---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~---~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....|-+|+-+.|+++.+. |+.++||.-..+.. . ...+..+|++.|.++.--.|.--.-++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 4567889999999998665 77778885433321 1 234567899999888655555444466
Q ss_pred EeCCeeEEEEeccCC-CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---cE
Q 022575 144 LEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NA 219 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 219 (295)
.+...-.|+|||++| .++.+++..... .+........++..|-..+.-||..+ |+|+||..+||++..++ .+
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~ 155 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITP 155 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCce
Confidence 667777899999965 488898887643 22222333677888888999999988 99999999999996554 35
Q ss_pred EEccccCCCCC
Q 022575 220 KLSDFGLAKDG 230 (295)
Q Consensus 220 kl~DFG~a~~~ 230 (295)
.++|||++...
T Consensus 156 ~lIdfgls~~s 166 (229)
T KOG3087|consen 156 ILIDFGLSSVS 166 (229)
T ss_pred EEEeecchhcc
Confidence 89999998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-13 Score=121.48 Aligned_cols=196 Identities=21% Similarity=0.142 Sum_probs=148.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..+|..+..||.|.|+.|+.+..+ ...+..+++|.+....... ...-..|+.+...+ .|.+++.++..|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r--------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKR--------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeec--------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 357888899999999999987533 2347788999876554322 22234566666555 489999999888
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcEEEc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLS 222 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~ 222 (295)
......|+-.|||+++++...+.-. ..+.+...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcc
Confidence 8888889999999999888776322 44677788899999999999999977 9999999999999876 778999
Q ss_pred cccCCCCCCCCCCcceeeccccccCcc--CceeeccCcccccceeeehhHHHHHHhccCCh
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYA--APEYMATGIFQLVLLLFTFECSLLHFSLQLPM 281 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 281 (295)
|||+.+.+.... ..+.+.-+++ +++......+..+.|++|||..+.+.+++.+.
T Consensus 410 ~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 410 DFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 999987532211 1122333344 55555666788999999999999999998863
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.2e-11 Score=99.75 Aligned_cols=141 Identities=22% Similarity=0.239 Sum_probs=99.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCC--CCccceeeEEEeC---C
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYH--PNLVKLIGYCLED---D 147 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~---~ 147 (295)
+.|+.|..+.||++...+ |..+++|....... .....+.+|.+++..+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 568899999999985431 56799998765432 123456789999988865 4567777776553 2
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------------------------------ 197 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------------------------------ 197 (295)
..++||||++|.++.+.+.. ..++......++.+++..|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA 148 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence 56899999999888765421 1234444555555666666666531
Q ss_pred ------------------------CCCeEeecCCCCCeEEcC--CCcEEEccccCCCC
Q 022575 198 ------------------------KAKVIYRDFKTSNILLDL--NYNAKLSDFGLAKD 229 (295)
Q Consensus 198 ------------------------~~~ivHrDlkp~Nill~~--~~~~kl~DFG~a~~ 229 (295)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999988 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=4e-10 Score=94.51 Aligned_cols=124 Identities=16% Similarity=0.126 Sum_probs=88.4
Q ss_pred CcEEEEEEcCccchhh-----------HHHHHHHHHHHcccCCCC--ccceeeEEEe-----CCeeEEEEeccCCC-CHH
Q 022575 102 GMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPN--LVKLIGYCLE-----DDHRLLVYEFMPKG-SLE 162 (295)
Q Consensus 102 ~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~n--i~~l~~~~~~-----~~~~~lv~e~~~~g-~L~ 162 (295)
|+.+.||......... ...+.+|.+.+..+...+ .+.++.+.+. ....+||+|++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 5678889764333110 113567888887774333 3344555543 23578999999875 899
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-------CCcEEEccccCCCC
Q 022575 163 NHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-------NYNAKLSDFGLAKD 229 (295)
Q Consensus 163 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-------~~~~kl~DFG~a~~ 229 (295)
+++..... .+........++.+++..+.-||+.| |+|+|+++.|||++. +..+.|+||+.+..
T Consensus 125 ~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99864321 23455667788999999999999988 999999999999975 46899999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.2e-10 Score=89.90 Aligned_cols=98 Identities=23% Similarity=0.254 Sum_probs=63.5
Q ss_pred HHHHHHHHHcccCCC--CccceeeEEEeCCeeEEEEeccC--CCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH-h
Q 022575 120 EWLTEIKHLGQLYHP--NLVKLIGYCLEDDHRLLVYEFMP--KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY-L 194 (295)
Q Consensus 120 ~~~~E~~~l~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~-l 194 (295)
+..+|.+.|.++... ++++++.+. ...|||||++ |..+..+.... +.......++.+++..+.. +
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHH
Confidence 456899999999755 577777542 3579999997 55554433322 1122345566667665554 5
Q ss_pred hcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 195 H~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
|..| |||+||.+.|||++++ .+.|+|||.+...
T Consensus 124 ~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 124 HKAG--IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HCTT--EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HhcC--ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 7877 9999999999999877 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.9e-09 Score=95.09 Aligned_cols=161 Identities=18% Similarity=0.187 Sum_probs=117.5
Q ss_pred CCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe----CCeeEEEEeccCC-CCHHHHHhhccCC-
Q 022575 98 RPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE----DDHRLLVYEFMPK-GSLENHLFRRASY- 171 (295)
Q Consensus 98 ~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~-g~L~~~l~~~~~~- 171 (295)
...+|..|++|++...+.........-++.++++.|+|+|++.+++.+ +..+++|++|.++ ++|.++-......
T Consensus 297 s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t 376 (655)
T KOG3741|consen 297 SNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFT 376 (655)
T ss_pred eccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccc
Confidence 344688999999954443333233356788999999999999998873 4578999999875 5787766543221
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeec
Q 022575 172 ----------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241 (295)
Q Consensus 172 ----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 241 (295)
....++..++.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|..-|+........
T Consensus 377 ~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------- 447 (655)
T KOG3741|consen 377 KRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------- 447 (655)
T ss_pred cccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCCC-------
Confidence 133567889999999999999999988 8889999999999999888888766654322211
Q ss_pred cccccCccCceeeccCcccccceeeehhHHHHHHhccC
Q 022575 242 VMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQL 279 (295)
Q Consensus 242 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 279 (295)
. |.++. -.+-|.=.||.+++-|.+|.
T Consensus 448 -------~--~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 448 -------T--EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred -------C--cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 0 11221 24568888999999999984
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.9e-09 Score=86.51 Aligned_cols=135 Identities=17% Similarity=0.124 Sum_probs=92.8
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----------------------hhHHHHHHHHHH
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------------------QGHLEWLTEIKH 127 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~~ 127 (295)
..+...||-|.-+.||.|... .|.++|+|.-..... -.+....+|.++
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 456789999999999999543 378899997533211 012245689999
Q ss_pred HcccCCC--CccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 022575 128 LGQLYHP--NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (295)
Q Consensus 128 l~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 205 (295)
|.+|.-. .+.+.+++ +...+||||++|-.|...-. .....-.++..|+.-+.-.-..| +||+|
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~G--iVHGD 227 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRRG--IVHGD 227 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHcC--ccccC
Confidence 9998644 77777664 55689999998866654321 11222233333333343333445 99999
Q ss_pred CCCCCeEEcCCCcEEEccccCCCC
Q 022575 206 FKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 206 lkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+.+-||++++||.+.++||--+..
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999966654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.5e-08 Score=80.05 Aligned_cols=105 Identities=22% Similarity=0.201 Sum_probs=80.7
Q ss_pred HHHHHHHHHcccC--CCCccceeeEEEeC----CeeEEEEeccCCC-CHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 022575 120 EWLTEIKHLGQLY--HPNLVKLIGYCLED----DHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192 (295)
Q Consensus 120 ~~~~E~~~l~~l~--h~ni~~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 192 (295)
+..+|.+.+..|. .=..++.+++.+.. ...++|+|++++. +|.+++..... .+......++.+++..+.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence 4567777776664 23355666666553 2458999999874 79999876432 445566788899999999
Q ss_pred HhhcCCCCeEeecCCCCCeEEcCCC---cEEEccccCCCCC
Q 022575 193 YLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLAKDG 230 (295)
Q Consensus 193 ~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~~~ 230 (295)
-||..| |+|+|+++.|||++.++ .+.|+||+.++..
T Consensus 133 ~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999988 99999999999998887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=8e-09 Score=93.81 Aligned_cols=142 Identities=17% Similarity=0.179 Sum_probs=91.2
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh------------------------------------
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG------------------------------------ 117 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 117 (295)
+.|+.++-|.||+|.+.. |+.||||+..+.-...
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 689999999999998773 8999999976531100
Q ss_pred ----HHHHHHHHHHHcccC-----CCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 022575 118 ----HLEWLTEIKHLGQLY-----HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188 (295)
Q Consensus 118 ----~~~~~~E~~~l~~l~-----h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~ 188 (295)
...+.+|...+.+++ .+++.=-.=+++-.....|+|||+.|..+.+...... ..++...+.....++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f 277 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF 277 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 012344555555442 2332222223334456789999999999888853322 2234333333222222
Q ss_pred HHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCC
Q 022575 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 189 ~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 232 (295)
+.-+-..| ++|.|..|.||+++.++++.+.|||+......
T Consensus 278 --~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 --LRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --HHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22222246 99999999999999999999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.2e-09 Score=99.36 Aligned_cols=100 Identities=19% Similarity=0.254 Sum_probs=79.1
Q ss_pred HHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcce-------eeccccccCccCceeeccC
Q 022575 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV-------STRVMGTYGYAAPEYMATG 257 (295)
Q Consensus 185 ~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 257 (295)
.+++.||.|+|.. ..+||++|.|++|.++..+.+||+.|+++.....+..... .....-...|.|||++...
T Consensus 106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3445899999986 5799999999999999999999999999875443221111 1112346789999999998
Q ss_pred cccccceeeehhHHHHHHh-ccCChhhee
Q 022575 258 IFQLVLLLFTFECSLLHFS-LQLPMCVLY 285 (295)
Q Consensus 258 ~~~~~~Di~slG~~l~el~-~g~~pf~~~ 285 (295)
..+.++|++|+|+++|.++ .|++.+...
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhcc
Confidence 8899999999999999999 677776654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=7.1e-10 Score=100.03 Aligned_cols=187 Identities=19% Similarity=0.100 Sum_probs=130.7
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCC-ccceeeEEEeCCe
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDH 148 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~ 148 (295)
+..-+-+++|+++++++.+ ...+. ....+.+... ....-++++|.+++||| .+..++-++.++.
T Consensus 244 s~~fh~fvK~altknpKkR---------ptaek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKR---------PTAEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccC---------CChhh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3444557899999998862 22222 2335555433 23346888999999999 7777777777889
Q ss_pred eEEEEeccCCC-CHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 149 RLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 149 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
.++.++++.++ +-........ ..+...+...+...-+.+++++|+.- -+|+| ||+..+ +..+..||+..
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSE---IALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred cchhhhhhcCCccccccCChhh---Hhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCC
Confidence 99999999776 2211111000 11222333445566677899999853 58998 887765 68999999998
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
..+.... ......+++.|+|||+...+.+....|.|+++.-..+|.-|.||-..
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 7665433 23456799999999999999999999999999988888888877543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.5e-08 Score=84.24 Aligned_cols=195 Identities=13% Similarity=0.111 Sum_probs=123.3
Q ss_pred CCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEE------
Q 022575 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC------ 143 (295)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~------ 143 (295)
.+.+.||+|+-+.+|-.-- .+. .+.|+..........+ .+..|... .||-+..=+.+=
T Consensus 14 ~~gr~LgqGgea~ly~l~e-----------~~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G 78 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-----------VRD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHG 78 (637)
T ss_pred CCCccccCCccceeeecch-----------hhc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhC
Confidence 4457899999999985411 111 3446655443332222 22223333 455433311110
Q ss_pred -EeCCeeEEEEeccCCCCHHHHHhh---ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 144 -LEDDHRLLVYEFMPKGSLENHLFR---RASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 144 -~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
......-++|+.+.+..=-..+.+ +........|...+..+..++.+.+-||.+| .+-+|+.++|+|+++++.+
T Consensus 79 ~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V 156 (637)
T COG4248 79 GRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKV 156 (637)
T ss_pred CCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceE
Confidence 011225577887766422222211 1112234678999999999999999999988 8889999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhcc-CChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQ-LPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g-~~pf~~~ 285 (295)
.|.|=..-.. ..+.......+|.+.|.+||.-. +..-+...|.|.||+++++++.| ..||.+.
T Consensus 157 ~LVdsDsfqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 157 VLVDSDSFQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred EEEcccceee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 9998322211 11222233457899999999765 23445789999999999999997 7888754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.7e-07 Score=73.89 Aligned_cols=138 Identities=19% Similarity=0.104 Sum_probs=96.7
Q ss_pred eccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc------hhhHHHHHHHHHHHcccCC--CCccceeeEEEeC--
Q 022575 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES------LQGHLEWLTEIKHLGQLYH--PNLVKLIGYCLED-- 146 (295)
Q Consensus 77 g~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~-- 146 (295)
|+||.+.|++..+. |..+=+|.-.... ......+.+|+..+.+|.. -.+.++.......
T Consensus 27 ~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~ 95 (216)
T PRK09902 27 RRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIE 95 (216)
T ss_pred CCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccC
Confidence 56888888887554 3357777654111 1234567889988888752 2355555222221
Q ss_pred --CeeEEEEeccCC-CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--EEE
Q 022575 147 --DHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKL 221 (295)
Q Consensus 147 --~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~kl 221 (295)
-..+||+|-+.+ -+|.+++.+... .+.+......++.+++..+.-||+.| +.|+|+-+.||+++.++. +++
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~l 171 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGF 171 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEE
Confidence 245899997743 589888865432 34566667788999999999999988 999999999999986677 999
Q ss_pred ccccCCCC
Q 022575 222 SDFGLAKD 229 (295)
Q Consensus 222 ~DFG~a~~ 229 (295)
+||--++.
T Consensus 172 IDlEk~r~ 179 (216)
T PRK09902 172 LDLEKSRR 179 (216)
T ss_pred EEhhccch
Confidence 99987764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.9e-07 Score=75.08 Aligned_cols=140 Identities=15% Similarity=0.086 Sum_probs=90.0
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHH---------HHHHHHHHcccC--
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---------WLTEIKHLGQLY-- 132 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~E~~~l~~l~-- 132 (295)
.....+|...+++-......|.+-..+ +..+++|.........+.. ..+++..+..++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~ 95 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNE 95 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHc
Confidence 455678888888888777777666544 6789999876554322211 123333333332
Q ss_pred -CCCccceeeEEE-----eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecC
Q 022575 133 -HPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (295)
Q Consensus 133 -h~ni~~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 206 (295)
-.....++.+.+ -....+++|||++|..|.++.. +.+ .+...+.+++.-||+.| ++|+|.
T Consensus 96 g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G--~~HGD~ 161 (229)
T PF06176_consen 96 GFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG--FYHGDP 161 (229)
T ss_pred CccccccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC--CccCCC
Confidence 222233222222 1234578999999988766432 222 23455667899999988 999999
Q ss_pred CCCCeEEcCCCcEEEccccCCCC
Q 022575 207 KTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 207 kp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.|.|++++.+ .++++||+..+.
T Consensus 162 hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 162 HPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred CcCcEEEECC-cEEEEECccccc
Confidence 9999999855 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.5e-07 Score=76.03 Aligned_cols=139 Identities=14% Similarity=0.135 Sum_probs=83.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCC--CccceeeEEEeCCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP--NLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~l~~~~~~~~~~~l 151 (295)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..- .+.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 56899999999984 13357788876533 223456788888887533 35778888877788889
Q ss_pred EEeccCCCC-HHHHH--------------hh-----ccC--CCCCCCHHHHHHHHH----------HHHH-HHHHh--hc
Q 022575 152 VYEFMPKGS-LENHL--------------FR-----RAS--YIQPLSWTIRMKVAL----------GAAK-GLAYL--HS 196 (295)
Q Consensus 152 v~e~~~~g~-L~~~l--------------~~-----~~~--~~~~~~~~~~~~~~~----------~i~~-~l~~l--H~ 196 (295)
|||+++|.+ +...+ .+ +.- ....+... ...+.. .+.. ...+| +.
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~ 150 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVP 150 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence 999998863 21111 11 000 00011100 000000 0011 11222 22
Q ss_pred CCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 197 DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 197 ~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
....++|+|+.|.||++++++ +.|+||+.+..
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 223579999999999999887 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=85.57 Aligned_cols=140 Identities=16% Similarity=0.111 Sum_probs=89.8
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-------------------------------------
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------------------------------------- 116 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------------------- 116 (295)
+.||.-+.|.||+|++++ |+.||||+-.+.-..
T Consensus 167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 679999999999997764 899999986543110
Q ss_pred hHHHHHHHHHHHcc----cCCCC------ccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHH
Q 022575 117 GHLEWLTEIKHLGQ----LYHPN------LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186 (295)
Q Consensus 117 ~~~~~~~E~~~l~~----l~h~n------i~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (295)
....|.+|.+...+ +.|-+ |.+++..+ .....|+||||+|..+.+.-.-.. ..++...+..-+.+
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~ 311 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVE 311 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHH
Confidence 01123444443333 33555 55554333 345689999999987766543322 22444444444443
Q ss_pred HHHHHHHhhcCCCCeEeecCCCCCeEEcC----CCcEEEccccCCCCCCC
Q 022575 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDL----NYNAKLSDFGLAKDGPT 232 (295)
Q Consensus 187 i~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~kl~DFG~a~~~~~ 232 (295)
+..-+-+. .| ++|.|-.|.||++.. +..+.+-|||+......
T Consensus 312 ~~~~qIf~--~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 312 AYLEQIFK--TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHh--cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 33222233 35 999999999999983 67899999999886543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1e-06 Score=71.69 Aligned_cols=149 Identities=18% Similarity=0.165 Sum_probs=94.9
Q ss_pred hhHHHhcCCCCCCCe---eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--------------------
Q 022575 61 NGLKTATRNFRPDSV---LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------------------- 117 (295)
Q Consensus 61 ~~~~~~~~~y~~~~~---lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------- 117 (295)
..+....++..+... |.+|.-+.||+|.- ..+..+|+|+.+......
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r 107 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR 107 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence 334444455555554 45677778999843 237789999875432211
Q ss_pred ----HHHHHHHHHHHcccC--CCCccceeeEEEeCCeeEEEEeccCCCCH-HHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q 022575 118 ----HLEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLLVYEFMPKGSL-ENHLFRRASYIQPLSWTIRMKVALGAAKG 190 (295)
Q Consensus 118 ----~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~~~~i~~~ 190 (295)
..+..+|.+.|.++. +-.+.+-+.+. ...|||||+....+ .-.|.. .++.......+..++++.
T Consensus 108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~ 178 (268)
T COG1718 108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEY 178 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHH
Confidence 112356777777763 44555555543 24699999943311 000110 122333566677778888
Q ss_pred HHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 191 LAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 191 l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
+.-|-. .+ +||+||..-|||+. ++.+.|+|||-|....
T Consensus 179 ~~~l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 179 MRRLYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHhcC--cccccchhhheEEE-CCeEEEEECccccccC
Confidence 887776 45 99999999999999 8899999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.1e-06 Score=71.48 Aligned_cols=140 Identities=19% Similarity=0.098 Sum_probs=80.9
Q ss_pred eeccCC-cEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEEEE
Q 022575 76 LGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVY 153 (295)
Q Consensus 76 lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~ 153 (295)
|-.|.. ..||+.... +..+.+|...... .....+|++++..+. +--+.+++++....+..++||
T Consensus 6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 344555 678887321 3468888876543 123456777777763 455677888777767789999
Q ss_pred eccCCCCHHHHHh----------------h-ccC-C-CCCCCHH--HHHHH-----------------------HHHHHH
Q 022575 154 EFMPKGSLENHLF----------------R-RAS-Y-IQPLSWT--IRMKV-----------------------ALGAAK 189 (295)
Q Consensus 154 e~~~~g~L~~~l~----------------~-~~~-~-~~~~~~~--~~~~~-----------------------~~~i~~ 189 (295)
|+++|.+|..... + +.- . ..++... ..... ..++..
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999877764421 0 000 0 0011100 00000 011111
Q ss_pred HHHHhh--cCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 190 GLAYLH--SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 190 ~l~~lH--~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.|.... ...+.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 111100 1123489999999999999877788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.8e-06 Score=66.17 Aligned_cols=131 Identities=18% Similarity=0.229 Sum_probs=87.6
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc----------------hhhHHHHHHHHHHHcccC----
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----------------LQGHLEWLTEIKHLGQLY---- 132 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 132 (295)
...||+|+.-.||.- + ......||++.... .....+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H-----------P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH-----------P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEEC-----------C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 467999999999863 1 12336788877655 111234455655544444
Q ss_pred --CCCccceeeEEEeCCeeEEEEeccCC------CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 022575 133 --HPNLVKLIGYCLEDDHRLLVYEFMPK------GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (295)
Q Consensus 133 --h~ni~~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 204 (295)
+.+|.+++|+.+++...-+|+|.+.+ .+|.+++.+.. ++. .....+.+ -.+||-+++ |+.+
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~~---f~~~l~~~~--Iv~~ 142 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALDE---FKRYLLDHH--IVIR 142 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHHH---HHHHHHHcC--Ceec
Confidence 88999999999999999999987632 47888885432 444 33333333 345666666 9999
Q ss_pred cCCCCCeEEcCC---C-cEEEcc-ccC
Q 022575 205 DFKTSNILLDLN---Y-NAKLSD-FGL 226 (295)
Q Consensus 205 Dlkp~Nill~~~---~-~~kl~D-FG~ 226 (295)
||+|.||++... . .+.|+| ||.
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeCCCC
Confidence 999999999432 2 578888 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=71.33 Aligned_cols=77 Identities=17% Similarity=0.198 Sum_probs=52.7
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCC--CccceeeEEEe---CCe
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP--NLVKLIGYCLE---DDH 148 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~l~~~~~~---~~~ 148 (295)
+.|+.|..+.||+.... +..+++|..... .....+.+|..++..+... .+.+++..... ...
T Consensus 3 ~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred ccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 56889999999998543 247999987655 3334556787777777422 35677764433 345
Q ss_pred eEEEEeccCCCCHHH
Q 022575 149 RLLVYEFMPKGSLEN 163 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~ 163 (295)
.+++|++++|..+..
T Consensus 70 ~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEESSEEHHH
T ss_pred ceEEEEEeccccccc
Confidence 689999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.3e-06 Score=66.51 Aligned_cols=125 Identities=30% Similarity=0.425 Sum_probs=86.3
Q ss_pred CCCCCCCeeeccCC-cEEEEEEecCCCcCCCCCCCCcEEEEEEcCc---cc-------hh-----------hHHHHHHHH
Q 022575 68 RNFRPDSVLGEGGF-GCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ---ES-------LQ-----------GHLEWLTEI 125 (295)
Q Consensus 68 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~---~~-------~~-----------~~~~~~~E~ 125 (295)
.+++..+.||.|.- |.||++... |..+|+|.... .. .. ...-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 68888999999999 999999876 67899999321 10 00 011366788
Q ss_pred HHHcccC---CCCc--cceeeEEEeCC------------------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHH
Q 022575 126 KHLGQLY---HPNL--VKLIGYCLEDD------------------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182 (295)
Q Consensus 126 ~~l~~l~---h~ni--~~l~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 182 (295)
+...+|+ +.++ ++.+||..-.. ...||.||.+... .+. ..
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~ 168 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IR 168 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hh
Confidence 8877775 4455 88888874321 1245666664432 112 22
Q ss_pred HHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 183 ~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
-+.+|..-|..+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 169 ~~~~~~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 3456677788999977 999999999987 4689999865
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.2e-06 Score=68.29 Aligned_cols=30 Identities=20% Similarity=0.196 Sum_probs=25.5
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.++|+|+.|.|||++.+...-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 389999999999998765557999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.1e-05 Score=76.85 Aligned_cols=81 Identities=17% Similarity=0.201 Sum_probs=54.3
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccC-CCCc--cceeeEEEeC--
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLY-HPNL--VKLIGYCLED-- 146 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--~~l~~~~~~~-- 146 (295)
.+.++.|.+..+|+...... .....+++|+...... .....+.+|.++++.+. |+++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 45678899999998754321 1113577777654321 22345678999999885 6655 7888777654
Q ss_pred -CeeEEEEeccCCCC
Q 022575 147 -DHRLLVYEFMPKGS 160 (295)
Q Consensus 147 -~~~~lv~e~~~~g~ 160 (295)
+..|+||||++|..
T Consensus 116 ~G~~flVME~v~G~~ 130 (822)
T PLN02876 116 IGTAFYIMEYLEGRI 130 (822)
T ss_pred CCCceEEEEecCCcc
Confidence 46799999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=61.69 Aligned_cols=130 Identities=17% Similarity=0.135 Sum_probs=84.2
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCcc-ceeeEEEeCCe
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLV-KLIGYCLEDDH 148 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~-~l~~~~~~~~~ 148 (295)
.+..+.|++|.+|.||++.+. +..+|+|+-..+.. +..+..|+++|..+.-.++. +++.+..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 345678999999999999776 55799998765543 34567899999888755553 4555433
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCC-CCCeEEcCCCcEEEccccCC
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFK-TSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk-p~Nill~~~~~~kl~DFG~a 227 (295)
.++.|||+.|-.|.+.-... ....+. .++.. .|.-+. .+|-|+.|. |...+|..++.+.|+||..|
T Consensus 87 ~~i~me~i~G~~L~~~~~~~-------~rk~l~----~vlE~-a~~LD~-~GI~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG-------DRKHLL----RVLEK-AYKLDR-LGIEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc-------cHHHHH----HHHHH-HHHHHH-hccchhhhcCCceeEEecCCcEEEEEccch
Confidence 34569999887887654321 122222 23333 222222 238887775 44444445559999999988
Q ss_pred CC
Q 022575 228 KD 229 (295)
Q Consensus 228 ~~ 229 (295)
+.
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 74
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=1e-05 Score=64.40 Aligned_cols=102 Identities=25% Similarity=0.211 Sum_probs=76.5
Q ss_pred HHHHHHcccCC-CCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-C
Q 022575 123 TEIKHLGQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA-K 200 (295)
Q Consensus 123 ~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~ 200 (295)
+|.-++..+.+ +++++++|+|- .+++.||...+++...-.. -......+|..+.+++.+++..+++++..-. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57778888865 69999999983 3578899976665422000 0000235789999999999999999986321 2
Q ss_pred eEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 201 VIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 201 ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+.-.|++|+|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77799999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.6e-07 Score=90.26 Aligned_cols=164 Identities=14% Similarity=-0.026 Sum_probs=119.1
Q ss_pred HHHHHHHHcccCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-
Q 022575 121 WLTEIKHLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD- 197 (295)
Q Consensus 121 ~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~- 197 (295)
...|...++...|+++.....-... ....|..++|+.+|.+.+.|-+.-.....+...-+.....+.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555556678888776654432 2345889999999999999976544334443333333333335566666654
Q ss_pred --CCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHH
Q 022575 198 --KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275 (295)
Q Consensus 198 --~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 275 (295)
|.--+|++||+-|.+|..+..+|+.++|+.+... ..........+++.|++|++...-.++.++|+|..++.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2236899999999999999999999999998321 122234456789999999998888899899999999999999
Q ss_pred hccCChhheee
Q 022575 276 SLQLPMCVLYL 286 (295)
Q Consensus 276 ~~g~~pf~~~~ 286 (295)
..|.++|....
T Consensus 1434 s~~n~~fi~fl 1444 (2724)
T KOG1826|consen 1434 SDGNAYFIFFL 1444 (2724)
T ss_pred hcccHHHHHHH
Confidence 99999987654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00015 Score=62.27 Aligned_cols=76 Identities=12% Similarity=-0.020 Sum_probs=52.0
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC---CCccceeeEEEe---C
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH---PNLVKLIGYCLE---D 146 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~ni~~l~~~~~~---~ 146 (295)
.+.||.|..+.||+.... +..+.+|..+... ....+..|.+.|+.|.- -.+.++++++.. .
T Consensus 19 ~~~i~~G~~~~vy~~~~~-----------~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 19 VECISEQPYAALWALYDS-----------QGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeecCCccceeEEEEEcC-----------CCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 457999999999986322 2246667743311 22356688888887742 467888887754 3
Q ss_pred CeeEEEEeccCCCCH
Q 022575 147 DHRLLVYEFMPKGSL 161 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L 161 (295)
+..+||||++++.++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999988754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.5e-05 Score=62.34 Aligned_cols=138 Identities=17% Similarity=0.115 Sum_probs=73.3
Q ss_pred eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCc-cceeeEEEeCCeeEEEEe
Q 022575 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLVYE 154 (295)
Q Consensus 76 lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e 154 (295)
+..|-...+|+... .+..+++|..............+|.++++.+....+ .+++... . -++|||
T Consensus 4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence 34577778887632 255688887554322111123567778877753323 4454433 2 368999
Q ss_pred ccCCCCHHHH--------------Hhh-cc--CCCCCCCHH-HHHHHHHHH---------HHHHHHhhcC------CCCe
Q 022575 155 FMPKGSLENH--------------LFR-RA--SYIQPLSWT-IRMKVALGA---------AKGLAYLHSD------KAKV 201 (295)
Q Consensus 155 ~~~~g~L~~~--------------l~~-~~--~~~~~~~~~-~~~~~~~~i---------~~~l~~lH~~------~~~i 201 (295)
|++|..+... +.+ +. ....++... .+..+..++ ...+..+-.. ...+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9988665321 111 10 001111111 111211111 1111111111 1348
Q ss_pred EeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 202 IYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 202 vHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+|+|+.|.||++++++ +.|+||..|..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999998876 88999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00021 Score=58.99 Aligned_cols=30 Identities=20% Similarity=0.259 Sum_probs=26.5
Q ss_pred CeEeecCCCCCeEEcC-CCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDL-NYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~ 229 (295)
.++|+|+.+.|||++. ++.+.|+||-.|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 4999999999999997 57899999987764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00042 Score=61.57 Aligned_cols=76 Identities=20% Similarity=0.152 Sum_probs=49.9
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc------c-hhhHHHHHHHHHHHccc---CCCCccceeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE------S-LQGHLEWLTEIKHLGQL---YHPNLVKLIGYC 143 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~ 143 (295)
+.||.|.+..||++.... .++.++||.-... . .-...+...|.+.|..+ ...++++++.+
T Consensus 32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 578999999999985432 1247999975311 1 11234556677777665 23567888776
Q ss_pred EeCCeeEEEEeccCCCC
Q 022575 144 LEDDHRLLVYEFMPKGS 160 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~ 160 (295)
+.+..++|||++++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 3455789999997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0014 Score=56.78 Aligned_cols=30 Identities=27% Similarity=0.307 Sum_probs=25.9
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+++|+|+.|.|||++.+...-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 499999999999998665558999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=6.7e-05 Score=63.70 Aligned_cols=133 Identities=17% Similarity=0.106 Sum_probs=88.4
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh----------------------hHHHHHHHHHH
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----------------------GHLEWLTEIKH 127 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~E~~~ 127 (295)
+.+.+.||-|.-+.||.+-..+ |.+.++|.-...... .+....+|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~----------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE----------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred hhhccccccccccceEEEecCC----------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 5677899999999999985543 777888854322110 12234578888
Q ss_pred HcccC-C-CCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 022575 128 LGQLY-H-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (295)
Q Consensus 128 l~~l~-h-~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 205 (295)
|+.|. | --+++.++ .+..++|||++.|..|.+.-.-. ....+. ..+..-+.-|..+| +||+|
T Consensus 164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly---~~lm~~Iv~la~~G--lIHgD 227 (465)
T KOG2268|consen 164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE-------DPPTLY---DDLMGLIVRLANHG--LIHGD 227 (465)
T ss_pred HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeecC-------ChHHHH---HHHHHHHHHHHHcC--ceecc
Confidence 88874 2 33555554 35678999999888886543211 112222 22222334455567 99999
Q ss_pred CCCCCeEEcCCCcEEEccccCCC
Q 022575 206 FKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 206 lkp~Nill~~~~~~kl~DFG~a~ 228 (295)
..-=||++++++.++++||--+.
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999996554
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0018 Score=55.48 Aligned_cols=143 Identities=17% Similarity=0.095 Sum_probs=78.3
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCC--Cccceee------EEE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP--NLVKLIG------YCL 144 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni~~l~~------~~~ 144 (295)
.+.|..|....+|+.... +..+++|..... ...+...|++++..+.+. .+.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 345667777789987432 345888987642 223344566666666322 2444433 123
Q ss_pred eCCeeEEEEeccCCCCHHH----HHhh----------c-cCCCC------CCCHHHHH----------HHHHHHHHHHHH
Q 022575 145 EDDHRLLVYEFMPKGSLEN----HLFR----------R-ASYIQ------PLSWTIRM----------KVALGAAKGLAY 193 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~----~l~~----------~-~~~~~------~~~~~~~~----------~~~~~i~~~l~~ 193 (295)
..+..++++++++|..+.. .... . ..... ...+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456789999998866432 1100 0 00000 00111000 001112223333
Q ss_pred hhc-----CCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 194 LHS-----DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 194 lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+-. ....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 332 113499999999999999877778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00063 Score=58.54 Aligned_cols=31 Identities=29% Similarity=0.222 Sum_probs=27.6
Q ss_pred CCeEeecCCCCCeEEcCC----CcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLN----YNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~----~~~kl~DFG~a~~ 229 (295)
..++|+|+.+.|||++.+ +.++|+||..|..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 458999999999999875 8899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0013 Score=56.98 Aligned_cols=141 Identities=15% Similarity=0.173 Sum_probs=88.4
Q ss_pred CCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch------------------------hh--HHHHHHHH
Q 022575 72 PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------------------------QG--HLEWLTEI 125 (295)
Q Consensus 72 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------------~~--~~~~~~E~ 125 (295)
+...|..|.-+.||.|.-. .|..+|||+.+..-+ .. ..+..+|+
T Consensus 148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4466888999999998433 377799998653211 00 12345788
Q ss_pred HHHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 022575 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (295)
Q Consensus 126 ~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 205 (295)
+.|.+|+...|.----... ....|||+|+.......-..+. ..++...+..+-.+++.-|.-|.+. +++||.|
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHAD 290 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQK-CRLVHAD 290 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHH-hceeccc
Confidence 8888876554432221111 2246999999432221111111 2355555666666666666666543 5599999
Q ss_pred CCCCCeEEcCCCcEEEccccCCCCC
Q 022575 206 FKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 206 lkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
|.--|+|+. +|.+.|+|-+-+...
T Consensus 291 LSEfN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 291 LSEFNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhhhhheEE-CCEEEEEEccccccC
Confidence 999999995 679999999877653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0019 Score=55.71 Aligned_cols=31 Identities=29% Similarity=0.281 Sum_probs=27.2
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3599999999999999887678999999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00055 Score=66.93 Aligned_cols=151 Identities=23% Similarity=0.161 Sum_probs=109.1
Q ss_pred HHHHHHHcccCCCCccceeeEEEeCCee----EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 022575 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD 197 (295)
Q Consensus 122 ~~E~~~l~~l~h~ni~~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 197 (295)
..|...+.++.|+|+..++.+....... .+..++|...++...++.-. ..+......+..++..||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3466777888999999999887654322 34457888889988887653 477888888999999999999987
Q ss_pred CCCeEeecCCCC---CeEEcCCCcEEEc--cccCCCCCCCCCCcceeeccccccCccCceeeccCccc--ccceeeehhH
Q 022575 198 KAKVIYRDFKTS---NILLDLNYNAKLS--DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ--LVLLLFTFEC 270 (295)
Q Consensus 198 ~~~ivHrDlkp~---Nill~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di~slG~ 270 (295)
. ..|.-|... +--.+.++.+.+. ||+..+........ .....+..|.+||......+. ...|+|.+|.
T Consensus 306 ~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c--cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 5 555544444 4444566667666 88888766544322 122346678889888766554 4579999999
Q ss_pred HHHHHhccCCh
Q 022575 271 SLLHFSLQLPM 281 (295)
Q Consensus 271 ~l~el~~g~~p 281 (295)
.+..+..|..+
T Consensus 381 l~~~~~~~~~i 391 (1351)
T KOG1035|consen 381 LLLQLSQGEDI 391 (1351)
T ss_pred HHhhhhhcCcc
Confidence 99999887654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0044 Score=54.38 Aligned_cols=145 Identities=16% Similarity=0.130 Sum_probs=77.4
Q ss_pred eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCc-cceeeEEEeCCeeEEEE
Q 022575 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLVY 153 (295)
Q Consensus 75 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~ 153 (295)
.|-.|-.-.+|++.+... ....+..|++|....... ......+|..++..+...++ .++++.+.. + .|.
T Consensus 43 ~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 343466778888754321 112346788888765432 22222568888877754333 355665532 2 578
Q ss_pred eccCCCCHHHH-------H-------hh-cc-C---CCCCCCHHHHHHHHHHH-----------------HHHHHH----
Q 022575 154 EFMPKGSLENH-------L-------FR-RA-S---YIQPLSWTIRMKVALGA-----------------AKGLAY---- 193 (295)
Q Consensus 154 e~~~~g~L~~~-------l-------~~-~~-~---~~~~~~~~~~~~~~~~i-----------------~~~l~~---- 193 (295)
+|+++.+|... + .+ +. . ......+..+..+..++ ...+..
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99877665421 0 00 00 0 00011122222222111 111111
Q ss_pred hhc--CCCCeEeecCCCCCeEEcC-CCcEEEccccCCCC
Q 022575 194 LHS--DKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKD 229 (295)
Q Consensus 194 lH~--~~~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~ 229 (295)
+.. ....++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 121 1124899999999999976 46799999998875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0066 Score=51.52 Aligned_cols=31 Identities=29% Similarity=0.398 Sum_probs=26.1
Q ss_pred CeEeecCCCCCeEEcCCCcE-EEccccCCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNA-KLSDFGLAKDG 230 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~-kl~DFG~a~~~ 230 (295)
.++|+|+.|.|||++.++.+ -|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 48999999999999875664 69999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.011 Score=51.58 Aligned_cols=30 Identities=17% Similarity=0.239 Sum_probs=25.4
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+||.+.||+++++ .++++||.++..
T Consensus 192 ~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred ceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 458999999999999765 588999987764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.012 Score=50.67 Aligned_cols=31 Identities=23% Similarity=0.443 Sum_probs=28.2
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
.++|+|+.+.||+++.++-+=|.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 5999999999999999888999999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0026 Score=55.12 Aligned_cols=72 Identities=19% Similarity=0.123 Sum_probs=53.1
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
.+.|++|++- |++|... ..-.++++..++.+.+.-+.-+ +.+.++-|||+...||||+ +|+|.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~l-ekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDIL-EKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhh-hhcCCcccccccccceeee-cCceEEEEeee
Confidence 4567888876 6665322 1234677788888766544444 4446799999999999999 99999999999
Q ss_pred CCC
Q 022575 227 AKD 229 (295)
Q Consensus 227 a~~ 229 (295)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.022 Score=49.74 Aligned_cols=29 Identities=17% Similarity=0.232 Sum_probs=25.6
Q ss_pred eEeecCCCCCeEEcC-CCcEEEccccCCCC
Q 022575 201 VIYRDFKTSNILLDL-NYNAKLSDFGLAKD 229 (295)
Q Consensus 201 ivHrDlkp~Nill~~-~~~~kl~DFG~a~~ 229 (295)
+.|.|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 789999999999974 57899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.056 Score=48.24 Aligned_cols=73 Identities=10% Similarity=0.033 Sum_probs=46.0
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-------hhHHHHHHHHHHHcccC---CCCccceeeE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------QGHLEWLTEIKHLGQLY---HPNLVKLIGY 142 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~ni~~l~~~ 142 (295)
.+.||.|....||+.... +..++||.-..... -...+...|.+.|..+. ..++++++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 457888999999997422 34588887652111 12223334555555542 3578889887
Q ss_pred EEeCCeeEEEEeccCC
Q 022575 143 CLEDDHRLLVYEFMPK 158 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~ 158 (295)
+. +..+++||++++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 76 456789999966
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.032 Score=48.21 Aligned_cols=30 Identities=17% Similarity=0.153 Sum_probs=27.6
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999988865
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.013 Score=49.87 Aligned_cols=72 Identities=22% Similarity=0.243 Sum_probs=43.5
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc---CCCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL---YHPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l---~h~ni~~l~~~~~~~~~~~ 150 (295)
+.|+-|....+|+.. ..++.+-+|.-... ....+..|.+-|+.| .--.+++++++....+..+
T Consensus 23 ~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp EEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred EecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 567888889998874 23677888977622 223455677766666 3456888999988888889
Q ss_pred EEEeccCCC
Q 022575 151 LVYEFMPKG 159 (295)
Q Consensus 151 lv~e~~~~g 159 (295)
|+|||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0089 Score=48.36 Aligned_cols=102 Identities=16% Similarity=0.147 Sum_probs=62.8
Q ss_pred EEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHH
Q 022575 105 IAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183 (295)
Q Consensus 105 vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 183 (295)
..+|++..-... ...-+.++.++++++. .|+++.. ......-+++|+|..... . ..-.+
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-------------~---~~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-------------N---FSNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-------------c---hhHHH
Confidence 344544433322 2334567788887753 4666652 122234588999843211 1 11111
Q ss_pred HHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 184 ~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..+ +..|.-.|+...+.+|+|..|+||+-|..|.+||.|-+.-
T Consensus 148 ~ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 148 TAG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111 3567788976678999999999999999999999997653
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.063 Score=43.81 Aligned_cols=58 Identities=28% Similarity=0.316 Sum_probs=40.8
Q ss_pred CcEEEEEEcCccchhhHHHHHHHHHHHcccC---CCCccceeeEEEeCCeeEEEEeccCCCCHH
Q 022575 102 GMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162 (295)
Q Consensus 102 ~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~ 162 (295)
..++-+|+=... ....|..|+.-|..+. --++.+++.+....++.|+||||++-+.+.
T Consensus 39 ~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 455677754332 2345667777666664 356788888888999999999999876554
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.021 Score=50.47 Aligned_cols=58 Identities=19% Similarity=0.172 Sum_probs=37.8
Q ss_pred eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeEeecCCCCCeEE
Q 022575 149 RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL-HSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ivHrDlkp~Nill 213 (295)
..|+-+|..|.++..++.... .++.....++.-.+.|+--+ --.+ ++|.|+.|.||++
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVli 378 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLI 378 (565)
T ss_pred ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEE
Confidence 356667888889998887653 34444444444334443222 2224 9999999999999
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.037 Score=49.08 Aligned_cols=75 Identities=16% Similarity=0.169 Sum_probs=45.3
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc-----c-hhhHHHHHHHHHHHcccC---CCCccceeeEE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-----S-LQGHLEWLTEIKHLGQLY---HPNLVKLIGYC 143 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-----~-~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~ 143 (295)
.+.||.|.-..||++... ..+..|+||.-..- . .-...+..-|.+.|+.+. -..+++++.+
T Consensus 34 ~~eigdGnlN~VfrV~~~---------~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDE---------QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEeeC---------CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 457899999999999542 12456888864211 1 112334455666666542 2357777654
Q ss_pred EeCCeeEEEEeccCC
Q 022575 144 LEDDHRLLVYEFMPK 158 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~ 158 (295)
+.+...+|||+++.
T Consensus 104 -D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 -DSVMNCCVMEDLSD 117 (409)
T ss_pred -CcHHhhHHHHhCcc
Confidence 34556788998854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.28 Score=43.74 Aligned_cols=29 Identities=24% Similarity=0.055 Sum_probs=24.4
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
...|.|+-+.|||.++ +.+.++||-.|..
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 4799999999999764 5699999988764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.012 Score=46.53 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.6
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
-.+|+|+.|.||++++++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 369999999999998776 99999999875
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.025 Score=48.73 Aligned_cols=50 Identities=24% Similarity=0.285 Sum_probs=33.8
Q ss_pred HHHHHHHHHHHHHHHHhh-----cCCCCeEeecCCCCCeEEcCC------------------CcEEEccccCCCCC
Q 022575 178 TIRMKVALGAAKGLAYLH-----SDKAKVIYRDFKTSNILLDLN------------------YNAKLSDFGLAKDG 230 (295)
Q Consensus 178 ~~~~~~~~~i~~~l~~lH-----~~~~~ivHrDlkp~Nill~~~------------------~~~kl~DFG~a~~~ 230 (295)
..+..++.||+ |-|+- +. .+++|-||||+|||+-+. -.++|.||.+++..
T Consensus 275 ~YvkfifLQia--LLyikIYelp~c-~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIA--LLYIKIYELPCC-TNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHH--HHHeeeecCCCc-ceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 45567777875 44522 11 249999999999999332 24678888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.052 Score=46.76 Aligned_cols=30 Identities=23% Similarity=0.249 Sum_probs=25.9
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 35999999999999987 6789999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.0097 Score=53.54 Aligned_cols=75 Identities=27% Similarity=0.468 Sum_probs=58.0
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceee
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
.....++|.....+|.|+||+|+.+. +...+..+|||.|...+.. ...+..+|...+..+.|+++++++.
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~---------n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~h 114 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQ---------NKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFH 114 (516)
T ss_pred hhhhhccccccccccccCccccCCcc---------ccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhhee
Confidence 34556789999999999999999884 3334557899998765433 3446678899999999999999988
Q ss_pred EEEeC
Q 022575 142 YCLED 146 (295)
Q Consensus 142 ~~~~~ 146 (295)
.|...
T Consensus 115 a~~~~ 119 (516)
T KOG1033|consen 115 AWYER 119 (516)
T ss_pred ceecC
Confidence 77643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.025 Score=45.89 Aligned_cols=29 Identities=31% Similarity=0.402 Sum_probs=20.7
Q ss_pred CeEeecCCCCCeEE-cCCCcEEEccccCCC
Q 022575 200 KVIYRDFKTSNILL-DLNYNAKLSDFGLAK 228 (295)
Q Consensus 200 ~ivHrDlkp~Nill-~~~~~~kl~DFG~a~ 228 (295)
-+.|.||.|.|||+ +.++.++|+||-.|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38899999999999 889999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.088 Score=44.48 Aligned_cols=47 Identities=19% Similarity=0.098 Sum_probs=34.2
Q ss_pred HHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 183 ~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.+..+-..+.-.+..-.-++|.|+.|.|+|.++.+.++|+||-.|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444444554443312389999999999999989999999987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 295 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-32 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-127
Identities = 82/224 (36%), Positives = 124/224 (55%), Gaps = 27/224 (12%)
Query: 46 EGEIL--LGSNIKSFSFNGLKTATRNFRP------DSVLGEGGFGCVFKGWIDEHTYAPA 97
E + L + SFSF LK T NF + +GEGGFG V+KG+++
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------- 53
Query: 98 RPGTGMVIAVKRL----NQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVY 153
+AVK+L + + + ++ EIK + + H NLV+L+G+ + D LVY
Sbjct: 54 ----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109
Query: 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213
+MP GSL + L PLSW +R K+A GAA G+ +LH + I+RD K++NILL
Sbjct: 110 VYMPNGSLLDRLSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILL 166
Query: 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG 257
D + AK+SDFGLA+ +Q+ +++R++GT Y APE + G
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RG 209
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 361 bits (930), Expect = e-126
Identities = 85/227 (37%), Positives = 126/227 (55%), Gaps = 12/227 (5%)
Query: 31 GSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWID 90
GS ++ S+ L+ L+ AT NF ++G G FG V+KG +
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 91 EHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRL 150
+ G +A+KR ES QG E+ TEI+ L HP+LV LIG+C E + +
Sbjct: 62 D----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111
Query: 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210
L+Y++M G+L+ HL+ +SW R+++ +GAA+GL YLH+ +I+RD K+ N
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSIN 169
Query: 211 ILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG 257
ILLD N+ K++DFG++K G Q+H+ST V GT GY PEY G
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG 216
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-106
Identities = 91/218 (41%), Positives = 128/218 (58%), Gaps = 13/218 (5%)
Query: 42 VPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGT 101
VP E + +K FS L+ A+ NF ++LG GGFG V+KG +
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------D 53
Query: 102 GMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGS 160
G ++AVKRL +E QG L++ TE++ + H NL++L G+C+ RLLVY +M GS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNA 219
+ + L R PL W R ++ALG+A+GLAYLH K+I+RD K +NILLD + A
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG 257
+ DFGLAK +HV+T V GT G+ APEY++TG
Sbjct: 174 VVGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTG 210
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-64
Identities = 59/215 (27%), Positives = 85/215 (39%), Gaps = 33/215 (15%)
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
L + + V G FGCV+K + +AVK + Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ- 61
Query: 118 HLEWL--TEIKHLGQLYHPNLVKLIGYCLEDDH----RLLVYEFMPKGSLENHLFRRASY 171
W E+ L + H N+++ IG L+ F KGSL + L
Sbjct: 62 --SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---- 115
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSD--------KAKVIYRDFKTSNILLDLNYNAKLSD 223
+SW +A A+GLAYLH D K + +RD K+ N+LL N A ++D
Sbjct: 116 -NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI 258
FGLA G + + +GT Y APE + I
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-54
Identities = 52/240 (21%), Positives = 92/240 (38%), Gaps = 39/240 (16%)
Query: 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
+ + N + ++G G +G V+KG +D +AVK + + Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ- 50
Query: 118 HLEWLTE--IKHLGQLYHPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRAS 170
++ E I + + H N+ + I LLV E+ P GSL +L
Sbjct: 51 --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--- 105
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSD-------KAKVIYRDFKTSNILLDLNYNAKLSD 223
W ++A +GLAYLH++ K + +RD + N+L+ + +SD
Sbjct: 106 --HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163
Query: 224 FGLAK------DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL 277
FGL+ G + + + +GT Y APE + + + + L
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-50
Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
+G G FG V + W G +AVK L ++ E+L E+ + +L
Sbjct: 44 KIGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN+V +G + + +V E++ +GSL L ++ + L R+ +A AKG+
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGM 150
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YLH+ +++R+ K+ N+L+D Y K+ DFGL++ + S S GT + AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAP 208
Query: 252 E 252
E
Sbjct: 209 E 209
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-47
Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 31/190 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-------EWLTEIKH 127
+G+GGFG V KG V+A+K L +G E+ E+
Sbjct: 26 QIGKGGFGLVHKG-----RLV----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ L HPN+VKL G +V EF+P G L + L +A P+ W++++++ L
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDI 131
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLD-----LNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
A G+ Y+ + +++RD ++ NI L AK++DFGL++ H + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGL 186
Query: 243 MGTYGYAAPE 252
+G + + APE
Sbjct: 187 LGNFQWMAPE 196
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 58/180 (32%), Positives = 86/180 (47%), Gaps = 23/180 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
V+G G FG V K + +A+K++ ES + ++ E++ L ++ HP
Sbjct: 15 VVGRGAFGVVCKA-----KW------RAKDVAIKQIESESERK--AFIVELRQLSRVNHP 61
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+VKL G CL + LV E+ GSL N L A + + M L ++G+AYL
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 195 HSDKAK-VIYRDFKTSNILLDLNYN-AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
HS + K +I+RD K N+LL K+ DFG A D T G+ + APE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPE 173
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-47
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 26/183 (14%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
L E G ++KG W G I VK L ++ E L
Sbjct: 17 KLNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 132 YHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HPN++ ++G C H L+ +MP GSL N L ++ + + +K AL A+
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMAR 122
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
G+A+LH+ + + + ++++D + A++S + S S M +
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWV 175
Query: 250 APE 252
APE
Sbjct: 176 APE 178
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-45
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G FG K T+ TG V+ +K L + + +L E+K + L HP
Sbjct: 17 VLGKGCFGQAIKV-----THR----ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N++K IG +D + E++ G+L + S W+ R+ A A G+AYL
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------------DGPTGSQSHVSTRV 242
HS +I+RD + N L+ N N ++DFGLA+ V
Sbjct: 125 HS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 243 MGTYGYAAPE 252
+G + APE
Sbjct: 183 VGNPYWMAPE 192
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-45
Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL 122
+T R+ +G+G +G V++G W E+ +AVK + + W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSSRDEK---SWF 48
Query: 123 --TEIKHLGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLS 176
TE+ + L H N++ I + H L+ + GSL ++L L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLD 103
Query: 177 WTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--K 228
+++ L A GLA+LH + K + +RD K+ NIL+ N ++D GLA
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPE 252
T + +GT Y APE
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPE 187
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-43
Identities = 68/259 (26%), Positives = 102/259 (39%), Gaps = 59/259 (22%)
Query: 10 DSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEG-EILLGSNIKSFSFNGLKTATR 68
D P + + TSGS S + + V RT I+L +I
Sbjct: 6 DRPFISEGTTLKDLIYDMTTSGSGSGLPLL--VQRTIARTIVLQESI------------- 50
Query: 69 NFRPDSVLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTE--I 125
G+G FG V++G W E +AVK + + W E I
Sbjct: 51 --------GKGRFGEVWRGKWRGEE------------VAVKIFSSREER---SWFREAEI 87
Query: 126 KHLGQLYHPNLVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
L H N++ I +D+ LV ++ GSL ++L R ++ +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMI 142
Query: 182 KVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTG 233
K+AL A GLA+LH + K + +RD K+ NIL+ N ++D GLA D T
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 234 SQSHVSTRVMGTYGYAAPE 252
+ +GT Y APE
Sbjct: 203 TIDIAPNHRVGTKRYMAPE 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 47/193 (24%), Positives = 75/193 (38%), Gaps = 35/193 (18%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL--TEIKHLGQL 131
+G+G +G V+ G W E +AVK W TEI +
Sbjct: 44 QIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWFRETEIYQTVLM 88
Query: 132 YHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
H N++ I ++ L+ ++ GSL ++L L +K+A +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSS 143
Query: 188 AKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVS 239
GL +LH++ K + +RD K+ NIL+ N ++D GLA T
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 240 TRVMGTYGYAAPE 252
+GT Y PE
Sbjct: 204 NTRVGTKRYMPPE 216
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-43
Identities = 40/184 (21%), Positives = 73/184 (39%), Gaps = 25/184 (13%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQL 131
++G+G FG V+ G W E +A++ ++ E + E+ Q
Sbjct: 40 LIGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQT 86
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
H N+V +G C+ H ++ +L + + L ++A KG+
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGM 143
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGY 248
YLH+ ++++D K+ N+ D N ++DFGL G + G +
Sbjct: 144 GYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 249 AAPE 252
APE
Sbjct: 201 LAPE 204
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-43
Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 35/192 (18%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL----EWLTEIKHLG 129
++G GGFG V++ W G +AVK + + E K
Sbjct: 14 IIGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
L HPN++ L G CL++ + LV EF G L L + + I + A+ A+
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIAR 116
Query: 190 GLAYLHSDK-AKVIYRDFKTSNILLD--------LNYNAKLSDFGLAKDGPTGSQSHVST 240
G+ YLH + +I+RD K+SNIL+ N K++DFGLA++
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKM 172
Query: 241 RVMGTYGYAAPE 252
G Y + APE
Sbjct: 173 SAAGAYAWMAPE 184
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-43
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 22/180 (12%)
Query: 76 LGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+G G FG V+KG W + +AVK LN + + E+ L +
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
H N++ +GY +V ++ SL +HL + + +A A+G+
Sbjct: 79 HVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMD 134
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
YLH+ +I+RD K++NI L + K+ DFGLA + S SH ++ G+ + APE
Sbjct: 135 YLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R+ + LG+G FG V Y P + TG V+AVK+L + + ++ EI+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 128 LGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L L H N+VK G C R L+ E++P GSL ++L + I ++
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-HIKLLQY--TS 121
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
KG+ YL + + I+RD T NIL++ K+ DFGL K
Sbjct: 122 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V Y P + TG V+AVK+L + + ++ EI+ L L H
Sbjct: 47 QQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101
Query: 134 PNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
N+VK G C R L+ E++P GSL ++L + I ++ KG+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID-HIKLLQY--TSQICKGM 158
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
YL + + I+RD T NIL++ K+ DFGL K
Sbjct: 159 EYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 58/165 (35%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIK 126
R + LGEG FG V Y P TG +AVK L ES H+ + EI+
Sbjct: 21 RFLKRIRDLGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L LYH N+VK G C ED L+ EF+P GSL+ +L + + I L ++ A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI-NLKQQLKY--A 132
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ KG+ YL S + ++RD N+L++ + K+ DFGL K
Sbjct: 133 VQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R+ + S LG+G FG V Y P TG ++AVK+L ++ EI+
Sbjct: 23 RHLKYISQLGKGNFGSVELC-----RYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 128 LGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMK 182
L L+ +VK G + LV E++P G L + L R + + L +
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY----- 132
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
+ KG+ YL S + ++RD NIL++ + K++DFGLAK P
Sbjct: 133 -SSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 60/170 (35%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIK 126
R + LGEG FG V Y P GTG ++AVK L ++ H W EI
Sbjct: 31 RYLKKIRDLGEGHFGKVSLY-----CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 127 HLGQLYHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L LYH +++K G C + LV E++P GSL ++L R + + L + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFA 140
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
+G+AYLH+ I+RD N+LLD + K+ DFGLAK P G
Sbjct: 141 QQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 15/186 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+G G FG VF G R +V AVK + ++L E + L Q H
Sbjct: 121 QIGRGNFGEVFSG--------RLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+V+LIG C + +V E + G L L +++ AA G+ Y
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEY 228
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L S I+RD N L+ K+SDFG++++ G + + APE
Sbjct: 229 LES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 254 MATGIF 259
+ G +
Sbjct: 287 LNYGRY 292
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-30
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 29/195 (14%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWL-TEI 125
R + D +G G F V+KG +D T + +A L L + + E
Sbjct: 26 RFLKFDIEIGRGSFKTVYKG-LDT--------ETTVEVAWCELQDRKLTKSERQRFKEEA 76
Query: 126 KHLGQLYHPNLVKLIGYCL---EDDHRLLVY-EFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ L L HPN+V+ + +++ E M G+L+ +L R + + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLR 132
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGLAKDGPTGSQSHVST 240
KGL +LH+ +I+RD K NI + + K+ D GLA ++ +
Sbjct: 133 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 188
Query: 241 RVMGTYGYAAPEYMA 255
V+GT PE+MA
Sbjct: 189 AVIGT-----PEFMA 198
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY 132
+LGEG FG V +G GT + +AVK + + S + E+L+E +
Sbjct: 41 ILGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 133 HPNLVKLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVAL 185
HPN+++L+G C+E +++ FM G L +L P ++ +K +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A G+ YL S++ ++RD N +L + ++DFGL+K
Sbjct: 155 DIALGMEYL-SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + + E L E + + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P++ +L+G CL L+ + MP G L +++ I L+W + AKG
Sbjct: 77 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ YL ++++RD N+L+ + K++DFGLAK
Sbjct: 130 MNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 50/197 (25%), Positives = 75/197 (38%), Gaps = 24/197 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+++ LGEGGF V E + G A+KR+ Q E E
Sbjct: 29 KHYLFIQKLGEGGFSYVDLV---EGLH------DGHFYALKRILCHEQQDREEAQREADM 79
Query: 128 LGQLYHPNLVKLIGYCLEDDHR----LLVYEFMPKGSLENHLFRRASYIQPLS-WTIRMK 182
HPN+++L+ YCL + L+ F +G+L N + R L+ I +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LW 138
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ LG +GL +H+ +RD K +NILL L D G +
Sbjct: 139 LLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 243 M-------GTYGYAAPE 252
+ T Y APE
Sbjct: 197 LQDWAAQRCTISYRAPE 213
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 44/213 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+F +VLG+G FG V K + A+K++ + L+E+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---RNA------LDSRYYAIKKIRHTEEKLS-TILSEVM 54
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-------------LVYEFMPKGSLENHLFRRASYIQ 173
L L H +V+ LE + + + E+ G+L + + Q
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 174 P-LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK---- 228
W + ++ L+Y+HS +I+RD K NI +D + N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQILEA----LSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 229 ---------DGPTGSQSHVSTRVMGTYGYAAPE 252
GS ++++ + GT Y A E
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAI-GTAMYVATE 200
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL-Y 132
V+GEG FG V K I + G M A+KR+ + S H ++ E++ L +L +
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIR----------- 180
HPN++ L+G C + L E+ P G+L + L R P
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230
+ A A+G+ YL S K + I+RD NIL+ NY AK++DFGL++
Sbjct: 145 LHFAADVARGMDYL-SQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQ 192
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 39/164 (23%), Positives = 68/164 (41%), Gaps = 17/164 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G F +FKG + Y + +K L++ + + +L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
+LV G C+ D +LV EF+ GSL+ +L ++ + W + + A A + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEV--AKQLAAAMHF 128
Query: 194 LHSDKAKVIYRDFKTSNILLDL--------NYNAKLSDFGLAKD 229
L + +I+ + NILL KLSD G++
Sbjct: 129 L-EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 40/162 (24%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG+G FG V++G + +A+K +N+ S++ +E+L E + +
Sbjct: 32 ELGQGSFGMVYEG----VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL------FRRASYIQPLSWTIRMKVALGA 187
++V+L+G + L++ E M +G L+++L + P S + +++A
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A G+AYL++ K ++RD N ++ ++ K+ DFG+ +D
Sbjct: 148 ADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 47/166 (28%), Positives = 69/166 (41%), Gaps = 17/166 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LGEG FG VF + M++AVK L + S ++ E + L L H
Sbjct: 48 ELGEGAFGKVFLA----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-----------ASYIQPLSWTIRMKV 183
++V+ G C E L+V+E+M G L L PL + V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A A G+ YL ++RD T N L+ K+ DFG+++D
Sbjct: 164 ASQVAAGMVYLAG--LHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKHLGQLYH 133
VLG G FG V+KG + P + +A+K L + + E L E + + +
Sbjct: 22 VLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
P++ +L+G CL L+ + MP G L +++ I L+W + AKG
Sbjct: 77 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ YL ++++RD N+L+ + K++DFGLAK
Sbjct: 130 MNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G +G V++G W + +AVK L +++++ E+L E + ++ H
Sbjct: 227 KLGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 275
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PNLV+L+G C + ++ EFM G+L ++L + M A + + Y
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM--ATQISSAMEY 333
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
L I+R+ N L+ N+ K++DFGL++ TG + APE
Sbjct: 334 LEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPES 390
Query: 254 MATGIF 259
+A F
Sbjct: 391 LAYNKF 396
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G +G V++G W +AVK L +++++ E+L E + ++ H
Sbjct: 20 KLGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 68
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PNLV+L+G C + ++ EFM G+L ++L R Q +S + + +A + + Y
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEY 126
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
L I+RD N L+ N+ K++DFGL++
Sbjct: 127 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR 159
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-28
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTEIKHLGQLY 132
+LG+G FG V + G+ + +AVK L + + E+L E + +
Sbjct: 30 MLGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 133 HPNLVKLIGYCLEDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVA 184
HP++ KL+G L + +++ FM G L L P + ++ ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A G+ YL S I+RD N +L + ++DFGL++
Sbjct: 144 VDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-28
Identities = 52/157 (33%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FGCV+ G G + AVK LN+ + ++LTE + H
Sbjct: 32 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 134 PNLVKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
PN++ L+G CL + L+V +M G L N + R P + + L AKG+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDL-IGFGLQVAKGMK 142
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
YL S K ++RD N +LD + K++DFGLA+D
Sbjct: 143 YLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 54/205 (26%), Positives = 79/205 (38%), Gaps = 47/205 (22%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+ LG GGFG V + H TG +A+K+ QE + E W EI+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---IHQD------TGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 128 LGQLYHPNLVKLI------GYCLEDDHRLLVYEFMPKGSLENHLFRR-----------AS 170
+ +L HPN+V +D LL E+ G L +L + +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA---KLSDFGLA 227
+ + + L YLH + ++I+RD K NI+L K+ D G A
Sbjct: 126 LLSDI------------SSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPE 252
K+ G V GT Y APE
Sbjct: 172 KELDQGELCT--EFV-GTLQYLAPE 193
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 33/202 (16%), Positives = 65/202 (32%), Gaps = 18/202 (8%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL 122
+ ++ +LGEG F V++ +K +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEA---TQGDLNDAK-NKQKFVLKVQKPANPWEFYIGT 115
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-QPLSWTIRM 181
++ L +K L + +LV E G+L N + + + + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-----------DLNYNAKLSDFGLAKDG 230
A+ + +H ++I+ D K N +L DL+ L D G + D
Sbjct: 176 SFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 231 PTGSQSHVSTRVMGTYGYAAPE 252
+ + T T G+ E
Sbjct: 234 KLFPKGTIFTAKCETSGFQCVE 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 30/231 (12%)
Query: 23 RKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTAT--------RNFRPDS 74
R+ SSS S+ +V T + +
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V +P + +AVK L + + + + ++E+ K +G+
Sbjct: 88 PLGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWT 178
H N++ L+G C +D ++ E+ KG+L +L R + +++
Sbjct: 146 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A+G+ YL S K I+RD N+L+ N K++DFGLA+D
Sbjct: 204 DLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARD 252
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYH 133
VLG G FG V KG + P + + +K + +S Q + +G L H
Sbjct: 20 VLGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP---LSWTIRMKVALGAAKG 190
++V+L+G C LV +++P GSL +H+ + + P L+W + AKG
Sbjct: 75 AHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKG 127
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ YL +++R+ N+LL +++DFG+A
Sbjct: 128 MYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
LGEG FG VF Y + M++AVK L +L ++ E + L L H +
Sbjct: 23 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 136 LVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWTIRMKV 183
+VK G C + D ++V+E+M G L L L + + +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
A A G+ YL S ++RD T N L+ N K+ DFG+++D
Sbjct: 139 ASQIASGMVYLAS--QHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 12/156 (7%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
++G G G V G V A+K L + + ++L+E +GQ H
Sbjct: 56 IIGSGDSGEVCYG-----RLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDH 109
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+++L G ++V E+M GSL+ L + + + G G+ Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRY 166
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L ++RD N+L+D N K+SDFGL++
Sbjct: 167 LSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G G FG V G W+++ +A+K + + ++ +++ E + + +L H
Sbjct: 15 EIGSGQFGLVHLGYWLNKDK-----------VAIKTIREGAMSEE-DFIEEAEVMMKLSH 62
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P LV+L G CLE LV EFM G L ++L R + + M L +G+AY
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGM--CLDVCEGMAY 119
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L A VI+RD N L+ N K+SDFG+ +
Sbjct: 120 LEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V +P + +AVK L + + + + ++E+ K +G+
Sbjct: 42 PLGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR---------- 180
H N++ L+G C +D ++ E+ KG+L +L R S+ I
Sbjct: 100 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 181 --MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A+G+ YL S K I+RD N+L+ N K++DFGLA+D
Sbjct: 158 DLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARD 206
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G+G FG V G + +AVK + ++ +L E + QL H
Sbjct: 28 TIGKGEFGDVMLGDYRGNK-----------VAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
NLV+L+G +E+ L +V E+M KGSL ++L R+ L +K +L + + Y
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L ++RD N+L+ + AK+SDFGL K+
Sbjct: 133 LEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 166
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 20/163 (12%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
+G+G FG V G + G +AVK + ++ +L E + QL H
Sbjct: 200 TIGKGEFGDVMLGDY------------RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRH 245
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
NLV+L+G +E+ L +V E+M KGSL ++L R + ++ +L + +
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF--SLDVCEAME 303
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
YL ++RD N+L+ + AK+SDFGL K+ +
Sbjct: 304 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 344
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-27
Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V G W ++ +AVK + + S+ E+ E + + +L H
Sbjct: 15 ELGSGQFGVVKLGKWKGQYD-----------VAVKMIKEGSMSED-EFFQEAQTMMKLSH 62
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P LVK G C ++ +V E++ G L N+L ++P S + M +G+A+
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEM--CYDVCEGMAF 119
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L S + I+RD N L+D + K+SDFG+ +
Sbjct: 120 LES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 22/196 (11%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WL 122
T+ + +LG+G VF+G H TG + A+K N S ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKK------TGDLFAIKVFNNISFLRPVDVQM 55
Query: 123 TEIKHLGQLYHPNLVKLIGY--CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
E + L +L H N+VKL H++L+ EF P GSL L S L +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEF 114
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 236
+ V G+ +L +++R+ K NI+ D KL+DFG A++
Sbjct: 115 LIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170
Query: 237 HVSTRVMGTYGYAAPE 252
+ GT Y P+
Sbjct: 171 QFVSLY-GTEEYLHPD 185
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 13/157 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FGCV+ G G + AVK LN+ + ++LTE + H
Sbjct: 96 VIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 134 PNLVKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
PN++ L+G CL + L+V +M G L N + R ++ + I L AKG+
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGF--GLQVAKGMK 206
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+L S K ++RD N +LD + K++DFGLA+D
Sbjct: 207 FLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 55/234 (23%), Positives = 85/234 (36%), Gaps = 33/234 (14%)
Query: 27 NGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFK 86
S S+++ + +LL +K + + +G G FG V +
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE-YREEVHWMTHQPRVGRGSFGEVHR 76
Query: 87 GWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146
D+ TG AVK++ E + E+ L P +V L G E
Sbjct: 77 M-KDK--------QTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREG 122
Query: 147 DHRLLVYEFMPKGSLENHLFRRASYIQ---PLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203
+ E + GSL I+ L + A +GL YLH+ ++++
Sbjct: 123 PWVNIFMELLEGGSL-------GQLIKQMGCLPEDRALYYLGQALEGLEYLHTR--RILH 173
Query: 204 RDFKTSNILLDLN-YNAKLSDFGLAK----DGPTGSQSHVSTRVMGTYGYAAPE 252
D K N+LL + A L DFG A DG S + GT + APE
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPE 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LG G FG V + + + + +AVK L ++E+ HLGQ
Sbjct: 53 TLGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ----------PLSWTIR 180
H N+V L+G C L++ E+ G L N L R++ ++ S
Sbjct: 109 --HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + A+G+A+L S I+RD N+LL + AK+ DFGLA+D
Sbjct: 167 LHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 7e-27
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V G W ++ +A+K + + S+ E++ E K + L H
Sbjct: 31 ELGTGQFGVVKYGKWRGQYD-----------VAIKMIKEGSMSED-EFIEEAKVMMNLSH 78
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L G C + ++ E+M G L N+L R + + M + + Y
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEM--CKDVCEAMEY 135
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L S + ++RD N L++ K+SDFGL++
Sbjct: 136 LES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 22/171 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LGEG FG V + +P +AVK L + + + + ++E+ K +G+
Sbjct: 76 PLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWT 178
H N++ L+G C +D ++ E+ KG+L +L R + + LS
Sbjct: 134 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 192 DLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FG V+KG + + +A+K L + + +++L E +GQ H
Sbjct: 51 VIGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
N+++L G + +++ E+M G+L+ L R + + M G A G+ Y
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGM--LRGIAAGMKY 162
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L + ++RD NIL++ N K+SDFGL++
Sbjct: 163 LAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 19/181 (10%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG+G +G V+ G + IA+K + + + EI L H
Sbjct: 29 VLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVALGAAKGLA 192
N+V+ +G E+ + E +P GSL L + ++ TI K L +GL
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLK 136
Query: 193 YLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
YLH + ++++RD K N+L++ + K+SDFG +K G T GT Y AP
Sbjct: 137 YLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTET-FTGTLQYMAP 192
Query: 252 E 252
E
Sbjct: 193 E 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 41/201 (20%), Positives = 76/201 (37%), Gaps = 22/201 (10%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
++ F + R + +G GG VF+ + A+K +N E
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEA 65
Query: 116 QGHL--EWLTEIKHLGQLYHPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY 171
+ EI +L +L + ++L Y + D + +V E L + L ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--- 121
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ + R + + +H +++ D K +N L+ + KL DFG+A
Sbjct: 122 -KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177
Query: 232 TGSQSHVSTRVMGTYGYAAPE 252
+ S V +GT Y PE
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPE 198
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQ 130
D LG G FG V KG+ +AVK L E+ L E L E + Q
Sbjct: 22 DKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L +P +V++IG C + +LV E G L +L ++ ++ I + + G
Sbjct: 75 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHV-KDKNIIEL--VHQVSMG 129
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ YL + ++RD N+LL + AK+SDFGL+K
Sbjct: 130 MKYL-EES-NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 54/162 (33%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LG G FG V++G + + P P V AVK L + S Q L++L E + + H
Sbjct: 78 GLGHGAFGEVYEG---QVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIR--MKVALGAAKG 190
N+V+ IG L+ R ++ E M G L++ L R QP S + + VA A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKD 229
YL + I+RD N LL AK+ DFG+A+D
Sbjct: 194 CQYL-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
+LGEG FG V++G + + G + +AVK ++ +L ++++E + L
Sbjct: 19 ILGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
HP++VKLIG E+ ++ E P G L ++L R + + +L K +A
Sbjct: 72 HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLY--SLQICKAMA 127
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
YL S ++RD NIL+ KL DFGL++
Sbjct: 128 YLES--INCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G+G FG V+ G + + A+K L++ +Q +L E + L H
Sbjct: 28 VIGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 134 PNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA 192
PN++ LIG L + ++ +M G L + R + I L A+G+
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISF--GLQVARGME 138
Query: 193 YLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----GPTGSQSHVSTRV----MG 244
YL K ++RD N +LD ++ K++DFGLA+D Q H R+
Sbjct: 139 YLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT- 195
Query: 245 TYGYAAPEYMATGIF 259
A E + T F
Sbjct: 196 -----ALESLQTYRF 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 19/186 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V+ G W +A+K L ++ +L E + + +L H
Sbjct: 191 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMSPE-AFLQEAQVMKKLRH 238
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L E+ +V E+M KGSL + L L + M A A G+AY
Sbjct: 239 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAY 295
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
+ ++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 296 VER--MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 352
Query: 254 MATGIF 259
G F
Sbjct: 353 ALYGRF 358
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 19/168 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGE FG V+KG H + PA +A+K L + E+ E +L H
Sbjct: 16 ELGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLSWTIRM 181
PN+V L+G +D +++ + G L L R + L +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ A G+ YL S V+++D T N+L+ N K+SD GL ++
Sbjct: 132 HLVAQIAAGMEYL-SSH-HVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 22/196 (11%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WL 122
T+ + +LG+G VF+G H TG + A+K N S ++ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKK------TGDLFAIKVFNNISFLRPVDVQM 55
Query: 123 TEIKHLGQLYHPNLVKLIGY--CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
E + L +L H N+VKL H++L+ EF P GSL L S L +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEF 114
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQS 236
+ V G+ +L +++R+ K NI+ D KL+DFG A++
Sbjct: 115 LIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDE 170
Query: 237 HVSTRVMGTYGYAAPE 252
+ GT Y P+
Sbjct: 171 QFVSLY-GTEEYLHPD 185
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 39/206 (18%), Positives = 77/206 (37%), Gaps = 39/206 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----- 123
++R L +G F + E A+K+ + L+ ++
Sbjct: 32 DYRIIRTLNQGKFNKIILC---EKD--------NKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 124 ------------EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRAS 170
E++ + + + + G + + + ++YE+M S+
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 171 YIQPLSWTIRMKVAL----GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226
+ + I ++V +Y+H++K + +RD K SNIL+D N KLSDFG
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 227 AKDGPTGSQSHVSTRVMGTYGYAAPE 252
++ + GTY + PE
Sbjct: 199 SEYMVDK---KIKG-SRGTYEFMPPE 220
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 51/163 (31%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLY 132
LG G FG V++G + +AVK L + S Q L++L E + +
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSP-----LQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHL-FRRASYIQPLSWTIR--MKVALGAAK 189
H N+V+ IG L+ R ++ E M G L++ L R QP S + + VA A
Sbjct: 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKD 229
G YL + I+RD N LL AK+ DFG+A+D
Sbjct: 152 GCQYL-EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 46/193 (23%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHL 128
LG+G FG V+ AR + ++A+K L + L+ L E++
Sbjct: 16 PLGKGKFGNVYL----------AREKQSKFILALKVLFKAQLEKAGVEHQLR--REVEIQ 63
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQPLSWTI 179
L HPN+++L GY D R+ L+ E+ P G++ L + A+YI L
Sbjct: 64 SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL---- 118
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
A L+Y HS + VI+RD K N+LL K++DFG + P+ + +
Sbjct: 119 --------ANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---T 165
Query: 240 TRVMGTYGYAAPE 252
+ GT Y PE
Sbjct: 166 D-LCGTLDYLPPE 177
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 55/201 (27%), Positives = 82/201 (40%), Gaps = 36/201 (17%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+F+ ++G GGFG VFK G +KR+ + + E+K
Sbjct: 11 MDFKEIELIGSGGFGQVFKAK---------HRIDGKTYVIKRVKYNNEKA----EREVKA 57
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL----------------LVYEFMPKGSLENHLFRRASY 171
L +L H N+V G D+ + EF KG+LE + +R
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG- 116
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ L + +++ KG+ Y+HS K +I RD K SNI L K+ DFGL
Sbjct: 117 -EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVT--- 170
Query: 232 TGSQSHVSTRVMGTYGYAAPE 252
+ TR GT Y +PE
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPE 191
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 35/207 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+F P LG GGFG VF+ A+KR+ + + E + E+K
Sbjct: 6 DFEPIQCLGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 128 LGQLYHPNLVKLIGYCLEDD---------HRLLVY---EFMPKGSLENHLFRRASYIQPL 175
L +L HP +V+ LE + ++ +Y + K +L++ + R I+
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEER 115
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK------- 228
++ + + L A+ + +LHS +++RD K SNI ++ K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173
Query: 229 ---DGPTGSQSHVSTRVMGTYGYAAPE 252
T +GT Y +PE
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPE 200
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 51/188 (27%), Positives = 69/188 (36%), Gaps = 23/188 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+F+ S LG G +G VFK G + AVKR + L E+
Sbjct: 58 SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108
Query: 127 -HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQ-PLSWTIRMKVA 184
H HP V+L E L E SL+ H + + W
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L LA+LHS +++ D K +NI L KL DFGL + G+ + G
Sbjct: 168 LA----LAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-G 218
Query: 245 TYGYAAPE 252
Y APE
Sbjct: 219 DPRYMAPE 226
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 19/186 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG+G FG V+ G W +A+K L ++ +L E + + +L H
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-----------VAIKTLKPGTMSPE-AFLQEAQVMKKLRH 321
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L E+ +V E+M KGSL + L L + M A A G+AY
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM--AAQIASGMAY 378
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEY 253
+ ++RD + +NIL+ N K++DFGLA+ ++ + APE
Sbjct: 379 VER--MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEA 435
Query: 254 MATGIF 259
G F
Sbjct: 436 ALYGRF 441
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHL---EWLTEIKHLGQ 130
LG+G FG V +G W A G + +AVK L + L +++ E+ +
Sbjct: 25 KLGDGSFGVVRRGEWD-------APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L H NL++L G L +V E P GSL + L + + L R A+ A+G
Sbjct: 78 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHF-LLGTLSRY--AVQVAEG 133
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ YL S + I+RD N+LL K+ DFGL +
Sbjct: 134 MGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 43/246 (17%), Positives = 85/246 (34%), Gaps = 33/246 (13%)
Query: 14 PNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPD 73
+G + S + + + + + S + S G R +
Sbjct: 7 SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-----RIYSIL 61
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKR-----LNQESLQGHLEWLTEIKHL 128
+G GG VF+ + A+K + ++L + EI +L
Sbjct: 62 KQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYL 108
Query: 129 GQLYHPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+L + ++L Y + D + +V E L + L ++ + + R
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKN 163
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ + +H +++ D K +N L+ + KL DFG+A + S V +G
Sbjct: 164 MLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 247 GYAAPE 252
Y PE
Sbjct: 221 NYMPPE 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
V+G G FG V G V A+K L + + ++L E +GQ H
Sbjct: 52 VVGAGEFGEVCSG-----RLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
PN+++L G + ++V E+M GSL++ L + + + + + G A G+ Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L SD ++RD NIL++ N K+SDFGL +
Sbjct: 163 L-SDM-GYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 18/156 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ G + +AVK L Q S+ +L E + QL H
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-----------VAVKSLKQGSMSPD-AFLAEANLMKQLQH 67
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LV+L ++ ++ E+M GSL + L + ++ + M A A+G+A+
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM--AAQIAEGMAF 124
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ I+RD + +NIL+ + K++DFGLA+
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 43/217 (19%), Positives = 84/217 (38%), Gaps = 31/217 (14%)
Query: 43 PRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG--WIDEHTYAPARPG 100
+ ++ F ++ + +GEG FG D Y
Sbjct: 3 HHHHHSSGVDLGTENLYFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYV----- 53
Query: 101 TGM-VIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG 159
+ I + R++ + + E E+ L + HPN+V+ E+ +V ++ G
Sbjct: 54 --IKEINISRMSSKERE---ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 160 SLENHLFRRASYIQP----LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
L + + + L W +++ L ++H K +++RD K+ NI L
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHDRK--ILHRDIKSQNIFLTK 160
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+ +L DFG+A+ S ++ +GT Y +PE
Sbjct: 161 DGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPE 195
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 55/194 (28%), Positives = 84/194 (43%), Gaps = 48/194 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVK-----RLNQESLQGHLEWLTEIKHL 128
LG+G FG V+ AR ++A+K +L +E ++ L EI+
Sbjct: 21 PLGKGKFGNVYL----------AREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQ 68
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQPLSWTI 179
L HPN++++ Y D R+ L+ EF P+G L L + A++++ L
Sbjct: 69 SHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL---- 123
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
A L Y H K VI+RD K N+L+ K++DFG + P+
Sbjct: 124 --------ADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----R 168
Query: 240 TRVM-GTYGYAAPE 252
R M GT Y PE
Sbjct: 169 RRTMCGTLDYLPPE 182
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH 133
LG G FG V+ + +AVK + S+ +L E + L H
Sbjct: 195 KLGAGQFGEVWMATYNKHTK-----------VAVKTMKPGSMSVE-AFLAEANVMKTLQH 242
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
LVKL ++ ++ EFM KGSL + L QPL I + A+G+A+
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAF 299
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ I+RD + +NIL+ + K++DFGLA+
Sbjct: 300 IEQ--RNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 27/176 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG VF+ ++AVK L +E S ++ E + + +
Sbjct: 54 DIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--------------------ASYIQ 173
PN+VKL+G C L++E+M G L L +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
PLS ++ +A A G+AYL K ++RD T N L+ N K++DFGL+++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 50/173 (28%), Positives = 70/173 (40%), Gaps = 26/173 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
LG G FG V + Y + M +AVK L L ++E+ +LG
Sbjct: 30 TLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--------------ASYIQPLS 176
H N+V L+G C L++ E+ G L N L R+ L
Sbjct: 86 --HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + AKG+A+L S I+RD NILL K+ DFGLA+D
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARD 194
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 14/158 (8%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL 131
D LG G FG V +G Y + +A+K L Q + E + E + + QL
Sbjct: 15 DIELGCGNFGSVRQG-----VYRM--RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+P +V+LIG C + +LV E G L L + I P+S + + G+
Sbjct: 68 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAEL--LHQVSMGM 123
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
YL +K ++RD N+LL + AK+SDFGL+K
Sbjct: 124 KYL-EEK-NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 13/156 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG V +G Y V A+K S ++L E + Q H
Sbjct: 22 CIGEGQFGDVHQG-----IYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P++VKLIG E+ ++ E G L + L R + S I A + LAY
Sbjct: 76 PHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLAS-LILY--AYQLSTALAY 131
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L S + ++RD N+L+ N KL DFGL++
Sbjct: 132 LES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 46/191 (24%), Positives = 80/191 (41%), Gaps = 24/191 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE---WLTEI 125
NFR + +G G F V++ G+ +A+K++ L + EI
Sbjct: 33 NFRIEKKIGRGQFSEVYRAA---------CLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS----WTIRM 181
L QL HPN++K +ED+ +V E G L + + + W +
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
++ L ++HS + V++RD K +N+ + KL D GL + + + +
Sbjct: 144 QLCSA----LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSL 196
Query: 242 VMGTYGYAAPE 252
V GT Y +PE
Sbjct: 197 V-GTPYYMSPE 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 51/200 (25%), Positives = 77/200 (38%), Gaps = 44/200 (22%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWL 122
R + LG+GGF F+ T V A K L + + +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---SDA------DTKEVFAGKIVPKSLLLKPHQREKMS-- 63
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQ 173
EI L H ++V G+ ED+ + +V E + SL RR Y++
Sbjct: 64 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+ G YLH ++ VI+RD K N+ L+ + K+ DFGLA
Sbjct: 123 QI------------VLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 234 SQSHVSTRVM-GTYGYAAPE 252
+ +V+ GT Y APE
Sbjct: 169 GERK---KVLCGTPNYIAPE 185
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 52/176 (29%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
LGEG FG V K + R G V AVK L + S + L+E L Q+ H
Sbjct: 30 TLGEGEFGKVVKA---TAFHLKGRAGYTTV-AVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--------------------ASYIQ 173
P+++KL G C +D LL+ E+ GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L+ + A ++G+ YL ++ K+++RD NIL+ K+SDFGL++D
Sbjct: 146 ALTMGDLISFAWQISQGMQYL-AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRD 199
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 51/200 (25%), Positives = 77/200 (38%), Gaps = 44/200 (22%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWL 122
R + LG+GGF F+ T V A K L + + +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEI---SDA------DTKEVFAGKIVPKSLLLKPHQREKMS-- 89
Query: 123 TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR--------ASYIQ 173
EI L H ++V G+ ED+ + +V E + SL RR Y++
Sbjct: 90 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 148
Query: 174 PLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+ G YLH ++ VI+RD K N+ L+ + K+ DFGLA
Sbjct: 149 QI------------VLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 234 SQSHVSTRVM-GTYGYAAPE 252
+ +V+ GT Y APE
Sbjct: 195 GERK---KVLCGTPNYIAPE 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 39/182 (21%), Positives = 70/182 (38%), Gaps = 22/182 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQLY 132
+G GG VF+ + A+K +N E + EI +L +L
Sbjct: 16 QIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 133 HPNL--VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
+ ++L Y + D + +V E L + L ++ + + R +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAA 250
+ +H +++ D K +N L+ + KL DFG+A + S V +GT Y
Sbjct: 121 VHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 251 PE 252
PE
Sbjct: 178 PE 179
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 27/173 (15%)
Query: 75 VLGEGGFGCVFKG-WIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLG 129
LG G FG V + + T +AVK L + + H ++E+ H+G
Sbjct: 34 PLGRGAFGQVIEADAFG-----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 130 QLYHPNLVKLIGYCL-EDDHRLLVYEFMPKGSLENHLFRR------------ASYIQPLS 176
H N+V L+G C +++ EF G+L +L + Y L+
Sbjct: 89 H--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 147 LEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARD 197
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
D LG G FG V +G Y + +A+K L Q E + E + + QL
Sbjct: 341 DIELGCGNFGSVRQG-----VYRM--RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+P +V+LIG C + +LV E G L L + I P+S + + G+
Sbjct: 394 DNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI-PVSNVAEL--LHQVSMGM 449
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
YL +K ++R+ N+LL + AK+SDFGL+K
Sbjct: 450 KYL-EEK-NFVHRNLAARNVLLVNRHYAKISDFGLSKA 485
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 31/178 (17%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEI---KHLGQ 130
VLG G FG V Y ++ G + +AVK L ++ ++E+ LG
Sbjct: 52 VLGSGAFGKVMNATA----YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------------------ASY 171
H N+V L+G C L++E+ G L N+L +
Sbjct: 108 --HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ L++ + A AKG+ +L ++RD N+L+ K+ DFGLA+D
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 52/204 (25%), Positives = 79/204 (38%), Gaps = 30/204 (14%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R VL EGGF V++ + +G A+KRL + + + E+
Sbjct: 28 LRLRVRRVLAEGGFAFVYEA---QDVG------SGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 128 LGQL-YHPNLVKLIGYCLEDDHR-------LLVYEFMPKGSLENHLFRRASYIQPLS-WT 178
+ +L HPN+V+ L+ + KG L L + S PLS T
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDT 137
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA---KDGPTGSQ 235
+ K+ + + ++H K +I+RD K N+LL KL DFG A P S
Sbjct: 138 VL-KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 236 SHVSTRVM-------GTYGYAAPE 252
S ++ T Y PE
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPE 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 8e-25
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 39/190 (20%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEW--LTEIKHLGQLY 132
LG+G F V++ E TG+ +A+K ++++++ + E+K QL
Sbjct: 19 LGKGSFAGVYRA---ESI------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR---------ASYIQPLSWTIRMK 182
HP++++L Y ED + + LV E G + +L R ++ +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------- 121
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
G+ YLHS +++RD SN+LL N N K++DFGLA + H T +
Sbjct: 122 -----ITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-L 172
Query: 243 MGTYGYAAPE 252
GT Y +PE
Sbjct: 173 CGTPNYISPE 182
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYH 133
+GEG FG V +G + M +A+K S ++L E + Q H
Sbjct: 397 CIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAY 193
P++VKLIG E + ++ E G L + L + + L+ I A + LAY
Sbjct: 451 PHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLILY--AYQLSTALAY 506
Query: 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
L S + ++RD N+L+ N KL DFGL++
Sbjct: 507 LES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 28/192 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+F P VLG G G + + +AVKR+ E E++ L
Sbjct: 25 SFCPKDVLGHGAEGTIVY----RGMF------DNRDVAVKRILPECFSFADR---EVQLL 71
Query: 129 GQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ HPN+++ + + + E +L+ ++ ++ + +
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQT 127
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAKLSDFGLAK--DGPTGSQSHVST 240
GLA+LHS +++RD K NIL+ A +SDFGL K S S S
Sbjct: 128 TSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 241 RVMGTYGYAAPE 252
GT G+ APE
Sbjct: 186 VP-GTEGWIAPE 196
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 42/245 (17%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE 120
N ++ + +LG G G V + ++ G +AVKR+ + L
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVF----QGSF------QGRPVAVKRMLIDFCDIALM 57
Query: 121 WLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
EIK L + HPN+++ D + E +L++ + + + L
Sbjct: 58 ---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQK 113
Query: 180 RMKVA---LGAAKGLAYLHSDKAKVIYRDFKTSNILLD-------------LNYNAKLSD 223
A G+A+LHS K+I+RD K NIL+ N +SD
Sbjct: 114 EYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 224 FGLAK---DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLP 280
FGL K G + +++++ GT G+ APE + T + FS+
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDI--FSMG-- 226
Query: 281 MCVLY 285
CV Y
Sbjct: 227 -CVFY 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 58/193 (30%), Positives = 81/193 (41%), Gaps = 28/193 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
F VLG GGFG VF A TG + A K+LN++ L + + + E
Sbjct: 186 WFLDFRVLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-- 182
K L +++ +V L Y E L LV M G + H++ R
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFY 294
Query: 183 ---VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ G L +LH +IYRD K N+LLD + N ++SD GLA + G
Sbjct: 295 TAQIVSG----LEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TK 347
Query: 240 TRVMGTYGYAAPE 252
GT G+ APE
Sbjct: 348 GYA-GTPGFMAPE 359
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-24
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 18/197 (9%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLE 120
+ + ++ +G G +G K R G ++ K L+ S+
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQM 51
Query: 121 WLTEIKHLGQLYHPNLVKLIG-YCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
++E+ L +L HPN+V+ + L +V E+ G L + + + Q L
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 179 IRMKVALGAAKGLAYLHSDKA---KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
++V L H V++RD K +N+ LD N KL DFGLA+
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDT 170
Query: 236 SHVSTRVMGTYGYAAPE 252
S T V GT Y +PE
Sbjct: 171 SFAKTFV-GTPYYMSPE 186
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 7e-24
Identities = 40/260 (15%), Positives = 83/260 (31%), Gaps = 37/260 (14%)
Query: 21 CSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGG 80
+R +S + S + + G + S G + R +VLG+
Sbjct: 28 FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERP--RTLVRGTVLGQED 85
Query: 81 FGCVFKGWIDEHT---YA------PARPGTGMVIAVKR-----------LNQESLQGHLE 120
+ D+ T + RP + + +K NQ+ + HL
Sbjct: 86 PYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPK-----GSLENHLFRRASYIQPL 175
++ + ++++ D L + P+ + L +S + L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLD-ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
R+++ L + LA LH +++ + +I+LD L+ F +
Sbjct: 204 VHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV------R 255
Query: 236 SHVSTRVMGTYGYAAPEYMA 255
+ G+ PE A
Sbjct: 256 DGARVVSSVSRGFEPPELEA 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-24
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 18/186 (9%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ + +G+G G V+ +D T G +A++++N + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEIL 69
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ + +PN+V + L D +V E++ GSL + + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE 124
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ L +LHS+ +VI+RD K+ NILL ++ + KL+DFG T QS ST V GT
Sbjct: 125 CLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRSTMV-GTP 180
Query: 247 GYAAPE 252
+ APE
Sbjct: 181 YWMAPE 186
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG+G FG V+K ++ T G + A K + +S + +++ EI+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
HP +VKL+G D ++ EF P G+++ + + L+ V +
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLE 128
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
L +LHS + +I+RD K N+L+ L + +L+DFG++
Sbjct: 129 ALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 61/193 (31%), Positives = 85/193 (44%), Gaps = 31/193 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
FR VLG+GGFG V A TG + A K+L ++ + + L E
Sbjct: 185 TFRQYRVLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-- 182
+ L ++ +V L Y E L LV M G L+ H++ P + R
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFY 291
Query: 183 ---VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ G L LH ++ ++YRD K NILLD + + ++SD GLA P G
Sbjct: 292 AAEICCG----LEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-- 343
Query: 240 TRVMGTYGYAAPE 252
RV GT GY APE
Sbjct: 344 GRV-GTVGYMAPE 355
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-23
Identities = 45/208 (21%), Positives = 68/208 (32%), Gaps = 39/208 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTE 124
T F +G G FG VFK + G + A+KR + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV---------KRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L H ++V+ EDDH L+ E+ GSL + + + +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-------------------YNAKLSDF 224
L +GL Y+HS +++ D K SNI + K+ D
Sbjct: 121 LLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
G S G + A E
Sbjct: 179 GHVT-----RISSPQVEE-GDSRFLANE 200
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHL 128
F +G+G FG VFKG ID T V+A+K ++ E + +E + EI L
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
Q P + K G L+D ++ E++ GS L PL T +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEP----GPLDETQIATILREIL 129
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
KGL YLHS+K I+RD K +N+LL + KL+DFG+A
Sbjct: 130 KGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-23
Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYH 133
V+G G V +A+KR+N E Q ++ L EI+ + Q +H
Sbjct: 22 VIGSGATAVVQAA-YCA--------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR-------MKVALG 186
PN+V + D LV + + GS+ + + + + S + ++ L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL- 131
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG----LAKDGPTGSQSHVSTRV 242
+GL YLH + I+RD K NILL + + +++DFG LA G T V
Sbjct: 132 --EGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 243 MGTYGYAAPEYM 254
GT + APE M
Sbjct: 188 -GTPCWMAPEVM 198
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 18/186 (9%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+GEG G V ++H+ G +AVK ++ Q E+
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ H N+V++ L + ++ EF+ G+L + + + L+ V
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEA 149
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ LAYLH+ VI+RD K+ +ILL L+ KLSDFG + + V GT
Sbjct: 150 VLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKSLV-GTP 205
Query: 247 GYAAPE 252
+ APE
Sbjct: 206 YWMAPE 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-23
Identities = 55/184 (29%), Positives = 80/184 (43%), Gaps = 19/184 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIKHL 128
F S LG G G VFK H +G+V+A K ++ E + E++ L
Sbjct: 35 FEKISELGAGNGGVVFKV---SHK------PSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ P +V G D + E M GSL+ L + I KV++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVI 141
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
KGL YL K+++RD K SNIL++ KL DFG++ S ++ V GT Y
Sbjct: 142 KGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-GTRSY 196
Query: 249 AAPE 252
+PE
Sbjct: 197 MSPE 200
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 1e-22
Identities = 52/196 (26%), Positives = 86/196 (43%), Gaps = 37/196 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTE- 124
+F ++G GGFG V+ + TG + A+K L+++ + + L E
Sbjct: 190 DFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 125 --IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ + P +V + Y +L + + M G L HL + + + M
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DM 294
Query: 182 K-----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ + LG L ++H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 295 RFYAAEIILG----LEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346
Query: 237 HVSTRVMGTYGYAAPE 252
V GT+GY APE
Sbjct: 347 -PHASV-GTHGYMAPE 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 43/215 (20%), Positives = 77/215 (35%), Gaps = 37/215 (17%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHT---YA---PARPGTGMVIAVKRLNQESLQGHLE 120
R +VLG+ + D+ T + P A+K++ +E L+ L
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLR--LR 133
Query: 121 WLTEIKHLGQ-------------LYHPNLVKLIGYCLEDDHRLLVYEF--MPK-----GS 160
L IK+ Q + P K+I L++ ++ F P+ +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
L +S + L R+++ L + LA LH +++ + +I+LD
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVF 251
Query: 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA 255
L+ F G+ S G+A PE A
Sbjct: 252 LTGFEHLV--RDGA----SAVSPIGRGFAPPETTA 280
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 49/185 (26%), Positives = 73/185 (39%), Gaps = 16/185 (8%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIK-H 127
P LG G +G V K H +G ++AVKR+ Q L ++
Sbjct: 9 LEPIMELGRGAYGVVEKM---RHV------PSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ + P V G + + E M SL+ + Q + I K+A+
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
K L +LHS K VI+RD K SN+L++ K+ DFG++ G
Sbjct: 119 VKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKP 174
Query: 248 YAAPE 252
Y APE
Sbjct: 175 YMAPE 179
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 33/249 (13%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
G S + S S+ V +G + + + + + ++ V
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKV-TTVVATPGQGPDRPQEVSYTDTKV 61
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G FG V++ + + +G ++A+K++ Q+ E++ + +L H N
Sbjct: 62 IGNGSFGVVYQAKLCD---------SGELVAIKKVLQDK----RFKNRELQIMRKLDHCN 108
Query: 136 LVKLIGYCLEDDHRL------LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL-GAA 188
+V+L + + LV +++P+ ++ + Q L I +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF 166
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQ--SHVSTRVMGT 245
+ LAY+HS + +RD K N+LLD + KL DFG AK G S++ +R
Sbjct: 167 RSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 246 YGYAAPEYM 254
Y Y APE +
Sbjct: 221 Y-YRAPELI 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 52/164 (31%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
+ F +G G FG V+ D V+A+K+++ Q + +W +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKMSYSGKQSNEKWQDIIK 103
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
E++ L +L HPN ++ G L + LV E+ GS + L +PL V
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAV 159
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
GA +GLAYLHS +I+RD K NILL KL DFG A
Sbjct: 160 THGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 57/187 (30%), Positives = 89/187 (47%), Gaps = 20/187 (10%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN-QESLQGHLEWLTEI 125
F LGEG +G V+K H TG ++A+K++ + LQ E + EI
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA---IHK------ETGQIVAIKQVPVESDLQ---EIIKEI 75
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ Q P++VK G ++ +V E+ GS+ + + R L+ +
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQ 132
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
KGL YLH + I+RD K NILL+ +AKL+DFG+A T + + +T + GT
Sbjct: 133 STLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQ-LTDTMAKRNTVI-GT 188
Query: 246 YGYAAPE 252
+ APE
Sbjct: 189 PFWMAPE 195
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 9e-22
Identities = 23/219 (10%), Positives = 43/219 (19%), Gaps = 47/219 (21%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
R + L G VF A+K + E
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVR---------DVERLEDFALKVFTMGAENSRSELERLHE 111
Query: 124 EIKHLGQLYHPNLVKLIGYC--------------------------LEDDHRLLVYEFMP 157
+L + + + LL+
Sbjct: 112 ATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS 171
Query: 158 --KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215
L + L + + + A L S +++ F N+ +
Sbjct: 172 VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIMP 229
Query: 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
+ L D YA E++
Sbjct: 230 DGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFL 263
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 35/194 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQESLQGHLEW----- 121
+ +GEG +G VFK + T G ++A+K +++
Sbjct: 4 KYEKIGKIGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESEDD-----PVIKKIA 49
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
L EI+ L QL HPNLV L+ LV+E+ ++ + L R +
Sbjct: 50 LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT 108
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSH-V 238
L + + + H I+RD K NIL+ + KL DFG A+ GP+ V
Sbjct: 109 WQTL---QAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 239 STRVMGTYGYAAPE 252
+TR Y +PE
Sbjct: 164 ATR-----WYRSPE 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 32/153 (20%), Positives = 59/153 (38%), Gaps = 15/153 (9%)
Query: 77 GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWL-TEIKHLGQLYHP 134
G V + TG + V+R+N E+ + +L E+ HP
Sbjct: 36 GFEDLMTVNLA---RYK------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V + D+ +V FM GS ++ + ++ ++ + G K L Y+
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
H ++R K S+IL+ ++ LS
Sbjct: 145 HHMG--YVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-21
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE 113
N + + + F+ + + G+G FG V G TGM +A+K++ Q+
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQD 59
Query: 114 SLQGHLEWLTEIKHLGQLYHPNLVKLI------GYCLEDDHRL-LVYEFMPKGSLENHLF 166
+ E L ++ L L+HPN+V+L G D L +V E++P +L
Sbjct: 60 PRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR 117
Query: 167 RRASYIQPLSWTIRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDF 224
I +KV L + + LH V +RD K N+L++ + KL DF
Sbjct: 118 NYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 225 GLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYM 254
G AK +++ +R Y Y APE +
Sbjct: 177 GSAKKLSPSEPNVAYICSR----Y-YRAPELI 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-21
Identities = 60/268 (22%), Positives = 95/268 (35%), Gaps = 51/268 (19%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
+ + N + + + +G + + K
Sbjct: 32 LNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKE 91
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL--- 122
+ + P V+G G V + H TG AVK + + + E L
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRC---VHR------ATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 123 -----TEIKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF--------- 166
E L Q+ HP+++ LI E + LV++ M KG E LF
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKG--E--LFDYLTEKVAL 197
Query: 167 --RRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224
+ I M+ L A +++LH+ +++RD K NILLD N +LSDF
Sbjct: 198 SEKETRSI--------MRSLLEA---VSFLHA--NNIVHRDLKPENILLDDNMQIRLSDF 244
Query: 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
G + G + + GT GY APE
Sbjct: 245 GFSCHLEPGEK--LRELC-GTPGYLAPE 269
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-20
Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 31/192 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LT 123
+ ++GEG +G V K + TG ++A+K+ + + +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDD---KMVKKIAMR 73
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
EIK L QL H NLV L+ C + LV+EF+ ++ + L + + +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSH-VST 240
+ G+ + HS +I+RD K NIL+ + KL DFG A+ P V+T
Sbjct: 133 II---NGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 241 RVMGTYGYAAPE 252
R Y APE
Sbjct: 188 R-----WYRAPE 194
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 19/188 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIK- 126
+ + +G G +G V K H +G ++AVKR+ + + L ++
Sbjct: 23 DLKDLGEIGRGAYGSVNKM---VHK------PSGQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ P +V+ G + + E M + + + + + I K+ L
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG--SQSHVSTRVMG 244
K L +L + K+I+RD K SNILLD + N KL DFG++ G S TR G
Sbjct: 134 TVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAG 187
Query: 245 TYGYAAPE 252
Y APE
Sbjct: 188 CRPYMAPE 195
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-20
Identities = 43/189 (22%), Positives = 81/189 (42%), Gaps = 24/189 (12%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN 135
+G G +G V+K + A+K++ + + EI L +L HPN
Sbjct: 29 VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 136 LVKLIGYCLED-DHRL-LVYEFMP---KGSLENHLFRRASYIQ-PLSWTIRMKVALGAAK 189
++ L L D ++ L++++ ++ H +A+ L + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNA----KLSDFGLAK--DGPTGSQSHVSTRVM 243
G+ YLH+ V++RD K +NIL+ K++D G A+ + P + + V+
Sbjct: 140 GIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 244 GTYGYAAPE 252
T+ Y APE
Sbjct: 198 -TFWYRAPE 205
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 26 GNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVF 85
G G+ + V + + ++ VLG+G FG V
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIF-----------------SDRYKGQRVLGKGSFGEVI 43
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEIKHLGQLYHPNLVKLIGY 142
+ TG AVK +++ ++ + L E++ L QL HPN++KL +
Sbjct: 44 LC---KDK------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94
Query: 143 CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 201
ED LV E G L + + R + + + I ++ L + Y+H K+
Sbjct: 95 F-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSG---ITYMHK--NKI 147
Query: 202 IYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
++RD K N+LL + N ++ DFGL+ S +GT Y APE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 25/184 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLY 132
LG G +G V T + A+K + + S+ + + L E+ L L
Sbjct: 44 KLGSGAYGEVLLC---RDK------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN++KL + ED LV E G L + + R + + + I +K L +
Sbjct: 95 HPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-IKQVLSG---V 149
Query: 192 AYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
YLH +++RD K N+LL + + K+ DFGL+ +GT Y
Sbjct: 150 TYLHK--HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYY 204
Query: 249 AAPE 252
APE
Sbjct: 205 IAPE 208
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 58/256 (22%), Positives = 97/256 (37%), Gaps = 45/256 (17%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
+ ++G + G++ + + + + + K NF V
Sbjct: 2 AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW----------LTEI 125
LG G +G VF + TG + A+K L + ++ + L I
Sbjct: 62 LGTGAYGKVFLV---RKI---SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-- 182
+ P LV L Y + + +L L+ +++ G L HL +R + + ++
Sbjct: 116 RQ-----SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIY 164
Query: 183 ---VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ L L +LH +IYRD K NILLD N + L+DFGL+K+
Sbjct: 165 VGEIVLA----LEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 240 TRVMGTYGYAAPEYMA 255
GT EYMA
Sbjct: 219 DFC-GT-----IEYMA 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-20
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 37/215 (17%)
Query: 52 GSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN 111
GS+ S + K F VLG+GG+G VF+ TG + A+K L
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQV---RKV---TGANTGKIFAMKVLK 54
Query: 112 QESL---QGHLEW-LTEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLF 166
+ + E L ++ HP +V LI Y + +L L+ E++ G L L
Sbjct: 55 KAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE 113
Query: 167 RRASYIQPLSWTIRMK-----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
R +++ +++ L +LH +IYRD K NI+L+ + KL
Sbjct: 114 REGIFMED-----TACFYLAEISMA----LGHLHQKG--IIYRDLKPENIMLNHQGHVKL 162
Query: 222 SDFGLAKDGPTGSQSHVSTRVM-GTYGYAAPEYMA 255
+DFGL K+ T GT EYMA
Sbjct: 163 TDFGLCKESIHDGT---VTHTFCGT-----IEYMA 189
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-20
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 21/179 (11%)
Query: 56 KSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL 115
+ L+ F ++G G +G V+KG T G + A+K ++
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVMDVTG- 61
Query: 116 QGHLEWLTEIKHLGQL-YHPNLVKLIG-----YCLEDDHRL-LVYEFMPKGSLENHLFRR 168
E EI L + +H N+ G D +L LV EF GS+ + + +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--K 119
Query: 169 ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+ L + +GL++LH K VI+RD K N+LL N KL DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-20
Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 40/226 (17%)
Query: 48 EILLG-SNIKSFSFNGLKTATRNFRPDSV---------LGEGGFGCVFKGWIDEHTYAPA 97
EI L S K F F L ++ P ++ LG G G V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---FER---- 157
Query: 98 RPGTGMVIAVKRLNQESLQGHLEW--------LTEIKHLGQLYHPNLVKLIGYCLEDDHR 149
T +A++ +++ TEI+ L +L HP ++K+ + + +
Sbjct: 158 --KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214
Query: 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209
+V E M G L + + + L A + YLH + +I+RD K
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLY-FYQMLLA---VQYLHEN--GIIHRDLKPE 268
Query: 210 NILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
N+LL + + K++DFG +K G S + T GT Y APE
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPE 311
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-20
Identities = 50/183 (27%), Positives = 87/183 (47%), Gaps = 25/183 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQL 131
+G+G FG V I + T + A+K +N++ + + E++ + L
Sbjct: 22 AIGKGSFGKVC---IVQKN------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 132 YHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAAK 189
HP LV L Y +D+ + +V + + G L HL + + + T+++ + L A
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMA- 127
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
L YL + + +I+RD K NILLD + + ++DF +A P + T + GT Y
Sbjct: 128 -LDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYM 181
Query: 250 APE 252
APE
Sbjct: 182 APE 184
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-19
Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH--LEWLTEIK 126
F VLG+G FG VF + + + A+K L + +L+ + E
Sbjct: 25 QFELLKVLGQGSFGKVFLV---KKI---SGSDARQLYAMKVLKKATLKVRDRVRTKMERD 78
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK--- 182
L ++ HP +VKL Y + + +L L+ +F+ G L L + + + +K
Sbjct: 79 ILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYL 132
Query: 183 --VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
+AL L +LHS +IYRD K NILLD + KL+DFGL+K+ +
Sbjct: 133 AELALA----LDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KA 183
Query: 241 RVM-GTYGYAAPEYMA 255
GT EYMA
Sbjct: 184 YSFCGT-----VEYMA 194
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-19
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 37/202 (18%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLEWL 122
K +F+ +LGEG F V AR T A+K L + H+
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVL----------ARELATSREYAIKILEKR----HIIKE 71
Query: 123 TEIKH-------LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP 174
++ + + +L HP VKL + +DD +L + G L ++ + S+ +
Sbjct: 72 NKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130
Query: 175 LSWTIRMKVA-LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
+ R A + +A L YLH +I+RD K NILL+ + + +++DFG AK
Sbjct: 131 CT---RFYTAEIVSA--LEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
Query: 234 SQSHVSTRVMGTYGYAAPEYMA 255
S+ + +GT +Y++
Sbjct: 184 SKQARANSFVGT-----AQYVS 200
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 56/227 (24%), Positives = 85/227 (37%), Gaps = 35/227 (15%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG 87
G+SGSS + + L + + + +G G G V+K
Sbjct: 1 GSSGSSGKQTGY-----------LTIGGQRYQAE-----INDLENLGEMGSGTCGQVWKM 44
Query: 88 WIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-LTEIK-HLGQLYHPNLVKLIGYCLE 145
TG VIAVK++ + + + L ++ L P +V+ G +
Sbjct: 45 R---FR------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205
+ + E M + + L +R P+ I K+ + K L YL VI+RD
Sbjct: 96 NTDVFIAMELMGTCAEK--LKKR--MQGPIPERILGKMTVAIVKALYYLKEKH-GVIHRD 150
Query: 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
K SNILLD KL DFG++ R G Y APE
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGR---LVDDKAKDRSAGCAAYMAPE 194
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 53/195 (27%), Positives = 78/195 (40%), Gaps = 36/195 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN------------QESLQGHLEWL 122
LG G +G V + A+K + ++++ E +
Sbjct: 43 KLGSGAYGEVLLC---KEK------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 123 -TEIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
EI L L HPN++KL ED LV EF G L + R + + + I
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI- 151
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
MK L + YLH +++RD K NILL + N K+ DFGL+ S+ +
Sbjct: 152 MKQILSG---ICYLHK--HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDY 203
Query: 238 VSTRVMGTYGYAAPE 252
+GT Y APE
Sbjct: 204 KLRDRLGTAYYIAPE 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 59/191 (30%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESL--QGHLEW-LTE 124
F +LG+G FG V + TG A+K L +E + + + LTE
Sbjct: 149 EFEYLKLLGKGTFGKVIL----------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L HP L L Y + RL V E+ G L HL R + + R +
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARF 252
Query: 184 -ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
L YLHS+K V+YRD K N++LD + + K++DFGL K+G + +
Sbjct: 253 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 308
Query: 243 M-GTYGYAAPE 252
GT Y APE
Sbjct: 309 FCGTPEYLAPE 319
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 28/196 (14%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--------QESLQGH 118
N+ P +LG G V + H T AVK ++ E +Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC---IHK------PTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 119 LEWL-TEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS 176
E E+ L ++ HPN+++L + LV++ M KG L ++L + + + +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
I M+ L + LH +++RD K NILLD + N KL+DFG + G +
Sbjct: 127 RKI-MRALLEV---ICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK- 179
Query: 237 HVSTRVMGTYGYAAPE 252
+ GT Y APE
Sbjct: 180 -LREVC-GTPSYLAPE 193
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 27/185 (14%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHP 134
LG G + V+KG +++ T G+ +A+K + +S +G + EI + +L H
Sbjct: 13 LGNGTYATVYKG-LNKTT--------GVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 135 NLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLSWTIR--MKVALGAAK 189
N+V+L ++ LV+EFM K +++ L+ ++ L +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN-LVKYFQWQLL---Q 119
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVSTRVMGTYG 247
GLA+ H +K +++RD K N+L++ KL DFGLA P + S V+ T
Sbjct: 120 GLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 248 YAAPE 252
Y AP+
Sbjct: 174 YRAPD 178
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-19
Identities = 52/194 (26%), Positives = 80/194 (41%), Gaps = 38/194 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLGEG V + T AVK + ++ E++ L Q H
Sbjct: 20 VLGEGAHARVQTC---INL------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSWTIRMKVALG 186
N+++LI + E+D LV+E M GS+ +H+ +R AS + ++
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV--------VQDVAS 122
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKD-GPTGSQSHVSTRV 242
A L +LH+ + +RD K NIL + K+ DF L G S +ST
Sbjct: 123 A---LDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 243 M----GTYGYAAPE 252
+ G+ Y APE
Sbjct: 178 LLTPCGSAEYMAPE 191
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-19
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
VLG G F VF + TG + A+K + + EI L ++ H
Sbjct: 16 VLGSGAFSEVFLV---KQR------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+V L H LV + + G L + + R Y + + + ++ L A + YL
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVLSA---VKYL 122
Query: 195 HSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
H +++RD K N+L + N ++DFGL+K G +ST GT GY AP
Sbjct: 123 HE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTAC-GTPGYVAP 176
Query: 252 E 252
E
Sbjct: 177 E 177
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 41/190 (21%), Positives = 68/190 (35%), Gaps = 31/190 (16%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ + GG G ++ RP + +K L + E + L
Sbjct: 82 YEVKGCIAHGGLGWIYLA---LDRNVNGRP-----VVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-----LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
++ HP++V++ + D +V E++ SL+ + L +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAY 187
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRV 242
L L+YLHS ++Y D K NI+L KL D G G +
Sbjct: 188 LLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------L 237
Query: 243 MGTYGYAAPE 252
GT G+ APE
Sbjct: 238 YGTPGFQAPE 247
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-19
Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNG--LKTATRNFRPDSVLGEGGFGCVF 85
+ S++ ++ V + P + IK + +G + + V+G G FG VF
Sbjct: 2 SFTMSNAPLNGVKLNPLDDP----NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 86 KGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145
+ + E + V A+K++ Q+ E++ + + HPN+V L +
Sbjct: 58 QAKLVE---------SDEV-AIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYS 103
Query: 146 DDHRL------LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL-GAAKGLAYLHSDK 198
+ + LV E++P+ ++ A Q + + +K+ + + LAY+HS
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHS-- 159
Query: 199 AKVIYRDFKTSNILLDLNYNA-KLSDFGLAKDGPTG--SQSHVSTRVMGTYGYAAPEYM 254
+ +RD K N+LLD KL DFG AK G + S++ +R Y Y APE +
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELI 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 9e-19
Identities = 52/185 (28%), Positives = 77/185 (41%), Gaps = 30/185 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
LGEG +G V + T +AVK ++ + E + EI L H
Sbjct: 15 LGEGAYGEVQLA---VNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----- 189
N+VK G+ E + + L E+ G L + + I M A +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPD-AQRFFHQL 114
Query: 190 --GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 248 YAAPE 252
Y APE
Sbjct: 173 YVAPE 177
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 52/216 (24%), Positives = 77/216 (35%), Gaps = 31/216 (14%)
Query: 52 GSNIKSFSFNGLKTATRNFR----PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV 107
G + + F V+G+G F V + + TG AV
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRC---INR------ETGQQFAV 54
Query: 108 KRLNQESLQGHLEW-----LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLE 162
K ++ E L HP++V+L+ D +V+EFM L
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC 114
Query: 163 NHLFRRASYIQPLS---WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLN 216
+ +RA S + M+ L A L Y H +I+RD K +LL + +
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHD--NNIIHRDVKPHCVLLASKENS 169
Query: 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
KL FG+A S RV GT + APE
Sbjct: 170 APVKLGGFGVAIQLG-ESGLVAGGRV-GTPHFMAPE 203
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 25/184 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWL-TEIKHLGQLY 132
+LG+G FG V K + T AVK +N+ S + + E++ L +L
Sbjct: 29 MLGKGSFGEVLKC---KDR------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 133 HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
HPN++KL ED +V E G L + + +R + + + I +K +
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSG---I 134
Query: 192 AYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
Y+H +++RD K NILL + + + K+ DFGL+ +GT Y
Sbjct: 135 TYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYY 189
Query: 249 AAPE 252
APE
Sbjct: 190 IAPE 193
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 30/195 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------- 121
+ LG G G V T +A+K +++
Sbjct: 11 EYIMSKTLGSGACGEVKLA---FER------KTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 122 -LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
TEI+ L +L HP ++K+ + + + +V E M G L + + +
Sbjct: 62 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY- 119
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
L A + YLH +I+RD K N+LL + + K++DFG +K G S
Sbjct: 120 FYQMLLA---VQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSL 172
Query: 238 VSTRVMGTYGYAAPE 252
+ T GT Y APE
Sbjct: 173 MRTLC-GTPTYLAPE 186
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 47/225 (20%), Positives = 80/225 (35%), Gaps = 60/225 (26%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLG 129
+G+G +G V T + A+K ++ Q + + TE++ +
Sbjct: 33 AIGQGSYGVVRVAI---------ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 130 QLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG-- 186
+L+HPN+ +L ED+ + LV E G L + L +K +
Sbjct: 84 KLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 187 ---------------------------AAK-------GLAYLHSDKAKVIYRDFKTSNIL 212
+ L YLH+ + +RD K N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFL 200
Query: 213 L--DLNYNAKLSDFGLAK---DGPTGSQSHVSTRVMGTYGYAAPE 252
+ ++ KL DFGL+K G ++T+ GT + APE
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 22/187 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKH 127
+ LGEG + V+KG T ++A+K + E +G + E+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSL 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L L H N+V L + LV+E++ K L+ +L + I + + + L
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-- 110
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA--KDGPTGSQSHVSTRVMGT 245
+GLAY H KV++RD K N+L++ KL+DFGLA K PT + + V+ T
Sbjct: 111 -RGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-T 163
Query: 246 YGYAAPE 252
Y P+
Sbjct: 164 LWYRPPD 170
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 44/192 (22%), Positives = 74/192 (38%), Gaps = 36/192 (18%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EIKHLGQ 130
+LGEG +G V + + T AVK L ++ L+ EI+ L +
Sbjct: 12 LLGEGSYGKVKEV---LDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 131 LYHPNLVKL--IGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L H N+++L + Y E +V E+ G E + + + + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--ML---DSV------PEKRFPVCQA 111
Query: 189 K--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
GL YLHS ++++D K N+LL K+S G+A+ +
Sbjct: 112 HGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 241 RVMGTYGYAAPE 252
G+ + PE
Sbjct: 170 TSQGSPAFQPPE 181
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 52/185 (28%), Positives = 77/185 (41%), Gaps = 30/185 (16%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT-EIKHLGQLYHP 134
LGEG +G V + T +AVK ++ + E + EI L H
Sbjct: 15 LGEGAYGEVQLA---VNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----- 189
N+VK G+ E + + L E+ G L + + I M A +
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPD-AQRFFHQL 114
Query: 190 --GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 248 YAAPE 252
Y APE
Sbjct: 173 YVAPE 177
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-18
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 54 NIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE 113
+ + T + +LG+G FG V K + T AVK +N+
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKC---KDR------ITQQEYAVKVINKA 58
Query: 114 SLQGHLE--WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY 171
S + L E++ L +L HPN++KL + +V E G L + + +R +
Sbjct: 59 SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAK 228
+ + I +K + Y+H +++RD K NILL + + + K+ DFGL+
Sbjct: 119 SEHDAARI-IKQVFSG---ITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPE 252
++ + R+ GT Y APE
Sbjct: 173 CFQQNTK--MKDRI-GTAYYIAPE 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-18
Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTE 124
+ N+ LG+G F V + H TG+ A K +N + L + E
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---VHK------TTGLEFAAKIINTKKLSARDFQKLERE 55
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ +L HPN+V+L E+ LV++ + G L + R Y + + ++
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQI 114
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L + +AY HS+ +++R+ K N+LL KL+DFGLA +
Sbjct: 115 LES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 167
Query: 242 VMGTYGYAAPE 252
GT GY +PE
Sbjct: 168 A-GTPGYLSPE 177
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 42/190 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G V+K A+ G A+K RL +E +++ EI
Sbjct: 10 IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIR-------EIS 52
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVA 184
L +L H N+VKL +LV+E + + L+ L ++ + T + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV--TAKSFLLQL 109
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRV 242
L G+AY H + V++RD K N+L++ K++DFGLA+ P +H +
Sbjct: 110 L---NGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EI 161
Query: 243 MGTYGYAAPE 252
+ T Y AP+
Sbjct: 162 V-TLWYRAPD 170
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 46/181 (25%), Positives = 74/181 (40%), Gaps = 21/181 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G +G V GT + A K++ + ++ + EI+ + L HP
Sbjct: 16 TIGRGSWGEVKIA---VQ------KGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
N+++L ++ LV E G L + + + + + I MK L A +AY
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYC 122
Query: 195 HSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP 251
H V +RD K N L + KL DFGLA G + +GT Y +P
Sbjct: 123 HK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSP 177
Query: 252 E 252
+
Sbjct: 178 Q 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTE 124
+ N+ LG+G F V + H TG+ A K +N + L + E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRC---VHK------TTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ +L HPN+V+L E+ LV++ + G L + R Y + + ++
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-IQQI 137
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L + +AY HS+ +++R+ K N+LL KL+DFGLA +
Sbjct: 138 LES---IAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGF 190
Query: 242 VMGTYGYAAPE 252
GT GY +PE
Sbjct: 191 A-GTPGYLSPE 200
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 56/257 (21%), Positives = 88/257 (34%), Gaps = 46/257 (17%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLG---SNIKSFSFNGLKTATRNFR- 71
G S + S++ ++ V L + F +
Sbjct: 28 GDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNS 87
Query: 72 -----PDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+LG G FG V K E T TG+ +A K + ++ E EI
Sbjct: 88 FYTVSKTEILGGGRFGQVHKC---EET------ATGLKLAAKIIKTRGMKDKEEVKNEIS 138
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLF--RRASYIQPLSW 177
+ QL H NL++L E + + LV E++ G L E++
Sbjct: 139 VMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF----- 192
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQ 235
MK G+ ++H +++ D K NIL K+ DFGLA+ +
Sbjct: 193 ---MKQICE---GIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 236 SHVSTRVMGTYGYAAPE 252
V GT + APE
Sbjct: 245 LKV---NFGTPEFLAPE 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 41/228 (17%)
Query: 16 GANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSV 75
G++ + + + + + S + + + + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTEIKHLGQLYH 133
+G G +G V + D+ V+A+K++ + E L L EI L +L H
Sbjct: 61 IGTGSYGHVCEA-YDKLE--------KRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 134 PNLVKL----IGYCLEDDHRL-LVYEFMP---------KGSLENHLFRRASYIQPLSWTI 179
++VK+ I +E L +V E L + Y L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY-NLL---- 166
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
G+ Y+HS A +++RD K +N L++ + + K+ DFGLA
Sbjct: 167 ---------VGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 62/255 (24%), Positives = 96/255 (37%), Gaps = 50/255 (19%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
S+ D N S + G++S V + +
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL---------------- 51
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
+ F +S LG G V++ + GT A+K L + + + TEI
Sbjct: 52 -SDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKTVDKKIVR--TEI 99
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR----- 180
L +L HPN++KL LV E + G L + + + Y + R
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY------SERDAADA 153
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSH 237
+K L A +AYLH +++RD K N+L + K++DFGL+K Q
Sbjct: 154 VKQILEA---VAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVL 206
Query: 238 VSTRVMGTYGYAAPE 252
+ T GT GY APE
Sbjct: 207 MKTVC-GTPGYCAPE 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-18
Identities = 47/216 (21%), Positives = 74/216 (34%), Gaps = 59/216 (27%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW----- 121
+ + G +G V G+ +A+KR+ G
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 122 ------LTEIKHLGQLYHPNLVKL----IGYCLEDDHRL-LVYEFM----------PKGS 160
L EI+ L +HPN++ L + + H+L LV E M +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV 130
Query: 161 LENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220
+ + Y L GL LH A V++RD NILL N +
Sbjct: 131 ISPQHIQYFMY-HIL-------------LGLHVLHE--AGVVHRDLHPGNILLADNNDIT 174
Query: 221 LSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYM 254
+ DF LA++ + +V+ R Y APE +
Sbjct: 175 ICDFNLAREDTADANKTHYVTHRW-----YRAPELV 205
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 46/189 (24%), Positives = 74/189 (39%), Gaps = 38/189 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
+G G + + H T M AVK +++ E + + GQ HP
Sbjct: 29 DIGVGSYSVCKRC---IHK------ATNMEFAVKIIDKSKRDPTEE-IEILLRYGQ--HP 76
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSWTIRMKVALGA 187
N++ L + + +V E M G L + + R+ AS + +
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--------LFTITKT 128
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNA---KLSDFGLAKDGPTGSQSHVSTRVM 243
+ YLH+ V++RD K SNIL D + N ++ DFG AK + + T
Sbjct: 129 ---VEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC- 181
Query: 244 GTYGYAAPE 252
T + APE
Sbjct: 182 YTANFVAPE 190
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-18
Identities = 51/258 (19%), Positives = 80/258 (31%), Gaps = 90/258 (34%)
Query: 68 RNFRPDSVLGEGGFGCVFKGW--IDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTE 124
+F P +G GGFG VF+ +D+ Y A+KR+ + + E + E
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNY-----------AIKRIRLPNRELAREKVMRE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRAS-------------- 170
+K L +L HP +V+ LE E + S
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 171 ----------------------YIQ------------------------PLSWTIRMKVA 184
YIQ + I +++A
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD----------GPTGS 234
+ +LHS +++RD K SNI ++ K+ DFGL
Sbjct: 175 EA----VEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 235 QSHVSTRVMGTYGYAAPE 252
T +GT Y +PE
Sbjct: 229 AYATHTGQVGTKLYMSPE 246
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 32/196 (16%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWL-TE 124
T ++ LG+G F V + G A +N + L + L E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRC---VKV------LAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR---- 180
+ L HPN+V+L E+ H L+++ + G L + R Y +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY------SEADASH 114
Query: 181 -MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQS 236
++ L A + + H V++R+ K N+LL KL+DFGLA + Q+
Sbjct: 115 CIQQILEA---VLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 237 HVSTRVMGTYGYAAPE 252
GT GY +PE
Sbjct: 170 -WFGFA-GTPGYLSPE 183
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-18
Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 24/184 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQ 130
V+G G F V + TG V A+K +N+ + E + E L
Sbjct: 68 VIGRGAFSEVAV----------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAA 188
+ +L + +D++ L LV E+ G L L + I P R +A + A
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEMA-RFYLAEIVMA 174
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+ +H ++RD K NILLD + +L+DFG V GT Y
Sbjct: 175 --IDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDY 229
Query: 249 AAPE 252
+PE
Sbjct: 230 LSPE 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 42/190 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G V+K A+ G ++A+K RL+ E +++ EI
Sbjct: 29 VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EIS 71
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVA 184
L +L+HPN+V LI + LV+EFM K L+ L + +Q I+ +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS--QIKIYLYQL 128
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRV 242
L +G+A+ H + +++RD K N+L++ + KL+DFGLA+ P S +H V
Sbjct: 129 L---RGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EV 180
Query: 243 MGTYGYAAPE 252
+ T Y AP+
Sbjct: 181 V-TLWYRAPD 189
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-------LTEIKHL 128
LGEG +G V+K ID T +A+KR+ E E + E+ L
Sbjct: 42 LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEH-----EEEGVPGTAIREVSLL 87
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLSWTIRMKVAL 185
+L H N+++L + L++E+ K ++ + I+ + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------ 141
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA-----KLSDFGLAKD--GPTGSQSHV 238
G+ + HS + ++RD K N+LL ++ + K+ DFGLA+ P +H
Sbjct: 142 --INGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH- 196
Query: 239 STRVMGTYGYAAPE 252
++ T Y PE
Sbjct: 197 --EII-TLWYRPPE 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-18
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 38/236 (16%)
Query: 28 GTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKG 87
G + ++ + S V + K + + F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML- 59
Query: 88 WIDEHTYAPARP-GTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKLIG 141
+ +G A+K L+++ + H L E + L + P LVKL
Sbjct: 60 ---------VKHKESGNHYAMKILDKQKVVKLKQIEHT--LNEKRILQAVNFPFLVKLE- 107
Query: 142 YCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK 200
+ +D+ L +V E++ G + +HL R + +P + ++ L YLHS
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHS--LD 161
Query: 201 VIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM-GTYGYAAPEYMA 255
+IYRD K N+L+D +++DFG AK T + GT PE +A
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGT-----PEALA 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-18
Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 24/184 (13%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPAR-PGTGMVIAVKRLNQESLQGHLE---WLTEIKHLGQ 130
V+G G FG V + V A+K LN+ + E + E L
Sbjct: 81 VIGRGAFGEVAV----------VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 131 LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA-LGAA 188
+ L Y +DD+ L LV ++ G L L + P R +A + A
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMA-RFYLAEMVIA 187
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+ +H ++RD K NIL+D+N + +L+DFG S V GT Y
Sbjct: 188 --IDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242
Query: 249 AAPE 252
+PE
Sbjct: 243 ISPE 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 61/187 (32%), Positives = 91/187 (48%), Gaps = 32/187 (17%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-----WLTEIKHLGQ 130
LGEG F V+K D++T ++A+K++ + L EIK L +
Sbjct: 18 LGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR--MKVALGAA 188
L HPN++ L+ + LV++FM LE + + + P I+ M + L
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS--HIKAYMLMTL--- 122
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQSH-VSTRVMGT 245
+GL YLH +++RD K +N+LLD N KL+DFGLAK P + +H V TR
Sbjct: 123 QGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---- 176
Query: 246 YGYAAPE 252
Y APE
Sbjct: 177 -WYRAPE 182
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 38/189 (20%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YH 133
LGEG F K H + AVK +++ + EI L H
Sbjct: 18 PLGEGSFSICRKC---VHK------KSNQAFAVKIISKRMEANTQK---EITALKLCEGH 65
Query: 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------ASYIQPLSWTIRMKVALG 186
PN+VKL + H LV E + G L + ++ ASYI M+ +
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--------MRKLVS 117
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A ++++H V++RD K N+L + N K+ DFG A+ P +Q + T
Sbjct: 118 A---VSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC- 170
Query: 244 GTYGYAAPE 252
T YAAPE
Sbjct: 171 FTLHYAAPE 179
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 47/189 (24%), Positives = 70/189 (37%), Gaps = 37/189 (19%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + TG V K +N EI + QL+HP
Sbjct: 58 ELGSGAFGVVHRC---VEK------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSL------ENHLF--RRASYIQPLSWTIRMKVAL 185
L+ L ED + + L+ EF+ G L E++ M+ A
Sbjct: 109 KLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY--------MRQAC 159
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVM 243
GL ++H +++ D K NI+ + + K+ DFGLA +
Sbjct: 160 E---GLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTT 211
Query: 244 GTYGYAAPE 252
T +AAPE
Sbjct: 212 ATAEFAAPE 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 45/187 (24%), Positives = 75/187 (40%), Gaps = 21/187 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
+R ++G GG G V++ E T R +A+K +++ L + T E
Sbjct: 36 YRLRRLVGRGGMGDVYEA---EDTVRE-RI-----VALKLMSET-LSSDPVFRTRMQREA 85
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ G+L P++V + + D + + L L R+ PL+ + +
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVR 141
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
L H A +RD K NIL+ + A L DFG+A + + +GT
Sbjct: 142 QIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGT 198
Query: 246 YGYAAPE 252
Y APE
Sbjct: 199 LYYMAPE 205
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 37/188 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+GEG +G VFK + T ++A+K RL+ + +L+ EI
Sbjct: 10 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALR-------EIC 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L H N+V+L D LV+EF + L+ + + P + L
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL- 111
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRVMG 244
KGL + HS V++RD K N+L++ N KL++FGLA+ P S V+
Sbjct: 112 --KGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV- 163
Query: 245 TYGYAAPE 252
T Y P+
Sbjct: 164 TLWYRPPD 171
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 41/198 (20%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F +LG+G FG V R TG A+K L +E + + + +TE
Sbjct: 6 DFDYLKLLGKGTFGKVIL----------VREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK- 182
+ L HP L L Y + RL V E+ G L HL R + + R +
Sbjct: 56 SRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARF 109
Query: 183 ----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+ L YLHS V+YRD K N++LD + + K++DFGL K+G +
Sbjct: 110 YGAEIVSA----LEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--- 160
Query: 239 STRVM-GTYGYAAPEYMA 255
+ + GT PEY+A
Sbjct: 161 TMKTFCGT-----PEYLA 173
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 42/198 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHL 119
NF+ +GEG +G V+K ++ T G V+A+K RL+ E +++
Sbjct: 4 NFQKVEKIGEGTYGVVYKA-RNKLT--------GEVVALKKIRLDTETEGVPSTAIR--- 51
Query: 120 EWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMP---KGSLENHLFRRASYIQPLS 176
EI L +L HPN+VKL+ ++ LV+EF+ K ++ S
Sbjct: 52 ----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS 107
Query: 177 WTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGS 234
+ ++ +GLA+ HS + V++RD K N+L++ KL+DFGLA+ P +
Sbjct: 108 YLFQL------LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 235 QSHVSTRVMGTYGYAAPE 252
+H V+ T Y APE
Sbjct: 160 YTH---EVV-TLWYRAPE 173
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 55/194 (28%), Positives = 78/194 (40%), Gaps = 42/194 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWL-TEIKHLGQLYH 133
LG G FG V E +G+ +K +N++ Q +E + EI+ L L H
Sbjct: 29 KLGSGAFGDVHLV---EER------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 134 PNLVKLIGYCLEDDHRL-LVYEFMPKGSL---------ENHLF--RRASYIQPLSWTIRM 181
PN++K+ ED H + +V E G L + + M
Sbjct: 80 PNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL--------M 130
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHV 238
K + A LAY HS V+++D K NIL + K+ DFGLA+
Sbjct: 131 KQMMNA---LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEH 182
Query: 239 STRVMGTYGYAAPE 252
ST GT Y APE
Sbjct: 183 STNAAGTALYMAPE 196
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-17
Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 48/194 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL-----QGHLEWLTEIKHL 128
LG G FG V R G A+K L +E + H E L
Sbjct: 13 TLGTGSFGRVHL----------IRSRHNGRYYAMKVLKKEIVVRLKQVEHT--NDERLML 60
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK----- 182
+ HP ++++ +D ++ ++ +++ G L + L + + P K
Sbjct: 61 SIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAAE 114
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
V L L YLHS +IYRD K NILLD N + K++DFG AK P T
Sbjct: 115 VCLA----LEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYT 162
Query: 243 M-GTYGYAAPEYMA 255
+ GT P+Y+A
Sbjct: 163 LCGT-----PDYIA 171
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 21/187 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
++ LG GG V+ D + +A+K + + E L E+
Sbjct: 13 YKIVDKLGGGGMSTVYLAE-DTIL--------NIKVAIKAIFIP-PREKEETLKRFEREV 62
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ QL H N+V +I EDD LV E++ +L ++ PLS +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTN 118
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
G+ + H ++++RD K NIL+D N K+ DFG+AK S + + V+GT
Sbjct: 119 QILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGT 175
Query: 246 YGYAAPE 252
Y +PE
Sbjct: 176 VQYFSPE 182
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 52/204 (25%), Positives = 75/204 (36%), Gaps = 49/204 (24%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----- 123
+ S LG G FG V W + VK + +E + W+
Sbjct: 25 KYSTMSPLGSGAFGFV---WTAVDKE------KNKEVVVKFIKKEKVLED-CWIEDPKLG 74
Query: 124 ----EIKHLGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGS-LENHLFRR-------AS 170
EI L ++ H N++K++ E+ LV E G L + R AS
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 171 YI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
YI Q +S + YL +I+RD K NI++ ++ KL DFG A
Sbjct: 134 YIFRQLVS-------------AVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPE 252
G + GT Y APE
Sbjct: 179 YLERGKLFYTFC---GTIEYCAPE 199
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 51/206 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ + + +G G +G V ID+ + G +A+K+L++ +S E
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKLSRPFQSEIFAKRAYRE 73
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSL-ENHLFRRAS 170
+ L + H N++ L+ L + + LV FM E +
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI----Q 129
Query: 171 YI--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
Y+ Q L KGL Y+HS A V++RD K N+ ++ + K+ DFGLA+
Sbjct: 130 YLVYQML-------------KGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPEYM 254
+V TR + Y APE +
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVI 195
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 49/200 (24%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE-------SLQGHLEWLTEIK 126
+G+G FG VFK T G +A+K + E +L+ EIK
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFPITALR-------EIK 68
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL--------LVYEFMP---KGSLENHLFR-RASYIQP 174
L L H N+V LI C LV++F G L N L + S I+
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPT 232
+ M++ L GL Y+H +K +++RD K +N+L+ + KL+DFGLA+
Sbjct: 129 V-----MQMLL---NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 233 GSQSHVSTRVMGTYGYAAPE 252
SQ + T + T Y PE
Sbjct: 179 NSQPNRYTNRVVTLWYRPPE 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-17
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 50/214 (23%)
Query: 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK--RLNQE----- 113
+GL A + + + +GEG +G VFK D G +A+K R+
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKA-RDLKN-------GGRFVALKRVRVQTGEEGMP 55
Query: 114 --SLQGHLEWLTEIKHLGQL---YHPNLVKLI----GYCLEDDHRL-LVYEFMP---KGS 160
+++ E+ L L HPN+V+L + + +L LV+E +
Sbjct: 56 LSTIR-------EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY 108
Query: 161 LENH--LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218
L+ I+ + + + +GL +LHS + V++RD K NIL+ +
Sbjct: 109 LDKVPEPGVPTETIKDMMFQL--------LRGLDFLHSHR--VVHRDLKPQNILVTSSGQ 158
Query: 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
KL+DFGLA+ Q +++ V+ T Y APE
Sbjct: 159 IKLADFGLAR--IYSFQMALTSVVV-TLWYRAPE 189
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 50/196 (25%), Positives = 75/196 (38%), Gaps = 50/196 (25%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLG G G V + H TG A+K L E+ H Q
Sbjct: 36 VLGLGVNGKVLEC---FHR------RTGQKCALKLLYDSPKAR-----QEVDHHWQASGG 81
Query: 134 PNLVKLIGYCLEDDHR-----LLVYEFMPKGSLENHLFRR---------ASYIQPLSWTI 179
P++V ++ E+ H L++ E M G L + + R A+ I
Sbjct: 82 PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI------- 133
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQS 236
M+ A + +LHS + +RD K N+L + + KL+DFG AK+ +
Sbjct: 134 -MRDIGTA---IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185
Query: 237 HVSTRVMGTYGYAAPE 252
+ T T Y APE
Sbjct: 186 -LQTPC-YTPYYVAPE 199
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 36/187 (19%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQL 131
+G+G F V H TG +A+K +++ L L E++ + L
Sbjct: 23 IGKGNFAKVKLA---RHIL------TGREVAIKIIDKTQLNPTSLQKLF--REVRIMKIL 71
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK-- 189
HPN+VKL + L+ E+ G + ++L RMK +K
Sbjct: 72 NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFR 121
Query: 190 ----GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ Y H + +++RD K N+LLD + N K++DFG + + G + G
Sbjct: 122 QIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GA 176
Query: 246 YGYAAPE 252
YAAPE
Sbjct: 177 PPYAAPE 183
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-16
Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 41/190 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LG G FG V G EH TG +AVK ++ + G ++ EI++L
Sbjct: 19 LGVGTFGKVKIG---EHQ------LTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKL 67
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HP+++KL Y + +V E++ G L +++ + R++
Sbjct: 68 FRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARR 115
Query: 189 K------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ Y H V++RD K N+LLD + NAK++DFGL+ G S
Sbjct: 116 LFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 171
Query: 243 MGTYGYAAPE 252
G+ YAAPE
Sbjct: 172 -GSPNYAAPE 180
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 42/193 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTEIKHLGQ 130
V+G+G FG V AR + AVK L ++++ + + ++E L +
Sbjct: 45 VIGKGSFGKVLL----------ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 131 -LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK-----V 183
+ HP LV L + + +L V +++ G L HL R +++P R + +
Sbjct: 95 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEI 148
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A L YLHS ++YRD K NILLD + L+DFGL K+ + +T
Sbjct: 149 ASA----LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTF 199
Query: 244 -GTYGYAAPEYMA 255
GT PEY+A
Sbjct: 200 CGT-----PEYLA 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 48/193 (24%), Positives = 69/193 (35%), Gaps = 45/193 (23%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + TG A K + EI+ + L HP
Sbjct: 164 ELGTGAFGVVHRV---TER------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR-------------ASYIQPLSWTIRM 181
LV L +D+ +++YEFM G E LF + Y++ +
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVEYMRQVCK---- 266
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVS 239
GL ++H + ++ D K NI+ + KL DFGL V
Sbjct: 267 --------GLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 240 TRVMGTYGYAAPE 252
GT +AAPE
Sbjct: 316 --TTGTAEFAAPE 326
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 40/202 (19%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----LT 123
+ P + +G G +G V+K D H+ G +A+K + + G +
Sbjct: 10 RYEPVAEIGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVR 60
Query: 124 EIKHLGQL---YHPNLVKLI----GYCLEDDHRL-LVYEFMP---KGSLENH--LFRRAS 170
E+ L +L HPN+V+L+ + + ++ LV+E + + L+ A
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 171 YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230
I+ L +GL +LH++ +++RD K NIL+ KL+DFGLA+
Sbjct: 121 TIKDLMRQF--------LRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR-- 168
Query: 231 PTGSQSHVSTRVMGTYGYAAPE 252
Q ++ V+ T Y APE
Sbjct: 169 IYSYQMALTPVVV-TLWYRAPE 189
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 47/235 (20%), Positives = 89/235 (37%), Gaps = 64/235 (27%)
Query: 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
GL+T+++ + LG G FG V + + E +G A+K++ Q+
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRYK---- 47
Query: 122 LTEIKHLGQLYHPNLVKLIGY-------------------------------------CL 144
E+ + L H N++KL+ Y
Sbjct: 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107
Query: 145 EDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL-GAAKGLAYLHSDKAKVI 202
+ L ++ E++P +L L + + + + + + + ++HS +
Sbjct: 108 SQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGIC 163
Query: 203 YRDFKTSNILLDLNYNA-KLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYM 254
+RD K N+L++ N KL DFG AK +++ +R + Y APE M
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELM 213
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 25/190 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEW-LTEI 125
+F VLG+G FG V R GT + AVK L ++ + +E + E
Sbjct: 342 DFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392
Query: 126 KHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
+ L P L +L C + RL V E++ G L H+ + + +P + ++
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
A+G L +L S +IYRD K N++LD + K++DFG+ K+ +T+
Sbjct: 452 AIG----LFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 502
Query: 244 -GTYGYAAPE 252
GT Y APE
Sbjct: 503 CGTPDYIAPE 512
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 34/186 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HP 134
LG G + VF+ + VK L + + EIK L L P
Sbjct: 44 LGRGKYSEVFEAINIT---------NNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLS-WTIR--MKVALGAAKGL 191
N++ L + R F + N F++ Q L+ + IR M L K L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQ--LYQTLTDYDIRFYMYEIL---KAL 143
Query: 192 AYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGY 248
Y HS +++RD K N+++D + +L D+GLA+ G + V++R +
Sbjct: 144 DYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----F 196
Query: 249 AAPEYM 254
PE +
Sbjct: 197 KGPELL 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 47/189 (24%), Positives = 75/189 (39%), Gaps = 30/189 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 19 ELGSGQFAIVKKC---REK------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQP-LSWTIRMKVALGA 187
Q+ HPN++ L +L+ E + G L + L ++ S + + I+ +
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL---- 125
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
G+ YLH+ K+ + D K NI+L + KL DFGLA + G + +
Sbjct: 126 -DGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179
Query: 244 GTYGYAAPE 252
GT + APE
Sbjct: 180 GTPEFVAPE 188
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-16
Identities = 57/264 (21%), Positives = 89/264 (33%), Gaps = 52/264 (19%)
Query: 6 SAETDSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKT 65
S P+P A + + ++ + + G IK +
Sbjct: 5 SQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYK 64
Query: 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI 125
T VLG G G V + + T A+K L E+
Sbjct: 65 VT-----SQVLGLGINGKVLQI---FNK------RTQEKFALKMLQDCPKAR-----REV 105
Query: 126 KHLGQLY-HPNLVKLIGYC----LEDDHRLLVYEFMPKGSL-------ENHLF--RRASY 171
+ + P++V+++ L+V E + G L + F R AS
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAK 228
I MK A + YLHS + +RD K N+L N KL+DFG AK
Sbjct: 166 I--------MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 229 DGPTGSQSHVSTRVMGTYGYAAPE 252
+ + + ++T T Y APE
Sbjct: 213 ETTSHNS--LTTPC-YTPYYVAPE 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 51/207 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ ++ +G G G V D +A+K+L++ ++ E
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSLENHLFRRASY 171
+ + + H N++ L+ LE+ + LV E M + L++ R SY
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMSY 168
Query: 172 I--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ Q L G+ +LHS A +I+RD K SNI++ + K+ DFGLA+
Sbjct: 169 LLYQML-------------CGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 230 GPTGSQS--HVSTRVMGTYGYAAPEYM 254
T +V TR Y APE +
Sbjct: 214 AGTSFMMTPYVVTRY-----YRAPEVI 235
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 46/186 (24%), Positives = 71/186 (38%), Gaps = 35/186 (18%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHP 134
+G G FG T ++AVK + + + +++ EI + L HP
Sbjct: 28 IGSGNFGVARLM---RDK------LTKELVAVKYIERGAAIDENVQ--REIINHRSLRHP 76
Query: 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK----- 189
N+V+ L H ++ E+ G L + R
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLL 126
Query: 190 -GLAYLHSDKAKVIYRDFKTSNILLDLNY--NAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
G++Y HS ++ +RD K N LLD + K+ DFG +K SQ + V GT
Sbjct: 127 SGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTP 181
Query: 247 GYAAPE 252
Y APE
Sbjct: 182 AYIAPE 187
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
++ S +G G +G V + + TG+ +AVK+L++ +S+ E
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
++ L + H N++ L+ LE+ + + LV M L Q L+
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADL-NNIVKCQKLT-D 131
Query: 179 IRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
++ + +GL Y+HS A +I+RD K SN+ ++ + K+ DFGLA+ +
Sbjct: 132 DHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 238 VSTRVMGTYGYAAPEYM 254
V+TR Y APE M
Sbjct: 190 VATRW-----YRAPEIM 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 39/206 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEI 125
+ +F+ S+LGEG +G V + T G ++A+K++ + L L EI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEPFDKPLFALRTLREI 60
Query: 126 KHLGQLYHPNLVKLI----GYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
K L H N++ + E+ + + ++ E M + + + Q LS
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST----QMLS-DDH 113
Query: 181 MKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA----KDGPT 232
++ L + + LH + VI+RD K SN+L++ N + K+ DFGLA +
Sbjct: 114 IQYFIYQTL---RAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 233 GSQSHVSTRVMGTY----GYAAPEYM 254
S+ M + Y APE M
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVM 194
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 41/190 (21%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LG G FG V G +H TG +AVK ++ + G + EI++L
Sbjct: 24 LGVGTFGKVKVG---KHE------LTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKL 72
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HP+++KL Y + + +V E++ G L +++ + R+
Sbjct: 73 FRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESRR 120
Query: 189 K------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
G+ Y H V++RD K N+LLD + NAK++DFGL+ G S
Sbjct: 121 LFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-- 176
Query: 243 MGTYGYAAPE 252
G+ YAAPE
Sbjct: 177 -GSPNYAAPE 185
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 32/194 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F VLG+G FG V + GT + AVK L ++ + +E + E
Sbjct: 21 DFNFLMVLGKGSFGKVML----------SERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L P L +L C + RL V E++ G L H+ + + +P + +
Sbjct: 71 KRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+A+G L +L S +IYRD K N++LD + K++DFG+ K+ +T+
Sbjct: 130 IAIG----LFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKT 180
Query: 243 M-GTYGYAAPEYMA 255
GT P+Y+A
Sbjct: 181 FCGT-----PDYIA 189
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 32/197 (16%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+R +G G +G V +D T G +A+K+L + +S E
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKLYRPFQSELFAKRAYRE 74
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWT 178
++ L + H N++ L+ L+D LV FM L + + L
Sbjct: 75 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDL-GKLMKHEKLG-E 127
Query: 179 IRMKVAL-GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
R++ + KGL Y+H+ A +I+RD K N+ ++ + K+ DFGLA+ + +
Sbjct: 128 DRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY 185
Query: 238 VSTRVMGTYGYAAPEYM 254
V TR Y APE +
Sbjct: 186 VVTRW-----YRAPEVI 197
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 42/204 (20%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ-ESLQGHLEWLTEI 125
+ S +GEG +G V D + +A+K+++ E L EI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISPFEHQTYCQRTLREI 76
Query: 126 KHLGQLYHPNLVKLIG----YCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
K L + H N++ + +E + +V + M E L + Q LS
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDL-YKLLKTQHLS-NDH 129
Query: 181 MKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS 236
+ L +GL Y+HS A V++RD K SN+LL+ + K+ DFGLA+
Sbjct: 130 ICYFLYQIL---RGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 237 ------HVSTRVMGTYGYAAPEYM 254
+V+TR Y APE M
Sbjct: 185 TGFLTEYVATR-----WYRAPEIM 203
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 51/195 (26%), Positives = 73/195 (37%), Gaps = 48/195 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESLQGHLEWLTEIKH------ 127
V+G G FG V R T V A+K L++ + ++
Sbjct: 76 VIGRGAFGEVQL----------VRHKSTRKVYAMKLLSKF----EMIKRSDSAFFWEERD 121
Query: 128 -LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ P +V+L Y +DD L +V E+MP G L N + V
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY-------------DVPE 167
Query: 186 GAAK--------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
A+ L +HS I+RD K N+LLD + + KL+DFG
Sbjct: 168 KWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 238 VSTRVMGTYGYAAPE 252
T V GT Y +PE
Sbjct: 226 CDTAV-GTPDYISPE 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 59/258 (22%), Positives = 97/258 (37%), Gaps = 59/258 (22%)
Query: 10 DSPLPNGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRN 69
D +P N G+G +++ + ++ F L+
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSS-----LGLQDFDL--LR----- 58
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTEI 125
V+G G + V R T + A++ + +E + ++W TE
Sbjct: 59 -----VIGRGSYAKVLL----------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 126 KHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK- 182
Q HP LV L C + + RL V E++ G L H+ R+ + +
Sbjct: 104 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARF 157
Query: 183 ----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
++L L YLH +IYRD K N+LLD + KL+D+G+ K+G
Sbjct: 158 YSAEISLA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--- 208
Query: 239 STRVM-GTYGYAAPEYMA 255
+T GT P Y+A
Sbjct: 209 TTSTFCGT-----PNYIA 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 51/209 (24%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
+ ++ +G G G V D +A+K+L++ ++ E
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKLSRPFQNQTHAKRAYRE 74
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRL-LVYEFMP-------KGSLENHLFRRASY 171
+ + + H N++ L+ LE+ + +V E M + L++ R SY
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH---ERMSY 131
Query: 172 I--QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+ Q L G+ +LHS A +I+RD K SNI++ + K+ DFGLA+
Sbjct: 132 LLYQML-------------CGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 230 GPTGSQS--HVSTRVMGTYGYAAPEYMAT 256
T +V TR Y APE +
Sbjct: 177 AGTSFMMTPYVVTRY-----YRAPEVILG 200
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 47/190 (24%), Positives = 75/190 (39%), Gaps = 32/190 (16%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 19 ELGSGQFAIVKKC---REK------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP-LSWTIRMKVALG 186
Q+ H N++ L E+ + L+ E + G L + L ++ S + + I+ +
Sbjct: 70 RQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL--- 125
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
G+ YLH+ K+ + D K NI+L + KL DFGLA + G +
Sbjct: 126 --DGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNI 178
Query: 243 MGTYGYAAPE 252
GT + APE
Sbjct: 179 FGTPEFVAPE 188
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 54/196 (27%), Positives = 80/196 (40%), Gaps = 37/196 (18%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F +LG+G FG VF A T A+K L ++ + +E + E
Sbjct: 18 DFILHKMLGKGSFGKVFL----------AEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 125 IKHLGQ-LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L HP L + + L V E++ G L H+ + R
Sbjct: 68 KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RAT 121
Query: 183 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ LG L +LHS ++YRD K NILLD + + K++DFG+ K+ G
Sbjct: 122 FYAAEIILG----LQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 173
Query: 238 VSTRVM-GTYGYAAPE 252
T GT Y APE
Sbjct: 174 -KTNTFCGTPDYIAPE 188
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 32/194 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
NF VLG+G FG V AR TG + AVK L ++ + +E +TE
Sbjct: 24 NFEFIRVLGKGSFGKVML----------ARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L HP L +L C + RL V EF+ G L H+ + + + + +
Sbjct: 74 KRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ L +LH +IYRD K N+LLD + KL+DFG+ K+G +T
Sbjct: 133 IISA----LMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTAT 183
Query: 243 M-GTYGYAAPEYMA 255
GT P+Y+A
Sbjct: 184 FCGT-----PDYIA 192
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 30/189 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K GTG A K + + L E+ L
Sbjct: 12 ELGSGQFAIVRKC---RQK------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
++ HPN++ L E+ + L+ E + G L + L + S + + +K L
Sbjct: 63 REIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-LKQILD- 119
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
G+ YLHS ++ + D K NI+L N KL DFG+A G++ +
Sbjct: 120 --GVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 172
Query: 244 GTYGYAAPE 252
GT + APE
Sbjct: 173 GTPEFVAPE 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 60/226 (26%)
Query: 59 SFNGLK-TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG 117
S N + LG GG G VF +D +A+K++ Q
Sbjct: 1 SMNIHGFDLGSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIVLTDPQS 51
Query: 118 HLEWLTEIKHLGQLYHPNLVKLI-------------GYCLEDDHRL-LVYEFMP------ 157
L EIK + +L H N+VK+ L + + + +V E+M
Sbjct: 52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 158 --KGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD- 214
+G L R Y Q L +GL Y+HS A V++RD K +N+ ++
Sbjct: 112 LEQGPLLEEHARLFMY-QLL-------------RGLKYIHS--ANVLHRDLKPANLFINT 155
Query: 215 LNYNAKLSDFGLAK--DGPTGSQSH----VSTRVMGTYGYAAPEYM 254
+ K+ DFGLA+ D + H + T+ Y +P +
Sbjct: 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK-----WYRSPRLL 196
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 42/199 (21%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARP-GTGMVIAVKRLNQESL--QGHLEW-LTE 124
+F V+G G + V R T + A+K + +E + ++W TE
Sbjct: 10 DFDLLRVIGRGSYAKVLL----------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 59
Query: 125 IKHLGQLY-HPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
Q HP LV L C + + RL V E++ G L H+ R+ + +
Sbjct: 60 KHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HAR 113
Query: 183 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
++L L YLH +IYRD K N+LLD + KL+D+G+ K+G
Sbjct: 114 FYSAEISLA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 165
Query: 238 VSTRVM-GTYGYAAPEYMA 255
+T GT P Y+A
Sbjct: 166 -TTSTFCGT-----PNYIA 178
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 45/189 (23%), Positives = 72/189 (38%), Gaps = 30/189 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LTEIKHL 128
LG G F V K TG+ A K + + + E+ L
Sbjct: 18 ELGSGQFAVVKKC---REK------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 129 GQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
++ HPN++ L E+ + L+ E + G L + L + S + + +K L
Sbjct: 69 KEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-LKQILNG 126
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
+ YLHS ++ + D K NI+L K+ DFGLA + +
Sbjct: 127 ---VYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIF 178
Query: 244 GTYGYAAPE 252
GT + APE
Sbjct: 179 GTPEFVAPE 187
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 48/258 (18%), Positives = 89/258 (34%), Gaps = 63/258 (24%)
Query: 15 NGANSKCSRKDGNGTSGSSSRVSSVSVVPRTEGEILLGSNIKSFSFNGLKTATRNFRPDS 74
+ + + + + + P E E L ++
Sbjct: 6 HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES----------------QYQVGP 49
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT------EIKHL 128
+LG GGFG V+ G + +A+K + ++ + E E+ L
Sbjct: 50 LLGSGGFGSVYSG---IRV------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 129 GQLYH--PNLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
++ +++L+ + D +L+ E P L + + R ++ L
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----------ALQEEL 150
Query: 186 GAAK------GLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGLA---KDGPTGSQ 235
+ + + H+ V++RD K NIL+DLN KL DFG KD
Sbjct: 151 ARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----- 203
Query: 236 SHVSTRVMGTYGYAAPEY 253
+ GT Y+ PE+
Sbjct: 204 -VYTDFD-GTRVYSPPEW 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 42/190 (22%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLGQ 130
LGEG FG V H T +A+K L + + +E EI +L
Sbjct: 17 LGEGSFGKVKLA---THYK------TQQKVALKFISRQLLKKSDMHMRVE--REISYLKL 65
Query: 131 LYHPNLVKLIGY-CLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L HP+++KL Y + + +V E+ G L +++ + RM G
Sbjct: 66 LRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK----------RMTEDEGRR 112
Query: 189 K------GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ Y H K +++RD K N+LLD N N K++DFGL+ G+ S
Sbjct: 113 FFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-- 168
Query: 243 MGTYGYAAPE 252
G+ YAAPE
Sbjct: 169 -GSPNYAAPE 177
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 25/192 (13%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT----EI 125
+ +LG GG V D +AVK L + L + E
Sbjct: 14 YELGEILGFGGMSEVHLAR-DLRD--------HRDVAVKVLRAD-LARDPSFYLRFRREA 63
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
++ L HP +V + + +V E++ +L + + P++ +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAI 119
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST- 240
+V A + L + H + +I+RD K +NI++ K+ DFG+A+ S T
Sbjct: 120 EVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 241 RVMGTYGYAAPE 252
V+GT Y +PE
Sbjct: 178 AVIGTAQYLSPE 189
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 44/210 (20%), Positives = 83/210 (39%), Gaps = 40/210 (19%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
N+ ++G G +G V+ D++T +A+K++N+ E L L E
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKVNRMFEDLIDCKRILRE 75
Query: 125 IKHLGQLYHPNLVKLI-----GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
I L +L +++L L+ D +V E S LF+ L+
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP---IFLT-EE 129
Query: 180 RMKV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQ 235
+K L G ++H + +I+RD K +N LL+ + + K+ DFGLA+ +
Sbjct: 130 HIKTILYNLL---LGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 236 SHVSTRVMGTYGYAAP---------EYMAT 256
+++ + ++ T
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 38/194 (19%), Positives = 65/194 (33%), Gaps = 48/194 (24%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP 134
LG G FG V + T + K + + EI L H
Sbjct: 12 DLGRGEFGIVHRC---VET------SSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHR 61
Query: 135 NLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRR-------------ASYIQPLSWTIR 180
N++ L E L +++EF+ + +F R SY+ +
Sbjct: 62 NILHLHESF-ESMEELVMIFEFISGL--D--IFERINTSAFELNEREIVSYVHQV----- 111
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHV 238
+ L +LHS + + D + NI+ ++ K+ +FG A+ G +
Sbjct: 112 -------CEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 239 STRVMGTYGYAAPE 252
+ Y APE
Sbjct: 163 ---LFTAPEYYAPE 173
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 50/218 (22%), Positives = 86/218 (39%), Gaps = 72/218 (33%)
Query: 76 LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLT------------ 123
+G+G +G V + A+K L+++ L +
Sbjct: 21 IGKGSYGVVKLA---YNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 124 --------------EIKHLGQLYHPNLVKL--IGYCLEDDHRLLVYEFMPKGSL------ 161
EI L +L HPN+VKL + +DH +V+E + +G +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 162 ----EN---HLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214
E+ F+ + G+ YLH K +I+RD K SN+L+
Sbjct: 132 KPLSEDQARFYFQ-----DLIK-------------GIEYLHYQK--IIHRDIKPSNLLVG 171
Query: 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPE 252
+ + K++DFG++ + GS + +S V GT + APE
Sbjct: 172 EDGHIKIADFGVSNE-FKGSDALLSNTV-GTPAFMAPE 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 49/206 (23%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLT--- 123
+R +LG+GGFG VF G + +A+K + + + L
Sbjct: 32 EYRLGPLLGKGGFGTVFAG---HRL------TDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 124 -EIKHLGQL----YHPNLVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRRASYIQPLSW 177
E+ L ++ HP +++L+ + + +LV E +P L +++ +
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-------- 134
Query: 178 TIRMKVALGAAK------GLAYLHSDKAKVIYRDFKTSNILLDLNYNA-KLSDFGLA--- 227
+ + + HS V++RD K NIL+DL KL DFG
Sbjct: 135 --PLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEY 253
D P + GT Y+ PE+
Sbjct: 191 HDEP------YTDFD-GTRVYSPPEW 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 38/207 (18%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQ--ESLQGHLEWLTE 124
R + LG+G +G V+K ID T G V+AVK++ ++ E
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 125 IKHLGQL-YHPNLVKLIGYCLEDDHR--LLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
I L +L H N+V L+ D+ R LV+++M E L L +
Sbjct: 59 IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDL-HAVIRANILE-PVHK 111
Query: 182 KV----ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSH 237
+ + K + YLHS +++RD K SNILL+ + K++DFGL++ +
Sbjct: 112 QYVVYQLI---KVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 238 VSTRVMGTYGYAAP--------EYMAT 256
+ + +Y+AT
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVAT 193
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 46/194 (23%), Positives = 71/194 (36%), Gaps = 42/194 (21%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK-----RLNQESLQGHLEWLTEIKHLG 129
LG G F V + TG A K R Q+ E L EI L
Sbjct: 36 ELGRGKFAVVRQC---ISK------STGQEYAAKFLKKRRRGQDCRA---EILHEIAVLE 83
Query: 130 QLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR--ASYIQPLS-----WTIRM 181
P ++ L +L+ E+ G E +F + +S I+
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLCLPELAEMVSENDVIRLIKQ 139
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAKDGPTGSQSHV 238
+ +G+ YLH + +++ D K NILL + K+ DFG+++ +
Sbjct: 140 IL-----EGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192
Query: 239 STRVMGTYGYAAPE 252
+MGT Y APE
Sbjct: 193 ---IMGTPEYLAPE 203
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-12
Identities = 43/171 (25%), Positives = 62/171 (36%), Gaps = 44/171 (25%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-H 133
VLG G G V + + T A+K L E++ +
Sbjct: 25 VLGLGINGKVLQI---FNK------RTQEKFALKMLQDCPKAR-----REVELHWRASQC 70
Query: 134 PNLVKLIGYC----LEDDHRLLVYEFMPKGSL-------ENHLF--RRASYIQPLSWTIR 180
P++V+++ L+V E + G L + F R AS I
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-------- 122
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSDFGLAK 228
MK A + YLHS + +RD K N+L N KL+DFG AK
Sbjct: 123 MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 7/106 (6%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQL 131
LG G FG V + + + T +AVK L + + H ++E+K L +
Sbjct: 27 GKPLGRGAFGQVIEADA----FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 132 -YHPNLVKLIGYCLEDDHRLLV-YEFMPKGSLENHLFRRASYIQPL 175
+H N+V L+G C + L+V EF G+L +L + + P
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 23/68 (33%), Positives = 31/68 (45%), Gaps = 2/68 (2%)
Query: 162 ENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221
E Y L+ + + AKG+ +L S K I+RD NILL K+
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKI 234
Query: 222 SDFGLAKD 229
DFGLA+D
Sbjct: 235 CDFGLARD 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 51/194 (26%), Positives = 76/194 (39%), Gaps = 32/194 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
NFR +G G FG + G ++ Y T +A+K +S L E +
Sbjct: 10 NFRVGKKIGCGNFGELRLG---KNLY------TNEYVAIKLEPMKSRAPQLHL--EYRFY 58
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
QL + ++ + + +V E + SLE LF L T+ M +A+
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLK-TVLM-IAIQL 114
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAK---DGPTGSQSHVS 239
+ Y+HS +IYRD K N L+ N + DF LAK D T H+
Sbjct: 115 ISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK--KHIP 170
Query: 240 TR----VMGTYGYA 249
R + GT Y
Sbjct: 171 YREHKSLTGTARYM 184
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 31/175 (17%), Positives = 60/175 (34%), Gaps = 21/175 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVK------RLNQES-----LQ 116
R ++ S G +++ T ++K RL E
Sbjct: 42 RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 117 GHLEWLTEIKHLGQLYHPNLVKLIGY-CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPL 175
L+ K L + +G+ +D +R LV + + SL+ + L
Sbjct: 101 KPLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPK-HVL 156
Query: 176 SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAK 228
S ++VA L +LH + ++ + NI +D ++ L+ +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 42/194 (21%), Positives = 70/194 (36%), Gaps = 32/194 (16%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ +GEG FG +F+G +A+K + S L E +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDAPQLRD--EYRTY 59
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L + + + E H +LV + + SLE L + T+ M A
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVK-TVAM-AAKQM 115
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK-----LSDFGLAK---DGPTGSQSHVS 239
+ +H ++YRD K N L+ + + DFG+ K D T H+
Sbjct: 116 LARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIP 171
Query: 240 TR----VMGTYGYA 249
R + GT Y
Sbjct: 172 YREKKNLSGTARYM 185
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 50/192 (26%), Positives = 75/192 (39%), Gaps = 30/192 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+R +G G FG ++ G D G +A+K ++ L E K
Sbjct: 10 RYRLGRKIGSGSFGDIYLG-TDIA--------AGEEVAIKLECVKTKHPQLHI--ESKIY 58
Query: 129 GQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ + + E D+ ++V E + SLE LF S L T+ + +A
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLK-TVLL-LADQM 114
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK---LSDFGLAK---DGPTGSQSHVSTR 241
+ Y+HS I+RD K N L+ L + DFGLAK D T H+ R
Sbjct: 115 ISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYR 170
Query: 242 ----VMGTYGYA 249
+ GT YA
Sbjct: 171 ENKNLTGTARYA 182
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 23/168 (13%), Positives = 52/168 (30%), Gaps = 20/168 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIK 126
+R G ++ D R +A+ ++ + + E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQAL-DTAL---DRQ-----VALTFVDPQGVLPDDVLQETLSRTL 83
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L ++ P + +++ L+V E++ GSL+ S ++
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQS 137
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
A H +A V S + + ++ + L+ D
Sbjct: 138 LAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD 183
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 52/192 (27%), Positives = 79/192 (41%), Gaps = 30/192 (15%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
FR +G G FG ++ G T +A+K N ++ L + E K
Sbjct: 8 KFRLGRKIGSGSFGEIYLGT---------NIQTNEEVAIKLENVKTKHPQLLY--ESKIY 56
Query: 129 GQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L + + + +E D+ +LV + + SLE LF S L T+ M +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLK-TVLM-LADQM 112
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK---LSDFGLAK---DGPTGSQSHVSTR 241
+ ++HS ++RD K N L+ L A + DFGLAK D T H+ R
Sbjct: 113 INRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYR 168
Query: 242 ----VMGTYGYA 249
+ GT YA
Sbjct: 169 ENKNLTGTARYA 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 3e-08
Identities = 33/214 (15%), Positives = 51/214 (23%), Gaps = 49/214 (22%)
Query: 53 SNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYA--------PARPGTGMV 104
FS T + +GEG FG VF+ D A P
Sbjct: 8 KGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 105 IAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-------------------- 144
+ + E + + L+ + + L
Sbjct: 65 KTFEEILPEII--ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 145 ----------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYL 194
+DD +V EF G + + S + LA
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTASLAVA 177
Query: 195 HSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAK 228
+ +RD N+LL KL K
Sbjct: 178 E-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 34/204 (16%), Positives = 72/204 (35%), Gaps = 32/204 (15%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW-----L 122
++ +G+GGFGC++ ++ G+ VK ++ E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESV----GSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 123 TEIKHLGQLYHPNLVKLIG----------YCLEDDHRLLVYEFMPKGSLENHLFRRASYI 172
+ + + + +K +G +R ++ + L+ ++ +
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANAKR 148
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAKD- 229
T+ ++L L Y+H + ++ D K SN+LL+ + L D+GLA
Sbjct: 149 FSRK-TVLQ-LSLRILDILEYIHE--HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 230 GPTGSQSHVSTR----VMGTYGYA 249
P G + GT +
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 43/193 (22%), Positives = 80/193 (41%), Gaps = 38/193 (19%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLGQ 130
S++G+G FG V K + D +A+K + N+++ Q E++ L
Sbjct: 60 SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAFLNQA----QIEVRLLEL 106
Query: 131 L--YHP----NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLF---RRASYIQPLSWTIRM 181
+ + +V L + + +H LV+E L +L+ R ++ + +S +
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNF-RGVSLNLTR 160
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKLSDFGLAKDGPTGSQSHVS 239
K A L +L + + +I+ D K NILL K+ DFG + ++
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220
Query: 240 TRVMGTYGYAAPE 252
+R Y +PE
Sbjct: 221 SRF-----YRSPE 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-06
Identities = 44/282 (15%), Positives = 82/282 (29%), Gaps = 103/282 (36%)
Query: 51 LGSNIKSFSFNGLKTA-TRN-------FRPDS-----VLGEGGFGCVFKGWIDEHTYAPA 97
L + I+S S N L+ A R F P + +L + W D
Sbjct: 355 LTTIIES-SLNVLEPAEYRKMFDRLSVFPPSAHIPTILL------SLI--WFDVIKSDV- 404
Query: 98 RPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYHPNLV----KLI 140
MV+ K L++ SL +LE ++++ L H ++V
Sbjct: 405 -----MVVVNK-LHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPK 457
Query: 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAK 200
+ +D + L+ + + S+I + H +
Sbjct: 458 TFDSDD---------LIPPYLDQYFY---SHI-------------------GH-HLKNIE 485
Query: 201 VIYRDFKTSNILLDLNY-NAKLSDFGLAKDGPTGSQSHVSTRVMGTY-GYAA---PEYMA 255
R + LD + K+ A + + + + Y Y P+Y
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ--LKFYKPYICDNDPKYE- 542
Query: 256 TGIFQLVLLLFTF------------ECSLLHFSLQLPMCVLY 285
+LV + F LL +L ++
Sbjct: 543 ----RLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 30/178 (16%), Positives = 60/178 (33%), Gaps = 30/178 (16%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------- 120
+ +G GGFG ++ + P VK QE+ E
Sbjct: 37 NQWVLGKKIGSGGFGLIYLA-FPTNK-----PEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 121 ----WLTEIKHLGQLYHPNLVKLIGY----CLEDDHRLLVYEFMPKGSLENHLFRRASYI 172
+ + QL + + G +R +V E + L+ +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISG---QN 145
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK--LSDFGLAK 228
+ +++ + L Y+H + ++ D K +N+LL + L+D+GL+
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 42/201 (20%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESLQGHLEWLTEIKHLGQL- 131
LG G F V+ D +A+K + + EIK L ++
Sbjct: 25 RKLGWGHFSTVWLAK-DMV--------NNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVN 73
Query: 132 ----------YHPNLVKLIGY----CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSW 177
+++KL+ + H ++V+E + + L + + +
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA---LIKKYEHRGIPL 130
Query: 178 TIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL------NYNAKLSDFGLAKDGP 231
+++ GL Y+H + +I+ D K N+L+++ K++D G A
Sbjct: 131 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 232 TGSQSHVSTRVMGTYGYAAPE 252
+ + TR Y +PE
Sbjct: 190 EHYTNSIQTRE-----YRSPE 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 56/202 (27%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRL-NQESL--QGHLEWLTEIKHLG 129
V+G+G FG V K + D +A+K + N++ Q EI+ L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHK--------VHQHVALKMVRNEKRFHRQA----AEEIRILE 148
Query: 130 QL--YHP----NLVKLIGYCLEDDHR--------LL---VYEFMPKGSLENHLFRRASYI 172
L N++ ++ R LL +YE + K
Sbjct: 149 HLRKQDKDNTMNVIHMLEN---FTFRNHICMTFELLSMNLYELIKKNKF----------- 194
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNA-KLSDFGLAKDG 230
Q S + K A + L LH K ++I+ D K NILL + K+ DFG +
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252
Query: 231 PTGSQSHVSTRVMGTYGYAAPE 252
+++ +R Y APE
Sbjct: 253 HQRVYTYIQSRF-----YRAPE 269
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 6/109 (5%)
Query: 147 DHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205
H +V+E + G L + S Q L K+ +GL YLH+ K ++I+ D
Sbjct: 118 THICMVFEVL--GHHL--LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTD 172
Query: 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM 254
K NILL +N A + S + T A ++
Sbjct: 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.24 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.8 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.89 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.04 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.09 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.14 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.15 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.65 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=405.55 Aligned_cols=200 Identities=23% Similarity=0.305 Sum_probs=180.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
..|++.+.||+|+||+||+|.. ..+|+.||||++..........+.+|+.+|+.++||||+++++++.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~---------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATV---------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEE---------CCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4699999999999999999954 4468999999998766556667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
.+|||||||+||+|.+++.+. .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999999753 4899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 218 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 218 AQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 87543322 234578999999999999999999999999999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=398.37 Aligned_cols=203 Identities=24% Similarity=0.310 Sum_probs=181.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.++||+|+||+||+|+. ..+++.||||++.+... .....+.+|+++|++++||||++++++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~---------~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARE---------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4799999999999999999954 44789999999976543 23456889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEc
Confidence 9999999999999999999998764 4899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+............+.+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998765443333445679999999999999999999999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=396.97 Aligned_cols=203 Identities=20% Similarity=0.267 Sum_probs=173.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|+. ..+++.||||++.+... .....+.+|+++|++++||||+++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKS---------TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEE---------TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 5899999999999999999954 34689999999976543 345578899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
++.+|||||||+||+|.++|...+. ..+++..+..++.||+.||+|||++| ||||||||+||||+.++.+||+|||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999999976543 45788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+..... .......+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 171 la~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 171 IARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp EESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99875321 11234568999999999999999999999999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=401.52 Aligned_cols=200 Identities=23% Similarity=0.305 Sum_probs=180.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+.|++.+.||+|+||.||+|.. ..+|+.||||++..........+.+|+.+|+.++||||+++++++.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~---------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATV---------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEE---------CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 5699999999999999999954 4468999999998766556667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
.+|||||||+||+|.+++... .+++..+..++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999999653 4899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 295 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 295 AQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp EECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 86543322 234578999999999999999999999999999999999999999754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=391.16 Aligned_cols=212 Identities=26% Similarity=0.358 Sum_probs=175.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|.+.+.||+|+||+||+|.+... .+..++..||||.++.......++|.+|+++|++++||||+++++++.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4778889999999999999987642 234568899999998877667778999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRAS-----------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
..|||||||++|+|.+++..... ...++++..++.++.||+.||+|||+++ ||||||||+||||+.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCC
Confidence 99999999999999999986532 1245899999999999999999999987 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ |++||...
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 9999999999987644433333445689999999999999999999999999999999998 89999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=387.69 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=180.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|.+.+.||+|+||+||+|.+... ....++..||||.++........++.+|+++|++++||||+++++++.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5788999999999999999987532 233468899999998777666778999999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRA---------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
..|||||||++|+|.++|...+ .....+++..++.++.||+.||+|||+++ ||||||||+||||+.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCc
Confidence 9999999999999999997643 22356899999999999999999999987 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |++||...
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999986433322222233569999999999999999999999999999999998 89999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-56 Score=374.94 Aligned_cols=198 Identities=25% Similarity=0.356 Sum_probs=171.0
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe--
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-- 145 (295)
|++.+.||+|+||+||+|... .++..||+|.+..... ....++.+|+++|++++||||+++++++.+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 477788999999999999544 4688999999975533 334568899999999999999999999875
Q ss_pred --CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEEEc
Q 022575 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLS 222 (295)
Q Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~ 222 (295)
.+.+|||||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++++||||||||+||||+ .++.+||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEE
Confidence 346899999999999999998763 58899999999999999999999877799999999999997 47899999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+|+..... .....+||+.|||||++. +.|+.++|||||||++|||++|.+||...
T Consensus 175 DFGla~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eCcCCEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999854322 234578999999999886 46999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=383.54 Aligned_cols=199 Identities=25% Similarity=0.287 Sum_probs=172.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+.|++.+.||+|+||+||+|+. ..+++.||||+++..... .+|+.+++.++||||+++++++.+.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~---------~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKD---------KQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEE---------CCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4688889999999999999954 446899999999765432 36999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEEccccC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSDFGL 226 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~DFG~ 226 (295)
.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999999998764 5899999999999999999999988 99999999999999987 699999999
Q ss_pred CCCCCCCCCc---ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 227 AKDGPTGSQS---HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 227 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|+........ .....++||+.|||||++.+..|+.++|||||||++|||++|.+||....
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9865432211 11234689999999999999999999999999999999999999997653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=383.70 Aligned_cols=204 Identities=26% Similarity=0.281 Sum_probs=173.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|+.. ....+++.||||++++.... ...++.+|+++|++++||||+++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKI------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEEC------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEc------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 57999999999999999999653 23446889999999765432 23357789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
++.+|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccc
Confidence 999999999999999999998764 4899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 172 la~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 172 LSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp EEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 9986433221 234578999999999999999999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=371.22 Aligned_cols=199 Identities=26% Similarity=0.354 Sum_probs=163.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||+||+|. +..+++.||||++.+... .....+.+|+++|+.++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~---------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEE---------CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEE---------ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 589999999999999999994 455789999999976543 23456889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+++..|+||||| +|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCS
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeec
Confidence 999999999999 789999998763 5899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+...... .....+||+.|||||++.+..| +.++|||||||++|+|++|.+||...
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 9998653322 2345689999999999998776 58999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=376.13 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=168.9
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..+++++.+.||+|+||+||+|.++ ..||||+++... .....++.+|+.++++++||||+++++++
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3468889999999999999999654 248999987543 23456789999999999999999999987
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
. ++..|||||||++|+|.++|.... ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 102 ~-~~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~D 175 (307)
T 3omv_A 102 T-KDNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGD 175 (307)
T ss_dssp C-SSSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECC
T ss_pred E-CCeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEee
Confidence 5 467899999999999999997654 45899999999999999999999987 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeecc---CcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|+..............+||+.|||||++.+ +.|+.++|||||||+||||++|++||...
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 999986544333333445689999999999863 46899999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=378.23 Aligned_cols=213 Identities=24% Similarity=0.325 Sum_probs=178.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++++.+.||+|+||+||+|.+... .+..+++.||||.++.... ....+|.+|+.++.+++||||+++++++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 4567788999999999999987531 2334678999999975533 3456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
+..+||||||++|+|.++|..... ....+++..++.++.||+.||+|||+++ ||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC
Confidence 999999999999999999975431 1245889999999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
+++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |.+||....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999986543332223344679999999999999999999999999999999998 899998653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=374.18 Aligned_cols=220 Identities=24% Similarity=0.304 Sum_probs=186.0
Q ss_pred hhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCC-CCcc
Q 022575 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYH-PNLV 137 (295)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h-~ni~ 137 (295)
..++....++|++.+.||+|+||+||+|.+... ....+++.||||.+...... ...++.+|+++|.+++| |||+
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 344555668999999999999999999987642 23345788999999765433 34568899999999975 8999
Q ss_pred ceeeEEEeC-CeeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 022575 138 KLIGYCLED-DHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (295)
Q Consensus 138 ~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 204 (295)
+++++|... +.+|||||||++|+|.++|+.... ....+++..++.++.||+.||+|||+++ ||||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHR 209 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHR 209 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecC
Confidence 999998764 568999999999999999976432 1245889999999999999999999988 9999
Q ss_pred cCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhh
Q 022575 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCV 283 (295)
Q Consensus 205 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~ 283 (295)
||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997655444434455689999999999999999999999999999999998 999997
Q ss_pred ee
Q 022575 284 LY 285 (295)
Q Consensus 284 ~~ 285 (295)
..
T Consensus 290 ~~ 291 (353)
T 4ase_A 290 GV 291 (353)
T ss_dssp TC
T ss_pred CC
Confidence 64
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=364.06 Aligned_cols=198 Identities=25% Similarity=0.413 Sum_probs=159.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||+||+|+.. .+++.||||.++..... ....+.+|+++|++++||||+++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET---------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 46899999999999999999543 46899999999754432 345688999999999999999999998765
Q ss_pred C------------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 147 D------------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 147 ~------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
+ .+|+|||||++|+|.+++...... ....+..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~ 152 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT 152 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC
Confidence 4 379999999999999999865432 33566778899999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCc----------ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQS----------HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 277 (295)
.++.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 9999999999999865432211 11234579999999999999999999999999999999996
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=360.84 Aligned_cols=201 Identities=26% Similarity=0.328 Sum_probs=164.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|.+.+.||+|+||+||+|.++ |+.||||+++...... .....|+..+.+++||||+++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~ 70 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence 56888899999999999999764 7889999997654322 22345677778899999999999998764
Q ss_pred ----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeEeecCCCCCeEEcCCC
Q 022575 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~~ 217 (295)
.+|||||||++|+|.+++.+. .+++..+..++.|++.||+|||++ .++||||||||+||||+.++
T Consensus 71 ~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence 579999999999999999764 488999999999999999999986 22499999999999999999
Q ss_pred cEEEccccCCCCCCCCCCc--ceeeccccccCccCceeeccC------cccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG------IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||++|.+||...
T Consensus 146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 9999999999864333221 112345799999999998754 5788999999999999999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=372.48 Aligned_cols=202 Identities=24% Similarity=0.334 Sum_probs=171.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|+. ..+|+.||||+++.... .....+.+|+++|+.++||||+++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARR---------RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 5899999999999999999954 44789999999975432 334567899999999999999999998764
Q ss_pred C------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 D------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. +.+|||||||+ |+|.+++.+. ..+++..+..++.||+.||+|||++| ||||||||+|||++.++.+
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~ 197 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCEL 197 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCE
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCE
Confidence 3 57899999995 7899999765 45899999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCC--cceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+|+.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|.+||...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 9999999986543221 1223457899999999998865 5689999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=381.83 Aligned_cols=200 Identities=26% Similarity=0.346 Sum_probs=173.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHH---HHHHHHHHHcccCCCCcccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHL---EWLTEIKHLGQLYHPNLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~---~~~~E~~~l~~l~h~ni~~l~ 140 (295)
.++|++.++||+|+||+||+|+. ..+|+.||||++.+.... ... ....++.++..++||||++++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~---------~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEE---------CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 46899999999999999999954 457999999999765432 111 223456777888999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
++|.+.+.+|||||||+||+|.++|.+.+ .+++..+..++.||+.||+|||++| ||||||||+||||+.+|++|
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEE
Confidence 99999999999999999999999998764 4899999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+|+...... ..+.+||+.|||||++.. ..|+.++|||||||++|||++|.+||...
T Consensus 333 L~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp ECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred ecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998754332 335689999999999975 47999999999999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=360.17 Aligned_cols=204 Identities=22% Similarity=0.249 Sum_probs=171.7
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
....++|++.+.||+|+||+||+|+.+ .+..+++.||+|.+.... ...++.+|+++|..+ +||||++++++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 344578999999999999999999754 233468899999987654 334567899999988 69999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcEEE
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKL 221 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl 221 (295)
+.+.+.+|+|||||++|+|.+++. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999999983 3788999999999999999999988 9999999999999876 79999
Q ss_pred ccccCCCCCCCCCC--------------------------cceeeccccccCccCceeeccC-cccccceeeehhHHHHH
Q 022575 222 SDFGLAKDGPTGSQ--------------------------SHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLH 274 (295)
Q Consensus 222 ~DFG~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~e 274 (295)
+|||+|+....... .......+||+.|||||++.+. .|+.++||||+||++||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999975432211 0112335799999999999875 58999999999999999
Q ss_pred HhccCChhhe
Q 022575 275 FSLQLPMCVL 284 (295)
Q Consensus 275 l~~g~~pf~~ 284 (295)
|++|++||..
T Consensus 240 ll~G~~Pf~~ 249 (361)
T 4f9c_A 240 LLSGRYPFYK 249 (361)
T ss_dssp HHHTCSSSSC
T ss_pred HHHCCCCCCC
Confidence 9999999954
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=375.68 Aligned_cols=201 Identities=23% Similarity=0.268 Sum_probs=180.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|.. ..+|+.||+|.+..........+.+|+.+|+.++||||+++++++.+.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~---------~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTE---------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred cccEEEEEEeeccCeEEEEEEE---------CCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 5899999999999999999954 4578999999998776666677889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC--CcEEEcccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN--YNAKLSDFG 225 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~DFG 225 (295)
.+|||||||+||+|.++|.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeecc
Confidence 9999999999999999996543 45899999999999999999999988 9999999999999754 899999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 998764432 234568999999999999999999999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=326.62 Aligned_cols=201 Identities=27% Similarity=0.319 Sum_probs=176.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+.+... .....+.+|+.++..++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREK---------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 58999999999999999999543 4689999999976532 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999998753 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 99986432221 234468999999999999999999999999999999999999999653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=340.16 Aligned_cols=211 Identities=20% Similarity=0.205 Sum_probs=180.3
Q ss_pred hhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHcccCCCCc
Q 022575 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQLYHPNL 136 (295)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~h~ni 136 (295)
..++....++|++.++||+|+||.||+|+.. .+++.||+|++.+..... ...+.+|..++..++||||
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I 136 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLK---------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEc---------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE
Confidence 3444555689999999999999999999654 358899999997543221 2236789999999999999
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
+++++++.+.+..|+||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~ 211 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN 211 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC
Confidence 999999999999999999999999999998643 45899999999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+||+|||+|+....... ......+||+.|+|||++. .+.++.++|||||||++|||++|.+||...
T Consensus 212 g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 212 GHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp SCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999976543322 2233468999999999997 567999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=319.25 Aligned_cols=201 Identities=22% Similarity=0.342 Sum_probs=179.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|. +..+++.||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEE---------ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 3689999999999999999994 3446889999999766655666788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999764 3788999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 219 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 986543322 233457999999999999999999999999999999999999999654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=329.25 Aligned_cols=202 Identities=28% Similarity=0.370 Sum_probs=172.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
.++|++.++||+|+||.||+|+.. .+++.||+|++.+... .....+.+|.+++..+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK---------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc---------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 368999999999999999999544 4688999999976532 2344567899999988 79999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+.+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~ 166 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLA 166 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEc
Confidence 999999999999999999999998763 4889999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+|+...... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 167 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 167 DFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 999998643222 1234568999999999999889999999999999999999999999754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=323.80 Aligned_cols=210 Identities=40% Similarity=0.666 Sum_probs=182.9
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|... ++..||+|.+..........+.+|+.++..++||||+++++++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 344579999999999999999999643 3788999998877666667788999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+++++|.+++.........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999999765543356899999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++...............||+.|+|||++.++.++.++|||||||++|||++|.+||...
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99997643322222233456899999999999999999999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=334.18 Aligned_cols=211 Identities=20% Similarity=0.170 Sum_probs=180.6
Q ss_pred hhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCc
Q 022575 60 FNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNL 136 (295)
Q Consensus 60 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni 136 (295)
+.+.....++|++.++||+|+||.||+|+.. .+++.||+|++.+.... ....+.+|..++..++||||
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~---------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I 123 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMK---------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe
Confidence 3444556689999999999999999999554 36899999999764322 22346789999999999999
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
+++++++.+.+..|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC 198 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC
Confidence 999999999999999999999999999998754 35889999999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeec-------cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-------TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+||+|||+++....... ......+||+.|+|||++. ...++.++|+|||||++|||++|.+||...
T Consensus 199 g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp SCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 9999999999986543321 1223468999999999997 457899999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=331.30 Aligned_cols=201 Identities=24% Similarity=0.333 Sum_probs=175.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh---HHHHHHHHHHHccc-CCCCccceeeE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
.++|++.++||+|+||.||+|+.. .+++.||+|++++..... ...+.+|..++.++ +||||++++++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 358999999999999999999554 468999999997654322 23467899998877 89999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+.+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEe
Confidence 999999999999999999999998763 4899999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+|+...... ......+||+.|+|||++.+..++.++|+|||||++|||++|.+||..
T Consensus 196 DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 196 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 999998633222 123456899999999999999999999999999999999999999953
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=335.57 Aligned_cols=207 Identities=22% Similarity=0.219 Sum_probs=177.4
Q ss_pred hHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccc
Q 022575 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVK 138 (295)
Q Consensus 62 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~ 138 (295)
++....++|++.++||+|+||.||+|... .+++.||+|++.+.... ....+.+|+.++..++||||++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 133 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHK---------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCC
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEEC---------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34455678999999999999999999544 46889999998754321 2234678999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 139 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
+++++.+.+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 134 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSC
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCC
Confidence 999999999999999999999999999753 3789999999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCc----ccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI----FQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+|+...... .......+||+.|+|||++.... ++.++|||||||++|||++|.+||...
T Consensus 207 ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp EEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 9999999998654332 11233568999999999998654 889999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=324.18 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=176.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
..+|++.+.||+|+||.||+|.. ..+++.||||++..... ....++.+|+++++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARH---------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEE---------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 35899999999999999999954 34689999999876532 33456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECST
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeec
Confidence 9999999999999999999997764 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCccc-ccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQ-LVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|.+||...
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 159 GFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp TCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 9997654332 23446899999999999988775 8999999999999999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=324.33 Aligned_cols=204 Identities=25% Similarity=0.365 Sum_probs=176.8
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCcccee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLI 140 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~ 140 (295)
...++|++.++||+|+||.||+|... .+++.||+|.+++... .....+..|..++..+ +||||++++
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFK---------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 44579999999999999999999554 4689999999976532 2344567888888876 899999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+++.+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEE
Confidence 99999999999999999999999998753 4889999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 159 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 159 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 999999986433221 234568999999999999999999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=319.47 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=175.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|+.. .+++.||+|.+.+... .....+.+|+.++..++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSR---------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 58999999999999999999543 4688999999976532 23456778999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeec
Confidence 9999999999999999999998753 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++..... ....+||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 999864321 23467999999999999999999999999999999999999999653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=326.19 Aligned_cols=214 Identities=16% Similarity=0.164 Sum_probs=176.3
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC---CCCccceee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIG 141 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~ 141 (295)
...++|++.+.||+|+||.||+|..... .+..+++.||+|.+...... ++..|++++..++ |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4457899999999999999999964321 23446889999999866433 4456666666665 999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-----
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRAS-YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----- 215 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----- 215 (295)
++...+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ ||||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCc
Confidence 99999999999999999999999986432 1246899999999999999999999988 999999999999988
Q ss_pred ------CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 216 ------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 216 ------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||++|.+||.....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 899999999999754322223334556899999999999999999999999999999999999999976644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=322.10 Aligned_cols=200 Identities=25% Similarity=0.340 Sum_probs=175.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
++|++.+.||+|+||.||+|+.. .+++.||+|.+.+... .....+.+|..++.++ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLK---------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEEC---------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 58999999999999999999554 4689999999976533 2334567899999887 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998753 4889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||..
T Consensus 154 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 154 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp GGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 999986432221 23446899999999999999999999999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=323.31 Aligned_cols=203 Identities=26% Similarity=0.304 Sum_probs=177.2
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCccceee
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLIG 141 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~~ 141 (295)
..++|++.++||+|+||.||+|... .+++.||+|++.+... .....+..|..++..+ +||||+++++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~ 88 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET---------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence 3468999999999999999999544 3588999999976532 2345577899999988 7999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
++.+.+..|+||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEE
Confidence 9999999999999999999999998763 4889999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 163 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 163 ADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 99999986432221 234568999999999999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=325.28 Aligned_cols=216 Identities=23% Similarity=0.325 Sum_probs=180.7
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|...... .....++..||+|.++.... ....++.+|+.++..+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3468999999999999999999764211 02334578899999976533 3445688999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
...+..|+||||+++|+|.+++...... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI 234 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 234 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhE
Confidence 9999999999999999999999875421 134788999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999986543332222233467889999999999999999999999999999999 99999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=322.78 Aligned_cols=201 Identities=24% Similarity=0.288 Sum_probs=176.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccCCCCcccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~l~ 140 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.++..++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~---------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC---------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 358999999999999999999543 46899999999765432 245678999999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--- 217 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--- 217 (295)
+++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCc
Confidence 9999999999999999999999999765 35899999999999999999999988 99999999999998877
Q ss_pred -cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 -NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 156 ~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 79999999998654432 223457999999999999889999999999999999999999999654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=318.66 Aligned_cols=218 Identities=42% Similarity=0.694 Sum_probs=188.6
Q ss_pred CCcceeehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHccc
Q 022575 53 SNIKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL 131 (295)
Q Consensus 53 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l 131 (295)
.....++..++....++|++.+.||+|+||.||+|... ++..||+|.+...... ....+.+|+.++..+
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 34567888999999999999999999999999999432 3788999999765432 223578999999999
Q ss_pred CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---CCCeEeecCCC
Q 022575 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD---KAKVIYRDFKT 208 (295)
Q Consensus 132 ~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~ivHrDlkp 208 (295)
+||||+++++++...+..++||||+++++|.+++.........+++..+..++.|++.||+|||++ + |+||||||
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp 162 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKA 162 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCch
Confidence 999999999999999999999999999999999987765556689999999999999999999998 7 99999999
Q ss_pred CCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 209 SNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 209 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred hhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999999999999999986543322 22334569999999999999999999999999999999999999995
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=315.37 Aligned_cols=205 Identities=28% Similarity=0.399 Sum_probs=178.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .++..||+|.+..........+.+|+.++.+++||||+++++++.+.+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHR---------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hHeeccceecCCCCEEEEEEEEC---------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 58899999999999999999554 358899999987766666778899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred eeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccc
Confidence 9999999999999999998754 45889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcc------------eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 228 KDGPTGSQSH------------VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 228 ~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+......... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 8653322111 0114579999999999999999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=312.69 Aligned_cols=203 Identities=24% Similarity=0.304 Sum_probs=172.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.+.||+|+||.||+|.. ..++..||+|.+.... ......+.+|+.++.+++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAED---------TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEE---------TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEE---------CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 46899999999999999999954 3468899999885432 23345678999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~D 154 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFD 154 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999998763 4889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999986543221 1223457999999999999999999999999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=315.92 Aligned_cols=201 Identities=16% Similarity=0.192 Sum_probs=177.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... .++..+|+|.+.... .....+.+|+.++..++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET---------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEEC---------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 368999999999999999999543 468999999987554 3345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC--CCcEEEccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSDF 224 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~DF 224 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 99999999999999999997653 35889999999999999999999988 999999999999987 789999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 149 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 9998754332 233457999999999999988999999999999999999999999654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=324.56 Aligned_cols=199 Identities=23% Similarity=0.313 Sum_probs=175.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+.+... .....+.+|+.++..++||||+++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKN---------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 58999999999999999999544 4688999999875432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEecc
Confidence 999999999999999999999865 34889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc---CcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|+++...... .....+||+.|+|||++.. ..++.++|||||||++|||++|.+||..
T Consensus 160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 9998654322 2345689999999999873 4589999999999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=325.81 Aligned_cols=201 Identities=28% Similarity=0.358 Sum_probs=168.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHH-HcccCCCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKH-LGQLYHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~-l~~l~h~ni~~l~~~~ 143 (295)
++|++.++||+|+||.||+|+.. .++..||+|++.+.... ....+..|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~---------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHK---------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEET---------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEc---------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 58999999999999999999544 46889999999765432 23345667766 4678999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEee
Confidence 99999999999999999999998753 4788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++...... ......+||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 183 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 183 FGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp CCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99998532221 1234568999999999999999999999999999999999999999654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=320.96 Aligned_cols=198 Identities=25% Similarity=0.299 Sum_probs=176.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+.+... .....+.+|+.++..++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHK---------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEEC---------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 58999999999999999999544 4688999999976532 23456788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+||||+++++|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccc
Confidence 9999999999999999999998764 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 999865332 23457999999999999999999999999999999999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=322.18 Aligned_cols=205 Identities=23% Similarity=0.244 Sum_probs=176.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-----hHHHHHHHHHHHcccCCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
++|++.+.||+|+||.||+|... .+++.||+|++...... ....+.+|+.++..++||||++++++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR---------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 47999999999999999999543 46889999998654321 34567899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc---E
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---A 219 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~ 219 (295)
+.+.+..|+||||+++++|.+.+.........+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcE
Confidence 99999999999999999999888765433345889999999999999999999988 999999999999976655 9
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 173 kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp EECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 9999999986543221 223457999999999999989999999999999999999999999653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=316.28 Aligned_cols=204 Identities=26% Similarity=0.340 Sum_probs=168.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
++|++.+.||+|+||.||+|+.. ....+++.||+|++.+... .....+.+|+.+++.++||||+++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKV------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEC------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEe------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 58999999999999999999654 2234689999999976532 2334567899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..|+||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEe
Confidence 99999999999999999999998753 4788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 99997543221 1233467999999999999889999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=333.63 Aligned_cols=206 Identities=27% Similarity=0.357 Sum_probs=180.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.++||+|+||.||+|... .+++.||+|++.+.... ....+.+|+.++..++||||+++++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK---------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 468999999999999999999543 46899999999765432 245678899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..|+||||++||+|.+++.........+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEee
Confidence 9999999999999999999999876533356899999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||...
T Consensus 333 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 333 LGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp CTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred cceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 999986543322 123458999999999999999999999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=323.71 Aligned_cols=197 Identities=22% Similarity=0.262 Sum_probs=160.8
Q ss_pred CCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcc-cCCCCccceeeEEEe
Q 022575 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ-LYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~ 145 (295)
++|.+. ++||+|+||.||+|... .+++.||||++... ..+.+|+.++.+ .+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~---------~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEEC---------CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 467665 78999999999999543 46899999998633 244578877644 589999999999876
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCc
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYN 218 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~ 218 (295)
.+..|+||||+++|+|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~ 202 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 202 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCC
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCcc
Confidence 5678999999999999999986542 45899999999999999999999988 999999999999987 789
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp EEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred EEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998643322 223467899999999999999999999999999999999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.22 Aligned_cols=201 Identities=22% Similarity=0.263 Sum_probs=177.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..........+.+|+.++..++||||+++++++.+.+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEK---------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCEEEEEEEEC---------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 58999999999999999999543 468899999998765555667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC--CCcEEEcccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL--NYNAKLSDFG 225 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~DFG 225 (295)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecc
Confidence 9999999999999999997643 35889999999999999999999988 999999999999974 5779999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 197 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 197 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 998654332 223357999999999999989999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=330.91 Aligned_cols=202 Identities=21% Similarity=0.308 Sum_probs=157.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||||++.... .....++.+|+.+|..++||||+++++++..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDK---------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp TTEEECCC-------CEEEEEEC---------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCeEEeeEeeecCCeEEEEEEEC---------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 68999999999999999999543 468899999986532 2345568899999999999999999999854
Q ss_pred C-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
. +..|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+|
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~k 196 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVK 196 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEE
T ss_pred CCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEe
Confidence 3 5689999998 67999999764 35899999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCc-------------------------ceeeccccccCccCceeec-cCcccccceeeehhHHHHH
Q 022575 221 LSDFGLAKDGPTGSQS-------------------------HVSTRVMGTYGYAAPEYMA-TGIFQLVLLLFTFECSLLH 274 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~e 274 (295)
|+|||+++........ ......+||+.|+|||++. ...++.++|||||||++||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 9999999865422111 1123457899999999864 5679999999999999999
Q ss_pred Hhc-----------cCChhhee
Q 022575 275 FSL-----------QLPMCVLY 285 (295)
Q Consensus 275 l~~-----------g~~pf~~~ 285 (295)
|++ |.|||.+.
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGS 298 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--
T ss_pred HHHhccccccccccccccCCCC
Confidence 999 67777554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=318.71 Aligned_cols=201 Identities=25% Similarity=0.352 Sum_probs=175.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++..++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC---------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 358999999999999999999543 4688999999976533 33456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---cEEE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAKL 221 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl 221 (295)
+.+..|+||||+++++|.+.+... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEE
Confidence 999999999999999999999765 35889999999999999999999988 99999999999997654 5999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998754332 123467999999999999889999999999999999999999999653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=316.92 Aligned_cols=203 Identities=25% Similarity=0.243 Sum_probs=173.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhceeeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 58999999999999999999544 36889999998655432 234577999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeec
Confidence 9999999999999999998765 34889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++...............||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 976533322222334679999999999987765 78999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=311.60 Aligned_cols=198 Identities=24% Similarity=0.319 Sum_probs=175.2
Q ss_pred CCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCee
Q 022575 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHR 149 (295)
Q Consensus 70 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~ 149 (295)
|...+.||+|+||.||+|... .+++.||||.+..........+.+|+.++..++||||+++++++...+..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREK---------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhccEEeccCCCeEEEEEEEC---------CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 666779999999999999544 35889999999776655666788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 150 LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
++||||+++++|.+++.+. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 118 ~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 190 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190 (321)
T ss_dssp EEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeee
Confidence 9999999999999998653 4889999999999999999999988 99999999999999999999999999986
Q ss_pred CCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 230 GPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 191 ISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 543221 223457999999999999999999999999999999999999999653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.91 Aligned_cols=196 Identities=23% Similarity=0.282 Sum_probs=168.0
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEEE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv 152 (295)
.+.||+|+||.||+|... .++..||+|++..........+.+|+.++.+++||||+++++++...+..++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET---------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEET---------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEc---------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 568999999999999543 35889999999877666667888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE--cCCCcEEEccccCCCCC
Q 022575 153 YEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL--DLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~~kl~DFG~a~~~ 230 (295)
|||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 165 ~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999987654 35888999999999999999999988 9999999999999 66789999999999865
Q ss_pred CCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 231 PTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
..... .....||+.|+|||++....++.++|||||||++|||++|.+||...
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 43322 22346999999999999889999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=334.53 Aligned_cols=205 Identities=28% Similarity=0.402 Sum_probs=179.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
...++|++.++||+|+||.||+|... .+++.||+|.+.+... .....+.+|+.+|..++||||+++++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~---------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 251 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 34567999999999999999999544 4689999999976532 23445789999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
++.+.+..|+||||++||+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL 327 (576)
T 2acx_A 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRI 327 (576)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEE
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEE
Confidence 99999999999999999999999976542 34889999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 328 ~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 328 SDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred EecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999998654332 223458999999999999999999999999999999999999999764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.15 Aligned_cols=202 Identities=24% Similarity=0.284 Sum_probs=175.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|.. ..+++.+|+|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~---------~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVK---------VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEE---------TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEE---------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 46899999999999999999953 446899999998765432 3456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc---CCCcEEE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKL 221 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl 221 (295)
+.+..|+||||+.+|+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEE
Confidence 9999999999999999999998763 4889999999999999999999988 99999999999998 5678999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 155 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 155 ADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp CCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 99999986543322 223467999999999999889999999999999999999999999653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=312.83 Aligned_cols=200 Identities=23% Similarity=0.277 Sum_probs=175.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccCCCCccceee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.++..++||||+++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 81 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceEeceEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 47999999999999999999543 46889999998765432 3456889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC----
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---- 217 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 217 (295)
++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSC
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCC
Confidence 999999999999999999999999764 35889999999999999999999988 99999999999998887
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 220 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220 (326)
T ss_dssp CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 89999999998654322 123457999999999999889999999999999999999999999653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=313.25 Aligned_cols=199 Identities=29% Similarity=0.369 Sum_probs=170.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... ++.||||++...... ......|+.++.+++||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 58999999999999999999654 678999999765432 334557999999999999999999998754
Q ss_pred ----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------CCCeEeecCCCCCeEE
Q 022575 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD----------KAKVIYRDFKTSNILL 213 (295)
Q Consensus 148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----------~~~ivHrDlkp~Nill 213 (295)
..++||||+++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill 164 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLL 164 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEE
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEE
Confidence 469999999999999999764 388999999999999999999997 7 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhee
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999976544332222334579999999999986 46778999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=314.42 Aligned_cols=200 Identities=25% Similarity=0.308 Sum_probs=174.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..+|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.+++.++||||+++++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 78 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY---------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 358999999999999999999543 46889999998754322 234678999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+ +|+|.+++.... .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 79 TTPTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp ECSSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECC
T ss_pred EeCCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEE
Confidence 9999999999999 789999987763 4889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...
T Consensus 152 FG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 152 FGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp SSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred eccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 99998654332 2234579999999999988776 68999999999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=310.97 Aligned_cols=207 Identities=26% Similarity=0.391 Sum_probs=169.4
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
....+|++.+.||+|+||.||+|... +..||+|++..... ....++.+|+.++.+++||||++++++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 33468999999999999999999653 67899999876543 334568899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+++.+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEEC
Confidence 9999999999999999999999976431 123888999999999999999999976669999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999997543321 1123457999999999999999999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=311.52 Aligned_cols=208 Identities=23% Similarity=0.328 Sum_probs=175.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.... ....+..||||.+.... ......+.+|+.++..++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRV------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECC------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEec------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3589999999999999999997652 22346679999997653 2345578899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCS
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999999999997653 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 998654432211 1222356788999999999999999999999999999999 99999654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=317.72 Aligned_cols=221 Identities=24% Similarity=0.289 Sum_probs=184.0
Q ss_pred ehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCc
Q 022575 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNL 136 (295)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni 136 (295)
....+....++|++.+.||+|+||.||+|.+... .+..+++.||||.+..... .....+.+|++++.++ +||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 3344455668999999999999999999976431 2455789999999976543 3345688999999999 79999
Q ss_pred cceeeEEEeCCe-eEEEEeccCCCCHHHHHhhccCC--------------------------------------------
Q 022575 137 VKLIGYCLEDDH-RLLVYEFMPKGSLENHLFRRASY-------------------------------------------- 171 (295)
Q Consensus 137 ~~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------- 171 (295)
+++++++...+. .++||||+++|+|.+++......
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 999999987654 89999999999999999865421
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCC
Q 022575 172 ------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233 (295)
Q Consensus 172 ------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 233 (295)
...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122888999999999999999999988 999999999999999999999999999866444
Q ss_pred CCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 234 SQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
..........||+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 33333445678999999999999999999999999999999998 99999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=327.99 Aligned_cols=202 Identities=28% Similarity=0.316 Sum_probs=168.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++..++||||+++++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 217 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEK---------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEc---------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence 357999999999999999999543 4689999999975432 2234567899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
...+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+ ++ |+||||||+|||++.++.+||+
T Consensus 218 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 218 QTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EETTEEEEEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEEC
T ss_pred eeCCEEEEEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEc
Confidence 99999999999999999999997753 58899999999999999999998 77 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 292 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 292 DFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 9999986433221 234468999999999999999999999999999999999999999654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=312.10 Aligned_cols=203 Identities=22% Similarity=0.301 Sum_probs=167.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++.+++||||+++++++.
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDL---------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEEC---------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 58999999999999999999543 4589999999976533 23446789999999999999999999987
Q ss_pred eCCe----eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 145 EDDH----RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 145 ~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
..+. .|+||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEE
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEE
Confidence 6543 499999999999999998653 4889999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999865433211 1223357999999999999999999999999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=307.73 Aligned_cols=204 Identities=25% Similarity=0.380 Sum_probs=160.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|. +..+++.||+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGL---------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp --------------CEEEEEE---------CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cceeEeeEECCCCCEEEEEEE---------ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 589999999999999999994 3446899999998755432 335677999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+..++||||++ ++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Df 152 (317)
T 2pmi_A 76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDF 152 (317)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcC
Confidence 99999999996 699999876432 2235888999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 153 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 153 GLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986533221 1233578999999999876 46899999999999999999999999654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=311.75 Aligned_cols=202 Identities=21% Similarity=0.172 Sum_probs=174.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.. ..+++.||||.+..... ...+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKN---------LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEE---------TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEE---------CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 36899999999999999999954 34689999999865432 23567899999999 99999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc-----EE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AK 220 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~k 220 (295)
.+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +|
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEE
T ss_pred CCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEE
Confidence 99999999999 999999998653 46899999999999999999999988 999999999999998887 99
Q ss_pred EccccCCCCCCCCCCcc-----eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 99999998643322211 123467999999999999999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=307.50 Aligned_cols=208 Identities=27% Similarity=0.403 Sum_probs=175.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|++.. .+..+++.||+|.+..........+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999997643 34557899999999877666667788999999999999999999998653
Q ss_pred --CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccC
Confidence 45899999999999999998764 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++......... .......+++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 999865433211 112234578889999999999999999999999999999999988754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=314.06 Aligned_cols=210 Identities=24% Similarity=0.229 Sum_probs=179.3
Q ss_pred cceeehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC--
Q 022575 55 IKSFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-- 132 (295)
Q Consensus 55 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-- 132 (295)
...+++.+.....++|++.+.||+|+||.||+|... .+++.||+|++.... .....+..|+.++..+.
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~ 91 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI---------DNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQND 91 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC---------CCCeEEEEEEeccch-hhhhhhHHHHHHHHHhccc
Confidence 334555555666789999999999999999999554 358899999997543 23345567888888886
Q ss_pred ---CCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 022575 133 ---HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (295)
Q Consensus 133 ---h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 209 (295)
||||+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 166 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPE 166 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcc
Confidence 999999999999999999999999 9999999987543 35889999999999999999999988 999999999
Q ss_pred CeEEcC-------------------------CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccce
Q 022575 210 NILLDL-------------------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLL 264 (295)
Q Consensus 210 Nill~~-------------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 264 (295)
|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++|
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccc
Confidence 999975 789999999999864332 22457899999999999999999999
Q ss_pred eeehhHHHHHHhccCChhhe
Q 022575 265 LFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 265 i~slG~~l~el~~g~~pf~~ 284 (295)
||||||++|+|++|.+||..
T Consensus 242 iwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCC
T ss_pred hHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999965
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.47 Aligned_cols=198 Identities=21% Similarity=0.243 Sum_probs=165.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|.. ..+++.||||++.... .....++.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEE---------CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 46899999999999999999954 3468999999997542 233456789999999999999999999997
Q ss_pred eC------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 ED------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
.. ...|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~ 202 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 202 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSC
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCC
Confidence 55 356999999954 67776643 3788999999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 203 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 203 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp EEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998654322 233468999999999999999999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=321.05 Aligned_cols=207 Identities=24% Similarity=0.345 Sum_probs=175.8
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
...++|++.+.||+|+||.||+|.... ++..||+|.+..... ....++.+|++++++++||||+++++++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445689999999999999999996543 578999999875532 2334678999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~D 256 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISD 256 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECc
Confidence 99899999999999999999998654 35788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+++...............+++.|+|||++..+.++.++|||||||++|||++ |.+||...
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~ 319 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL 319 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986433211111111235778999999999999999999999999999998 99999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.62 Aligned_cols=199 Identities=25% Similarity=0.289 Sum_probs=160.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+.... ....+.+|+.++.+++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQK---------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 468999999999999999999654 357899999987553 334567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~D 223 (295)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEcc
Confidence 99999999999999999997653 4889999999999999999999988 999999999999975 88999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99998653321 223457999999999999989999999999999999999999999654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=306.78 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=169.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 58999999999999999999653 3788999998755332 23567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||++ ++|.+.+.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 91 ERCLTLVFEFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEEcCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCc
Confidence 999999999996 58888887654 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 165 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 165 LARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp TCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 9986543221 2233578999999999876 56899999999999999999999999653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=319.53 Aligned_cols=213 Identities=26% Similarity=0.329 Sum_probs=175.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.+... .+..++..||||.+.... .....++.+|+.++.+++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 36899999999999999999976531 134468899999997543 2344567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---cE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRAS---YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NA 219 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 219 (295)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999987542 2235888999999999999999999988 99999999999998555 59
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999974322111112233568999999999999999999999999999999998 99999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=308.59 Aligned_cols=205 Identities=24% Similarity=0.391 Sum_probs=170.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 76 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK---------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET 76 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET---------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred hcCceeeEecCCCCeEEEEEEEc---------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence 57999999999999999999654 3588999999875443 3455688999999999999999999998664
Q ss_pred C---------------------------------------------------------eeEEEEeccCCCCHHHHHhhcc
Q 022575 147 D---------------------------------------------------------HRLLVYEFMPKGSLENHLFRRA 169 (295)
Q Consensus 147 ~---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~ 169 (295)
+ ..++||||+++++|.+++....
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 156 (332)
T 3qd2_B 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156 (332)
T ss_dssp CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence 3 3799999999999999998764
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCc----------cee
Q 022575 170 SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQS----------HVS 239 (295)
Q Consensus 170 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~----------~~~ 239 (295)
.. ....+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 157 ~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 157 SL-EDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp SG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred Cc-cchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 32 34566778999999999999999988 999999999999999999999999999865443211 112
Q ss_pred eccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 240 TRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 240 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
....||+.|+|||++.+..++.++|||||||++|||++|.+|+..
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence 335799999999999999999999999999999999999988754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=303.01 Aligned_cols=199 Identities=25% Similarity=0.320 Sum_probs=169.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR---------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC---------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 47999999999999999999544 4588999999865433 233567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||++ ++|.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg 146 (292)
T 3o0g_A 73 DKKLTLVFEFCD-QDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999996 46766665543 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCc-ccccceeeehhHHHHHHhccCChhh
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-FQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 147 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 147 LARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp TCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 9986533221 223457899999999998765 8999999999999999998877653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=317.64 Aligned_cols=203 Identities=27% Similarity=0.360 Sum_probs=162.0
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccC-CCCccceeeE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY-HPNLVKLIGY 142 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-h~ni~~l~~~ 142 (295)
..++|++.+.||+|+||.||+|.. ..+++.||||++.... .....++.+|+.++..+. ||||++++++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSID---------RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEE---------TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEE---------CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 447899999999999999999954 3468999999986542 234456789999999997 9999999999
Q ss_pred EEeCC--eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 143 CLEDD--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 143 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+...+ ..|+||||++ ++|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~k 149 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVK 149 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEE
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEE
Confidence 98654 6899999996 6999998763 4788899999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCC-------------------CcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCC
Q 022575 221 LSDFGLAKDGPTGS-------------------QSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLP 280 (295)
Q Consensus 221 l~DFG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~ 280 (295)
|+|||+|+...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|.+
T Consensus 150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 229 (388)
T 3oz6_A 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229 (388)
T ss_dssp ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence 99999997543211 0112234589999999999986 678999999999999999999999
Q ss_pred hhhee
Q 022575 281 MCVLY 285 (295)
Q Consensus 281 pf~~~ 285 (295)
||...
T Consensus 230 pf~~~ 234 (388)
T 3oz6_A 230 IFPGS 234 (388)
T ss_dssp SCCCS
T ss_pred CCCCC
Confidence 99754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=315.67 Aligned_cols=205 Identities=18% Similarity=0.186 Sum_probs=175.4
Q ss_pred CCCCCCCeeecc--CCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 68 RNFRPDSVLGEG--GFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
++|++.+.||+| +||.||+|... .+++.||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYK---------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEc---------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 589999999999 99999999544 4689999999976542 2345677899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcc
Confidence 999999999999999999999987532 45889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCC-----cceeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||.+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 999864322111 011122478999999999987 57999999999999999999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=336.62 Aligned_cols=204 Identities=26% Similarity=0.302 Sum_probs=177.4
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHccc-CCCCcccee
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQL-YHPNLVKLI 140 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~h~ni~~l~ 140 (295)
...++|++.++||+|+||.||+|... .+++.||||++++... .....+..|..++..+ +||||++++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERK---------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEES---------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEEC---------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34578999999999999999999654 3688999999976432 2344567899999987 799999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+++.+.+.+||||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+|
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEE
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEE
Confidence 99999999999999999999999998764 4889999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 483 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 483 IADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp ECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 999999985432221 234568999999999999999999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=305.74 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=166.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--------------------------hHHHH
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------------------------GHLEW 121 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~ 121 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNE---------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEET---------TTTEEEEEEEEECC-------------------------------CHH
T ss_pred cceEEEeEEeecCCEEEEEEEEC---------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence 58999999999999999999543 46899999998654321 12357
Q ss_pred HHHHHHHcccCCCCccceeeEEEe--CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 022575 122 LTEIKHLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA 199 (295)
Q Consensus 122 ~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 199 (295)
.+|+++++.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~- 157 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQK- 157 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 889999999999999999999987 5688999999999999876533 35889999999999999999999988
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCc---ccccceeeehhHHHHHHh
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI---FQLVLLLFTFECSLLHFS 276 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~ 276 (295)
|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred -eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 99999999999999999999999999986543221 223457999999999997654 478899999999999999
Q ss_pred ccCChhhee
Q 022575 277 LQLPMCVLY 285 (295)
Q Consensus 277 ~g~~pf~~~ 285 (295)
+|.+||...
T Consensus 235 ~g~~pf~~~ 243 (298)
T 2zv2_A 235 FGQCPFMDE 243 (298)
T ss_dssp HSSCSSCCS
T ss_pred HCCCCCCCc
Confidence 999999653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=307.13 Aligned_cols=203 Identities=26% Similarity=0.324 Sum_probs=174.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|++++.+++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 358999999999999999999554 3588999999976543 334567799999999999999999999987
Q ss_pred CC--eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE----cCCCcE
Q 022575 146 DD--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNA 219 (295)
Q Consensus 146 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~ 219 (295)
.+ ..++||||+++++|.+++...... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceE
Confidence 65 779999999999999999875421 23889999999999999999999988 9999999999999 788889
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeec--------cCcccccceeeehhHHHHHHhccCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA--------TGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||+|||+++....... .....||+.|+|||++. +..++.++|||||||++|||++|.+||..
T Consensus 156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999986544322 23357999999999986 57889999999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=322.30 Aligned_cols=200 Identities=26% Similarity=0.340 Sum_probs=175.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|.+.+.||+|+||.||+|... .+++.||||++...... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~---------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEET---------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 58999999999999999999543 46899999999765332 2456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++++|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEec
Confidence 999999999999999999999765 35889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 161 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp SSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 9998654332 2234579999999999988766 68999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=313.20 Aligned_cols=208 Identities=24% Similarity=0.351 Sum_probs=165.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|+... ....+..||||.++... .....++.+|+.++.+++||||+++++++..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3589999999999999999996541 22357789999997653 2345578899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCc
Confidence 999999999999999999997654 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 998654332111 1112245788999999999999999999999999999997 99999654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=313.02 Aligned_cols=199 Identities=23% Similarity=0.234 Sum_probs=164.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDK---------LTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEET---------TTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcEEEEEEeccCCCEEEEEEEEC---------CCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 58999999999999999999543 4688999999975442 2345679999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--EEEcccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKLSDFG 225 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~kl~DFG 225 (295)
..++||||+++++|.+++...+ .+++..+..++.|++.||+|||++| |+||||||+|||++.++. +||+|||
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999999997653 4889999999999999999999988 999999999999987765 9999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCccccc-ceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLV-LLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 164 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred ccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 997532222 2234579999999999988877654 89999999999999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=306.42 Aligned_cols=215 Identities=25% Similarity=0.293 Sum_probs=180.3
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
...++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+.++..++||||+++++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3346899999999999999999976421 1233578999999976532 3445678999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASY--------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 203 (295)
...+..++||||+++++|.+++...... ...+++..+..++.||+.||.|||+++ |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 9999999999999999999999875421 134788999999999999999999988 999
Q ss_pred ecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChh
Q 022575 204 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMC 282 (295)
Q Consensus 204 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf 282 (295)
|||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986544332222233467889999999999999999999999999999999 99999
Q ss_pred hee
Q 022575 283 VLY 285 (295)
Q Consensus 283 ~~~ 285 (295)
...
T Consensus 254 ~~~ 256 (314)
T 2ivs_A 254 PGI 256 (314)
T ss_dssp TTC
T ss_pred CCC
Confidence 754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=301.69 Aligned_cols=203 Identities=26% Similarity=0.400 Sum_probs=168.3
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----hhHHHHHHHHHHHccc---CCCCcc
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQL---YHPNLV 137 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~ni~ 137 (295)
..++|++.+.||+|+||.||+|. +..+++.||+|.+..... .....+.+|+.+++.+ +||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEE---------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 34699999999999999999994 445689999999864321 1123445666666555 599999
Q ss_pred ceeeEEEeCC-----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 138 KLIGYCLEDD-----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 138 ~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
++++++.... ..+++|||+. ++|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil 152 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENIL 152 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 9999998765 5799999995 699999987643 34899999999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 153 VTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp ECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred EcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999998654322 223467999999999999999999999999999999999999999654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=310.93 Aligned_cols=216 Identities=24% Similarity=0.325 Sum_probs=179.4
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
....++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+.++.+++||||++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34457899999999999999999976531 1123568999999986543 334568899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASY--------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 202 (295)
+...+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 99999999999999999999999874321 145889999999999999999999988 99
Q ss_pred eecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCCh
Q 022575 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPM 281 (295)
Q Consensus 203 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p 281 (295)
||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |.+|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999875432221122233568999999999998899999999999999999999 9999
Q ss_pred hhee
Q 022575 282 CVLY 285 (295)
Q Consensus 282 f~~~ 285 (295)
|...
T Consensus 277 ~~~~ 280 (343)
T 1luf_A 277 YYGM 280 (343)
T ss_dssp TTTS
T ss_pred CCCC
Confidence 9754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=310.79 Aligned_cols=215 Identities=25% Similarity=0.311 Sum_probs=180.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|...... ......+..||+|++..... ....++.+|++++..+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 468999999999999999999764311 01234567899999976533 3345688999999999 8999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
..+..++||||+++++|.+++...... ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVL 223 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEE
Confidence 999999999999999999999875421 135899999999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999986544332223334567899999999999999999999999999999999 99999754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.77 Aligned_cols=209 Identities=18% Similarity=0.180 Sum_probs=170.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-----------HHHHHHHHHHHcccCCCC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------HLEWLTEIKHLGQLYHPN 135 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~n 135 (295)
.++|++.+.||+|+||.||+|..... .....++.||+|.+....... ......|+..+..++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 45899999999999999999977542 122347889999986654211 112345677788899999
Q ss_pred ccceeeEEEeC----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 136 LVKLIGYCLED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 136 i~~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
|+++++++... ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Ni 183 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNL 183 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHE
Confidence 99999998765 4589999999 999999998754 45899999999999999999999988 99999999999
Q ss_pred EEc--CCCcEEEccccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 212 LLD--LNYNAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 212 ll~--~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998 8899999999999754322111 111334699999999999998999999999999999999999999985
Q ss_pred e
Q 022575 285 Y 285 (295)
Q Consensus 285 ~ 285 (295)
.
T Consensus 264 ~ 264 (364)
T 3op5_A 264 N 264 (364)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.71 Aligned_cols=215 Identities=25% Similarity=0.354 Sum_probs=178.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+.++.++ +||||++++++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3457899999999999999999976421 2234678899999975432 3345678999999999 89999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASY-------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIY 203 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 203 (295)
+...+..++||||+++++|.+++...... ...+++..+..++.||+.||+|||+++ |+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 99999999999999999999999865421 123788999999999999999999988 999
Q ss_pred ecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChh
Q 022575 204 RDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMC 282 (295)
Q Consensus 204 rDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf 282 (295)
|||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986544333323334567889999999998999999999999999999998 99999
Q ss_pred hee
Q 022575 283 VLY 285 (295)
Q Consensus 283 ~~~ 285 (295)
...
T Consensus 276 ~~~ 278 (344)
T 1rjb_A 276 PGI 278 (344)
T ss_dssp TTC
T ss_pred ccC
Confidence 764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=303.46 Aligned_cols=203 Identities=26% Similarity=0.298 Sum_probs=169.2
Q ss_pred CCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
+.|++. +.||+|+||.||+|. +..+++.||||.+..........+.+|+.++.++ +||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCI---------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEE---------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEE---------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 578874 789999999999994 3446889999999766555566788999999885 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc---EEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~ 222 (295)
.+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEE
Confidence 999999999999999999998763 4889999999999999999999988 999999999999988776 9999
Q ss_pred cccCCCCCCCCCC-----cceeeccccccCccCceeecc-----CcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMAT-----GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||++........ ........||+.|+|||++.. ..++.++|||||||++|+|++|.+||...
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 9999976432211 111123469999999999875 56889999999999999999999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=301.81 Aligned_cols=200 Identities=25% Similarity=0.344 Sum_probs=168.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47899999999999999999642 4788999998755432 23567799999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 145 (288)
T 1ob3_A 72 KKRLVLVFEHLD-QDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFG 145 (288)
T ss_dssp SSCEEEEEECCS-EEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCeEEEEEEecC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECc
Confidence 999999999996 59999987653 45888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 146 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9875432211 12234689999999998754 5899999999999999999999999653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=308.14 Aligned_cols=207 Identities=22% Similarity=0.338 Sum_probs=168.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|..... .......||+|.+..... ....++.+|+.++.+++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 5899999999999999999976531 122244578998865432 3456788999999999999999999999875
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+ .++++||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcc
Confidence 4 788999999999999998754 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............+|+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 986543333222333467889999999999999999999999999999999 99999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=297.57 Aligned_cols=200 Identities=21% Similarity=0.286 Sum_probs=176.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... .++..+|+|.+..........+.+|++++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK---------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC---------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 358999999999999999999544 35788999999876656667788999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 223 (295)
+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999999997753 4889999999999999999999988 9999999999999 7889999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|.+||...
T Consensus 153 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 153 FGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp CTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 99997654332 2233579999999998865 5899999999999999999999999653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.97 Aligned_cols=213 Identities=22% Similarity=0.337 Sum_probs=161.4
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|..... ......||+|.+.... .....++.+|++++++++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 3446899999999999999999965431 1122479999997653 2345678899999999999999999999
Q ss_pred EEeCCee------EEEEeccCCCCHHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 143 CLEDDHR------LLVYEFMPKGSLENHLFRRAS--YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 143 ~~~~~~~------~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
+...+.. ++||||+.+++|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~ 171 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA 171 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc
Confidence 9877655 999999999999999976432 1125889999999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 243 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc
Confidence 999999999999986544332222233457889999999999999999999999999999999 99999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=307.61 Aligned_cols=207 Identities=22% Similarity=0.342 Sum_probs=170.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|..... .......||+|.+..... .....+.+|+.++..++||||+++++++. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 5899999999999999999976531 122244588888754432 22335668999999999999999999886 4
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred CccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCc
Confidence 66899999999999999997653 35788889999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............||+.|+|||++.++.++.++|||||||++|+|++ |.+||...
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 987654443333344578889999999999999999999999999999999 99999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.58 Aligned_cols=199 Identities=23% Similarity=0.331 Sum_probs=165.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||||++.... .....++.+|+.+|+.++||||+++++++..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~---------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDK---------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CCEEEEEEEeecCCEEEEEEEEC---------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 58999999999999999999543 468999999997542 2345578899999999999999999999977
Q ss_pred C-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
. +..|+||||+ +++|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIA-DSDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp SCTTTCCCEEEEEECC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEE
T ss_pred CCCCcCCeEEEEEecC-CcCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEE
Confidence 6 5689999999 46999999764 35899999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCc--------------------ceeeccccccCccCceee-ccCcccccceeeehhHHHHHHhccC
Q 022575 221 LSDFGLAKDGPTGSQS--------------------HVSTRVMGTYGYAAPEYM-ATGIFQLVLLLFTFECSLLHFSLQL 279 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~ 279 (295)
|+|||+++........ ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999865432211 112456899999999986 4567999999999999999999844
Q ss_pred Chh
Q 022575 280 PMC 282 (295)
Q Consensus 280 ~pf 282 (295)
.||
T Consensus 250 ~p~ 252 (432)
T 3n9x_A 250 QSH 252 (432)
T ss_dssp TTT
T ss_pred ccc
Confidence 433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.53 Aligned_cols=193 Identities=25% Similarity=0.281 Sum_probs=150.0
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~l 151 (295)
.+.||+|+||.||+|... .+++.||+|.+.... ...+.+|+.++..+. ||||+++++++.+.+..|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK---------KSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEET---------TTCCEEEEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEEC---------CCCCEEEEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 378999999999999544 468899999996543 345668999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC---cEEEccccCCC
Q 022575 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---NAKLSDFGLAK 228 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~DFG~a~ 228 (295)
||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999999875 35899999999999999999999988 99999999999997765 89999999998
Q ss_pred CCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 229 DGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 158 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 158 LKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 5433221 223457899999999999999999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=296.93 Aligned_cols=202 Identities=25% Similarity=0.327 Sum_probs=175.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ...++.+|+.++.+++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4689999999999999999996552 66799999976543 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred CceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcc
Confidence 99999999999999999998764 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 151 TRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp EEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 9865433221 2223456778999999998899999999999999999999 99999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.42 Aligned_cols=214 Identities=26% Similarity=0.324 Sum_probs=182.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|..... .+..++..||+|.+..... .....+.+|+.++.++ +||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 346899999999999999999975321 2345688999999976543 3445688999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASY--------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 209 (295)
...+..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~ 174 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccc
Confidence 9999999999999999999999875421 124889999999999999999999988 999999999
Q ss_pred CeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 210 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999987655443333334567889999999999999999999999999999998 99999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=308.92 Aligned_cols=196 Identities=22% Similarity=0.278 Sum_probs=168.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ..+|++++.++ +||||+++++++.+.
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHK---------ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred ccEEEEEEEeeCCCEEEEEEEEC---------CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 57999999999999999999543 46899999999765432 24688888877 799999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC----CcEEEc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN----YNAKLS 222 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~kl~ 222 (295)
+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++| |+||||||+|||+..+ +.+||+
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEE
Confidence 99999999999999999997653 4889999999999999999999988 9999999999998443 359999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 9999986543221 22345799999999999988899999999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=302.89 Aligned_cols=208 Identities=27% Similarity=0.350 Sum_probs=180.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE--e
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL--E 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~--~ 145 (295)
++|++.+.||+|+||.||+|.+.. .+..++..||+|.+..........+.+|++++.+++||||+++++++. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 589999999999999999997643 345578999999998776666677889999999999999999999887 4
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGG
T ss_pred CceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccc
Confidence 566899999999999999998754 35889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 998654333211 122346888899999999999999999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=299.99 Aligned_cols=206 Identities=23% Similarity=0.316 Sum_probs=163.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.... ....+..||+|.+..... .....+.+|+.++.+++||||+++++++ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred hHHeEEEeEeeecCCeeEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 3689999999999999999997652 223467899999876433 3345688999999999999999999997 4
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccc
Confidence 567899999999999999997654 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++........ ......+|+.|+|||++....++.++|||||||++|||++ |.+||...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 99865432211 1223457889999999998899999999999999999996 99999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.17 Aligned_cols=216 Identities=39% Similarity=0.647 Sum_probs=182.9
Q ss_pred cceeehhhHHHhcCCCCCC------CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc----hhhHHHHHHH
Q 022575 55 IKSFSFNGLKTATRNFRPD------SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES----LQGHLEWLTE 124 (295)
Q Consensus 55 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E 124 (295)
...|++.++....++|... +.||+|+||.||+|... +..||+|.+.... ......+.+|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~E 80 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQE 80 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHHH
Confidence 4567788888888877766 89999999999999642 6789999986532 2234567899
Q ss_pred HHHHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 022575 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (295)
Q Consensus 125 ~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 204 (295)
+.++..++||||+++++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ |+||
T Consensus 81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~ 157 (307)
T 2nru_A 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH--HIHR 157 (307)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecC
Confidence 9999999999999999999999999999999999999999975432 245889999999999999999999988 9999
Q ss_pred cCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 205 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||||+||+++.++.+||+|||++................||+.|+|||++. +.++.++|||||||++|+|++|.+||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCccc
Confidence 999999999999999999999998654433322333457999999999876 4689999999999999999999999976
Q ss_pred e
Q 022575 285 Y 285 (295)
Q Consensus 285 ~ 285 (295)
.
T Consensus 237 ~ 237 (307)
T 2nru_A 237 H 237 (307)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=302.87 Aligned_cols=201 Identities=25% Similarity=0.322 Sum_probs=176.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|.+.+.||+|+||.||++... .+++.||+|.+.... ......+.+|+.++..++||||+++++++.
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 58999999999999999999544 358899999986543 234456788999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeec
Confidence 9999999999999999999987653 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 186 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 186 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 99986543221 123457999999999999989999999999999999999999999753
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=298.80 Aligned_cols=207 Identities=30% Similarity=0.405 Sum_probs=174.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|.+.. .+..+++.||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 468999999999999999997643 3455799999999975543 2345678999999999999999999999876
Q ss_pred --CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Df 170 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDF 170 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCC
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcc
Confidence 66899999999999999997654 45889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++......... .......||..|+|||++.+..++.++|||||||++|+|++|.+|+..
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 999865443321 122335688899999999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=311.46 Aligned_cols=204 Identities=25% Similarity=0.290 Sum_probs=172.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
++|++.+.||+|+||.||+|+... ...+++.||||+++.... .....+.+|++++..+ .||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 589999999999999999997541 234689999999976432 2233456799999999 69999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEES
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEe
Confidence 999999999999999999999998753 4889999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||..
T Consensus 202 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 202 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred eCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 9999986533221 12334579999999999985 3578999999999999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=303.75 Aligned_cols=200 Identities=24% Similarity=0.284 Sum_probs=175.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccCCCCccceee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
++|++.+.||+|+||.||+|... .++..||+|.+...... ...++.+|+.++..++||||+++++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 82 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREK---------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEEC---------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 57999999999999999999543 46889999998765332 2456889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC----
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---- 217 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 217 (295)
++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSC
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcC
Confidence 999999999999999999999999764 35889999999999999999999988 99999999999999888
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred CEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 799999999986543321 23356999999999999889999999999999999999999999653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=297.68 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=174.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ...++.+|+.++.+++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999997542 66799999976543 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 152 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred CceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccc
Confidence 99999999999999999997654 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 153 TRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp GGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 985433211 11223456788999999998999999999999999999999 99999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.62 Aligned_cols=202 Identities=21% Similarity=0.270 Sum_probs=166.5
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCC--CCccceee
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYH--PNLVKLIG 141 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h--~ni~~l~~ 141 (295)
..++|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.++..++| |||+++++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 76 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence 3468999999999999999999542 378899999865432 334567899999999986 99999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
++...+..++|||+ .+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||
T Consensus 77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 77 YEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp EEECSSEEEEEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEE
T ss_pred eEeeCCEEEEEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEE
Confidence 99999999999995 588999999875 35888999999999999999999988 99999999999997 678999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeecc-----------CcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 99999987654433323345679999999999865 67889999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=296.60 Aligned_cols=202 Identities=26% Similarity=0.404 Sum_probs=155.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESI---------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEc---------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 57999999999999999999543 35889999998754322 2356789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~df 156 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADF 156 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEee
Confidence 9999999999999999999998653 45889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 157 GLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp TTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred cceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 99986543221 122357899999999999889999999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=309.53 Aligned_cols=210 Identities=22% Similarity=0.229 Sum_probs=170.9
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-----hhHHHHHHHHHHHcccCCCCccce
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-----QGHLEWLTEIKHLGQLYHPNLVKL 139 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~h~ni~~l 139 (295)
...++|++.+.||+|+||.||+|... .++..||+|++..... .....+.+|++++..++||||+++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 93 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIEN---------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhheeecceeeecCCeEEEEEEEC---------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence 44568999999999999999999543 4588999999865432 334568899999999999999999
Q ss_pred eeEEEeCCeeEEEEeccCCCCHHHHHhhccCC------------------------------------CCCCCHHHHHHH
Q 022575 140 IGYCLEDDHRLLVYEFMPKGSLENHLFRRASY------------------------------------IQPLSWTIRMKV 183 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~~~~~~~~~~ 183 (295)
++++.+.+..++||||+++++|.+++...... ...+++..+..+
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 99999999999999999999999998632110 112356778889
Q ss_pred HHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC--cEEEccccCCCCCCCCCC--cceeeccccccCccCceeecc--C
Q 022575 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY--NAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMAT--G 257 (295)
Q Consensus 184 ~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~ 257 (295)
+.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||++.+ .
T Consensus 174 ~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 174 MRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 999999999999988 99999999999998776 899999999975422111 112234579999999999875 6
Q ss_pred cccccceeeehhHHHHHHhccCChhhee
Q 022575 258 IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 258 ~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.++.++|||||||++|||++|.+||...
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~ 279 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGV 279 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 7889999999999999999999999653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=301.25 Aligned_cols=197 Identities=26% Similarity=0.274 Sum_probs=165.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHccc-CCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||+||+|... .+++.||||++..... ....+...|+..+..+ +||||+++++++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK---------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET---------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEEC---------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 57999999999999999999654 3588999998865432 3334455666666555 8999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccc
Confidence 999999999999 779999988764 46899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
|++....... ......||+.|+|||++.+ .++.++|||||||++|||++|.+||.
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred eeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9987653322 2233569999999998875 78999999999999999999976554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=305.16 Aligned_cols=197 Identities=28% Similarity=0.401 Sum_probs=171.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
+.|++.+.||+|+||.||+|... .+++.||||.+..... .....+.+|++++.+++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV---------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEc---------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 45888999999999999999543 3689999999865432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Df 198 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDF 198 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCC
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeec
Confidence 9999999999996 68888886544 46889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++...... ....||+.|+|||++. .+.++.++|||||||++|||++|.+||...
T Consensus 199 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 199 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999865321 2357999999999985 567899999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.99 Aligned_cols=201 Identities=23% Similarity=0.296 Sum_probs=173.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--------hHHHHHHHHHHHcccCCCCccc
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVK 138 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~ 138 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..++||||++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~ 93 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK---------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET---------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred ccceEEEeEEEecCCEEEEEEEEC---------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence 468999999999999999999543 46899999998765321 2234567999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCC-CHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 139 LIGYCLEDDHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 139 l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
+++++...+..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDF 167 (335)
T ss_dssp EEEEEECSSEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCC
Confidence 999999999999999999766 9999997653 4889999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...
T Consensus 168 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred cEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 999999999986543322 233579999999999988776 78999999999999999999999754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.06 Aligned_cols=202 Identities=19% Similarity=0.157 Sum_probs=173.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.. ..+++.||+|.+..... ...+.+|+.++..+ +|+|++++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEE---------CCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 46899999999999999999954 34589999999865432 23466899999999 79999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc-----EE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AK 220 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~k 220 (295)
....++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~k 151 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIY 151 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEE
Confidence 99999999999 999999998754 45899999999999999999999988 999999999999987776 99
Q ss_pred EccccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 9999999865433221 1123457999999999999989999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=295.23 Aligned_cols=199 Identities=28% Similarity=0.516 Sum_probs=169.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-------HHHHHHHHHHHcccCCCCcccee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-------HLEWLTEIKHLGQLYHPNLVKLI 140 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~h~ni~~l~ 140 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+....... ...+.+|+.++.+++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLV---------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEET---------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEc---------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 58999999999999999999654 358899999986543321 15678999999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 218 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-- 218 (295)
+++.+.. ++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++.+|+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~ 164 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCC
Confidence 9986554 79999999999999887654 4689999999999999999999997666999999999999988776
Q ss_pred ---EEEccccCCCCCCCCCCcceeeccccccCccCceee--ccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 ---AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM--ATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++.... ......||+.|+|||++ ....++.++|||||||++|+|++|.+||...
T Consensus 165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999985332 23345799999999998 4557889999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=309.96 Aligned_cols=200 Identities=21% Similarity=0.264 Sum_probs=166.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccC--CCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY--HPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~ 143 (295)
++|++.+.||+|+||.||+|... .++.||||.+.... ......+.+|+.++..++ ||||+++++++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 57999999999999999999532 27889999986543 234456889999999996 59999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..|+||| +.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECC
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEe
Confidence 99999999999 55889999998753 5788889999999999999999988 99999999999995 68999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeecc-----------CcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++..............+||+.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 999987644332222344679999999999875 46889999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=298.54 Aligned_cols=203 Identities=24% Similarity=0.254 Sum_probs=170.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER---------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEc---------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 57999999999999999999544 3588999999876543 2346678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 223 (295)
+..++||||+++++|.+++.........+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEe
Confidence 9999999999999999999764322356899999999999999999999988 9999999999999 5568899999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||...
T Consensus 171 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 171 FGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp CCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 99998654322 223457999999999875 57889999999999999999999999654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=315.09 Aligned_cols=199 Identities=27% Similarity=0.377 Sum_probs=172.2
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
...++|++.+.||+|+||.||+|.+. +..||||.++... ....+.+|+.++++++||||+++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 44578899999999999999999654 5689999998654 4457889999999999999999999987
Q ss_pred eCC-eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 145 EDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 145 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
..+ ..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECC
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEee
Confidence 765 78999999999999999987643 34688899999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 333 fG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 390 (450)
T 1k9a_A 333 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390 (450)
T ss_dssp CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred CCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998543221 12357889999999999999999999999999999998 99999754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=301.99 Aligned_cols=207 Identities=22% Similarity=0.338 Sum_probs=167.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|..... .......||+|.+.... .....++.+|+.++..++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 6899999999999999999976531 12224457888875443 23456788999999999999999999999875
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
. .++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred C-ceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 5 788999999999999998754 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++...............+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 987544333222333457889999999999999999999999999999999 99999764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.29 Aligned_cols=216 Identities=23% Similarity=0.329 Sum_probs=178.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|...... .....++..||+|.+..... .....+.+|+.++..+ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 3468999999999999999999765311 01234678899999976543 3345678999999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
...+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 188 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNV 188 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceE
Confidence 9999999999999999999999865421 134788999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999986544332222233467889999999998999999999999999999999 99999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=299.69 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=168.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|++++.+++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR---------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC---------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 58999999999999999999544 35889999988655432 24457789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCC
Confidence 99999999999999999887654 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 148 FARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9986543221 1234578999999999876 57899999999999999999999999654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=305.56 Aligned_cols=200 Identities=23% Similarity=0.334 Sum_probs=163.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh--HHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+....... ...+.+|+.+++.++||||+++++++..
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDT---------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEEC---------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 58999999999999999999543 468999999997654332 3456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE-----cCCCcEE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-----DLNYNAK 220 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-----~~~~~~k 220 (295)
.+..++||||++ ++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+|
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEE
T ss_pred CCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEE
Confidence 999999999996 59999998764 4889999999999999999999988 9999999999999 4555699
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 178 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 178 IGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 999999975432211 12335689999999999864 5899999999999999999999999654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=294.73 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=172.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.++..++||||+++++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEc---------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence 358999999999999999999544 35789999998654322 244678899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 79 HDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECS
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999998763 4888999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 153 FGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 99986543322 23357899999999999989999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=305.70 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=165.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhH-HHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGH-LEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+........ ..+.+|+.++..++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK---------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEEC---------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 47999999999999999999544 3588999999875543221 1345799999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred CEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcc
Confidence 99999999995 69999988764 45888999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 147 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 147 ARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp EECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 976433221 2233578999999999876 56899999999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=299.86 Aligned_cols=214 Identities=22% Similarity=0.370 Sum_probs=167.6
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceee
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
....++|.+.+.||+|+||.||+|.... ...++..||+|.+..... .....+.+|+.++.+++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEEC------TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEec------cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 3445789999999999999999997653 334577899999976532 33456889999999999999999999
Q ss_pred EEEeCC-----eeEEEEeccCCCCHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 142 YCLEDD-----HRLLVYEFMPKGSLENHLFRRA--SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 142 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
++...+ ..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++ |+||||||+|||++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~ 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence 998765 3499999999999999995432 22246889999999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 999999999999986544332222233467889999999999999999999999999999999 88998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=297.57 Aligned_cols=202 Identities=21% Similarity=0.257 Sum_probs=166.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..++||||+++++++.
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDT---------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEc---------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 58999999999999999999543 35889999999765332 2356789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Df 178 (309)
T 2h34_A 105 IDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDF 178 (309)
T ss_dssp ETTEEEEEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSC
T ss_pred eCCeEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecC
Confidence 9999999999999999999998753 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ .......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 179 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 179 GIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred ccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 99976543221 1223457899999999999999999999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=307.82 Aligned_cols=196 Identities=23% Similarity=0.307 Sum_probs=164.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|.. ..+++.||||.+.... .....++.+|+.+++.++||||+++++++..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95 (367)
T ss_dssp SSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred ceEEEeEEeeecCCeEEEEEEE---------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence 5899999999999999999954 3468999999986542 2234567899999999999999999999986
Q ss_pred CC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 DD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.+ ..|+||||+ +++|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCE
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCE
Confidence 63 459999999 88999999763 4788999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999864322 233578999999999887 68999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=293.86 Aligned_cols=201 Identities=25% Similarity=0.351 Sum_probs=175.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++.+++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK---------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc---------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 468999999999999999999544 3588999999876543 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc---EEE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKL 221 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl 221 (295)
..+..++||||+++++|.+.+.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl 149 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKL 149 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999999999987763 4889999999999999999999988 999999999999976655 999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 150 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 210 (284)
T 3kk8_A 150 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210 (284)
T ss_dssp CCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence 9999997654332 123357999999999999999999999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=298.49 Aligned_cols=205 Identities=21% Similarity=0.259 Sum_probs=173.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|....... .....+..||+|.+..........+.+|+.++.+++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3689999999999999999997653110 00011357999999877666677889999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--------
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-------- 218 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-------- 218 (295)
+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999998754 34888999999999999999999988 999999999999988887
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhcc-CChhhe
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQ-LPMCVL 284 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g-~~pf~~ 284 (295)
+||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||..
T Consensus 160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99999999875422 123468999999999987 6789999999999999999995 555543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.64 Aligned_cols=206 Identities=24% Similarity=0.364 Sum_probs=178.1
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
....+|++.+.||+|+||.||+|.+.. ++..||||.+..... ...++.+|+.++++++||||+++++++.
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 344678999999999999999997653 478899999976543 4567889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCT
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeec
Confidence 99999999999999999999986543 45888999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+++...... ........+++.|+|||++....++.++|||||||++|||++ |.+||...
T Consensus 363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9998654322 111223456789999999999999999999999999999999 99999754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.36 Aligned_cols=205 Identities=31% Similarity=0.437 Sum_probs=174.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
.|++.+.||+|+||.||++.+.. .+..+++.||+|++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 45999999999999999997653 4556799999999986543 3355688999999999999999999999884
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
...++||||+++++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGG
T ss_pred CceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcc
Confidence 6789999999999999999764 3889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++......... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 99876443321 1123346888999999999999999999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=294.59 Aligned_cols=203 Identities=25% Similarity=0.247 Sum_probs=174.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR---------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEeecCCCcEEEEEEEC---------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence 58999999999999999999544 3588999999875443 3345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~ 151 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL 151 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCC
Confidence 9999999999999999998654 35889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+................||+.|+|||++.+..+ +.++||||||+++|+|++|.+||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 976433222222334578999999999987665 78999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=308.75 Aligned_cols=203 Identities=23% Similarity=0.320 Sum_probs=166.7
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|... .+++.||+|++...... ..+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~---------~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI---------ESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET---------TTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC---------CCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhhee
Confidence 344578999999999999999999543 46899999988654322 23699999999999999999998
Q ss_pred EeC--------------------------------------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHH
Q 022575 144 LED--------------------------------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185 (295)
Q Consensus 144 ~~~--------------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~ 185 (295)
... ...++||||++ ++|.+.+.........+++..+..++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 543 34889999996 688888875433335689999999999
Q ss_pred HHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccc
Q 022575 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVL 263 (295)
Q Consensus 186 ~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 263 (295)
||+.||.|||++| |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++
T Consensus 149 qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 149 QLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcch
Confidence 9999999999988 99999999999997 688999999999986543321 2345789999999998865 489999
Q ss_pred eeeehhHHHHHHhccCChhhee
Q 022575 264 LLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 264 Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||||||++|||++|.+||...
T Consensus 224 DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 224 DLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=319.29 Aligned_cols=206 Identities=23% Similarity=0.320 Sum_probs=175.0
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
+....++|++.+.||+|+||.||+|.+.. +..||||.++... .....+.+|+.++++++||||++++++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34455789999999999999999997653 6779999998654 345678899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+. .+..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEEC
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEe
Confidence 86 6678999999999999999976432 24778889999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|||+++...... ........+|+.|+|||++..+.++.++|||||||++|||++ |.+||...
T Consensus 327 DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~ 389 (454)
T 1qcf_A 327 DFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389 (454)
T ss_dssp STTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999998653221 111122346788999999998999999999999999999999 99999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=294.66 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=176.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|.+.+.||+|+||.||+|... .+++.+|+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA---------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC---------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 358999999999999999999544 3588999999865432 3345678899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEe
Confidence 99999999999999999999987653 4889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 218 (294)
T 2rku_A 159 FGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218 (294)
T ss_dssp CTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999986543221 123357899999999999888999999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=301.54 Aligned_cols=219 Identities=24% Similarity=0.296 Sum_probs=182.2
Q ss_pred hhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHccc-CCCCccc
Q 022575 61 NGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQL-YHPNLVK 138 (295)
Q Consensus 61 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l-~h~ni~~ 138 (295)
..+....++|++.+.||+|+||.||+|..... .+..+++.||+|.+...... ....+.+|+.++.++ +||||++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 34445567999999999999999999975431 23456899999999765432 345678999999999 6999999
Q ss_pred eeeEEEeCC-eeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 022575 139 LIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (295)
Q Consensus 139 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 205 (295)
+++++...+ ..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+++ |+|||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~d 173 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD 173 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccccc
Confidence 999987754 489999999999999999875431 123788999999999999999999988 99999
Q ss_pred CCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 206 FKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 206 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |.+||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987644433333344568899999999999999999999999999999998 9999975
Q ss_pred e
Q 022575 285 Y 285 (295)
Q Consensus 285 ~ 285 (295)
.
T Consensus 254 ~ 254 (316)
T 2xir_A 254 V 254 (316)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=298.49 Aligned_cols=202 Identities=22% Similarity=0.293 Sum_probs=171.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ...++.+|++++..++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 3589999999999999999996552 66799999986543 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred CCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccc
Confidence 99999999999999999997643 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 976433211 11122356788999999998899999999999999999998 99999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=314.25 Aligned_cols=202 Identities=15% Similarity=0.135 Sum_probs=163.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc---chhhHHHHHHHH---HHHcccCCCCcccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTEI---KHLGQLYHPNLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~---~~l~~l~h~ni~~l~ 140 (295)
.++|++.+.||+|+||.||+|.. ..+++.||||++... .......+.+|+ +.+.+++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATD---------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC----------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEE---------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 46799999999999999999953 346889999998743 223445678899 555666899999998
Q ss_pred -------eEEEeCCe-----------------eEEEEeccCCCCHHHHHhhccCCC---CCCCHHHHHHHHHHHHHHHHH
Q 022575 141 -------GYCLEDDH-----------------RLLVYEFMPKGSLENHLFRRASYI---QPLSWTIRMKVALGAAKGLAY 193 (295)
Q Consensus 141 -------~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~ 193 (295)
+++...+. .|++|||+ +|+|.+++....... ..+++..++.++.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 76665532 78999999 689999998754211 123457788899999999999
Q ss_pred hhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-----------ccccc
Q 022575 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-----------IFQLV 262 (295)
Q Consensus 194 lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 262 (295)
||+++ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.+
T Consensus 222 LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99988 99999999999999999999999999985322 2334578 999999999987 89999
Q ss_pred ceeeehhHHHHHHhccCChhheee
Q 022575 263 LLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 263 ~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+|||||||++|||++|.+||....
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC----
T ss_pred hhHHHHHHHHHHHHHCCCCCcccc
Confidence 999999999999999999997653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=298.67 Aligned_cols=200 Identities=25% Similarity=0.329 Sum_probs=172.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+..........+.+|+.++..++||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR---------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 358999999999999999999543 35889999999766544455678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 223 (295)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred CEEEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEcc
Confidence 99999999999999999997653 4788999999999999999999988 9999999999999 7889999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 153 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 153 FGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999754322 122346899999999999999999999999999999999999999653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=312.14 Aligned_cols=202 Identities=23% Similarity=0.292 Sum_probs=164.1
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--------hHHHHHHHHHHHcccCCCCc
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNL 136 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni 136 (295)
...++|.+.+.||+|+||.||+|... .+++.||+|++...... ....+.+|+.+|++++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEEC---------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 34578999999999999999999544 46889999998764321 12246789999999999999
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
+++++++. .+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~ 275 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQ 275 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecC
Confidence 99999975 45689999999999999988765 35889999999999999999999988 9999999999999654
Q ss_pred C---cEEEccccCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 Y---NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+ .+||+|||+++...... .....+||+.|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 276 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~ 347 (419)
T 3i6u_A 276 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 347 (419)
T ss_dssp SSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 4 59999999998754322 233467999999999985 367889999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=311.52 Aligned_cols=203 Identities=25% Similarity=0.316 Sum_probs=173.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|... .+++.||||++..... .....+.+|++++.+++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK---------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC---------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 358999999999999999999554 3588999999976543 234567799999999999999999999987
Q ss_pred CC--eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE----cCCCcE
Q 022575 146 DD--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DLNYNA 219 (295)
Q Consensus 146 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~ 219 (295)
.+ ..++||||+++++|.+++...... ..+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeE
Confidence 65 779999999999999999765421 23889999999999999999999988 9999999999999 778889
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeecc--------CcccccceeeehhHHHHHHhccCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--------GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|.+||..
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999998654322 1234579999999999875 6788999999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=304.85 Aligned_cols=215 Identities=25% Similarity=0.313 Sum_probs=179.3
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|..... ........||+|.+..... .....+.+|+.++..+ +||||++++++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3346899999999999999999976532 1122356899999976543 3445688999999999 89999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASY----------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
+...+..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 99999999999999999999999764310 235788999999999999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999986543333222334567889999999998899999999999999999998 99999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=304.75 Aligned_cols=203 Identities=29% Similarity=0.410 Sum_probs=166.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-----HHHHHHHHHHHcccCCCCcccee
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLI 140 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~h~ni~~l~ 140 (295)
..++|++.+.||+|+||.||+|. +..+++.||+|.+....... ...+.+|+.++..++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEE---------ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 34689999999999999999994 34468899999997543221 23567899999999999999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+++...+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEE
Confidence 999999999999999965 8998887654 35777889999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 153 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 153 LADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp ECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999986543221 22345789999999998754 5889999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=318.18 Aligned_cols=199 Identities=24% Similarity=0.310 Sum_probs=168.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK---------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET---------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cCeEEeeEEecCCCEEEEEEEEC---------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 47999999999999999999543 4688999999876532 234567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC---CcEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~ 222 (295)
.+..|+||||+++|+|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEE
Confidence 999999999999999999987763 4888999999999999999999988 9999999999999764 459999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||++....... .....+||+.|+|||++. +.++.++|||||||++|+|++|.+||...
T Consensus 182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 999998654322 223457999999999876 57999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=316.16 Aligned_cols=200 Identities=25% Similarity=0.296 Sum_probs=171.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-------------hhHHHHHHHHHHHcccCC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------------QGHLEWLTEIKHLGQLYH 133 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~h 133 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++|
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 105 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK---------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC
T ss_pred ccceEEEeEecccCCeEEEEEEEC---------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999999999544 4688999999876432 124567899999999999
Q ss_pred CCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 134 ~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
|||+++++++.+.+..|+|||||++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILL 179 (504)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEE
T ss_pred CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEE
Confidence 999999999999999999999999999999997763 4889999999999999999999988 9999999999999
Q ss_pred cCCC---cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 214 DLNY---NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 214 ~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.++ .+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||...
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8776 69999999998654332 223457999999999876 56899999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.74 Aligned_cols=199 Identities=26% Similarity=0.332 Sum_probs=171.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 92 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET---------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEEC---------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence 58999999999999999999543 4688999999865432 235567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc---CCCcEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~ 222 (295)
.+..|+||||+.+++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 93 SSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEE
Confidence 999999999999999999997763 4889999999999999999999988 99999999999994 45679999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999998654322 2234579999999999875 6899999999999999999999999654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=303.48 Aligned_cols=217 Identities=21% Similarity=0.373 Sum_probs=179.3
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceee
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
+....++|++.+.||+|+||.||+|..... ....++..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 344457899999999999999999975421 1223478899999976543 34456889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRAS------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
++...+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAE 173 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECT
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcC
Confidence 99999999999999999999999976431 1234688999999999999999999988 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999985433221112223457889999999998899999999999999999999 89998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.63 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=174.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.++..++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREK---------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEc---------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 58999999999999999999544 35889999998654322 2356789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecc
Confidence 9999999999999999999998763 4789999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++....... .....|++.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 9987543221 23357899999999999989999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=296.13 Aligned_cols=198 Identities=25% Similarity=0.338 Sum_probs=162.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcc--cCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... ++.||||++..... ..+..|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGGGH---HHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccccc---hhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 468999999999999999999653 77899999875532 333455555544 89999999999875
Q ss_pred eC----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCeEeecCCCCCeE
Q 022575 145 ED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH--------SDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 145 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~~~ivHrDlkp~Nil 212 (295)
.. ...++||||+++|+|.+++... .+++..+..++.|++.||+||| +++ |+||||||+|||
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nil 145 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNIL 145 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEE
T ss_pred cccCCCceeEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEE
Confidence 43 4579999999999999999643 4889999999999999999999 777 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcc--eeeccccccCccCceeeccC------cccccceeeehhHHHHHHhcc------
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG------IFQLVLLLFTFECSLLHFSLQ------ 278 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g------ 278 (295)
++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 9999999999999997543322211 12234799999999999876 677899999999999999999
Q ss_pred ----CChhhee
Q 022575 279 ----LPMCVLY 285 (295)
Q Consensus 279 ----~~pf~~~ 285 (295)
.+||...
T Consensus 226 ~~~~~~pf~~~ 236 (301)
T 3q4u_A 226 VEDYKPPFYDV 236 (301)
T ss_dssp CCCCCCTTTTT
T ss_pred ccccccccccc
Confidence 7888553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=298.05 Aligned_cols=193 Identities=21% Similarity=0.289 Sum_probs=167.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEe-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE- 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~- 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+.... ...+.+|+.++..++ ||||+++++++..
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINI---------TNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CceEEEEEecccCCeEEEEEEEC---------CCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 58999999999999999999543 358899999997543 346778999999997 9999999999988
Q ss_pred -CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEEcc
Q 022575 146 -DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSD 223 (295)
Q Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~D 223 (295)
....++||||+.+++|.+++. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~D 174 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID 174 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEe
Confidence 567899999999999999884 3778889999999999999999988 99999999999999776 899999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 175 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 175 WGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999986543322 233578999999999887 6789999999999999999999999843
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=302.70 Aligned_cols=203 Identities=27% Similarity=0.361 Sum_probs=170.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET---------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEEC---------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 58999999999999999999544 36889999998655432 23467789999999999999999999987
Q ss_pred C--------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 146 D--------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 146 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
. +..++||||++ ++|.+.+.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDG 161 (351)
T ss_dssp C--------CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTS
T ss_pred cccccccCCceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCC
Confidence 3 46899999996 58888776543 45889999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCC--cceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQ--SHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999976542221 112234578999999999876 46899999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.29 Aligned_cols=200 Identities=24% Similarity=0.310 Sum_probs=172.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccCCCCccceee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++.+++||||+++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK---------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc---------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence 57999999999999999999544 35889999998654322 3557889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC----
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---- 217 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 217 (295)
++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSC
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCC
Confidence 999999999999999999999999765 35889999999999999999999988 99999999999998877
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 150 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 89999999998653322 123356899999999999889999999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=299.60 Aligned_cols=207 Identities=24% Similarity=0.362 Sum_probs=179.5
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|.... ++..||+|.+.... .....+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 78 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 78 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3445789999999999999999996553 57899999997654 3455778999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~D 154 (288)
T 3kfa_A 79 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVAD 154 (288)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEcc
Confidence 999999999999999999999987543 45889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 155 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 155 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp CCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999986543322 22333457889999999998999999999999999999999 99999754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=299.48 Aligned_cols=209 Identities=22% Similarity=0.344 Sum_probs=169.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.... .....+..||+|.+..... .....+.+|+.++..++||||+++++++..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hHHhhcccEEecCCCeEEEEEEEec-----CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 3678889999999999999997653 1223356799999976532 334568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCC
Confidence 999999999999999999997654 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 998654322111 1122346789999999998899999999999999999998 99999653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=293.91 Aligned_cols=201 Identities=23% Similarity=0.282 Sum_probs=170.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+..... ....++.+|+..+..+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR---------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc---------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 358999999999999999999544 3588999999875432 3445678899999998 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-------
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------- 216 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------- 216 (295)
.+.+..++||||+++++|.+++.........+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC---------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccc
Confidence 9999999999999999999999875433345889999999999999999999988 9999999999999844
Q ss_pred ------------CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhh
Q 022575 217 ------------YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 217 ------------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998654322 23589999999999866 66789999999999999999998764
Q ss_pred e
Q 022575 284 L 284 (295)
Q Consensus 284 ~ 284 (295)
.
T Consensus 233 ~ 233 (289)
T 1x8b_A 233 N 233 (289)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.22 Aligned_cols=199 Identities=22% Similarity=0.292 Sum_probs=170.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc------CCCCcccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL------YHPNLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~h~ni~~l~ 140 (295)
..+|++.+.||+|+||.||+|... .+++.||||++.... .....+.+|++++..+ +|+||++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~---------~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH---------KVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred cCcEEEEEEcccCccEEEEEEEEC---------CCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 358999999999999999999544 468999999997653 2234456677777665 578999999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 218 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-- 218 (295)
+++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 166 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 166 ENFTFRNHICMTFELL-SMNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCC
T ss_pred eecccCCeEEEEEecc-CCCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcc
Confidence 9999999999999999 5799999987543 45889999999999999999999988 999999999999999887
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 241 vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999754322 22357999999999999999999999999999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.19 Aligned_cols=205 Identities=25% Similarity=0.348 Sum_probs=171.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.... ...++..||+|.+.... ......+.+|+.++..++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 3689999999999999999997653 23346779999997653 3345678899999999999999999999764
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccC
Confidence 55789999999999999998754 45888999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||..
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 99865432211 1223457889999999998899999999999999999998 9999964
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=289.87 Aligned_cols=198 Identities=22% Similarity=0.288 Sum_probs=171.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.++.+++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 58999999999999999999754 67899999976542 334568899999999999999999999987
Q ss_pred C--CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 146 D--DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 146 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
. +..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++.+|+||||||+|||++.++.++|+|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred CCCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence 7 778999999999999999987542 358999999999999999999999766799999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccc---cceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQL---VLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++..... ....||+.|+|||++.+..++. ++|||||||++|||++|.+||...
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 988765322 1246899999999998765554 799999999999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=296.04 Aligned_cols=205 Identities=22% Similarity=0.322 Sum_probs=165.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.+|++.+.||+|+||.||+|... .++..||+|.+.... ......+.+|+.++..++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACL---------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEET---------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEc---------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47999999999999999999544 358899999987532 234556789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEec
Confidence 999999999999999999999764433356889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 181 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 181 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99976533221 123356899999999999999999999999999999999999999653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=304.89 Aligned_cols=198 Identities=21% Similarity=0.229 Sum_probs=161.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|.. ..+++.||||.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYD---------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEE---------CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 36899999999999999999954 3468899999986532 233456789999999999999999999997
Q ss_pred eCC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
..+ ..|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSC
T ss_pred cccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCC
Confidence 665 7899999995 588888852 3788899999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 166 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 166 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp EEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998653321 223457999999999999989999999999999999999999999654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=317.84 Aligned_cols=199 Identities=26% Similarity=0.351 Sum_probs=173.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDK---------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEEC---------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 58999999999999999999543 4688999999865432 34567889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEE
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKL 221 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl 221 (295)
..+..++||||+.+++|.+.+.... .+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999999999997653 4889999999999999999999988 9999999999999 56789999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...
T Consensus 171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 9999997654332 1234579999999999865 6899999999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.88 Aligned_cols=205 Identities=23% Similarity=0.302 Sum_probs=168.4
Q ss_pred CCCCCCC-eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+++.+.+ .||+|+||.||+|.+... ..+..||||.++.... ....++.+|+++|.+++||||+++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3444444 799999999999976531 2467899999986533 345678899999999999999999999876
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCS
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeecc
Confidence 56899999999999999997653 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++........ .......+|+.|+|||++....++.++|||||||++|||++ |.+||...
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99875433211 11122345789999999999999999999999999999998 99999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=297.55 Aligned_cols=208 Identities=27% Similarity=0.401 Sum_probs=177.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|.+.. .+..+++.||+|.+..........+.+|+.++..++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3579999999999999999997643 24456899999999877666667788999999999999999999988654
Q ss_pred C--eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 147 D--HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 147 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+ ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecC
Confidence 4 6899999999999999998764 45889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 9998654432211 11224577889999999988999999999999999999999988864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=290.24 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=170.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
+.|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEec---------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 56888899999999999999544 3588999999875532 344567899999999999999999999876
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEE
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAK 220 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~k 220 (295)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+++.+|+||||||+|||++ .++.+|
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEE
Confidence 356899999999999999998753 47889999999999999999999766699999999999997 789999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++...... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||...
T Consensus 173 l~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999754332 123457999999999876 56899999999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=294.62 Aligned_cols=201 Identities=26% Similarity=0.384 Sum_probs=160.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... ..||+|.+..... .....+.+|+.++++++||||++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 468999999999999999999643 2499999875532 3445688999999999999999999965
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Df 164 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDF 164 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCC
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccc
Confidence 5567899999999999999997654 45889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++................||+.|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 228 (289)
T 3og7_A 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228 (289)
T ss_dssp C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence 9998654322222333457999999999986 567889999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.46 Aligned_cols=211 Identities=21% Similarity=0.249 Sum_probs=175.7
Q ss_pred ehhhHHHhcCCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHccc-CCC
Q 022575 59 SFNGLKTATRNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL-YHP 134 (295)
Q Consensus 59 ~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l-~h~ 134 (295)
.+.......++|.+. +.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..+ .||
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISK---------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 334445556678887 89999999999999544 45889999998765432 355778999999998 469
Q ss_pred CccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 135 ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
||+++++++...+..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~ 165 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLS 165 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEES
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEe
Confidence 999999999999999999999999999999865432 45889999999999999999999988 99999999999998
Q ss_pred C---CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 215 L---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 215 ~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7 7899999999998654322 123357999999999999999999999999999999999999999654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.78 Aligned_cols=200 Identities=27% Similarity=0.355 Sum_probs=173.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.++..++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK---------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC---------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 468999999999999999999544 3588999999876532 334567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Df 176 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 176 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEEC
Confidence 999999999999999999998763 478899999999999999999985 7 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998643211 123357999999999999999999999999999999999999999653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=299.11 Aligned_cols=207 Identities=24% Similarity=0.292 Sum_probs=172.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+..........+.+|+.++..++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGL---------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEec---------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 368999999999999999999543 3588999999876655666778899999999999999999999873
Q ss_pred ---CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 146 ---DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
....++||||+.+++|.+++.........+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEE
Confidence 34789999999999999999875433466899999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcc-------eeeccccccCccCceeeccC---cccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQSH-------VSTRVMGTYGYAAPEYMATG---IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||++.......... ......||+.|+|||++... .++.++|||||||++|+|++|.+||..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 999987543211100 01123579999999998754 378999999999999999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.21 Aligned_cols=199 Identities=25% Similarity=0.326 Sum_probs=163.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED- 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~- 146 (295)
.+|++.++||+|+||.||+|... .+++.||||.+..... ...+|+++++.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 47899999999999999999654 3588999999865432 123699999999999999999988542
Q ss_pred -----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-CcEE
Q 022575 147 -----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAK 220 (295)
Q Consensus 147 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 220 (295)
...++||||++ ++|.+.+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 121 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEE
Confidence 23679999996 4777777643322356899999999999999999999988 9999999999999965 5689
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus 198 l~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp ECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999986543321 2345789999999998764 7899999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=314.22 Aligned_cols=205 Identities=25% Similarity=0.338 Sum_probs=169.8
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|.+.. +..||||.++.... ....+.+|+.++++++||||+++++++
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3445688999999999999999997653 46799999986543 345788999999999999999999998
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.. +..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred cC-CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECC
Confidence 65 678999999999999999976432 34788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+++....... .......+++.|+|||++..+.++.++|||||||++|||++ |.+||...
T Consensus 324 fG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 324 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 999986543221 11223457889999999999999999999999999999999 99999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.94 Aligned_cols=196 Identities=24% Similarity=0.352 Sum_probs=153.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|.. ..+++.||||++.... .....++.+|+.+++.++||||+++++++..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFD---------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp TTEEEEEECC----CCEEEEEE---------TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CceEEeeEEeecCCeEEEEEEE---------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 6899999999999999999954 3468999999997542 2344567899999999999999999999875
Q ss_pred C------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 D------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. ...|+++|++ +++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCE
Confidence 4 5679999999 7899998865 34889999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||...
T Consensus 172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999864322 234579999999999886 67899999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=301.04 Aligned_cols=203 Identities=27% Similarity=0.353 Sum_probs=174.2
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--------hhHHHHHHHHHHHccc-CCC
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQL-YHP 134 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~ 134 (295)
....++|++.+.||+|+||.||+|... .+|+.||||++..... .....+.+|+.++..+ +||
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~---------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 160 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHR---------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hhhhhhcccceEEecCCCEEEEEEEEC---------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 344568999999999999999999654 3588999998865431 1134567899999999 799
Q ss_pred CccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 135 NLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 135 ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
||+++++++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD 234 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence 9999999999999999999999999999999865 34889999999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc------CcccccceeeehhHHHHHHhccCChhhe
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus 235 ~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp TTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 999999999999986543321 234579999999999863 3588999999999999999999999965
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=298.92 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=168.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++..++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNK---------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEET---------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEEC---------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 48999999999999999999544 35889999988554322 23456789999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCC
Confidence 99999999999998888876554 34889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 170 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 170 FARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9976533221 22335789999999999875 7899999999999999999999999754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.45 Aligned_cols=207 Identities=28% Similarity=0.421 Sum_probs=162.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
..|++.+.||+|+||.||+|.... .......||+|.+.... .....++.+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 357778999999999999997642 11234578999987543 2345678899999999999999999998754
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecc
Confidence 467899999999999999997654 45788899999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCc--ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 99865332211 11223457889999999999999999999999999999999 78888654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=292.22 Aligned_cols=200 Identities=29% Similarity=0.367 Sum_probs=175.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+.|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN---------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEEC---------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 47899999999999999999543 3588999999865542 3356778999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeeccc
Confidence 999999999999999999865 34889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 166 AGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp CEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 976533221 123457899999999999999999999999999999999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.41 Aligned_cols=205 Identities=22% Similarity=0.260 Sum_probs=170.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.++|++.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.++..++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~---------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLD---------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEB---------TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEE---------CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 46899999999999999999954 34688999999976542 234568899999999999999999999
Q ss_pred EE--eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 143 CL--EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 143 ~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
+. ..+..++||||+.++ |.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEE
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEE
Confidence 84 445789999999765 8787766433 45889999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccC--cccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999865433322233445799999999998754 3478999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.46 Aligned_cols=205 Identities=16% Similarity=0.186 Sum_probs=165.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-----------hHHHHHHHHHHHcccCCCC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----------GHLEWLTEIKHLGQLYHPN 135 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n 135 (295)
.++|++.+.||+|+||.||+|.... ...++..+|+|.+...... ....+.+|+..+..++|||
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTN------KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESS------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecC------CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3689999999999999999997653 1224778999998765321 1123567888999999999
Q ss_pred ccceeeEEEe----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 136 LVKLIGYCLE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 136 i~~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
|+++++++.. ....|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 182 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANL 182 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHE
Confidence 9999999988 77899999999 999999997654 5889999999999999999999988 99999999999
Q ss_pred EEcCCC--cEEEccccCCCCCCCCCC-----cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 212 LLDLNY--NAKLSDFGLAKDGPTGSQ-----SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 212 ll~~~~--~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998877 999999999975432211 1111345799999999999998999999999999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=293.84 Aligned_cols=207 Identities=29% Similarity=0.412 Sum_probs=169.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEE-e
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCL-E 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~ 145 (295)
.+|++.+.||+|+||.||+|.... .......+|+|.+..... .....+.+|+.++++++||||+++++++. .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 478889999999999999997642 223456799999876433 34456889999999999999999999864 4
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 173 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFG 173 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred CCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccc
Confidence 567899999999999999997644 45788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCc--ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++........ .......||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 99865432211 11233467889999999999999999999999999999999 66777654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=302.25 Aligned_cols=201 Identities=25% Similarity=0.328 Sum_probs=170.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|++++.+++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDN---------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred ccEEEEEEeecCCCeEEEEEEEC---------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 58999999999999999999543 4688999999975433 2345678999999999999999999999765
Q ss_pred -----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 147 -----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 147 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
...|+||||+. ++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp STTTCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred CccccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEE
Confidence 36899999995 6999998753 4889999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcc-eeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998654322111 12345799999999987654 5899999999999999999999999654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=291.82 Aligned_cols=205 Identities=23% Similarity=0.308 Sum_probs=172.1
Q ss_pred CCCCCCC-eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|.+.+ .||+|+||.||+|.+.. ..++..||+|.+..... .....+.+|++++..++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEecc-------CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4666666 99999999999997542 22478899999987533 3455688999999999999999999999 5
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECccc
Confidence 567899999999999999997543 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 217 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99865433221 11222356899999999998899999999999999999998 99999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=293.80 Aligned_cols=202 Identities=28% Similarity=0.380 Sum_probs=171.0
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
..++|++.+.||+|+||.||+|... .+++.||+|.+.... ....+.+|+.++..++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK---------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET---------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC---------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 3468999999999999999999544 358899999987543 34567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg 170 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFG 170 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecc
Confidence 999999999999999999997543 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 171 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 171 VAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp TCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 9976433221 123357899999999999889999999999999999999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=289.24 Aligned_cols=199 Identities=28% Similarity=0.425 Sum_probs=161.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh----hHHHHHHHHHHHcccCCCCccceeeE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ----GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.++|++.+.||+|+||.||+|... +..||+|.+...... ....+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 368999999999999999999643 678999998754332 23567889999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeEeecCCCCCeEEcC------
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKA-KVIYRDFKTSNILLDL------ 215 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~~------ 215 (295)
+...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++. +|+||||||+|||++.
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~ 149 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSC
T ss_pred EecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccc
Confidence 9999999999999999999999854 358899999999999999999999763 3889999999999986
Q ss_pred --CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 216 --NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 216 --~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 150 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 150 LSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred ccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7789999999998643322 12346899999999999889999999999999999999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=292.13 Aligned_cols=205 Identities=25% Similarity=0.350 Sum_probs=173.5
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|... .+..||+|.+..... ....+.+|++++..++||||+++++++
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 344578999999999999999999754 266899999976542 345778999999999999999999987
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
. .+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 78 T-QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred c-CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECC
Confidence 6 4568999999999999999976431 24888999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||++........ .......+++.|+|||++.++.++.++||||||+++|+|++ |.+||...
T Consensus 153 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 999986543221 11223456889999999998899999999999999999999 99998653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.23 Aligned_cols=208 Identities=25% Similarity=0.303 Sum_probs=158.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEe-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE- 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~- 145 (295)
.+|++.++||+|+||.||+|... .+++.||+|.+..........+.+|+.++.++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDV---------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEET---------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceEEEEEEEccCCceEEEEEEEC---------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 58999999999999999999543 358899999987666555667889999999996 9999999999853
Q ss_pred -------CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 146 -------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 146 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
....+++|||+ +|+|.+++..... ...+++..+..++.||+.||.|||+++.+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred ccccccCCceEEEEEEec-CCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 34579999999 5799999876322 13589999999999999999999997666999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcc----------eeeccccccCccCceee---ccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSH----------VSTRVMGTYGYAAPEYM---ATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|.+||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998654322111 11134689999999998 5667899999999999999999999999764
Q ss_pred e
Q 022575 286 L 286 (295)
Q Consensus 286 ~ 286 (295)
.
T Consensus 257 ~ 257 (337)
T 3ll6_A 257 A 257 (337)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=291.36 Aligned_cols=199 Identities=28% Similarity=0.399 Sum_probs=171.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
...+|++.+.||+|+||.||+|... .+++.||+|.+.... ..+.+|+.++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHR---------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEET---------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEc---------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 3468999999999999999999654 358899999987553 244689999999999999999998865
Q ss_pred ----------------CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 022575 146 ----------------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (295)
Q Consensus 146 ----------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 209 (295)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~ 151 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPS 151 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHH
Confidence 3457999999999999999976532 45889999999999999999999988 999999999
Q ss_pred CeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 210 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||++.++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 152 Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 152 NIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp GEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred HEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999999999999999986543321 2234689999999999998999999999999999999999988754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=289.31 Aligned_cols=201 Identities=25% Similarity=0.320 Sum_probs=167.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQ---------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEEC---------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 468999999999999999999544 3588999999875432 2345678999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d 154 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIAD 154 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEee
Confidence 99999999999999999999998763 4788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|.+||...
T Consensus 155 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 155 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99998654322 1223468999999999987765 68999999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=289.15 Aligned_cols=204 Identities=24% Similarity=0.327 Sum_probs=170.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|....+||+|+||.||+|... .++..||+|.+..........+.+|+.++..++||||+++++++...+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDL---------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEET---------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEeecCcEEEEEEEEC---------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 35566679999999999999543 358899999997765555667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-CCcEEEccccC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGL 226 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~DFG~ 226 (295)
..++||||+++++|.+++..... ...+++..+..++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence 99999999999999999976532 134678888999999999999999988 999999999999987 89999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCc--ccccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI--FQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+........ ......||+.|+|||++.++. ++.++||||||+++|+|++|.+||...
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 986533211 123357899999999997654 789999999999999999999999653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=297.53 Aligned_cols=205 Identities=26% Similarity=0.355 Sum_probs=167.5
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
...++|++.+.||+|+||.||+|... .+++.||+|.+.... .....+.+|+.++.++ +||||+++++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHV---------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEEC---------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34568999999999999999999654 358899999986543 2345678899999998 799999999999
Q ss_pred Ee------CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 144 LE------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 144 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
.. .+..++||||+++++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCC
Confidence 87 4678999999999999999986532 45888999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||++........ ......||+.|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999986533211 123357899999999987 567889999999999999999999999654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=290.95 Aligned_cols=202 Identities=25% Similarity=0.327 Sum_probs=174.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... .+..||+|.+..... ....+.+|++++..++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 368999999999999999999654 267899999986543 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM 150 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccc
Confidence 99999999999999999997654 45788999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+....... ........+++.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 151 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 98643211 111123457889999999998899999999999999999999 89999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=296.79 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=169.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... .++..||+|.+..........+.+|+.++..++||||+++++++...+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNK---------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEET---------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred cceeecceeccCCCeEEEEEEEc---------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 58999999999999999999654 358899999998776666678889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCC
Confidence 9999999999999999987654 45889999999999999999999988 999999999999999999999999987
Q ss_pred CCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... ........||+.|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 532110 01122346899999999984 567889999999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=293.27 Aligned_cols=207 Identities=23% Similarity=0.353 Sum_probs=172.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRK---------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEEC---------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence 58999999999999999999544 3588999999875432 344568899999999999999999998864
Q ss_pred --CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeEeecCCCCCeEEcCCCcEE
Q 022575 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---AKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~~k 220 (295)
.+..++||||+++++|.+++.........+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence 56889999999999999999875543356899999999999999999999864 2399999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|.+||...
T Consensus 157 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 157 LGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp ECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 999999976433221 122356899999999999889999999999999999999999999764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.84 Aligned_cols=199 Identities=24% Similarity=0.351 Sum_probs=159.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
.++|++.+.||+|+||.||+|... ++.||||++........ ....|+..+..++||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~-~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQNF-INEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeeccchhhH-HHHHHHHHHHhccCcchhhheeccccc
Confidence 368999999999999999999653 68899999875442221 12234444556899999999986643
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCCeEeecCCCCCeE
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD---------KAKVIYRDFKTSNIL 212 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---------~~~ivHrDlkp~Nil 212 (295)
....++||||+++|+|.+++.... .++..+..++.||+.||.|||++ + |+||||||+|||
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nil 152 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVL 152 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEE
Confidence 235689999999999999997653 57888899999999999999998 6 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCC------cceeeccccccCccCceeecc-------CcccccceeeehhHHHHHHhccC
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQ------SHVSTRVMGTYGYAAPEYMAT-------GIFQLVLLLFTFECSLLHFSLQL 279 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~ 279 (295)
++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999999999999976533211 111224579999999999986 56778999999999999999997
Q ss_pred Chhhe
Q 022575 280 PMCVL 284 (295)
Q Consensus 280 ~pf~~ 284 (295)
.||..
T Consensus 233 ~p~~~ 237 (336)
T 3g2f_A 233 TDLFP 237 (336)
T ss_dssp GGGST
T ss_pred CcCCC
Confidence 66643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.26 Aligned_cols=205 Identities=24% Similarity=0.328 Sum_probs=170.5
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.|.+.+.||+|+||.||+|.+.. ....+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 56667899999999999997653 223456799999876443 34556889999999999999999999998766
Q ss_pred ee-EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 148 HR-LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 148 ~~-~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
.. +++|||+.+++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred CCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCC
Confidence 55 99999999999999997644 45788999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCC--cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhe
Q 022575 227 AKDGPTGSQ--SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~ 284 (295)
++....... ........+|+.|+|||.+.+..++.++|||||||++|+|++ |.|||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 986533221 111233467899999999999999999999999999999999 5566544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=298.88 Aligned_cols=212 Identities=27% Similarity=0.339 Sum_probs=170.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|.+... .+..++..||+|.+.... .....++.+|+.++.+++||||+++++++...
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 5899999999999999999975421 134468899999997543 23445688999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCcEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASY---IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAK 220 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k 220 (295)
+..|+||||+++++|.+++...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++. +..+|
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999875421 134788999999999999999999988 999999999999984 44699
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 999999874322222222233568999999999998899999999999999999998 99999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=288.87 Aligned_cols=201 Identities=26% Similarity=0.308 Sum_probs=173.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---------hhHHHHHHHHHHHcccC-CCCc
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---------QGHLEWLTEIKHLGQLY-HPNL 136 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~ni 136 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++.++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEEc---------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 368999999999999999999544 4689999999865431 12345778999999995 9999
Q ss_pred cceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
+++++++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD 160 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC
Confidence 99999999999999999999999999999875 35889999999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeec------cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA------TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|.+||...
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 999999999998654322 123357899999999985 456889999999999999999999998643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=296.65 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=169.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcE--EEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV--IAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
++|++.+.||+|+||.||+|.... ++.. +|+|.+..... .....+.+|++++.++ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 589999999999999999996543 3554 49998865322 2344678899999999 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
...+..++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceE
Confidence 99999999999999999999997653 22246889999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|++.++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999987432211 1122357889999999998899999999999999999998 99999654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=290.62 Aligned_cols=205 Identities=25% Similarity=0.309 Sum_probs=170.4
Q ss_pred cCCCCCCC-eeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 67 TRNFRPDS-VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 67 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
.++|++.+ .||+|+||.||+|.+.. ..++..||+|.+...... ...++.+|++++..++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecC-------CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35788888 99999999999996542 235789999999765332 245688999999999999999999998
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECC
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEcc
Confidence 5677899999999999999998753 4889999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99998654433211 1122346789999999998899999999999999999999 99999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.67 Aligned_cols=210 Identities=24% Similarity=0.343 Sum_probs=157.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
...++|++.+.||+|+||.||+|.. ..+++.||+|.+..... ....++.+|+.++..++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYC---------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEE---------CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 3447899999999999999999943 34588999999876542 2345677899999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRA----SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
...+..++||||+++++|.+++.... .....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCE
Confidence 99999999999999999999997521 11245889999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCC---cceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQ---SHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||++........ ........||+.|+|||++.. ..++.++|||||||++|+|++|.+||...
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 9999999875433211 111233578999999999875 46899999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=292.50 Aligned_cols=203 Identities=22% Similarity=0.256 Sum_probs=158.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHH-HHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHL-EWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~-~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+...... ... .+..+...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHV---------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEec---------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 468999999999999999999543 36899999999765322 222 2344555678889999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
..+..++||||++ ++|.+++.........+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEee
Confidence 9999999999996 599888876433335689999999999999999999997 7 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceee----ccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----ATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++........ .....||+.|+|||++ ....++.++|||||||++|+|++|.+||..
T Consensus 154 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 154 FGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 999986543221 2234699999999996 456789999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.41 Aligned_cols=202 Identities=22% Similarity=0.222 Sum_probs=166.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE-Ee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC-LE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~-~~ 145 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+...... ..+.+|+.++..++|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEc---------CCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 468999999999999999999543 46889999986554322 2467899999999988877766554 67
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~ 222 (295)
.+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~ 150 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEe
Confidence 78889999999 999999998544 45899999999999999999999988 9999999999999 788999999
Q ss_pred cccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 99999865433221 1123457999999999999999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=296.51 Aligned_cols=200 Identities=25% Similarity=0.313 Sum_probs=167.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--------hhHHHHHHHHHHHcccCCCCccc
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLYHPNLVK 138 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni~~ 138 (295)
.++|++.+.||+|+||.||+|... .+++.||||.+..... .....+.+|+.++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 79 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFER---------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred hhceeEeeEEecCCCEEEEEEEEc---------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence 358999999999999999999544 4688999999876432 12234778999999999999999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 139 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
+++++...+ .++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 80 IKNFFDAED-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEEEEESSS-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSS
T ss_pred EeeEEcCCc-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCC
Confidence 999987655 89999999999999998764 35889999999999999999999988 999999999999987664
Q ss_pred ---EEEccccCCCCCCCCCCcceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 ---AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|.+||...
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp SCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred CCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999998653321 123357899999999974 467889999999999999999999999654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=303.20 Aligned_cols=198 Identities=25% Similarity=0.331 Sum_probs=161.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.+|++.++||+|+||.||+|.... +..+|+|++...... ..+|+++++.++||||+++++++...+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 479999999999999999996543 334888877543221 136999999999999999999986544
Q ss_pred e------eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEE
Q 022575 148 H------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAK 220 (295)
Q Consensus 148 ~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~k 220 (295)
. .++||||+++ ++.+.+.........+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred CCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEE
Confidence 3 7899999965 555555433222356899999999999999999999988 99999999999998 799999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus 183 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 245 (394)
T 4e7w_A 183 LIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245 (394)
T ss_dssp ECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999986533322 2345789999999998765 5899999999999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=321.74 Aligned_cols=198 Identities=26% Similarity=0.313 Sum_probs=164.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 151 (295)
+.||+|+||.||+|.+.. ..++..||||+++.... ....++.+|+.++.+++||||+++++++.. +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEcC-------CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 479999999999997643 23578899999976543 235678899999999999999999999864 56889
Q ss_pred EEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 447 v~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred EEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 99999999999999765 34889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 232 TGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
..... .......+|+.|+|||++....++.++|||||||++|||++ |.+||...
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 33221 11223456889999999999999999999999999999998 99999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=292.74 Aligned_cols=195 Identities=30% Similarity=0.432 Sum_probs=162.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|... ++.||+|.+.... ....+.+|++++.+++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 57899999999999999999654 5779999997543 3456789999999999999999999876 4
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc---CCCCeEeecCCCCCeEEcCCCc-EEEcc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS---DKAKVIYRDFKTSNILLDLNYN-AKLSD 223 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~ivHrDlkp~Nill~~~~~-~kl~D 223 (295)
..++||||+++++|.+++..... ...++...++.++.|++.||+|||+ ++ |+||||||+|||++.++. +||+|
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECC
T ss_pred CcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcc
Confidence 58999999999999999976532 1346788899999999999999999 56 999999999999988886 79999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 150 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 150 FGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp CCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 9999754322 12346899999999999989999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.14 Aligned_cols=198 Identities=14% Similarity=0.018 Sum_probs=151.6
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHH---HHHcccCCCCcccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEI---KHLGQLYHPNLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~---~~l~~l~h~ni~~l~ 140 (295)
..+|++.+.||+|+||.||+|... .+++.||+|++..... .....+.+|+ ..|.. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~ 130 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDV---------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDR 130 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred ceeeeeeeeccCCCCEEEEEEEEC---------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence 346899999999999999999544 3589999999987543 2234556674 55555 799987755
Q ss_pred -------eEEEeC-----------------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHH------HHHHHHHHHH
Q 022575 141 -------GYCLED-----------------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR------MKVALGAAKG 190 (295)
Q Consensus 141 -------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~------~~~~~~i~~~ 190 (295)
+++... ...|+||||++ ++|.+++..... .+.+... ..++.||+.|
T Consensus 131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~a 206 (371)
T 3q60_A 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRL 206 (371)
T ss_dssp -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHH
Confidence 555443 23799999997 899999987542 2333344 5677999999
Q ss_pred HHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc--Ccccccceeeeh
Q 022575 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTF 268 (295)
Q Consensus 191 l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~sl 268 (295)
|+|||+++ |+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||
T Consensus 207 L~~LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 207 AANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp HHHHHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred HHHHHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 99999988 99999999999999999999999999986432 1223457799999999987 689999999999
Q ss_pred hHHHHHHhccCChhhee
Q 022575 269 ECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 269 G~~l~el~~g~~pf~~~ 285 (295)
||++|||++|.+||...
T Consensus 280 G~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp HHHHHHHHHSSCSTTBC
T ss_pred HHHHHHHHhCCCCCCCc
Confidence 99999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.74 Aligned_cols=208 Identities=22% Similarity=0.288 Sum_probs=167.8
Q ss_pred ehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-----------hHHHHHHHHHH
Q 022575 59 SFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-----------GHLEWLTEIKH 127 (295)
Q Consensus 59 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~ 127 (295)
...++....++|++.+.||+|+||.||+|... .+..||||.+...... ....+.+|+.+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 34566677889999999999999999999532 2789999998653221 13567899999
Q ss_pred HcccCCCCccceeeEEEeC-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 022575 128 LGQLYHPNLVKLIGYCLED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (295)
Q Consensus 128 l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 202 (295)
+.+++||||+++++++... ...|+||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+++ |+
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iv 156 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAG--VV 156 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc--CE
Confidence 9999999999999998653 36799999996 68888887543 45889999999999999999999988 99
Q ss_pred eecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCCh
Q 022575 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPM 281 (295)
Q Consensus 203 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p 281 (295)
||||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 233 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence 99999999999999999999999997543322 1233578999999999886 6789999999999999999999999
Q ss_pred hhee
Q 022575 282 CVLY 285 (295)
Q Consensus 282 f~~~ 285 (295)
|...
T Consensus 234 f~~~ 237 (362)
T 3pg1_A 234 FRGS 237 (362)
T ss_dssp CCCS
T ss_pred CCCC
Confidence 9754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.03 Aligned_cols=205 Identities=25% Similarity=0.338 Sum_probs=174.0
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|.+.. +..||||.++.... ...++.+|+++|++++||||+++++++
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~ 331 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV 331 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3445678899999999999999997653 46799999986543 345788999999999999999999998
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.. +..|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~D 406 (535)
T 2h8h_A 332 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVAD 406 (535)
T ss_dssp CS-SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred ee-ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcc
Confidence 65 678999999999999999976432 34788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
||+++...... ........++..|+|||++..+.++.++|||||||++|||++ |.+||...
T Consensus 407 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 407 FGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp TTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred cccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998654321 111122356788999999999999999999999999999999 99999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=317.25 Aligned_cols=209 Identities=23% Similarity=0.311 Sum_probs=173.0
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
....++|++.+.||+|+||.||+|.+.. ....+..||+|.+..... .....+.+|+.++.+++||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECC------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEec------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3445689999999999999999997653 223467899999876433 334568899999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+. .+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEEC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEE
Confidence 84 567899999999999999998654 35888999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 534 DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 534 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999875433221 1223457889999999998899999999999999999997 99999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=302.55 Aligned_cols=199 Identities=22% Similarity=0.260 Sum_probs=168.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC--------CCCccc
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--------HPNLVK 138 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni~~ 138 (295)
.++|++.+.||+|+||.||+|+.. .+++.||+|++.... .....+.+|+++++.++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI---------QGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEec---------CCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 368999999999999999999543 468999999997543 33456778999998885 788999
Q ss_pred eeeEEE----eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEE
Q 022575 139 LIGYCL----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILL 213 (295)
Q Consensus 139 l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill 213 (295)
+++++. .....++||||+ +++|.+.+..... ..+++..+..++.||+.||+|||++ + |+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll 180 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE
Confidence 999987 445789999999 6677777765432 4588999999999999999999997 7 9999999999999
Q ss_pred cCCC-------------------------------------------------cEEEccccCCCCCCCCCCcceeecccc
Q 022575 214 DLNY-------------------------------------------------NAKLSDFGLAKDGPTGSQSHVSTRVMG 244 (295)
Q Consensus 214 ~~~~-------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~g 244 (295)
+.++ .+||+|||++...... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 8775 7999999999865332 223478
Q ss_pred ccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 245 TYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 245 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.72 Aligned_cols=203 Identities=22% Similarity=0.275 Sum_probs=170.0
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CC-----Cccc
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HP-----NLVK 138 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----ni~~ 138 (295)
...++|++.+.||+|+||.||+|... .+++.||||++.... ....++..|++++..++ |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDR---------VEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEc---------CCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 34579999999999999999999543 468899999997543 23345567888877774 44 4999
Q ss_pred eeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc--CC
Q 022575 139 LIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LN 216 (295)
Q Consensus 139 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~ 216 (295)
+++++...+..++||||+. ++|.+++..... ..+++..+..++.|++.||.|||++..+|+||||||+|||++ .+
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 9999999999999999995 699999987542 358899999999999999999996444599999999999994 57
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 198 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 88999999999865332 22357899999999999999999999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.17 Aligned_cols=206 Identities=21% Similarity=0.312 Sum_probs=156.6
Q ss_pred CCCCC-CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 68 RNFRP-DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 68 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
+.|.+ .++||+|+||.||+|.... ..++..||+|.+...... ..+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~-------~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESS-------SSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEcc-------CCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 35666 4589999999999997542 235788999999765432 356789999999999999999999965
Q ss_pred -CCeeEEEEeccCCCCHHHHHhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE----cC
Q 022575 146 -DDHRLLVYEFMPKGSLENHLFRRAS-----YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL----DL 215 (295)
Q Consensus 146 -~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~ 215 (295)
....|+||||+. ++|.+++..... ....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCC
Confidence 678999999995 688888864321 1124889999999999999999999988 9999999999999 67
Q ss_pred CCcEEEccccCCCCCCCCCCc-ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 889999999999865432211 122346799999999999874 5899999999999999999999999654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.32 Aligned_cols=206 Identities=24% Similarity=0.316 Sum_probs=157.5
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
....++|++.+.||+|+||.||+|... .++..||||.+..... ......+|++.+..++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEK---------STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp HHHHTTEEEC----------CEEEEET---------TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred hhhccceEEEEEEecCCCeEEEEEEEC---------CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence 344579999999999999999999544 3588999998855432 223456788888889999999999999
Q ss_pred EeCCe-------eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCeEeecCCCCCeEEc
Q 022575 144 LEDDH-------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH--SDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 144 ~~~~~-------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~~ivHrDlkp~Nill~ 214 (295)
...+. .++||||+.+ +|.+.+.........+++..+..++.|++.||.||| +++ |+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVN 165 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEE
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEe
Confidence 76443 7899999965 666665543333356888999999999999999999 766 99999999999998
Q ss_pred C-CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 215 L-NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 215 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 6 89999999999986543321 2345789999999998755 4899999999999999999999999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=290.70 Aligned_cols=194 Identities=23% Similarity=0.353 Sum_probs=158.5
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcc--cCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|... +..||+|++..... .....|.+++.. ++||||++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 34468999999999999999999653 67899999864432 233445555544 489999999999
Q ss_pred EEeC----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCCeEeecCCCCC
Q 022575 143 CLED----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD--------KAKVIYRDFKTSN 210 (295)
Q Consensus 143 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~~~ivHrDlkp~N 210 (295)
+... ...++||||+++++|.+++... .+++..++.++.|++.||.|||++ + |+||||||+|
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~N 172 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKN 172 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGG
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHH
Confidence 9887 7899999999999999999654 488999999999999999999987 6 9999999999
Q ss_pred eEEcCCCcEEEccccCCCCCCCCCCcc--eeeccccccCccCceeeccCccccc------ceeeehhHHHHHHhccC
Q 022575 211 ILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATGIFQLV------LLLFTFECSLLHFSLQL 279 (295)
Q Consensus 211 ill~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Di~slG~~l~el~~g~ 279 (295)
||++.++.+||+|||+++......... ......||+.|+|||++.+..+... +|||||||++|||++|.
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 999999999999999997653322211 1124579999999999987665554 99999999999999993
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.13 Aligned_cols=202 Identities=24% Similarity=0.290 Sum_probs=164.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE--
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL-- 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-- 144 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+.........++.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN---------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET---------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEEC---------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 368999999999999999999544 468999999997766666677889999999999999999999873
Q ss_pred ------------eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 145 ------------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 145 ------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
..+..++||||++ ++|.+++.+ ..+++..+..++.|++.||+|||+++ |+||||||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil 152 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLF 152 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence 3467899999996 699999864 34788999999999999999999988 999999999999
Q ss_pred Ec-CCCcEEEccccCCCCCCCCCCc-ceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 213 LD-LNYNAKLSDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 213 l~-~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++ .++.+||+|||+++........ .......+|+.|+|||++.. ..++.++|||||||++|+|++|.+||...
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence 97 5679999999999865332111 11233467999999998875 67899999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=287.26 Aligned_cols=202 Identities=22% Similarity=0.222 Sum_probs=169.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEE-Ee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYC-LE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~-~~ 145 (295)
.++|++.+.||+|+||.||+|... .+++.||+|.+...... .++.+|+.++..++|++++..+..+ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET---------TTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc---------CCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 468999999999999999999543 35899999998655432 3567899999999988866665544 66
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~ 222 (295)
.+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEe
Confidence 78889999999 999999997544 45899999999999999999999988 9999999999999 488899999
Q ss_pred cccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999865433221 1123457999999999999999999999999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=304.51 Aligned_cols=202 Identities=23% Similarity=0.210 Sum_probs=170.9
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC-CCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|... .+++.||||++...... .++.+|++++..++| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI---------QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET---------TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC---------CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 468999999999999999999543 35889999987654332 246789999999976 566666677788
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE---cCCCcEEEc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL---DLNYNAKLS 222 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~ 222 (295)
.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++ ||||||||+|||| +.++.+||+
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~ 148 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYII 148 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEEC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEE
Confidence 88999999999 999999998644 45899999999999999999999988 9999999999999 688999999
Q ss_pred cccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~ 216 (483)
T 3sv0_A 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (483)
T ss_dssp CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99999865433221 1122467999999999999999999999999999999999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=289.16 Aligned_cols=197 Identities=27% Similarity=0.382 Sum_probs=163.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|... +..||+|.+.... ....+.+|+.++.+++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 468999999999999999999643 6789999997653 345678999999999999999999987554
Q ss_pred -CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 147 -DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecc
Confidence 478999999999999999976532 23788889999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 987543321 22357889999999998899999999999999999998 99998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=291.15 Aligned_cols=200 Identities=24% Similarity=0.309 Sum_probs=171.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCC------Ccccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP------NLVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~------ni~~l~ 140 (295)
.++|++.+.||+|+||.||+|... ..+++.||+|++.... .....+.+|+.++..++|+ ++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 468999999999999999999643 2357899999997543 3345567888888887655 599999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-----
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL----- 215 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----- 215 (295)
+++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecccccc
Confidence 9999999999999999 8999999987643 35789999999999999999999988 999999999999987
Q ss_pred --------------CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCCh
Q 022575 216 --------------NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPM 281 (295)
Q Consensus 216 --------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 281 (295)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 668999999999864322 2235789999999999998999999999999999999999999
Q ss_pred hhee
Q 022575 282 CVLY 285 (295)
Q Consensus 282 f~~~ 285 (295)
|...
T Consensus 234 f~~~ 237 (339)
T 1z57_A 234 FPTH 237 (339)
T ss_dssp CCCS
T ss_pred CCCC
Confidence 9754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=300.33 Aligned_cols=208 Identities=15% Similarity=0.140 Sum_probs=168.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccc--------
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVK-------- 138 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~-------- 138 (295)
.++|++.+.||+|+||.||+|....... ......++.||+|.+... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLT-CDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCcc-ccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3689999999999999999997653100 000113788999998754 24668999999999999887
Q ss_pred -------eeeEEEe-CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCC
Q 022575 139 -------LIGYCLE-DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSN 210 (295)
Q Consensus 139 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 210 (295)
+++++.. .+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~N 189 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAEN 189 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHH
Confidence 6777776 67889999999 9999999987522 45899999999999999999999988 9999999999
Q ss_pred eEEcCCC--cEEEccccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 211 ILLDLNY--NAKLSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 211 ill~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999765432111 01133479999999999998899999999999999999999999998
Q ss_pred ee
Q 022575 284 LY 285 (295)
Q Consensus 284 ~~ 285 (295)
..
T Consensus 270 ~~ 271 (352)
T 2jii_A 270 NC 271 (352)
T ss_dssp GG
T ss_pred cC
Confidence 64
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.75 Aligned_cols=206 Identities=27% Similarity=0.405 Sum_probs=164.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|.+.. ....+..||+|.+..... .....+.+|++++..++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEecc------CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 589999999999999999997642 112345799999876532 34556889999999999999999999987
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+ .++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Df 165 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDF 165 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccc
Confidence 655 899999999999999998754 45889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 225 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 9998654432211 1223467889999999998899999999999999999999 99999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=294.97 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=168.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|... .+++.||||.+..... .....+.+|+.++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK---------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC---------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 368999999999999999999544 3688999999975432 234567799999999999999999998765
Q ss_pred C-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 146 D-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
. ...++||||+. ++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEE
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEE
Confidence 4 67899999995 6999998763 4889999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCCcc--------eeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSH--------VSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|.+||...
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998654321110 1123578999999998765 67899999999999999999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=297.39 Aligned_cols=196 Identities=22% Similarity=0.304 Sum_probs=166.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|.+.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 368999999999999999999543 4689999999976432 23456789999999999999999999998
Q ss_pred eCCee------EEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDDHR------LLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
..+.. ++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~ 182 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCE 182 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCC
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCC
Confidence 77655 99999995 68888773 23889999999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 183 ~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 183 LKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp EEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999864322 233578999999999887 68899999999999999999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.43 Aligned_cols=200 Identities=20% Similarity=0.278 Sum_probs=173.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-----------------HHHHHHHHHHHc
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----------------HLEWLTEIKHLG 129 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~E~~~l~ 129 (295)
.++|++.+.||+|+||.||+|.. +++.||+|.+....... ...+.+|+.++.
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 46899999999999999999964 38899999987543321 167889999999
Q ss_pred ccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHH------HhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeE
Q 022575 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH------LFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVI 202 (295)
Q Consensus 130 ~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~iv 202 (295)
.++||||+++++++...+..++||||+++++|.++ +.... ...+++..+..++.|++.||.|||+ ++ |+
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~ 174 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEKN--IC 174 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccCC--Ee
Confidence 99999999999999999999999999999999998 44321 2568999999999999999999998 87 99
Q ss_pred eecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccc-cceeeehhHHHHHHhccCC
Q 022575 203 YRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQL-VLLLFTFECSLLHFSLQLP 280 (295)
Q Consensus 203 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~slG~~l~el~~g~~ 280 (295)
||||||+|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|.+
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999865332 23345799999999999877 6766 9999999999999999999
Q ss_pred hhhee
Q 022575 281 MCVLY 285 (295)
Q Consensus 281 pf~~~ 285 (295)
||...
T Consensus 251 pf~~~ 255 (348)
T 2pml_X 251 PFSLK 255 (348)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 99754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=289.13 Aligned_cols=204 Identities=27% Similarity=0.393 Sum_probs=169.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHccc---CCCCcccee
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLI 140 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~l~ 140 (295)
..++|++.+.||+|+||.||+|.... .+++.||+|.+...... ....+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 34689999999999999999996532 24789999998654322 122345666666655 899999999
Q ss_pred eEEE-----eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC
Q 022575 141 GYCL-----EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL 215 (295)
Q Consensus 141 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 215 (295)
+++. .....++||||+. ++|.+++..... ..+++..+..++.|++.||.|||++| |+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~ 155 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTS 155 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcC
Confidence 9987 4567899999996 699999987543 34889999999999999999999988 999999999999999
Q ss_pred CCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 216 NYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 216 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999998653221 223457899999999999989999999999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=289.61 Aligned_cols=194 Identities=27% Similarity=0.385 Sum_probs=163.2
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcc--cCCCCccceee
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQ--LYHPNLVKLIG 141 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~ 141 (295)
....++|++.+.||+|+||.||+|... ++.||+|.+.... ...+.+|.+++.. ++||||+++++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 344578999999999999999999653 7889999997543 3355678877776 78999999999
Q ss_pred EEEeCC----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCeEeecCCCC
Q 022575 142 YCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH--------SDKAKVIYRDFKTS 209 (295)
Q Consensus 142 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~~~ivHrDlkp~ 209 (295)
++...+ ..++||||+++++|.+++.+. .+++..++.++.|++.||.||| +++ |+||||||+
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~ 176 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSK 176 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGG
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHH
Confidence 998876 789999999999999999763 4889999999999999999999 766 999999999
Q ss_pred CeEEcCCCcEEEccccCCCCCCCCCCcc--eeeccccccCccCceeeccC------cccccceeeehhHHHHHHhcc
Q 022575 210 NILLDLNYNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMATG------IFQLVLLLFTFECSLLHFSLQ 278 (295)
Q Consensus 210 Nill~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g 278 (295)
|||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 9999999999999999997543322111 12335799999999998765 455799999999999999999
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=289.57 Aligned_cols=210 Identities=21% Similarity=0.270 Sum_probs=168.2
Q ss_pred eehhhHHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccC--C
Q 022575 58 FSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLY--H 133 (295)
Q Consensus 58 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~--h 133 (295)
+.+..+....++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++ |
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 87 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGC
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccC
Confidence 334444555678999999999999999999543 37889999986543 234456789999999997 5
Q ss_pred CCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE
Q 022575 134 PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL 213 (295)
Q Consensus 134 ~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 213 (295)
|||+++++++...+..++|||+ .+++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 88 ~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~ 160 (313)
T 3cek_A 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLI 160 (313)
T ss_dssp TTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred CceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEE
Confidence 9999999999999999999994 5889999998753 5788899999999999999999988 9999999999999
Q ss_pred cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc-----------CcccccceeeehhHHHHHHhccCChh
Q 022575 214 DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-----------GIFQLVLLLFTFECSLLHFSLQLPMC 282 (295)
Q Consensus 214 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~pf 282 (295)
+ ++.+||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 161 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (313)
T 3cek_A 161 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239 (313)
T ss_dssp E-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred E-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence 6 48999999999986544332222234578999999999875 47889999999999999999999999
Q ss_pred hee
Q 022575 283 VLY 285 (295)
Q Consensus 283 ~~~ 285 (295)
...
T Consensus 240 ~~~ 242 (313)
T 3cek_A 240 QQI 242 (313)
T ss_dssp TTC
T ss_pred hhH
Confidence 754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.00 Aligned_cols=198 Identities=22% Similarity=0.279 Sum_probs=144.8
Q ss_pred CCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHH-HHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEI-KHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~-~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|.+. ++||+|+||.||+|... .+++.||+|++..... ..+|+ ..+..++||||+++++++..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~-----~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHR---------RTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEESSHH-----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEEC---------CCCCEEEEEEecCcHH-----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 488885 47999999999999544 4588999999865421 12233 33556789999999999876
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCc
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYN 218 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~ 218 (295)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCce
Confidence 4458999999999999999987643 46899999999999999999999988 999999999999976 455
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheeee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYLT 287 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 287 (295)
+||+|||+++...... .....||+.|+|||++....++.++|||||||++|+|++|.+||.....
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 9999999998643221 2235789999999999999999999999999999999999999976643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.49 Aligned_cols=195 Identities=25% Similarity=0.357 Sum_probs=160.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe--
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-- 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-- 145 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+.... .....+.+|+.++..++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA---------LDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred ccchhhheeccCCcEEEEEEEEc---------CCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 57999999999999999999543 358899999996532 345567899999999999999999998865
Q ss_pred -----------CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 146 -----------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 146 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID 150 (303)
T ss_dssp CCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred chhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc
Confidence 356799999999999999998654 45778889999999999999999988 99999999999999
Q ss_pred CCCcEEEccccCCCCCCCCCC------------cceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhc
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQ------------SHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSL 277 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~ 277 (295)
.++.+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999986532210 1112335789999999998754 78999999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.15 Aligned_cols=201 Identities=25% Similarity=0.329 Sum_probs=172.0
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~---------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR---------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc---------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 3468999999999999999999543 3588999999865432 3455778999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC---CcEE
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN---YNAK 220 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~k 220 (295)
...+..++||||+++++|.+.+.... .+++..+..++.||+.||.|||+++ ++||||||+||+++.+ +.+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEE
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEE
Confidence 99999999999999999999987653 4889999999999999999999988 9999999999999654 4699
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|.+||...
T Consensus 165 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 165 IIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (287)
T ss_dssp ECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence 999999986543221 223468999999998865 5899999999999999999999999654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.99 Aligned_cols=205 Identities=23% Similarity=0.308 Sum_probs=151.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHH-HHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIK-HLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||.||+|... .+++.||||.+..... ....++..|+. +++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHK---------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEET---------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEc---------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 368999999999999999999544 3589999999976532 23334556665 777889999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRA-SYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
..+..++||||+. ++|.+++.... .....+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEEC
T ss_pred eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEc
Confidence 9999999999996 58888876421 1125688999999999999999999997 7 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceee----ccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----ATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|||+++....... .....||+.|+|||++ .+..++.++|||||||++|+|++|.+||....
T Consensus 169 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 169 DFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp CCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999986543221 2234689999999998 45678999999999999999999999997643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=289.60 Aligned_cols=200 Identities=20% Similarity=0.245 Sum_probs=169.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCC------cccee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN------LVKLI 140 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n------i~~l~ 140 (295)
.++|++.+.||+|+||.||+|..... .+..||+|++.... .....+.+|+.++..++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 46899999999999999999965431 24789999997543 33455678888888887655 99999
Q ss_pred eEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEE-------
Q 022575 141 GYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILL------- 213 (295)
Q Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill------- 213 (295)
+++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccc
Confidence 9999999999999999 6788887766532 45889999999999999999999988 9999999999999
Q ss_pred ------------cCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCCh
Q 022575 214 ------------DLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPM 281 (295)
Q Consensus 214 ------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p 281 (295)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 56789999999999864322 2335799999999999999999999999999999999999999
Q ss_pred hhee
Q 022575 282 CVLY 285 (295)
Q Consensus 282 f~~~ 285 (295)
|...
T Consensus 239 f~~~ 242 (355)
T 2eu9_A 239 FQTH 242 (355)
T ss_dssp CCCS
T ss_pred CCCC
Confidence 9754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.73 Aligned_cols=195 Identities=22% Similarity=0.301 Sum_probs=164.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|.+.+.||+|+||.||+|... .+++.||||.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDK---------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ceEEEeeeEecCCCeEEEEEEEC---------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence 68999999999999999999543 4689999999976432 234567899999999999999999999987
Q ss_pred CCe------eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 DDH------RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.+. .++||||+. ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~ 165 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCEL 165 (353)
T ss_dssp CSSGGGCCCCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCE
T ss_pred ccccccceeEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcE
Confidence 654 499999995 688877642 3889999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus 166 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 166 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred EEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999864322 223578999999999876 67899999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=289.35 Aligned_cols=200 Identities=25% Similarity=0.328 Sum_probs=163.3
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHccc----CCCC
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQL----YHPN 135 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l----~h~n 135 (295)
..++|++.+.||+|+||.||+|. +..+++.||+|.+...... ....+.+|+.++.++ +|||
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGH---------RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEE---------CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred hhhceEEeeEEEcCCCEEEEEEE---------EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence 34689999999999999999994 3446889999999765432 122345788888888 8999
Q ss_pred ccceeeEEEeCCeeEEEEec-cCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc
Q 022575 136 LVKLIGYCLEDDHRLLVYEF-MPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD 214 (295)
Q Consensus 136 i~~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 214 (295)
|+++++++...+..++|||+ +.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILID 173 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEe
Confidence 99999999999999999999 78999999998753 4889999999999999999999988 99999999999998
Q ss_pred -CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhe
Q 022575 215 -LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 215 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.++.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 88999999999998654322 233568999999999887666 4689999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=290.25 Aligned_cols=201 Identities=20% Similarity=0.265 Sum_probs=171.2
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccC--CCCc
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLY--HPNL 136 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~ni 136 (295)
...++|++.+.||+|+||.||+|... .+++.||+|.+...... ....+.+|+.++.+++ |+||
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRV---------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEET---------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred CccCceEEEEEEeeCCCeEEEEEEEC---------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 34568999999999999999999543 35899999998765322 1234567999999986 5999
Q ss_pred cceeeEEEeCCeeEEEEeccCC-CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-
Q 022575 137 VKLIGYCLEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD- 214 (295)
Q Consensus 137 ~~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~- 214 (295)
+++++++...+..++|||++.+ ++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDL 184 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEET
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeC
Confidence 9999999999999999999976 89999998753 4788999999999999999999988 99999999999998
Q ss_pred CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhe
Q 022575 215 LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 215 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.++.+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|.+||..
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 78899999999998654322 233569999999999987665 7889999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=294.07 Aligned_cols=200 Identities=18% Similarity=0.183 Sum_probs=167.3
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-----------CCC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----------HPN 135 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 135 (295)
.++|++.+.||+|+||.||+|... .+++.||||.+.... .....+.+|+.++.+++ |||
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM---------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCeEEEEEeeeecCCeEEEEEEec---------CCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 368999999999999999999543 468999999997543 23445678888888876 899
Q ss_pred ccceeeEEEeCC----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCC
Q 022575 136 LVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSN 210 (295)
Q Consensus 136 i~~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~N 210 (295)
|+++++++...+ ..+++|||+ +++|.+++..... ..+++..+..++.||+.||+|||++ + |+||||||+|
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~N 162 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN 162 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGG
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHH
Confidence 999999998654 789999999 8999999987543 4488999999999999999999997 7 9999999999
Q ss_pred eEEc------CCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 211 ILLD------LNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 211 ill~------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
||++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 4458999999999765332 2234789999999999999999999999999999999999999986
Q ss_pred ee
Q 022575 285 YL 286 (295)
Q Consensus 285 ~~ 286 (295)
..
T Consensus 238 ~~ 239 (373)
T 1q8y_A 238 DE 239 (373)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=288.30 Aligned_cols=203 Identities=19% Similarity=0.253 Sum_probs=165.8
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|.... .+|+|.+..... .....+.+|+.++.+++||||++++++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 345789999999999999999996542 389999875432 223346689999999999999999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+...+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ ++.+||+
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEEC
T ss_pred EecCCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEe
Confidence 999999999999999999999997654 45788999999999999999999988 99999999999998 6799999
Q ss_pred cccCCCCCCCCC---CcceeeccccccCccCceeecc---------CcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGS---QSHVSTRVMGTYGYAAPEYMAT---------GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||++....... .........||+.|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999987542211 1111223468999999999874 35789999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=296.32 Aligned_cols=201 Identities=26% Similarity=0.263 Sum_probs=154.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 146 (295)
+.|.+.++||+|+||+||.+... +++.||||.+.... ...+.+|+.++..+ +||||+++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 45666789999999999765322 47899999986543 33567899999876 899999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCC---CHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-------
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPL---SWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN------- 216 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~---~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------- 216 (295)
+..|+||||+. |+|.+++.......... .+..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccc
Confidence 99999999995 69999998654321111 22345679999999999999988 9999999999999654
Q ss_pred ------CcEEEccccCCCCCCCCCCcc--eeeccccccCccCceeecc-------CcccccceeeehhHHHHHHhc-cCC
Q 022575 217 ------YNAKLSDFGLAKDGPTGSQSH--VSTRVMGTYGYAAPEYMAT-------GIFQLVLLLFTFECSLLHFSL-QLP 280 (295)
Q Consensus 217 ------~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~ 280 (295)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 489999999998754432211 1223579999999999875 578999999999999999999 999
Q ss_pred hhhe
Q 022575 281 MCVL 284 (295)
Q Consensus 281 pf~~ 284 (295)
||..
T Consensus 239 Pf~~ 242 (434)
T 2rio_A 239 PFGD 242 (434)
T ss_dssp TTCS
T ss_pred CCCC
Confidence 9964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.27 Aligned_cols=192 Identities=18% Similarity=0.123 Sum_probs=158.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--------hhHHHHHHHHHHHcccC------
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--------QGHLEWLTEIKHLGQLY------ 132 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 132 (295)
.++|++.+.||+|+||.||+|+. +++.||||++..... .....+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 35799999999999999999964 378999999976532 12356678888887775
Q ss_pred ---CCCccceeeEEE------------------------------eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHH
Q 022575 133 ---HPNLVKLIGYCL------------------------------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179 (295)
Q Consensus 133 ---h~ni~~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 179 (295)
||||+++.+++. ..+..|+||||+++|++.+.+.+ ..+++..
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~ 162 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLAT 162 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHH
Confidence 777777777643 26789999999999977666643 3478999
Q ss_pred HHHHHHHHHHHHHHhh-cCCCCeEeecCCCCCeEEcCCC--------------------cEEEccccCCCCCCCCCCcce
Q 022575 180 RMKVALGAAKGLAYLH-SDKAKVIYRDFKTSNILLDLNY--------------------NAKLSDFGLAKDGPTGSQSHV 238 (295)
Q Consensus 180 ~~~~~~~i~~~l~~lH-~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~DFG~a~~~~~~~~~~~ 238 (295)
+..++.||+.||+||| +++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 163 ~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------ 234 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------
T ss_pred HHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------
Confidence 9999999999999999 888 99999999999999887 899999999986432
Q ss_pred eeccccccCccCceeeccCcccccceeeehhHH-HHHHhccCChhhe
Q 022575 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECS-LLHFSLQLPMCVL 284 (295)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~-l~el~~g~~pf~~ 284 (295)
....||+.|+|||++.+.. +.++|||||+++ .++++.|.+||..
T Consensus 235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred -CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 1247999999999998665 889999998877 7889999999965
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=296.01 Aligned_cols=199 Identities=25% Similarity=0.310 Sum_probs=155.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~ 146 (295)
.+|.+.++||+|+||.|+..... +++.||||++...... .+.+|+++++.+ +||||+++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 46888999999999996543221 3788999999765433 235799999998 799999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-----CCcEEE
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAKL 221 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl 221 (295)
+..|+||||+. ++|.+++..... ...+..+..++.||+.||+|||+++ |+||||||+|||++. ...+||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999999995 699999976542 2333456788999999999999988 999999999999943 335889
Q ss_pred ccccCCCCCCCCCCc-ceeeccccccCccCceeec---cCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 222 SDFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMA---TGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+|||+++........ .......||+.|+|||++. ...++.++|||||||++|||++ |.+||...
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 999999875433211 1233467999999999997 4567789999999999999999 99998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=304.96 Aligned_cols=202 Identities=27% Similarity=0.383 Sum_probs=171.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
++|++.+.||+|+||.||+| .+..++..||||.+.... ......+.+|++++..++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 58999999999999999998 455578999999987643 3345568899999999999999999998755
Q ss_pred -----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc--
Q 022575 146 -----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN-- 218 (295)
Q Consensus 146 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-- 218 (295)
.+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSC
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCce
Confidence 6678999999999999999986542 134778889999999999999999988 999999999999987665
Q ss_pred -EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 219 -AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 219 -~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 162 ~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp EEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 9999999998754332 22345799999999999999999999999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=308.99 Aligned_cols=195 Identities=24% Similarity=0.365 Sum_probs=165.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|..... +++.||||.+..... .....+.+|+.++.+++||||+++++++..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 46899999999999999999965431 478899999865432 344567899999999999999999999987
Q ss_pred CCe-----eEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 146 DDH-----RLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 ~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
.+. .|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+|
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~k 221 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLK 221 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEE
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEE
Confidence 665 6999999999999887643 4889999999999999999999988 9999999999999875 999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+++..... ....||+.|+|||++.++ ++.++|||||||++|+|++|.+||...
T Consensus 222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 9999999865332 235799999999998765 488999999999999999999998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.38 Aligned_cols=199 Identities=26% Similarity=0.308 Sum_probs=150.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHH-HHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLE-WLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~-~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||.||+|... .+++.||||.+...... ...+ +..+..++..++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFR---------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GGEEEEEEC------CEEEEEET---------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEe---------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 58999999999999999999654 35889999999765432 2223 3344556788899999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.+..++||||+ ++.+..+..... ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CCcEEEEEecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEEC
Confidence 99999999999 666666655433 4588999999999999999999985 7 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++....... ......||+.|+|||++. ...++.++|||||||++|+|++|.+||..
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 9997653322 122346899999999984 45788999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.49 Aligned_cols=173 Identities=12% Similarity=0.002 Sum_probs=150.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|... .+++.||+|.+..... .....+.+|+.++.+++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT---------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET---------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEec---------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 58999999999999999999544 3589999999976543 23456889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
..+..|+||||+++++|.+++.+. .....+..++.|++.||+|||++| |+||||||+|||++.++.+||+++
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSC
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEec
Confidence 999999999999999999999542 344567889999999999999988 999999999999999999999854
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
| |++| ++.++|||||||++|||++|.+||....
T Consensus 174 ~----------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 174 A----------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp C----------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred c----------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3 3333 6889999999999999999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.03 Aligned_cols=201 Identities=18% Similarity=0.146 Sum_probs=153.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHHHHHHHHHHcccCC-CCcc-----
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLEWLTEIKHLGQLYH-PNLV----- 137 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~h-~ni~----- 137 (295)
.+.|+..++||+|+||.||+|... .+++.||||++...... ....+.+|+.++..++| +|..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~---------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ---------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEec---------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 356788899999999999999544 46889999998744322 24567899999999977 2211
Q ss_pred ----c------------eeeEEEe-----CCeeEEEEeccCCCCHHHHHhhc---cCCCCCCCHHHHHHHHHHHHHHHHH
Q 022575 138 ----K------------LIGYCLE-----DDHRLLVYEFMPKGSLENHLFRR---ASYIQPLSWTIRMKVALGAAKGLAY 193 (295)
Q Consensus 138 ----~------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~ 193 (295)
. +..++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 1 1111111 12357778776 78999998522 1112457778889999999999999
Q ss_pred hhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceee----------ccCcccccc
Q 022575 194 LHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYM----------ATGIFQLVL 263 (295)
Q Consensus 194 lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~ 263 (295)
||+++ |+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ ....++.++
T Consensus 227 LH~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 227 LHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HHHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HHhCC--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 99988 999999999999999999999999998764321 334578 999999999 555788999
Q ss_pred eeeehhHHHHHHhccCChhhee
Q 022575 264 LLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 264 Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||||||++|||++|.+||...
T Consensus 299 DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTT
T ss_pred hHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=263.44 Aligned_cols=177 Identities=21% Similarity=0.265 Sum_probs=149.9
Q ss_pred CCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHH-cccCCCCccceeeEEEe
Q 022575 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL-GQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~h~ni~~l~~~~~~ 145 (295)
++|.+. ++||+|+||.||+|... .+++.||+|.+... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~---------~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNK---------RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEc---------CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 467776 78999999999999543 45889999998643 2445788877 55689999999999987
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCc
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYN 218 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~ 218 (295)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCc
Confidence 6778999999999999999987543 45899999999999999999999988 999999999999988 788
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+||+|||++.... +..++.++|||||||++|+|++|.+||....
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 9999999885421 2457889999999999999999999997653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.15 Aligned_cols=171 Identities=18% Similarity=0.122 Sum_probs=128.5
Q ss_pred CCCcEEEEEEcCccc----------hhhHHHHHHHHHHHccc-CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhc
Q 022575 100 GTGMVIAVKRLNQES----------LQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR 168 (295)
Q Consensus 100 ~~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 168 (295)
..|+.+++|.+.+.. .....++.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.+.
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~ 336 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG 336 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence 358889999986542 12345688999999999 7999999999999999999999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCc
Q 022575 169 ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248 (295)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 248 (295)
+ +++.. .|+.||+.||+|+|++| ||||||||+|||++.++.+||+|||+|+....... .....+||+.|
T Consensus 337 ~----~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~Y 405 (569)
T 4azs_A 337 E----EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFV 405 (569)
T ss_dssp C----CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHH
T ss_pred C----CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhh
Confidence 4 35543 57899999999999988 99999999999999999999999999987543322 23456899999
Q ss_pred cCceeeccCcccccceeeehhHHHHHHhccCChh
Q 022575 249 AAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMC 282 (295)
Q Consensus 249 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf 282 (295)
||||++.+ .+..++|+||+|++++++.++..++
T Consensus 406 mAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 406 FVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHC------------------CCCCTTHHHH
T ss_pred ccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 99999875 5677899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-33 Score=254.75 Aligned_cols=185 Identities=15% Similarity=0.161 Sum_probs=143.7
Q ss_pred CCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--------hHHHHHHHHHHHcccCCCCccceeeE
Q 022575 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
...++||+|+||.||+|... +..+++|........ ...++.+|++++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 44678999999999999433 567888876443221 13357899999999999999966666
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+...+..|+||||+++++|.+++.. +..++.|++.||+|||+++ |+||||||+|||++. .+||+
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEEC
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEE
Confidence 6678888999999999999999865 3578999999999999988 999999999999998 99999
Q ss_pred cccCCCCCCCCCCcc-----eeeccccccCccCceeecc--CcccccceeeehhHHHHHHhccCChh
Q 022575 223 DFGLAKDGPTGSQSH-----VSTRVMGTYGYAAPEYMAT--GIFQLVLLLFTFECSLLHFSLQLPMC 282 (295)
Q Consensus 223 DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~pf 282 (295)
|||+++......... ......||+.|||||++.. ..|+...|+|+..+-.++-+.++.+|
T Consensus 472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999998764322111 1235689999999999986 67888999999999998888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=205.89 Aligned_cols=161 Identities=12% Similarity=0.033 Sum_probs=124.1
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch------------------hhHHHHHHHHH
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------------------QGHLEWLTEIK 126 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~ 126 (295)
.....|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~ 156 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 156 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH
T ss_pred hCCeEEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHH
Confidence 3345677779999999999999965 2488999999965432 12446789999
Q ss_pred HHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecC
Q 022575 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDF 206 (295)
Q Consensus 127 ~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 206 (295)
++.+++ | +++.+++.. +..|+||||+++++|.+ +.. .....++.|++.||.|||++| |+||||
T Consensus 157 ~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g--iiHrDl 219 (282)
T 1zar_A 157 ALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG--IVHGDL 219 (282)
T ss_dssp HHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred HHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC--CEeCCC
Confidence 999998 4 666665543 55799999999999988 421 123468999999999999988 999999
Q ss_pred CCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeecc----------Ccccccceeeeh
Q 022575 207 KTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT----------GIFQLVLLLFTF 268 (295)
Q Consensus 207 kp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Di~sl 268 (295)
||+|||++ ++.+||+|||+|+. +..|+|||++.. ..|...+|+|.+
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999999 99999999999863 445789998763 345556666543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=176.09 Aligned_cols=138 Identities=17% Similarity=0.082 Sum_probs=104.4
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcE--EEEEEcCccchh------------------------hHHHHH
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMV--IAVKRLNQESLQ------------------------GHLEWL 122 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~ 122 (295)
-|.+.+.||+|+||.||+|.... +|.. ||||+++..... ....+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 36788999999999999996521 3778 999987543211 113567
Q ss_pred HHHHHHcccCCCCc--cceeeEEEeCCeeEEEEeccCC-C----CHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 022575 123 TEIKHLGQLYHPNL--VKLIGYCLEDDHRLLVYEFMPK-G----SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLH 195 (295)
Q Consensus 123 ~E~~~l~~l~h~ni--~~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 195 (295)
+|+++|..+.|+++ +.+++. +..+|||||+.+ | +|.+.... .++..+..++.|++.+|.|||
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHH
Confidence 89999999988764 444432 356899999932 3 67665432 123456788999999999999
Q ss_pred -cCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 196 -SDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 196 -~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
++| |+||||||+|||++. .++|+|||+|...
T Consensus 188 ~~~g--ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAE--LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSC--EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCC--EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 877 999999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-20 Score=159.53 Aligned_cols=139 Identities=13% Similarity=0.067 Sum_probs=98.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--------------h--------HHHHHHHH
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--------------G--------HLEWLTEI 125 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~--------~~~~~~E~ 125 (295)
.-|++.+.||+|+||.||+|... .|+.||||+++..... . +....+|.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~ 164 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF 164 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred CEEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence 34899999999999999999532 4889999987532110 0 01123566
Q ss_pred HHHcccCCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeec
Q 022575 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRD 205 (295)
Q Consensus 126 ~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 205 (295)
..|.++.+.++.-..-+... ..+|||||+.|++|.++... .....++.|++.+|.+||++| |||||
T Consensus 165 ~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g--IVHrD 230 (397)
T 4gyi_A 165 AFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG--LIHGD 230 (397)
T ss_dssp HHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred HHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC--CcCCC
Confidence 77777654443222111112 24799999998888654321 123567889999999999988 99999
Q ss_pred CCCCCeEEcCCC----------cEEEccccCCCCC
Q 022575 206 FKTSNILLDLNY----------NAKLSDFGLAKDG 230 (295)
Q Consensus 206 lkp~Nill~~~~----------~~kl~DFG~a~~~ 230 (295)
|||.|||+++++ .+.|+||+-+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.8e-14 Score=120.12 Aligned_cols=143 Identities=13% Similarity=-0.010 Sum_probs=108.2
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~ 145 (295)
...|++...++.|+.+.||++... +..+++|............+.+|+++++.+. +..+.++++++..
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-----------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~ 81 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-----------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence 357888888888889999998421 5689999987532222335678888888884 6788899999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK--------------------------- 198 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--------------------------- 198 (295)
.+..|+||||++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred CCceEEEEEecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 99999999999999998753211 112356778888899999710
Q ss_pred ------------------------------CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 ------------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ------------------------------~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|++|.|||++.+..+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 2389999999999998765567999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.5e-12 Score=108.13 Aligned_cols=136 Identities=17% Similarity=0.036 Sum_probs=93.3
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCC--ccceeeEEEeC
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN--LVKLIGYCLED 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n--i~~l~~~~~~~ 146 (295)
.+.+..+.+.|..+.||++... ++..+++|...... ...+..|+.++..+.+.+ +.+++++....
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3444333345666999998432 35679999876542 224567888888875434 66788888887
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---------------------------- 198 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---------------------------- 198 (295)
+..++||||++|.+|. ... ... ..++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~-------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCCEEEEEecCCcccC--cCc-------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 8899999999998883 211 111 244556666677777532
Q ss_pred ----------------------------CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 ----------------------------AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ----------------------------~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1299999999999998776567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=6.9e-12 Score=109.32 Aligned_cols=140 Identities=14% Similarity=0.189 Sum_probs=101.1
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcC--ccch-hhHHHHHHHHHHHcccC--CCCccceeeEEEeC-
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLN--QESL-QGHLEWLTEIKHLGQLY--HPNLVKLIGYCLED- 146 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~- 146 (295)
.+.|+.|.++.||+.... +..+++|+.. .... .....+.+|.+++..+. +..+++++.++.+.
T Consensus 43 ~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp EEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred EEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 467889999999998532 3568888776 3321 22335668998888886 45688899888766
Q ss_pred --CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 022575 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD--------------------------- 197 (295)
Q Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------------------------- 197 (295)
+..|+||||++|..+.+... ..++......++.+++..|..||+.
T Consensus 112 ~~g~~~~vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ 185 (359)
T ss_dssp TTSSCEEEEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred ccCCeEEEEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence 45799999999877743211 2356777788889999999999962
Q ss_pred -----------------------------CCCeEeecCCCCCeEEcCCCc--EEEccccCCCC
Q 022575 198 -----------------------------KAKVIYRDFKTSNILLDLNYN--AKLSDFGLAKD 229 (295)
Q Consensus 198 -----------------------------~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 229 (295)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.24 E-value=3.5e-12 Score=108.61 Aligned_cols=188 Identities=16% Similarity=0.170 Sum_probs=115.7
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCC--ccceeeEEEeCC--
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPN--LVKLIGYCLEDD-- 147 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--i~~l~~~~~~~~-- 147 (295)
.+.++.|....||+. +..+++|..... .....+.+|.+++..+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 456899999999986 245888886543 23445678998888773 332 445555443332
Q ss_pred -eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 022575 148 -HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD----------------------------- 197 (295)
Q Consensus 148 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----------------------------- 197 (295)
..|+||++++|.+|.+.... .++......++.+++..|..||+.
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS 162 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcccCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence 34899999999888653321 244455555666666666666641
Q ss_pred ---------------------------CCCeEeecCCCCCeEEcC--CCcEEEccccCCCCCCCCCCcc-----------
Q 022575 198 ---------------------------KAKVIYRDFKTSNILLDL--NYNAKLSDFGLAKDGPTGSQSH----------- 237 (295)
Q Consensus 198 ---------------------------~~~ivHrDlkp~Nill~~--~~~~kl~DFG~a~~~~~~~~~~----------- 237 (295)
...++|+|++|.||+++. ...+.|+||+.+.......+..
T Consensus 163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~ 242 (304)
T 3sg8_A 163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGM 242 (304)
T ss_dssp TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCH
T ss_pred ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCH
Confidence 124799999999999988 4567899999886421110000
Q ss_pred -eeeccccccCccC-ceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 238 -VSTRVMGTYGYAA-PEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 238 -~~~~~~gt~~y~a-PE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
....+........ |+... ......++|+++.+++.+.+|.++|..
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 0000000001111 22211 122346899999999999999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=6.5e-08 Score=82.22 Aligned_cols=74 Identities=20% Similarity=0.107 Sum_probs=53.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCC---CccceeeEEE-eCCee
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHP---NLVKLIGYCL-EDDHR 149 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~---ni~~l~~~~~-~~~~~ 149 (295)
+.++.|....||+. +..+++|..... .....+.+|.++|..+.+. .+.+++.+.. ..+..
T Consensus 25 ~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~ 88 (306)
T 3tdw_A 25 ESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP 88 (306)
T ss_dssp EEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred eecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence 46788888899986 455888885322 2344677899999988642 3667777664 34567
Q ss_pred EEEEeccCCCCHHH
Q 022575 150 LLVYEFMPKGSLEN 163 (295)
Q Consensus 150 ~lv~e~~~~g~L~~ 163 (295)
++|||+++|.+|.+
T Consensus 89 ~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 89 FVGYRKVQGQILGE 102 (306)
T ss_dssp EEEEECCCSEECHH
T ss_pred EEEEeccCCeECch
Confidence 89999999988765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.2e-07 Score=78.87 Aligned_cols=134 Identities=17% Similarity=0.085 Sum_probs=87.8
Q ss_pred eeccCCc-EEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEEEE
Q 022575 76 LGEGGFG-CVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLVY 153 (295)
Q Consensus 76 lg~G~~g-~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~ 153 (295)
+..|..| .||+... ...+..+++|.-.... ...+..|...|..+. +--+.+++.++.+.+..|+||
T Consensus 32 ~~~G~S~~~v~rl~~---------~~~~~~~~lk~~~~~~---~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 32 DNVGQSGATIYRLYG---------KPNAPELFLKHGKGSV---ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EECSSSSCEEEEEEC---------CTTCCCEEEEEEETHH---HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCCcCCeEEEEEe---------cCCCeEEEEEECCCCC---HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 4445554 6887632 2235678888765432 334567888887763 344788999999999999999
Q ss_pred eccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 022575 154 EFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------------------------------------ 197 (295)
Q Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------------------------------------ 197 (295)
|+++|.++.+...... .....+..++...|.-||+.
T Consensus 100 e~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp ECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 9999988776543211 01122333334444444421
Q ss_pred --------------------CCCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 198 --------------------KAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 198 --------------------~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999776667999988764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=4e-07 Score=78.92 Aligned_cols=86 Identities=2% Similarity=-0.124 Sum_probs=51.6
Q ss_pred Cee-eccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc---hhhHHHHHHHHHHHcccC-C--CCccceeeEEEeC
Q 022575 74 SVL-GEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES---LQGHLEWLTEIKHLGQLY-H--PNLVKLIGYCLED 146 (295)
Q Consensus 74 ~~l-g~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~ni~~l~~~~~~~ 146 (295)
+.| +.|....+|+....... .....+..+++|...... ......+..|..++..+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456 77888889987432000 000014568888765433 101124457777777763 2 3577888776554
Q ss_pred ---CeeEEEEeccCCCCHH
Q 022575 147 ---DHRLLVYEFMPKGSLE 162 (295)
Q Consensus 147 ---~~~~lv~e~~~~g~L~ 162 (295)
+..|+|||+++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.7e-06 Score=76.07 Aligned_cols=76 Identities=14% Similarity=0.090 Sum_probs=47.1
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-------hhHHHHHHHHHHHcccCC--C-CccceeeE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-------QGHLEWLTEIKHLGQLYH--P-NLVKLIGY 142 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-ni~~l~~~ 142 (295)
.+.||.|..+.||++.... .+..+++|....... ....++..|.+++..+.. + .+.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 3578999999999985331 356799997643211 112244678888776632 3 44566644
Q ss_pred EEeCCeeEEEEeccCCC
Q 022575 143 CLEDDHRLLVYEFMPKG 159 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g 159 (295)
+.+..++|||++++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455578999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=1.6e-05 Score=68.12 Aligned_cols=31 Identities=23% Similarity=0.216 Sum_probs=27.6
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4599999999999998888999999998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=0.00012 Score=62.17 Aligned_cols=74 Identities=18% Similarity=0.104 Sum_probs=56.0
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC---CCCccceeeEEEeCCeeE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY---HPNLVKLIGYCLEDDHRL 150 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~ 150 (295)
+.|+.|....+|+.... +..+++|..... ....+..|.+.|+.|. ...+++++.+....+..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-----------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~ 107 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-----------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSF 107 (312)
T ss_dssp EEECCSSSSEEEEEESS-----------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEE
T ss_pred EEeCCccceeeeEEEEC-----------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceE
Confidence 56888999999997422 567888876543 2345667888887773 367888999888888899
Q ss_pred EEEeccCCCCH
Q 022575 151 LVYEFMPKGSL 161 (295)
Q Consensus 151 lv~e~~~~g~L 161 (295)
+|||++++..+
T Consensus 108 lvme~l~G~~~ 118 (312)
T 3jr1_A 108 LLLEALNKSKN 118 (312)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeccCCCC
Confidence 99999988754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00012 Score=61.29 Aligned_cols=79 Identities=16% Similarity=0.163 Sum_probs=53.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC---CCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH---PNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---~ni~~l~~~~~ 144 (295)
....-.+.+|.|..+.||+....+ |+.|++|+-..........+..|.+.|+.|.- -.+++++.+.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~D----------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELAD----------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETT----------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-
T ss_pred CCeEEEEecCCCCCeEEEEEEECC----------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-
Confidence 344445778999999999986653 78899998765443333346678888877732 2355565542
Q ss_pred eCCeeEEEEeccCCCC
Q 022575 145 EDDHRLLVYEFMPKGS 160 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~ 160 (295)
..++||||+.++.
T Consensus 84 ---~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 ---DRTLAMEWVDERP 96 (288)
T ss_dssp ---TTEEEEECCCCCC
T ss_pred ---CceEEEEeecccC
Confidence 2478999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.0001 Score=65.15 Aligned_cols=30 Identities=13% Similarity=0.210 Sum_probs=26.5
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|++|.|||++.++ ++|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3499999999999998776 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00022 Score=60.05 Aligned_cols=30 Identities=17% Similarity=0.045 Sum_probs=25.3
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 34899999999999 5667899999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00094 Score=56.55 Aligned_cols=30 Identities=27% Similarity=0.225 Sum_probs=25.6
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 489999999999998775568999988753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00097 Score=56.84 Aligned_cols=31 Identities=29% Similarity=0.284 Sum_probs=26.9
Q ss_pred CCeEeecCCCCCeEEcCC----CcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLN----YNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~----~~~kl~DFG~a~~ 229 (295)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999874 6899999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0016 Score=55.25 Aligned_cols=29 Identities=21% Similarity=0.283 Sum_probs=25.1
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3489999999999998 4 899999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0007 Score=58.91 Aligned_cols=149 Identities=15% Similarity=0.151 Sum_probs=78.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv 152 (295)
+.|..|-...+|++...... ......+..+++|+.... ........+|.++++.+. +.-..++++.+. + .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence 45666777889998643210 001123567888886332 122334457888887773 333466766553 3 289
Q ss_pred EeccCCCCHHH--------------HHhh-cc---CCCCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 022575 153 YEFMPKGSLEN--------------HLFR-RA---SYIQPL--SWTIRMKVALGAAK-------------------GLAY 193 (295)
Q Consensus 153 ~e~~~~g~L~~--------------~l~~-~~---~~~~~~--~~~~~~~~~~~i~~-------------------~l~~ 193 (295)
|||++|.+|.. .+.+ +. ...... .+..+..+..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998755431 1110 00 011111 13344444433211 1222
Q ss_pred ----hhc--CCCCeEeecCCCCCeEEcCC----CcEEEccccCCCC
Q 022575 194 ----LHS--DKAKVIYRDFKTSNILLDLN----YNAKLSDFGLAKD 229 (295)
Q Consensus 194 ----lH~--~~~~ivHrDlkp~Nill~~~----~~~kl~DFG~a~~ 229 (295)
|.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 12348999999999999876 7899999988763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00057 Score=60.62 Aligned_cols=80 Identities=15% Similarity=0.046 Sum_probs=46.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv 152 (295)
+.|+.|....||++....... .....+..+++|+...... ...+..|..++..+. +.-..++++.+. + .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 457778888999986542100 0011246788888743211 134456888887774 322366776543 3 389
Q ss_pred EeccCCCCH
Q 022575 153 YEFMPKGSL 161 (295)
Q Consensus 153 ~e~~~~g~L 161 (295)
+||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999976443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0025 Score=56.90 Aligned_cols=74 Identities=16% Similarity=0.098 Sum_probs=43.2
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCc-cceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv 152 (295)
+.|+.|-...+|++.... .+..+++|+...... .......|..++..|...++ .++++.+ .+ .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF--TN--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEE
Confidence 456667778899885431 246788887644321 11111468888887754444 5677765 23 359
Q ss_pred EeccCCCCH
Q 022575 153 YEFMPKGSL 161 (295)
Q Consensus 153 ~e~~~~g~L 161 (295)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0015 Score=56.49 Aligned_cols=82 Identities=10% Similarity=0.039 Sum_probs=41.9
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCC-ccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPN-LVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv 152 (295)
+.|+.|....+|+........ ...+..+..+++|+....... ......|.+++..+...+ ..++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 456677778899885432000 000112357888876543211 112246777777664223 45676544 2 3789
Q ss_pred EeccCCCCH
Q 022575 153 YEFMPKGSL 161 (295)
Q Consensus 153 ~e~~~~g~L 161 (295)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.012 Score=50.28 Aligned_cols=31 Identities=13% Similarity=0.101 Sum_probs=27.2
Q ss_pred CCeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 199 AKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 199 ~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.03 E-value=0.011 Score=46.72 Aligned_cols=103 Identities=14% Similarity=-0.046 Sum_probs=67.1
Q ss_pred CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcce
Q 022575 159 GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238 (295)
Q Consensus 159 g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 238 (295)
-+|.++|+..+ .++++++++.++.|.+.+|.-+-.+.. -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 48999998877 789999999999999998877621110 11223457899999999998774 1110
Q ss_pred eeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCCh
Q 022575 239 STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPM 281 (295)
Q Consensus 239 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p 281 (295)
.....+.|||... ...+.+.-|||||+++|.-+- |.++
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1123466888653 244577889999999998776 4444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.053 Score=47.78 Aligned_cols=81 Identities=12% Similarity=-0.007 Sum_probs=44.7
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv 152 (295)
+.|..|-...+|+........ .....+..+++++..... .......+|.++++.+. +.-..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 456667778899886542110 001125678888865432 11112236777776663 33345666533 2 3789
Q ss_pred EeccCCCCH
Q 022575 153 YEFMPKGSL 161 (295)
Q Consensus 153 ~e~~~~g~L 161 (295)
|||++|.+|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.09 E-value=0.97 Score=35.69 Aligned_cols=84 Identities=8% Similarity=0.035 Sum_probs=57.4
Q ss_pred CCCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCeEeecCCCCC
Q 022575 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLA-YLHSDKAKVIYRDFKTSN 210 (295)
Q Consensus 132 ~h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~ivHrDlkp~N 210 (295)
.||++ --..-.+.+.+.+.++.-+++.=...++ .++....++++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCce
Confidence 57777 3334466777777776653332223332 2566777888888776555 4543 5788899999
Q ss_pred eEEcCCCcEEEccccCCC
Q 022575 211 ILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 211 ill~~~~~~kl~DFG~a~ 228 (295)
|+++.++.+++.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.14 E-value=0.74 Score=36.24 Aligned_cols=91 Identities=10% Similarity=0.077 Sum_probs=61.5
Q ss_pred HHHHHcccCCCCccceeeEEEeCCeeEEEEeccCCC-CHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 022575 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKG-SLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVI 202 (295)
Q Consensus 124 E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 202 (295)
|+.+|.. .||+++.. .+-.+.+.+.+.++.-+.+ ++.. + ..++....+.++.+|+....+++. -+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~----r~ 101 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT----RY 101 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS----SE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC----ce
Confidence 4433333 58888876 4556667666666544322 2222 2 236677888888888876655553 46
Q ss_pred eecCCCCCeEEcCCCcEEEccccCCC
Q 022575 203 YRDFKTSNILLDLNYNAKLSDFGLAK 228 (295)
Q Consensus 203 HrDlkp~Nill~~~~~~kl~DFG~a~ 228 (295)
|--|.|+||+++.++.+++.--|+-.
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETT
T ss_pred EEEEecceEEEcCCCCEEEEEccCcc
Confidence 88899999999999999999887643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.15 E-value=0.19 Score=43.88 Aligned_cols=29 Identities=28% Similarity=0.290 Sum_probs=24.7
Q ss_pred eEeecCCCCCeEE------cCCCcEEEccccCCCC
Q 022575 201 VIYRDFKTSNILL------DLNYNAKLSDFGLAKD 229 (295)
Q Consensus 201 ivHrDlkp~Nill------~~~~~~kl~DFG~a~~ 229 (295)
++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.65 E-value=0.13 Score=45.93 Aligned_cols=63 Identities=8% Similarity=0.040 Sum_probs=18.3
Q ss_pred CCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEE------EEcCccchh--hHHHHHHHHHHHcccCCCCccceeeE
Q 022575 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAV------KRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vai------K~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
.+.+.|| ||.||++.+..+ ..+||+ |........ ....+.+|..++..++|||+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 3456676 999999976531 245777 655433222 22356778888888999999999987
Q ss_pred EEe
Q 022575 143 CLE 145 (295)
Q Consensus 143 ~~~ 145 (295)
-..
T Consensus 213 ~~~ 215 (463)
T 3cxl_A 213 KVH 215 (463)
T ss_dssp EEE
T ss_pred EEe
Confidence 654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 295 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 19/198 (9%)
Query: 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-W 121
++ +F S LG G G VFK +G+V+A K ++ E
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 122 LTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ E++ L + P +V G D + E M GSL+ L + + I
Sbjct: 52 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILG 107
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
KV++ KGL YL K K+++RD K SNIL++ KL DFG++ ++
Sbjct: 108 KVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 162
Query: 242 VMGTYGYAAPEYMATGIF 259
+GT Y +PE + +
Sbjct: 163 FVGTRSYMSPERLQGTHY 180
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-49
Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 16/189 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+G G FG V+KG + + + + + + Q + E+ L
Sbjct: 9 QITVGQRIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ H N++ +GY +V ++ SL +HL + + +A A
Sbjct: 59 RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTA 114
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+ YLH +I+RD K++NI L + K+ DFGLA S SH ++ G+ +
Sbjct: 115 QGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 249 AAPEYMATG 257
APE +
Sbjct: 173 MAPEVIRMQ 181
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-48
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
N VLG G FG V Y ++ G + +AVK L +++ E ++E+K
Sbjct: 38 NLEFGKVLGSGAFGKVMNA----TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------------ 168
+ QL H N+V L+G C L++E+ G L N+L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 169 -ASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
+ L++ + A AKG+ +L ++RD N+L+ K+ DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF 259
+D + S V + APE + GI+
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-47
Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG+G FG V+K T ++ A K ++ +S + +++ EI L
Sbjct: 13 FWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEELEDYMVEIDIL 63
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
HPN+VKL+ +++ ++ EF G+++ + +PL+ + V
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTL 120
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
L YLH K+I+RD K NIL L+ + KL+DFG++ Q +GT +
Sbjct: 121 DALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYW 176
Query: 249 AAPEYMATG 257
APE +
Sbjct: 177 MAPEVVMCE 185
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 3e-47
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 24/233 (10%)
Query: 55 IKSFSFNGLKTATRNF---------RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVI 105
I F+F A R F + + V+G G FG V G + + +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFV 57
Query: 106 AVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENH 164
A+K L + + ++L+E +GQ HPN++ L G + +++ EFM GSL++
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 165 LFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224
L + + + + G A G+ YL ++RD NIL++ N K+SDF
Sbjct: 118 LRQN---DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDF 172
Query: 225 GLAKDGPTGSQSHVSTRV---MGTYGYAAPEYMATGIFQLVLLLFTFECSLLH 274
GL++ + T + APE + F ++++ +
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-47
Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 24/227 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
++ LGEG +G V T +AVK ++ + E EI
Sbjct: 6 DWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L H N+VK G+ E + + L E+ G L + + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQL 112
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
G+ YLH + +RD K N+LLD N K+SDFGLA ++ + ++ GT
Sbjct: 113 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 248 YAAPEYMATG--------IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286
Y APE + ++ ++L L + C Y
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 57/222 (25%), Positives = 85/222 (38%), Gaps = 22/222 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
LG G FG V + Y + M +AVK L + E ++E+K
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI-------------- 172
L L H N+V L+G C L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 173 QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPT 232
L + + AKG+A+L S I+RD NILL K+ DFGLA+D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 233 GSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLH 274
S V + APE + ++ ++++ L
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-46
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 30/231 (12%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEI 125
R + D +G G F V+KG T + +A L L + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 126 KHLGQLYHPNLVKLIGYCLE----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
+ L L HPN+V+ +LV E M G+L+ +L R + + +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLR 115
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILL-DLNYNAKLSDFGLAKDGPTGSQSHVST 240
KGL +LH+ +I+RD K NI + + K+ D GLA ++ +
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 241 RVMGTYGYAAPEYM------ATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285
V+GT + APE + ++ + + S +S +Y
Sbjct: 172 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 3e-46
Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 24/193 (12%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LT 123
+ F +G G FG V+ V+A+K+++ Q + +W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
E++ L +L HPN ++ G L + LV E+ + + + +PL V
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAV 120
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVM 243
GA +GLAYLHS +I+RD K NILL KL DFG A + +
Sbjct: 121 THGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFV 172
Query: 244 GTYGYAAPEYMAT 256
GT + APE +
Sbjct: 173 GTPYWMAPEVILA 185
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-46
Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 17/192 (8%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
++ LG G FG V G +A+K + + S E++ E K
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ L H LV+L G C + ++ E+M G L N+L +++
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDV 109
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
+ + YL S + ++RD N L++ K+SDFGL++ + S
Sbjct: 110 CEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVR 166
Query: 248 YAAPEYMATGIF 259
++ PE + F
Sbjct: 167 WSPPEVLMYSKF 178
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-46
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 17/206 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V+ G+ + +AVK L Q S+ +L E +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGSMSPD-AFLAEANLM 62
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
QL H LV+L + ++ E+M GSL + L + L+ + +A A
Sbjct: 63 KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIA 119
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+A++ I+RD + +NIL+ + K++DFGLA+ ++ +
Sbjct: 120 EGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKW 176
Query: 249 AAPEYMATGIFQLVLLLFTFECSLLH 274
APE + G F + +++F L
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTE 202
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 9e-46
Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 27/212 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
N +GEG FG VF+ ++AVK L +E+ ++ E
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAP----GLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYI--------------- 172
+ + +PN+VKL+G C L++E+M G L L + +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 173 -----QPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227
PLS ++ +A A G+AYL K ++RD T N L+ N K++DFGL+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF 259
++ + + PE + +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHLGQL 131
D LG G FG V +G + +A+K L Q + + E + E + + QL
Sbjct: 14 DIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 132 YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGL 191
+P +V+LIG C + + +LV E G L L + + + + ++ + G+
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGM 122
Query: 192 AYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTYGYAA 250
YL + ++RD N+LL + AK+SDFGL+K G S + + A
Sbjct: 123 KYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 251 PEYMATGIFQLVLLLFTFECSLLH 274
PE + F ++++ ++
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWE 204
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 18/198 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIK 126
++ +G G +G K R G ++ K L+ S+ ++E+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 127 HLGQLYHPNLVKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L +L HPN+V+ ++ + +V E+ G L + + + Q L ++V
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 185 LGAAKGLAYLHS---DKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
L H V++RD K +N+ LD N KL DFGLA+ + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKA 173
Query: 242 VMGTYGYAAPEYMATGIF 259
+GT Y +PE M +
Sbjct: 174 FVGTPYYMSPEQMNRMSY 191
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-44
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 23/193 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
+ + +G+G FG V G G +AVK + ++ +L E
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATAQ--AFLAEASV 53
Query: 128 LGQLYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ QL H NLV+L+G +E+ L +V E+M KGSL ++L R L +K +L
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLD 111
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ + YL + ++RD N+L+ + AK+SDFGL K+ S
Sbjct: 112 VCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPV 164
Query: 247 GYAAPEYMATGIF 259
+ APE + F
Sbjct: 165 KWTAPEALREKKF 177
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 2e-44
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 15/191 (7%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G +G V++G + +AVK L +++++ E+L E +
Sbjct: 18 DITMKHKLGGGQYGEVYEGV---------WKKYSLTVAVKTLKEDTMEVE-EFLKEAAVM 67
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
++ HPNLV+L+G C + ++ EFM G+L ++L Q +S + + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQIS 125
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+ YL I+RD N L+ N+ K++DFGL++ G +
Sbjct: 126 SAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 182
Query: 249 AAPEYMATGIF 259
APE +A F
Sbjct: 183 TAPESLAYNKF 193
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-44
Identities = 49/194 (25%), Positives = 79/194 (40%), Gaps = 22/194 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEI 125
+F LG+G FG V+ + ++A+K L + L + E+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYIT 113
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
A L+Y HS +VI+RD K N+LL K++DFG + P S T + GT
Sbjct: 114 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 246 YGYAAPEYMATGIF 259
Y PE + +
Sbjct: 168 LDYLPPEMIEGRMH 181
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-43
Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 29/205 (14%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKH 127
R +G+G FG V++G G +AVK + + EI
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREERSWFR-EAEIYQ 50
Query: 128 LGQLYHPNLVKLIGYCLEDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
L H N++ I +D+ LV ++ GSL ++L R ++ +K+
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKL 105
Query: 184 ALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNYNAKLSDFGLAK--DGPTGSQ 235
AL A GLA+LH + K + +RD K+ NIL+ N ++D GLA D T +
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 236 SHVSTRVMGTYGYAAPEYMATGIFQ 260
+GT Y APE + I
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINM 190
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-43
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL--EWLTEIKHLGQ 130
D LG G FG V KG+ +AVK L E+ L E L E + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 131 LYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKG 190
L +P +V++IG C E + +LV E G L +L + + + +++ + G
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMG 119
Query: 191 LAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG-SQSHVSTRVMGTYGYA 249
+ YL ++ ++RD N+LL + AK+SDFGL+K + T +
Sbjct: 120 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 250 APEYMATGIFQLVLLLFTFECSLLH 274
APE + F +++F +
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWE 202
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-43
Identities = 54/196 (27%), Positives = 87/196 (44%), Gaps = 16/196 (8%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE 124
++ R LG+G FG V +G D + G + +AVK L + L + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ + L H NL++L G L ++ V E P GSL + L + + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYA 117
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV-STRVM 243
+ A+G+ YL S + I+RD N+LL K+ DFGL + P +V
Sbjct: 118 VQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 244 GTYGYAAPEYMATGIF 259
+ + APE + T F
Sbjct: 176 VPFAWCAPESLKTRTF 191
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-42
Identities = 46/214 (21%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
LG+G FG V++G + +A+K +N+ S++ +E+L E
Sbjct: 21 KITMSRELGQGSFGMVYEGVAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------ASYIQPLSWTIRM 181
+ + ++V+L+G + L++ E M +G L+++L + P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTR 241
++A A G+AYL+++K ++RD N ++ ++ K+ DFG+ +D +
Sbjct: 137 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 242 VMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
+ + +PE + G+F +++F L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-42
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+F + V+G G FGCV+ G + ++ G + AVK LN+ + G + +LTE
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGII 81
Query: 128 LGQLYHPNLVKLIGYCLEDD-HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ HPN++ L+G CL + L+V +M G L N + + + L
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQ 138
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD--GPTGSQSHVSTRVMG 244
AKG+ +L K ++RD N +LD + K++DFGLA+D H T
Sbjct: 139 VAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 245 TYGYAAPEYMATGIFQLVLLLFTFECSLL 273
+ A E + T F +++F L
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLW 225
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-42
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 17/191 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+G G FG V G+ +A+K + E +++ E + +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVM 54
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+L HP LV+L G CLE LV+EFM G L ++L + + + + L
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVC 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
+G+AYL VI+RD N L+ N K+SDFG+ + Q ST +
Sbjct: 112 EGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKW 168
Query: 249 AAPEYMATGIF 259
A+PE + +
Sbjct: 169 ASPEVFSFSRY 179
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKH 127
+ + V+GEG FG V K I + G M A+KR+ + S H ++ E++
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQP 174
L +L HPN++ L+G C + L E+ P G+L + L + S
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
LS + A A+G+ YL + I+RD NIL+ NY AK++DFGL++
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 235 QSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLH 274
+ T + A E + ++ ++++ L
Sbjct: 182 K---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-42
Identities = 48/206 (23%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHL 128
F+ VLG G FG V+KG + P + +A+K L + S + + E L E +
Sbjct: 11 FKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ +P++ +L+G CL +L + + MP G L +++ I + + A
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIA 121
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
KG+ YL ++++RD N+L+ + K++DFGLAK + + + +
Sbjct: 122 KGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 249 AAPEYMATGIFQLVLLLFTFECSLLH 274
A E + I+ ++++ ++
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWE 205
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-41
Identities = 46/197 (23%), Positives = 73/197 (37%), Gaps = 18/197 (9%)
Query: 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLE 120
K +F+ +LGEG F V T A+K L + +
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPY 54
Query: 121 WLTEIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIR 180
E + +L HP VKL +D+ + G L ++ + T
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCT 110
Query: 181 MKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVST 240
L YLH +I+RD K NILL+ + + +++DFG AK S+ +
Sbjct: 111 RFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 241 RVMGTYGYAAPEYMATG 257
+GT Y +PE +
Sbjct: 169 SFVGTAQYVSPELLTEK 185
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-40
Identities = 48/208 (23%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
V+G G FG V+KG + + P +A+K L + ++L E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+GQ H N+++L G + +++ E+M G+L+ L + S + + G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGI 119
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMGTY 246
A G+ YL + ++RD NIL++ N K+SDFGL++ ++ ++
Sbjct: 120 AAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 247 GYAAPEYMATGIFQLVLLLFTFECSLLH 274
+ APE ++ F +++F +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWE 205
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-40
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 25/227 (11%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK 126
+ + +G+G G V+ TG +A++++N + + EI
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
+ + +PN+V + L D +V E++ GSL + + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRE 124
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ L +LHS +VI+RD K+ NILL ++ + KL+DFG + + ++GT
Sbjct: 125 CLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTP 180
Query: 247 GYAAPEYMATG-------IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286
+ APE + I+ L ++ + + P+ LYL
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (355), Expect = 3e-40
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 19/193 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V + TG V K +N EI +
Sbjct: 30 YYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
QL+HP L+ L + +L+ EF+ G L + + +S + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQAC 137
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+GL ++H +++ D K NI+ + + K+ DFGLA T
Sbjct: 138 EGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATA 192
Query: 247 GYAAPEYMATGIF 259
+AAPE +
Sbjct: 193 EFAAPEIVDREPV 205
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-40
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 17/191 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ R + LG+G FG V+ G + +A+K L + +L E + +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVM 66
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+L H LV+L ++ +V E+M KGSL + L + L + +A A
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIA 123
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGY 248
G+AY+ + ++RD + +NIL+ N K++DFGLA+ ++ +
Sbjct: 124 SGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKW 180
Query: 249 AAPEYMATGIF 259
APE G F
Sbjct: 181 TAPEAALYGRF 191
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-40
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 14/207 (6%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKH 127
+GEG FG V +G + +A+K + E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
+ Q HP++VKLIG ++ ++ E G L + L R L + A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQL 117
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
+ LAYL S + ++RD N+L+ N KL DFGL++ S + +++
Sbjct: 118 STALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIK 174
Query: 248 YAAPEYMATGIFQLVLLLFTFECSLLH 274
+ APE + F ++ F +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWE 201
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (350), Expect = 2e-39
Identities = 47/191 (24%), Positives = 69/191 (36%), Gaps = 19/191 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++ LG G FG V + TG A K + EI+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L HP LV L +D+ +++YEFM G L + +S ++
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVC 134
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYN--AKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
KGL ++H ++ D K NI+ + KL DFGL V GT
Sbjct: 135 KGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTA 189
Query: 247 GYAAPEYMATG 257
+AAPE
Sbjct: 190 EFAAPEVAEGK 200
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 3e-39
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 21/221 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKH 127
+ LG G FG V + + + T +AVK L + + H ++E+K
Sbjct: 14 RLKLGKPLGRGAFGQVIEA----DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 128 LGQ-LYHPNLVKLIGYCLEDDHRL-LVYEFMPKGSLENHLFRRASYIQP----------- 174
L +H N+V L+G C + L ++ EF G+L +L + + P
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 175 -LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTG 233
L+ + + AKG+ +L S K I+RD NILL K+ DFGLA+D
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 234 SQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLH 274
+ APE + ++ + +++F L
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (345), Expect = 2e-38
Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 25/195 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTE- 124
+F ++G GGFG V+ + TG + A+K L+++ + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 125 --IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ + P +V + D + + M G L HL + + + +
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRV 242
+ L GL ++H+ V+YRD K +NILLD + + ++SD GLA D
Sbjct: 116 IIL----GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHAS 165
Query: 243 MGTYGYAAPEYMATG 257
+GT+GY APE + G
Sbjct: 166 VGTHGYMAPEVLQKG 180
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-37
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHL-EWLTEIKH 127
LGEG FG V +P +AVK L ++ + L + ++E++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 128 LGQLY-HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRR------------ASYIQP 174
+ + H N++ L+G C +D ++ E+ KG+L +L R + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 175 LSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGS 234
LS + A A+G+ YL S K I+RD N+L+ + K++DFGLA+D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 235 QSHVSTRVMGTYGYAAPEYMATGIF 259
+T + APE + I+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIY 214
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-36
Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 14/193 (7%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEI 125
+ S +GEG +G V + + +A+K+++ Q + + L EI
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
K L + H N++ + + ++ + L++ Q LS
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLY 116
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTRVMG 244
+GL Y+HS A V++RD K SN+LL+ + K+ DFGLA+ P + T +
Sbjct: 117 QILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 245 TYGYAAPEYMATG 257
T Y APE M
Sbjct: 175 TRWYRAPEIMLNS 187
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (321), Expect = 8e-36
Identities = 50/199 (25%), Positives = 77/199 (38%), Gaps = 28/199 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-------- 120
N+ P +LG G V + T AVK ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 121 -WLTEIKHLGQL-YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
L E+ L ++ HPN+++L + LV++ M KG L ++L + LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEK 110
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
K+ + + LH +++RD K NILLD + N KL+DFG +
Sbjct: 111 ETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEK 165
Query: 239 STRVMGTYGYAAPEYMATG 257
V GT Y APE +
Sbjct: 166 LREVCGTPSYLAPEIIECS 184
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-35
Identities = 48/193 (24%), Positives = 75/193 (38%), Gaps = 21/193 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
+F +LG+G FG VF T A+K L ++ + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 126 KHLG-QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
+ L HP L + ++ V E++ G L H+ + A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYA 109
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
GL +LH ++YRD K NILLD + + K++DFG+ K+ G G
Sbjct: 110 AEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCG 165
Query: 245 TYGYAAPEYMATG 257
T Y APE +
Sbjct: 166 TPDYIAPEILLGQ 178
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (313), Expect = 1e-34
Identities = 47/231 (20%), Positives = 90/231 (38%), Gaps = 30/231 (12%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG---HLEWLTEIK 126
+ +LG GG V +AVK L + + +L + E +
Sbjct: 9 YELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRL----LVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+ L HP +V + + +V E++ +L + + P++ ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIE 115
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD-GPTGSQSHVSTR 241
V A + L + H +I+RD K +NI++ K+ DFG+A+ +G+ +
Sbjct: 116 VIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 242 VMGTYGYAAPEYMATG-------IFQLVLLLFTFECSLLHFSLQLPMCVLY 285
V+GT Y +PE ++ L +L+ F+ P+ V Y
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 2e-34
Identities = 46/192 (23%), Positives = 77/192 (40%), Gaps = 22/192 (11%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE-WLTEIKHL 128
+ VLG G F V T ++A+K + +++L+G EI L
Sbjct: 11 YDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
++ HPN+V L H L+ + + G L + + + + ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVL 117
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
+ YLH +++RD K N+L + +SDFGL+K V + GT
Sbjct: 118 DAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGT 172
Query: 246 YGYAAPEYMATG 257
GY APE +A
Sbjct: 173 PGYVAPEVLAQK 184
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-33
Identities = 55/185 (29%), Positives = 81/185 (43%), Gaps = 22/185 (11%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLG 129
LGEG F V+K T ++A+K++ + L EIK L
Sbjct: 5 FLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 130 QLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
+L HPN++ L+ + LV++FM L+ + L +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQ 111
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYA 249
GL YLH +++RD K +N+LLD N KL+DFGLAK GS + T + T Y
Sbjct: 112 GLEYLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYR 167
Query: 250 APEYM 254
APE +
Sbjct: 168 APELL 172
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-33
Identities = 33/193 (17%), Positives = 65/193 (33%), Gaps = 20/193 (10%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+ LG G FG V + + K + + + EI L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
H N++ L + ++++EF+ + + A L+ +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVC 112
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYNA--KLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ L +LHS + + D + NI+ ++ K+ +FG A+ G + +
Sbjct: 113 EALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167
Query: 247 GYAAPEYMATGIF 259
Y APE +
Sbjct: 168 EYYAPEVHQHDVV 180
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 6e-33
Identities = 53/195 (27%), Positives = 80/195 (41%), Gaps = 23/195 (11%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE---SLQGHLEWLTE 124
++F+ LG G FG V G A+K L +E L+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
L + HP ++++ G + ++ +++ LF Q + A
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYA 110
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
L YLHS +IYRD K NILLD N + K++DFG AK P V+ + G
Sbjct: 111 AEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCG 163
Query: 245 TYGYAAPEYMATGIF 259
T Y APE ++T +
Sbjct: 164 TPDYIAPEVVSTKPY 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-32
Identities = 42/197 (21%), Positives = 74/197 (37%), Gaps = 27/197 (13%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLE------WLT 123
++ +LG GGFG V+ G R + +A+K + ++ + E
Sbjct: 6 YQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 124 EIKHLGQL--YHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRM 181
E+ L ++ +++L+ + D +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELAR 113
Query: 182 KVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVST 240
+ + + H V++RD K NIL+DLN KL DFG + V T
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167
Query: 241 RVMGTYGYAAPEYMATG 257
GT Y+ PE++
Sbjct: 168 DFDGTRVYSPPEWIRYH 184
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
NF+ +GEG +G V+K TG V+A+K++ ++ + EI
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L HPN+VKL+ ++ LV+EF+ + + F AS + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQ 110
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+GLA+ HS +V++RD K N+L++ KL+DFGLA+ + + V+ +
Sbjct: 111 LLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLW 167
Query: 247 GYAAPEYMATGIFQLVLLLFTFECSLLHF 275
A + + + +++ C
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEM 196
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-31
Identities = 44/195 (22%), Positives = 73/195 (37%), Gaps = 28/195 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW------LT 123
+ LG G F V K TG+ A K + + +
Sbjct: 12 YDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 124 EIKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKV 183
E+ L ++ HPN++ L +L+ E + G L + L + + L+ +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEF 118
Query: 184 ALGAAKGLAYLHSDKAKVIYRDFKTSNILLD----LNYNAKLSDFGLAKDGPTGSQSHVS 239
G+ YLHS ++ + D K NI+L K+ DFGLA G++
Sbjct: 119 LKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173
Query: 240 TRVMGTYGYAAPEYM 254
+ GT + APE +
Sbjct: 174 KNIFGTPEFVAPEIV 188
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 7e-31
Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 62 GLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW 121
GL A + + + +GEG +G VFK G +A+KR+ ++ + +
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPL 52
Query: 122 -----LTEIKHLGQLYHPNLVKLIGYCL-----EDDHRLLVYEFMPKGSLENHLFRRASY 171
+ ++HL HPN+V+L C + LV+E + +
Sbjct: 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-- 110
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ + +GL +LHS +V++RD K NIL+ + KL+DFGLA+
Sbjct: 111 -PGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR--- 164
Query: 232 TGSQSHVSTRVMGTYGYAAPEYMATGIF 259
S T V+ T Y APE + +
Sbjct: 165 IYSFQMALTSVVVTLWYRAPEVLLQSSY 192
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 42/188 (22%), Positives = 70/188 (37%), Gaps = 29/188 (15%)
Query: 75 VLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIK-HLGQLYH 133
VLG G G V + + T A+K L + E++ H
Sbjct: 19 VLGLGINGKVLQIF---------NKRTQEKFALKMLQDCP-----KARREVELHWRASQC 64
Query: 134 PNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAK 189
P++V+++ L+V E + G L + + R Q + ++ +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGE 122
Query: 190 GLAYLHSDKAKVIYRDFKTSNILLDLNYN---AKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
+ YLHS + +RD K N+L KL+DFG AK+ + + T
Sbjct: 123 AIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTP 177
Query: 247 GYAAPEYM 254
Y APE +
Sbjct: 178 YYVAPEVL 185
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (284), Expect = 2e-30
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 19/191 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ +GEG +G V+K A+ G A+K++ E + EI
Sbjct: 3 KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L H N+VKL +LV+E + + + L L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQ 108
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
G+AY H +V++RD K N+L++ K++DFGLA+ + + ++ +
Sbjct: 109 LLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLW 165
Query: 247 GYAAPEYMATG 257
A M +
Sbjct: 166 YRAPDVLMGSK 176
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-30
Identities = 61/228 (26%), Positives = 89/228 (39%), Gaps = 27/228 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
+F +LG+G FG V TG A+K L +E + E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L HP L L D V E+ G L HL R + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGA 112
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
L YLHS V+YRD K N++LD + + K++DFGL K+G + + GT
Sbjct: 113 EIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 246 YGYAAPEYMATG-------IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286
Y APE + + L ++++ C L F Q + L
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 9e-30
Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 25/193 (12%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
++ V+G G FG V++ +G ++A+K++ Q+ + E++ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAK---------LCDSGELVAIKKVLQDKRFKN----RELQIM 67
Query: 129 GQLYHPNLVKLIGYCLEDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMK 182
+L H N+V+L + + LV +++P+ + Q L
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKL 126
Query: 183 VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQSHVSTR 241
+ LAY+HS + +RD K N+LLD + KL DFG AK G + +
Sbjct: 127 YMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182
Query: 242 VMGTYGYAAPEYM 254
+ Y A
Sbjct: 183 ICSRYYRAPELIF 195
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 6e-29
Identities = 43/233 (18%), Positives = 73/233 (31%), Gaps = 33/233 (14%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+R +G G FG ++ G G +A+K ++ L E K
Sbjct: 9 YRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVKTKHPQLH--IESKIYK 57
Query: 130 QLYHPNLVKLIGYCLED-DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
+ + I +C + D+ ++V E + + F + S + +A
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMI 113
Query: 189 KGLAYLHSDKAKVIYRDFKTSNIL---LDLNYNAKLSDFGLAK-----DGPTGSQSHVST 240
+ Y+HS I+RD K N L + DFGLAK +
Sbjct: 114 SRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 241 RVMGTYGYAAPEYMATG-------IFQLVLLLFTFECSLLHFSLQLPMCVLYL 286
+ GT YA+ + L +L F L +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-29
Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 27/201 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG--HLEWLTEIK 126
+ + +G+G FG VFK TG +A+K++ E+ + + L EIK
Sbjct: 11 KYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 127 HLGQLYHPNLVKLIGYCLE--------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWT 178
L L H N+V LI C LV++F + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLS 117
Query: 179 IRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHV 238
+V GL Y+H +K +++RD K +N+L+ + KL+DFGLA+ S
Sbjct: 118 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 239 S--TRVMGTYGYAAPEYMATG 257
+ T + T Y PE +
Sbjct: 176 NRYTNRVVTLWYRPPELLLGE 196
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (275), Expect = 7e-29
Identities = 39/190 (20%), Positives = 69/190 (36%), Gaps = 28/190 (14%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ LG G + VF+ + VK L + + EIK L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVKKK---KIKREIKIL 83
Query: 129 GQL-YHPNLVKLIGYCLEDDHRL--LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
L PN++ L + R LV+E + + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMY 136
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDL-NYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
K L Y H +++RD K N+++D + +L D+GLA+ G + +
Sbjct: 137 EILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVA 191
Query: 245 TYGYAAPEYM 254
+ + PE +
Sbjct: 192 SRYFKGPELL 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 2e-28
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 23/192 (11%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEW---LTEI 125
F LG G FG V +G A+K L+++ + + L E
Sbjct: 42 QFDRIKTLGTGSFGRVMLVK---------HKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 126 KHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVAL 185
+ L + P LVKL ++ + +V E++ G + +HL R S A
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAA 148
Query: 186 GAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGT 245
YLHS +IYRD K N+L+D +++DFG AK + + GT
Sbjct: 149 QIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 246 YGYAAPEYMATG 257
APE + +
Sbjct: 202 PEALAPEIILSK 213
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (264), Expect = 1e-27
Identities = 34/196 (17%), Positives = 63/196 (32%), Gaps = 26/196 (13%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHL 128
+++ +GEG FG +F+G +A+K + S L E +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRRSDAPQLR--DEYRTY 54
Query: 129 GQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAA 188
L + + Y ++ ++ + SLE+ L + S A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQML 111
Query: 189 KGLAYLHSDKAKVIYRDFKTSNILLDLNYN-----AKLSDFGLAK-----DGPTGSQSHV 238
+ +H ++YRD K N L+ + + DFG+ K
Sbjct: 112 ARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 239 STRVMGTYGYAAPEYM 254
+ GT Y +
Sbjct: 170 KKNLSGTARYMSINTH 185
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-27
Identities = 38/190 (20%), Positives = 72/190 (37%), Gaps = 17/190 (8%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKH 127
+R +G G +G V TG +A+K+L + E++
Sbjct: 20 YRDLQPVGSGAYGAVCSAV---------DGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 128 LGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGA 187
L + H N++ L+ D+ +F + + L +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 188 AKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYG 247
KGL Y+H+ A +I+RD K N+ ++ + K+ DFGLA+ + S ++ V+ +
Sbjct: 131 LKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMTGYVVTRWY 184
Query: 248 YAAPEYMATG 257
A +
Sbjct: 185 RAPEVILNWM 194
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-26
Identities = 46/191 (24%), Positives = 75/191 (39%), Gaps = 19/191 (9%)
Query: 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIK 126
+ +GEG +G VFK T ++A+KR+ + L EI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 127 HLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALG 186
L +L H N+V+L D LV+EF + + I
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQ 109
Query: 187 AAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTY 246
KGL + H V++RD K N+L++ N KL++FGLA+ + + + + T
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTL 165
Query: 247 GYAAPEYMATG 257
Y P+ +
Sbjct: 166 WYRPPDVLFGA 176
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 7e-26
Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 18/206 (8%)
Query: 57 SFSFNGLKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL- 115
+ + + K NF VLG G +G VF + TG + A+K L + ++
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLV------RKISGHDTGKLYAMKVLKKATIV 66
Query: 116 ---QGHLEWLTEIKHLGQLYH-PNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASY 171
+ TE + L + P LV L + L+ +++ G L HL +R
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--- 123
Query: 172 IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231
+ + L +LH K +IYRD K NILLD N + L+DFGL+K+
Sbjct: 124 -ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-F 179
Query: 232 TGSQSHVSTRVMGTYGYAAPEYMATG 257
++ + GT Y AP+ + G
Sbjct: 180 VADETERAYDFCGTIEYMAPDIVRGG 205
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 1e-22
Identities = 41/195 (21%), Positives = 71/195 (36%), Gaps = 29/195 (14%)
Query: 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEI 125
+ ++ +G G G V + +A+K+L++ E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 126 KHLGQLYHPNLVKLIGYCL------EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
+ + H N++ L+ E LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHER 120
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVS 239
+ G+ +LHS +I+RD K SNI++ + K+ DFGLA+ T S +
Sbjct: 121 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175
Query: 240 TRVMGTYGYAAPEYM 254
T + T Y APE +
Sbjct: 176 TPYVVTRYYRAPEVI 190
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 6e-22
Identities = 46/193 (23%), Positives = 78/193 (40%), Gaps = 18/193 (9%)
Query: 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE--SLQGHLEWLTE 124
++ S +G G +G V + TG+ +AVK+L++ S+ E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 125 IKHLGQLYHPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVA 184
++ L + H N++ L+ + L Q L+ +
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 185 LGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMG 244
+GL Y+HS A +I+RD K SN+ ++ + K+ DFGLA+ +V+TR
Sbjct: 128 YQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 245 TYGYAAPEYMATG 257
Y APE M
Sbjct: 183 --WYRAPEIMLNW 193
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.9 bits (206), Expect = 5e-19
Identities = 33/219 (15%), Positives = 69/219 (31%), Gaps = 24/219 (10%)
Query: 70 FRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLG 129
+ LG G F V+ +A+K + + + EIK L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQ 64
Query: 130 QLYHPNLVKLIGYCLEDDHRLL-VYEFMPKGSLENHLFRRASYIQPLSWTIRMK------ 182
++ + K +LL + + + L+ + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 183 -----VALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-YNAKLSDFGLAKDGPTGSQS 236
++ GL Y+H + +I+ D K N+L+++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 237 HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHF 275
T + T Y +PE + + +++ C +
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 3e-15
Identities = 21/170 (12%), Positives = 43/170 (25%), Gaps = 38/170 (22%)
Query: 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----------QGHLEWLT 123
++GEG VF VK G L +
Sbjct: 6 KLMGEGKESAVFN----------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 124 EIKHLGQLYHPNLVKLIGYC----LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTI 179
+ L KL G + ++ E + + +
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVEN 104
Query: 180 RMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229
+V + +A + +++ D N+L+ + DF + +
Sbjct: 105 PDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.93 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.56 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=370.92 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=179.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||+||+|. +..+|+.||||.+........+.+.+|+.++++++||||+++++++.+++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~---------~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEE---------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEE---------ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 479999999999999999994 44568999999998766666677899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+|||||++|+|.+++.+. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhh
Confidence 999999999999999988653 4889999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...
T Consensus 164 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred eeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 87543322 234467999999999999999999999999999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=372.13 Aligned_cols=203 Identities=25% Similarity=0.242 Sum_probs=175.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||+||+|.. ..+++.||||++...... ...++.+|+.++++++||||+++++++.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVN---------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 5799999999999999999954 346899999999765432 345678999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchh
Confidence 9999999999999999999764 35899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+..............+||+.|||||++.+..+ +.++|||||||++|||++|++||...
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 987544333333445689999999999988776 68899999999999999999999654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-55 Score=363.65 Aligned_cols=199 Identities=26% Similarity=0.410 Sum_probs=177.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||+||+|... .+++.||+|++.+... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK---------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEEC---------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 47999999999999999999543 4689999999875433 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+++..|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeeccc
Confidence 9999999999999999999998764 4899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+...... .....||+.|||||++.+..++.++|||||||++|||++|.+||...
T Consensus 151 G~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 151 GWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 9998654322 23467999999999999999999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=368.42 Aligned_cols=203 Identities=24% Similarity=0.307 Sum_probs=176.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||+||+|... .+++.||||++.+... .....+.+|++++++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL---------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET---------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC---------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 47999999999999999999543 4688999999976432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+++..|+|||||++|+|.+++...+ .+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DF 152 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 152 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccc
Confidence 9999999999999999999988764 5899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 9998765443333344568999999999999999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-55 Score=365.45 Aligned_cols=207 Identities=23% Similarity=0.351 Sum_probs=166.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|+. ..+++.||+|.+..... .....+.+|++++++++||||+++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRR---------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEE---------CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 5799999999999999999954 34689999999976643 234567899999999999999999999864
Q ss_pred --CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeEeecCCCCCeEEcCCCcEE
Q 022575 146 --DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDK---AKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~~k 220 (295)
.+.+|+|||||++|+|.+++.+.......+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 45689999999999999999765433356899999999999999999999854 2499999999999999999999
Q ss_pred EccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~ 217 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence 999999986543221 234568999999999999999999999999999999999999999764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=366.80 Aligned_cols=202 Identities=25% Similarity=0.394 Sum_probs=177.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
+.|++.+.||+|+||.||+|... .++..||+|++..........+.+|+++|++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK---------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC---------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 46899999999999999999544 468899999998766666677889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+|||||++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a 157 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVS 157 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhh
Confidence 9999999999999999987654 45899999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeec-----cCcccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMA-----TGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+..... ........||+.|+|||++. ...|+.++|||||||++|||++|.+||...
T Consensus 158 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 158 AKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp EECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 754221 11123467999999999984 456889999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=372.97 Aligned_cols=200 Identities=27% Similarity=0.353 Sum_probs=175.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||+||+|+. ..+++.||+|+++.... ....++.+|+.+|+.++||||+++++++.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSH---------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEE---------TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 46899999999999999999954 34689999999876533 334568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD-KAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
.+..|+||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeC
Confidence 999999999999999999998764 488999999999999999999974 7 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+..... .....+||+.|+|||++.+..|+.++||||+||++|||++|++||...
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999854221 223468999999999999999999999999999999999999999653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=367.87 Aligned_cols=202 Identities=27% Similarity=0.309 Sum_probs=179.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|+. ..+++.||||++++... .....+.+|+.+|++++||||+++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~---------~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVRE---------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 5899999999999999999954 44689999999976533 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+.+|+|||||++|+|.+++.+.+ .+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+||
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred cccccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeec
Confidence 9999999999999999999998764 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
|+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||....
T Consensus 150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 99986543222 2345689999999999999999999999999999999999999997653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=358.38 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=169.0
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc--hhhHHHHHHHHHHHcccCCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES--LQGHLEWLTEIKHLGQLYHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||+||+|.++ ..||||+++... ......+.+|+.++.+++||||++++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 34568999999999999999999643 249999987543 3345678899999999999999999998
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+. .+..++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+
T Consensus 73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~ 146 (276)
T d1uwha_ 73 ST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIG 146 (276)
T ss_dssp EC-SSSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEEC
T ss_pred Ee-ccEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEc
Confidence 64 466899999999999999997654 45899999999999999999999987 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeecc---CcccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+|+...............||+.|||||++.+ +.|+.++|||||||++|||++|.+||...
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 9999987544333333445689999999999864 45899999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=354.66 Aligned_cols=199 Identities=25% Similarity=0.351 Sum_probs=170.7
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
.|++.+.||+|+||+||+|... .++..||+|.+..... .....+.+|+++|++++||||+++++++.+
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~---------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDT---------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEEC---------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 4477789999999999999543 4688999999876532 334568899999999999999999999875
Q ss_pred ---CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc-CCCcEEE
Q 022575 146 ---DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD-LNYNAKL 221 (295)
Q Consensus 146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl 221 (295)
...+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++.+|+||||||+|||++ .++.+||
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl 156 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 156 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEE
Confidence 346799999999999999998763 58899999999999999999999877799999999999996 5789999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+|+..... .....+||+.|||||++.+ .++.++|||||||++|||++|.+||...
T Consensus 157 ~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 157 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 999999854322 2345689999999998865 6999999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-53 Score=367.20 Aligned_cols=201 Identities=23% Similarity=0.267 Sum_probs=179.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|.. ..+|+.||||++........+.+.+|+.+|++++||||+++++++.+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~---------~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTE---------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEE---------TTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4899999999999999999954 3468999999998777666777889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc--CCCcEEEcccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSDFG 225 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~DFG 225 (295)
..|+|||||++|+|.+++.+.. ..+++..+..++.||+.||+|||++| ||||||||+|||++ .++.+||+|||
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecc
Confidence 9999999999999999996543 45899999999999999999999988 99999999999995 46789999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+...... ......||+.|||||++.+..++.++|||||||++|+|++|.+||...
T Consensus 172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 998754332 234468999999999999999999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-53 Score=367.21 Aligned_cols=201 Identities=22% Similarity=0.260 Sum_probs=179.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|.. ..+++.||||++..........+.+|+.+|++++||||+++++++.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVE---------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4799999999999999999954 4468999999998776666667889999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc--CCCcEEEcccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD--LNYNAKLSDFG 225 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~DFG 225 (295)
.+|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||++| ||||||||+||||+ .++.+||+|||
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecc
Confidence 9999999999999999886654 45899999999999999999999988 99999999999997 67899999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 998764432 234467999999999999999999999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-53 Score=362.61 Aligned_cols=200 Identities=25% Similarity=0.328 Sum_probs=161.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-HHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-HLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+.|++.+.||+|+||+||+|+.. .+++.||||.+.+..... ...+.+|+.+|+.++||||+++++++.++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK---------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG 79 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET---------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cceEEEEEEeeccCeEEEEEEEC---------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 57999999999999999999543 468999999997654332 34567899999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEc---CCCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLD---LNYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~D 223 (295)
+..|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||+. .++.+||+|
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEec
Confidence 9999999999999999999765 35899999999999999999999988 99999999999994 578999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|+...... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 99998653322 223467999999999999999999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-52 Score=359.63 Aligned_cols=198 Identities=26% Similarity=0.354 Sum_probs=176.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||+||+|+. ..+|+.||||++.+... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~---------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRS---------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 4799999999999999999954 34689999999975432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..|+|||||+||+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecC
Confidence 9999999999999999999988764 4788888999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+..... ....+||+.|||||++.+..|+.++|||||||++|||++|.+||...
T Consensus 149 G~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 149 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 999875432 23468999999999999999999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-53 Score=359.19 Aligned_cols=204 Identities=25% Similarity=0.355 Sum_probs=176.8
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
...++|++.+.||+|+||+||+|.+.. +++.||||.++... ...+++.+|+++|++++||||+++++++.
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 344689999999999999999996653 58899999997654 34567889999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..++|||||++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccc
Confidence 99999999999999999999976543 56889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhh
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
|+|+....... .......||+.|+|||++.++.|+.++|||||||++|||++|..||.
T Consensus 160 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 160 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99987544322 22333468999999999999999999999999999999999655443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-52 Score=356.16 Aligned_cols=196 Identities=27% Similarity=0.386 Sum_probs=172.2
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.|+..+.||+|+||+||+|+. ..+++.||||.+..... .....+.+|+.+|++++||||+++++++.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARD---------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEE---------CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence 589999999999999999954 34689999999876543 234568899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
++..|+|||||.+|+|..++... ..+++..+..++.||+.||.|||++| ||||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCT
T ss_pred CCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecc
Confidence 99999999999999998776654 35899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeecc---CcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT---GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+.... .....||+.|||||++.+ +.|+.++|||||||++|||++|.+||...
T Consensus 161 ~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 161 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 9986432 223579999999999863 46899999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=352.24 Aligned_cols=200 Identities=23% Similarity=0.274 Sum_probs=176.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccCCCCccceee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
++|++.+.||+|+||+||+|+.. .+|+.||||++++.... ..+.+.+|+.+|++++||||+++++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 80 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK---------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET---------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEEC---------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 57999999999999999999543 46899999998654322 2456889999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC----
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY---- 217 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 217 (295)
++.+.+..|+|||||++|+|.+++.+.+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSC
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCccc
Confidence 9999999999999999999999998763 5899999999999999999999988 99999999999998776
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 49999999998754332 223457999999999999999999999999999999999999999764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-52 Score=353.93 Aligned_cols=208 Identities=23% Similarity=0.330 Sum_probs=167.0
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
++|++.++||+|+||+||+|.+.. .......||||.+..... ....++.+|+++|++++||||+++++++...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKL------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 578889999999999999997653 112345799999876533 3456789999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCccc
Confidence 99999999999999999887654 45899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcce---eeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 227 AKDGPTGSQSHV---STRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 227 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
|+.......... .....||+.|||||++.++.++.++|||||||++|||++ |.+||....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 986543322111 122457999999999999999999999999999999998 899997653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=348.37 Aligned_cols=201 Identities=25% Similarity=0.338 Sum_probs=166.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||.||+|.+.+ +..||||.++... ....++.+|++++++++||||+++++++..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 588999999999999999997642 6689999997654 34567899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred ceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchh
Confidence 9999999999999999987654 45788999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+........ ......||+.|+|||++.+..|+.++|||||||++|||++ |.|||...
T Consensus 149 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 149 RFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred eeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 865443222 2233578999999999999999999999999999999999 56766543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-52 Score=359.54 Aligned_cols=198 Identities=25% Similarity=0.297 Sum_probs=177.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|.. ..+|+.||||++.+... .....+.+|+++|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~---------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKH---------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEE---------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 4799999999999999999954 34689999999875432 23456789999999999999999999999
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+.+..++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DF 185 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeec
Confidence 9999999999999999999998764 4889999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|+..... .....||+.|||||++.+..++.++|||||||++|||++|.+||...
T Consensus 186 G~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 999875432 23467999999999999999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=358.67 Aligned_cols=214 Identities=25% Similarity=0.359 Sum_probs=178.4
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.++||+|+||+||+|..... ........||+|.+..... .....+.+|+.++.++ +||||+++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 346899999999999999999977542 1223456799999865432 3345678999999998 899999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEee
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASY-------------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYR 204 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 204 (295)
.+.+..|+|||||++|+|.++|...... ...+++..++.++.||+.||+|||+++ ||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 9999999999999999999999765321 134788999999999999999999988 9999
Q ss_pred cCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhh
Q 022575 205 DFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCV 283 (295)
Q Consensus 205 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~ 283 (295)
||||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++ |.+||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987554443333445678999999999999999999999999999999997 899997
Q ss_pred ee
Q 022575 284 LY 285 (295)
Q Consensus 284 ~~ 285 (295)
..
T Consensus 269 ~~ 270 (325)
T d1rjba_ 269 GI 270 (325)
T ss_dssp TC
T ss_pred CC
Confidence 65
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=348.80 Aligned_cols=203 Identities=25% Similarity=0.349 Sum_probs=172.9
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
...++|++.+.||+|+||.||+|.++ ++..||||.++... .....+.+|+.++.+++||||+++++++.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 33468999999999999999999765 26789999997654 34557899999999999999999999875
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
++..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+||
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred -cCCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccc
Confidence 4668999999999999998865542 35899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhcc-CChhhe
Q 022575 225 GLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQ-LPMCVL 284 (295)
Q Consensus 225 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~pf~~ 284 (295)
|+|+....... .......||+.|+|||++..+.++.++|||||||++|||++| .|||..
T Consensus 154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99987544322 122345789999999999999999999999999999999995 566554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=346.51 Aligned_cols=205 Identities=23% Similarity=0.314 Sum_probs=173.3
Q ss_pred CCCCCCCe-eeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSV-LGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~-lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|.+.+. ||+|+||.||+|.++.. ..+..||||.++.... ....++.+|+++|.+++||||+++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 46677774 99999999999976531 2466899999976543 345678899999999999999999999865
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
+..|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccch
Confidence 56899999999999999986554 46899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+|+........ .......||+.|+|||++..+.++.++|||||||++|||++ |.+||...
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 99865443322 12233568999999999999999999999999999999998 99999765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-51 Score=357.52 Aligned_cols=199 Identities=26% Similarity=0.342 Sum_probs=171.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---hHHH---HHHHHHHHcccCCCCccceee
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---GHLE---WLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~---~~~E~~~l~~l~h~ni~~l~~ 141 (295)
++|++.++||+|+||.||+|+. ..+|+.||||++.+.... .... ..+|+.+++.++||||+++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~---------~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEE---------CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 5899999999999999999954 446899999998754332 1122 234577888889999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEE
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKL 221 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 221 (295)
++.+.+..|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEE
Confidence 9999999999999999999999998764 4788999999999999999999988 999999999999999999999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+|+...... ....+||+.|+|||++.. ..|+.++|||||||++|||++|++||...
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 9999998654332 234579999999999975 46899999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=350.66 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=175.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHc-ccCCCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLG-QLYHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~-~l~h~ni~~l~~~~ 143 (295)
++|++.++||+|+||+||+|+. ..+++.||||++++... .....+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~---------~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEF---------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE---------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEE---------CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 5799999999999999999954 44689999999975432 23345667777665 68999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcc
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSD 223 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 223 (295)
.+++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~D 146 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIAD 146 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred ccCCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccc
Confidence 99999999999999999999998764 4788999999999999999999988 99999999999999999999999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+++....... ......||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 147 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 147 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 999986543322 233468999999999999999999999999999999999999999754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=349.91 Aligned_cols=200 Identities=17% Similarity=0.193 Sum_probs=176.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.+.||+|+||+||+|.. ..+++.||||.++.... ....+.+|+++|+.++||||+++++++.+++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~---------~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVE---------TSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred cceEEEEEEecCCCeEEEEEEE---------CCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 5899999999999999999954 44689999999987653 3445779999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC--CcEEEcccc
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN--YNAKLSDFG 225 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~DFG 225 (295)
.+|+|||||+||+|.+++...+ ..+++..+..++.||+.||+|||++| |+||||||+|||++.+ ..+||+|||
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccc
Confidence 9999999999999999997654 35899999999999999999999988 9999999999999754 589999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|.+||...
T Consensus 150 ~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred hhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 998654332 233457899999999999999999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=338.96 Aligned_cols=202 Identities=22% Similarity=0.293 Sum_probs=178.4
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|++.++||+|+||+||+|+++ ++..||||.++.... ...++.+|+.++.+++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 68999999999999999999765 367899999986654 3457899999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLS 147 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred ceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhh
Confidence 9999999999999999987654 45788999999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
+........ ......||+.|+|||++.+..++.++|||||||++|||++ |++||....
T Consensus 148 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred eeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 865443322 2234578999999999999999999999999999999998 899998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=342.93 Aligned_cols=198 Identities=26% Similarity=0.308 Sum_probs=166.6
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEeCCeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDDHRLL 151 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~l 151 (295)
+.||+|+||.||+|.++. ..+++.||||.++.... ....++.+|+++|++++||||+++++++.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC-------SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEcc-------CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 479999999999997653 22578899999975432 234578999999999999999999999865 56789
Q ss_pred EEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCCC
Q 022575 152 VYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDGP 231 (295)
Q Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 231 (295)
||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++...
T Consensus 85 vmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcc
Confidence 99999999999999875 35899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 232 TGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
...... ......||+.|||||++.++.++.++|||||||++|||++ |.+||...
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence 433221 2233578999999999999999999999999999999997 89999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-50 Score=341.66 Aligned_cols=203 Identities=21% Similarity=0.295 Sum_probs=168.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|.. ..+++.||||+++.... .....+.+|+++++.++||||+++++++.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARD---------LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence 5799999999999999999954 34689999999976543 23446889999999999999999999998
Q ss_pred eCC----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEE
Q 022575 145 EDD----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAK 220 (295)
Q Consensus 145 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 220 (295)
..+ ..|+||||++|++|.+++...+ .+++..+..++.||+.||+|||++| |+||||||+|||++.++.++
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEE
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccce
Confidence 754 3799999999999999987764 4889999999999999999999988 99999999999999999999
Q ss_pred EccccCCCCCCCCCC-cceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQ-SHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||.+........ .......+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 999999875433222 12234468999999999999999999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=341.17 Aligned_cols=207 Identities=23% Similarity=0.341 Sum_probs=167.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
+.|++.++||+|+||.||+|.++.. .......||||.+...... ...++.+|++++.+++||||+++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4688889999999999999987642 2223467999999765433 345688999999999999999999999999
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+.+++|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999887654 45889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCc-ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhcc-CChhhe
Q 022575 227 AKDGPTGSQS-HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQ-LPMCVL 284 (295)
Q Consensus 227 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~pf~~ 284 (295)
++........ .......||+.|||||++.++.++.++|||||||++|||++| .|||..
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc
Confidence 9865443221 122335689999999999999999999999999999999995 555543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-50 Score=337.83 Aligned_cols=201 Identities=26% Similarity=0.305 Sum_probs=175.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh---------hHHHHHHHHHHHcccC-CCCcc
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ---------GHLEWLTEIKHLGQLY-HPNLV 137 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~ni~ 137 (295)
++|++.+.||+|+||+||+|+.. .+++.||||++++.... ....+.+|+.++++++ ||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~---------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK---------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET---------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEEC---------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 58999999999999999999543 46899999998654321 1235789999999997 99999
Q ss_pred ceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 138 KLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 138 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
++++++.+++..|||||||++|+|.++|...+ .+++..+..++.||+.||+|||++| |+||||||+|||++.++
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDM 147 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTC
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCC
Confidence 99999999999999999999999999998764 5899999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeecc------CcccccceeeehhHHHHHHhccCChhheee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT------GIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|.+||....
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 99999999998754432 2234679999999999863 356789999999999999999999997653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=347.82 Aligned_cols=198 Identities=22% Similarity=0.259 Sum_probs=169.0
Q ss_pred CCCCCC-CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHccc-CCCCccceeeEEEe
Q 022575 68 RNFRPD-SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQL-YHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~ 145 (295)
++|.+. ++||+|+||+||+|+. ..+++.||||+++.. ..+.+|+.++.++ +||||+++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFN---------KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEE---------TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEE---------CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 578876 4699999999999954 346899999998643 2456799887654 89999999999876
Q ss_pred ----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCc
Q 022575 146 ----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYN 218 (295)
Q Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~ 218 (295)
...+|+|||||+||+|.+++.+.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++. ++.
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccc
Confidence 3568999999999999999986543 46899999999999999999999988 999999999999975 567
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+||+|||+|+....... ....+||+.|||||++.+..|+.++|||||||++|+|++|.+||....
T Consensus 153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 99999999986544322 234579999999999999999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=339.20 Aligned_cols=207 Identities=23% Similarity=0.310 Sum_probs=165.8
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||.||+|.+.. ....+..||||.++..... ....+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3589999999999999999997653 2234678999998755433 3456889999999999999999999985
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
++..|+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--
T ss_pred cCeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccch
Confidence 567899999999999999887654 45889999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
+|+........ ......||+.|+|||++.++.++.++|||||||++|||++ |.+||....
T Consensus 154 ~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 154 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred hheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 99865433221 2334568999999999999999999999999999999987 899998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=343.78 Aligned_cols=207 Identities=22% Similarity=0.337 Sum_probs=170.5
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccc-hhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQES-LQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.++||+|+||+||+|.+... .......||+|.+.... .....++.+|+.++++++||||+++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4799999999999999999976531 12234579999886543 23456789999999999999999999999865
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
..++++||+.+++|.+.+.... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 157 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred -CeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecccc
Confidence 5678889999999999887764 56889999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||...
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 987654443333344568999999999999999999999999999999998 88998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=338.98 Aligned_cols=202 Identities=25% Similarity=0.341 Sum_probs=167.0
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.++|++.+.||+|+||.||+|++++ +..||||.++... .....+.+|+.++.+++||||+++++++. .
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~ 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence 4689999999999999999997653 4579999997654 34567899999999999999999999985 5
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccC
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGL 226 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 226 (295)
+..++||||+++|+|..++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred CCeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccch
Confidence 668999999999999999876532 35899999999999999999999988 99999999999999999999999999
Q ss_pred CCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhcc-CChhhee
Q 022575 227 AKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQ-LPMCVLY 285 (295)
Q Consensus 227 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~pf~~~ 285 (295)
++........ ......||+.|+|||++..+.++.++|||||||++|||++| .|||...
T Consensus 160 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 160 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 9865433222 22335789999999999999999999999999999999995 4555443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-50 Score=342.19 Aligned_cols=218 Identities=24% Similarity=0.308 Sum_probs=181.0
Q ss_pred HHHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh-hHHHHHHHHHHHcccCCCCccceee
Q 022575 63 LKTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ-GHLEWLTEIKHLGQLYHPNLVKLIG 141 (295)
Q Consensus 63 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~h~ni~~l~~ 141 (295)
+....++|++.+.||+|+||+||+|++... ....++..||||+++..... ...++.+|+.++++++||||+++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 334456899999999999999999987531 23346789999999765433 3557899999999999999999999
Q ss_pred EEEeCCeeEEEEeccCCCCHHHHHhhccC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCe
Q 022575 142 YCLEDDHRLLVYEFMPKGSLENHLFRRAS--------------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKV 201 (295)
Q Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 201 (295)
++...+..+++|||+++|+|.+++..... ....+++..+..++.|++.||+|||+++ |
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--i 161 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F 161 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--e
Confidence 99999999999999999999999975321 1234788899999999999999999988 9
Q ss_pred EeecCCCCCeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccC-C
Q 022575 202 IYRDFKTSNILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQL-P 280 (295)
Q Consensus 202 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~ 280 (295)
|||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999997543333333334567899999999999999999999999999999999985 7
Q ss_pred hhheee
Q 022575 281 MCVLYL 286 (295)
Q Consensus 281 pf~~~~ 286 (295)
||....
T Consensus 242 p~~~~~ 247 (301)
T d1lufa_ 242 PYYGMA 247 (301)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 887653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=339.99 Aligned_cols=215 Identities=25% Similarity=0.315 Sum_probs=169.6
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGY 142 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~ 142 (295)
...++|++.+.||+|+||.||+|.+... ....+++.||||.++.... .....+.+|...+.++ +|+||+.++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 4456899999999999999999986542 2344678999999976543 3345677888888777 68999999998
Q ss_pred EEeC-CeeEEEEeccCCCCHHHHHhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 022575 143 CLED-DHRLLVYEFMPKGSLENHLFRRAS------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (295)
Q Consensus 143 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 209 (295)
+... +..++|||||++|+|.+++..... ....+++..+..++.||+.||+|||+++ ||||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~ 163 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 163 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence 8665 468999999999999999976532 1234789999999999999999999988 999999999
Q ss_pred CeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhcc-CChhhee
Q 022575 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQ-LPMCVLY 285 (295)
Q Consensus 210 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~pf~~~ 285 (295)
||||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| .+||...
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865444333334456799999999999999999999999999999999986 5788654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=340.66 Aligned_cols=196 Identities=29% Similarity=0.373 Sum_probs=163.3
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhh-----HHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQG-----HLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
.++||+|+||+||+|+ +..+++.||||+++...... ...+.+|+.++++++||||+++++++..++
T Consensus 3 l~~lG~G~fg~Vy~~~---------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEE---------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEE---------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 4689999999999994 44578999999997654322 235789999999999999999999999999
Q ss_pred eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCC
Q 022575 148 HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLA 227 (295)
Q Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 227 (295)
..|+||||+.++++..+.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccc
Confidence 999999999887766655433 45788889999999999999999988 999999999999999999999999999
Q ss_pred CCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 228 KDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+....... .....+||+.|+|||++... .|+.++|||||||++|||++|.+||...
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 87544322 22345799999999998754 6799999999999999999999999653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=333.68 Aligned_cols=206 Identities=27% Similarity=0.404 Sum_probs=166.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch---hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL---QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
++|++.+.||+|+||.||+|.++. .......||||.+++... ....++.+|+.+|++++||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 579999999999999999998763 223456799999876532 33457899999999999999999999996
Q ss_pred eCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccc
Q 022575 145 EDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDF 224 (295)
Q Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DF 224 (295)
+ +..++||||+++|+|.+++..+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCC
T ss_pred e-cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccc
Confidence 5 56789999999999999887765 45899999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCCcc-eeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 225 GLAKDGPTGSQSH-VSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 225 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|+++......... ......|+..|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 9999764443222 2233467889999999999999999999999999999998 89999765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=337.33 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=168.9
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|.. ..+++.||||+++..... ....+.+|+++|++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARN---------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEE---------CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 5899999999999999999954 346889999999765432 24567899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..|+||||+. +++.+++..... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~e~~~-~~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG 147 (298)
T d1gz8a_ 73 ENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFG 147 (298)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ccceeEEEeecC-Cchhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCC
Confidence 999999999995 455555544332 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCc-ccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-FQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|+....... ......||+.|+|||++.... ++.++|||||||++|+|++|++||...
T Consensus 148 ~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 148 LARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp HHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 9976433221 223357999999999987665 578999999999999999999999643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=334.81 Aligned_cols=199 Identities=22% Similarity=0.290 Sum_probs=169.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh------hHHHHHHHHHHHcccC--CCCccce
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ------GHLEWLTEIKHLGQLY--HPNLVKL 139 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--h~ni~~l 139 (295)
++|++.++||+|+||.||+|.. ..+++.||||.+.+.... ...++.+|+.++++++ ||||+++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIR---------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence 5899999999999999999954 346899999998754321 1223568999999986 8999999
Q ss_pred eeEEEeCCeeEEEEeccCC-CCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC-C
Q 022575 140 IGYCLEDDHRLLVYEFMPK-GSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN-Y 217 (295)
Q Consensus 140 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~ 217 (295)
++++.+++..|+||||+.+ +++.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTT
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCC
Confidence 9999999999999999975 5788888765 35889999999999999999999988 9999999999999854 7
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcc-cccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIF-QLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|.+||...
T Consensus 149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 9999999999864332 2334689999999999987665 67899999999999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=330.53 Aligned_cols=197 Identities=27% Similarity=0.379 Sum_probs=164.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEe-
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE- 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~- 145 (295)
.++|++.+.||+|+||.||+|.++ +..||||.++... ..+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 357889999999999999999764 6789999997653 34568899999999999999999998854
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..|+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccc
Confidence 4568999999999999999976532 35789999999999999999999987 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
+++..... .....+|+.|+|||++.++.++.++|||||||++|||++ |++||...
T Consensus 149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 149 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred cceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence 99864332 223468999999999999999999999999999999998 78888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=334.69 Aligned_cols=214 Identities=26% Similarity=0.323 Sum_probs=183.1
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.++||+|+||.||+|.+... .+..++..||||+++.... ....++.+|+.++.++ +||||+++++++
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 346899999999999999999987532 2345788999999976543 3455688999999999 699999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCC
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRAS--------------YIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTS 209 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 209 (295)
.+.+..++|||||++|+|.+++..... ....+++..+..++.||+.||+|||+++ +|||||||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~ 174 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence 999999999999999999999976532 1235888999999999999999999988 999999999
Q ss_pred CeEEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhhee
Q 022575 210 NILLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLY 285 (295)
Q Consensus 210 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~ 285 (295)
|||++.++.+||+|||+++...............||+.|+|||++..+.++.++|||||||++|||++ |.|||...
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997655444444455689999999999999999999999999999999998 77777654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=333.44 Aligned_cols=217 Identities=24% Similarity=0.305 Sum_probs=176.8
Q ss_pred hcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 66 ATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 66 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
..++|++.+.||+|+||.||+|+..... ......+..||||.++.... ....++.+|...+.++ +||||+++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~--~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCC--cccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3468999999999999999999765321 01223457899999976543 3346778899999888 799999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRASY------------IQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
.+++..++||||+++|+|.++|...... ...+++..++.++.||+.||+|||+++ ||||||||+||
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~Ni 166 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 166 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccce
Confidence 9999999999999999999999765321 245899999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhc-cCChhheee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSL-QLPMCVLYL 286 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~ 286 (295)
|++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999986644433333444678999999999999999999999999999999998 789987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=328.24 Aligned_cols=201 Identities=26% Similarity=0.327 Sum_probs=163.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeCC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLEDD 147 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~ 147 (295)
++|.+.+.||+|+||.||+|+++ |+.||||+++..... ......|+..+.+++||||+++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~ 70 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN 70 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence 57888899999999999999754 788999999755422 122234666667889999999999998654
Q ss_pred ----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeEeecCCCCCeEEcCCC
Q 022575 148 ----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSD------KAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 148 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~~ 217 (295)
..|+||||+++|+|.+++++. .+++..++.++.|++.||.|||+. ..+||||||||+||||+.++
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 71 GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred CcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 579999999999999999764 488999999999999999999973 13499999999999999999
Q ss_pred cEEEccccCCCCCCCCCCc--ceeeccccccCccCceeeccC------cccccceeeehhHHHHHHhccCChhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG------IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||+||||++|.+||...
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 9999999999865433221 122346799999999998754 4788999999999999999999887653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=329.90 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=165.5
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHccc---CCCCccceee
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQL---YHPNLVKLIG 141 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l---~h~ni~~l~~ 141 (295)
.++|++.+.||+|+||+||+|.... ..++.||||+++..... ....+.+|+.+|+.+ +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~--------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEEC--------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 4689999999999999999996432 23678999998654322 122345677666555 7999999999
Q ss_pred EEEe-----CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCC
Q 022575 142 YCLE-----DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLN 216 (295)
Q Consensus 142 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 216 (295)
++.. ....+++|||+.++.+........ ..+++..+..++.|++.||+|||+++ ||||||||+|||++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC
Confidence 9864 246799999998776654444333 45889999999999999999999988 9999999999999999
Q ss_pred CcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 217 YNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 217 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+.+||+|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|.+||...
T Consensus 153 ~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 999999999988643322 234568999999999999999999999999999999999999999654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=325.05 Aligned_cols=202 Identities=28% Similarity=0.428 Sum_probs=168.0
Q ss_pred CCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc-chhhHHHHHHHHHHHcccCCCCccceeeEEEe-CCeeE
Q 022575 73 DSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE-SLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLE-DDHRL 150 (295)
Q Consensus 73 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~ 150 (295)
.++||+|+||+||+|.+... ..+...||||.++.. ......++.+|+++|.+++||||+++++++.. ++..+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECC------CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 57899999999999987532 223457999999754 33455678999999999999999999999876 46889
Q ss_pred EEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEccccCCCCC
Q 022575 151 LVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFGLAKDG 230 (295)
Q Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 230 (295)
+|||||++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 9999999999999987654 45678888999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCc--ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 231 PTGSQS--HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 231 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
...... .......||+.|+|||.+..+.++.++||||||+++|||++|..||...
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 443221 1223356899999999999999999999999999999999977666543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=327.98 Aligned_cols=204 Identities=27% Similarity=0.413 Sum_probs=169.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCc--EEEEEEcCccch-hhHHHHHHHHHHHccc-CCCCccceeeEE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGM--VIAVKRLNQESL-QGHLEWLTEIKHLGQL-YHPNLVKLIGYC 143 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~--~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni~~l~~~~ 143 (295)
++|++.++||+|+||+||+|.+.. ++. .||||.+..... ...+.+.+|+++|.++ +||||+++++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 588999999999999999997653 233 578888754432 3445688999999998 799999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCe
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRA------------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNI 211 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 211 (295)
.+.+..++||||+++|+|.++|.... .....+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 158 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceE
Confidence 99999999999999999999997541 22356899999999999999999999988 99999999999
Q ss_pred EEcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccC-Chhhee
Q 022575 212 LLDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQL-PMCVLY 285 (295)
Q Consensus 212 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~pf~~~ 285 (295)
|++.++.+||+|||+++....... .....||+.|+|||.+.++.++.++|||||||++|||++|. +||...
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 999999999999999986433221 22346899999999999999999999999999999999965 677654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=329.43 Aligned_cols=215 Identities=21% Similarity=0.376 Sum_probs=179.2
Q ss_pred HhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEE
Q 022575 65 TATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYC 143 (295)
Q Consensus 65 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~ 143 (295)
...++|++.+.||+|+||.||+|.+... ....++..||||+++.... .....+.+|+.++++++||||+++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 4446899999999999999999976521 1122467899999975433 3445688999999999999999999999
Q ss_pred EeCCeeEEEEeccCCCCHHHHHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 144 LEDDHRLLVYEFMPKGSLENHLFRRA------SYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
...+..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCc
Confidence 99999999999999999999987542 12234688889999999999999999987 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccC-Chhhee
Q 022575 218 NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQL-PMCVLY 285 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~pf~~~ 285 (295)
++||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||++|. +||...
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 99999999998654433322233456899999999999999999999999999999999984 777654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-47 Score=324.29 Aligned_cols=200 Identities=24% Similarity=0.326 Sum_probs=167.8
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchh--hHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQ--GHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.++||+|+||+||+|... +++.||||++...... ....+.+|+.+|++++||||+++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999653 4789999999765432 24578899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..+++|||+.++.+..+.... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG 145 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFG 145 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTT
T ss_pred CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccc
Confidence 99999999999776666555443 45899999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
.|........ ......|++.|+|||.+... .++.++|||||||++|||++|++||...
T Consensus 146 ~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 146 LARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp HHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 9976433221 12334689999999998754 5689999999999999999999999643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.3e-47 Score=320.85 Aligned_cols=202 Identities=19% Similarity=0.156 Sum_probs=171.4
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCC-CCccceeeEEEe
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYH-PNLVKLIGYCLE 145 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~ 145 (295)
.++|++.+.||+|+||+||+|.. ..+++.||||++..... ...+.+|++.+..+.| +|++.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~---------~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTN---------LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEE---------TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 46899999999999999999954 34689999998865432 2245678888888865 899999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC-----CCcEE
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL-----NYNAK 220 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~k 220 (295)
....++||||+ +++|.+++.... ..++...+..++.|++.||+|||++| |+||||||+|||++. ++.+|
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceE
Confidence 99999999999 789999987655 45889999999999999999999988 999999999999964 57899
Q ss_pred EccccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhee
Q 022575 221 LSDFGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 221 l~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++|.+||...
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 9999999865332211 1223467999999999999999999999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=326.84 Aligned_cols=205 Identities=26% Similarity=0.298 Sum_probs=174.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch----hhHHHHHHHHHHHcccCC-CCccceeeE
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL----QGHLEWLTEIKHLGQLYH-PNLVKLIGY 142 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~h-~ni~~l~~~ 142 (295)
++|++.+.||+|+||.||+|+.. .+..+|+.||||.+++... .....+.+|++++++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 57999999999999999999654 2345789999999976532 223456789999999976 899999999
Q ss_pred EEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
+.+.+..+++|||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEES
T ss_pred eccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEe
Confidence 999999999999999999999998774 3678889999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCcceeeccccccCccCceeeccC--cccccceeeehhHHHHHHhccCChhhee
Q 022575 223 DFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG--IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 223 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|||+++........ ......|++.|+|||.+... .++.++|||||||+||+|++|.+||...
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999865433222 23346799999999999754 4678999999999999999999999654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=328.39 Aligned_cols=198 Identities=25% Similarity=0.327 Sum_probs=162.9
Q ss_pred CCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCccceeeEEEeC--
Q 022575 69 NFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNLVKLIGYCLED-- 146 (295)
Q Consensus 69 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-- 146 (295)
+|+..++||+|+||+||+|+.. .+++.||||++...... ..+|+++|++++||||+++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~---------~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC---------DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET---------TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEEC---------CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 6888899999999999999544 46899999999765322 23799999999999999999998653
Q ss_pred ----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEE
Q 022575 147 ----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKL 221 (295)
Q Consensus 147 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl 221 (295)
.++|+|||||+++ +.+.+.........+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEE
T ss_pred cCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeE
Confidence 3578999999654 54444432222356899999999999999999999988 99999999999999775 8999
Q ss_pred ccccCCCCCCCCCCcceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhee
Q 022575 222 SDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 222 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|++||...
T Consensus 165 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 165 CDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp CCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred ecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 9999998654332 2234579999999998875 47899999999999999999999999654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=327.09 Aligned_cols=201 Identities=24% Similarity=0.310 Sum_probs=164.7
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch-hhHHHHHHHHHHHcccCCCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL-QGHLEWLTEIKHLGQLYHPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~ 146 (295)
.+|++.+.||+|+||+||+|.. ..+++.||||++.+... ....++.+|+.+|++++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYD---------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEE---------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCeEEEEEEeeccCeEEEEEEE---------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 5799999999999999999953 44689999999976543 3345678999999999999999999998765
Q ss_pred C----eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEc
Q 022575 147 D----HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLS 222 (295)
Q Consensus 147 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 222 (295)
. ..+++++|+.+|+|.+++... .+++..+..++.||+.||+|||++| ||||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred cccccceEEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEc
Confidence 3 234445566699999999754 4899999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCCc-ceeeccccccCccCceeecc-CcccccceeeehhHHHHHHhccCChhhe
Q 022575 223 DFGLAKDGPTGSQS-HVSTRVMGTYGYAAPEYMAT-GIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 223 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|||+|+........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|++||..
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 99999864332211 11234579999999999854 4678999999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=327.47 Aligned_cols=197 Identities=23% Similarity=0.307 Sum_probs=164.1
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||+||+|.. ..+++.||||+++.... .....+.+|+++|+.++||||+++++++.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVD---------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEE---------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 46899999999999999999954 34689999999976432 23456789999999999999999999998
Q ss_pred eCC------eeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCc
Q 022575 145 EDD------HRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYN 218 (295)
Q Consensus 145 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 218 (295)
..+ .+|+||||+ +.+|..++... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~ 159 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCE 159 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCC
T ss_pred cCccccccceEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccc
Confidence 665 469999999 77888877543 4899999999999999999999988 999999999999999999
Q ss_pred EEEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 219 AKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 219 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
+||+|||+|+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||...
T Consensus 160 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 160 LKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp EEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 999999999865332 2345799999999998864 5689999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=322.39 Aligned_cols=202 Identities=27% Similarity=0.335 Sum_probs=164.1
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|+.. .+++.||||++..... ....++.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~---------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR---------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET---------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 58999999999999999999544 4689999999865533 234567899999999999999999998865
Q ss_pred --------CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC
Q 022575 146 --------DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY 217 (295)
Q Consensus 146 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 217 (295)
.+..|+||||+.++.+....... ..+++..+..++.|++.||+|||++| |+||||||+|||++.++
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDG 154 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTS
T ss_pred ccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCC
Confidence 34679999999776655443332 45888999999999999999999988 99999999999999999
Q ss_pred cEEEccccCCCCCCCCCCc--ceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhe
Q 022575 218 NAKLSDFGLAKDGPTGSQS--HVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 218 ~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|++||..
T Consensus 155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 9999999999765432211 122335799999999998765 689999999999999999999999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-46 Score=316.53 Aligned_cols=202 Identities=22% Similarity=0.184 Sum_probs=167.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccCCCCc-cceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLYHPNL-VKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-~~l~~~~~~~ 146 (295)
++|++.+.||+|+||.||+|+.. .+++.||||++...... .++..|+++++.++|+|+ +.+..++.+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~---------~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI---------AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET---------TTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC---------CCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 57999999999999999999543 46889999988765332 346789999999987665 5556667788
Q ss_pred CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcC---CCcEEEcc
Q 022575 147 DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDL---NYNAKLSD 223 (295)
Q Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~D 223 (295)
+..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++| |+||||||+|||++. +..+||+|
T Consensus 76 ~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~D 149 (299)
T d1ckia_ 76 DYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIID 149 (299)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECC
T ss_pred CEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeec
Confidence 8999999999 677877776544 45899999999999999999999988 999999999999853 55799999
Q ss_pred ccCCCCCCCCCCc-----ceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 224 FGLAKDGPTGSQS-----HVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 224 FG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
||+|+........ .......||+.|||||++.+..++.++|||||||++|||++|.+||....
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 9999865433221 12334679999999999999999999999999999999999999997653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=320.85 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=166.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeC
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLED 146 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~ 146 (295)
++|++.+.||+|+||+||+|+. ..+++.||||+++... ..++.+|+.+|..++ ||||+++++++...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~---------~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAIN---------ITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEE---------CCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 5899999999999999999953 4468999999997654 346678999999995 99999999999854
Q ss_pred --CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCC-cEEEcc
Q 022575 147 --DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNY-NAKLSD 223 (295)
Q Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~D 223 (295)
...++|||||.+++|.++. ..+++..+..++.||+.||+|||++| ||||||||+|||++.++ .+||+|
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecc
Confidence 5689999999999987654 34889999999999999999999988 99999999999998655 689999
Q ss_pred ccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 224 FGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 224 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
||+|+....... .....||+.|+|||.+.+. .++.++||||+||++|||++|.+||...
T Consensus 174 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 174 WGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp GGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 999986544322 2345789999999998865 5799999999999999999999998653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=311.43 Aligned_cols=199 Identities=25% Similarity=0.303 Sum_probs=171.6
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.+.||+|+||+||+|+. ..+++.||||+++.... ....++.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~---------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKN---------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEE---------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEE---------CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 4799999999999999999954 34689999999865432 335578899999999999999999999999
Q ss_pred CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcEEEcccc
Q 022575 146 DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNAKLSDFG 225 (295)
Q Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~DFG 225 (295)
.+..+++++++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG 146 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFG 146 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecc
Confidence 99999999999998888887655 35788999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCCCcceeeccccccCccCceeeccCc-ccccceeeehhHHHHHHhccCChhh
Q 022575 226 LAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGI-FQLVLLLFTFECSLLHFSLQLPMCV 283 (295)
Q Consensus 226 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~ 283 (295)
.|+........ .....+++.|+|||++.... ++.++|||||||++|||++|..||.
T Consensus 147 ~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 147 LARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp TCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred hhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 99875443322 22346788999999988664 6899999999999999999998864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=318.27 Aligned_cols=196 Identities=21% Similarity=0.252 Sum_probs=158.3
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEEe
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCLE 145 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~ 145 (295)
++|++.++||+|+||+||+|+. ..+++.||||++..... ....++.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d---------~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYD---------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEE---------TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEE---------CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 5899999999999999999954 44699999999975432 334467899999999999999999999964
Q ss_pred C------CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 146 D------DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 146 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
. ...|+|||||.+ ++.+.+. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCE
T ss_pred ccccccCceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccce
Confidence 3 678999999965 5555543 34789999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhhe
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVL 284 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 284 (295)
|++|||+++...... ......||+.|+|||++.+..++.++||||+||++++|++|++||..
T Consensus 159 kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp EECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 999999988654332 23345799999999999999999999999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=318.19 Aligned_cols=198 Identities=22% Similarity=0.312 Sum_probs=164.7
Q ss_pred cCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch--hhHHHHHHHHHHHcccCCCCccceeeEEE
Q 022575 67 TRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL--QGHLEWLTEIKHLGQLYHPNLVKLIGYCL 144 (295)
Q Consensus 67 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~ 144 (295)
.++|++.+.||+|+||+||+|+. ..+++.||||++.+... ....++.+|+++|++++||||+++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~---------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFD---------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEE---------TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEE---------CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 36899999999999999999954 34689999999976532 33456789999999999999999999986
Q ss_pred eC-----CeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeEEcCCCcE
Q 022575 145 ED-----DHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNILLDLNYNA 219 (295)
Q Consensus 145 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 219 (295)
.. ...+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~ 160 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 160 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred eccccccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccc
Confidence 43 3346667778899999998653 4899999999999999999999988 9999999999999999999
Q ss_pred EEccccCCCCCCCCCCcceeeccccccCccCceeeccC-cccccceeeehhHHHHHHhccCChhhee
Q 022575 220 KLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATG-IFQLVLLLFTFECSLLHFSLQLPMCVLY 285 (295)
Q Consensus 220 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~ 285 (295)
|++|||++..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|.+||...
T Consensus 161 kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 161 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp EECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 9999999976432 22345799999999987765 4689999999999999999999999653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-39 Score=281.74 Aligned_cols=201 Identities=18% Similarity=0.160 Sum_probs=157.2
Q ss_pred CCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-----------CCCc
Q 022575 68 RNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-----------HPNL 136 (295)
Q Consensus 68 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni 136 (295)
.+|++.++||+|+||+||+|+. ..+++.||||+++..... ...+.+|+++++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~---------~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKD---------MVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEE---------TTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEE---------CCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 4699999999999999999954 446899999999866432 345567888877764 5789
Q ss_pred cceeeEEEe--CCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCeEeecCCCCCeEE
Q 022575 137 VKLIGYCLE--DDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHS-DKAKVIYRDFKTSNILL 213 (295)
Q Consensus 137 ~~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~ivHrDlkp~Nill 213 (295)
+++++++.. ....+++++++..+.......... ....+++..+..++.||+.||+|||+ .| |+||||||+|||+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll 159 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLM 159 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeee
Confidence 999988764 356677777765544333332221 22567889999999999999999997 66 9999999999999
Q ss_pred cCCC------cEEEccccCCCCCCCCCCcceeeccccccCccCceeeccCcccccceeeehhHHHHHHhccCChhheee
Q 022575 214 DLNY------NAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAPEYMATGIFQLVLLLFTFECSLLHFSLQLPMCVLYL 286 (295)
Q Consensus 214 ~~~~------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 286 (295)
+.++ .++++|||.+...... ....+||+.|+|||++....++.++|+||+||++++|++|++||....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 7665 3999999999754322 234579999999999999999999999999999999999999997653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=8.9e-28 Score=189.96 Aligned_cols=165 Identities=13% Similarity=0.048 Sum_probs=117.7
Q ss_pred CCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccch------------------hhHHHHHHHHHHHcccC
Q 022575 71 RPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESL------------------QGHLEWLTEIKHLGQLY 132 (295)
Q Consensus 71 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 132 (295)
.+.++||+|+||.||+|... +|+.||||+++.... ........|...+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 45689999999999999643 378999998753211 01123456888999999
Q ss_pred CCCccceeeEEEeCCeeEEEEeccCCCCHHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeEeecCCCCCeE
Q 022575 133 HPNLVKLIGYCLEDDHRLLVYEFMPKGSLENHLFRRASYIQPLSWTIRMKVALGAAKGLAYLHSDKAKVIYRDFKTSNIL 212 (295)
Q Consensus 133 h~ni~~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 212 (295)
|++++..+++. ..+++|||+++..+.+ ++......++.|++.+|.|||++| |+||||||+|||
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NIL 135 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVL 135 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhhee
Confidence 99999987653 2379999998765432 233345678899999999999988 999999999999
Q ss_pred EcCCCcEEEccccCCCCCCCCCCcceeeccccccCccCc--ee---eccCcccccceeeehhHHHH
Q 022575 213 LDLNYNAKLSDFGLAKDGPTGSQSHVSTRVMGTYGYAAP--EY---MATGIFQLVLLLFTFECSLL 273 (295)
Q Consensus 213 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~Di~slG~~l~ 273 (295)
++++ .++|+|||.|+....... ..|... +. .....|+.++|+||+.--+.
T Consensus 136 v~~~-~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp EETT-EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred eeCC-CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9865 599999999976432211 111111 00 11357889999999875544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.88 E-value=5.9e-09 Score=84.46 Aligned_cols=91 Identities=11% Similarity=-0.058 Sum_probs=61.5
Q ss_pred HHhcCCCCCCCeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeE
Q 022575 64 KTATRNFRPDSVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGY 142 (295)
Q Consensus 64 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~ 142 (295)
......|++.+..+-++.+.||+.... +..+++|+...........+.+|...+..+. +--+.+++.+
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~~-----------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~ 78 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-----------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF 78 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEECS-----------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEeC-----------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE
Confidence 344456766665544555789987432 5567888876554433334557777766653 4446788888
Q ss_pred EEeCCeeEEEEeccCCCCHHHHH
Q 022575 143 CLEDDHRLLVYEFMPKGSLENHL 165 (295)
Q Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l 165 (295)
...++..++||++++|.++.+..
T Consensus 79 ~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 79 ERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEETTEEEEEEECCSSEEHHHHT
T ss_pred EecCCceEEEEEecccccccccc
Confidence 88889999999999888775543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=2.5e-06 Score=68.09 Aligned_cols=73 Identities=21% Similarity=0.117 Sum_probs=48.1
Q ss_pred eeccC-CcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC--CCCccceeeEEEeCCeeEEE
Q 022575 76 LGEGG-FGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY--HPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 76 lg~G~-~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv 152 (295)
+..|. -+.||+.... .+..+++|........ .+..|...++.+. .-.+.+++.+..+.+..++|
T Consensus 18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 33444 3678987433 3556888887655433 2345666665553 33467888888888889999
Q ss_pred EeccCCCCH
Q 022575 153 YEFMPKGSL 161 (295)
Q Consensus 153 ~e~~~~g~L 161 (295)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999987655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=9.5e-06 Score=69.14 Aligned_cols=76 Identities=13% Similarity=0.052 Sum_probs=45.3
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCcc------ch-hhHHHHHHHHHHHcccC---CCCccceeeEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQE------SL-QGHLEWLTEIKHLGQLY---HPNLVKLIGYC 143 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~------~~-~~~~~~~~E~~~l~~l~---h~ni~~l~~~~ 143 (295)
+.||.|....||++... ..++.+++|.-... .. ....+...|.+.|..+. ...+++++.+
T Consensus 32 ~eig~G~~N~vfrV~~~---------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~- 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQ---------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS- 101 (392)
T ss_dssp EECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred EEeCCCceEeEEEEEeC---------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-
Confidence 46899999999998432 24677889864321 11 11223345776666552 2446666654
Q ss_pred EeCCeeEEEEeccCCCC
Q 022575 144 LEDDHRLLVYEFMPKGS 160 (295)
Q Consensus 144 ~~~~~~~lv~e~~~~g~ 160 (295)
+.+..++|||++.+..
T Consensus 102 -d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 102 -DTEMAVTVMEDLSHLK 117 (392)
T ss_dssp -ETTTTEEEECCCTTSE
T ss_pred -cCCCCEEEEeccCCcc
Confidence 4556789999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00077 Score=55.34 Aligned_cols=28 Identities=21% Similarity=0.218 Sum_probs=23.4
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
.+||+|+.+.|||++++ ..++||+.|..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 48999999999999743 46899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.93 E-value=0.0015 Score=55.05 Aligned_cols=80 Identities=15% Similarity=0.047 Sum_probs=48.0
Q ss_pred CeeeccCCcEEEEEEecCCCcCCCCCCCCcEEEEEEcCccchhhHHHHHHHHHHHcccC-CCCccceeeEEEeCCeeEEE
Q 022575 74 SVLGEGGFGCVFKGWIDEHTYAPARPGTGMVIAVKRLNQESLQGHLEWLTEIKHLGQLY-HPNLVKLIGYCLEDDHRLLV 152 (295)
Q Consensus 74 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv 152 (295)
+.|+-|---.+|++...+... ........|.+++..... ......+|..+++.+. +.-..++++++. + .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence 467667778899987665321 112234556777654222 2223457888887774 444457777663 2 688
Q ss_pred EeccCCCCH
Q 022575 153 YEFMPKGSL 161 (295)
Q Consensus 153 ~e~~~~g~L 161 (295)
+||++|.+|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999976443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.56 E-value=0.033 Score=44.76 Aligned_cols=30 Identities=27% Similarity=0.225 Sum_probs=26.5
Q ss_pred CeEeecCCCCCeEEcCCCcEEEccccCCCC
Q 022575 200 KVIYRDFKTSNILLDLNYNAKLSDFGLAKD 229 (295)
Q Consensus 200 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 229 (295)
++||+|+.++||+++.+...-|+||+.|..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999887678999998853
|